data_2lrs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lrs _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.456 ' N ' HD12 ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.838 0.352 . . . . 1.42 110.855 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 23' ' ' TRP . 35.4 t -68.29 -40.92 81.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.412 0.625 . . . . 1.98 109.775 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.2 tp -62.22 -50.03 73.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.095 -0.957 . . . . 1.77 110.219 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -60.18 -36.81 78.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.966 -1.015 . . . . 4.47 111.635 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt -73.3 -3.25 25.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.394 0.616 . . . . 1.67 111.646 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 64.95 43.63 3.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.396 -1.274 . . . . 2.37 110.648 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.467 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 19.1 m0 -105.14 162.79 18.67 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.742 -0.663 . . . . 0.4 109.426 174.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 34.4 Cg_endo -67.92 -178.8 1.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.073 1.849 . . . . 0.6 110.75 171.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.456 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.7 mmt -80.66 127.89 73.88 Favored Pre-proline 0 C--N 1.322 -0.596 0 O-C-N 121.984 -0.447 . . . . 1.56 109.892 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 22.0 Cg_exo -63.4 167.99 12.05 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.947 2.431 . . . . 0.68 113.462 -174.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.5 t -86.6 140.37 29.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.952 -1.022 . . . . 1.02 109.979 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.463 ' CD1' ' HZ ' ' A' ' 44' ' ' PHE . 69.4 m-85 -145.57 110.99 5.35 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.566 -0.531 . . . . 0.87 109.566 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.487 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 72.7 ttt180 -158.68 130.37 6.56 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 110.359 -0.237 . . . . 4.22 110.359 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 70.0 m -64.23 124.49 21.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.339 -0.392 . . . . 2.19 110.766 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -82.53 -32.59 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.248 0.547 . . . . 1.87 110.362 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.8 tttp . . . . . 0 C--N 1.319 -0.754 0 CA-C-N 115.568 -0.742 . . . . 2.76 109.475 174.379 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 107.726 -1.213 . . . . 4.07 107.726 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -110.57 131.65 54.87 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.103 0.477 . . . . 1.16 110.387 -172.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.0 m -120.01 130.99 54.99 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.876 -1.157 . . . . 1.08 107.876 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.711 ' CZ ' HG23 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -137.94 151.79 48.33 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.642 -0.503 . . . . 0.21 109.642 -173.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -125.47 136.47 9.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.232 -0.508 . . . . 0.2 111.987 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.711 HG23 ' CZ ' ' A' ' 44' ' ' PHE . 1.3 t -107.72 154.41 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 117.14 0.47 . . . . 1.45 109.856 -175.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.556 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 10.9 ptt180 -149.51 145.23 26.75 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.681 -0.859 . . . . 3.01 108.681 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 26' ' ' PRO . 61.0 t -125.5 155.85 34.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.355 -0.384 . . . . 1.07 110.394 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -95.12 83.87 3.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.601 0.715 . . . . 1.81 110.37 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.442 HG23 ' CZ2' ' A' ' 23' ' ' TRP . 30.1 p -72.92 103.08 3.62 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.423 -1.262 . . . . 1.08 108.944 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.9 t -46.06 -32.97 3.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.654 -0.703 . . . . 1.72 112.858 -170.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -72.31 -22.57 61.16 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.753 0.649 . . . . 1.3 112.753 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -134.56 -45.69 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.022 -0.424 . . . . 4.21 111.279 -175.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 126.64 -154.34 19.14 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.914 -0.584 . . . . 0.24 112.343 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.556 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 7.1 m95 -49.22 120.28 3.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.97 0.453 . . . . 0.47 110.882 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 42.8 p -70.33 172.99 7.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.647 -0.706 . . . . 1.07 111.418 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -61.05 131.84 51.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.883 -0.784 . . . . 1.84 108.883 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -64.64 114.96 4.76 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.342 0.591 . . . . 1.0 109.749 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 59.8 m -92.21 97.42 10.89 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.095 -0.957 . . . . 0.44 110.258 -175.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.66 126.22 38.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.647 -0.706 . . . . 1.49 110.361 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.22 -170.99 47.82 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.47 -0.787 . . . . 0.24 111.727 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.595 ' O ' ' HG2' ' A' ' 64' ' ' MET . 41.4 mt-10 -88.36 152.07 49.45 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 110.281 -0.266 . . . . 1.37 110.281 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.12 107.91 0.32 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.643 2.229 . . . . 0.79 111.256 172.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.595 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 95.8 mmm -110.4 147.23 35.93 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.202 -0.454 . . . . 1.4 110.482 -173.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.24 4.36 7.06 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.739 2.292 . . . . 0.37 113.765 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.428 ' HB2' ' HG3' ' A' ' 69' ' ' LYS . 26.9 m -147.53 137.15 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.742 -0.466 . . . . 1.63 109.742 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.3 m -65.29 -28.77 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.178 -0.465 . . . . 1.88 112.046 -171.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -71.19 -36.16 71.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.4 -0.364 . . . . 3.34 110.454 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HG3' ' HB2' ' A' ' 66' ' ' SER . 46.9 mtpt -74.47 -28.33 60.98 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.764 -0.458 . . . . 1.91 109.764 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.49 -59.03 6.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.831 -0.622 . . . . 1.07 110.623 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.619 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 56.8 mttm -53.6 -58.59 6.64 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.086 -0.506 . . . . 2.9 111.471 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.581 ' O ' HG22 ' A' ' 76' ' ' VAL . 29.6 t70 -57.69 -42.37 83.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.656 -0.702 . . . . 2.01 112.718 -173.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 m -70.31 -36.63 74.43 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 121.006 -0.278 . . . . 1.8 111.418 -175.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.417 ' HB1' ' CE2' ' A' ' 44' ' ' PHE . . . -67.36 -42.89 82.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.613 0.721 . . . . 1.07 109.541 174.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.636 ' O ' ' HG ' ' A' ' 79' ' ' LEU . . . -54.23 -34.67 61.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.48 -1.236 . . . . 1.01 111.533 176.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 72' ' ' ASP . 98.3 t -64.56 -34.79 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.007 0.432 . . . . 1.53 110.7 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.3 mt -74.6 -33.07 62.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.818 0.818 . . . . 1.12 109.194 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 75' ' ' ALA . 26.5 tp -64.1 -37.31 86.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.547 -1.206 . . . . 1.44 110.272 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 20.8 mt -60.66 -28.27 68.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.233 -0.894 . . . . 2.23 110.835 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -72.98 -36.69 67.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.042 0.448 . . . . 2.13 110.027 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.2 tt -66.86 -46.22 75.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.645 0.735 . . . . 1.84 109.052 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.8 mp -70.61 -11.35 60.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.915 -1.039 . . . . 1.82 112.051 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.7 t30 . . . . . 0 C--N 1.321 -0.639 0 CA-C-O 121.592 0.71 . . . . 2.08 109.65 176.568 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 17' ' ' ILE . 2.5 mp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.787 0.327 . . . . 1.42 110.72 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.401 ' SG ' HG12 ' A' ' 48' ' ' VAL . 34.4 t -69.3 -42.11 75.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.312 0.577 . . . . 1.98 109.824 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.3 tp -61.8 -49.31 76.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.309 -0.859 . . . . 1.77 110.398 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -63.97 -31.44 72.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.799 -1.091 . . . . 4.47 111.395 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.436 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 27.7 mmmt -74.31 3.11 7.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.362 -0.381 . . . . 1.67 111.459 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 67.69 27.95 7.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.306 -0.861 . . . . 2.37 110.25 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -94.65 160.2 31.93 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.389 -0.823 . . . . 0.4 109.429 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.49 -169.53 0.43 Allowed 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.178 1.919 . . . . 0.6 111.554 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.455 ' HE3' ' HA ' ' A' ' 25' ' ' MET . 9.3 mmt -78.28 134.63 62.59 Favored Pre-proline 0 C--N 1.324 -0.542 0 O-C-N 122.163 -0.336 . . . . 1.56 110.649 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.62 156.69 64.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.648 2.232 . . . . 0.68 112.042 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.429 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 12.9 t -89.32 142.6 27.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.899 -0.591 . . . . 1.02 110.082 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.47 ' CD2' ' CZ ' ' A' ' 44' ' ' PHE . 62.6 m-85 -142.21 111.98 6.78 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.308 -0.627 . . . . 0.87 109.308 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.55 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 33.7 ttm180 -163.03 122.69 2.21 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.473 -0.566 . . . . 4.22 109.473 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 73.8 m -61.77 131.33 49.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.196 0.522 . . . . 2.19 111.833 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.408 ' H ' ' HA ' ' A' ' 44' ' ' PHE . 27.2 m -82.98 -30.74 8.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.372 -0.831 . . . . 1.87 110.357 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.7 tttp . . . . . 0 C--N 1.317 -0.839 0 CA-C-N 115.539 -0.755 . . . . 2.76 110.125 174.289 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 . . . . . 0 N--CA 1.445 -0.677 0 N-CA-C 107.084 -1.45 . . . . 4.07 107.084 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -109.47 134.27 52.08 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.253 0.549 . . . . 1.16 110.45 -169.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.8 m -123.24 127.08 48.09 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.02 -1.104 . . . . 1.08 108.02 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.666 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -138.47 154.4 48.83 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.789 -0.448 . . . . 0.21 109.789 -171.045 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.421 ' CA ' HD12 ' A' ' 60' ' ' ILE . . . -127.41 137.39 9.83 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.209 -0.52 . . . . 0.2 111.923 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.666 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.3 t -107.33 153.98 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 N-CA-C 108.853 -0.795 . . . . 1.45 108.853 -176.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.548 ' O ' ' HZ3' ' A' ' 55' ' ' TRP . 11.3 ptt180 -143.63 146.77 33.52 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.521 -0.918 . . . . 3.01 108.521 173.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.401 HG12 ' SG ' ' A' ' 18' ' ' CYS . 74.7 t -125.36 150.71 30.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.757 -0.656 . . . . 1.07 109.688 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -91.63 84.51 5.49 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.458 0.647 . . . . 1.81 109.686 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.3 p -71.71 109.87 5.89 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.627 -1.17 . . . . 1.08 109.45 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 62.0 p -50.56 -22.54 2.02 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.731 -1.122 . . . . 1.72 114.021 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -92.08 -15.63 27.52 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.374 0.509 . . . . 1.3 112.374 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -136.24 -40.47 0.66 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.097 -0.377 . . . . 4.21 111.878 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.57 -154.45 16.95 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 121.282 -0.485 . . . . 0.24 112.801 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.548 ' HZ3' ' O ' ' A' ' 47' ' ' ARG . 30.1 m95 -57.75 123.42 15.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.396 0.617 . . . . 0.47 111.265 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.0 p -74.48 152.85 39.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.138 -0.937 . . . . 1.07 110.879 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -62.05 129.41 40.72 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.231 -0.655 . . . . 1.84 109.231 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -50.63 125.01 12.01 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.445 -0.798 . . . . 1.0 112.985 -173.019 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.431 ' SG ' HD12 ' A' ' 81' ' ' LEU . 58.9 m -86.95 100.85 12.9 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.174 -1.375 . . . . 0.44 108.865 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.421 HD12 ' CA ' ' A' ' 45' ' ' GLY . 29.2 mm -83.07 123.92 39.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.919 -0.582 . . . . 1.49 110.703 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.84 -175.86 51.03 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 121.052 -0.594 . . . . 0.24 112.002 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HG2' ' OG ' ' A' ' 73' ' ' SER . 11.1 pt-20 -87.02 149.46 47.69 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 110.167 -0.309 . . . . 1.37 110.167 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.33 108.76 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.813 2.342 . . . . 0.79 111.61 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.407 ' SD ' ' HG3' ' A' ' 69' ' ' LYS . 15.1 mmt -108.87 143.75 28.22 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.166 -0.47 . . . . 1.4 110.964 -174.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -83.34 10.47 3.65 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.683 2.255 . . . . 0.37 112.845 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.7 m -153.15 138.03 17.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.444 -0.576 . . . . 1.63 109.444 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 m -68.63 -25.76 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 112.253 0.464 . . . . 1.88 112.253 -173.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -73.06 -41.39 64.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.672 0.272 . . . . 3.34 111.075 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.407 ' HG3' ' SD ' ' A' ' 64' ' ' MET . 7.2 ptmm? -82.08 -17.62 45.93 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.891 -0.323 . . . . 1.91 110.334 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.93 -61.78 2.37 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.198 -0.455 . . . . 1.07 111.175 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.623 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -56.39 -42.58 78.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.589 0.233 . . . . 2.9 111.09 177.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -53.44 -46.37 69.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.868 -0.605 . . . . 2.01 112.199 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.635 ' O ' HG11 ' A' ' 76' ' ' VAL . 41.9 t -62.93 -45.07 94.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.039 0.447 . . . . 1.8 111.185 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.82 81.45 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.294 0.568 . . . . 1.07 110.23 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.487 ' O ' HD22 ' A' ' 79' ' ' LEU . . . -56.88 -37.57 71.56 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.274 -0.875 . . . . 1.01 112.069 177.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.635 HG11 ' O ' ' A' ' 73' ' ' SER . 1.8 p -70.95 -26.82 28.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 O-C-N 121.917 -0.489 . . . . 1.53 110.669 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.3 mt -78.79 -31.61 46.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.791 0.805 . . . . 1.12 109.401 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.402 ' HB3' ' O ' ' A' ' 75' ' ' ALA . 28.0 tp -66.88 -36.77 83.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.865 -1.061 . . . . 1.44 110.461 175.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 75' ' ' ALA . 3.6 mm? -61.21 -25.4 67.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.736 -0.666 . . . . 2.23 110.861 175.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -71.71 -37.94 70.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.093 0.473 . . . . 2.13 109.968 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.431 HD12 ' SG ' ' A' ' 59' ' ' CYS . 1.3 tt -62.99 -47.24 83.99 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.049 -0.723 . . . . 1.84 109.049 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mp -74.39 0.91 12.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.191 -0.913 . . . . 1.82 111.661 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.2 t30 . . . . . 0 C--N 1.322 -0.613 0 CA-C-O 121.763 0.792 . . . . 2.08 109.38 175.011 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 17' ' ' ILE . 2.8 mp . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 121.449 0.642 . . . . 1.42 109.961 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.3 m -65.1 -42.91 93.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.029 -0.987 . . . . 1.98 110.204 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.83 -51.98 67.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.877 -1.056 . . . . 1.77 110.284 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -57.02 -37.08 71.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.398 -0.819 . . . . 4.47 111.923 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -72.81 1.96 7.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.066 -0.515 . . . . 1.67 111.975 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.2 t30 65.59 32.67 9.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.938 -1.028 . . . . 2.37 109.699 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.459 ' CH2' HG22 ' A' ' 50' ' ' THR . 38.2 m0 -99.21 160.58 27.23 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.201 -0.909 . . . . 0.4 109.367 175.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.42 170.65 18.78 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.126 1.884 . . . . 0.6 110.048 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 50.0 mmm -72.68 134.49 81.7 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 110.347 -0.242 . . . . 1.56 110.347 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.82 161.39 32.83 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.962 2.441 . . . . 0.68 113.117 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.524 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 16.6 t -87.63 141.49 28.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.961 -1.018 . . . . 1.02 109.841 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.445 ' HD2' ' CZ ' ' A' ' 44' ' ' PHE . 78.6 m-85 -139.56 110.67 6.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.815 -0.809 . . . . 0.87 108.815 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.446 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 26.7 ttm180 -153.39 123.45 6.95 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.972 -0.381 . . . . 4.22 109.972 -176.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.476 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 62.5 m -61.87 124.93 22.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.136 0.493 . . . . 2.19 111.381 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.442 ' H ' ' HA ' ' A' ' 44' ' ' PHE . 53.3 t -80.74 -29.97 11.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.615 -0.72 . . . . 1.87 109.784 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.7 tptt . . . . . 0 N--CA 1.447 -0.605 0 CA-C-N 115.883 -0.599 . . . . 2.76 110.22 178.252 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 109.476 -0.564 . . . . 4.07 109.476 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -109.87 136.26 49.45 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.311 -0.859 . . . . 1.16 110.041 -173.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.3 m -118.44 125.91 50.93 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.938 -1.134 . . . . 1.08 107.938 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.667 ' CZ ' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -132.65 151.75 51.87 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 121.843 -0.535 . . . . 0.21 109.802 -171.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.415 ' CA ' HD12 ' A' ' 60' ' ' ILE . . . -125.57 129.16 6.78 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.14 -0.784 . . . . 0.2 111.14 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.667 ' HB ' ' CZ ' ' A' ' 44' ' ' PHE . 7.3 p -109.94 145.94 15.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 110.057 -0.349 . . . . 1.45 110.057 -173.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.622 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 2.9 ptp180 -140.32 145.92 37.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.836 -0.802 . . . . 3.01 108.836 -176.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.6 t -125.89 154.55 34.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.461 -0.336 . . . . 1.07 110.29 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -93.85 83.92 4.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.61 0.719 . . . . 1.81 110.086 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.459 HG22 ' CH2' ' A' ' 23' ' ' TRP . 30.2 p -70.96 116.43 11.25 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.523 -1.217 . . . . 1.08 110.062 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 p -51.13 -25.72 5.6 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.583 -1.189 . . . . 1.72 113.522 -172.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -92.95 -12.89 29.67 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.745 0.646 . . . . 1.3 112.745 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -136.74 -42.03 0.6 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.792 -0.567 . . . . 4.21 111.703 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.15 -152.83 17.12 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.891 -0.484 . . . . 0.24 111.891 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.622 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 9.4 m95 -54.15 117.78 3.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.119 0.485 . . . . 0.47 110.956 176.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 56.1 p -69.59 150.6 46.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.436 -0.802 . . . . 1.07 110.315 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -61.18 116.96 4.98 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.3 -1.0 . . . . 1.84 108.3 171.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 3.9 pt-20 -55.39 140.57 39.38 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 114.802 -1.09 . . . . 1.0 111.934 -168.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 63.8 m -97.83 101.79 13.38 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.804 -1.089 . . . . 0.44 109.458 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.415 HD12 ' CA ' ' A' ' 45' ' ' GLY . 25.6 mm -73.54 120.33 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.575 -0.739 . . . . 1.49 110.143 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.58 -165.25 39.3 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.934 -0.65 . . . . 0.24 112.265 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 64' ' ' MET . 43.6 mt-10 -80.69 139.56 50.76 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.926 -0.398 . . . . 1.37 109.926 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.96 110.38 0.62 Allowed 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.14 1.893 . . . . 0.79 110.415 171.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.661 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 16.9 mmt -113.06 141.33 25.43 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.086 -0.507 . . . . 1.4 111.312 -169.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.06 9.55 2.72 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.763 2.309 . . . . 0.37 113.132 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.3 m -154.55 137.18 15.16 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.454 -0.573 . . . . 1.63 109.454 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.4 m -65.64 -34.18 68.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.295 0.85 . . . . 1.88 113.295 -170.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -67.32 -40.94 86.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.589 0.233 . . . . 3.34 111.459 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.661 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 0.5 OUTLIER -81.2 -20.2 41.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.844 0.354 . . . . 1.91 110.451 -179.339 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.38 -61.41 2.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.24 -0.436 . . . . 1.07 111.2 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.563 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 13.2 ptmm? -56.19 -43.75 78.75 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.051 0.453 . . . . 2.9 110.674 176.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.466 ' O ' HG22 ' A' ' 76' ' ' VAL . 36.8 t70 -51.98 -47.05 65.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.113 -0.949 . . . . 2.01 112.022 177.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.5 t -60.65 -47.53 85.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.612 0.244 . . . . 1.8 111.606 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.04 -38.78 89.24 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.175 0.512 . . . . 1.07 110.488 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.64 -37.25 65.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.238 -0.892 . . . . 1.01 111.294 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 91.7 t -59.16 -42.05 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 CA-C-O 120.837 0.351 . . . . 1.53 110.849 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.2 mt -77.17 -30.42 54.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.597 0.713 . . . . 1.12 109.661 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.1 tp -65.73 -44.43 86.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.808 -1.087 . . . . 1.44 111.052 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.3 -21.57 66.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.654 -0.703 . . . . 2.23 111.493 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 8.6 mm-40 -73.71 -38.37 64.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.348 0.594 . . . . 2.13 109.862 173.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 tt -66.78 -46.18 76.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.013 -0.994 . . . . 1.84 109.382 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mp -65.29 -16.7 63.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.349 -0.841 . . . . 1.82 112.338 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 121.484 0.659 . . . . 2.08 109.799 177.15 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.489 ' N ' HD12 ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 121.158 0.504 . . . . 1.42 109.968 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 22.5 m -66.92 -44.68 80.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.613 -0.721 . . . . 1.98 109.747 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.1 tp -61.39 -46.83 88.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.713 -1.131 . . . . 1.77 110.151 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -62.26 -36.15 81.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.654 -1.157 . . . . 4.47 111.334 -177.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 11.0 mmmm -74.15 6.03 3.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 1.67 111.611 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.4 t30 67.03 30.8 7.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.82 0.819 . . . . 2.37 110.268 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -96.23 158.85 33.3 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.562 -0.744 . . . . 0.4 109.277 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.88 -171.43 0.57 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.318 2.012 . . . . 0.6 111.515 173.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.454 ' HE3' ' HA ' ' A' ' 25' ' ' MET . 26.9 mmt -75.95 138.88 69.19 Favored Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 110.063 -0.347 . . . . 1.56 110.063 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 6.3 Cg_exo -72.79 164.6 35.12 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.361 2.04 . . . . 0.68 112.468 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.401 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 23.0 t -89.57 144.17 26.23 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.261 -0.881 . . . . 1.02 109.941 178.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.52 ' HD2' ' CZ ' ' A' ' 44' ' ' PHE . 66.0 m-85 -139.6 111.08 7.11 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.625 -0.88 . . . . 0.87 108.625 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.468 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 20.5 ttp-105 -144.79 119.95 10.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.88 -0.415 . . . . 4.22 109.88 -173.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 21.3 p -66.98 124.55 23.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.098 0.475 . . . . 2.19 110.534 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 43' ' ' THR . 23.3 m -85.82 -41.5 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 116.106 -0.497 . . . . 1.87 111.102 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.1 tttt . . . . . 0 C--N 1.323 -0.562 0 C-N-CA 121.172 -0.211 . . . . 2.76 111.32 179.601 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 . . . . . 0 N--CA 1.444 -0.73 0 N-CA-C 107.109 -1.441 . . . . 4.07 107.109 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -109.89 130.8 55.48 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.393 -0.595 . . . . 1.16 109.393 -172.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.446 ' O ' HG21 ' A' ' 31' ' ' VAL . 5.4 m -123.19 131.84 53.83 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.994 -1.113 . . . . 1.08 107.994 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.717 ' CZ ' HG21 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -142.35 155.75 45.18 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.588 -0.523 . . . . 0.21 109.588 -174.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.453 ' HA3' HD11 ' A' ' 60' ' ' ILE . . . -128.74 139.66 11.16 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.9 -0.667 . . . . 0.2 112.507 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.717 HG21 ' CZ ' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -106.74 156.8 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.767 -0.457 . . . . 1.45 109.767 -176.307 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.604 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 18.6 ptt180 -147.28 148.27 31.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.92 -0.77 . . . . 3.01 108.92 172.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 26' ' ' PRO . 86.0 t -127.31 154.79 38.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.296 -0.411 . . . . 1.07 110.616 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -91.13 84.15 5.66 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.19 0.519 . . . . 1.81 110.248 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.2 p -70.4 115.52 9.68 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.175 -0.92 . . . . 1.08 109.611 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.2 p -51.04 -27.19 7.4 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.724 -1.125 . . . . 1.72 113.404 -172.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -98.81 -8.43 25.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.601 0.593 . . . . 1.3 112.601 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -129.0 -47.66 1.23 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.871 -0.518 . . . . 4.21 111.469 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.13 -151.69 17.23 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.648 -0.706 . . . . 0.24 111.795 -175.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.604 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.7 m95 -54.85 120.4 6.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.065 0.46 . . . . 0.47 111.051 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.5 p -73.38 162.67 29.06 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.749 -0.66 . . . . 1.07 111.288 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -60.0 129.41 41.66 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.314 -0.625 . . . . 1.84 109.314 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -59.03 115.08 2.91 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.714 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.45 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 59.7 m -87.92 97.6 11.03 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.924 -1.035 . . . . 0.44 110.037 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.453 HD11 ' HA3' ' A' ' 45' ' ' GLY . 32.3 mm -76.02 123.92 33.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.449 -0.796 . . . . 1.49 110.417 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.06 -170.49 44.8 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.987 -0.625 . . . . 0.24 112.021 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.612 ' O ' ' HG2' ' A' ' 64' ' ' MET . 44.5 mt-10 -89.14 150.82 45.83 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 110.045 -0.354 . . . . 1.37 110.045 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.98 109.32 1.09 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.562 2.174 . . . . 0.79 111.378 176.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.612 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 90.9 mmm -114.94 144.46 32.05 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.119 -0.491 . . . . 1.4 110.207 -171.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.55 12.26 2.2 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.534 2.156 . . . . 0.37 113.537 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.456 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 19.9 m -154.86 138.96 16.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.413 -0.588 . . . . 1.63 109.413 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -66.98 -28.17 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.769 0.655 . . . . 1.88 112.769 -170.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.01 -42.08 73.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.833 0.349 . . . . 3.34 110.92 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.456 ' HG2' ' HB2' ' A' ' 66' ' ' SER . 4.3 ptpp? -81.48 -18.1 46.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.421 -0.354 . . . . 1.91 110.678 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.79 -59.24 5.75 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.45 -0.341 . . . . 1.07 110.486 172.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.613 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 57.9 mttp -52.81 -47.06 67.91 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.325 -0.398 . . . . 2.9 110.543 175.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -50.21 -50.0 50.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.416 -0.811 . . . . 2.01 112.128 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.57 ' O ' HG11 ' A' ' 76' ' ' VAL . 45.2 t -61.37 -44.49 97.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.83 0.347 . . . . 1.8 111.252 -177.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.498 ' HB2' ' CE2' ' A' ' 44' ' ' PHE . . . -68.64 -47.42 66.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.168 0.509 . . . . 1.07 110.867 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.476 ' O ' HD21 ' A' ' 79' ' ' LEU . . . -55.6 -36.55 67.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.403 -0.817 . . . . 1.01 112.059 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.57 HG11 ' O ' ' A' ' 73' ' ' SER . 2.0 p -71.42 -27.66 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 121.205 0.526 . . . . 1.53 110.617 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.9 mt -79.04 -31.83 44.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.727 0.775 . . . . 1.12 109.436 175.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.422 ' HB3' ' O ' ' A' ' 75' ' ' ALA . 28.6 tp -63.79 -35.29 80.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.107 -0.952 . . . . 1.44 110.406 173.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.476 HD21 ' O ' ' A' ' 75' ' ' ALA . 3.5 mm? -62.25 -22.65 66.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.565 -0.743 . . . . 2.23 111.449 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -69.41 -38.0 77.71 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.318 0.58 . . . . 2.13 109.715 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.449 HD11 ' SG ' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -68.31 -31.17 70.4 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.225 1.012 . . . . 1.84 109.635 179.421 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.3 mp -84.58 -3.18 58.32 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.145 -0.934 . . . . 1.82 112.28 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 . . . . . 0 C--N 1.32 -0.687 0 CA-C-O 121.586 0.708 . . . . 2.08 109.81 177.21 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 17' ' ' ILE . 2.7 mp . . . . . 0 N--CA 1.461 0.113 0 CA-C-O 121.148 0.499 . . . . 1.42 109.883 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.435 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 68.5 m -64.78 -42.64 94.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.477 -0.783 . . . . 1.98 109.969 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.66 -45.1 91.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.872 -1.058 . . . . 1.77 110.543 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -65.52 -35.34 80.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.33 -0.85 . . . . 4.47 111.068 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 9.1 mmmm -76.07 4.02 9.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 1.67 111.162 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.6 t30 66.02 38.84 4.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.248 -0.887 . . . . 2.37 110.27 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.435 ' CE3' ' HA ' ' A' ' 18' ' ' CYS . 37.9 m0 -104.04 156.62 35.44 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.414 -0.812 . . . . 0.4 109.431 175.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.13 -172.84 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.36 2.04 . . . . 0.6 111.05 171.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.442 ' HE3' ' HA ' ' A' ' 25' ' ' MET . 29.4 mmt -75.19 142.9 76.08 Favored Pre-proline 0 N--CA 1.447 -0.617 0 O-C-N 122.078 -0.389 . . . . 1.56 110.511 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 3.1 Cg_exo -76.24 165.32 29.67 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.718 2.279 . . . . 0.68 112.864 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.3 t -83.58 141.99 31.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.247 -0.888 . . . . 1.02 110.059 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.475 ' CD1' ' HZ ' ' A' ' 44' ' ' PHE . 66.5 m-85 -145.98 110.18 4.98 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.034 -0.728 . . . . 0.87 109.034 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.524 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 23.7 ttm180 -158.63 128.39 5.79 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.394 -0.225 . . . . 4.22 110.394 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 86.4 m -63.34 123.48 18.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.846 0.355 . . . . 2.19 110.688 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -84.49 -34.27 9.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.298 0.57 . . . . 1.87 109.805 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.5 tttp . . . . . 0 C--N 1.32 -0.715 0 CA-C-N 115.581 -0.736 . . . . 2.76 109.294 177.013 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 . . . . . 0 N--CA 1.442 -0.848 0 N-CA-C 106.553 -1.647 . . . . 4.07 106.553 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 6.9 m-85 -110.23 131.86 54.68 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.368 -0.533 . . . . 1.16 109.777 -169.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.1 m -122.2 132.02 54.23 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.813 -1.18 . . . . 1.08 107.813 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.72 ' CZ ' HG23 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -142.24 153.16 43.75 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.553 -0.536 . . . . 0.21 109.553 -173.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -127.55 140.7 12.03 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.099 -0.572 . . . . 0.2 112.327 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.72 HG23 ' CZ ' ' A' ' 44' ' ' PHE . 2.1 t -105.91 156.36 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 109.605 -0.517 . . . . 1.45 109.605 -175.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 56' ' ' THR . 5.3 tpp85 -142.64 145.57 33.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.558 -0.904 . . . . 3.01 108.558 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.423 HG23 HD13 ' A' ' 78' ' ' LEU . 61.8 t -131.36 153.11 38.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 110.058 -0.349 . . . . 1.07 110.058 177.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -96.29 85.14 3.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.442 0.639 . . . . 1.81 110.015 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 54' ' ' GLY . 26.2 p -69.29 106.99 3.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.69 -1.141 . . . . 1.08 109.106 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 t -49.77 -26.8 4.19 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.834 0.679 . . . . 1.72 112.834 -171.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -88.17 -18.27 29.11 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.428 0.529 . . . . 1.3 112.428 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -129.82 -46.29 1.15 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.015 0.436 . . . . 4.21 111.294 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 125.6 -156.04 19.19 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.933 -0.576 . . . . 0.24 112.607 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -52.28 119.72 4.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.22 0.533 . . . . 0.47 110.89 175.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.438 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 46.3 p -68.95 -179.26 1.43 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.987 -1.006 . . . . 1.07 112.487 -173.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.38 132.22 43.65 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.577 -0.898 . . . . 1.84 108.577 171.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -64.81 114.44 4.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.581 0.705 . . . . 1.0 110.766 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.473 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 61.5 m -88.19 97.82 11.22 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.56 -1.2 . . . . 0.44 109.999 -177.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.426 HD11 ' HA3' ' A' ' 45' ' ' GLY . 26.9 mm -81.58 122.03 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.666 -0.697 . . . . 1.49 110.07 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.76 -171.0 47.76 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.073 -0.584 . . . . 0.24 112.428 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.585 ' O ' ' HG2' ' A' ' 64' ' ' MET . 33.0 mt-10 -81.91 146.38 55.68 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 110.023 -0.362 . . . . 1.37 110.023 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 27.7 Cg_exo -62.8 109.62 0.94 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.487 2.125 . . . . 0.79 110.907 171.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.585 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 89.6 mmm -115.4 149.1 42.27 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.208 -0.451 . . . . 1.4 110.081 -172.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.2 12.33 2.34 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.594 2.196 . . . . 0.37 113.535 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.422 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 30.0 t -154.99 142.2 19.41 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.658 -0.497 . . . . 1.63 109.658 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.6 m -68.2 -27.95 39.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.619 -0.718 . . . . 1.88 111.946 -173.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -64.6 -50.53 66.84 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.245 0.545 . . . . 3.34 110.851 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.422 ' HG2' ' HB3' ' A' ' 66' ' ' SER . 15.4 ptpt -79.66 -17.54 53.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.455 -0.793 . . . . 1.91 110.708 -174.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.11 -54.28 47.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.185 -0.461 . . . . 1.07 109.823 172.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.656 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 54.5 mtmt -56.05 -52.0 65.82 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.015 -0.539 . . . . 2.9 111.018 176.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.588 ' O ' HG22 ' A' ' 76' ' ' VAL . 4.6 m-20 -53.74 -46.72 70.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.561 . . . . 2.01 112.308 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 t -58.24 -46.01 86.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 1.8 110.981 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.518 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -69.01 -43.42 74.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.986 -0.552 . . . . 1.07 110.491 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.5 ' O ' HD22 ' A' ' 79' ' ' LEU . . . -54.49 -36.93 64.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.465 -0.789 . . . . 1.01 111.4 176.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 72' ' ' ASP . 91.0 t -63.06 -37.96 80.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 121.119 0.485 . . . . 1.53 110.293 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.8 mt -77.85 -24.25 48.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.865 0.84 . . . . 1.12 109.533 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.423 HD13 HG23 ' A' ' 48' ' ' VAL . 16.7 tp -69.15 -37.94 78.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.134 -0.939 . . . . 1.44 110.468 171.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 75' ' ' ALA . 3.3 mm? -65.14 -28.78 69.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.755 -0.657 . . . . 2.23 112.146 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -77.27 -31.61 55.02 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.887 -0.725 . . . . 2.13 110.085 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.05 -47.69 85.21 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.708 -0.849 . . . . 1.84 108.708 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mp -71.77 -4.38 27.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.12 -0.945 . . . . 1.82 112.036 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 121.601 0.715 . . . . 2.08 109.686 179.155 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.477 ' N ' HD13 ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.861 0.362 . . . . 1.42 111.007 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.464 ' SG ' ' HE3' ' A' ' 23' ' ' TRP . 36.2 t -71.61 -39.06 70.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.754 0.787 . . . . 1.98 109.157 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 tt -64.47 -46.26 83.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.552 -1.204 . . . . 1.77 110.079 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -61.63 -31.5 71.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.025 -0.534 . . . . 4.47 111.412 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 53.8 mmtt -73.12 -3.88 29.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.329 0.585 . . . . 1.67 111.447 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.0 t30 64.51 30.77 12.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.511 -1.222 . . . . 2.37 110.173 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.464 ' HE3' ' SG ' ' A' ' 18' ' ' CYS . 33.6 m0 -89.6 165.56 24.83 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.367 -0.833 . . . . 0.4 109.088 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 36.9 Cg_endo -69.44 -176.6 1.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 121.973 1.782 . . . . 0.6 111.186 170.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.463 ' HA ' ' HE2' ' A' ' 25' ' ' MET . 21.4 mmt -74.77 137.52 73.57 Favored Pre-proline 0 C--N 1.323 -0.566 0 O-C-N 122.257 -0.277 . . . . 1.56 110.366 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -70.04 161.69 45.04 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.812 2.342 . . . . 0.68 112.457 -177.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.5 t -88.12 138.03 31.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.411 -0.813 . . . . 1.02 110.191 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.499 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 63.3 m-85 -143.78 111.28 5.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.651 -0.5 . . . . 0.87 109.651 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.482 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 79.3 ttt180 -164.17 131.61 3.32 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.977 -0.379 . . . . 4.22 109.977 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 8.8 p -64.53 130.6 44.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.054 0.454 . . . . 2.19 111.326 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.5 t -86.32 -28.45 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.666 -0.697 . . . . 1.87 109.9 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.3 tttp . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 109.169 -0.678 . . . . 2.76 109.169 176.589 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 . . . . . 0 N--CA 1.444 -0.75 0 N-CA-C 107.948 -1.13 . . . . 4.07 107.948 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 8.2 m-85 -109.05 133.84 52.46 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.823 -0.626 . . . . 1.16 110.438 -169.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.1 m -119.8 116.33 25.66 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.851 -1.166 . . . . 1.08 107.851 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.69 ' CE2' ' HA ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -126.93 153.1 46.25 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.898 -0.408 . . . . 0.21 109.898 -170.06 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -126.87 140.38 11.89 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.574 -0.61 . . . . 0.2 111.574 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.681 HG23 ' CZ ' ' A' ' 44' ' ' PHE . 1.7 t -105.66 156.1 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.636 -0.505 . . . . 1.45 109.636 -175.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.712 ' HD2' ' O ' ' A' ' 56' ' ' THR . 0.4 OUTLIER -142.24 145.87 34.55 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.478 -0.934 . . . . 3.01 108.478 177.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.41 HG11 ' CZ3' ' A' ' 23' ' ' TRP . 38.8 t -132.08 150.71 33.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.544 -0.298 . . . . 1.07 110.293 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -94.61 83.66 4.14 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.825 0.821 . . . . 1.81 109.528 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.407 HG23 ' CH2' ' A' ' 23' ' ' TRP . 23.0 p -75.0 101.23 4.4 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.192 -1.367 . . . . 1.08 109.21 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t -43.76 -35.24 1.8 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.84 0.856 . . . . 1.72 113.173 -170.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.86 -33.36 72.95 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.598 0.592 . . . . 1.3 112.598 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -131.12 -38.6 1.22 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.806 0.336 . . . . 4.21 111.875 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.24 -151.96 16.88 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 116.253 -0.431 . . . . 0.24 112.272 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -52.91 126.24 19.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.172 0.51 . . . . 0.47 110.858 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.712 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 37.4 p -74.2 -174.71 2.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.351 -0.84 . . . . 1.07 112.372 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -76.62 169.92 17.39 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.82 -1.178 . . . . 1.84 107.82 165.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -92.34 119.78 32.23 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.222 0.534 . . . . 1.0 111.372 -171.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.454 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 28.6 m -85.46 97.61 10.13 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.104 -0.953 . . . . 0.44 109.293 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.4 mm -86.92 121.16 37.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.196 -0.456 . . . . 1.49 110.613 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.64 -174.47 49.94 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.835 -0.698 . . . . 0.24 111.519 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.648 ' O ' ' HG2' ' A' ' 64' ' ' MET . 42.8 mm-40 -85.89 148.41 48.21 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.687 0.244 . . . . 1.37 110.452 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 40.7 Cg_exo -57.26 109.14 0.42 Allowed 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.571 2.18 . . . . 0.79 111.186 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.648 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.0 mmm -117.32 149.97 45.55 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.692 -0.484 . . . . 1.4 109.692 -172.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -80.77 15.01 1.9 Allowed 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.539 2.16 . . . . 0.37 114.817 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.1 t -163.8 145.87 9.35 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.96 -0.463 . . . . 1.63 110.402 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.4 t -59.18 -50.98 77.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.315 0.487 . . . . 1.88 112.315 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -55.57 -43.81 76.27 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.202 0.445 . . . . 3.34 112.202 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HE3' ' HE2' ' A' ' 64' ' ' MET . 0.4 OUTLIER -80.88 -21.89 40.26 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.991 -0.284 . . . . 1.91 110.607 -178.206 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.91 -56.15 19.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.756 -0.202 . . . . 1.07 111.039 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.69 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 32.3 pttt -56.6 -42.04 78.04 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 120.917 0.389 . . . . 2.9 110.129 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.496 ' O ' HG21 ' A' ' 76' ' ' VAL . 31.3 t70 -54.17 -47.7 71.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.544 -0.753 . . . . 2.01 112.068 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.4 t -60.09 -45.84 91.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.34 . . . . 1.8 111.457 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.432 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -69.87 -40.6 75.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.039 0.447 . . . . 1.07 110.925 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.438 ' O ' HD12 ' A' ' 79' ' ' LEU . . . -52.52 -33.97 47.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.505 -0.771 . . . . 1.01 111.307 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 72' ' ' ASP . 96.9 t -61.24 -37.41 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.967 0.413 . . . . 1.53 110.739 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.1 mt -77.29 -33.09 55.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.75 0.785 . . . . 1.12 109.597 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.426 HD22 HG13 ' A' ' 46' ' ' VAL . 15.3 tp -65.5 -40.83 93.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.716 -1.129 . . . . 1.44 110.58 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 75' ' ' ALA . 7.2 mp -61.57 -26.14 67.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.435 -0.802 . . . . 2.23 111.045 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.82 -35.55 62.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.239 0.543 . . . . 2.13 110.076 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.41 -46.17 77.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.35 -0.841 . . . . 1.84 109.329 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mp -70.45 -9.8 57.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.295 -0.866 . . . . 1.82 111.971 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 121.679 0.752 . . . . 2.08 109.456 174.864 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.469 HD11 ' N ' ' A' ' 17' ' ' ILE . 2.7 mp . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 121.041 0.448 . . . . 1.42 110.52 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.421 ' SG ' HG13 ' A' ' 48' ' ' VAL . 47.3 t -69.54 -40.52 76.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.631 0.729 . . . . 1.98 109.512 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.1 tp -63.73 -49.53 72.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.867 -1.061 . . . . 1.77 110.661 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.418 ' C ' ' H ' ' A' ' 22' ' ' ASN . 73.7 ttt180 -61.0 -36.63 79.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.383 -0.826 . . . . 4.47 111.745 -177.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -73.29 8.75 1.55 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 1.67 111.985 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.418 ' H ' ' C ' ' A' ' 20' ' ' ARG . 63.3 t30 60.21 34.67 21.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.261 -0.881 . . . . 2.37 110.065 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.433 ' CZ3' HG12 ' A' ' 48' ' ' VAL . 41.6 m0 -97.12 163.34 20.17 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 114.93 -1.032 . . . . 0.4 108.818 174.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 44.3 Cg_endo -70.0 -168.33 0.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.029 1.819 . . . . 0.6 111.497 173.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.431 ' HE3' ' HA ' ' A' ' 25' ' ' MET . 4.7 mmt -80.18 136.26 53.7 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.97 -0.381 . . . . 1.56 109.97 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.403 ' HG3' ' SG ' ' A' ' 18' ' ' CYS . 6.4 Cg_exo -71.42 162.8 41.18 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.597 2.198 . . . . 0.68 112.24 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.7 t -87.36 140.14 29.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.568 -0.742 . . . . 1.02 109.759 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.513 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 66.4 m-85 -140.8 109.82 6.13 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.265 -1.013 . . . . 0.87 108.265 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.585 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 33.8 ptt180 -145.24 130.71 18.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.891 0.377 . . . . 4.22 110.524 -173.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.9 t -65.76 119.84 11.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.201 -0.454 . . . . 2.19 110.529 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.3 t -86.73 -42.93 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.975 -0.557 . . . . 1.87 110.737 -177.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.0 tttm . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 120.751 0.31 . . . . 2.76 110.664 179.267 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 107.799 -1.186 . . . . 4.07 107.799 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -109.0 141.2 41.45 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.966 0.413 . . . . 1.16 110.57 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.446 ' HG1' ' HA ' ' A' ' 63' ' ' PRO . 29.4 m -129.93 124.77 33.89 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.551 -0.75 . . . . 1.08 109.172 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.689 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -132.96 156.89 46.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.652 -0.499 . . . . 0.21 109.652 -173.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -130.12 142.06 13.29 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.912 -0.661 . . . . 0.2 112.015 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.689 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.5 t -105.36 156.29 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 117.027 0.413 . . . . 1.45 110.286 -174.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.526 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -137.01 142.04 42.51 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.928 -1.138 . . . . 3.01 107.928 178.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.433 HG12 ' CZ3' ' A' ' 23' ' ' TRP . 39.6 t -132.68 149.96 32.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 110.609 -0.145 . . . . 1.07 110.609 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -99.86 88.43 3.78 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.632 0.73 . . . . 1.81 110.889 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.5 p -68.52 113.33 5.96 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.38 -1.282 . . . . 1.08 109.634 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.3 m -49.22 -25.99 2.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.311 -0.858 . . . . 1.72 113.265 -176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -93.45 -16.78 24.18 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.527 0.566 . . . . 1.3 112.527 -176.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -134.9 -46.72 0.73 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.035 0.445 . . . . 4.21 111.315 -172.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.12 -156.59 19.08 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.8 -0.636 . . . . 0.24 112.698 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.526 ' CZ3' ' HB3' ' A' ' 47' ' ' ARG . 20.4 m95 -52.77 121.75 7.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.149 0.5 . . . . 0.47 111.312 176.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 42.3 p -73.42 177.41 5.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.478 -0.783 . . . . 1.07 111.912 -175.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -66.88 133.07 49.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.076 -0.713 . . . . 1.84 109.076 172.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.463 ' HB2' ' NH1' ' A' ' 47' ' ' ARG . 26.0 tt0 -65.39 110.75 2.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.24 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.482 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 62.0 m -84.89 97.65 9.88 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.567 -1.197 . . . . 0.44 109.913 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.413 HD13 ' HA3' ' A' ' 45' ' ' GLY . 32.1 mm -76.96 124.13 34.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.428 -0.805 . . . . 1.49 110.599 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.75 -170.28 46.87 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.922 -0.581 . . . . 0.24 112.657 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.61 ' O ' ' HG2' ' A' ' 64' ' ' MET . 36.6 mt-10 -83.93 151.34 60.55 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-O 120.603 0.239 . . . . 1.37 110.995 -175.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.446 ' HA ' ' HG1' ' A' ' 43' ' ' THR . 24.4 Cg_exo -63.71 99.22 0.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.754 2.303 . . . . 0.79 110.961 170.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.61 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 92.4 mmm -113.59 138.64 22.68 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.514 -0.312 . . . . 1.4 110.561 -170.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.79 7.35 2.82 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.669 2.246 . . . . 0.37 113.422 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.4 t -144.85 136.79 25.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.113 -0.699 . . . . 1.63 109.113 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.23 -28.11 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.897 -0.592 . . . . 1.88 111.726 -175.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -67.99 -43.21 79.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.11 -0.495 . . . . 3.34 110.481 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -74.21 -26.29 60.17 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.077 -0.511 . . . . 1.91 109.745 -176.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.73 -58.98 6.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.875 -0.602 . . . . 1.07 110.581 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.66 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 66.3 mttm -54.1 -51.72 63.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.391 -0.368 . . . . 2.9 111.07 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.551 ' O ' HG22 ' A' ' 76' ' ' VAL . 18.3 m-20 -53.45 -49.04 68.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.828 -0.624 . . . . 2.01 112.672 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.5 p -64.13 -38.68 91.93 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.922 -0.311 . . . . 1.8 111.253 -175.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.83 -46.18 72.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.31 0.576 . . . . 1.07 110.301 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.491 ' O ' HD12 ' A' ' 79' ' ' LEU . . . -53.31 -36.4 61.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.9 -1.046 . . . . 1.01 111.628 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 72' ' ' ASP . 96.1 t -63.83 -36.95 78.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.946 0.403 . . . . 1.53 110.763 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.7 mt -77.92 -28.9 49.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.738 0.78 . . . . 1.12 109.833 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.405 HD12 ' HB ' ' A' ' 46' ' ' VAL . 19.3 tp -66.54 -45.1 80.53 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.954 -1.021 . . . . 1.44 110.589 173.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 75' ' ' ALA . 7.0 mp -62.96 -30.75 71.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.441 -0.799 . . . . 2.23 112.358 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -78.87 -30.84 45.29 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.013 -0.675 . . . . 2.13 110.389 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.7 tt -65.19 -45.0 86.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.673 -0.862 . . . . 1.84 108.673 174.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mp -65.53 -20.65 66.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.928 -1.033 . . . . 1.82 111.878 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 . . . . . 0 C--N 1.325 -0.46 0 CA-C-O 121.778 0.799 . . . . 2.08 109.172 179.004 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 17' ' ' ILE . 2.4 mp . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.869 0.366 . . . . 1.42 110.593 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.0 t -71.86 -42.23 67.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.925 -0.579 . . . . 1.98 109.955 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.9 tp -61.92 -48.73 79.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.282 -0.872 . . . . 1.77 110.443 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -56.61 -37.36 70.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.954 -1.021 . . . . 4.47 111.854 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -73.45 0.37 12.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.291 -0.413 . . . . 1.67 111.426 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.5 t30 70.99 20.26 5.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.206 -0.906 . . . . 2.37 110.172 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -86.81 158.57 53.42 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.433 -0.803 . . . . 0.4 109.723 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.94 -168.82 0.25 Allowed 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 122.425 2.084 . . . . 0.6 111.449 174.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.431 ' HA ' ' HE1' ' A' ' 25' ' ' MET . 7.2 mmt -83.6 134.93 44.0 Favored Pre-proline 0 C--N 1.322 -0.624 0 O-C-N 122.032 -0.417 . . . . 1.56 109.91 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -67.14 166.99 21.26 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.807 2.338 . . . . 0.68 113.133 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.482 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 33.0 t -84.74 144.01 28.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.998 -1.001 . . . . 1.02 109.898 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.5 ' HD1' ' CZ ' ' A' ' 44' ' ' PHE . 72.4 m-85 -142.96 110.78 5.91 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.826 -0.805 . . . . 0.87 108.826 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.516 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 45.6 ttm105 -156.64 124.14 5.4 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.522 -0.547 . . . . 4.22 109.522 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -69.23 128.0 35.08 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.062 -0.517 . . . . 2.19 110.184 -176.559 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 43' ' ' THR . 26.8 m -78.85 -33.92 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.287 0.565 . . . . 1.87 109.625 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.6 tttm . . . . . 0 C--N 1.32 -0.715 0 CA-C-N 115.418 -0.81 . . . . 2.76 109.605 171.361 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 . . . . . 0 CA--C 1.514 -0.405 0 N-CA-C 107.77 -1.196 . . . . 4.07 107.77 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 7.5 m-85 -111.14 130.82 55.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.112 0.482 . . . . 1.16 110.028 -173.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 31' ' ' VAL . 16.4 m -118.47 127.59 53.8 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.874 -1.158 . . . . 1.08 107.874 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.691 ' CZ ' HG23 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -138.5 150.58 46.55 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.317 -0.623 . . . . 0.21 109.317 -174.14 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.31 141.08 12.26 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.915 -0.66 . . . . 0.2 112.313 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.691 HG23 ' CZ ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -107.37 156.05 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.628 -0.508 . . . . 1.45 109.628 -176.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.633 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 16.7 ptp180 -145.67 147.82 32.39 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.806 -0.813 . . . . 3.01 108.806 173.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.431 HG23 HD11 ' A' ' 82' ' ' LEU . 94.2 t -124.79 152.26 30.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 123.086 0.241 . . . . 1.07 110.64 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -95.14 85.25 4.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.708 0.766 . . . . 1.81 110.146 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.1 p -67.26 112.9 4.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.346 -1.297 . . . . 1.08 109.365 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -52.48 -26.46 12.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.659 -0.7 . . . . 1.72 112.215 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -94.85 -16.42 22.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.506 0.558 . . . . 1.3 112.506 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -132.63 -46.55 0.88 Allowed 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.934 -0.479 . . . . 4.21 111.493 -175.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.13 -158.07 20.9 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.13 -0.557 . . . . 0.24 113.142 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.633 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.1 m95 -52.48 118.53 3.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.863 0.364 . . . . 0.47 110.719 175.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.4 p -71.75 161.35 31.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.786 -0.643 . . . . 1.07 111.005 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -61.66 125.77 24.98 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.131 -0.692 . . . . 1.84 109.131 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -59.49 124.81 21.28 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.246 -0.888 . . . . 1.0 111.245 -173.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 52.7 m -96.75 99.09 10.7 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.73 -1.123 . . . . 0.44 110.361 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.7 mp -76.57 126.93 37.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.918 -0.583 . . . . 1.49 110.37 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.57 -166.82 41.88 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.436 -0.802 . . . . 0.24 112.634 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -91.24 135.94 27.7 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 110.096 -0.335 . . . . 1.37 110.096 -178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 50.4 Cg_exo -54.8 115.23 2.27 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.101 2.534 . . . . 0.79 112.174 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 14.7 mmt -112.93 152.22 44.71 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.766 -0.652 . . . . 1.4 111.236 -172.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -85.25 9.88 3.95 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.666 2.244 . . . . 0.37 112.911 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -155.63 138.63 15.44 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.477 -0.564 . . . . 1.63 109.477 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.06 -27.88 42.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.588 -0.733 . . . . 1.88 112.748 -170.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -72.17 -42.3 66.07 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.822 -0.351 . . . . 3.34 111.045 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -80.74 -18.01 49.16 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.914 -0.315 . . . . 1.91 110.316 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.39 -59.22 5.47 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.337 -0.392 . . . . 1.07 110.391 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.621 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 8.9 mtmp? -51.85 -47.1 64.58 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 116.303 -0.408 . . . . 2.9 111.16 175.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.536 ' O ' HG23 ' A' ' 76' ' ' VAL . 15.0 m-20 -50.86 -51.56 50.13 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.404 0.44 . . . . 2.01 112.074 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.9 t -60.66 -43.75 97.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.638 0.256 . . . . 1.8 111.249 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.64 -43.0 77.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.074 0.464 . . . . 1.07 110.53 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.492 ' O ' HD11 ' A' ' 79' ' ' LEU . . . -54.24 -38.19 65.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.338 -0.846 . . . . 1.01 111.454 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 72' ' ' ASP . 99.0 t -65.37 -36.53 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-O 120.815 0.34 . . . . 1.53 110.757 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.7 mt -73.95 -34.43 64.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.784 0.802 . . . . 1.12 109.208 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.44 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 28.5 tp -65.51 -43.05 91.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.401 -1.272 . . . . 1.44 110.887 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.492 HD11 ' O ' ' A' ' 75' ' ' ALA . 7.2 mp -62.57 -24.94 67.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.704 -0.68 . . . . 2.23 111.134 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 76' ' ' VAL . 39.5 mt-10 -74.01 -39.52 63.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.159 0.504 . . . . 2.13 109.68 175.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.99 -51.7 65.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.331 -0.85 . . . . 1.84 110.324 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 78' ' ' LEU . 34.6 mt -65.76 -18.1 65.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.578 -1.192 . . . . 1.82 111.594 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 . . . . . 0 C--N 1.321 -0.663 0 CA-C-O 122.04 0.924 . . . . 2.08 109.352 176.896 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.469 ' N ' HD13 ' A' ' 17' ' ' ILE . 2.8 mp . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.909 0.385 . . . . 1.42 110.807 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.615 ' SG ' ' HG3' ' A' ' 26' ' ' PRO . 42.8 t -60.21 -38.78 84.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.572 0.701 . . . . 1.98 109.985 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.5 tp -63.78 -43.99 94.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.767 -1.106 . . . . 1.77 110.355 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.415 ' C ' ' H ' ' A' ' 22' ' ' ASN . 23.2 ttm180 -66.9 -33.12 74.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.652 -1.158 . . . . 4.47 111.529 -176.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 28.9 mmmt -73.95 6.54 3.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 1.67 111.469 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 20' ' ' ARG . 64.0 t30 61.9 28.75 17.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.132 -0.94 . . . . 2.37 110.522 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.477 ' CH2' HG23 ' A' ' 50' ' ' THR . 37.1 m0 -91.03 162.92 31.37 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.487 -0.779 . . . . 0.4 109.051 174.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -67.45 -170.31 0.25 Allowed 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 121.984 1.79 . . . . 0.6 111.535 173.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.414 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 1.6 mmt -81.8 130.98 58.73 Favored Pre-proline 0 C--N 1.321 -0.643 0 O-C-N 122.036 -0.415 . . . . 1.56 110.281 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.615 ' HG3' ' SG ' ' A' ' 18' ' ' CYS . 11.0 Cg_exo -68.46 168.01 20.87 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.632 2.221 . . . . 0.68 112.192 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.8 t -88.82 137.56 32.21 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.543 -0.753 . . . . 1.02 110.052 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.481 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 84.9 m-85 -146.46 109.35 4.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.632 -0.507 . . . . 0.87 109.632 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.444 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 78.9 ttt180 -160.07 130.17 5.41 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 110.066 -0.346 . . . . 4.22 110.066 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.422 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 63.5 m -61.78 126.42 27.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.076 0.465 . . . . 2.19 110.809 -178.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.22 -39.58 12.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.804 -0.634 . . . . 1.87 111.326 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.462 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 32.3 mmtt . . . . . 0 C--N 1.323 -0.574 0 CA-C-O 121.022 0.439 . . . . 2.76 111.884 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HD3' ' H ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 121.515 0.674 . . . . 4.07 109.624 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -109.54 139.88 44.0 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.96 -1.018 . . . . 1.16 109.448 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 32' ' ' LYS . 32.9 m -123.66 123.77 41.29 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.462 -0.94 . . . . 1.08 108.462 -175.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.644 ' CZ ' ' HB ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -125.82 152.27 45.67 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.609 -0.515 . . . . 0.21 109.609 -173.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.22 126.94 5.92 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.455 -0.658 . . . . 0.2 111.455 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.644 ' HB ' ' CZ ' ' A' ' 44' ' ' PHE . 7.4 p -109.27 149.26 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 110.002 -0.37 . . . . 1.45 110.002 -176.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.563 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 11.2 ptt180 -145.14 150.48 36.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.017 -0.735 . . . . 3.01 109.017 176.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.503 HG11 ' SG ' ' A' ' 18' ' ' CYS . 67.4 t -125.99 155.45 35.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.022 -0.535 . . . . 1.07 111.005 -176.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -95.6 83.78 3.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.758 0.789 . . . . 1.81 110.061 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.477 HG23 ' CH2' ' A' ' 23' ' ' TRP . 24.9 p -69.56 112.24 5.93 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.163 -1.38 . . . . 1.08 109.446 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.5 t -50.74 -23.61 2.82 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.961 0.726 . . . . 1.72 112.961 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -77.89 -29.54 50.29 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.129 0.789 . . . . 1.3 113.129 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -138.11 -36.62 0.59 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.599 -0.441 . . . . 4.21 111.977 -173.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.6 -147.86 17.29 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.904 -0.665 . . . . 0.24 112.663 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.563 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.3 m95 -49.8 119.93 3.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.315 0.579 . . . . 0.47 111.891 177.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -73.91 167.12 22.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.248 -0.887 . . . . 1.07 110.721 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -63.06 128.57 36.47 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.259 -0.645 . . . . 1.84 109.259 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.39 114.44 3.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.566 0.698 . . . . 1.0 110.511 -176.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.1 m -90.93 102.63 15.4 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.707 -1.133 . . . . 0.44 110.328 -175.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.08 122.25 26.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.649 -0.705 . . . . 1.49 110.228 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -78.36 -173.14 41.61 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.687 -0.688 . . . . 0.24 112.566 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 64' ' ' MET . 50.6 mt-10 -86.15 137.6 35.01 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 110.289 -0.263 . . . . 1.37 110.289 -177.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.07 104.92 0.13 Allowed 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 123.071 2.514 . . . . 0.79 111.566 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.644 ' SD ' ' HE2' ' A' ' 69' ' ' LYS . 16.5 mmt -113.15 147.36 37.15 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.578 -0.737 . . . . 1.4 111.133 -172.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.71 13.21 2.17 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.717 2.278 . . . . 0.37 113.241 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.8 t -155.61 138.91 15.71 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.451 -0.574 . . . . 1.63 109.451 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.06 -23.23 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.146 -0.479 . . . . 1.88 112.244 -172.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -71.45 -45.33 62.88 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.748 0.309 . . . . 3.34 110.786 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.644 ' HE2' ' SD ' ' A' ' 64' ' ' MET . 19.0 ptmt -81.79 -16.94 49.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.367 -0.379 . . . . 1.91 110.377 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.78 -56.0 27.1 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.018 -0.537 . . . . 1.07 109.868 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.592 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 56.6 mtpt -49.91 -51.59 39.59 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 115.995 -0.548 . . . . 2.9 111.543 174.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.7 m-20 -51.96 -47.48 64.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.765 0.654 . . . . 2.01 112.765 -177.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 83.9 p -62.78 -39.14 93.29 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.69 -0.404 . . . . 1.8 111.251 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.6 -38.97 70.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.304 0.573 . . . . 1.07 110.025 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.57 -30.75 69.98 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.389 -0.823 . . . . 1.01 111.54 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 72' ' ' ASP . 96.1 t -70.35 -32.59 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.191 0.52 . . . . 1.53 110.31 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.6 mt -73.86 -27.48 61.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.042 0.925 . . . . 1.12 109.218 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.3 tp -65.72 -33.58 76.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.679 -1.146 . . . . 1.44 109.931 173.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 76' ' ' VAL . 3.1 mm? -60.72 -38.67 85.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.909 -0.587 . . . . 2.23 111.961 177.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -81.0 -33.42 33.69 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.489 -0.484 . . . . 2.13 110.245 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.31 -53.32 59.08 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.294 -0.632 . . . . 1.84 109.294 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.34 -3.24 5.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.981 -1.009 . . . . 1.82 112.204 174.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 . . . . . 0 C--N 1.323 -0.547 0 N-CA-C 108.641 -0.874 . . . . 2.08 108.641 176.15 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.461 ' N ' HD13 ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 C--O 1.231 0.12 0 CA-C-O 121.006 0.431 . . . . 1.42 110.315 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.439 ' SG ' ' HE3' ' A' ' 23' ' ' TRP . 19.6 t -64.96 -42.02 94.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.59 -0.732 . . . . 1.98 109.568 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.9 tp -60.85 -48.18 82.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.86 -1.064 . . . . 1.77 110.53 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.44 -36.12 75.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.001 -0.999 . . . . 4.47 110.981 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 30.2 mmmt -74.0 2.8 7.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.869 -0.605 . . . . 1.67 111.574 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 71.77 20.68 4.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.065 0.936 . . . . 2.37 109.71 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.439 ' HE3' ' SG ' ' A' ' 18' ' ' CYS . 35.3 m0 -91.93 155.35 43.32 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.403 -0.817 . . . . 0.4 109.437 175.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -63.56 -173.73 0.19 Allowed 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.808 2.338 . . . . 0.6 111.795 168.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.452 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 21.7 mmt -81.99 131.46 56.77 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 116.253 -0.43 . . . . 1.56 110.308 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 22.3 Cg_exo -62.98 160.26 34.59 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.715 2.277 . . . . 0.68 112.822 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.441 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 13.6 t -84.79 142.01 30.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.21 -0.905 . . . . 1.02 109.791 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.485 ' CD2' ' CZ ' ' A' ' 44' ' ' PHE . 71.2 m-85 -139.54 110.96 7.05 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.81 -0.811 . . . . 0.87 108.81 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.525 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 43.3 ttt180 -145.5 122.86 11.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.521 0.201 . . . . 4.22 110.525 -174.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.479 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 76.5 m -63.57 120.81 12.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.766 0.317 . . . . 2.19 110.569 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.8 m -86.05 -38.54 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.314 -0.403 . . . . 1.87 111.105 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.0 tttt . . . . . 0 C--N 1.322 -0.619 0 CA-C-O 120.865 0.364 . . . . 2.76 110.882 -179.78 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 108.997 -0.742 . . . . 4.07 108.997 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -110.05 143.88 39.44 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.307 -0.861 . . . . 1.16 110.879 -171.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.7 m -129.05 137.51 51.33 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.302 -0.863 . . . . 1.08 109.025 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.707 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -141.16 153.64 45.46 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.283 -0.636 . . . . 0.21 109.283 -176.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -125.09 139.28 11.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 0.2 111.914 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.707 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.1 t -106.8 154.02 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 117.096 0.448 . . . . 1.45 109.895 -174.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.572 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 18.0 ptp180 -145.06 144.05 30.77 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.481 -0.933 . . . . 3.01 108.481 172.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.427 HG22 HD12 ' A' ' 78' ' ' LEU . 97.3 t -122.64 152.81 27.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.392 -0.367 . . . . 1.07 110.664 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -92.37 83.46 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.542 0.687 . . . . 1.81 109.953 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.2 p -74.52 109.77 8.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.792 -1.095 . . . . 1.08 109.527 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.2 t -49.21 -27.85 4.02 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.93 0.715 . . . . 1.72 112.93 -172.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -84.44 -21.21 30.8 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.299 0.481 . . . . 1.3 112.299 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.09 -44.85 1.03 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.167 0.508 . . . . 4.21 111.073 -173.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.46 -152.04 16.87 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.762 -0.654 . . . . 0.24 111.834 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.572 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 5.5 m95 -53.78 119.98 5.67 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.171 0.51 . . . . 0.47 110.638 173.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.9 p -69.2 170.44 10.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.58 -0.737 . . . . 1.07 111.521 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -63.68 125.68 25.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.453 -0.943 . . . . 1.84 108.453 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 38.2 tt0 -61.58 118.38 6.97 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.621 0.724 . . . . 1.0 110.666 -175.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.556 ' SG ' HD11 ' A' ' 81' ' ' LEU . 57.2 m -91.94 98.18 11.42 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.785 -1.098 . . . . 0.44 110.499 -175.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.7 mp -74.63 124.34 32.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.945 -0.57 . . . . 1.49 110.313 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.72 -167.65 43.72 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.1 -0.955 . . . . 0.24 112.848 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 64' ' ' MET . 40.9 mt-10 -89.74 148.62 40.38 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-O 120.545 0.212 . . . . 1.37 111.013 -174.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.57 106.7 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.814 2.342 . . . . 0.79 111.396 172.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.548 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.4 mmm -115.08 143.49 30.31 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.077 -0.51 . . . . 1.4 110.409 -173.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.32 3.89 5.38 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.737 2.291 . . . . 0.37 113.312 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.9 t -143.65 140.06 29.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.498 -0.556 . . . . 1.63 109.498 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.6 m -64.62 -32.93 59.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.772 -0.649 . . . . 1.88 111.482 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -64.07 -42.13 97.1 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 120.927 0.394 . . . . 3.34 110.559 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.417 ' HE2' ' CE ' ' A' ' 64' ' ' MET . 43.4 mtpt -74.6 -25.16 59.08 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.99 -0.55 . . . . 1.91 110.091 -177.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.52 -59.81 4.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.792 -0.64 . . . . 1.07 110.696 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.693 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 52.8 pttt -61.92 -43.03 99.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.726 -0.215 . . . . 2.9 110.91 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.515 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.9 m-20 -52.35 -50.8 61.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.879 0.696 . . . . 2.01 112.879 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.3 p -66.54 -39.45 88.56 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.882 0.327 . . . . 1.8 111.882 -175.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.474 ' HB1' ' CE2' ' A' ' 44' ' ' PHE . . . -68.18 -42.29 80.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.262 0.553 . . . . 1.07 110.464 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.48 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -53.72 -36.05 61.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.222 -0.899 . . . . 1.01 111.275 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 72' ' ' ASP . 94.9 t -62.36 -37.13 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.009 0.433 . . . . 1.53 110.595 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.0 mt -75.11 -32.94 61.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.611 0.719 . . . . 1.12 109.543 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.427 HD12 HG22 ' A' ' 48' ' ' VAL . 19.1 tp -64.59 -39.21 93.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.825 -1.08 . . . . 1.44 110.905 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.7 mm? -59.52 -28.24 66.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.578 -0.737 . . . . 2.23 111.039 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -72.76 -35.4 67.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.081 0.467 . . . . 2.13 110.695 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.556 HD11 ' SG ' ' A' ' 59' ' ' CYS . 1.3 tt -62.96 -49.57 74.22 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.968 -0.753 . . . . 1.84 108.968 175.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 mp -70.16 -2.77 14.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.198 -0.91 . . . . 1.82 111.655 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 . . . . . 0 C--N 1.322 -0.6 0 CA-C-O 121.481 0.658 . . . . 2.08 109.478 178.296 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.458 ' N ' HD12 ' A' ' 17' ' ' ILE . 2.3 mp . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 121.042 0.449 . . . . 1.42 110.325 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.4 m -68.56 -44.64 74.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.906 0.86 . . . . 1.98 110.003 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 tt -62.43 -45.69 91.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.228 -1.351 . . . . 1.77 110.483 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.411 ' NH2' HG21 ' A' ' 17' ' ' ILE . 51.8 ttp85 -60.37 -38.2 83.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.578 -0.737 . . . . 4.47 111.644 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.449 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 28.2 mmmt -72.93 0.39 11.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.549 -0.751 . . . . 1.67 112.082 -176.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 62.87 51.05 3.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.092 0.948 . . . . 2.37 110.011 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.414 ' CZ3' ' HG ' ' A' ' 82' ' ' LEU . 39.6 m0 -113.26 166.11 11.85 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.183 -0.917 . . . . 0.4 109.223 175.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.62 162.04 33.35 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.957 1.771 . . . . 0.6 109.407 167.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 65.2 mmm -74.75 127.96 86.22 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 110.212 -0.292 . . . . 1.56 110.212 -173.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HB3' HG22 ' A' ' 48' ' ' VAL . 1.2 Cg_endo -50.99 163.63 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 124.01 3.14 . . . . 0.68 114.887 -173.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.452 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 25.3 t -81.02 144.25 31.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.338 -1.301 . . . . 1.02 109.232 175.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.484 ' HD2' ' CZ ' ' A' ' 44' ' ' PHE . 72.6 m-85 -140.52 111.76 7.2 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.844 -0.798 . . . . 0.87 108.844 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.46 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 36.4 ttm180 -151.92 124.07 8.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.042 -0.355 . . . . 4.22 110.042 -176.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.441 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 83.8 m -66.84 124.92 24.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.953 0.406 . . . . 2.19 110.435 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -85.2 -35.81 10.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.835 -0.62 . . . . 1.87 110.829 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.6 tptt . . . . . 0 C--N 1.318 -0.768 0 CA-C-N 115.985 -0.552 . . . . 2.76 110.277 178.081 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 108.535 -0.913 . . . . 4.07 108.535 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 8.0 m-85 -112.84 132.09 55.43 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.63 -0.714 . . . . 1.16 110.158 -174.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.0 m -119.85 130.01 54.68 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.064 -1.087 . . . . 1.08 108.064 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.684 ' CZ ' HG23 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -137.81 152.66 49.35 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.526 -0.546 . . . . 0.21 109.526 -175.049 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.82 138.74 10.49 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.037 -0.602 . . . . 0.2 111.901 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.684 HG23 ' CZ ' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -105.93 157.71 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 109.503 -0.554 . . . . 1.45 109.503 -176.691 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.585 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 24.2 ptt180 -146.72 141.81 27.16 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.983 -1.118 . . . . 3.01 107.983 173.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 26' ' ' PRO . 39.8 t -118.62 155.47 20.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.523 -0.308 . . . . 1.07 110.374 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -96.05 84.04 3.75 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.635 0.731 . . . . 1.81 109.635 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.537 ' OG1' ' HB2' ' A' ' 53' ' ' ARG . 37.7 p -68.29 113.33 5.8 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.298 -1.319 . . . . 1.08 109.223 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.0 t -52.48 -27.29 15.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.776 -0.647 . . . . 1.72 112.664 -171.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -100.54 -4.69 28.14 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.416 0.525 . . . . 1.3 112.416 -176.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.537 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 68.6 mtt180 -130.44 -52.25 1.09 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.232 0.539 . . . . 4.21 110.897 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.73 -152.86 17.21 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.326 -0.852 . . . . 0.24 112.397 -175.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.585 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.4 m95 -55.79 120.28 7.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.067 0.461 . . . . 0.47 111.23 176.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.9 p -71.73 161.54 30.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.742 -0.663 . . . . 1.07 110.837 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.96 132.15 51.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.271 -0.641 . . . . 1.84 109.271 174.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -56.57 116.94 3.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.58 -0.737 . . . . 1.0 110.937 -175.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.1 m -93.19 97.89 10.94 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.908 -1.042 . . . . 0.44 110.114 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.3 mm -75.62 123.77 32.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.572 -0.74 . . . . 1.49 110.619 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.36 -167.01 42.77 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.867 -0.606 . . . . 0.24 112.073 177.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -88.44 137.2 30.76 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 110.236 -0.283 . . . . 1.37 110.236 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 50.2 Cg_exo -53.79 116.35 2.95 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.843 2.362 . . . . 0.79 111.602 176.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.651 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 18.6 mmt -115.37 153.01 47.53 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.113 -0.494 . . . . 1.4 111.082 -173.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -82.23 9.79 3.83 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.897 2.398 . . . . 0.37 113.135 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.9 t -155.78 139.38 15.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.2 -0.667 . . . . 1.63 109.2 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.65 -22.86 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 1.88 111.901 -173.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -75.24 -42.93 54.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.901 0.381 . . . . 3.34 110.597 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.651 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 0.2 OUTLIER -82.31 -17.36 46.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.188 -0.46 . . . . 1.91 110.384 178.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.76 -57.55 12.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.252 -0.431 . . . . 1.07 110.425 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.632 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 61.2 mttm -52.66 -49.34 65.41 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.072 -0.513 . . . . 2.9 110.433 174.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.509 ' O ' HG21 ' A' ' 76' ' ' VAL . 25.9 t70 -49.34 -49.87 42.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.933 -1.031 . . . . 2.01 112.3 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.0 t -58.42 -48.53 80.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.788 0.328 . . . . 1.8 111.453 -178.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.51 83.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.28 0.562 . . . . 1.07 110.777 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.423 ' O ' HD11 ' A' ' 79' ' ' LEU . . . -60.38 -30.74 69.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.475 -0.784 . . . . 1.01 111.646 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 72' ' ' ASP . 73.9 t -63.72 -37.81 80.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 121.09 0.472 . . . . 1.53 110.248 176.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.92 -28.73 58.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.841 -0.618 . . . . 1.12 109.796 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mt -60.1 -44.32 94.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.341 -0.845 . . . . 1.44 110.553 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.423 HD11 ' O ' ' A' ' 75' ' ' ALA . 7.6 mp -61.47 -28.42 69.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.518 -0.764 . . . . 2.23 111.777 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -71.95 -44.54 63.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.859 0.361 . . . . 2.13 110.46 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.2 tt -61.39 -48.94 78.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.608 0.718 . . . . 1.84 109.23 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.414 ' HG ' ' CZ3' ' A' ' 23' ' ' TRP . 1.6 mp -65.02 -20.12 66.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.792 -1.094 . . . . 1.82 112.414 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.2 t30 . . . . . 0 C--N 1.323 -0.57 0 CA-C-O 121.691 0.757 . . . . 2.08 109.528 179.698 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.456 ' N ' HD13 ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 CA--C 1.522 -0.111 0 CA-C-O 121.016 0.436 . . . . 1.42 110.119 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.0 m -65.54 -43.99 88.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.654 -0.703 . . . . 1.98 110.007 177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.5 tp -60.02 -52.1 66.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.249 -0.887 . . . . 1.77 110.081 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -55.81 -41.6 74.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.908 -1.042 . . . . 4.47 111.451 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -75.06 0.87 14.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.867 -0.606 . . . . 1.67 112.096 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.8 t30 68.11 25.43 7.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.905 0.859 . . . . 2.37 110.007 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -91.52 161.36 34.58 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.314 -0.857 . . . . 0.4 109.79 176.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -74.08 178.82 6.41 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 122.149 1.899 . . . . 0.6 110.763 168.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.406 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 23.9 mmt -80.05 139.94 53.39 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 116.081 -0.509 . . . . 1.56 110.01 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 12.1 Cg_exo -67.17 159.01 54.13 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.507 2.138 . . . . 0.68 112.578 -174.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.5 t -82.12 143.89 31.15 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.314 -0.857 . . . . 1.02 109.392 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.552 ' HD2' ' CZ ' ' A' ' 44' ' ' PHE . 64.7 m-85 -136.71 110.19 7.96 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.474 -0.935 . . . . 0.87 108.474 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.535 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 67.6 mtp180 -143.0 122.33 13.06 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.658 -0.247 . . . . 4.22 110.638 -173.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 35.5 t -71.4 120.49 17.06 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.979 -0.378 . . . . 2.19 109.979 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -86.55 -35.68 9.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.234 -0.439 . . . . 1.87 111.384 -176.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.1 tptt . . . . . 0 C--N 1.32 -0.685 0 CA-C-O 121.287 0.565 . . . . 2.76 111.13 179.787 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 107.772 -1.195 . . . . 4.07 107.772 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -110.35 136.57 49.32 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.119 0.485 . . . . 1.16 110.365 -168.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 m -126.4 133.49 51.27 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.335 -0.848 . . . . 1.08 109.056 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.718 ' CZ ' HG23 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -140.37 152.89 46.13 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.305 -0.628 . . . . 0.21 109.305 -174.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -126.24 139.89 11.7 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.801 -0.714 . . . . 0.2 112.287 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.718 HG23 ' CZ ' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -107.75 156.14 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.908 -0.405 . . . . 1.45 109.908 -176.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.518 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 11.7 ptp180 -146.45 148.86 32.69 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.526 -0.916 . . . . 3.01 108.526 172.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.0 t -123.75 152.4 29.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 O-C-N 123.157 0.286 . . . . 1.07 110.616 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -94.62 88.82 5.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.765 0.793 . . . . 1.81 110.243 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.56 ' OG1' ' HB3' ' A' ' 53' ' ' ARG . 37.7 p -71.65 113.3 8.54 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.422 -1.263 . . . . 1.08 109.585 177.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.9 t -52.09 -25.23 8.28 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.925 0.713 . . . . 1.72 112.925 -172.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -113.32 12.12 18.78 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.599 -0.44 . . . . 1.3 112.012 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.56 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 41.5 ttm180 -146.56 -50.27 0.21 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.946 0.403 . . . . 4.21 110.886 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.77 -162.47 19.0 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 116.156 -0.474 . . . . 0.24 113.03 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.518 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 15.3 m95 -52.57 117.97 3.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.111 0.481 . . . . 0.47 110.765 174.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.0 p -70.83 178.89 2.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.36 -0.836 . . . . 1.07 112.063 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -63.73 134.83 56.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.517 -0.765 . . . . 1.84 109.697 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.65 113.53 4.31 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.399 0.619 . . . . 1.0 110.166 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.486 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 63.7 m -88.75 97.4 11.12 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.966 -1.016 . . . . 0.44 109.849 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.3 mm -81.66 122.92 37.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.451 -0.795 . . . . 1.49 110.068 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.26 -171.97 48.15 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.953 -0.641 . . . . 0.24 112.037 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.602 ' O ' ' HG2' ' A' ' 64' ' ' MET . 40.1 mt-10 -86.35 151.08 53.12 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.972 -0.381 . . . . 1.37 109.972 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.68 112.6 1.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.379 2.053 . . . . 0.79 110.83 172.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.602 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 97.1 mmm -115.51 142.44 28.82 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.384 -0.371 . . . . 1.4 110.35 -173.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.99 14.32 1.54 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.66 2.24 . . . . 0.37 113.713 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.446 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 30.0 t -157.57 143.2 17.29 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.646 -0.502 . . . . 1.63 109.646 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.1 m -71.44 -22.31 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.892 -0.595 . . . . 1.88 111.675 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -73.56 -47.31 41.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.119 -0.492 . . . . 3.34 110.419 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.446 ' HG2' ' HB3' ' A' ' 66' ' ' SER . 15.5 ptpt -81.15 -16.86 51.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.863 -0.608 . . . . 1.91 110.768 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.1 -56.21 24.95 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.316 -0.402 . . . . 1.07 110.47 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.635 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 55.5 mttp -54.19 -47.18 72.35 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.186 -0.461 . . . . 2.9 110.837 176.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.564 ' O ' HG22 ' A' ' 76' ' ' VAL . 19.6 m-20 -52.09 -49.45 63.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.017 -0.538 . . . . 2.01 111.85 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.7 t -59.95 -46.64 88.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.595 0.236 . . . . 1.8 111.538 -175.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.452 ' HB1' ' CE2' ' A' ' 44' ' ' PHE . . . -66.38 -42.04 88.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.189 0.519 . . . . 1.07 110.554 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.448 ' O ' HD11 ' A' ' 79' ' ' LEU . . . -53.33 -38.26 63.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.209 -0.905 . . . . 1.01 111.516 177.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 72' ' ' ASP . 57.6 t -63.02 -36.68 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.897 0.38 . . . . 1.53 110.743 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 85.3 mt -74.66 -32.88 62.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.765 0.793 . . . . 1.12 109.44 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.9 tp -65.42 -39.38 92.07 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.557 -1.201 . . . . 1.44 110.781 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.448 HD11 ' O ' ' A' ' 75' ' ' ALA . 7.3 mp -58.94 -29.86 67.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.745 -0.662 . . . . 2.23 111.045 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -69.84 -38.6 76.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.08 0.467 . . . . 2.13 110.422 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.475 HD13 ' SG ' ' A' ' 59' ' ' CYS . 1.4 tt -63.85 -52.56 59.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.543 -0.753 . . . . 1.84 109.607 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.2 mp -67.26 -10.32 49.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.402 -0.817 . . . . 1.82 112.219 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.4 t30 . . . . . 0 C--N 1.32 -0.681 0 CA-C-O 121.498 0.666 . . . . 2.08 109.87 179.136 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 17' ' ' ILE . 2.7 mp . . . . . 0 CA--C 1.52 -0.176 0 CA-C-O 121.403 0.621 . . . . 1.42 109.813 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.0 m -55.32 -40.18 70.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.577 -1.192 . . . . 1.98 110.786 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.1 tp -61.78 -53.52 54.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.039 -0.982 . . . . 1.77 110.584 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -61.61 -28.9 69.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.303 -0.862 . . . . 4.47 111.242 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -73.75 2.51 8.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.958 -0.564 . . . . 1.67 112.338 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.9 t30 63.9 37.59 9.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.278 -0.874 . . . . 2.37 110.056 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.576 ' CH2' HG21 ' A' ' 50' ' ' THR . 34.9 m0 -103.63 160.18 26.93 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.421 -0.809 . . . . 0.4 109.657 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.33 177.98 3.44 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.256 1.971 . . . . 0.6 111.265 171.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.462 ' HA ' ' HE1' ' A' ' 25' ' ' MET . 24.4 mmt -71.83 127.29 90.95 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 120.824 0.345 . . . . 1.56 110.721 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 23.7 Cg_exo -62.19 159.43 34.97 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.749 2.299 . . . . 0.68 111.928 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.507 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 10.5 t -88.61 140.3 29.59 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.696 -0.684 . . . . 1.02 109.721 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.487 ' HD2' ' CZ ' ' A' ' 44' ' ' PHE . 74.1 m-85 -137.15 110.77 8.05 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.247 -1.02 . . . . 0.87 108.247 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.564 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 37.8 ttm180 -136.17 117.9 15.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.473 0.178 . . . . 4.22 110.79 -172.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.453 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 73.0 m -62.01 116.93 5.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.889 0.376 . . . . 2.19 110.29 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.6 t -87.36 -41.92 14.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.929 -0.578 . . . . 1.87 110.809 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 27.0 tptp . . . . . 0 C--N 1.325 -0.492 0 CA-C-O 121.068 0.461 . . . . 2.76 111.208 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.415 ' HB2' ' HB3' ' A' ' 63' ' ' PRO . 9.5 ptm180 . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.511 0.672 . . . . 4.07 111.012 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -109.85 131.77 54.76 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.015 -0.993 . . . . 1.16 109.197 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 32' ' ' LYS . 27.6 m -130.49 125.15 33.64 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.705 -0.68 . . . . 1.08 109.169 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.737 ' CZ ' HG21 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -139.13 153.86 48.04 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.655 -0.498 . . . . 0.21 109.655 -175.038 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 60' ' ' ILE . . . -127.99 138.93 10.73 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.99 -0.624 . . . . 0.2 112.2 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.737 HG21 ' CZ ' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -107.01 158.46 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 110.166 -0.309 . . . . 1.45 110.166 -174.672 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.565 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 19.7 ptt180 -148.3 146.99 28.81 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.835 -0.802 . . . . 3.01 108.835 173.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.433 HG22 HD13 ' A' ' 78' ' ' LEU . 28.6 t -124.3 156.75 32.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.565 0.221 . . . . 1.07 110.889 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -94.61 83.89 4.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.397 0.618 . . . . 1.81 110.031 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.576 HG21 ' CH2' ' A' ' 23' ' ' TRP . 34.4 p -78.1 105.73 9.51 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.932 -1.031 . . . . 1.08 109.71 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.2 m -43.98 -33.06 1.3 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.069 -0.969 . . . . 1.72 113.042 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.422 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 4.6 p-10 -63.02 -40.17 96.95 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.758 0.651 . . . . 1.3 112.758 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -129.01 -37.56 1.7 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.993 0.425 . . . . 4.21 111.653 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.76 -148.24 16.74 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.93 -0.577 . . . . 0.24 112.364 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.565 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.9 m95 -51.24 119.19 3.81 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.17 0.509 . . . . 0.47 111.342 175.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.3 p -69.48 167.55 16.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.559 -0.746 . . . . 1.07 110.735 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.85 132.84 49.63 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.829 -0.804 . . . . 1.84 108.829 174.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 40.9 tt0 -65.76 115.75 6.23 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.912 -1.04 . . . . 1.0 110.706 -174.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.8 m -96.14 105.3 17.33 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.63 -1.168 . . . . 0.44 110.65 -174.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.484 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 1.8 mp -88.03 132.13 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.305 0.574 . . . . 1.49 111.305 -177.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.54 -176.62 51.05 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 114.909 -1.041 . . . . 0.24 111.809 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 64' ' ' MET . 13.0 pt-20 -92.07 158.06 40.04 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.816 0.308 . . . . 1.37 110.673 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.415 ' HB3' ' HB2' ' A' ' 41' ' ' ARG . 72.0 Cg_exo -50.45 105.21 0.1 OUTLIER 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.398 2.732 . . . . 0.79 112.683 174.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.0 mmm -108.74 145.27 31.29 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 110.152 -0.314 . . . . 1.4 110.152 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.85 13.13 2.22 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.703 2.269 . . . . 0.37 113.75 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.414 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 14.4 t -154.05 142.11 20.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.498 -0.927 . . . . 1.63 108.498 177.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.0 p -71.74 -22.01 21.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.149 -0.478 . . . . 1.88 110.529 -174.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -73.13 -39.4 65.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.021 -0.536 . . . . 3.34 109.616 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HG3' ' HB3' ' A' ' 66' ' ' SER . 27.5 mtpp -75.34 -23.39 57.22 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.975 -0.557 . . . . 1.91 109.943 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.08 -53.41 58.55 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.579 -0.737 . . . . 1.07 109.93 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.629 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 66.4 mttm -52.49 -54.58 30.57 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 115.611 -0.722 . . . . 2.9 111.067 176.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.516 ' O ' HG23 ' A' ' 76' ' ' VAL . 33.4 m-20 -55.22 -44.78 75.74 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.945 -0.571 . . . . 2.01 112.452 -177.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.482 ' OG ' ' HG2' ' A' ' 62' ' ' GLU . 44.3 t -59.25 -46.29 88.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 1.8 111.113 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.417 ' HB2' ' CE2' ' A' ' 44' ' ' PHE . . . -68.44 -38.7 81.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.185 0.517 . . . . 1.07 110.15 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.494 ' O ' HD12 ' A' ' 79' ' ' LEU . . . -56.44 -37.35 70.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.261 -0.881 . . . . 1.01 111.514 177.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 72' ' ' ASP . 94.7 t -63.24 -38.08 81.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.981 0.42 . . . . 1.53 110.679 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.7 mt -77.82 -23.35 49.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.885 0.85 . . . . 1.12 109.334 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.467 HD11 ' HB ' ' A' ' 46' ' ' VAL . 16.4 tp -70.34 -49.01 53.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.716 -1.129 . . . . 1.44 110.403 173.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 75' ' ' ALA . 6.2 mp -53.67 -34.12 57.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.581 -0.736 . . . . 2.23 112.248 -177.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -78.86 -34.02 45.33 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.373 -0.531 . . . . 2.13 110.855 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.87 -51.68 60.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.883 0.373 . . . . 1.84 110.086 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -71.43 -7.46 47.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 1.82 111.37 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 C--N 1.319 -0.719 0 CA-C-O 121.442 0.639 . . . . 2.08 109.841 175.531 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 N--CA 1.46 0.031 0 CA-C-O 120.875 0.369 . . . . 1.42 110.688 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.5 t -63.89 -45.33 89.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.367 0.603 . . . . 1.98 110.273 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.19 -44.1 97.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.109 -0.95 . . . . 1.77 110.838 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -65.13 -33.75 76.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.971 -1.013 . . . . 4.47 111.12 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.478 ' HZ1' ' HB3' ' A' ' 21' ' ' LYS . 4.6 mmmp? -74.18 2.69 8.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.123 -0.49 . . . . 1.67 111.574 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 67.39 30.2 7.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.935 0.874 . . . . 2.37 109.991 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 27.7 m0 -93.54 160.24 33.35 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.406 -0.815 . . . . 0.4 109.073 174.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.6 -173.29 0.67 Allowed 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.183 1.922 . . . . 0.6 111.087 172.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.441 ' HE3' ' HA ' ' A' ' 25' ' ' MET . 5.9 mmt -75.64 145.67 79.08 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.677 -0.49 . . . . 1.56 109.677 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 2.7 Cg_exo -74.89 165.96 30.29 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.495 2.13 . . . . 0.68 112.421 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.3 t -84.73 144.4 28.54 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.161 -0.927 . . . . 1.02 109.912 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.515 ' HD1' ' CZ ' ' A' ' 44' ' ' PHE . 69.0 m-85 -143.95 109.93 5.34 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.361 -0.607 . . . . 0.87 109.361 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.513 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 14.0 ptm180 -152.52 128.92 10.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.949 0.404 . . . . 4.22 110.874 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.412 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 77.3 m -65.89 124.87 23.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.865 -0.607 . . . . 2.19 111.286 -176.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -84.82 -37.67 12.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.808 -0.633 . . . . 1.87 110.286 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 121.173 0.511 . . . . 2.76 111.178 -179.318 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.064 -0.717 . . . . 4.07 109.064 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -109.56 149.1 30.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.532 -0.758 . . . . 1.16 110.877 -172.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.5 m -129.76 129.6 44.32 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.142 -0.935 . . . . 1.08 109.289 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.724 ' CZ ' HG21 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -137.13 153.65 50.46 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.069 -0.715 . . . . 0.21 109.069 -174.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -126.66 138.73 10.82 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.757 -0.735 . . . . 0.2 112.317 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.724 HG21 ' CZ ' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -107.15 158.6 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 109.309 -0.626 . . . . 1.45 109.309 -177.124 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.574 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 11.8 ptp180 -148.49 148.96 30.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.05 -0.722 . . . . 3.01 109.05 173.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.442 HG22 HD11 ' A' ' 78' ' ' LEU . 73.9 t -125.06 153.7 32.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 123.309 0.381 . . . . 1.07 110.627 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -92.52 85.31 5.28 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.562 0.696 . . . . 1.81 110.576 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.2 p -73.32 112.37 9.32 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.933 -1.031 . . . . 1.08 109.716 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 t -49.84 -28.4 6.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.68 -0.691 . . . . 1.72 112.151 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -82.24 -22.78 35.69 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.154 0.798 . . . . 1.3 113.154 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -134.47 -43.66 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.905 -0.497 . . . . 4.21 111.609 -173.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.77 -152.57 16.88 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 116.093 -0.503 . . . . 0.24 111.896 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.574 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.9 m95 -53.01 120.79 6.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.99 0.424 . . . . 0.47 110.686 174.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.2 p -71.05 160.96 31.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.679 -0.691 . . . . 1.07 111.0 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -60.64 128.34 36.1 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.221 -0.659 . . . . 1.84 109.221 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -54.71 123.58 13.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.931 -1.032 . . . . 1.0 111.026 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.431 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 57.8 m -95.77 97.8 9.96 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.356 -0.838 . . . . 0.44 110.124 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.12 126.23 38.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.556 -0.747 . . . . 1.49 110.887 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.5 -177.89 51.87 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.238 -0.892 . . . . 0.24 112.896 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -85.14 147.08 46.76 Favored Pre-proline 0 C--N 1.317 -0.826 0 N-CA-C 109.966 -0.383 . . . . 1.37 109.966 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.05 105.79 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.643 2.228 . . . . 0.79 111.45 175.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.634 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 16.3 mmt -113.27 139.84 23.62 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.152 -0.477 . . . . 1.4 111.192 -173.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.74 10.14 2.39 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.662 2.242 . . . . 0.37 113.323 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.8 t -152.54 137.88 17.55 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.144 -0.687 . . . . 1.63 109.144 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -68.06 -23.21 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 1.88 111.688 -173.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -74.1 -44.99 51.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.904 0.383 . . . . 3.34 110.423 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.634 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 0.2 OUTLIER -81.04 -17.76 49.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 1.91 109.973 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.87 -56.65 19.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.847 -0.615 . . . . 1.07 110.092 173.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.636 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 58.1 mtpt -50.92 -48.16 60.76 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 116.261 -0.427 . . . . 2.9 110.753 174.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.525 ' O ' HG23 ' A' ' 76' ' ' VAL . 36.8 m-20 -52.46 -51.72 57.89 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.389 0.514 . . . . 2.01 112.389 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.2 p -60.9 -40.23 92.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.707 0.289 . . . . 1.8 111.456 -175.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.38 -44.97 70.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.144 0.497 . . . . 1.07 110.376 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.505 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -55.99 -35.99 67.4 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.306 -0.861 . . . . 1.01 111.754 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 72' ' ' ASP . 91.8 t -64.92 -38.23 82.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.978 0.418 . . . . 1.53 110.7 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.6 mt -76.42 -26.43 55.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.916 0.865 . . . . 1.12 109.271 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.493 ' HG ' ' CD2' ' A' ' 82' ' ' LEU . 16.0 tp -70.98 -54.5 11.04 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.553 -1.203 . . . . 1.44 111.256 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.505 HD13 ' O ' ' A' ' 75' ' ' ALA . 4.2 mp -55.32 -29.24 57.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.914 -0.584 . . . . 2.23 112.546 -174.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.86 -33.8 60.02 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.276 -0.57 . . . . 2.13 110.598 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.1 -50.54 63.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.108 -0.496 . . . . 1.84 110.091 -177.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.493 ' CD2' ' HG ' ' A' ' 78' ' ' LEU . 1.4 mm? -67.04 -29.45 69.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 1.82 111.124 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 C--N 1.32 -0.704 0 N-CA-C 109.329 -0.619 . . . . 2.08 109.329 -179.943 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 mp . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 121.353 0.597 . . . . 1.42 110.457 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.536 ' SG ' ' HB2' ' A' ' 23' ' ' TRP . 22.4 t -75.18 -38.49 60.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.397 -0.82 . . . . 1.98 109.708 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.7 tp -60.1 -53.08 62.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.139 -0.937 . . . . 1.77 110.606 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -56.53 -37.94 71.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.064 -0.971 . . . . 4.47 111.71 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.8 mmtm -73.96 5.63 4.06 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.993 -0.549 . . . . 1.67 111.918 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 66.48 27.22 9.83 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.597 -0.728 . . . . 2.37 110.937 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.536 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.0 m0 -101.0 154.11 37.34 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.557 -0.747 . . . . 0.4 109.011 175.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.91 173.65 14.14 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.232 1.955 . . . . 0.6 110.631 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.43 ' HA ' ' HE1' ' A' ' 25' ' ' MET . 31.6 mmt -62.26 127.4 89.62 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.791 0.329 . . . . 1.56 110.921 -177.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.528 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 70.1 Cg_exo -54.89 165.01 2.9 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.567 2.845 . . . . 0.68 113.678 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.478 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 25.1 t -89.58 142.39 27.72 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.987 -1.006 . . . . 1.02 109.388 177.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.528 ' CE1' ' HB2' ' A' ' 26' ' ' PRO . 95.9 m-85 -140.75 108.72 5.71 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.277 -1.008 . . . . 0.87 108.277 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.525 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 48.7 mmt-85 -147.83 118.5 7.52 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.324 -0.621 . . . . 4.22 109.324 -173.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 15.5 p -69.47 129.09 38.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.041 0.448 . . . . 2.19 110.953 -177.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.1 m -85.79 -32.81 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.82 -0.627 . . . . 1.87 111.15 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.0 tttm . . . . . 0 C--N 1.319 -0.718 0 CA-C-N 116.081 -0.509 . . . . 2.76 110.226 177.199 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 . . . . . 0 N--CA 1.448 -0.553 0 CA-C-O 121.181 0.515 . . . . 4.07 109.66 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.609 ' CZ ' HG22 ' A' ' 67' ' ' VAL . 71.2 m-85 -111.54 131.43 55.25 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.469 -0.787 . . . . 1.16 110.191 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 m -120.24 121.68 39.23 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.466 -1.309 . . . . 1.08 107.466 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.677 ' CZ ' HG21 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -136.85 151.28 48.94 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.631 -0.507 . . . . 0.21 109.631 -170.158 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.454 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -123.69 137.96 11.19 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.204 -0.522 . . . . 0.2 111.932 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.677 HG21 ' CZ ' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -106.75 155.57 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 109.731 -0.47 . . . . 1.45 109.731 -174.636 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.617 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 8.3 ptp85 -147.95 142.31 26.3 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.626 -0.879 . . . . 3.01 108.626 176.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.436 HG23 HD13 ' A' ' 82' ' ' LEU . 95.4 t -124.65 153.24 31.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.342 -0.39 . . . . 1.07 110.381 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -92.01 82.8 5.1 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.723 0.773 . . . . 1.81 110.203 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 35.3 p -67.94 116.82 9.02 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.438 -1.256 . . . . 1.08 110.143 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.8 p -51.95 -26.53 10.67 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.462 -1.244 . . . . 1.72 113.013 -176.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -89.11 -17.42 29.27 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.032 0.753 . . . . 1.3 113.032 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -139.16 -44.72 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.488 0.585 . . . . 4.21 112.408 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.66 -150.61 17.14 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.919 -0.658 . . . . 0.24 112.337 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.617 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.9 m95 -53.66 118.17 3.71 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.034 0.445 . . . . 0.47 110.771 176.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.3 p -65.63 165.06 13.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.56 -0.745 . . . . 1.07 111.37 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -61.46 135.27 57.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.046 -0.724 . . . . 1.84 109.046 172.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.94 113.27 2.0 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.889 -175.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 60.1 m -91.39 97.32 11.02 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.089 -0.959 . . . . 0.44 109.831 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.454 HD13 ' HA3' ' A' ' 45' ' ' GLY . 13.2 mm -81.84 126.01 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 115.832 -0.622 . . . . 1.49 110.251 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.82 -170.84 47.07 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.913 -0.66 . . . . 0.24 111.96 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.593 ' O ' ' HG2' ' A' ' 64' ' ' MET . 38.7 mt-10 -88.54 145.07 34.62 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.214 -0.662 . . . . 1.37 109.214 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -55.83 110.44 0.56 Allowed 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.587 2.191 . . . . 0.79 111.758 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.593 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.8 mmm -112.2 140.59 23.75 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.633 -0.506 . . . . 1.4 109.633 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.61 18.51 0.96 Allowed 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.637 2.225 . . . . 0.37 113.667 -175.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.417 ' HB2' ' CD ' ' A' ' 69' ' ' LYS . 28.7 m -157.56 139.09 13.83 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.227 -0.657 . . . . 1.63 109.227 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.609 HG22 ' CZ ' ' A' ' 42' ' ' PHE . 1.1 t -67.35 -38.67 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.335 -0.848 . . . . 1.88 112.259 -167.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -71.21 -39.71 71.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.463 -0.335 . . . . 3.34 111.118 -175.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.417 ' CD ' ' HB2' ' A' ' 66' ' ' SER . 17.3 ptmt -80.92 -18.52 46.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.888 0.375 . . . . 1.91 110.182 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.62 -55.9 25.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 1.07 110.645 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.622 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 5.6 ptpp? -58.54 -43.18 89.19 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 116.592 -0.276 . . . . 2.9 110.767 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.564 ' O ' HG23 ' A' ' 76' ' ' VAL . 5.7 m-20 -54.92 -47.08 74.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 2.01 111.973 176.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.2 t -58.65 -46.36 87.32 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.851 0.358 . . . . 1.8 111.321 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.412 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -68.85 -42.81 76.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.022 0.439 . . . . 1.07 110.589 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.498 ' O ' HD12 ' A' ' 79' ' ' LEU . . . -56.12 -34.19 65.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.447 -0.797 . . . . 1.01 111.517 177.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 72' ' ' ASP . 94.2 t -63.51 -36.57 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.916 0.389 . . . . 1.53 110.61 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.98 -34.04 64.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.712 0.767 . . . . 1.12 109.271 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.489 HD21 ' CG1' ' A' ' 46' ' ' VAL . 26.3 tp -64.82 -42.56 94.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.602 -1.181 . . . . 1.44 110.797 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.498 HD12 ' O ' ' A' ' 75' ' ' ALA . 7.3 mp -60.33 -26.96 66.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.03 -0.532 . . . . 2.23 111.215 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -71.37 -40.0 70.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.227 0.537 . . . . 2.13 110.274 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.8 tp -65.55 -46.55 79.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.359 -0.837 . . . . 1.84 110.077 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 78' ' ' LEU . 42.2 mt -70.09 -12.89 61.93 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.514 -1.221 . . . . 1.82 111.19 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 . . . . . 0 C--N 1.317 -0.828 0 CA-C-O 121.588 0.709 . . . . 2.08 109.554 176.694 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.444 HD11 ' N ' ' A' ' 17' ' ' ILE . 2.5 mp . . . . . 0 C--O 1.232 0.164 0 CA-C-O 121.006 0.431 . . . . 1.42 110.734 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 23' ' ' TRP . 41.2 t -72.29 -39.81 68.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.274 0.559 . . . . 1.98 109.971 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.0 tp -61.08 -51.54 68.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.305 -0.861 . . . . 1.77 110.153 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -54.98 -36.53 65.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.218 -0.901 . . . . 4.47 111.489 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -72.52 1.84 7.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.906 -0.588 . . . . 1.67 111.971 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 64.96 26.08 12.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.35 -0.841 . . . . 2.37 111.361 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.425 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 34.0 m0 -96.62 154.29 38.52 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.695 -0.483 . . . . 0.4 109.695 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.87 169.71 20.58 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.519 2.146 . . . . 0.6 110.811 173.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.449 ' HA ' ' HE2' ' A' ' 25' ' ' MET . 26.8 mmt -63.03 130.22 93.97 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.691 -0.231 . . . . 1.56 111.106 -175.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.31 165.78 25.71 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.881 2.387 . . . . 0.68 112.865 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.411 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 16.8 t -87.97 141.34 28.65 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.045 -0.98 . . . . 1.02 109.995 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.472 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 75.6 m-85 -138.92 110.63 7.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.768 -0.827 . . . . 0.87 108.768 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.5 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 78.0 mtp180 -148.29 123.93 10.47 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 110.165 -0.309 . . . . 4.22 110.165 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 71.2 m -61.12 121.08 11.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.997 0.427 . . . . 2.19 110.648 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.2 t -82.34 -38.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.787 -0.642 . . . . 1.87 110.046 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--N 1.324 -0.54 0 N-CA-C 109.297 -0.631 . . . . 2.76 109.297 176.795 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 107.102 -1.444 . . . . 4.07 107.102 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -108.92 131.2 55.26 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.285 0.564 . . . . 1.16 109.743 -172.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.6 m -120.01 118.0 29.5 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.886 -1.153 . . . . 1.08 107.886 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.696 ' CZ ' HG21 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -129.74 153.56 48.07 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.329 -0.619 . . . . 0.21 109.329 -172.266 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -127.79 137.76 10.01 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.514 -0.634 . . . . 0.2 111.514 178.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.696 HG21 ' CZ ' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -105.99 155.0 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 N-CA-C 109.406 -0.59 . . . . 1.45 109.406 -177.462 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.565 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 12.4 ptp180 -143.68 141.27 30.46 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 107.784 -1.191 . . . . 3.01 107.784 173.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.1 t -117.19 152.4 19.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.304 -0.407 . . . . 1.07 110.11 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -94.95 83.62 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.049 0.928 . . . . 1.81 109.853 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.8 p -70.48 116.05 10.37 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.775 -1.557 . . . . 1.08 109.488 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.4 t -52.49 -28.2 19.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.924 -0.58 . . . . 1.72 110.254 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -63.36 -56.27 17.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.402 -0.817 . . . . 1.3 112.755 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -122.99 -33.43 3.34 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.156 0.428 . . . . 4.21 112.156 -171.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.56 -149.87 16.93 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 121.149 -0.548 . . . . 0.24 112.324 -177.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.565 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.9 m95 -54.04 117.81 3.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.929 0.395 . . . . 0.47 111.045 175.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.1 p -67.63 170.02 8.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.57 -0.741 . . . . 1.07 111.413 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -65.32 126.65 28.88 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.191 -1.04 . . . . 1.84 108.191 172.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -58.71 114.62 2.6 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.557 0.694 . . . . 1.0 110.49 -175.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.464 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 59.8 m -87.02 97.01 10.48 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.944 -1.025 . . . . 0.44 109.659 -177.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.435 HD12 ' HA3' ' A' ' 45' ' ' GLY . 21.6 mm -77.63 120.67 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.341 -0.845 . . . . 1.49 109.593 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.51 -165.8 35.56 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.757 -0.735 . . . . 0.24 112.217 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 64' ' ' MET . 38.6 mt-10 -92.66 142.22 25.47 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.259 -0.645 . . . . 1.37 109.259 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.51 114.63 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.693 2.262 . . . . 0.79 111.952 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.637 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 95.8 mmm -118.58 138.88 26.3 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.216 -0.447 . . . . 1.4 109.941 -174.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.15 11.64 1.44 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.637 2.225 . . . . 0.37 113.827 -175.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.464 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 50.5 m -152.67 137.59 17.16 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.317 -0.623 . . . . 1.63 109.317 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.71 -31.79 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 113.147 0.795 . . . . 1.88 113.147 -169.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -69.83 -42.44 73.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.766 0.317 . . . . 3.34 111.25 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.464 ' HG2' ' HB2' ' A' ' 66' ' ' SER . 17.3 ptpt -81.0 -18.9 45.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.369 -0.378 . . . . 1.91 110.49 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.51 -57.94 10.79 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.342 -0.39 . . . . 1.07 110.299 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.668 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 53.1 mtmt -56.51 -45.37 81.12 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.25 -0.432 . . . . 2.9 110.729 175.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.478 ' O ' HG21 ' A' ' 76' ' ' VAL . 22.3 t70 -49.79 -50.13 45.98 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.887 -0.597 . . . . 2.01 111.812 176.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.0 t -58.91 -47.56 84.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 1.8 111.618 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.99 81.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.251 0.548 . . . . 1.07 111.007 -177.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.595 ' O ' ' HG ' ' A' ' 79' ' ' LEU . . . -60.44 -29.94 69.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.553 -0.749 . . . . 1.01 111.692 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 72' ' ' ASP . 55.6 t -65.71 -32.82 59.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 121.102 0.477 . . . . 1.53 109.961 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.3 mt -74.26 -30.76 62.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.856 -0.611 . . . . 1.12 109.506 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 6.2 mt -61.87 -42.64 99.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.195 -0.911 . . . . 1.44 110.24 175.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 17.8 mt -58.3 -35.59 72.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.199 -0.91 . . . . 2.23 111.037 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -69.67 -43.81 71.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.895 0.379 . . . . 2.13 110.268 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.0 tt -62.87 -47.57 82.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.716 -0.675 . . . . 1.84 109.259 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.35 -32.91 72.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.081 -0.963 . . . . 1.82 111.68 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 121.358 0.599 . . . . 2.08 110.597 178.793 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.469 HD11 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.817 0.341 . . . . 1.42 110.607 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.407 ' SG ' ' HE3' ' A' ' 23' ' ' TRP . 54.1 t -72.24 -41.19 67.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.661 0.743 . . . . 1.98 109.247 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.75 -42.85 99.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.628 -1.169 . . . . 1.77 109.614 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -61.65 -33.9 74.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.556 -0.747 . . . . 4.47 110.919 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 31.6 mmmt -74.28 2.07 10.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.029 -0.532 . . . . 1.67 111.485 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.9 t30 68.24 27.04 6.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.998 0.904 . . . . 2.37 109.712 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.407 ' HE3' ' SG ' ' A' ' 18' ' ' CYS . 41.8 m0 -92.67 160.88 33.48 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.017 -0.992 . . . . 0.4 109.055 174.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.38 -169.53 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.106 1.871 . . . . 0.6 111.482 173.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.459 ' HA ' ' HE1' ' A' ' 25' ' ' MET . 10.6 mmt -77.22 132.5 70.08 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.79 -0.448 . . . . 1.56 109.79 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.63 164.37 26.73 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.512 2.141 . . . . 0.68 112.268 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.485 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 22.5 t -87.84 140.99 28.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.494 -0.776 . . . . 1.02 109.859 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.519 ' HD1' ' CZ ' ' A' ' 44' ' ' PHE . 66.1 m-85 -141.19 111.04 6.54 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.889 -0.782 . . . . 0.87 108.889 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.509 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 36.2 ttm180 -153.01 128.68 10.1 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.196 -0.298 . . . . 4.22 110.196 -175.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 7.8 p -65.32 124.68 22.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.924 0.392 . . . . 2.19 110.459 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m -82.57 -34.61 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.141 0.496 . . . . 1.87 110.302 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.7 tttt . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.681 -0.691 . . . . 2.76 110.201 174.095 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 . . . . . 0 CA--C 1.512 -0.512 0 N-CA-C 106.471 -1.677 . . . . 4.07 106.471 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -111.0 130.15 55.68 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 120.474 -0.49 . . . . 1.16 110.284 -172.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.6 m -121.92 125.43 46.37 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.03 -1.1 . . . . 1.08 108.03 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.71 ' CZ ' HG23 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -134.36 151.61 51.32 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.582 -0.525 . . . . 0.21 109.582 -175.108 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.91 139.41 11.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.96 -0.638 . . . . 0.2 111.883 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.71 HG23 ' CZ ' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -107.05 157.6 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 N-CA-C 110.03 -0.359 . . . . 1.45 110.03 -174.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.615 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 15.2 ptp180 -148.5 147.39 29.04 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.674 -0.862 . . . . 3.01 108.674 171.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.427 HG23 HD12 ' A' ' 78' ' ' LEU . 73.0 t -124.98 153.07 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.474 -0.33 . . . . 1.07 110.807 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -93.89 84.54 4.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.729 0.776 . . . . 1.81 110.213 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.429 ' OG1' ' HB3' ' A' ' 53' ' ' ARG . 40.3 p -72.52 108.11 5.41 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.374 -1.285 . . . . 1.08 109.05 177.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.1 t -49.83 -28.28 6.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.011 -0.541 . . . . 1.72 112.251 -175.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -88.44 -15.82 34.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.705 0.631 . . . . 1.3 112.705 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.429 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 25.3 ttm180 -132.22 -49.38 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.915 -0.491 . . . . 4.21 111.307 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 125.59 -156.82 19.48 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.842 -0.617 . . . . 0.24 112.288 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.615 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.7 m95 -52.0 117.95 3.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.969 0.414 . . . . 0.47 110.611 173.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 47.9 p -69.85 168.98 14.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.533 -0.758 . . . . 1.07 111.306 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.48 125.51 25.93 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.164 -0.68 . . . . 1.84 109.164 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 45.4 tt0 -60.75 118.11 6.22 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.297 -0.865 . . . . 1.0 111.036 -174.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 68.6 m -97.96 102.26 13.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.713 -1.13 . . . . 0.44 110.731 -175.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.43 127.7 36.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.77 -0.65 . . . . 1.49 110.533 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.15 -161.93 34.93 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.574 -0.739 . . . . 0.24 113.019 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 64' ' ' MET . 32.5 mt-10 -92.03 131.94 33.85 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.744 -0.228 . . . . 1.37 110.612 -175.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.9 108.92 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.765 2.31 . . . . 0.79 111.477 175.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.456 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 7.1 mmt -110.96 151.51 43.03 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.006 -0.543 . . . . 1.4 111.772 -171.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.59 5.78 6.06 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.949 2.432 . . . . 0.37 112.989 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.4 t -151.61 142.39 22.87 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.5 -0.556 . . . . 1.63 109.5 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.4 t -62.16 -33.3 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.457 -0.792 . . . . 1.88 111.406 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -66.76 -37.07 83.89 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.242 -0.435 . . . . 3.34 110.439 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.456 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 29.1 mtpp -74.27 -31.44 62.53 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.079 -0.509 . . . . 1.91 110.315 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.74 -60.89 2.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.68 -0.691 . . . . 1.07 110.955 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.518 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 32.6 mmtp -51.46 -49.51 61.62 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.289 -0.414 . . . . 2.9 110.995 176.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.498 ' O ' HG21 ' A' ' 76' ' ' VAL . 17.4 t70 -51.84 -52.27 50.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.281 -0.872 . . . . 2.01 112.566 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 91.6 p -62.4 -41.31 98.57 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.835 0.309 . . . . 1.8 111.835 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.481 ' HB2' ' CE2' ' A' ' 44' ' ' PHE . . . -69.46 -41.44 76.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.222 0.534 . . . . 1.07 110.543 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.414 ' O ' HD21 ' A' ' 79' ' ' LEU . . . -54.23 -33.68 58.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.231 -0.895 . . . . 1.01 111.395 176.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 72' ' ' ASP . 88.7 t -62.55 -37.96 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 120.971 0.415 . . . . 1.53 110.833 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.08 -30.47 62.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.868 0.842 . . . . 1.12 109.042 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.427 HD12 HG23 ' A' ' 48' ' ' VAL . 18.1 tp -67.3 -42.88 82.99 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.438 -1.255 . . . . 1.44 110.329 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.414 HD21 ' O ' ' A' ' 75' ' ' ALA . 3.9 mm? -61.26 -29.5 69.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.713 -0.676 . . . . 2.23 110.971 177.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 76' ' ' VAL . 35.1 mt-10 -75.98 -38.5 57.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.932 0.396 . . . . 2.13 110.112 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.9 tt -62.65 -48.95 77.11 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.277 -0.638 . . . . 1.84 109.277 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.9 -14.73 60.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.324 -0.853 . . . . 1.82 112.191 177.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.5 t30 . . . . . 0 C--N 1.322 -0.627 0 CA-C-O 121.633 0.73 . . . . 2.08 109.613 178.528 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.423 HD11 ' N ' ' A' ' 17' ' ' ILE . 2.3 mp . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 121.537 0.684 . . . . 1.42 110.11 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.501 ' SG ' ' HG3' ' A' ' 26' ' ' PRO . 57.6 m -66.41 -43.65 85.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.072 -0.967 . . . . 1.98 110.412 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.7 tp -63.81 -53.03 57.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.964 -1.016 . . . . 1.77 111.194 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -59.23 -35.51 73.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.893 -0.594 . . . . 4.47 111.371 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 37.3 mmtt -74.18 -1.26 19.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.126 0.489 . . . . 1.67 111.939 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 61.89 36.8 15.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.851 -1.068 . . . . 2.37 110.632 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.404 ' CZ3' ' HG ' ' A' ' 82' ' ' LEU . 29.8 m0 -94.7 161.73 27.82 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.489 -0.778 . . . . 0.4 109.014 173.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.18 177.98 4.0 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.965 1.776 . . . . 0.6 110.459 170.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.439 ' HA ' ' HE2' ' A' ' 25' ' ' MET . 22.0 mmt -77.61 123.08 86.66 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-O 120.931 0.396 . . . . 1.56 110.403 -176.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.501 ' HG3' ' SG ' ' A' ' 18' ' ' CYS . 9.6 Cg_endo -56.47 163.15 7.08 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.695 2.93 . . . . 0.68 114.015 -176.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 25.6 t -88.46 143.35 27.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.811 -1.086 . . . . 1.02 110.461 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.55 ' HD1' ' CZ ' ' A' ' 44' ' ' PHE . 65.5 m-85 -143.33 111.37 6.1 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.146 -0.687 . . . . 0.87 109.146 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.469 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 79.2 ttt180 -155.71 129.87 8.78 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.599 -0.519 . . . . 4.22 109.599 -176.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.457 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 13.8 p -69.78 132.0 45.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.216 0.531 . . . . 2.19 111.2 -176.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.71 -31.66 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.61 -0.723 . . . . 1.87 109.983 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 115.984 -0.553 . . . . 2.76 110.897 -179.93 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 107.545 -1.28 . . . . 4.07 107.545 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -109.64 134.64 51.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.015 0.436 . . . . 1.16 110.355 -170.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.7 m -123.61 120.6 33.29 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.66 -0.867 . . . . 1.08 108.66 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.725 ' CZ ' HG23 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -131.58 154.18 49.12 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.649 -0.5 . . . . 0.21 109.649 -172.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -128.5 140.44 11.76 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.951 -0.642 . . . . 0.2 112.168 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.725 HG23 ' CZ ' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -106.93 154.81 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 109.661 -0.496 . . . . 1.45 109.661 -176.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.577 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 12.4 ptp180 -145.79 142.7 29.13 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.907 -1.146 . . . . 3.01 107.907 173.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.472 HG22 ' HB3' ' A' ' 26' ' ' PRO . 43.7 t -124.8 156.04 33.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.714 -0.221 . . . . 1.07 110.606 -178.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -91.89 84.19 5.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.739 0.78 . . . . 1.81 109.782 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.8 p -78.25 103.14 8.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.581 -1.19 . . . . 1.08 109.167 177.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 t -44.25 -34.87 2.04 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.351 -0.84 . . . . 1.72 113.095 -170.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -68.26 -26.95 65.93 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.858 0.688 . . . . 1.3 112.858 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -132.24 -42.2 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.013 0.435 . . . . 4.21 111.487 -174.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.49 -150.02 16.94 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.965 -0.562 . . . . 0.24 112.03 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.577 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.9 m95 -51.5 120.06 4.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.024 0.44 . . . . 0.47 111.327 175.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.6 p -68.34 156.92 36.79 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.726 -0.67 . . . . 1.07 110.346 176.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -61.84 124.88 21.98 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.866 -0.79 . . . . 1.84 108.866 173.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -59.64 118.03 5.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.104 -0.953 . . . . 1.0 111.242 -170.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.409 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 50.6 m -93.3 102.64 14.91 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.704 -1.134 . . . . 0.44 110.614 -174.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.02 128.56 38.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.819 -0.628 . . . . 1.49 110.739 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.27 -167.58 43.51 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.478 -0.783 . . . . 0.24 111.999 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.63 ' O ' ' HG2' ' A' ' 64' ' ' MET . 40.9 mt-10 -86.62 148.14 45.61 Favored Pre-proline 0 C--N 1.318 -0.795 0 O-C-N 122.731 -0.276 . . . . 1.37 110.311 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.62 107.87 0.42 Allowed 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.492 2.128 . . . . 0.79 110.753 170.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.63 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 95.9 mmm -114.62 148.77 41.04 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.063 -0.517 . . . . 1.4 110.139 -172.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.74 8.67 4.13 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.619 2.212 . . . . 0.37 113.667 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.9 m -153.88 137.91 16.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.349 -0.612 . . . . 1.63 109.349 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.567 ' O ' ' HD3' ' A' ' 71' ' ' LYS . 28.3 m -64.84 -29.3 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 112.646 0.61 . . . . 1.88 112.646 -170.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.68 -42.86 77.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.965 0.412 . . . . 3.34 111.33 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -81.84 -18.21 44.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.362 -0.381 . . . . 1.91 111.058 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.42 -51.22 68.39 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.517 -0.549 . . . . 1.07 109.517 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.64 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -52.57 -51.56 59.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.135 -0.939 . . . . 2.9 110.461 174.018 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -52.76 -46.95 67.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.254 -0.884 . . . . 2.01 112.277 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.516 ' O ' HG13 ' A' ' 76' ' ' VAL . 95.7 p -65.58 -39.36 91.54 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.901 -0.319 . . . . 1.8 111.5 -176.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.415 ' HB1' ' CE2' ' A' ' 44' ' ' PHE . . . -70.99 -48.15 54.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.026 0.441 . . . . 1.07 110.552 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.51 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -54.31 -38.89 66.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.501 -0.772 . . . . 1.01 111.808 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 73' ' ' SER . 3.0 p -72.25 -26.62 25.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 1.53 110.958 -176.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.8 mt -78.2 -34.07 49.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.852 0.834 . . . . 1.12 109.402 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.5 tp -64.68 -38.65 91.73 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.691 -1.14 . . . . 1.44 110.693 175.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.51 HD13 ' O ' ' A' ' 75' ' ' ALA . 6.1 mp -61.09 -26.26 67.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.548 -0.751 . . . . 2.23 111.357 177.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -70.61 -38.04 73.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.479 0.657 . . . . 2.13 109.985 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.34 -46.96 75.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.134 -0.939 . . . . 1.84 109.177 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.404 ' HG ' ' CZ3' ' A' ' 23' ' ' TRP . 1.7 mp -69.22 -13.58 62.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.191 -0.913 . . . . 1.82 111.686 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.6 t30 . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 122.011 0.91 . . . . 2.08 109.208 175.953 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.468 ' N ' HD12 ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.731 0.301 . . . . 1.42 111.045 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.589 ' SG ' ' HD3' ' A' ' 26' ' ' PRO . 53.3 t -62.22 -41.1 98.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.445 0.64 . . . . 1.98 110.388 -176.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 38.5 tp -62.27 -51.97 65.6 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.001 -0.999 . . . . 1.77 110.899 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.9 ttp-105 -61.59 -31.89 71.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.262 -0.881 . . . . 4.47 111.525 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -72.58 -1.59 16.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.961 -0.563 . . . . 1.67 111.437 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.4 m120 59.67 27.79 17.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.853 -1.067 . . . . 2.37 111.841 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.471 ' CH2' HG21 ' A' ' 50' ' ' THR . 27.3 m0 -85.4 162.86 47.09 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.234 -0.654 . . . . 0.4 109.234 174.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.08 174.34 7.09 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 121.981 1.788 . . . . 0.6 110.437 170.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.452 ' HA ' ' HE2' ' A' ' 25' ' ' MET . 5.7 mmt -79.2 132.94 61.55 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.981 0.42 . . . . 1.56 111.402 -170.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.589 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 12.1 Cg_endo -58.82 156.42 32.99 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.832 3.021 . . . . 0.68 113.819 -177.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.1 t -90.35 144.21 26.03 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.841 -1.072 . . . . 1.02 110.238 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.54 ' CD2' ' CZ ' ' A' ' 44' ' ' PHE . 60.7 m-85 -141.58 110.32 6.12 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.933 -0.766 . . . . 0.87 108.933 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.534 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 57.5 mtp180 -146.05 125.67 13.33 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 110.39 -0.226 . . . . 4.22 110.39 -176.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.519 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 74.6 m -65.24 126.77 29.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.749 0.309 . . . . 2.19 110.795 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 43' ' ' THR . 30.5 m -87.48 -38.67 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 1.87 110.927 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.4 tttt . . . . . 0 C--N 1.325 -0.484 0 CA-C-N 116.411 -0.359 . . . . 2.76 110.764 177.975 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.018 -0.734 . . . . 4.07 109.018 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -110.47 136.01 50.27 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.025 -0.534 . . . . 1.16 110.807 -172.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.404 ' O ' HG22 ' A' ' 31' ' ' VAL . 16.7 m -124.6 127.84 47.98 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.234 -1.024 . . . . 1.08 108.234 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.734 ' CZ ' HG21 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -142.85 154.4 44.11 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.499 -0.556 . . . . 0.21 109.499 -175.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -126.85 139.75 11.46 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.903 -0.665 . . . . 0.2 112.519 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.734 HG21 ' CZ ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -107.18 159.02 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.659 -0.497 . . . . 1.45 109.659 -175.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.617 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 14.6 ptp180 -148.43 147.87 29.66 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.61 -0.885 . . . . 3.01 108.61 171.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.451 HG22 ' HB3' ' A' ' 26' ' ' PRO . 85.1 t -125.76 156.18 35.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.305 -0.407 . . . . 1.07 110.178 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -92.12 82.2 5.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.087 0.47 . . . . 1.81 109.949 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.471 HG21 ' CH2' ' A' ' 23' ' ' TRP . 41.5 p -74.5 107.2 6.49 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.548 -0.751 . . . . 1.08 109.479 178.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.7 t -47.53 -30.54 3.58 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.825 0.676 . . . . 1.72 112.825 -173.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -80.32 -14.58 58.25 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.417 0.895 . . . . 1.3 113.417 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -140.07 -42.09 0.43 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.525 0.602 . . . . 4.21 111.105 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 122.75 -153.75 16.95 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 116.111 -0.495 . . . . 0.24 112.048 -178.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.617 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 9.4 m95 -51.81 120.48 5.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.812 0.339 . . . . 0.47 110.732 173.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 47.4 p -68.92 157.73 36.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.709 -0.678 . . . . 1.07 111.045 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -58.22 131.67 51.28 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.065 -0.717 . . . . 1.84 109.065 174.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.66 113.02 2.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.744 0.783 . . . . 1.0 111.262 -171.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.449 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 38.7 m -85.87 98.67 10.9 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.177 -1.374 . . . . 0.44 109.984 -176.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.447 HD11 ' HA3' ' A' ' 45' ' ' GLY . 19.1 mm -80.71 128.96 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 115.892 -0.594 . . . . 1.49 110.364 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.11 175.21 49.87 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.921 -0.872 . . . . 0.24 110.921 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.597 ' O ' ' HG2' ' A' ' 64' ' ' MET . 12.5 pt-20 -85.5 150.5 54.18 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.572 -0.529 . . . . 1.37 109.572 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.97 109.97 0.39 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.651 2.234 . . . . 0.79 111.692 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.597 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 98.0 mmm -114.73 139.19 23.8 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.816 -0.629 . . . . 1.4 109.493 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.69 13.69 0.73 Allowed 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.576 2.184 . . . . 0.37 114.072 -174.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.486 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 28.6 m -157.46 143.1 17.36 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.715 -0.476 . . . . 1.63 109.715 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.77 -41.23 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.337 -0.847 . . . . 1.88 112.693 -170.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.35 -42.39 96.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.919 0.39 . . . . 3.34 111.146 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.486 ' HG2' ' HB2' ' A' ' 66' ' ' SER . 15.8 ptpt -81.26 -18.95 44.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.462 -0.335 . . . . 1.91 110.67 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.45 -55.63 25.81 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.397 -0.365 . . . . 1.07 110.301 171.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.602 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 53.5 mtpt -54.29 -52.17 62.31 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 116.063 -0.517 . . . . 2.9 110.29 175.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.38 -42.13 73.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.128 -0.942 . . . . 2.01 112.194 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.535 ' O ' HG11 ' A' ' 76' ' ' VAL . 17.1 t -62.75 -43.06 99.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.778 0.323 . . . . 1.8 110.981 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.424 ' HB1' ' CE2' ' A' ' 44' ' ' PHE . . . -69.95 -44.4 69.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.134 0.493 . . . . 1.07 110.401 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.484 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -57.52 -38.51 74.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.631 -0.713 . . . . 1.01 112.208 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.535 HG11 ' O ' ' A' ' 73' ' ' SER . 3.1 p -68.79 -31.19 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 O-C-N 121.952 -0.467 . . . . 1.53 110.669 -178.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.5 mt -76.19 -31.79 58.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.808 0.813 . . . . 1.12 109.103 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.405 ' HB3' ' O ' ' A' ' 75' ' ' ALA . 14.3 tp -66.16 -43.31 87.33 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.496 -1.229 . . . . 1.44 110.728 175.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.484 HD13 ' O ' ' A' ' 75' ' ' ALA . 6.3 mp -59.15 -29.19 67.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 2.23 111.424 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 6.2 mm-40 -71.78 -38.93 70.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.191 -0.459 . . . . 2.13 110.698 177.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.3 tp -75.05 -41.97 58.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.908 0.861 . . . . 1.84 110.335 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 82' ' ' LEU . 8.7 tp -65.4 -38.92 91.43 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.062 -1.426 . . . . 1.82 111.341 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.1 t30 . . . . . 0 C--N 1.318 -0.793 0 CA-C-N 114.804 -1.089 . . . . 2.08 109.816 173.332 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 17' ' ' ILE . 2.4 mp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.998 0.428 . . . . 1.42 110.638 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.8 t -71.57 -41.73 68.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.987 -0.551 . . . . 1.98 110.218 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.8 -54.63 42.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.357 -0.838 . . . . 1.77 110.605 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -58.06 -33.89 69.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.211 -0.904 . . . . 4.47 111.906 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HB3' ' CE2' ' A' ' 23' ' ' TRP . 34.4 mmtt -72.71 4.02 4.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.071 0.462 . . . . 1.67 111.968 -178.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 63.28 38.71 10.15 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.867 -1.06 . . . . 2.37 110.28 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.441 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 29.0 m0 -104.81 165.09 13.88 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.423 -0.808 . . . . 0.4 109.631 176.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 55.0 Cg_endo -72.39 -171.51 0.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.349 2.033 . . . . 0.6 110.913 170.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.456 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 12.0 mmt -82.33 135.94 46.68 Favored Pre-proline 0 C--N 1.323 -0.582 0 O-C-N 122.024 -0.422 . . . . 1.56 110.633 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 14.4 Cg_exo -68.88 168.45 20.33 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.916 2.411 . . . . 0.68 113.045 -177.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.2 t -89.51 141.23 28.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.936 -1.029 . . . . 1.02 110.32 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.467 ' CD2' ' HZ ' ' A' ' 44' ' ' PHE . 67.7 m-85 -144.17 110.52 5.51 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.29 -0.633 . . . . 0.87 109.29 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.478 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 24.2 ttm180 -156.52 128.42 7.31 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.751 0.31 . . . . 4.22 110.512 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.451 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 4.5 p -65.68 124.26 21.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.069 0.461 . . . . 2.19 110.957 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.7 m -87.57 -37.07 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.987 -0.552 . . . . 1.87 111.439 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.9 tttt . . . . . 0 C--N 1.321 -0.634 0 CA-C-O 121.06 0.457 . . . . 2.76 110.52 -179.707 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 108.4 -0.963 . . . . 4.07 108.4 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -110.31 135.66 50.7 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.904 -0.589 . . . . 1.16 110.637 -170.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.8 m -122.54 130.69 53.3 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.868 -1.16 . . . . 1.08 107.868 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.72 ' CZ ' HG23 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -139.18 151.33 46.5 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.417 -0.586 . . . . 0.21 109.417 -174.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.462 ' HA3' HD12 ' A' ' 60' ' ' ILE . . . -125.58 136.84 9.94 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.973 -0.632 . . . . 0.2 112.017 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.72 HG23 ' CZ ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -107.1 156.72 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 109.308 -0.627 . . . . 1.45 109.308 -176.899 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.567 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 16.2 ptt180 -148.99 147.7 28.88 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.774 -0.825 . . . . 3.01 108.774 171.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 26' ' ' PRO . 78.2 t -125.13 153.44 32.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.076 -0.511 . . . . 1.07 110.339 -177.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -93.58 83.4 4.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.507 0.67 . . . . 1.81 109.835 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 54' ' ' GLY . 29.6 p -69.89 105.58 2.86 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.628 -1.169 . . . . 1.08 108.963 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.1 t -43.78 -44.33 6.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.804 0.668 . . . . 1.72 112.804 -169.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -81.5 -6.44 58.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.254 0.835 . . . . 1.3 113.254 -175.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -133.1 -48.65 0.86 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.739 -0.601 . . . . 4.21 111.547 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 123.71 -153.68 17.35 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.899 -0.591 . . . . 0.24 112.585 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.567 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 5.2 m95 -52.43 117.61 2.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.869 0.366 . . . . 0.47 110.676 174.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.0 p -68.48 169.78 10.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.725 -0.671 . . . . 1.07 111.214 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -62.41 129.45 40.72 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.708 -0.849 . . . . 1.84 108.708 172.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -60.63 119.74 8.68 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.39 0.614 . . . . 1.0 110.609 -176.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.56 ' SG ' HD11 ' A' ' 81' ' ' LEU . 51.5 m -92.34 98.52 11.54 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.892 -1.049 . . . . 0.44 110.231 -175.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.462 HD12 ' HA3' ' A' ' 45' ' ' GLY . 24.6 mm -80.42 124.02 37.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.778 -0.646 . . . . 1.49 110.066 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.99 -174.84 50.0 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.882 -0.675 . . . . 0.24 112.243 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.554 ' O ' ' HG2' ' A' ' 64' ' ' MET . 42.9 mt-10 -83.81 152.01 62.1 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 109.728 -0.471 . . . . 1.37 109.728 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.43 109.14 1.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.363 2.042 . . . . 0.79 111.222 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.554 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 89.3 mmm -115.37 141.57 27.41 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.697 -0.483 . . . . 1.4 109.697 -173.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.05 17.97 1.1 Allowed 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.57 2.18 . . . . 0.37 113.581 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.414 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 11.2 t -155.09 139.91 17.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.315 -0.624 . . . . 1.63 109.315 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.2 -23.88 27.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.838 -0.619 . . . . 1.88 111.032 -173.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -73.96 -43.69 57.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.039 0.447 . . . . 3.34 110.235 -176.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HG2' ' HB3' ' A' ' 66' ' ' SER . 5.7 ptpp? -81.64 -18.37 44.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.939 -0.573 . . . . 1.91 110.634 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.28 -57.49 12.56 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.496 -0.32 . . . . 1.07 110.496 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.453 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 61.5 mttm -52.95 -50.08 64.78 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.946 0.403 . . . . 2.9 110.257 174.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.522 ' O ' HG21 ' A' ' 76' ' ' VAL . 32.1 t70 -51.54 -51.56 54.3 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.362 -0.835 . . . . 2.01 112.295 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.4 t -56.31 -46.64 79.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.787 0.327 . . . . 1.8 111.178 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.417 ' HB1' ' CE2' ' A' ' 44' ' ' PHE . . . -69.5 -43.14 73.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.259 -0.428 . . . . 1.07 110.951 -177.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.91 -41.06 70.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.819 -0.628 . . . . 1.01 111.84 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 72' ' ' ASP . 97.0 t -63.64 -35.04 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.043 0.449 . . . . 1.53 110.731 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.6 mt -74.89 -36.63 62.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.732 0.777 . . . . 1.12 109.66 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.411 HD21 ' CG1' ' A' ' 46' ' ' VAL . 21.0 tp -64.72 -43.12 94.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.749 -1.114 . . . . 1.44 111.103 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 mp -62.69 -21.13 65.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.85 -0.613 . . . . 2.23 111.497 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -76.43 -38.44 55.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.752 0.31 . . . . 2.13 110.234 174.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.56 HD11 ' SG ' ' A' ' 59' ' ' CYS . 0.8 OUTLIER -66.35 -42.98 87.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.766 0.793 . . . . 1.84 109.063 178.579 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.41 ' HG ' ' CZ3' ' A' ' 23' ' ' TRP . 1.6 mp -69.24 -17.75 63.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.678 -1.146 . . . . 1.82 111.943 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 . . . . . 0 C--N 1.319 -0.734 0 N-CA-C 108.833 -0.803 . . . . 2.08 108.833 174.811 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.3 t30 . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.483 0.182 . . . . 2.72 110.773 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -61.39 -44.43 97.16 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.614 0.245 . . . . 2.46 111.379 -175.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.456 ' N ' HD12 ' A' ' 17' ' ' ILE . 2.6 mp -64.23 -41.32 92.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.088 -0.505 . . . . 1.42 110.855 -176.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 23' ' ' TRP . 35.4 t -68.29 -40.92 81.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.412 0.625 . . . . 1.98 109.775 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.2 tp -62.22 -50.03 73.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.095 -0.957 . . . . 1.77 110.219 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -60.18 -36.81 78.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.966 -1.015 . . . . 4.47 111.635 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.0 mmtt -73.3 -3.25 25.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.394 0.616 . . . . 1.67 111.646 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 64.95 43.63 3.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.396 -1.274 . . . . 2.37 110.648 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.467 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 19.1 m0 -105.14 162.79 18.67 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.742 -0.663 . . . . 0.4 109.426 174.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 34.4 Cg_endo -67.92 -178.8 1.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.073 1.849 . . . . 0.6 110.75 171.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.456 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 16.7 mmt -80.66 127.89 73.88 Favored Pre-proline 0 C--N 1.322 -0.596 0 O-C-N 121.984 -0.447 . . . . 1.56 109.892 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 22.0 Cg_exo -63.4 167.99 12.05 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.947 2.431 . . . . 0.68 113.462 -174.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.5 t -86.6 140.37 29.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.952 -1.022 . . . . 1.02 109.979 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.463 ' CD1' ' HZ ' ' A' ' 44' ' ' PHE . 69.4 m-85 -145.57 110.99 5.35 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.566 -0.531 . . . . 0.87 109.566 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.487 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 72.7 ttt180 -158.68 130.37 6.56 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 110.359 -0.237 . . . . 4.22 110.359 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 70.0 m -64.23 124.49 21.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.339 -0.392 . . . . 2.19 110.766 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -82.53 -32.59 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.248 0.547 . . . . 1.87 110.362 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -136.37 124.21 22.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.568 -0.742 . . . . 2.76 109.475 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.549 ' HG2' ' CD1' ' A' ' 42' ' ' PHE . 3.1 tm-20 -148.0 127.34 13.07 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.672 -0.492 . . . . 2.6 109.672 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.24 -177.84 52.12 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.834 -0.698 . . . . 2.17 112.315 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.06 -148.99 19.51 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.688 -0.768 . . . . 2.13 111.959 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.96 57.75 3.95 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 123.411 2.741 . . . . 3.0 112.663 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 70.01 -59.59 0.5 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.811 0.845 . . . . 2.94 112.465 176.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -79.03 18.06 0.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.334 . . . . 2.36 111.631 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -126.32 39.26 3.97 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.955 0.407 . . . . 1.84 110.812 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -88.29 18.23 4.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.495 0.664 . . . . 2.53 110.198 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -85.6 138.68 32.0 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.726 -1.213 . . . . 4.07 107.726 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.549 ' CD1' ' HG2' ' A' ' 33' ' ' GLU . 5.6 m-85 -110.57 131.65 54.87 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.103 0.477 . . . . 1.16 110.387 -172.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.0 m -120.01 130.99 54.99 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.876 -1.157 . . . . 1.08 107.876 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.711 ' CZ ' HG23 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -137.94 151.79 48.33 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.642 -0.503 . . . . 0.21 109.642 -173.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -125.47 136.47 9.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.232 -0.508 . . . . 0.2 111.987 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.711 HG23 ' CZ ' ' A' ' 44' ' ' PHE . 1.3 t -107.72 154.41 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 117.14 0.47 . . . . 1.45 109.856 -175.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.556 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 10.9 ptt180 -149.51 145.23 26.75 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.681 -0.859 . . . . 3.01 108.681 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 26' ' ' PRO . 61.0 t -125.5 155.85 34.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.355 -0.384 . . . . 1.07 110.394 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -95.12 83.87 3.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.601 0.715 . . . . 1.81 110.37 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.442 HG23 ' CZ2' ' A' ' 23' ' ' TRP . 30.1 p -72.92 103.08 3.62 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.423 -1.262 . . . . 1.08 108.944 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.9 t -46.06 -32.97 3.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.654 -0.703 . . . . 1.72 112.858 -170.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -72.31 -22.57 61.16 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.753 0.649 . . . . 1.3 112.753 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -134.56 -45.69 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.022 -0.424 . . . . 4.21 111.279 -175.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 126.64 -154.34 19.14 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.914 -0.584 . . . . 0.24 112.343 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.556 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 7.1 m95 -49.22 120.28 3.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.97 0.453 . . . . 0.47 110.882 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 42.8 p -70.33 172.99 7.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.647 -0.706 . . . . 1.07 111.418 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -61.05 131.84 51.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.883 -0.784 . . . . 1.84 108.883 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -64.64 114.96 4.76 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.342 0.591 . . . . 1.0 109.749 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 59.8 m -92.21 97.42 10.89 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.095 -0.957 . . . . 0.44 110.258 -175.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.66 126.22 38.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.647 -0.706 . . . . 1.49 110.361 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.22 -170.99 47.82 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.47 -0.787 . . . . 0.24 111.727 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.595 ' O ' ' HG2' ' A' ' 64' ' ' MET . 41.4 mt-10 -88.36 152.07 49.45 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 110.281 -0.266 . . . . 1.37 110.281 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.12 107.91 0.32 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.643 2.229 . . . . 0.79 111.256 172.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.595 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 95.8 mmm -110.4 147.23 35.93 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.202 -0.454 . . . . 1.4 110.482 -173.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.24 4.36 7.06 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.739 2.292 . . . . 0.37 113.765 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.428 ' HB2' ' HG3' ' A' ' 69' ' ' LYS . 26.9 m -147.53 137.15 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.742 -0.466 . . . . 1.63 109.742 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.3 m -65.29 -28.77 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.178 -0.465 . . . . 1.88 112.046 -171.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -71.19 -36.16 71.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.4 -0.364 . . . . 3.34 110.454 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HG3' ' HB2' ' A' ' 66' ' ' SER . 46.9 mtpt -74.47 -28.33 60.98 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.764 -0.458 . . . . 1.91 109.764 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.49 -59.03 6.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.831 -0.622 . . . . 1.07 110.623 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.619 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 56.8 mttm -53.6 -58.59 6.64 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.086 -0.506 . . . . 2.9 111.471 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.581 ' O ' HG22 ' A' ' 76' ' ' VAL . 29.6 t70 -57.69 -42.37 83.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.656 -0.702 . . . . 2.01 112.718 -173.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 m -70.31 -36.63 74.43 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 121.006 -0.278 . . . . 1.8 111.418 -175.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.417 ' HB1' ' CE2' ' A' ' 44' ' ' PHE . . . -67.36 -42.89 82.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.613 0.721 . . . . 1.07 109.541 174.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.636 ' O ' ' HG ' ' A' ' 79' ' ' LEU . . . -54.23 -34.67 61.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.48 -1.236 . . . . 1.01 111.533 176.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 72' ' ' ASP . 98.3 t -64.56 -34.79 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.007 0.432 . . . . 1.53 110.7 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.3 mt -74.6 -33.07 62.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.818 0.818 . . . . 1.12 109.194 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 75' ' ' ALA . 26.5 tp -64.1 -37.31 86.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.547 -1.206 . . . . 1.44 110.272 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 20.8 mt -60.66 -28.27 68.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.233 -0.894 . . . . 2.23 110.835 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 89.8 mt-10 -72.98 -36.69 67.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.042 0.448 . . . . 2.13 110.027 178.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.2 tt -66.86 -46.22 75.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.645 0.735 . . . . 1.84 109.052 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.8 mp -70.61 -11.35 60.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.915 -1.039 . . . . 1.82 112.051 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -85.18 -4.46 59.16 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.592 0.71 . . . . 2.08 109.65 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 50.6 mttp -114.41 45.77 1.48 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.286 -0.87 . . . . 4.6 109.621 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.0 p . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.902 -0.571 . . . . 3.96 111.183 -175.364 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 111.174 0.064 . . . . 2.72 111.174 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -62.98 -45.28 93.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.773 0.32 . . . . 2.46 111.149 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 17' ' ' ILE . 2.5 mp -62.19 -43.62 98.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.927 -0.579 . . . . 1.42 110.72 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.401 ' SG ' HG12 ' A' ' 48' ' ' VAL . 34.4 t -69.3 -42.11 75.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.312 0.577 . . . . 1.98 109.824 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.3 tp -61.8 -49.31 76.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.309 -0.859 . . . . 1.77 110.398 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -63.97 -31.44 72.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.799 -1.091 . . . . 4.47 111.395 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.436 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 27.7 mmmt -74.31 3.11 7.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.362 -0.381 . . . . 1.67 111.459 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 67.69 27.95 7.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.306 -0.861 . . . . 2.37 110.25 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -94.65 160.2 31.93 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.389 -0.823 . . . . 0.4 109.429 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.49 -169.53 0.43 Allowed 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.178 1.919 . . . . 0.6 111.554 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.455 ' HE3' ' HA ' ' A' ' 25' ' ' MET . 9.3 mmt -78.28 134.63 62.59 Favored Pre-proline 0 C--N 1.324 -0.542 0 O-C-N 122.163 -0.336 . . . . 1.56 110.649 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.62 156.69 64.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.648 2.232 . . . . 0.68 112.042 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.429 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 12.9 t -89.32 142.6 27.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.899 -0.591 . . . . 1.02 110.082 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.47 ' CD2' ' CZ ' ' A' ' 44' ' ' PHE . 62.6 m-85 -142.21 111.98 6.78 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.308 -0.627 . . . . 0.87 109.308 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.55 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 33.7 ttm180 -163.03 122.69 2.21 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.473 -0.566 . . . . 4.22 109.473 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 73.8 m -61.77 131.33 49.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.196 0.522 . . . . 2.19 111.833 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.408 ' H ' ' HA ' ' A' ' 44' ' ' PHE . 27.2 m -82.98 -30.74 8.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.372 -0.831 . . . . 1.87 110.357 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -135.12 124.88 25.35 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.539 -0.755 . . . . 2.76 110.125 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -151.16 141.06 21.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.542 -0.754 . . . . 2.6 109.178 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.16 177.32 51.37 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.695 -0.764 . . . . 2.17 113.311 173.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.16 -156.18 26.88 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.815 -0.914 . . . . 2.13 110.815 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.43 -74.0 0.02 OUTLIER 'Trans proline' 0 CA--C 1.529 0.247 0 C-N-CA 122.498 2.132 . . . . 3.0 111.722 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -164.63 -41.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.994 -0.548 . . . . 2.94 109.877 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -71.9 -4.02 25.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.758 -0.656 . . . . 2.36 110.818 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.78 32.15 6.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.218 -0.446 . . . . 1.84 110.921 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -92.36 17.86 9.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.441 0.639 . . . . 2.53 109.607 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -84.18 137.36 33.55 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.084 -1.45 . . . . 4.07 107.084 169.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -109.47 134.27 52.08 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.253 0.549 . . . . 1.16 110.45 -169.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.8 m -123.24 127.08 48.09 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.02 -1.104 . . . . 1.08 108.02 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.666 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -138.47 154.4 48.83 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.789 -0.448 . . . . 0.21 109.789 -171.045 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.421 ' CA ' HD12 ' A' ' 60' ' ' ILE . . . -127.41 137.39 9.83 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.209 -0.52 . . . . 0.2 111.923 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.666 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.3 t -107.33 153.98 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 N-CA-C 108.853 -0.795 . . . . 1.45 108.853 -176.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.548 ' O ' ' HZ3' ' A' ' 55' ' ' TRP . 11.3 ptt180 -143.63 146.77 33.52 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.521 -0.918 . . . . 3.01 108.521 173.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.401 HG12 ' SG ' ' A' ' 18' ' ' CYS . 74.7 t -125.36 150.71 30.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.757 -0.656 . . . . 1.07 109.688 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -91.63 84.51 5.49 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.458 0.647 . . . . 1.81 109.686 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.3 p -71.71 109.87 5.89 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.627 -1.17 . . . . 1.08 109.45 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 62.0 p -50.56 -22.54 2.02 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.731 -1.122 . . . . 1.72 114.021 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -92.08 -15.63 27.52 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.374 0.509 . . . . 1.3 112.374 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -136.24 -40.47 0.66 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.097 -0.377 . . . . 4.21 111.878 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.57 -154.45 16.95 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 121.282 -0.485 . . . . 0.24 112.801 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.548 ' HZ3' ' O ' ' A' ' 47' ' ' ARG . 30.1 m95 -57.75 123.42 15.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.396 0.617 . . . . 0.47 111.265 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.0 p -74.48 152.85 39.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.138 -0.937 . . . . 1.07 110.879 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -62.05 129.41 40.72 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.231 -0.655 . . . . 1.84 109.231 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -50.63 125.01 12.01 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.445 -0.798 . . . . 1.0 112.985 -173.019 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.431 ' SG ' HD12 ' A' ' 81' ' ' LEU . 58.9 m -86.95 100.85 12.9 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.174 -1.375 . . . . 0.44 108.865 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.421 HD12 ' CA ' ' A' ' 45' ' ' GLY . 29.2 mm -83.07 123.92 39.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.919 -0.582 . . . . 1.49 110.703 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.84 -175.86 51.03 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 121.052 -0.594 . . . . 0.24 112.002 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HG2' ' OG ' ' A' ' 73' ' ' SER . 11.1 pt-20 -87.02 149.46 47.69 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 110.167 -0.309 . . . . 1.37 110.167 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.33 108.76 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.813 2.342 . . . . 0.79 111.61 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.407 ' SD ' ' HG3' ' A' ' 69' ' ' LYS . 15.1 mmt -108.87 143.75 28.22 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.166 -0.47 . . . . 1.4 110.964 -174.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -83.34 10.47 3.65 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.683 2.255 . . . . 0.37 112.845 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.7 m -153.15 138.03 17.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.444 -0.576 . . . . 1.63 109.444 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 m -68.63 -25.76 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 112.253 0.464 . . . . 1.88 112.253 -173.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -73.06 -41.39 64.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.672 0.272 . . . . 3.34 111.075 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.407 ' HG3' ' SD ' ' A' ' 64' ' ' MET . 7.2 ptmm? -82.08 -17.62 45.93 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.891 -0.323 . . . . 1.91 110.334 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.93 -61.78 2.37 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.198 -0.455 . . . . 1.07 111.175 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.623 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -56.39 -42.58 78.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.589 0.233 . . . . 2.9 111.09 177.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -53.44 -46.37 69.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.868 -0.605 . . . . 2.01 112.199 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.635 ' O ' HG11 ' A' ' 76' ' ' VAL . 41.9 t -62.93 -45.07 94.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.039 0.447 . . . . 1.8 111.185 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.82 81.45 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.294 0.568 . . . . 1.07 110.23 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.487 ' O ' HD22 ' A' ' 79' ' ' LEU . . . -56.88 -37.57 71.56 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.274 -0.875 . . . . 1.01 112.069 177.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.635 HG11 ' O ' ' A' ' 73' ' ' SER . 1.8 p -70.95 -26.82 28.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 O-C-N 121.917 -0.489 . . . . 1.53 110.669 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.3 mt -78.79 -31.61 46.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.791 0.805 . . . . 1.12 109.401 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.402 ' HB3' ' O ' ' A' ' 75' ' ' ALA . 28.0 tp -66.88 -36.77 83.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.865 -1.061 . . . . 1.44 110.461 175.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 75' ' ' ALA . 3.6 mm? -61.21 -25.4 67.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.736 -0.666 . . . . 2.23 110.861 175.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 44.6 mt-10 -71.71 -37.94 70.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.093 0.473 . . . . 2.13 109.968 175.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.431 HD12 ' SG ' ' A' ' 59' ' ' CYS . 1.3 tt -62.99 -47.24 83.99 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.049 -0.723 . . . . 1.84 109.049 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mp -74.39 0.91 12.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.191 -0.913 . . . . 1.82 111.661 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -97.55 -14.24 21.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.763 0.792 . . . . 2.08 109.38 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 8.2 mtmp? -120.2 43.73 2.62 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.945 -1.025 . . . . 4.6 110.188 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.251 1.134 0 CA-C-N 115.43 -0.805 . . . . 3.96 110.907 -179.569 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 111.826 0.306 . . . . 2.72 111.826 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -70.4 -37.31 74.47 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.317 -0.239 . . . . 2.46 111.395 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 17' ' ' ILE . 2.8 mp -63.95 -41.68 93.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.449 0.642 . . . . 1.42 109.961 174.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.3 m -65.1 -42.91 93.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.029 -0.987 . . . . 1.98 110.204 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.83 -51.98 67.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.877 -1.056 . . . . 1.77 110.284 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -57.02 -37.08 71.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.398 -0.819 . . . . 4.47 111.923 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -72.81 1.96 7.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.066 -0.515 . . . . 1.67 111.975 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.2 t30 65.59 32.67 9.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.938 -1.028 . . . . 2.37 109.699 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.459 ' CH2' HG22 ' A' ' 50' ' ' THR . 38.2 m0 -99.21 160.58 27.23 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.201 -0.909 . . . . 0.4 109.367 175.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.42 170.65 18.78 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.126 1.884 . . . . 0.6 110.048 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 50.0 mmm -72.68 134.49 81.7 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 110.347 -0.242 . . . . 1.56 110.347 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.82 161.39 32.83 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.962 2.441 . . . . 0.68 113.117 -177.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.524 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 16.6 t -87.63 141.49 28.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.961 -1.018 . . . . 1.02 109.841 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.445 ' HD2' ' CZ ' ' A' ' 44' ' ' PHE . 78.6 m-85 -139.56 110.67 6.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.815 -0.809 . . . . 0.87 108.815 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.446 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 26.7 ttm180 -153.39 123.45 6.95 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.972 -0.381 . . . . 4.22 109.972 -176.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.476 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 62.5 m -61.87 124.93 22.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.136 0.493 . . . . 2.19 111.381 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.442 ' H ' ' HA ' ' A' ' 44' ' ' PHE . 53.3 t -80.74 -29.97 11.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.615 -0.72 . . . . 1.87 109.784 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -134.93 129.7 34.69 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.883 -0.599 . . . . 2.76 110.22 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -98.92 154.08 18.32 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.846 -1.07 . . . . 2.6 109.892 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 40' ' ' LYS . . . -74.86 137.04 21.7 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.884 -0.674 . . . . 2.17 112.687 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.06 -142.94 1.99 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.638 -0.315 . . . . 2.13 112.976 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.58 -67.35 0.11 Allowed 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.997 3.131 . . . . 3.0 112.914 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.68 -41.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.994 0.426 . . . . 2.94 109.949 175.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -71.74 5.97 2.22 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.748 -0.66 . . . . 2.36 111.199 176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.81 31.1 1.17 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.243 -0.435 . . . . 1.84 110.272 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.499 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 31.9 tptt -84.29 20.03 1.73 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.159 -0.473 . . . . 2.53 111.901 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -83.58 135.93 34.44 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.688 -0.805 . . . . 4.07 109.476 174.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -109.87 136.26 49.45 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.311 -0.859 . . . . 1.16 110.041 -173.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.3 m -118.44 125.91 50.93 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.938 -1.134 . . . . 1.08 107.938 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.667 ' CZ ' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -132.65 151.75 51.87 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 121.843 -0.535 . . . . 0.21 109.802 -171.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.415 ' CA ' HD12 ' A' ' 60' ' ' ILE . . . -125.57 129.16 6.78 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.14 -0.784 . . . . 0.2 111.14 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.667 ' HB ' ' CZ ' ' A' ' 44' ' ' PHE . 7.3 p -109.94 145.94 15.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 110.057 -0.349 . . . . 1.45 110.057 -173.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.622 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 2.9 ptp180 -140.32 145.92 37.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.836 -0.802 . . . . 3.01 108.836 -176.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.6 t -125.89 154.55 34.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.461 -0.336 . . . . 1.07 110.29 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -93.85 83.92 4.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.61 0.719 . . . . 1.81 110.086 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.459 HG22 ' CH2' ' A' ' 23' ' ' TRP . 30.2 p -70.96 116.43 11.25 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.523 -1.217 . . . . 1.08 110.062 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 p -51.13 -25.72 5.6 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.583 -1.189 . . . . 1.72 113.522 -172.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -92.95 -12.89 29.67 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.745 0.646 . . . . 1.3 112.745 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -136.74 -42.03 0.6 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.792 -0.567 . . . . 4.21 111.703 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.15 -152.83 17.12 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.891 -0.484 . . . . 0.24 111.891 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.622 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 9.4 m95 -54.15 117.78 3.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.119 0.485 . . . . 0.47 110.956 176.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 56.1 p -69.59 150.6 46.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.436 -0.802 . . . . 1.07 110.315 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -61.18 116.96 4.98 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.3 -1.0 . . . . 1.84 108.3 171.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 3.9 pt-20 -55.39 140.57 39.38 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 114.802 -1.09 . . . . 1.0 111.934 -168.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 63.8 m -97.83 101.79 13.38 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.804 -1.089 . . . . 0.44 109.458 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.415 HD12 ' CA ' ' A' ' 45' ' ' GLY . 25.6 mm -73.54 120.33 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.575 -0.739 . . . . 1.49 110.143 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.58 -165.25 39.3 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.934 -0.65 . . . . 0.24 112.265 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 64' ' ' MET . 43.6 mt-10 -80.69 139.56 50.76 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.926 -0.398 . . . . 1.37 109.926 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.96 110.38 0.62 Allowed 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.14 1.893 . . . . 0.79 110.415 171.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.661 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 16.9 mmt -113.06 141.33 25.43 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.086 -0.507 . . . . 1.4 111.312 -169.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.06 9.55 2.72 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.763 2.309 . . . . 0.37 113.132 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.3 m -154.55 137.18 15.16 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.454 -0.573 . . . . 1.63 109.454 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.4 m -65.64 -34.18 68.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.295 0.85 . . . . 1.88 113.295 -170.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -67.32 -40.94 86.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.589 0.233 . . . . 3.34 111.459 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.661 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 0.5 OUTLIER -81.2 -20.2 41.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.844 0.354 . . . . 1.91 110.451 -179.339 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.38 -61.41 2.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.24 -0.436 . . . . 1.07 111.2 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.563 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 13.2 ptmm? -56.19 -43.75 78.75 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.051 0.453 . . . . 2.9 110.674 176.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.466 ' O ' HG22 ' A' ' 76' ' ' VAL . 36.8 t70 -51.98 -47.05 65.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.113 -0.949 . . . . 2.01 112.022 177.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.5 t -60.65 -47.53 85.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.612 0.244 . . . . 1.8 111.606 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.04 -38.78 89.24 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.175 0.512 . . . . 1.07 110.488 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.64 -37.25 65.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.238 -0.892 . . . . 1.01 111.294 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 91.7 t -59.16 -42.05 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 CA-C-O 120.837 0.351 . . . . 1.53 110.849 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.2 mt -77.17 -30.42 54.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.597 0.713 . . . . 1.12 109.661 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.1 tp -65.73 -44.43 86.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.808 -1.087 . . . . 1.44 111.052 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.3 -21.57 66.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.654 -0.703 . . . . 2.23 111.493 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 8.6 mm-40 -73.71 -38.37 64.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.348 0.594 . . . . 2.13 109.862 173.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 tt -66.78 -46.18 76.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.013 -0.994 . . . . 1.84 109.382 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mp -65.29 -16.7 63.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.349 -0.841 . . . . 1.82 112.338 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -83.99 -4.93 59.09 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.484 0.659 . . . . 2.08 109.799 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -121.76 39.76 3.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.523 -0.762 . . . . 4.6 110.484 -176.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.603 -0.713 . . . . 3.96 110.298 -179.029 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 111.84 0.311 . . . . 2.72 111.84 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -68.42 -46.35 70.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.992 0.425 . . . . 2.46 111.189 -174.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.489 ' N ' HD12 ' A' ' 17' ' ' ILE . 2.6 mp -66.7 -34.97 73.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.637 -0.71 . . . . 1.42 109.968 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 22.5 m -66.92 -44.68 80.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.613 -0.721 . . . . 1.98 109.747 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.1 tp -61.39 -46.83 88.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.713 -1.131 . . . . 1.77 110.151 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -62.26 -36.15 81.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.654 -1.157 . . . . 4.47 111.334 -177.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 11.0 mmmm -74.15 6.03 3.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 1.67 111.611 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.4 t30 67.03 30.8 7.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.82 0.819 . . . . 2.37 110.268 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -96.23 158.85 33.3 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.562 -0.744 . . . . 0.4 109.277 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.88 -171.43 0.57 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.318 2.012 . . . . 0.6 111.515 173.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.454 ' HE3' ' HA ' ' A' ' 25' ' ' MET . 26.9 mmt -75.95 138.88 69.19 Favored Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 110.063 -0.347 . . . . 1.56 110.063 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 6.3 Cg_exo -72.79 164.6 35.12 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.361 2.04 . . . . 0.68 112.468 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.401 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 23.0 t -89.57 144.17 26.23 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.261 -0.881 . . . . 1.02 109.941 178.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.52 ' HD2' ' CZ ' ' A' ' 44' ' ' PHE . 66.0 m-85 -139.6 111.08 7.11 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.625 -0.88 . . . . 0.87 108.625 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.468 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 20.5 ttp-105 -144.79 119.95 10.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.88 -0.415 . . . . 4.22 109.88 -173.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 21.3 p -66.98 124.55 23.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.098 0.475 . . . . 2.19 110.534 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 43' ' ' THR . 23.3 m -85.82 -41.5 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 116.106 -0.497 . . . . 1.87 111.102 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -137.35 128.76 28.19 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.172 -0.211 . . . . 2.76 111.32 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -148.32 141.73 25.28 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.555 0.534 . . . . 2.6 110.206 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.95 -57.67 5.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.621 -0.799 . . . . 2.17 113.424 173.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.39 -144.36 48.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.677 -0.773 . . . . 2.13 111.692 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.38 -52.53 6.22 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.884 2.389 . . . . 3.0 111.149 174.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 175.26 -41.85 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.061 -0.972 . . . . 2.94 109.502 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -80.9 18.96 0.91 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.53 -0.759 . . . . 2.36 111.644 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.15 61.37 0.91 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.065 0.459 . . . . 1.84 110.7 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -85.37 16.88 3.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 121.381 0.61 . . . . 2.53 110.575 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -83.07 136.86 34.33 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.109 -1.441 . . . . 4.07 107.109 169.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -109.89 130.8 55.48 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.393 -0.595 . . . . 1.16 109.393 -172.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.446 ' O ' HG21 ' A' ' 31' ' ' VAL . 5.4 m -123.19 131.84 53.83 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.994 -1.113 . . . . 1.08 107.994 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.717 ' CZ ' HG21 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -142.35 155.75 45.18 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.588 -0.523 . . . . 0.21 109.588 -174.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.453 ' HA3' HD11 ' A' ' 60' ' ' ILE . . . -128.74 139.66 11.16 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.9 -0.667 . . . . 0.2 112.507 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.717 HG21 ' CZ ' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -106.74 156.8 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.767 -0.457 . . . . 1.45 109.767 -176.307 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.604 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 18.6 ptt180 -147.28 148.27 31.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.92 -0.77 . . . . 3.01 108.92 172.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 26' ' ' PRO . 86.0 t -127.31 154.79 38.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.296 -0.411 . . . . 1.07 110.616 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -91.13 84.15 5.66 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.19 0.519 . . . . 1.81 110.248 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.2 p -70.4 115.52 9.68 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.175 -0.92 . . . . 1.08 109.611 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.2 p -51.04 -27.19 7.4 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.724 -1.125 . . . . 1.72 113.404 -172.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -98.81 -8.43 25.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.601 0.593 . . . . 1.3 112.601 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -129.0 -47.66 1.23 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.871 -0.518 . . . . 4.21 111.469 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.13 -151.69 17.23 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.648 -0.706 . . . . 0.24 111.795 -175.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.604 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.7 m95 -54.85 120.4 6.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.065 0.46 . . . . 0.47 111.051 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.5 p -73.38 162.67 29.06 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.749 -0.66 . . . . 1.07 111.288 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -60.0 129.41 41.66 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.314 -0.625 . . . . 1.84 109.314 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -59.03 115.08 2.91 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.714 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.45 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 59.7 m -87.92 97.6 11.03 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.924 -1.035 . . . . 0.44 110.037 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.453 HD11 ' HA3' ' A' ' 45' ' ' GLY . 32.3 mm -76.02 123.92 33.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.449 -0.796 . . . . 1.49 110.417 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.06 -170.49 44.8 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.987 -0.625 . . . . 0.24 112.021 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.612 ' O ' ' HG2' ' A' ' 64' ' ' MET . 44.5 mt-10 -89.14 150.82 45.83 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 110.045 -0.354 . . . . 1.37 110.045 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.98 109.32 1.09 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.562 2.174 . . . . 0.79 111.378 176.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.612 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 90.9 mmm -114.94 144.46 32.05 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.119 -0.491 . . . . 1.4 110.207 -171.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.55 12.26 2.2 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.534 2.156 . . . . 0.37 113.537 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.456 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 19.9 m -154.86 138.96 16.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.413 -0.588 . . . . 1.63 109.413 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -66.98 -28.17 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.769 0.655 . . . . 1.88 112.769 -170.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.01 -42.08 73.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.833 0.349 . . . . 3.34 110.92 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.456 ' HG2' ' HB2' ' A' ' 66' ' ' SER . 4.3 ptpp? -81.48 -18.1 46.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.421 -0.354 . . . . 1.91 110.678 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.79 -59.24 5.75 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.45 -0.341 . . . . 1.07 110.486 172.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.613 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 57.9 mttp -52.81 -47.06 67.91 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.325 -0.398 . . . . 2.9 110.543 175.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -50.21 -50.0 50.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.416 -0.811 . . . . 2.01 112.128 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.57 ' O ' HG11 ' A' ' 76' ' ' VAL . 45.2 t -61.37 -44.49 97.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.83 0.347 . . . . 1.8 111.252 -177.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.498 ' HB2' ' CE2' ' A' ' 44' ' ' PHE . . . -68.64 -47.42 66.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.168 0.509 . . . . 1.07 110.867 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.476 ' O ' HD21 ' A' ' 79' ' ' LEU . . . -55.6 -36.55 67.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.403 -0.817 . . . . 1.01 112.059 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.57 HG11 ' O ' ' A' ' 73' ' ' SER . 2.0 p -71.42 -27.66 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 121.205 0.526 . . . . 1.53 110.617 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.9 mt -79.04 -31.83 44.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.727 0.775 . . . . 1.12 109.436 175.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.422 ' HB3' ' O ' ' A' ' 75' ' ' ALA . 28.6 tp -63.79 -35.29 80.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.107 -0.952 . . . . 1.44 110.406 173.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.476 HD21 ' O ' ' A' ' 75' ' ' ALA . 3.5 mm? -62.25 -22.65 66.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.565 -0.743 . . . . 2.23 111.449 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -69.41 -38.0 77.71 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.318 0.58 . . . . 2.13 109.715 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.565 ' O ' HG22 ' A' ' 85' ' ' THR . 0.9 OUTLIER -68.31 -31.17 70.4 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.225 1.012 . . . . 1.84 109.635 179.421 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.3 mp -84.58 -3.18 58.32 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.145 -0.934 . . . . 1.82 112.28 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -111.68 -17.15 13.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.586 0.708 . . . . 2.08 109.81 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -147.9 148.69 31.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.919 -1.037 . . . . 4.6 108.913 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.482 -0.77 . . . . 3.96 110.772 -166.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.1 p30 . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.515 0.198 . . . . 2.72 111.205 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -75.08 -41.93 57.78 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.576 0.213 . . . . 2.46 111.576 -173.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 17' ' ' ILE . 2.7 mp -64.41 -39.78 86.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.148 0.499 . . . . 1.42 109.883 174.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.435 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 68.5 m -64.78 -42.64 94.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.477 -0.783 . . . . 1.98 109.969 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.66 -45.1 91.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.872 -1.058 . . . . 1.77 110.543 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -65.52 -35.34 80.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.33 -0.85 . . . . 4.47 111.068 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 9.1 mmmm -76.07 4.02 9.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 1.67 111.162 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.6 t30 66.02 38.84 4.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.248 -0.887 . . . . 2.37 110.27 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.435 ' CE3' ' HA ' ' A' ' 18' ' ' CYS . 37.9 m0 -104.04 156.62 35.44 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.414 -0.812 . . . . 0.4 109.431 175.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.13 -172.84 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.36 2.04 . . . . 0.6 111.05 171.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.442 ' HE3' ' HA ' ' A' ' 25' ' ' MET . 29.4 mmt -75.19 142.9 76.08 Favored Pre-proline 0 N--CA 1.447 -0.617 0 O-C-N 122.078 -0.389 . . . . 1.56 110.511 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 3.1 Cg_exo -76.24 165.32 29.67 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.718 2.279 . . . . 0.68 112.864 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.3 t -83.58 141.99 31.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.247 -0.888 . . . . 1.02 110.059 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.475 ' CD1' ' HZ ' ' A' ' 44' ' ' PHE . 66.5 m-85 -145.98 110.18 4.98 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.034 -0.728 . . . . 0.87 109.034 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.524 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 23.7 ttm180 -158.63 128.39 5.79 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.394 -0.225 . . . . 4.22 110.394 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 86.4 m -63.34 123.48 18.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.846 0.355 . . . . 2.19 110.688 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -84.49 -34.27 9.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.298 0.57 . . . . 1.87 109.805 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -136.01 116.48 13.74 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.581 -0.736 . . . . 2.76 109.294 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -152.03 134.02 14.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.327 -0.397 . . . . 2.6 110.889 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 56.96 63.91 4.89 Favored Glycine 0 C--N 1.332 0.307 0 O-C-N 123.404 0.44 . . . . 2.17 113.637 172.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 39' ' ' ALA . . . -94.74 -155.61 31.66 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.533 -0.841 . . . . 2.13 112.054 176.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -70.49 74.55 1.6 Allowed 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.418 2.745 . . . . 3.0 113.097 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.44 ' C ' ' H ' ' A' ' 39' ' ' ALA . . . 69.26 -65.12 0.31 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.487 0.715 . . . . 2.94 112.48 175.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -71.49 9.72 0.77 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.592 0.357 . . . . 2.36 111.502 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 37' ' ' ALA . . . -129.27 40.9 3.55 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.952 0.406 . . . . 1.84 110.855 -177.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -94.66 9.74 37.63 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 122.212 1.006 . . . . 2.53 108.818 169.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -85.18 132.24 34.32 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.553 -1.647 . . . . 4.07 106.553 161.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 6.9 m-85 -110.23 131.86 54.68 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.368 -0.533 . . . . 1.16 109.777 -169.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.1 m -122.2 132.02 54.23 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.813 -1.18 . . . . 1.08 107.813 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.72 ' CZ ' HG23 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -142.24 153.16 43.75 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.553 -0.536 . . . . 0.21 109.553 -173.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -127.55 140.7 12.03 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.099 -0.572 . . . . 0.2 112.327 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.72 HG23 ' CZ ' ' A' ' 44' ' ' PHE . 2.1 t -105.91 156.36 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 109.605 -0.517 . . . . 1.45 109.605 -175.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 56' ' ' THR . 5.3 tpp85 -142.64 145.57 33.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.558 -0.904 . . . . 3.01 108.558 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.423 HG23 HD13 ' A' ' 78' ' ' LEU . 61.8 t -131.36 153.11 38.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 110.058 -0.349 . . . . 1.07 110.058 177.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -96.29 85.14 3.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.442 0.639 . . . . 1.81 110.015 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 54' ' ' GLY . 26.2 p -69.29 106.99 3.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.69 -1.141 . . . . 1.08 109.106 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 t -49.77 -26.8 4.19 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.834 0.679 . . . . 1.72 112.834 -171.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -88.17 -18.27 29.11 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.428 0.529 . . . . 1.3 112.428 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -129.82 -46.29 1.15 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.015 0.436 . . . . 4.21 111.294 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 125.6 -156.04 19.19 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.933 -0.576 . . . . 0.24 112.607 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -52.28 119.72 4.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.22 0.533 . . . . 0.47 110.89 175.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.438 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 46.3 p -68.95 -179.26 1.43 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.987 -1.006 . . . . 1.07 112.487 -173.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.38 132.22 43.65 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.577 -0.898 . . . . 1.84 108.577 171.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -64.81 114.44 4.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.581 0.705 . . . . 1.0 110.766 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.473 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 61.5 m -88.19 97.82 11.22 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.56 -1.2 . . . . 0.44 109.999 -177.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.426 HD11 ' HA3' ' A' ' 45' ' ' GLY . 26.9 mm -81.58 122.03 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.666 -0.697 . . . . 1.49 110.07 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.76 -171.0 47.76 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.073 -0.584 . . . . 0.24 112.428 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.585 ' O ' ' HG2' ' A' ' 64' ' ' MET . 33.0 mt-10 -81.91 146.38 55.68 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 110.023 -0.362 . . . . 1.37 110.023 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 27.7 Cg_exo -62.8 109.62 0.94 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.487 2.125 . . . . 0.79 110.907 171.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.585 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 89.6 mmm -115.4 149.1 42.27 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.208 -0.451 . . . . 1.4 110.081 -172.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.2 12.33 2.34 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.594 2.196 . . . . 0.37 113.535 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.422 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 30.0 t -154.99 142.2 19.41 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.658 -0.497 . . . . 1.63 109.658 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.6 m -68.2 -27.95 39.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.619 -0.718 . . . . 1.88 111.946 -173.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -64.6 -50.53 66.84 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.245 0.545 . . . . 3.34 110.851 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.422 ' HG2' ' HB3' ' A' ' 66' ' ' SER . 15.4 ptpt -79.66 -17.54 53.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.455 -0.793 . . . . 1.91 110.708 -174.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.11 -54.28 47.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.185 -0.461 . . . . 1.07 109.823 172.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.656 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 54.5 mtmt -56.05 -52.0 65.82 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.015 -0.539 . . . . 2.9 111.018 176.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.588 ' O ' HG22 ' A' ' 76' ' ' VAL . 4.6 m-20 -53.74 -46.72 70.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.561 . . . . 2.01 112.308 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 t -58.24 -46.01 86.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 1.8 110.981 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.518 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -69.01 -43.42 74.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.986 -0.552 . . . . 1.07 110.491 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.5 ' O ' HD22 ' A' ' 79' ' ' LEU . . . -54.49 -36.93 64.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.465 -0.789 . . . . 1.01 111.4 176.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 72' ' ' ASP . 91.0 t -63.06 -37.96 80.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 121.119 0.485 . . . . 1.53 110.293 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.8 mt -77.85 -24.25 48.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.865 0.84 . . . . 1.12 109.533 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.423 HD13 HG23 ' A' ' 48' ' ' VAL . 16.7 tp -69.15 -37.94 78.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.134 -0.939 . . . . 1.44 110.468 171.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 75' ' ' ALA . 3.3 mm? -65.14 -28.78 69.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.755 -0.657 . . . . 2.23 112.146 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.621 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 8.8 pt-20 -77.27 -31.61 55.02 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.887 -0.725 . . . . 2.13 110.085 176.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.05 -47.69 85.21 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.708 -0.849 . . . . 1.84 108.708 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mp -71.77 -4.38 27.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.12 -0.945 . . . . 1.82 112.036 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -93.91 -14.48 25.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.601 0.715 . . . . 2.08 109.686 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.621 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 41.1 mtpt -112.64 40.44 2.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.062 -0.972 . . . . 4.6 110.343 -176.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.509 -0.757 . . . . 3.96 110.542 -177.594 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.8 t30 . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.596 0.236 . . . . 2.72 110.976 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.0 -42.07 99.75 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.801 0.334 . . . . 2.46 111.357 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.477 ' N ' HD13 ' A' ' 17' ' ' ILE . 2.6 mp -65.86 -39.21 84.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.083 -0.508 . . . . 1.42 111.007 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.464 ' SG ' ' HE3' ' A' ' 23' ' ' TRP . 36.2 t -71.61 -39.06 70.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.754 0.787 . . . . 1.98 109.157 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 tt -64.47 -46.26 83.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.552 -1.204 . . . . 1.77 110.079 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -61.63 -31.5 71.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.025 -0.534 . . . . 4.47 111.412 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 53.8 mmtt -73.12 -3.88 29.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.329 0.585 . . . . 1.67 111.447 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.0 t30 64.51 30.77 12.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.511 -1.222 . . . . 2.37 110.173 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.464 ' HE3' ' SG ' ' A' ' 18' ' ' CYS . 33.6 m0 -89.6 165.56 24.83 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.367 -0.833 . . . . 0.4 109.088 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 36.9 Cg_endo -69.44 -176.6 1.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 121.973 1.782 . . . . 0.6 111.186 170.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.463 ' HA ' ' HE2' ' A' ' 25' ' ' MET . 21.4 mmt -74.77 137.52 73.57 Favored Pre-proline 0 C--N 1.323 -0.566 0 O-C-N 122.257 -0.277 . . . . 1.56 110.366 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -70.04 161.69 45.04 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.812 2.342 . . . . 0.68 112.457 -177.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.5 t -88.12 138.03 31.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.411 -0.813 . . . . 1.02 110.191 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.499 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 63.3 m-85 -143.78 111.28 5.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.651 -0.5 . . . . 0.87 109.651 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.482 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 79.3 ttt180 -164.17 131.61 3.32 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.977 -0.379 . . . . 4.22 109.977 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 8.8 p -64.53 130.6 44.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.054 0.454 . . . . 2.19 111.326 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.5 t -86.32 -28.45 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.666 -0.697 . . . . 1.87 109.9 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -136.25 120.74 18.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.169 -0.678 . . . . 2.76 109.169 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.471 ' HG2' ' CD1' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -150.84 126.11 10.01 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.007 -0.542 . . . . 2.6 109.775 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.65 165.65 39.59 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.601 -0.809 . . . . 2.17 112.547 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.84 -155.57 26.85 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 111.567 -0.613 . . . . 2.13 111.567 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.09 -71.44 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 123.378 2.719 . . . . 3.0 112.673 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.64 -47.85 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.216 0.532 . . . . 2.94 109.86 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -80.84 18.48 0.99 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.517 -0.765 . . . . 2.36 111.186 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -122.05 32.17 5.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.138 0.494 . . . . 1.84 110.85 -177.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 27.8 tptt -93.39 17.1 11.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 122.015 0.912 . . . . 2.53 109.369 174.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -85.53 137.86 32.59 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.479 -1.237 . . . . 4.07 107.948 167.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.471 ' CD1' ' HG2' ' A' ' 33' ' ' GLU . 8.2 m-85 -109.05 133.84 52.46 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.823 -0.626 . . . . 1.16 110.438 -169.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.1 m -119.8 116.33 25.66 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.851 -1.166 . . . . 1.08 107.851 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.69 ' CE2' ' HA ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -126.93 153.1 46.25 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.898 -0.408 . . . . 0.21 109.898 -170.06 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -126.87 140.38 11.89 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.574 -0.61 . . . . 0.2 111.574 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.681 HG23 ' CZ ' ' A' ' 44' ' ' PHE . 1.7 t -105.66 156.1 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.636 -0.505 . . . . 1.45 109.636 -175.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.712 ' HD2' ' O ' ' A' ' 56' ' ' THR . 0.4 OUTLIER -142.24 145.87 34.55 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.478 -0.934 . . . . 3.01 108.478 177.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.41 HG11 ' CZ3' ' A' ' 23' ' ' TRP . 38.8 t -132.08 150.71 33.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.544 -0.298 . . . . 1.07 110.293 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -94.61 83.66 4.14 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.825 0.821 . . . . 1.81 109.528 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.407 HG23 ' CH2' ' A' ' 23' ' ' TRP . 23.0 p -75.0 101.23 4.4 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.192 -1.367 . . . . 1.08 109.21 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t -43.76 -35.24 1.8 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.84 0.856 . . . . 1.72 113.173 -170.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.86 -33.36 72.95 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.598 0.592 . . . . 1.3 112.598 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -131.12 -38.6 1.22 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.806 0.336 . . . . 4.21 111.875 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.24 -151.96 16.88 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 116.253 -0.431 . . . . 0.24 112.272 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -52.91 126.24 19.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.172 0.51 . . . . 0.47 110.858 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.712 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 37.4 p -74.2 -174.71 2.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.351 -0.84 . . . . 1.07 112.372 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -76.62 169.92 17.39 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.82 -1.178 . . . . 1.84 107.82 165.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -92.34 119.78 32.23 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.222 0.534 . . . . 1.0 111.372 -171.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.454 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 28.6 m -85.46 97.61 10.13 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.104 -0.953 . . . . 0.44 109.293 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.4 mm -86.92 121.16 37.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.196 -0.456 . . . . 1.49 110.613 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.64 -174.47 49.94 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.835 -0.698 . . . . 0.24 111.519 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.648 ' O ' ' HG2' ' A' ' 64' ' ' MET . 42.8 mm-40 -85.89 148.41 48.21 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.687 0.244 . . . . 1.37 110.452 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 40.7 Cg_exo -57.26 109.14 0.42 Allowed 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.571 2.18 . . . . 0.79 111.186 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.648 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.0 mmm -117.32 149.97 45.55 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.692 -0.484 . . . . 1.4 109.692 -172.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -80.77 15.01 1.9 Allowed 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.539 2.16 . . . . 0.37 114.817 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.1 t -163.8 145.87 9.35 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.96 -0.463 . . . . 1.63 110.402 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.4 t -59.18 -50.98 77.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.315 0.487 . . . . 1.88 112.315 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -55.57 -43.81 76.27 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.202 0.445 . . . . 3.34 112.202 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HE3' ' HE2' ' A' ' 64' ' ' MET . 0.4 OUTLIER -80.88 -21.89 40.26 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.991 -0.284 . . . . 1.91 110.607 -178.206 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.91 -56.15 19.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.756 -0.202 . . . . 1.07 111.039 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.69 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 32.3 pttt -56.6 -42.04 78.04 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 120.917 0.389 . . . . 2.9 110.129 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.496 ' O ' HG21 ' A' ' 76' ' ' VAL . 31.3 t70 -54.17 -47.7 71.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.544 -0.753 . . . . 2.01 112.068 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.4 t -60.09 -45.84 91.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.34 . . . . 1.8 111.457 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.432 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -69.87 -40.6 75.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.039 0.447 . . . . 1.07 110.925 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.438 ' O ' HD12 ' A' ' 79' ' ' LEU . . . -52.52 -33.97 47.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.505 -0.771 . . . . 1.01 111.307 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 72' ' ' ASP . 96.9 t -61.24 -37.41 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.967 0.413 . . . . 1.53 110.739 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.1 mt -77.29 -33.09 55.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.75 0.785 . . . . 1.12 109.597 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.426 HD22 HG13 ' A' ' 46' ' ' VAL . 15.3 tp -65.5 -40.83 93.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.716 -1.129 . . . . 1.44 110.58 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 75' ' ' ALA . 7.2 mp -61.57 -26.14 67.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.435 -0.802 . . . . 2.23 111.045 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.82 -35.55 62.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.239 0.543 . . . . 2.13 110.076 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.41 -46.17 77.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.35 -0.841 . . . . 1.84 109.329 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mp -70.45 -9.8 57.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.295 -0.866 . . . . 1.82 111.971 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -86.41 -7.54 58.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.679 0.752 . . . . 2.08 109.456 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -113.5 44.73 1.53 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.217 -0.901 . . . . 4.6 109.896 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.8 p . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.487 -0.768 . . . . 3.96 110.339 -179.402 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.5 p30 . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 111.425 0.158 . . . . 2.72 111.425 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.4 -44.69 78.21 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.816 0.302 . . . . 2.46 111.816 -172.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.469 HD11 ' N ' ' A' ' 17' ' ' ILE . 2.7 mp -66.02 -35.83 76.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.041 0.448 . . . . 1.42 110.52 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.421 ' SG ' HG13 ' A' ' 48' ' ' VAL . 47.3 t -69.54 -40.52 76.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.631 0.729 . . . . 1.98 109.512 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.1 tp -63.73 -49.53 72.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.867 -1.061 . . . . 1.77 110.661 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.418 ' C ' ' H ' ' A' ' 22' ' ' ASN . 73.7 ttt180 -61.0 -36.63 79.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.383 -0.826 . . . . 4.47 111.745 -177.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -73.29 8.75 1.55 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 1.67 111.985 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.418 ' H ' ' C ' ' A' ' 20' ' ' ARG . 63.3 t30 60.21 34.67 21.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.261 -0.881 . . . . 2.37 110.065 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.433 ' CZ3' HG12 ' A' ' 48' ' ' VAL . 41.6 m0 -97.12 163.34 20.17 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 114.93 -1.032 . . . . 0.4 108.818 174.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 44.3 Cg_endo -70.0 -168.33 0.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.029 1.819 . . . . 0.6 111.497 173.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.431 ' HE3' ' HA ' ' A' ' 25' ' ' MET . 4.7 mmt -80.18 136.26 53.7 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.97 -0.381 . . . . 1.56 109.97 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.403 ' HG3' ' SG ' ' A' ' 18' ' ' CYS . 6.4 Cg_exo -71.42 162.8 41.18 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.597 2.198 . . . . 0.68 112.24 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.7 t -87.36 140.14 29.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.568 -0.742 . . . . 1.02 109.759 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.513 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 66.4 m-85 -140.8 109.82 6.13 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.265 -1.013 . . . . 0.87 108.265 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.585 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 33.8 ptt180 -145.24 130.71 18.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.891 0.377 . . . . 4.22 110.524 -173.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 33' ' ' GLU . 43.9 t -65.76 119.84 11.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.201 -0.454 . . . . 2.19 110.529 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.3 t -86.73 -42.93 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.975 -0.557 . . . . 1.87 110.737 -177.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -137.83 126.82 24.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.751 0.31 . . . . 2.76 110.664 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.563 ' HG3' ' CD1' ' A' ' 42' ' ' PHE . 40.2 tt0 -150.13 141.01 22.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.849 -0.614 . . . . 2.6 109.699 175.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.68 -161.84 46.58 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.555 -0.831 . . . . 2.17 112.687 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.59 -149.17 20.75 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.07 -0.812 . . . . 2.13 111.07 -174.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -52.17 -65.75 0.13 Allowed 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 123.018 2.478 . . . . 3.0 111.884 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -173.41 -41.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.291 0.567 . . . . 2.94 109.784 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -81.35 19.11 1.01 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.579 -0.737 . . . . 2.36 111.528 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -119.42 43.13 2.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.972 0.415 . . . . 1.84 111.655 -173.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -87.98 17.16 5.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.616 0.722 . . . . 2.53 109.69 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -85.75 132.99 34.02 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.799 -1.186 . . . . 4.07 107.799 169.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.563 ' CD1' ' HG3' ' A' ' 33' ' ' GLU . 6.8 m-85 -109.0 141.2 41.45 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.966 0.413 . . . . 1.16 110.57 -169.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.446 ' HG1' ' HA ' ' A' ' 63' ' ' PRO . 29.4 m -129.93 124.77 33.89 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.551 -0.75 . . . . 1.08 109.172 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.689 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -132.96 156.89 46.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.652 -0.499 . . . . 0.21 109.652 -173.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -130.12 142.06 13.29 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.912 -0.661 . . . . 0.2 112.015 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.689 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.5 t -105.36 156.29 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 117.027 0.413 . . . . 1.45 110.286 -174.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.526 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -137.01 142.04 42.51 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.928 -1.138 . . . . 3.01 107.928 178.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.433 HG12 ' CZ3' ' A' ' 23' ' ' TRP . 39.6 t -132.68 149.96 32.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 110.609 -0.145 . . . . 1.07 110.609 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -99.86 88.43 3.78 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.632 0.73 . . . . 1.81 110.889 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.5 p -68.52 113.33 5.96 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.38 -1.282 . . . . 1.08 109.634 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 52.3 m -49.22 -25.99 2.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.311 -0.858 . . . . 1.72 113.265 -176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -93.45 -16.78 24.18 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.527 0.566 . . . . 1.3 112.527 -176.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -134.9 -46.72 0.73 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.035 0.445 . . . . 4.21 111.315 -172.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.12 -156.59 19.08 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.8 -0.636 . . . . 0.24 112.698 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.526 ' CZ3' ' HB3' ' A' ' 47' ' ' ARG . 20.4 m95 -52.77 121.75 7.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.149 0.5 . . . . 0.47 111.312 176.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 42.3 p -73.42 177.41 5.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.478 -0.783 . . . . 1.07 111.912 -175.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -66.88 133.07 49.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.076 -0.713 . . . . 1.84 109.076 172.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.463 ' HB2' ' NH1' ' A' ' 47' ' ' ARG . 26.0 tt0 -65.39 110.75 2.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.24 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.482 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 62.0 m -84.89 97.65 9.88 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.567 -1.197 . . . . 0.44 109.913 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.413 HD13 ' HA3' ' A' ' 45' ' ' GLY . 32.1 mm -76.96 124.13 34.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.428 -0.805 . . . . 1.49 110.599 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.75 -170.28 46.87 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.922 -0.581 . . . . 0.24 112.657 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.61 ' O ' ' HG2' ' A' ' 64' ' ' MET . 36.6 mt-10 -83.93 151.34 60.55 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-O 120.603 0.239 . . . . 1.37 110.995 -175.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.446 ' HA ' ' HG1' ' A' ' 43' ' ' THR . 24.4 Cg_exo -63.71 99.22 0.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.754 2.303 . . . . 0.79 110.961 170.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.61 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 92.4 mmm -113.59 138.64 22.68 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.514 -0.312 . . . . 1.4 110.561 -170.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.79 7.35 2.82 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.669 2.246 . . . . 0.37 113.422 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.4 t -144.85 136.79 25.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.113 -0.699 . . . . 1.63 109.113 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.23 -28.11 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.897 -0.592 . . . . 1.88 111.726 -175.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -67.99 -43.21 79.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.11 -0.495 . . . . 3.34 110.481 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -74.21 -26.29 60.17 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.077 -0.511 . . . . 1.91 109.745 -176.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.73 -58.98 6.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.875 -0.602 . . . . 1.07 110.581 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.66 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 66.3 mttm -54.1 -51.72 63.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.391 -0.368 . . . . 2.9 111.07 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.551 ' O ' HG22 ' A' ' 76' ' ' VAL . 18.3 m-20 -53.45 -49.04 68.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.828 -0.624 . . . . 2.01 112.672 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.5 p -64.13 -38.68 91.93 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.922 -0.311 . . . . 1.8 111.253 -175.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.83 -46.18 72.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.31 0.576 . . . . 1.07 110.301 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.491 ' O ' HD12 ' A' ' 79' ' ' LEU . . . -53.31 -36.4 61.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.9 -1.046 . . . . 1.01 111.628 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 72' ' ' ASP . 96.1 t -63.83 -36.95 78.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.946 0.403 . . . . 1.53 110.763 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.7 mt -77.92 -28.9 49.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.738 0.78 . . . . 1.12 109.833 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.405 HD12 ' HB ' ' A' ' 46' ' ' VAL . 19.3 tp -66.54 -45.1 80.53 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.954 -1.021 . . . . 1.44 110.589 173.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 75' ' ' ALA . 7.0 mp -62.96 -30.75 71.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.441 -0.799 . . . . 2.23 112.358 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -78.87 -30.84 45.29 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.013 -0.675 . . . . 2.13 110.389 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.7 tt -65.19 -45.0 86.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.673 -0.862 . . . . 1.84 108.673 174.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mp -65.53 -20.65 66.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.928 -1.033 . . . . 1.82 111.878 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -87.38 -4.83 59.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.778 0.799 . . . . 2.08 109.172 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -115.9 38.52 3.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.255 -0.884 . . . . 4.6 109.574 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.8 p . . . . . 0 C--O 1.249 1.041 0 CA-C-N 115.111 -0.95 . . . . 3.96 110.96 -177.821 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 120.297 0.094 . . . . 2.72 111.152 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -65.67 -42.59 91.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.396 0.141 . . . . 2.46 111.146 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 17' ' ' ILE . 2.4 mp -59.62 -41.56 85.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.869 0.366 . . . . 1.42 110.593 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.0 t -71.86 -42.23 67.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.925 -0.579 . . . . 1.98 109.955 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.9 tp -61.92 -48.73 79.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.282 -0.872 . . . . 1.77 110.443 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -56.61 -37.36 70.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.954 -1.021 . . . . 4.47 111.854 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -73.45 0.37 12.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.291 -0.413 . . . . 1.67 111.426 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.5 t30 70.99 20.26 5.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.206 -0.906 . . . . 2.37 110.172 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -86.81 158.57 53.42 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.433 -0.803 . . . . 0.4 109.723 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.94 -168.82 0.25 Allowed 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 122.425 2.084 . . . . 0.6 111.449 174.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.431 ' HA ' ' HE1' ' A' ' 25' ' ' MET . 7.2 mmt -83.6 134.93 44.0 Favored Pre-proline 0 C--N 1.322 -0.624 0 O-C-N 122.032 -0.417 . . . . 1.56 109.91 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -67.14 166.99 21.26 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.807 2.338 . . . . 0.68 113.133 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.482 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 33.0 t -84.74 144.01 28.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.998 -1.001 . . . . 1.02 109.898 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.5 ' HD1' ' CZ ' ' A' ' 44' ' ' PHE . 72.4 m-85 -142.96 110.78 5.91 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.826 -0.805 . . . . 0.87 108.826 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.516 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 45.6 ttm105 -156.64 124.14 5.4 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.522 -0.547 . . . . 4.22 109.522 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -69.23 128.0 35.08 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.062 -0.517 . . . . 2.19 110.184 -176.559 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 43' ' ' THR . 26.8 m -78.85 -33.92 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.287 0.565 . . . . 1.87 109.625 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -134.94 128.58 32.79 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.418 -0.81 . . . . 2.76 109.605 171.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -145.58 138.77 26.23 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.847 -0.427 . . . . 2.6 109.847 175.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.47 -150.8 44.0 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.233 -0.984 . . . . 2.17 111.902 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.31 -162.06 12.89 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 110.455 -1.058 . . . . 2.13 110.455 -173.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 39' ' ' ALA . 32.0 Cg_exo -60.53 160.49 23.91 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.338 2.025 . . . . 3.0 112.132 177.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.32 -45.6 54.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.153 0.427 . . . . 2.94 112.153 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -71.71 -13.99 61.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 2.36 111.742 -177.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.412 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . . . -117.01 38.4 3.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.804 0.335 . . . . 1.84 111.3 -174.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -84.14 20.39 1.59 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.11 0.481 . . . . 2.53 110.551 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -82.67 139.59 33.61 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.77 -1.196 . . . . 4.07 107.77 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 7.5 m-85 -111.14 130.82 55.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.112 0.482 . . . . 1.16 110.028 -173.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 31' ' ' VAL . 16.4 m -118.47 127.59 53.8 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.874 -1.158 . . . . 1.08 107.874 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.691 ' CZ ' HG23 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -138.5 150.58 46.55 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.317 -0.623 . . . . 0.21 109.317 -174.14 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.31 141.08 12.26 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.915 -0.66 . . . . 0.2 112.313 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.691 HG23 ' CZ ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -107.37 156.05 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.628 -0.508 . . . . 1.45 109.628 -176.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.633 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 16.7 ptp180 -145.67 147.82 32.39 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.806 -0.813 . . . . 3.01 108.806 173.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.431 HG23 HD11 ' A' ' 82' ' ' LEU . 94.2 t -124.79 152.26 30.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 123.086 0.241 . . . . 1.07 110.64 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -95.14 85.25 4.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.708 0.766 . . . . 1.81 110.146 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.1 p -67.26 112.9 4.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.346 -1.297 . . . . 1.08 109.365 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -52.48 -26.46 12.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.659 -0.7 . . . . 1.72 112.215 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -94.85 -16.42 22.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.506 0.558 . . . . 1.3 112.506 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -132.63 -46.55 0.88 Allowed 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.934 -0.479 . . . . 4.21 111.493 -175.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.13 -158.07 20.9 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.13 -0.557 . . . . 0.24 113.142 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.633 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.1 m95 -52.48 118.53 3.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.863 0.364 . . . . 0.47 110.719 175.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.4 p -71.75 161.35 31.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.786 -0.643 . . . . 1.07 111.005 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -61.66 125.77 24.98 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.131 -0.692 . . . . 1.84 109.131 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -59.49 124.81 21.28 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.246 -0.888 . . . . 1.0 111.245 -173.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 52.7 m -96.75 99.09 10.7 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.73 -1.123 . . . . 0.44 110.361 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.7 mp -76.57 126.93 37.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.918 -0.583 . . . . 1.49 110.37 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.57 -166.82 41.88 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.436 -0.802 . . . . 0.24 112.634 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -91.24 135.94 27.7 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 110.096 -0.335 . . . . 1.37 110.096 -178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 50.4 Cg_exo -54.8 115.23 2.27 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.101 2.534 . . . . 0.79 112.174 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 14.7 mmt -112.93 152.22 44.71 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.766 -0.652 . . . . 1.4 111.236 -172.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -85.25 9.88 3.95 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.666 2.244 . . . . 0.37 112.911 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -155.63 138.63 15.44 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.477 -0.564 . . . . 1.63 109.477 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.06 -27.88 42.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.588 -0.733 . . . . 1.88 112.748 -170.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -72.17 -42.3 66.07 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.822 -0.351 . . . . 3.34 111.045 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -80.74 -18.01 49.16 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.914 -0.315 . . . . 1.91 110.316 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.39 -59.22 5.47 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.337 -0.392 . . . . 1.07 110.391 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.621 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 8.9 mtmp? -51.85 -47.1 64.58 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 116.303 -0.408 . . . . 2.9 111.16 175.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.536 ' O ' HG23 ' A' ' 76' ' ' VAL . 15.0 m-20 -50.86 -51.56 50.13 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.404 0.44 . . . . 2.01 112.074 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.9 t -60.66 -43.75 97.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.638 0.256 . . . . 1.8 111.249 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.64 -43.0 77.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.074 0.464 . . . . 1.07 110.53 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.492 ' O ' HD11 ' A' ' 79' ' ' LEU . . . -54.24 -38.19 65.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.338 -0.846 . . . . 1.01 111.454 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 72' ' ' ASP . 99.0 t -65.37 -36.53 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-O 120.815 0.34 . . . . 1.53 110.757 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.7 mt -73.95 -34.43 64.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.784 0.802 . . . . 1.12 109.208 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.44 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 28.5 tp -65.51 -43.05 91.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.401 -1.272 . . . . 1.44 110.887 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.492 HD11 ' O ' ' A' ' 75' ' ' ALA . 7.2 mp -62.57 -24.94 67.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.704 -0.68 . . . . 2.23 111.134 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 76' ' ' VAL . 39.5 mt-10 -74.01 -39.52 63.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.159 0.504 . . . . 2.13 109.68 175.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.99 -51.7 65.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.331 -0.85 . . . . 1.84 110.324 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 78' ' ' LEU . 34.6 mt -65.76 -18.1 65.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.578 -1.192 . . . . 1.82 111.594 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -88.98 -1.62 58.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.04 0.924 . . . . 2.08 109.352 176.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 28.4 mtpp -107.46 -146.55 0.4 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.564 -1.198 . . . . 4.6 108.763 175.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.25 1.131 0 O-C-N 124.373 1.046 . . . . 3.96 112.591 176.374 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 . . . . . 0 N--CA 1.485 1.292 0 N-CA-C 111.878 0.325 . . . . 2.72 111.878 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -66.68 -41.65 87.77 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.884 0.374 . . . . 2.46 111.478 -171.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.469 ' N ' HD13 ' A' ' 17' ' ' ILE . 2.8 mp -69.29 -42.61 81.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.193 -0.458 . . . . 1.42 110.807 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.615 ' SG ' ' HG3' ' A' ' 26' ' ' PRO . 42.8 t -60.21 -38.78 84.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.572 0.701 . . . . 1.98 109.985 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.5 tp -63.78 -43.99 94.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.767 -1.106 . . . . 1.77 110.355 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.415 ' C ' ' H ' ' A' ' 22' ' ' ASN . 23.2 ttm180 -66.9 -33.12 74.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.652 -1.158 . . . . 4.47 111.529 -176.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 28.9 mmmt -73.95 6.54 3.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 1.67 111.469 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 20' ' ' ARG . 64.0 t30 61.9 28.75 17.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.132 -0.94 . . . . 2.37 110.522 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.477 ' CH2' HG23 ' A' ' 50' ' ' THR . 37.1 m0 -91.03 162.92 31.37 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.487 -0.779 . . . . 0.4 109.051 174.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -67.45 -170.31 0.25 Allowed 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 121.984 1.79 . . . . 0.6 111.535 173.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.414 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 1.6 mmt -81.8 130.98 58.73 Favored Pre-proline 0 C--N 1.321 -0.643 0 O-C-N 122.036 -0.415 . . . . 1.56 110.281 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.615 ' HG3' ' SG ' ' A' ' 18' ' ' CYS . 11.0 Cg_exo -68.46 168.01 20.87 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.632 2.221 . . . . 0.68 112.192 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.8 t -88.82 137.56 32.21 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.543 -0.753 . . . . 1.02 110.052 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.481 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 84.9 m-85 -146.46 109.35 4.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.632 -0.507 . . . . 0.87 109.632 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.444 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 78.9 ttt180 -160.07 130.17 5.41 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 110.066 -0.346 . . . . 4.22 110.066 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.422 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 63.5 m -61.78 126.42 27.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.076 0.465 . . . . 2.19 110.809 -178.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.22 -39.58 12.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.804 -0.634 . . . . 1.87 111.326 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.462 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 32.3 mmtt -136.8 171.34 14.65 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.022 0.439 . . . . 2.76 111.884 -173.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -149.67 158.41 44.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.134 -0.939 . . . . 2.6 109.264 -175.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.45 -78.98 0.2 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.494 -0.86 . . . . 2.17 113.801 -173.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.92 -126.47 1.94 Allowed Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.424 -0.67 . . . . 2.13 111.424 -171.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -67.18 -172.2 0.33 Allowed 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 123.887 3.058 . . . . 3.0 112.362 173.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.97 -37.9 72.24 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.459 0.54 . . . . 2.94 112.459 -174.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -73.08 -13.16 61.15 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.221 0.452 . . . . 2.36 112.221 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -126.69 99.16 5.66 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.048 -0.353 . . . . 1.84 110.048 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -128.3 20.92 6.22 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.276 -0.638 . . . . 2.53 109.276 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HD3' ' H ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -83.74 131.96 34.88 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.002 -0.679 . . . . 4.07 109.624 -177.157 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -109.54 139.88 44.0 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.96 -1.018 . . . . 1.16 109.448 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 32' ' ' LYS . 32.9 m -123.66 123.77 41.29 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.462 -0.94 . . . . 1.08 108.462 -175.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.644 ' CZ ' ' HB ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -125.82 152.27 45.67 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.609 -0.515 . . . . 0.21 109.609 -173.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.22 126.94 5.92 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.455 -0.658 . . . . 0.2 111.455 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.644 ' HB ' ' CZ ' ' A' ' 44' ' ' PHE . 7.4 p -109.27 149.26 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 110.002 -0.37 . . . . 1.45 110.002 -176.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.563 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 11.2 ptt180 -145.14 150.48 36.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.017 -0.735 . . . . 3.01 109.017 176.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.503 HG11 ' SG ' ' A' ' 18' ' ' CYS . 67.4 t -125.99 155.45 35.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.022 -0.535 . . . . 1.07 111.005 -176.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -95.6 83.78 3.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.758 0.789 . . . . 1.81 110.061 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.477 HG23 ' CH2' ' A' ' 23' ' ' TRP . 24.9 p -69.56 112.24 5.93 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.163 -1.38 . . . . 1.08 109.446 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.5 t -50.74 -23.61 2.82 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.961 0.726 . . . . 1.72 112.961 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -77.89 -29.54 50.29 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.129 0.789 . . . . 1.3 113.129 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -138.11 -36.62 0.59 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.599 -0.441 . . . . 4.21 111.977 -173.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.6 -147.86 17.29 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.904 -0.665 . . . . 0.24 112.663 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.563 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.3 m95 -49.8 119.93 3.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.315 0.579 . . . . 0.47 111.891 177.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -73.91 167.12 22.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.248 -0.887 . . . . 1.07 110.721 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -63.06 128.57 36.47 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.259 -0.645 . . . . 1.84 109.259 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.39 114.44 3.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.566 0.698 . . . . 1.0 110.511 -176.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.1 m -90.93 102.63 15.4 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.707 -1.133 . . . . 0.44 110.328 -175.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.08 122.25 26.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.649 -0.705 . . . . 1.49 110.228 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -78.36 -173.14 41.61 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.687 -0.688 . . . . 0.24 112.566 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 64' ' ' MET . 50.6 mt-10 -86.15 137.6 35.01 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 110.289 -0.263 . . . . 1.37 110.289 -177.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.07 104.92 0.13 Allowed 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 123.071 2.514 . . . . 0.79 111.566 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.644 ' SD ' ' HE2' ' A' ' 69' ' ' LYS . 16.5 mmt -113.15 147.36 37.15 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.578 -0.737 . . . . 1.4 111.133 -172.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.71 13.21 2.17 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.717 2.278 . . . . 0.37 113.241 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.8 t -155.61 138.91 15.71 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.451 -0.574 . . . . 1.63 109.451 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.06 -23.23 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.146 -0.479 . . . . 1.88 112.244 -172.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -71.45 -45.33 62.88 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.748 0.309 . . . . 3.34 110.786 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.644 ' HE2' ' SD ' ' A' ' 64' ' ' MET . 19.0 ptmt -81.79 -16.94 49.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.367 -0.379 . . . . 1.91 110.377 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.78 -56.0 27.1 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.018 -0.537 . . . . 1.07 109.868 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.592 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 56.6 mtpt -49.91 -51.59 39.59 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 115.995 -0.548 . . . . 2.9 111.543 174.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.7 m-20 -51.96 -47.48 64.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.765 0.654 . . . . 2.01 112.765 -177.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 83.9 p -62.78 -39.14 93.29 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.69 -0.404 . . . . 1.8 111.251 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.6 -38.97 70.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.304 0.573 . . . . 1.07 110.025 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.57 -30.75 69.98 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.389 -0.823 . . . . 1.01 111.54 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 72' ' ' ASP . 96.1 t -70.35 -32.59 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.191 0.52 . . . . 1.53 110.31 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.6 mt -73.86 -27.48 61.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.042 0.925 . . . . 1.12 109.218 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.3 tp -65.72 -33.58 76.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.679 -1.146 . . . . 1.44 109.931 173.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 76' ' ' VAL . 3.1 mm? -60.72 -38.67 85.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.909 -0.587 . . . . 2.23 111.961 177.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -81.0 -33.42 33.69 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.489 -0.484 . . . . 2.13 110.245 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.31 -53.32 59.08 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.294 -0.632 . . . . 1.84 109.294 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.34 -3.24 5.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.981 -1.009 . . . . 1.82 112.204 174.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -100.58 -6.56 25.15 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.641 -0.874 . . . . 2.08 108.641 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -114.16 30.82 7.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.12 -0.946 . . . . 4.6 109.79 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.3 p . . . . . 0 C--O 1.25 1.101 0 CA-C-N 114.898 -1.046 . . . . 3.96 110.375 -177.506 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 111.783 0.29 . . . . 2.72 111.783 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -64.98 -40.65 95.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.64 0.257 . . . . 2.46 111.303 -173.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.461 ' N ' HD13 ' A' ' 17' ' ' ILE . 2.6 mp -64.58 -41.88 93.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.006 0.431 . . . . 1.42 110.315 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.439 ' SG ' ' HE3' ' A' ' 23' ' ' TRP . 19.6 t -64.96 -42.02 94.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.59 -0.732 . . . . 1.98 109.568 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.9 tp -60.85 -48.18 82.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.86 -1.064 . . . . 1.77 110.53 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.44 -36.12 75.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.001 -0.999 . . . . 4.47 110.981 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 30.2 mmmt -74.0 2.8 7.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.869 -0.605 . . . . 1.67 111.574 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 71.77 20.68 4.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.065 0.936 . . . . 2.37 109.71 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.439 ' HE3' ' SG ' ' A' ' 18' ' ' CYS . 35.3 m0 -91.93 155.35 43.32 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.403 -0.817 . . . . 0.4 109.437 175.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -63.56 -173.73 0.19 Allowed 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.808 2.338 . . . . 0.6 111.795 168.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.452 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 21.7 mmt -81.99 131.46 56.77 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 116.253 -0.43 . . . . 1.56 110.308 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 22.3 Cg_exo -62.98 160.26 34.59 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.715 2.277 . . . . 0.68 112.822 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.441 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 13.6 t -84.79 142.01 30.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.21 -0.905 . . . . 1.02 109.791 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.485 ' CD2' ' CZ ' ' A' ' 44' ' ' PHE . 71.2 m-85 -139.54 110.96 7.05 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.81 -0.811 . . . . 0.87 108.81 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.525 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 43.3 ttt180 -145.5 122.86 11.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.521 0.201 . . . . 4.22 110.525 -174.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.479 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 76.5 m -63.57 120.81 12.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.766 0.317 . . . . 2.19 110.569 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.8 m -86.05 -38.54 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.314 -0.403 . . . . 1.87 111.105 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -136.36 127.75 28.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.865 0.364 . . . . 2.76 110.882 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -112.0 144.49 41.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.756 -0.656 . . . . 2.6 109.397 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 40' ' ' LYS . . . -73.12 154.5 49.59 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.704 -0.76 . . . . 2.17 113.487 -173.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.69 -132.46 0.37 Allowed Glycine 0 N--CA 1.452 -0.281 0 O-C-N 123.919 0.423 . . . . 2.13 113.938 -176.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -42.18 -71.91 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 124.858 3.706 . . . . 3.0 114.015 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.403 ' C ' ' H ' ' A' ' 39' ' ' ALA . . . -169.08 -37.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 2.94 110.537 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 39.1 p-80 -73.5 7.65 2.24 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.116 -0.493 . . . . 2.36 111.195 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 41' ' ' ARG . . . -146.89 32.88 0.92 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.106 -0.497 . . . . 1.84 110.216 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.451 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 20.4 tptt -79.03 23.28 0.36 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.186 0.517 . . . . 2.53 111.517 -175.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.412 ' H ' ' C ' ' A' ' 39' ' ' ALA . 23.3 ptt180 -81.18 133.22 35.42 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.997 -0.742 . . . . 4.07 108.997 176.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.442 ' CZ ' ' HG3' ' A' ' 40' ' ' LYS . 14.4 m-85 -110.05 143.88 39.44 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.307 -0.861 . . . . 1.16 110.879 -171.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.7 m -129.05 137.51 51.33 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.302 -0.863 . . . . 1.08 109.025 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.707 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -141.16 153.64 45.46 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.283 -0.636 . . . . 0.21 109.283 -176.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -125.09 139.28 11.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 0.2 111.914 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.707 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.1 t -106.8 154.02 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 117.096 0.448 . . . . 1.45 109.895 -174.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.572 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 18.0 ptp180 -145.06 144.05 30.77 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.481 -0.933 . . . . 3.01 108.481 172.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.427 HG22 HD12 ' A' ' 78' ' ' LEU . 97.3 t -122.64 152.81 27.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.392 -0.367 . . . . 1.07 110.664 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -92.37 83.46 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.542 0.687 . . . . 1.81 109.953 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.2 p -74.52 109.77 8.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.792 -1.095 . . . . 1.08 109.527 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.2 t -49.21 -27.85 4.02 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.93 0.715 . . . . 1.72 112.93 -172.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -84.44 -21.21 30.8 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.299 0.481 . . . . 1.3 112.299 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.09 -44.85 1.03 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.167 0.508 . . . . 4.21 111.073 -173.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.46 -152.04 16.87 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.762 -0.654 . . . . 0.24 111.834 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.572 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 5.5 m95 -53.78 119.98 5.67 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.171 0.51 . . . . 0.47 110.638 173.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.9 p -69.2 170.44 10.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.58 -0.737 . . . . 1.07 111.521 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -63.68 125.68 25.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.453 -0.943 . . . . 1.84 108.453 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 38.2 tt0 -61.58 118.38 6.97 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.621 0.724 . . . . 1.0 110.666 -175.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.556 ' SG ' HD11 ' A' ' 81' ' ' LEU . 57.2 m -91.94 98.18 11.42 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.785 -1.098 . . . . 0.44 110.499 -175.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.7 mp -74.63 124.34 32.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.945 -0.57 . . . . 1.49 110.313 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.72 -167.65 43.72 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.1 -0.955 . . . . 0.24 112.848 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.548 ' O ' ' HG2' ' A' ' 64' ' ' MET . 40.9 mt-10 -89.74 148.62 40.38 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-O 120.545 0.212 . . . . 1.37 111.013 -174.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.57 106.7 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.814 2.342 . . . . 0.79 111.396 172.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.548 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.4 mmm -115.08 143.49 30.31 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.077 -0.51 . . . . 1.4 110.409 -173.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.32 3.89 5.38 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.737 2.291 . . . . 0.37 113.312 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.9 t -143.65 140.06 29.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.498 -0.556 . . . . 1.63 109.498 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.6 m -64.62 -32.93 59.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.772 -0.649 . . . . 1.88 111.482 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -64.07 -42.13 97.1 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 120.927 0.394 . . . . 3.34 110.559 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.417 ' HE2' ' CE ' ' A' ' 64' ' ' MET . 43.4 mtpt -74.6 -25.16 59.08 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.99 -0.55 . . . . 1.91 110.091 -177.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.52 -59.81 4.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.792 -0.64 . . . . 1.07 110.696 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.693 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 52.8 pttt -61.92 -43.03 99.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.726 -0.215 . . . . 2.9 110.91 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.515 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.9 m-20 -52.35 -50.8 61.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.879 0.696 . . . . 2.01 112.879 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.3 p -66.54 -39.45 88.56 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.882 0.327 . . . . 1.8 111.882 -175.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.474 ' HB1' ' CE2' ' A' ' 44' ' ' PHE . . . -68.18 -42.29 80.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.262 0.553 . . . . 1.07 110.464 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.48 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -53.72 -36.05 61.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.222 -0.899 . . . . 1.01 111.275 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 72' ' ' ASP . 94.9 t -62.36 -37.13 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.009 0.433 . . . . 1.53 110.595 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.0 mt -75.11 -32.94 61.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.611 0.719 . . . . 1.12 109.543 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.427 HD12 HG22 ' A' ' 48' ' ' VAL . 19.1 tp -64.59 -39.21 93.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.825 -1.08 . . . . 1.44 110.905 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.7 mm? -59.52 -28.24 66.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.578 -0.737 . . . . 2.23 111.039 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -72.76 -35.4 67.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.081 0.467 . . . . 2.13 110.695 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.556 HD11 ' SG ' ' A' ' 59' ' ' CYS . 1.3 tt -62.96 -49.57 74.22 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.968 -0.753 . . . . 1.84 108.968 175.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 mp -70.16 -2.77 14.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.198 -0.91 . . . . 1.82 111.655 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -97.96 -13.07 21.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.481 0.658 . . . . 2.08 109.478 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -113.74 43.67 1.76 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.313 -0.858 . . . . 4.6 110.427 -178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.532 -0.746 . . . . 3.96 110.197 -179.491 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 26.7 p-10 . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 111.035 0.013 . . . . 2.72 111.035 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -68.91 -46.87 67.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.971 0.415 . . . . 2.46 110.804 -176.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.458 ' N ' HD12 ' A' ' 17' ' ' ILE . 2.3 mp -62.97 -39.59 85.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.544 -0.753 . . . . 1.42 110.325 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.4 m -68.56 -44.64 74.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.906 0.86 . . . . 1.98 110.003 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 15' ' ' ASN . 3.5 tt -62.43 -45.69 91.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.228 -1.351 . . . . 1.77 110.483 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.411 ' NH2' HG21 ' A' ' 17' ' ' ILE . 51.8 ttp85 -60.37 -38.2 83.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.578 -0.737 . . . . 4.47 111.644 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.449 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 28.2 mmmt -72.93 0.39 11.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.549 -0.751 . . . . 1.67 112.082 -176.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 62.87 51.05 3.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.092 0.948 . . . . 2.37 110.011 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.414 ' CZ3' ' HG ' ' A' ' 82' ' ' LEU . 39.6 m0 -113.26 166.11 11.85 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.183 -0.917 . . . . 0.4 109.223 175.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.62 162.04 33.35 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.957 1.771 . . . . 0.6 109.407 167.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 65.2 mmm -74.75 127.96 86.22 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 110.212 -0.292 . . . . 1.56 110.212 -173.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HB3' HG22 ' A' ' 48' ' ' VAL . 1.2 Cg_endo -50.99 163.63 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 124.01 3.14 . . . . 0.68 114.887 -173.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.452 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 25.3 t -81.02 144.25 31.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.338 -1.301 . . . . 1.02 109.232 175.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.484 ' HD2' ' CZ ' ' A' ' 44' ' ' PHE . 72.6 m-85 -140.52 111.76 7.2 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.844 -0.798 . . . . 0.87 108.844 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.46 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 36.4 ttm180 -151.92 124.07 8.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.042 -0.355 . . . . 4.22 110.042 -176.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.441 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 83.8 m -66.84 124.92 24.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.953 0.406 . . . . 2.19 110.435 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -85.2 -35.81 10.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.835 -0.62 . . . . 1.87 110.829 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -140.9 127.04 19.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.985 -0.552 . . . . 2.76 110.277 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.429 ' HB2' ' CD1' ' A' ' 42' ' ' PHE . 7.6 pt-20 -151.01 154.92 37.97 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.974 -0.38 . . . . 2.6 109.974 176.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.46 -171.42 29.31 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.595 -0.812 . . . . 2.17 112.949 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.16 -145.27 12.57 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.915 -0.874 . . . . 2.13 110.915 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -73.56 52.99 2.58 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 123.192 2.595 . . . . 3.0 112.415 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 68.51 -57.76 0.49 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.957 0.903 . . . . 2.94 112.48 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -77.86 18.0 0.52 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.827 0.346 . . . . 2.36 111.478 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.59 44.22 2.76 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.338 0.589 . . . . 1.84 110.114 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.6 tptp -81.55 19.71 0.99 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.79 -0.641 . . . . 2.53 110.517 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -83.46 135.52 34.64 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.535 -0.913 . . . . 4.07 108.535 174.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 8.0 m-85 -112.84 132.09 55.43 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.63 -0.714 . . . . 1.16 110.158 -174.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.0 m -119.85 130.01 54.68 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.064 -1.087 . . . . 1.08 108.064 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.684 ' CZ ' HG23 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -137.81 152.66 49.35 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.526 -0.546 . . . . 0.21 109.526 -175.049 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.82 138.74 10.49 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.037 -0.602 . . . . 0.2 111.901 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.684 HG23 ' CZ ' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -105.93 157.71 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 109.503 -0.554 . . . . 1.45 109.503 -176.691 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.585 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 24.2 ptt180 -146.72 141.81 27.16 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.983 -1.118 . . . . 3.01 107.983 173.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 26' ' ' PRO . 39.8 t -118.62 155.47 20.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.523 -0.308 . . . . 1.07 110.374 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -96.05 84.04 3.75 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.635 0.731 . . . . 1.81 109.635 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.537 ' OG1' ' HB2' ' A' ' 53' ' ' ARG . 37.7 p -68.29 113.33 5.8 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.298 -1.319 . . . . 1.08 109.223 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.0 t -52.48 -27.29 15.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.776 -0.647 . . . . 1.72 112.664 -171.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -100.54 -4.69 28.14 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.416 0.525 . . . . 1.3 112.416 -176.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.537 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 68.6 mtt180 -130.44 -52.25 1.09 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.232 0.539 . . . . 4.21 110.897 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.73 -152.86 17.21 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.326 -0.852 . . . . 0.24 112.397 -175.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.585 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.4 m95 -55.79 120.28 7.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.067 0.461 . . . . 0.47 111.23 176.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.9 p -71.73 161.54 30.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.742 -0.663 . . . . 1.07 110.837 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.96 132.15 51.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.271 -0.641 . . . . 1.84 109.271 174.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -56.57 116.94 3.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.58 -0.737 . . . . 1.0 110.937 -175.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.1 m -93.19 97.89 10.94 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.908 -1.042 . . . . 0.44 110.114 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.3 mm -75.62 123.77 32.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.572 -0.74 . . . . 1.49 110.619 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.36 -167.01 42.77 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.867 -0.606 . . . . 0.24 112.073 177.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -88.44 137.2 30.76 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 110.236 -0.283 . . . . 1.37 110.236 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 50.2 Cg_exo -53.79 116.35 2.95 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.843 2.362 . . . . 0.79 111.602 176.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.651 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 18.6 mmt -115.37 153.01 47.53 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.113 -0.494 . . . . 1.4 111.082 -173.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -82.23 9.79 3.83 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.897 2.398 . . . . 0.37 113.135 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.9 t -155.78 139.38 15.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.2 -0.667 . . . . 1.63 109.2 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.65 -22.86 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 1.88 111.901 -173.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -75.24 -42.93 54.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.901 0.381 . . . . 3.34 110.597 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.651 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 0.2 OUTLIER -82.31 -17.36 46.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.188 -0.46 . . . . 1.91 110.384 178.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.76 -57.55 12.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.252 -0.431 . . . . 1.07 110.425 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.632 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 61.2 mttm -52.66 -49.34 65.41 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.072 -0.513 . . . . 2.9 110.433 174.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.509 ' O ' HG21 ' A' ' 76' ' ' VAL . 25.9 t70 -49.34 -49.87 42.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.933 -1.031 . . . . 2.01 112.3 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.0 t -58.42 -48.53 80.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.788 0.328 . . . . 1.8 111.453 -178.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.51 83.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.28 0.562 . . . . 1.07 110.777 -176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.423 ' O ' HD11 ' A' ' 79' ' ' LEU . . . -60.38 -30.74 69.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.475 -0.784 . . . . 1.01 111.646 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 72' ' ' ASP . 73.9 t -63.72 -37.81 80.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 121.09 0.472 . . . . 1.53 110.248 176.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.92 -28.73 58.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.841 -0.618 . . . . 1.12 109.796 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mt -60.1 -44.32 94.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.341 -0.845 . . . . 1.44 110.553 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.423 HD11 ' O ' ' A' ' 75' ' ' ALA . 7.6 mp -61.47 -28.42 69.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.518 -0.764 . . . . 2.23 111.777 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -71.95 -44.54 63.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.859 0.361 . . . . 2.13 110.46 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.2 tt -61.39 -48.94 78.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.608 0.718 . . . . 1.84 109.23 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.414 ' HG ' ' CZ3' ' A' ' 23' ' ' TRP . 1.6 mp -65.02 -20.12 66.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.792 -1.094 . . . . 1.82 112.414 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -92.31 -3.74 54.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.691 0.757 . . . . 2.08 109.528 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -114.09 36.14 3.83 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.305 -0.861 . . . . 4.6 109.859 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.25 1.1 0 CA-C-N 115.186 -0.916 . . . . 3.96 110.819 -177.691 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 111.51 0.189 . . . . 2.72 111.51 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -66.45 -46.51 76.18 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.902 0.382 . . . . 2.46 110.372 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.456 ' N ' HD13 ' A' ' 17' ' ' ILE . 2.6 mp -62.75 -39.35 84.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.762 -0.654 . . . . 1.42 110.119 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.0 m -65.54 -43.99 88.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.654 -0.703 . . . . 1.98 110.007 177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.5 tp -60.02 -52.1 66.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.249 -0.887 . . . . 1.77 110.081 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -55.81 -41.6 74.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.908 -1.042 . . . . 4.47 111.451 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -75.06 0.87 14.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.867 -0.606 . . . . 1.67 112.096 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.8 t30 68.11 25.43 7.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.905 0.859 . . . . 2.37 110.007 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -91.52 161.36 34.58 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.314 -0.857 . . . . 0.4 109.79 176.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -74.08 178.82 6.41 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 122.149 1.899 . . . . 0.6 110.763 168.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.406 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 23.9 mmt -80.05 139.94 53.39 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 116.081 -0.509 . . . . 1.56 110.01 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 12.1 Cg_exo -67.17 159.01 54.13 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.507 2.138 . . . . 0.68 112.578 -174.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.5 t -82.12 143.89 31.15 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.314 -0.857 . . . . 1.02 109.392 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.552 ' HD2' ' CZ ' ' A' ' 44' ' ' PHE . 64.7 m-85 -136.71 110.19 7.96 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.474 -0.935 . . . . 0.87 108.474 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.535 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 67.6 mtp180 -143.0 122.33 13.06 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.658 -0.247 . . . . 4.22 110.638 -173.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 35.5 t -71.4 120.49 17.06 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.979 -0.378 . . . . 2.19 109.979 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -86.55 -35.68 9.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.234 -0.439 . . . . 1.87 111.384 -176.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -136.27 123.62 21.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.287 0.565 . . . . 2.76 111.13 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.471 ' HG3' ' CD1' ' A' ' 42' ' ' PHE . 43.3 tt0 -152.86 129.37 10.7 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.886 -1.052 . . . . 2.6 109.867 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.1 176.72 45.0 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.429 -0.891 . . . . 2.17 113.099 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.0 -151.59 23.64 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.129 -0.788 . . . . 2.13 111.129 -177.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.409 ' HB2' ' H ' ' A' ' 37' ' ' ALA . 76.8 Cg_exo -52.7 -73.46 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.18 2.587 . . . . 3.0 112.549 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.409 ' H ' ' HB2' ' A' ' 36' ' ' PRO . . . -161.09 -43.97 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.095 0.474 . . . . 2.94 109.982 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -78.04 12.02 2.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.8 -0.636 . . . . 2.36 111.17 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.94 28.35 8.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.163 0.506 . . . . 1.84 110.856 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 22.8 tptt -90.22 15.81 9.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.056 0.931 . . . . 2.53 108.973 175.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.04 135.04 34.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.456 -1.247 . . . . 4.07 107.772 167.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.471 ' CD1' ' HG3' ' A' ' 33' ' ' GLU . 10.9 m-85 -110.35 136.57 49.32 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.119 0.485 . . . . 1.16 110.365 -168.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 m -126.4 133.49 51.27 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.335 -0.848 . . . . 1.08 109.056 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.718 ' CZ ' HG23 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -140.37 152.89 46.13 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.305 -0.628 . . . . 0.21 109.305 -174.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -126.24 139.89 11.7 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.801 -0.714 . . . . 0.2 112.287 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.718 HG23 ' CZ ' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -107.75 156.14 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.908 -0.405 . . . . 1.45 109.908 -176.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.518 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 11.7 ptp180 -146.45 148.86 32.69 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.526 -0.916 . . . . 3.01 108.526 172.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.0 t -123.75 152.4 29.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 O-C-N 123.157 0.286 . . . . 1.07 110.616 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -94.62 88.82 5.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.765 0.793 . . . . 1.81 110.243 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.56 ' OG1' ' HB3' ' A' ' 53' ' ' ARG . 37.7 p -71.65 113.3 8.54 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.422 -1.263 . . . . 1.08 109.585 177.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.9 t -52.09 -25.23 8.28 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.925 0.713 . . . . 1.72 112.925 -172.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -113.32 12.12 18.78 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.599 -0.44 . . . . 1.3 112.012 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.56 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 41.5 ttm180 -146.56 -50.27 0.21 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.946 0.403 . . . . 4.21 110.886 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.77 -162.47 19.0 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 116.156 -0.474 . . . . 0.24 113.03 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.518 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 15.3 m95 -52.57 117.97 3.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.111 0.481 . . . . 0.47 110.765 174.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.0 p -70.83 178.89 2.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.36 -0.836 . . . . 1.07 112.063 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -63.73 134.83 56.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.517 -0.765 . . . . 1.84 109.697 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.65 113.53 4.31 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.399 0.619 . . . . 1.0 110.166 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.486 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 63.7 m -88.75 97.4 11.12 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.966 -1.016 . . . . 0.44 109.849 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.3 mm -81.66 122.92 37.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.451 -0.795 . . . . 1.49 110.068 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.26 -171.97 48.15 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.953 -0.641 . . . . 0.24 112.037 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.602 ' O ' ' HG2' ' A' ' 64' ' ' MET . 40.1 mt-10 -86.35 151.08 53.12 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.972 -0.381 . . . . 1.37 109.972 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.68 112.6 1.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.379 2.053 . . . . 0.79 110.83 172.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.602 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 97.1 mmm -115.51 142.44 28.82 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.384 -0.371 . . . . 1.4 110.35 -173.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.99 14.32 1.54 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.66 2.24 . . . . 0.37 113.713 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.446 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 30.0 t -157.57 143.2 17.29 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.646 -0.502 . . . . 1.63 109.646 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.1 m -71.44 -22.31 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.892 -0.595 . . . . 1.88 111.675 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -73.56 -47.31 41.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.119 -0.492 . . . . 3.34 110.419 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.446 ' HG2' ' HB3' ' A' ' 66' ' ' SER . 15.5 ptpt -81.15 -16.86 51.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.863 -0.608 . . . . 1.91 110.768 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.1 -56.21 24.95 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.316 -0.402 . . . . 1.07 110.47 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.635 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 55.5 mttp -54.19 -47.18 72.35 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.186 -0.461 . . . . 2.9 110.837 176.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.564 ' O ' HG22 ' A' ' 76' ' ' VAL . 19.6 m-20 -52.09 -49.45 63.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.017 -0.538 . . . . 2.01 111.85 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.7 t -59.95 -46.64 88.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.595 0.236 . . . . 1.8 111.538 -175.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.452 ' HB1' ' CE2' ' A' ' 44' ' ' PHE . . . -66.38 -42.04 88.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.189 0.519 . . . . 1.07 110.554 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.448 ' O ' HD11 ' A' ' 79' ' ' LEU . . . -53.33 -38.26 63.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.209 -0.905 . . . . 1.01 111.516 177.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 72' ' ' ASP . 57.6 t -63.02 -36.68 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.897 0.38 . . . . 1.53 110.743 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 85.3 mt -74.66 -32.88 62.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.765 0.793 . . . . 1.12 109.44 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.9 tp -65.42 -39.38 92.07 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.557 -1.201 . . . . 1.44 110.781 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.448 HD11 ' O ' ' A' ' 75' ' ' ALA . 7.3 mp -58.94 -29.86 67.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.745 -0.662 . . . . 2.23 111.045 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -69.84 -38.6 76.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.08 0.467 . . . . 2.13 110.422 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.475 HD13 ' SG ' ' A' ' 59' ' ' CYS . 1.4 tt -63.85 -52.56 59.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.543 -0.753 . . . . 1.84 109.607 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.2 mp -67.26 -10.32 49.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.402 -0.817 . . . . 1.82 112.219 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -93.72 -9.61 37.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.498 0.666 . . . . 2.08 109.87 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -123.55 43.09 3.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.721 -0.672 . . . . 4.6 110.506 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.417 -0.801 . . . . 3.96 109.984 179.171 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 . . . . . 0 N--CA 1.482 1.168 0 N-CA-C 111.332 0.123 . . . . 2.72 111.332 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -68.0 -39.1 83.28 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.778 0.323 . . . . 2.46 111.217 -174.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 17' ' ' ILE . 2.7 mp -64.44 -48.96 82.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.403 0.621 . . . . 1.42 109.813 176.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.0 m -55.32 -40.18 70.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.577 -1.192 . . . . 1.98 110.786 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.1 tp -61.78 -53.52 54.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.039 -0.982 . . . . 1.77 110.584 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -61.61 -28.9 69.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.303 -0.862 . . . . 4.47 111.242 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -73.75 2.51 8.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.958 -0.564 . . . . 1.67 112.338 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.9 t30 63.9 37.59 9.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.278 -0.874 . . . . 2.37 110.056 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.576 ' CH2' HG21 ' A' ' 50' ' ' THR . 34.9 m0 -103.63 160.18 26.93 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.421 -0.809 . . . . 0.4 109.657 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.33 177.98 3.44 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.256 1.971 . . . . 0.6 111.265 171.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.462 ' HA ' ' HE1' ' A' ' 25' ' ' MET . 24.4 mmt -71.83 127.29 90.95 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 120.824 0.345 . . . . 1.56 110.721 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 23.7 Cg_exo -62.19 159.43 34.97 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.749 2.299 . . . . 0.68 111.928 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.507 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 10.5 t -88.61 140.3 29.59 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.696 -0.684 . . . . 1.02 109.721 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.487 ' HD2' ' CZ ' ' A' ' 44' ' ' PHE . 74.1 m-85 -137.15 110.77 8.05 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.247 -1.02 . . . . 0.87 108.247 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.564 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 37.8 ttm180 -136.17 117.9 15.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.473 0.178 . . . . 4.22 110.79 -172.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.453 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 73.0 m -62.01 116.93 5.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.889 0.376 . . . . 2.19 110.29 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.6 t -87.36 -41.92 14.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.929 -0.578 . . . . 1.87 110.809 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 27.0 tptp -139.86 130.98 26.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.068 0.461 . . . . 2.76 111.208 -178.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -101.38 154.88 18.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.054 -0.975 . . . . 2.6 108.926 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 40' ' ' LYS . . . -69.9 -69.26 1.42 Allowed Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.968 -1.11 . . . . 2.17 113.515 -172.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 36' ' ' PRO . . . 124.65 -123.89 5.23 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.166 -1.016 . . . . 2.13 112.143 -170.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HD3' ' HA3' ' A' ' 35' ' ' GLY . 24.4 Cg_exo -65.19 -162.44 0.05 OUTLIER 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 124.12 3.214 . . . . 3.0 113.525 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.52 -46.1 20.36 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.199 -0.313 . . . . 2.94 111.816 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -70.05 -24.29 63.23 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.123 0.487 . . . . 2.36 110.656 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -122.88 91.22 3.45 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.841 -0.8 . . . . 1.84 108.841 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.465 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 21.4 tptm -126.73 21.27 7.03 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.55 -0.908 . . . . 2.53 108.55 -177.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.415 ' HB2' ' HB3' ' A' ' 63' ' ' PRO . 9.5 ptm180 -79.8 138.08 37.15 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.562 -0.745 . . . . 4.07 111.012 -171.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -109.85 131.77 54.76 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.015 -0.993 . . . . 1.16 109.197 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 32' ' ' LYS . 27.6 m -130.49 125.15 33.64 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.705 -0.68 . . . . 1.08 109.169 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.737 ' CZ ' HG21 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -139.13 153.86 48.04 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.655 -0.498 . . . . 0.21 109.655 -175.038 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 60' ' ' ILE . . . -127.99 138.93 10.73 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.99 -0.624 . . . . 0.2 112.2 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.737 HG21 ' CZ ' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -107.01 158.46 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 110.166 -0.309 . . . . 1.45 110.166 -174.672 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.565 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 19.7 ptt180 -148.3 146.99 28.81 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.835 -0.802 . . . . 3.01 108.835 173.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.433 HG22 HD13 ' A' ' 78' ' ' LEU . 28.6 t -124.3 156.75 32.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.565 0.221 . . . . 1.07 110.889 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -94.61 83.89 4.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.397 0.618 . . . . 1.81 110.031 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.576 HG21 ' CH2' ' A' ' 23' ' ' TRP . 34.4 p -78.1 105.73 9.51 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.932 -1.031 . . . . 1.08 109.71 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.2 m -43.98 -33.06 1.3 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.069 -0.969 . . . . 1.72 113.042 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.422 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 4.6 p-10 -63.02 -40.17 96.95 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.758 0.651 . . . . 1.3 112.758 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -129.01 -37.56 1.7 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.993 0.425 . . . . 4.21 111.653 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.76 -148.24 16.74 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.93 -0.577 . . . . 0.24 112.364 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.565 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.9 m95 -51.24 119.19 3.81 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.17 0.509 . . . . 0.47 111.342 175.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.3 p -69.48 167.55 16.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.559 -0.746 . . . . 1.07 110.735 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.85 132.84 49.63 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.829 -0.804 . . . . 1.84 108.829 174.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 40.9 tt0 -65.76 115.75 6.23 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.912 -1.04 . . . . 1.0 110.706 -174.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.8 m -96.14 105.3 17.33 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.63 -1.168 . . . . 0.44 110.65 -174.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.484 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 1.8 mp -88.03 132.13 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.305 0.574 . . . . 1.49 111.305 -177.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.54 -176.62 51.05 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 114.909 -1.041 . . . . 0.24 111.809 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 64' ' ' MET . 13.0 pt-20 -92.07 158.06 40.04 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.816 0.308 . . . . 1.37 110.673 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.415 ' HB3' ' HB2' ' A' ' 41' ' ' ARG . 72.0 Cg_exo -50.45 105.21 0.1 OUTLIER 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.398 2.732 . . . . 0.79 112.683 174.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.0 mmm -108.74 145.27 31.29 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 110.152 -0.314 . . . . 1.4 110.152 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.85 13.13 2.22 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.703 2.269 . . . . 0.37 113.75 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.414 ' HB3' ' HG3' ' A' ' 69' ' ' LYS . 14.4 t -154.05 142.11 20.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.498 -0.927 . . . . 1.63 108.498 177.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.0 p -71.74 -22.01 21.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.149 -0.478 . . . . 1.88 110.529 -174.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -73.13 -39.4 65.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.021 -0.536 . . . . 3.34 109.616 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HG3' ' HB3' ' A' ' 66' ' ' SER . 27.5 mtpp -75.34 -23.39 57.22 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.975 -0.557 . . . . 1.91 109.943 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.08 -53.41 58.55 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.579 -0.737 . . . . 1.07 109.93 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.629 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 66.4 mttm -52.49 -54.58 30.57 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 115.611 -0.722 . . . . 2.9 111.067 176.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.516 ' O ' HG23 ' A' ' 76' ' ' VAL . 33.4 m-20 -55.22 -44.78 75.74 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.945 -0.571 . . . . 2.01 112.452 -177.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.482 ' OG ' ' HG2' ' A' ' 62' ' ' GLU . 44.3 t -59.25 -46.29 88.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 1.8 111.113 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.417 ' HB2' ' CE2' ' A' ' 44' ' ' PHE . . . -68.44 -38.7 81.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.185 0.517 . . . . 1.07 110.15 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.494 ' O ' HD12 ' A' ' 79' ' ' LEU . . . -56.44 -37.35 70.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.261 -0.881 . . . . 1.01 111.514 177.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 72' ' ' ASP . 94.7 t -63.24 -38.08 81.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.981 0.42 . . . . 1.53 110.679 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.7 mt -77.82 -23.35 49.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.885 0.85 . . . . 1.12 109.334 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.467 HD11 ' HB ' ' A' ' 46' ' ' VAL . 16.4 tp -70.34 -49.01 53.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.716 -1.129 . . . . 1.44 110.403 173.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 75' ' ' ALA . 6.2 mp -53.67 -34.12 57.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.581 -0.736 . . . . 2.23 112.248 -177.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -78.86 -34.02 45.33 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.373 -0.531 . . . . 2.13 110.855 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.87 -51.68 60.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.883 0.373 . . . . 1.84 110.086 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -71.43 -7.46 47.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 1.82 111.37 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -94.09 -6.49 44.93 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.442 0.639 . . . . 2.08 109.841 175.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -115.71 39.08 3.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.708 -0.678 . . . . 4.6 110.174 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.251 1.144 0 CA-C-N 115.363 -0.835 . . . . 3.96 110.038 -179.005 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 111.451 0.167 . . . . 2.72 111.451 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.46 -46.78 85.9 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.783 0.29 . . . . 2.46 111.783 -176.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 17' ' ' ILE . 2.6 mp -60.83 -47.53 92.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.035 -0.53 . . . . 1.42 110.688 -177.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.5 t -63.89 -45.33 89.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.367 0.603 . . . . 1.98 110.273 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.19 -44.1 97.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.109 -0.95 . . . . 1.77 110.838 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -65.13 -33.75 76.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.971 -1.013 . . . . 4.47 111.12 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.478 ' HZ1' ' HB3' ' A' ' 21' ' ' LYS . 4.6 mmmp? -74.18 2.69 8.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.123 -0.49 . . . . 1.67 111.574 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 67.39 30.2 7.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.935 0.874 . . . . 2.37 109.991 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 27.7 m0 -93.54 160.24 33.35 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.406 -0.815 . . . . 0.4 109.073 174.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.6 -173.29 0.67 Allowed 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.183 1.922 . . . . 0.6 111.087 172.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.441 ' HE3' ' HA ' ' A' ' 25' ' ' MET . 5.9 mmt -75.64 145.67 79.08 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.677 -0.49 . . . . 1.56 109.677 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 2.7 Cg_exo -74.89 165.96 30.29 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.495 2.13 . . . . 0.68 112.421 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.3 t -84.73 144.4 28.54 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.161 -0.927 . . . . 1.02 109.912 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.515 ' HD1' ' CZ ' ' A' ' 44' ' ' PHE . 69.0 m-85 -143.95 109.93 5.34 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.361 -0.607 . . . . 0.87 109.361 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.513 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 14.0 ptm180 -152.52 128.92 10.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.949 0.404 . . . . 4.22 110.874 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.412 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 77.3 m -65.89 124.87 23.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.865 -0.607 . . . . 2.19 111.286 -176.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -84.82 -37.67 12.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.808 -0.633 . . . . 1.87 110.286 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -135.78 131.47 35.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.173 0.511 . . . . 2.76 111.178 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -99.79 152.39 20.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.923 -1.035 . . . . 2.6 108.819 174.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 40' ' ' LYS . . . -85.14 163.47 37.77 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.284 -0.96 . . . . 2.17 112.69 -176.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.67 -142.56 1.37 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.678 -0.296 . . . . 2.13 113.056 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.73 -74.13 0.03 OUTLIER 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.817 3.011 . . . . 3.0 113.117 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.21 -36.39 0.08 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.028 0.442 . . . . 2.94 110.053 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -70.22 -9.65 56.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.742 -0.663 . . . . 2.36 110.799 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.402 ' C ' ' H ' ' A' ' 41' ' ' ARG . . . -132.99 29.94 4.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.065 -0.516 . . . . 1.84 110.516 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.503 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 15.2 tptp -79.05 22.5 0.39 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.136 0.493 . . . . 2.53 111.332 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.402 ' H ' ' C ' ' A' ' 39' ' ' ALA . 65.3 mtm180 -83.53 132.32 34.94 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.064 -0.717 . . . . 4.07 109.064 177.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 40' ' ' LYS . 7.0 m-85 -109.56 149.1 30.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.532 -0.758 . . . . 1.16 110.877 -172.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.5 m -129.76 129.6 44.32 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.142 -0.935 . . . . 1.08 109.289 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.724 ' CZ ' HG21 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -137.13 153.65 50.46 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.069 -0.715 . . . . 0.21 109.069 -174.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -126.66 138.73 10.82 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.757 -0.735 . . . . 0.2 112.317 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.724 HG21 ' CZ ' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -107.15 158.6 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 109.309 -0.626 . . . . 1.45 109.309 -177.124 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.574 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 11.8 ptp180 -148.49 148.96 30.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.05 -0.722 . . . . 3.01 109.05 173.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.442 HG22 HD11 ' A' ' 78' ' ' LEU . 73.9 t -125.06 153.7 32.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 123.309 0.381 . . . . 1.07 110.627 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -92.52 85.31 5.28 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.562 0.696 . . . . 1.81 110.576 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.2 p -73.32 112.37 9.32 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.933 -1.031 . . . . 1.08 109.716 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 t -49.84 -28.4 6.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.68 -0.691 . . . . 1.72 112.151 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -82.24 -22.78 35.69 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.154 0.798 . . . . 1.3 113.154 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -134.47 -43.66 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.905 -0.497 . . . . 4.21 111.609 -173.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.77 -152.57 16.88 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 116.093 -0.503 . . . . 0.24 111.896 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.574 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.9 m95 -53.01 120.79 6.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.99 0.424 . . . . 0.47 110.686 174.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.2 p -71.05 160.96 31.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.679 -0.691 . . . . 1.07 111.0 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -60.64 128.34 36.1 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.221 -0.659 . . . . 1.84 109.221 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -54.71 123.58 13.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.931 -1.032 . . . . 1.0 111.026 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.431 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 57.8 m -95.77 97.8 9.96 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.356 -0.838 . . . . 0.44 110.124 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.12 126.23 38.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.556 -0.747 . . . . 1.49 110.887 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.5 -177.89 51.87 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.238 -0.892 . . . . 0.24 112.896 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -85.14 147.08 46.76 Favored Pre-proline 0 C--N 1.317 -0.826 0 N-CA-C 109.966 -0.383 . . . . 1.37 109.966 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.05 105.79 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.643 2.228 . . . . 0.79 111.45 175.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.634 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 16.3 mmt -113.27 139.84 23.62 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.152 -0.477 . . . . 1.4 111.192 -173.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.74 10.14 2.39 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.662 2.242 . . . . 0.37 113.323 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.8 t -152.54 137.88 17.55 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.144 -0.687 . . . . 1.63 109.144 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -68.06 -23.21 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 1.88 111.688 -173.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -74.1 -44.99 51.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.904 0.383 . . . . 3.34 110.423 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.634 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 0.2 OUTLIER -81.04 -17.76 49.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 1.91 109.973 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.87 -56.65 19.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.847 -0.615 . . . . 1.07 110.092 173.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.636 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 58.1 mtpt -50.92 -48.16 60.76 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 116.261 -0.427 . . . . 2.9 110.753 174.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.525 ' O ' HG23 ' A' ' 76' ' ' VAL . 36.8 m-20 -52.46 -51.72 57.89 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.389 0.514 . . . . 2.01 112.389 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.2 p -60.9 -40.23 92.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.707 0.289 . . . . 1.8 111.456 -175.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.38 -44.97 70.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.144 0.497 . . . . 1.07 110.376 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.505 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -55.99 -35.99 67.4 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.306 -0.861 . . . . 1.01 111.754 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 72' ' ' ASP . 91.8 t -64.92 -38.23 82.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.978 0.418 . . . . 1.53 110.7 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.6 mt -76.42 -26.43 55.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.916 0.865 . . . . 1.12 109.271 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.493 ' HG ' ' CD2' ' A' ' 82' ' ' LEU . 16.0 tp -70.98 -54.5 11.04 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.553 -1.203 . . . . 1.44 111.256 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.505 HD13 ' O ' ' A' ' 75' ' ' ALA . 4.2 mp -55.32 -29.24 57.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.914 -0.584 . . . . 2.23 112.546 -174.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.86 -33.8 60.02 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.276 -0.57 . . . . 2.13 110.598 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.1 -50.54 63.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.108 -0.496 . . . . 1.84 110.091 -177.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.493 ' CD2' ' HG ' ' A' ' 78' ' ' LEU . 1.4 mm? -67.04 -29.45 69.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 1.82 111.124 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 84' ' ' LYS . 2.2 t-20 -86.64 2.69 47.49 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.329 -0.619 . . . . 2.08 109.329 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 83' ' ' ASN . 23.5 mtmm 71.59 119.71 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.5 -1.227 . . . . 4.6 111.448 177.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.213 -0.899 . . . . 3.96 110.233 -175.033 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 111.258 0.095 . . . . 2.72 111.258 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.32 -39.07 93.17 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.62 0.23 . . . . 2.46 111.62 -172.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 mp -56.63 -41.98 75.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.353 0.597 . . . . 1.42 110.457 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.536 ' SG ' ' HB2' ' A' ' 23' ' ' TRP . 22.4 t -75.18 -38.49 60.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.397 -0.82 . . . . 1.98 109.708 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.7 tp -60.1 -53.08 62.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.139 -0.937 . . . . 1.77 110.606 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -56.53 -37.94 71.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.064 -0.971 . . . . 4.47 111.71 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.8 mmtm -73.96 5.63 4.06 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.993 -0.549 . . . . 1.67 111.918 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 66.48 27.22 9.83 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.597 -0.728 . . . . 2.37 110.937 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.536 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.0 m0 -101.0 154.11 37.34 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.557 -0.747 . . . . 0.4 109.011 175.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.91 173.65 14.14 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.232 1.955 . . . . 0.6 110.631 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.43 ' HA ' ' HE1' ' A' ' 25' ' ' MET . 31.6 mmt -62.26 127.4 89.62 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.791 0.329 . . . . 1.56 110.921 -177.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.528 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 70.1 Cg_exo -54.89 165.01 2.9 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.567 2.845 . . . . 0.68 113.678 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.478 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 25.1 t -89.58 142.39 27.72 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.987 -1.006 . . . . 1.02 109.388 177.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.528 ' CE1' ' HB2' ' A' ' 26' ' ' PRO . 95.9 m-85 -140.75 108.72 5.71 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.277 -1.008 . . . . 0.87 108.277 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.525 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 48.7 mmt-85 -147.83 118.5 7.52 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.324 -0.621 . . . . 4.22 109.324 -173.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 15.5 p -69.47 129.09 38.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.041 0.448 . . . . 2.19 110.953 -177.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.1 m -85.79 -32.81 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.82 -0.627 . . . . 1.87 111.15 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -136.66 124.44 22.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.081 -0.509 . . . . 2.76 110.226 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.78 159.17 44.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.109 -0.496 . . . . 2.6 110.463 177.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.41 145.83 15.76 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.152 -1.023 . . . . 2.17 112.999 174.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.38 163.31 12.7 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.043 -0.823 . . . . 2.13 111.043 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -44.67 -75.59 0.03 OUTLIER 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 123.633 2.889 . . . . 3.0 112.529 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.26 -44.58 0.08 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.568 -0.53 . . . . 2.94 109.568 173.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -70.79 -8.98 56.37 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.81 -0.632 . . . . 2.36 110.33 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' A' ' 41' ' ' ARG . . . -120.85 15.67 11.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.266 0.555 . . . . 1.84 110.882 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -79.08 21.43 0.44 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.235 -0.893 . . . . 2.53 109.972 177.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.474 ' H ' ' C ' ' A' ' 39' ' ' ALA . 11.2 ptp180 -82.1 144.26 30.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.63 -0.713 . . . . 4.07 109.66 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.609 ' CZ ' HG22 ' A' ' 67' ' ' VAL . 71.2 m-85 -111.54 131.43 55.25 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.469 -0.787 . . . . 1.16 110.191 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 m -120.24 121.68 39.23 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.466 -1.309 . . . . 1.08 107.466 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.677 ' CZ ' HG21 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -136.85 151.28 48.94 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.631 -0.507 . . . . 0.21 109.631 -170.158 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.454 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -123.69 137.96 11.19 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.204 -0.522 . . . . 0.2 111.932 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.677 HG21 ' CZ ' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -106.75 155.57 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 109.731 -0.47 . . . . 1.45 109.731 -174.636 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.617 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 8.3 ptp85 -147.95 142.31 26.3 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.626 -0.879 . . . . 3.01 108.626 176.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.436 HG23 HD13 ' A' ' 82' ' ' LEU . 95.4 t -124.65 153.24 31.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.342 -0.39 . . . . 1.07 110.381 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -92.01 82.8 5.1 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.723 0.773 . . . . 1.81 110.203 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 35.3 p -67.94 116.82 9.02 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.438 -1.256 . . . . 1.08 110.143 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.8 p -51.95 -26.53 10.67 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.462 -1.244 . . . . 1.72 113.013 -176.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -89.11 -17.42 29.27 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.032 0.753 . . . . 1.3 113.032 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -139.16 -44.72 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.488 0.585 . . . . 4.21 112.408 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.66 -150.61 17.14 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.919 -0.658 . . . . 0.24 112.337 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.617 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.9 m95 -53.66 118.17 3.71 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.034 0.445 . . . . 0.47 110.771 176.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.3 p -65.63 165.06 13.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.56 -0.745 . . . . 1.07 111.37 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -61.46 135.27 57.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.046 -0.724 . . . . 1.84 109.046 172.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.94 113.27 2.0 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.889 -175.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 60.1 m -91.39 97.32 11.02 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.089 -0.959 . . . . 0.44 109.831 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.454 HD13 ' HA3' ' A' ' 45' ' ' GLY . 13.2 mm -81.84 126.01 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 115.832 -0.622 . . . . 1.49 110.251 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.82 -170.84 47.07 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.913 -0.66 . . . . 0.24 111.96 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.593 ' O ' ' HG2' ' A' ' 64' ' ' MET . 38.7 mt-10 -88.54 145.07 34.62 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.214 -0.662 . . . . 1.37 109.214 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -55.83 110.44 0.56 Allowed 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.587 2.191 . . . . 0.79 111.758 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.593 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.8 mmm -112.2 140.59 23.75 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.633 -0.506 . . . . 1.4 109.633 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.61 18.51 0.96 Allowed 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.637 2.225 . . . . 0.37 113.667 -175.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.417 ' HB2' ' CD ' ' A' ' 69' ' ' LYS . 28.7 m -157.56 139.09 13.83 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.227 -0.657 . . . . 1.63 109.227 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.609 HG22 ' CZ ' ' A' ' 42' ' ' PHE . 1.1 t -67.35 -38.67 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.335 -0.848 . . . . 1.88 112.259 -167.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -71.21 -39.71 71.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.463 -0.335 . . . . 3.34 111.118 -175.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.417 ' CD ' ' HB2' ' A' ' 66' ' ' SER . 17.3 ptmt -80.92 -18.52 46.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.888 0.375 . . . . 1.91 110.182 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.62 -55.9 25.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 1.07 110.645 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.622 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 5.6 ptpp? -58.54 -43.18 89.19 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 116.592 -0.276 . . . . 2.9 110.767 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.564 ' O ' HG23 ' A' ' 76' ' ' VAL . 5.7 m-20 -54.92 -47.08 74.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 2.01 111.973 176.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.2 t -58.65 -46.36 87.32 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.851 0.358 . . . . 1.8 111.321 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.412 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -68.85 -42.81 76.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.022 0.439 . . . . 1.07 110.589 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.498 ' O ' HD12 ' A' ' 79' ' ' LEU . . . -56.12 -34.19 65.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.447 -0.797 . . . . 1.01 111.517 177.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 72' ' ' ASP . 94.2 t -63.51 -36.57 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.916 0.389 . . . . 1.53 110.61 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.98 -34.04 64.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.712 0.767 . . . . 1.12 109.271 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.489 HD21 ' CG1' ' A' ' 46' ' ' VAL . 26.3 tp -64.82 -42.56 94.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.602 -1.181 . . . . 1.44 110.797 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.498 HD12 ' O ' ' A' ' 75' ' ' ALA . 7.3 mp -60.33 -26.96 66.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.03 -0.532 . . . . 2.23 111.215 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -71.37 -40.0 70.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.227 0.537 . . . . 2.13 110.274 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.8 tp -65.55 -46.55 79.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.359 -0.837 . . . . 1.84 110.077 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 78' ' ' LEU . 42.2 mt -70.09 -12.89 61.93 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.514 -1.221 . . . . 1.82 111.19 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -88.81 -7.7 55.71 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.588 0.709 . . . . 2.08 109.554 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -104.27 40.68 1.42 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.322 -0.854 . . . . 4.6 110.197 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.248 1.019 0 CA-C-N 115.205 -0.907 . . . . 3.96 110.018 -179.819 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 121.027 0.442 . . . . 2.72 110.402 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -61.32 -41.98 97.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.068 -0.514 . . . . 2.46 111.539 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.444 HD11 ' N ' ' A' ' 17' ' ' ILE . 2.5 mp -61.51 -38.49 80.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.61 -0.723 . . . . 1.42 110.734 -178.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 23' ' ' TRP . 41.2 t -72.29 -39.81 68.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.274 0.559 . . . . 1.98 109.971 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.0 tp -61.08 -51.54 68.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.305 -0.861 . . . . 1.77 110.153 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -54.98 -36.53 65.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.218 -0.901 . . . . 4.47 111.489 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -72.52 1.84 7.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.906 -0.588 . . . . 1.67 111.971 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 64.96 26.08 12.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.35 -0.841 . . . . 2.37 111.361 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.425 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 34.0 m0 -96.62 154.29 38.52 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.695 -0.483 . . . . 0.4 109.695 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.87 169.71 20.58 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.519 2.146 . . . . 0.6 110.811 173.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.449 ' HA ' ' HE2' ' A' ' 25' ' ' MET . 26.8 mmt -63.03 130.22 93.97 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.691 -0.231 . . . . 1.56 111.106 -175.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.31 165.78 25.71 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.881 2.387 . . . . 0.68 112.865 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.411 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 16.8 t -87.97 141.34 28.65 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.045 -0.98 . . . . 1.02 109.995 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.472 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 75.6 m-85 -138.92 110.63 7.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.768 -0.827 . . . . 0.87 108.768 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.5 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 78.0 mtp180 -148.29 123.93 10.47 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 110.165 -0.309 . . . . 4.22 110.165 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 71.2 m -61.12 121.08 11.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.997 0.427 . . . . 2.19 110.648 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.2 t -82.34 -38.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.787 -0.642 . . . . 1.87 110.046 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -136.14 123.31 21.69 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.297 -0.631 . . . . 2.76 109.297 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -150.19 137.47 19.61 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.1 -0.5 . . . . 2.6 110.646 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.57 -67.14 3.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.966 -0.635 . . . . 2.17 112.935 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.24 -157.4 36.43 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.986 -0.626 . . . . 2.13 112.406 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.99 -58.77 0.91 Allowed 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.031 2.488 . . . . 3.0 112.161 175.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -175.41 -49.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.466 0.651 . . . . 2.94 109.792 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -79.07 18.29 0.66 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.14 -0.936 . . . . 2.36 111.508 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -122.97 49.41 1.65 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.153 0.501 . . . . 1.84 110.724 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -88.15 14.38 9.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.369 0.604 . . . . 2.53 109.931 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -86.31 132.77 33.9 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.102 -1.444 . . . . 4.07 107.102 166.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -108.92 131.2 55.26 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.285 0.564 . . . . 1.16 109.743 -172.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.6 m -120.01 118.0 29.5 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.886 -1.153 . . . . 1.08 107.886 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.696 ' CZ ' HG21 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -129.74 153.56 48.07 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.329 -0.619 . . . . 0.21 109.329 -172.266 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -127.79 137.76 10.01 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.514 -0.634 . . . . 0.2 111.514 178.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.696 HG21 ' CZ ' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -105.99 155.0 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 N-CA-C 109.406 -0.59 . . . . 1.45 109.406 -177.462 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.565 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 12.4 ptp180 -143.68 141.27 30.46 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 107.784 -1.191 . . . . 3.01 107.784 173.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.1 t -117.19 152.4 19.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.304 -0.407 . . . . 1.07 110.11 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -94.95 83.62 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.049 0.928 . . . . 1.81 109.853 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.8 p -70.48 116.05 10.37 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.775 -1.557 . . . . 1.08 109.488 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.4 t -52.49 -28.2 19.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.924 -0.58 . . . . 1.72 110.254 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -63.36 -56.27 17.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.402 -0.817 . . . . 1.3 112.755 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -122.99 -33.43 3.34 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.156 0.428 . . . . 4.21 112.156 -171.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.56 -149.87 16.93 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 121.149 -0.548 . . . . 0.24 112.324 -177.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.565 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.9 m95 -54.04 117.81 3.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.929 0.395 . . . . 0.47 111.045 175.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.1 p -67.63 170.02 8.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.57 -0.741 . . . . 1.07 111.413 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -65.32 126.65 28.88 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.191 -1.04 . . . . 1.84 108.191 172.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -58.71 114.62 2.6 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.557 0.694 . . . . 1.0 110.49 -175.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.464 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 59.8 m -87.02 97.01 10.48 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.944 -1.025 . . . . 0.44 109.659 -177.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.435 HD12 ' HA3' ' A' ' 45' ' ' GLY . 21.6 mm -77.63 120.67 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.341 -0.845 . . . . 1.49 109.593 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.51 -165.8 35.56 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.757 -0.735 . . . . 0.24 112.217 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 64' ' ' MET . 38.6 mt-10 -92.66 142.22 25.47 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.259 -0.645 . . . . 1.37 109.259 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.51 114.63 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.693 2.262 . . . . 0.79 111.952 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.637 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 95.8 mmm -118.58 138.88 26.3 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.216 -0.447 . . . . 1.4 109.941 -174.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.15 11.64 1.44 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.637 2.225 . . . . 0.37 113.827 -175.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.464 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 50.5 m -152.67 137.59 17.16 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.317 -0.623 . . . . 1.63 109.317 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.71 -31.79 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 113.147 0.795 . . . . 1.88 113.147 -169.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -69.83 -42.44 73.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.766 0.317 . . . . 3.34 111.25 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.464 ' HG2' ' HB2' ' A' ' 66' ' ' SER . 17.3 ptpt -81.0 -18.9 45.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.369 -0.378 . . . . 1.91 110.49 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.51 -57.94 10.79 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.342 -0.39 . . . . 1.07 110.299 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.668 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 53.1 mtmt -56.51 -45.37 81.12 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.25 -0.432 . . . . 2.9 110.729 175.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.478 ' O ' HG21 ' A' ' 76' ' ' VAL . 22.3 t70 -49.79 -50.13 45.98 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.887 -0.597 . . . . 2.01 111.812 176.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.0 t -58.91 -47.56 84.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 1.8 111.618 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.99 81.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.251 0.548 . . . . 1.07 111.007 -177.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.595 ' O ' ' HG ' ' A' ' 79' ' ' LEU . . . -60.44 -29.94 69.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.553 -0.749 . . . . 1.01 111.692 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 72' ' ' ASP . 55.6 t -65.71 -32.82 59.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 121.102 0.477 . . . . 1.53 109.961 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.3 mt -74.26 -30.76 62.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.856 -0.611 . . . . 1.12 109.506 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 6.2 mt -61.87 -42.64 99.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.195 -0.911 . . . . 1.44 110.24 175.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 17.8 mt -58.3 -35.59 72.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.199 -0.91 . . . . 2.23 111.037 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -69.67 -43.81 71.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.895 0.379 . . . . 2.13 110.268 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.0 tt -62.87 -47.57 82.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.716 -0.675 . . . . 1.84 109.259 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.35 -32.91 72.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.081 -0.963 . . . . 1.82 111.68 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -78.17 -6.77 55.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.358 0.599 . . . . 2.08 110.597 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -114.79 40.2 2.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.277 0.56 . . . . 4.6 110.163 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 C--O 1.25 1.084 0 CA-C-N 115.318 -0.855 . . . . 3.96 110.967 179.932 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 111.665 0.246 . . . . 2.72 111.665 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -64.63 -38.0 89.49 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.74 0.305 . . . . 2.46 111.106 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.469 HD11 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -65.29 -38.35 82.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.177 -0.465 . . . . 1.42 110.607 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.407 ' SG ' ' HE3' ' A' ' 23' ' ' TRP . 54.1 t -72.24 -41.19 67.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.661 0.743 . . . . 1.98 109.247 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.75 -42.85 99.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.628 -1.169 . . . . 1.77 109.614 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -61.65 -33.9 74.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.556 -0.747 . . . . 4.47 110.919 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 31.6 mmmt -74.28 2.07 10.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.029 -0.532 . . . . 1.67 111.485 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.9 t30 68.24 27.04 6.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.998 0.904 . . . . 2.37 109.712 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.407 ' HE3' ' SG ' ' A' ' 18' ' ' CYS . 41.8 m0 -92.67 160.88 33.48 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.017 -0.992 . . . . 0.4 109.055 174.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.38 -169.53 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.106 1.871 . . . . 0.6 111.482 173.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.459 ' HA ' ' HE1' ' A' ' 25' ' ' MET . 10.6 mmt -77.22 132.5 70.08 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.79 -0.448 . . . . 1.56 109.79 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.63 164.37 26.73 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.512 2.141 . . . . 0.68 112.268 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.485 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 22.5 t -87.84 140.99 28.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.494 -0.776 . . . . 1.02 109.859 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.519 ' HD1' ' CZ ' ' A' ' 44' ' ' PHE . 66.1 m-85 -141.19 111.04 6.54 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.889 -0.782 . . . . 0.87 108.889 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.509 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 36.2 ttm180 -153.01 128.68 10.1 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.196 -0.298 . . . . 4.22 110.196 -175.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 7.8 p -65.32 124.68 22.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.924 0.392 . . . . 2.19 110.459 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m -82.57 -34.61 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.141 0.496 . . . . 1.87 110.302 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -139.99 125.33 18.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.681 -0.691 . . . . 2.76 110.201 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.449 ' HG3' ' CD1' ' A' ' 42' ' ' PHE . 36.3 tt0 -152.03 139.78 19.86 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.441 -0.577 . . . . 2.6 109.441 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.81 -137.3 21.32 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.34 -0.933 . . . . 2.17 112.487 178.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.54 -140.06 15.91 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.215 -0.993 . . . . 2.13 112.016 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -53.32 -68.73 0.06 OUTLIER 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 123.575 2.85 . . . . 3.0 112.304 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -177.48 -44.66 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.011 -0.54 . . . . 2.94 110.511 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -71.86 -23.25 61.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.936 -0.575 . . . . 2.36 111.855 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.67 57.96 4.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.073 0.463 . . . . 1.84 111.329 -172.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.494 ' HB2' ' HZ1' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -92.09 18.61 7.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.379 0.609 . . . . 2.53 110.045 177.725 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -83.4 140.48 32.36 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 106.471 -1.677 . . . . 4.07 106.471 168.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.449 ' CD1' ' HG3' ' A' ' 33' ' ' GLU . 9.0 m-85 -111.0 130.15 55.68 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 120.474 -0.49 . . . . 1.16 110.284 -172.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.6 m -121.92 125.43 46.37 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.03 -1.1 . . . . 1.08 108.03 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.71 ' CZ ' HG23 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -134.36 151.61 51.32 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.582 -0.525 . . . . 0.21 109.582 -175.108 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.91 139.41 11.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.96 -0.638 . . . . 0.2 111.883 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.71 HG23 ' CZ ' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -107.05 157.6 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 N-CA-C 110.03 -0.359 . . . . 1.45 110.03 -174.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.615 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 15.2 ptp180 -148.5 147.39 29.04 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.674 -0.862 . . . . 3.01 108.674 171.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.427 HG23 HD12 ' A' ' 78' ' ' LEU . 73.0 t -124.98 153.07 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.474 -0.33 . . . . 1.07 110.807 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -93.89 84.54 4.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.729 0.776 . . . . 1.81 110.213 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.429 ' OG1' ' HB3' ' A' ' 53' ' ' ARG . 40.3 p -72.52 108.11 5.41 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.374 -1.285 . . . . 1.08 109.05 177.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.1 t -49.83 -28.28 6.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.011 -0.541 . . . . 1.72 112.251 -175.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -88.44 -15.82 34.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.705 0.631 . . . . 1.3 112.705 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.429 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 25.3 ttm180 -132.22 -49.38 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.915 -0.491 . . . . 4.21 111.307 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 125.59 -156.82 19.48 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.842 -0.617 . . . . 0.24 112.288 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.615 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.7 m95 -52.0 117.95 3.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.969 0.414 . . . . 0.47 110.611 173.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 47.9 p -69.85 168.98 14.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.533 -0.758 . . . . 1.07 111.306 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.48 125.51 25.93 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.164 -0.68 . . . . 1.84 109.164 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 45.4 tt0 -60.75 118.11 6.22 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.297 -0.865 . . . . 1.0 111.036 -174.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 68.6 m -97.96 102.26 13.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.713 -1.13 . . . . 0.44 110.731 -175.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.43 127.7 36.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.77 -0.65 . . . . 1.49 110.533 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.15 -161.93 34.93 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.574 -0.739 . . . . 0.24 113.019 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 64' ' ' MET . 32.5 mt-10 -92.03 131.94 33.85 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.744 -0.228 . . . . 1.37 110.612 -175.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.9 108.92 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.765 2.31 . . . . 0.79 111.477 175.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.456 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 7.1 mmt -110.96 151.51 43.03 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.006 -0.543 . . . . 1.4 111.772 -171.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.59 5.78 6.06 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.949 2.432 . . . . 0.37 112.989 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.4 t -151.61 142.39 22.87 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.5 -0.556 . . . . 1.63 109.5 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.4 t -62.16 -33.3 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.457 -0.792 . . . . 1.88 111.406 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -66.76 -37.07 83.89 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.242 -0.435 . . . . 3.34 110.439 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.456 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 29.1 mtpp -74.27 -31.44 62.53 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.079 -0.509 . . . . 1.91 110.315 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.74 -60.89 2.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.68 -0.691 . . . . 1.07 110.955 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.518 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 32.6 mmtp -51.46 -49.51 61.62 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.289 -0.414 . . . . 2.9 110.995 176.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.498 ' O ' HG21 ' A' ' 76' ' ' VAL . 17.4 t70 -51.84 -52.27 50.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.281 -0.872 . . . . 2.01 112.566 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 91.6 p -62.4 -41.31 98.57 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.835 0.309 . . . . 1.8 111.835 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.481 ' HB2' ' CE2' ' A' ' 44' ' ' PHE . . . -69.46 -41.44 76.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.222 0.534 . . . . 1.07 110.543 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.414 ' O ' HD21 ' A' ' 79' ' ' LEU . . . -54.23 -33.68 58.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.231 -0.895 . . . . 1.01 111.395 176.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 72' ' ' ASP . 88.7 t -62.55 -37.96 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 120.971 0.415 . . . . 1.53 110.833 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.08 -30.47 62.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.868 0.842 . . . . 1.12 109.042 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.427 HD12 HG23 ' A' ' 48' ' ' VAL . 18.1 tp -67.3 -42.88 82.99 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.438 -1.255 . . . . 1.44 110.329 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.414 HD21 ' O ' ' A' ' 75' ' ' ALA . 3.9 mm? -61.26 -29.5 69.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.713 -0.676 . . . . 2.23 110.971 177.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 76' ' ' VAL . 35.1 mt-10 -75.98 -38.5 57.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.932 0.396 . . . . 2.13 110.112 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.9 tt -62.65 -48.95 77.11 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.277 -0.638 . . . . 1.84 109.277 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.9 -14.73 60.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.324 -0.853 . . . . 1.82 112.191 177.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -96.51 -6.79 36.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.633 0.73 . . . . 2.08 109.613 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -113.69 34.35 4.64 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.291 -0.868 . . . . 4.6 110.108 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.251 1.146 0 CA-C-N 115.442 -0.799 . . . . 3.96 109.892 -179.102 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 111.5 0.185 . . . . 2.72 111.5 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -68.11 -47.68 67.5 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.855 0.36 . . . . 2.46 110.543 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.423 HD11 ' N ' ' A' ' 17' ' ' ILE . 2.3 mp -58.46 -43.45 86.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.565 -0.743 . . . . 1.42 110.11 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.501 ' SG ' ' HG3' ' A' ' 26' ' ' PRO . 57.6 m -66.41 -43.65 85.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.072 -0.967 . . . . 1.98 110.412 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.7 tp -63.81 -53.03 57.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.964 -1.016 . . . . 1.77 111.194 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -59.23 -35.51 73.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.893 -0.594 . . . . 4.47 111.371 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 37.3 mmtt -74.18 -1.26 19.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.126 0.489 . . . . 1.67 111.939 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 61.89 36.8 15.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.851 -1.068 . . . . 2.37 110.632 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.404 ' CZ3' ' HG ' ' A' ' 82' ' ' LEU . 29.8 m0 -94.7 161.73 27.82 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.489 -0.778 . . . . 0.4 109.014 173.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.18 177.98 4.0 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.965 1.776 . . . . 0.6 110.459 170.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.439 ' HA ' ' HE2' ' A' ' 25' ' ' MET . 22.0 mmt -77.61 123.08 86.66 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-O 120.931 0.396 . . . . 1.56 110.403 -176.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.501 ' HG3' ' SG ' ' A' ' 18' ' ' CYS . 9.6 Cg_endo -56.47 163.15 7.08 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.695 2.93 . . . . 0.68 114.015 -176.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 25.6 t -88.46 143.35 27.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.811 -1.086 . . . . 1.02 110.461 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.55 ' HD1' ' CZ ' ' A' ' 44' ' ' PHE . 65.5 m-85 -143.33 111.37 6.1 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.146 -0.687 . . . . 0.87 109.146 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.469 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 79.2 ttt180 -155.71 129.87 8.78 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.599 -0.519 . . . . 4.22 109.599 -176.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.457 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 13.8 p -69.78 132.0 45.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.216 0.531 . . . . 2.19 111.2 -176.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.71 -31.66 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.61 -0.723 . . . . 1.87 109.983 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -143.44 127.06 17.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.984 -0.553 . . . . 2.76 110.897 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -150.27 139.31 21.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.543 -0.753 . . . . 2.6 110.044 176.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.12 167.1 37.34 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.743 -0.741 . . . . 2.17 114.072 172.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 163.02 -151.24 20.87 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.122 -0.791 . . . . 2.13 111.122 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.67 -68.9 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 123.144 2.563 . . . . 3.0 112.144 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 39' ' ' ALA . . . -168.0 -38.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.284 0.564 . . . . 2.94 109.499 176.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -78.91 18.95 0.56 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.49 -0.777 . . . . 2.36 110.866 174.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 37' ' ' ALA . . . -125.93 29.63 5.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.062 0.458 . . . . 1.84 111.633 -174.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -90.78 17.79 7.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.701 0.762 . . . . 2.53 109.409 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -85.54 134.84 34.01 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.545 -1.28 . . . . 4.07 107.545 168.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -109.64 134.64 51.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.015 0.436 . . . . 1.16 110.355 -170.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.7 m -123.61 120.6 33.29 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.66 -0.867 . . . . 1.08 108.66 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.725 ' CZ ' HG23 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -131.58 154.18 49.12 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.649 -0.5 . . . . 0.21 109.649 -172.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -128.5 140.44 11.76 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.951 -0.642 . . . . 0.2 112.168 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.725 HG23 ' CZ ' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -106.93 154.81 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 109.661 -0.496 . . . . 1.45 109.661 -176.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.577 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 12.4 ptp180 -145.79 142.7 29.13 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.907 -1.146 . . . . 3.01 107.907 173.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.472 HG22 ' HB3' ' A' ' 26' ' ' PRO . 43.7 t -124.8 156.04 33.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.714 -0.221 . . . . 1.07 110.606 -178.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -91.89 84.19 5.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.739 0.78 . . . . 1.81 109.782 178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.8 p -78.25 103.14 8.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.581 -1.19 . . . . 1.08 109.167 177.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 t -44.25 -34.87 2.04 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.351 -0.84 . . . . 1.72 113.095 -170.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -68.26 -26.95 65.93 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.858 0.688 . . . . 1.3 112.858 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -132.24 -42.2 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.013 0.435 . . . . 4.21 111.487 -174.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.49 -150.02 16.94 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.965 -0.562 . . . . 0.24 112.03 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.577 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.9 m95 -51.5 120.06 4.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.024 0.44 . . . . 0.47 111.327 175.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.6 p -68.34 156.92 36.79 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.726 -0.67 . . . . 1.07 110.346 176.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -61.84 124.88 21.98 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.866 -0.79 . . . . 1.84 108.866 173.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -59.64 118.03 5.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.104 -0.953 . . . . 1.0 111.242 -170.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.409 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 50.6 m -93.3 102.64 14.91 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.704 -1.134 . . . . 0.44 110.614 -174.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.02 128.56 38.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.819 -0.628 . . . . 1.49 110.739 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.27 -167.58 43.51 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.478 -0.783 . . . . 0.24 111.999 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.63 ' O ' ' HG2' ' A' ' 64' ' ' MET . 40.9 mt-10 -86.62 148.14 45.61 Favored Pre-proline 0 C--N 1.318 -0.795 0 O-C-N 122.731 -0.276 . . . . 1.37 110.311 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.62 107.87 0.42 Allowed 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.492 2.128 . . . . 0.79 110.753 170.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.63 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 95.9 mmm -114.62 148.77 41.04 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.063 -0.517 . . . . 1.4 110.139 -172.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.74 8.67 4.13 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.619 2.212 . . . . 0.37 113.667 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.9 m -153.88 137.91 16.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.349 -0.612 . . . . 1.63 109.349 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.567 ' O ' ' HD3' ' A' ' 71' ' ' LYS . 28.3 m -64.84 -29.3 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 112.646 0.61 . . . . 1.88 112.646 -170.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.68 -42.86 77.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.965 0.412 . . . . 3.34 111.33 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -81.84 -18.21 44.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.362 -0.381 . . . . 1.91 111.058 -177.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.42 -51.22 68.39 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.517 -0.549 . . . . 1.07 109.517 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.64 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -52.57 -51.56 59.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.135 -0.939 . . . . 2.9 110.461 174.018 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -52.76 -46.95 67.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.254 -0.884 . . . . 2.01 112.277 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.516 ' O ' HG13 ' A' ' 76' ' ' VAL . 95.7 p -65.58 -39.36 91.54 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.901 -0.319 . . . . 1.8 111.5 -176.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.415 ' HB1' ' CE2' ' A' ' 44' ' ' PHE . . . -70.99 -48.15 54.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.026 0.441 . . . . 1.07 110.552 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.51 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -54.31 -38.89 66.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.501 -0.772 . . . . 1.01 111.808 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 73' ' ' SER . 3.0 p -72.25 -26.62 25.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 1.53 110.958 -176.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.8 mt -78.2 -34.07 49.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.852 0.834 . . . . 1.12 109.402 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.5 tp -64.68 -38.65 91.73 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.691 -1.14 . . . . 1.44 110.693 175.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.51 HD13 ' O ' ' A' ' 75' ' ' ALA . 6.1 mp -61.09 -26.26 67.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.548 -0.751 . . . . 2.23 111.357 177.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -70.61 -38.04 73.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.479 0.657 . . . . 2.13 109.985 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.34 -46.96 75.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.134 -0.939 . . . . 1.84 109.177 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.404 ' HG ' ' CZ3' ' A' ' 23' ' ' TRP . 1.7 mp -69.22 -13.58 62.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.191 -0.913 . . . . 1.82 111.686 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -84.17 -4.45 58.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.011 0.91 . . . . 2.08 109.208 175.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.482 ' HB3' ' HZ3' ' A' ' 84' ' ' LYS . 8.4 mtpm? -118.65 45.86 1.96 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.886 -1.052 . . . . 4.6 109.668 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.569 -0.729 . . . . 3.96 110.847 -178.237 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.0 t30 . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 120.609 0.242 . . . . 2.72 110.735 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -61.8 -45.45 93.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.98 0.419 . . . . 2.46 111.221 -171.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.468 ' N ' HD12 ' A' ' 17' ' ' ILE . 2.6 mp -64.71 -49.1 81.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.7 -0.682 . . . . 1.42 111.045 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.589 ' SG ' ' HD3' ' A' ' 26' ' ' PRO . 53.3 t -62.22 -41.1 98.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.445 0.64 . . . . 1.98 110.388 -176.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 38.5 tp -62.27 -51.97 65.6 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.001 -0.999 . . . . 1.77 110.899 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.9 ttp-105 -61.59 -31.89 71.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.262 -0.881 . . . . 4.47 111.525 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -72.58 -1.59 16.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.961 -0.563 . . . . 1.67 111.437 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.4 m120 59.67 27.79 17.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.853 -1.067 . . . . 2.37 111.841 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.471 ' CH2' HG21 ' A' ' 50' ' ' THR . 27.3 m0 -85.4 162.86 47.09 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.234 -0.654 . . . . 0.4 109.234 174.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.08 174.34 7.09 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 121.981 1.788 . . . . 0.6 110.437 170.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.452 ' HA ' ' HE2' ' A' ' 25' ' ' MET . 5.7 mmt -79.2 132.94 61.55 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.981 0.42 . . . . 1.56 111.402 -170.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.589 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 12.1 Cg_endo -58.82 156.42 32.99 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.832 3.021 . . . . 0.68 113.819 -177.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.1 t -90.35 144.21 26.03 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.841 -1.072 . . . . 1.02 110.238 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.54 ' CD2' ' CZ ' ' A' ' 44' ' ' PHE . 60.7 m-85 -141.58 110.32 6.12 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.933 -0.766 . . . . 0.87 108.933 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.534 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 57.5 mtp180 -146.05 125.67 13.33 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 110.39 -0.226 . . . . 4.22 110.39 -176.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.519 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 74.6 m -65.24 126.77 29.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.749 0.309 . . . . 2.19 110.795 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 43' ' ' THR . 30.5 m -87.48 -38.67 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 1.87 110.927 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -140.84 130.28 23.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.411 -0.359 . . . . 2.76 110.764 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.01 151.3 35.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.134 -0.485 . . . . 2.6 110.708 175.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.27 -167.92 39.03 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.959 -0.638 . . . . 2.17 113.313 175.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.72 -150.59 21.6 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.076 -0.81 . . . . 2.13 111.076 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -52.03 -57.21 2.27 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 123.104 2.536 . . . . 3.0 111.882 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -177.59 -50.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.528 -0.76 . . . . 2.94 109.373 177.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -77.57 19.46 0.37 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.183 -0.917 . . . . 2.36 111.701 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.92 45.7 2.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.972 0.415 . . . . 1.84 111.025 -176.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -83.21 18.93 1.58 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.032 0.444 . . . . 2.53 110.659 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -85.58 141.12 30.06 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.018 -0.734 . . . . 4.07 109.018 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -110.47 136.01 50.27 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.025 -0.534 . . . . 1.16 110.807 -172.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.404 ' O ' HG22 ' A' ' 31' ' ' VAL . 16.7 m -124.6 127.84 47.98 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.234 -1.024 . . . . 1.08 108.234 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.734 ' CZ ' HG21 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -142.85 154.4 44.11 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.499 -0.556 . . . . 0.21 109.499 -175.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -126.85 139.75 11.46 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.903 -0.665 . . . . 0.2 112.519 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.734 HG21 ' CZ ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -107.18 159.02 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.659 -0.497 . . . . 1.45 109.659 -175.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.617 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 14.6 ptp180 -148.43 147.87 29.66 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.61 -0.885 . . . . 3.01 108.61 171.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.451 HG22 ' HB3' ' A' ' 26' ' ' PRO . 85.1 t -125.76 156.18 35.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.305 -0.407 . . . . 1.07 110.178 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -92.12 82.2 5.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.087 0.47 . . . . 1.81 109.949 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.471 HG21 ' CH2' ' A' ' 23' ' ' TRP . 41.5 p -74.5 107.2 6.49 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.548 -0.751 . . . . 1.08 109.479 178.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.7 t -47.53 -30.54 3.58 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.825 0.676 . . . . 1.72 112.825 -173.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -80.32 -14.58 58.25 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.417 0.895 . . . . 1.3 113.417 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -140.07 -42.09 0.43 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.525 0.602 . . . . 4.21 111.105 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 122.75 -153.75 16.95 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 116.111 -0.495 . . . . 0.24 112.048 -178.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.617 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 9.4 m95 -51.81 120.48 5.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.812 0.339 . . . . 0.47 110.732 173.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 47.4 p -68.92 157.73 36.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.709 -0.678 . . . . 1.07 111.045 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -58.22 131.67 51.28 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.065 -0.717 . . . . 1.84 109.065 174.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.66 113.02 2.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.744 0.783 . . . . 1.0 111.262 -171.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.449 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 38.7 m -85.87 98.67 10.9 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.177 -1.374 . . . . 0.44 109.984 -176.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.447 HD11 ' HA3' ' A' ' 45' ' ' GLY . 19.1 mm -80.71 128.96 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 115.892 -0.594 . . . . 1.49 110.364 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.11 175.21 49.87 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.921 -0.872 . . . . 0.24 110.921 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.597 ' O ' ' HG2' ' A' ' 64' ' ' MET . 12.5 pt-20 -85.5 150.5 54.18 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.572 -0.529 . . . . 1.37 109.572 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.97 109.97 0.39 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.651 2.234 . . . . 0.79 111.692 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.597 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 98.0 mmm -114.73 139.19 23.8 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.816 -0.629 . . . . 1.4 109.493 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.69 13.69 0.73 Allowed 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.576 2.184 . . . . 0.37 114.072 -174.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.486 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 28.6 m -157.46 143.1 17.36 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.715 -0.476 . . . . 1.63 109.715 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.77 -41.23 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.337 -0.847 . . . . 1.88 112.693 -170.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.35 -42.39 96.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.919 0.39 . . . . 3.34 111.146 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.486 ' HG2' ' HB2' ' A' ' 66' ' ' SER . 15.8 ptpt -81.26 -18.95 44.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.462 -0.335 . . . . 1.91 110.67 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.45 -55.63 25.81 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.397 -0.365 . . . . 1.07 110.301 171.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.602 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 53.5 mtpt -54.29 -52.17 62.31 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 116.063 -0.517 . . . . 2.9 110.29 175.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.38 -42.13 73.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.128 -0.942 . . . . 2.01 112.194 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.535 ' O ' HG11 ' A' ' 76' ' ' VAL . 17.1 t -62.75 -43.06 99.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.778 0.323 . . . . 1.8 110.981 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.424 ' HB1' ' CE2' ' A' ' 44' ' ' PHE . . . -69.95 -44.4 69.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.134 0.493 . . . . 1.07 110.401 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.484 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -57.52 -38.51 74.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.631 -0.713 . . . . 1.01 112.208 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.535 HG11 ' O ' ' A' ' 73' ' ' SER . 3.1 p -68.79 -31.19 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 O-C-N 121.952 -0.467 . . . . 1.53 110.669 -178.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.5 mt -76.19 -31.79 58.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.808 0.813 . . . . 1.12 109.103 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.405 ' HB3' ' O ' ' A' ' 75' ' ' ALA . 14.3 tp -66.16 -43.31 87.33 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.496 -1.229 . . . . 1.44 110.728 175.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.484 HD13 ' O ' ' A' ' 75' ' ' ALA . 6.3 mp -59.15 -29.19 67.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 2.23 111.424 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 6.2 mm-40 -71.78 -38.93 70.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.191 -0.459 . . . . 2.13 110.698 177.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.3 tp -75.05 -41.97 58.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.908 0.861 . . . . 1.84 110.335 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 84' ' ' LYS . 8.7 tp -65.4 -38.92 91.43 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.062 -1.426 . . . . 1.82 111.341 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -68.04 -3.58 10.65 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.804 -1.089 . . . . 2.08 109.816 173.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.479 ' H ' ' C ' ' A' ' 82' ' ' LEU . 82.4 mttt 62.1 157.69 0.05 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.175 -1.375 . . . . 4.6 111.585 -173.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.8 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.918 -0.563 . . . . 3.96 110.853 -162.216 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.9 p30 . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 111.683 0.253 . . . . 2.72 111.683 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -66.35 -45.86 78.77 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.837 0.351 . . . . 2.46 111.221 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 17' ' ' ILE . 2.4 mp -61.38 -41.5 90.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.662 -0.699 . . . . 1.42 110.638 -178.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.8 t -71.57 -41.73 68.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.987 -0.551 . . . . 1.98 110.218 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.8 -54.63 42.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.357 -0.838 . . . . 1.77 110.605 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -58.06 -33.89 69.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.211 -0.904 . . . . 4.47 111.906 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HB3' ' CE2' ' A' ' 23' ' ' TRP . 34.4 mmtt -72.71 4.02 4.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.071 0.462 . . . . 1.67 111.968 -178.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 63.28 38.71 10.15 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.867 -1.06 . . . . 2.37 110.28 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.441 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 29.0 m0 -104.81 165.09 13.88 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.423 -0.808 . . . . 0.4 109.631 176.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 55.0 Cg_endo -72.39 -171.51 0.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.349 2.033 . . . . 0.6 110.913 170.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.456 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 12.0 mmt -82.33 135.94 46.68 Favored Pre-proline 0 C--N 1.323 -0.582 0 O-C-N 122.024 -0.422 . . . . 1.56 110.633 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 14.4 Cg_exo -68.88 168.45 20.33 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.916 2.411 . . . . 0.68 113.045 -177.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.2 t -89.51 141.23 28.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.936 -1.029 . . . . 1.02 110.32 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.467 ' CD2' ' HZ ' ' A' ' 44' ' ' PHE . 67.7 m-85 -144.17 110.52 5.51 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.29 -0.633 . . . . 0.87 109.29 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.478 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 24.2 ttm180 -156.52 128.42 7.31 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.751 0.31 . . . . 4.22 110.512 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.451 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 4.5 p -65.68 124.26 21.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.069 0.461 . . . . 2.19 110.957 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.7 m -87.57 -37.07 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.987 -0.552 . . . . 1.87 111.439 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -135.89 122.7 21.16 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.06 0.457 . . . . 2.76 110.52 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.402 ' HG3' ' CD1' ' A' ' 42' ' ' PHE . 26.4 tt0 -151.45 143.22 23.73 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.323 -0.853 . . . . 2.6 110.289 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.93 -170.85 38.4 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.143 -1.027 . . . . 2.17 114.018 171.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.78 -155.32 26.1 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.442 -1.063 . . . . 2.13 110.442 -173.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -53.85 -65.43 0.13 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.944 2.429 . . . . 3.0 111.999 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -170.46 -42.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.692 -0.686 . . . . 2.94 109.623 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -78.81 18.22 0.63 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.439 -0.8 . . . . 2.36 111.226 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.19 36.32 4.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.434 0.635 . . . . 1.84 110.646 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -87.88 19.0 3.74 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.747 -0.66 . . . . 2.53 110.618 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -82.84 134.05 35.11 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.4 -0.963 . . . . 4.07 108.4 172.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.402 ' CD1' ' HG3' ' A' ' 33' ' ' GLU . 23.4 m-85 -110.31 135.66 50.7 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.904 -0.589 . . . . 1.16 110.637 -170.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.8 m -122.54 130.69 53.3 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.868 -1.16 . . . . 1.08 107.868 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.72 ' CZ ' HG23 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -139.18 151.33 46.5 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.417 -0.586 . . . . 0.21 109.417 -174.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.462 ' HA3' HD12 ' A' ' 60' ' ' ILE . . . -125.58 136.84 9.94 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.973 -0.632 . . . . 0.2 112.017 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.72 HG23 ' CZ ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -107.1 156.72 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 109.308 -0.627 . . . . 1.45 109.308 -176.899 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.567 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 16.2 ptt180 -148.99 147.7 28.88 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.774 -0.825 . . . . 3.01 108.774 171.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 26' ' ' PRO . 78.2 t -125.13 153.44 32.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.076 -0.511 . . . . 1.07 110.339 -177.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -93.58 83.4 4.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.507 0.67 . . . . 1.81 109.835 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 54' ' ' GLY . 29.6 p -69.89 105.58 2.86 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.628 -1.169 . . . . 1.08 108.963 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.1 t -43.78 -44.33 6.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.804 0.668 . . . . 1.72 112.804 -169.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -81.5 -6.44 58.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.254 0.835 . . . . 1.3 113.254 -175.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -133.1 -48.65 0.86 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.739 -0.601 . . . . 4.21 111.547 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 123.71 -153.68 17.35 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.899 -0.591 . . . . 0.24 112.585 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.567 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 5.2 m95 -52.43 117.61 2.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.869 0.366 . . . . 0.47 110.676 174.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.0 p -68.48 169.78 10.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.725 -0.671 . . . . 1.07 111.214 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -62.41 129.45 40.72 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.708 -0.849 . . . . 1.84 108.708 172.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -60.63 119.74 8.68 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.39 0.614 . . . . 1.0 110.609 -176.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.56 ' SG ' HD11 ' A' ' 81' ' ' LEU . 51.5 m -92.34 98.52 11.54 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.892 -1.049 . . . . 0.44 110.231 -175.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.462 HD12 ' HA3' ' A' ' 45' ' ' GLY . 24.6 mm -80.42 124.02 37.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.778 -0.646 . . . . 1.49 110.066 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.99 -174.84 50.0 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.882 -0.675 . . . . 0.24 112.243 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.554 ' O ' ' HG2' ' A' ' 64' ' ' MET . 42.9 mt-10 -83.81 152.01 62.1 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 109.728 -0.471 . . . . 1.37 109.728 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.43 109.14 1.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.363 2.042 . . . . 0.79 111.222 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.554 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 89.3 mmm -115.37 141.57 27.41 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.697 -0.483 . . . . 1.4 109.697 -173.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.05 17.97 1.1 Allowed 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.57 2.18 . . . . 0.37 113.581 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.414 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 11.2 t -155.09 139.91 17.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.315 -0.624 . . . . 1.63 109.315 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.2 -23.88 27.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.838 -0.619 . . . . 1.88 111.032 -173.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -73.96 -43.69 57.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.039 0.447 . . . . 3.34 110.235 -176.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HG2' ' HB3' ' A' ' 66' ' ' SER . 5.7 ptpp? -81.64 -18.37 44.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.939 -0.573 . . . . 1.91 110.634 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.28 -57.49 12.56 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.496 -0.32 . . . . 1.07 110.496 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.453 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 61.5 mttm -52.95 -50.08 64.78 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.946 0.403 . . . . 2.9 110.257 174.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.522 ' O ' HG21 ' A' ' 76' ' ' VAL . 32.1 t70 -51.54 -51.56 54.3 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.362 -0.835 . . . . 2.01 112.295 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.4 t -56.31 -46.64 79.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.787 0.327 . . . . 1.8 111.178 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.417 ' HB1' ' CE2' ' A' ' 44' ' ' PHE . . . -69.5 -43.14 73.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.259 -0.428 . . . . 1.07 110.951 -177.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.91 -41.06 70.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.819 -0.628 . . . . 1.01 111.84 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 72' ' ' ASP . 97.0 t -63.64 -35.04 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.043 0.449 . . . . 1.53 110.731 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.6 mt -74.89 -36.63 62.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.732 0.777 . . . . 1.12 109.66 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.411 HD21 ' CG1' ' A' ' 46' ' ' VAL . 21.0 tp -64.72 -43.12 94.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.749 -1.114 . . . . 1.44 111.103 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 mp -62.69 -21.13 65.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.85 -0.613 . . . . 2.23 111.497 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -76.43 -38.44 55.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.752 0.31 . . . . 2.13 110.234 174.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.56 HD11 ' SG ' ' A' ' 59' ' ' CYS . 0.8 OUTLIER -66.35 -42.98 87.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.766 0.793 . . . . 1.84 109.063 178.579 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.41 ' HG ' ' CZ3' ' A' ' 23' ' ' TRP . 1.6 mp -69.24 -17.75 63.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.678 -1.146 . . . . 1.82 111.943 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.617 ' O ' ' HB2' ' A' ' 84' ' ' LYS . 22.9 t-20 -88.51 0.83 55.89 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.833 -0.803 . . . . 2.08 108.833 174.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.617 ' HB2' ' O ' ' A' ' 83' ' ' ASN . 53.5 mtpt 80.32 146.76 0.09 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.384 -1.28 . . . . 4.6 110.161 -178.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.782 -0.627 . . . . 3.96 110.432 -168.764 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.838 0.352 . . . . 0.80000000000000004 110.855 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 23' ' ' TRP . 35.4 t -68.29 -40.92 81.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.412 0.625 . . . . 1.3500000000000001 109.775 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.2 tp -62.22 -50.03 73.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.095 -0.957 . . . . 1.1599999999999999 110.219 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -60.18 -36.81 78.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.966 -1.015 . . . . 3.8399999999999999 111.635 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.406 ' HB3' ' CE2' ' A' ' 23' ' ' TRP . 49.0 mmtt -73.3 -3.25 25.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.394 0.616 . . . . 1.1000000000000001 111.646 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 64.95 43.63 3.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.396 -1.274 . . . . 1.9199999999999999 110.648 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.486 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 19.1 m0 -105.14 162.79 18.67 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.742 -0.663 . . . . 0.40000000000000002 109.426 174.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 34.4 Cg_endo -67.92 -178.8 1.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.073 1.849 . . . . 0.44 110.75 171.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 16.7 mmt -80.66 127.89 73.88 Favored Pre-proline 0 C--N 1.322 -0.596 0 O-C-N 121.984 -0.447 . . . . 1.0 109.892 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HB3' HG22 ' A' ' 48' ' ' VAL . 22.0 Cg_exo -63.4 167.99 12.05 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.947 2.431 . . . . 0.46000000000000002 113.462 -174.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.5 t -86.6 140.37 29.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.952 -1.022 . . . . 0.29999999999999999 109.979 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.464 ' CD1' ' HZ ' ' A' ' 44' ' ' PHE . 69.4 m-85 -145.57 110.99 5.35 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.566 -0.531 . . . . 0.29999999999999999 109.566 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.488 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 72.7 ttt180 -158.68 130.37 6.56 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 110.359 -0.237 . . . . 3.6899999999999999 110.359 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.5 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 70.0 m -64.23 124.49 21.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.339 -0.392 . . . . 1.53 110.766 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -82.53 -32.59 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.248 0.547 . . . . 1.1499999999999999 110.362 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.8 tttp . . . . . 0 C--N 1.319 -0.754 0 CA-C-N 115.568 -0.742 . . . . 2.25 109.475 174.379 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 107.726 -1.213 . . . . 3.6400000000000001 107.726 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -110.57 131.65 54.87 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.103 0.477 . . . . 0.79000000000000004 110.387 -172.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.0 m -120.01 130.99 54.99 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.876 -1.157 . . . . 0.26000000000000001 107.876 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.727 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -137.94 151.79 48.33 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.642 -0.503 . . . . 0.17000000000000001 109.642 -173.853 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -125.47 136.47 9.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.232 -0.508 . . . . 0.17000000000000001 111.987 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.727 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.3 t -107.72 154.41 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 117.14 0.47 . . . . 0.80000000000000004 109.856 -175.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.56 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 10.9 ptt180 -149.51 145.23 26.75 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.681 -0.859 . . . . 2.6200000000000001 108.681 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.616 HG23 HD11 ' A' ' 78' ' ' LEU . 61.0 t -125.5 155.85 34.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.355 -0.384 . . . . 0.23999999999999999 110.394 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -95.12 83.87 3.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.601 0.715 . . . . 1.5900000000000001 110.37 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.456 HG22 ' CZ2' ' A' ' 23' ' ' TRP . 30.1 p -72.92 103.08 3.62 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.423 -1.262 . . . . 0.33000000000000002 108.944 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.9 t -46.06 -32.97 3.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.654 -0.703 . . . . 1.3200000000000001 112.858 -170.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -72.31 -22.57 61.16 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.753 0.649 . . . . 1.3 112.753 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -134.56 -45.69 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.022 -0.424 . . . . 3.6800000000000002 111.279 -175.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 126.64 -154.34 19.14 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.914 -0.584 . . . . 0.19 112.343 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.56 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 7.1 m95 -49.22 120.28 3.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.97 0.453 . . . . 0.39000000000000001 110.882 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 42.8 p -70.33 172.99 7.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.647 -0.706 . . . . 0.35999999999999999 111.418 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -61.05 131.84 51.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.883 -0.784 . . . . 1.8400000000000001 108.883 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 27.0 tt0 -64.64 114.96 4.76 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.342 0.591 . . . . 1.0 109.749 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 59.8 m -92.21 97.42 10.89 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.095 -0.957 . . . . 0.35999999999999999 110.258 -175.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.66 126.22 38.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.647 -0.706 . . . . 0.73999999999999999 110.361 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.22 -170.99 47.82 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.47 -0.787 . . . . 0.23000000000000001 111.727 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.607 ' O ' ' HG2' ' A' ' 64' ' ' MET . 41.4 mt-10 -88.36 152.07 49.45 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 110.281 -0.266 . . . . 1.3700000000000001 110.281 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.12 107.91 0.32 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.643 2.229 . . . . 0.51000000000000001 111.256 172.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.607 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 95.8 mmm -110.4 147.23 35.93 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.202 -0.454 . . . . 0.67000000000000004 110.482 -173.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.24 4.36 7.06 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.739 2.292 . . . . 0.32000000000000001 113.765 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.441 ' HB2' ' HG3' ' A' ' 69' ' ' LYS . 26.9 m -147.53 137.15 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.742 -0.466 . . . . 1.3 109.742 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.3 m -65.29 -28.77 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.178 -0.465 . . . . 1.1399999999999999 112.046 -171.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -71.19 -36.16 71.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.4 -0.364 . . . . 2.8199999999999998 110.454 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.441 ' HG3' ' HB2' ' A' ' 66' ' ' SER . 46.9 mtpt -74.47 -28.33 60.98 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.764 -0.458 . . . . 1.3600000000000001 109.764 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.49 -59.03 6.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.831 -0.622 . . . . 0.20999999999999999 110.623 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.632 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 56.8 mttm -53.6 -58.59 6.64 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.086 -0.506 . . . . 2.4199999999999999 111.471 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.589 ' O ' HG23 ' A' ' 76' ' ' VAL . 29.6 t70 -57.69 -42.37 83.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.656 -0.702 . . . . 2.0099999999999998 112.718 -173.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 m -70.31 -36.63 74.43 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 121.006 -0.278 . . . . 1.1399999999999999 111.418 -175.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.415 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -67.36 -42.89 82.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.613 0.721 . . . . 0.17999999999999999 109.541 174.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 79' ' ' LEU . . . -54.23 -34.67 61.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.48 -1.236 . . . . 0.26000000000000001 111.533 176.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 72' ' ' ASP . 98.3 t -64.56 -34.79 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.007 0.432 . . . . 0.82999999999999996 110.7 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.3 mt -74.6 -33.07 62.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.818 0.818 . . . . 0.39000000000000001 109.194 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.616 HD11 HG23 ' A' ' 48' ' ' VAL . 26.5 tp -64.1 -37.31 86.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.547 -1.206 . . . . 0.81000000000000005 110.272 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 20.8 mt -60.66 -28.27 68.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.233 -0.894 . . . . 1.6100000000000001 110.835 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -72.98 -36.69 67.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.042 0.448 . . . . 2.1299999999999999 110.027 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.2 tt -66.86 -46.22 75.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.645 0.735 . . . . 1.1699999999999999 109.052 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.456 ' HB3' HG21 ' A' ' 17' ' ' ILE . 3.8 mp -70.61 -11.35 60.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.915 -1.039 . . . . 1.1499999999999999 112.051 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.7 t30 . . . . . 0 C--N 1.321 -0.639 0 CA-C-O 121.592 0.71 . . . . 1.46 109.65 176.568 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.483 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.5 mp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.787 0.327 . . . . 0.80000000000000004 110.72 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.416 ' SG ' HG13 ' A' ' 48' ' ' VAL . 34.4 t -69.3 -42.11 75.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.312 0.577 . . . . 1.3500000000000001 109.824 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.3 tp -61.8 -49.31 76.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.309 -0.859 . . . . 1.1599999999999999 110.398 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -63.97 -31.44 72.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.799 -1.091 . . . . 3.8399999999999999 111.395 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.431 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 27.7 mmmt -74.31 3.11 7.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.362 -0.381 . . . . 1.1000000000000001 111.459 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.4 t30 67.69 27.95 7.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.306 -0.861 . . . . 1.9199999999999999 110.25 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -94.65 160.2 31.93 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.389 -0.823 . . . . 0.40000000000000002 109.429 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.49 -169.53 0.43 Allowed 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.178 1.919 . . . . 0.44 111.554 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.429 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 9.3 mmt -78.28 134.63 62.59 Favored Pre-proline 0 C--N 1.324 -0.542 0 O-C-N 122.163 -0.336 . . . . 1.0 110.649 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 16.7 Cg_exo -66.62 156.69 64.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.648 2.232 . . . . 0.46000000000000002 112.042 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.45 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 12.9 t -89.32 142.6 27.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.899 -0.591 . . . . 0.29999999999999999 110.082 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.477 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 62.6 m-85 -142.21 111.98 6.78 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.308 -0.627 . . . . 0.29999999999999999 109.308 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.564 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 33.7 ttm180 -163.03 122.69 2.21 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.473 -0.566 . . . . 3.6899999999999999 109.473 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 73.8 m -61.77 131.33 49.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.196 0.522 . . . . 1.53 111.833 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.425 ' H ' ' HA ' ' A' ' 44' ' ' PHE . 27.2 m -82.98 -30.74 8.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.372 -0.831 . . . . 1.1499999999999999 110.357 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.7 tttp . . . . . 0 C--N 1.317 -0.839 0 CA-C-N 115.539 -0.755 . . . . 2.25 110.125 174.289 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 . . . . . 0 N--CA 1.445 -0.677 0 N-CA-C 107.084 -1.45 . . . . 3.6400000000000001 107.084 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -109.47 134.27 52.08 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.253 0.549 . . . . 0.79000000000000004 110.45 -169.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.8 m -123.24 127.08 48.09 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.02 -1.104 . . . . 0.26000000000000001 108.02 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.676 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -138.47 154.4 48.83 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.789 -0.448 . . . . 0.17000000000000001 109.789 -171.045 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.44 ' CA ' HD13 ' A' ' 60' ' ' ILE . . . -127.41 137.39 9.83 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.209 -0.52 . . . . 0.17000000000000001 111.923 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.676 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.3 t -107.33 153.98 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 N-CA-C 108.853 -0.795 . . . . 0.80000000000000004 108.853 -176.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.544 ' O ' ' HZ3' ' A' ' 55' ' ' TRP . 11.3 ptt180 -143.63 146.77 33.52 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.521 -0.918 . . . . 2.6200000000000001 108.521 173.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.416 HG13 ' SG ' ' A' ' 18' ' ' CYS . 74.7 t -125.36 150.71 30.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.757 -0.656 . . . . 0.23999999999999999 109.688 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -91.63 84.51 5.49 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.458 0.647 . . . . 1.5900000000000001 109.686 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.3 p -71.71 109.87 5.89 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.627 -1.17 . . . . 0.33000000000000002 109.45 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 62.0 p -50.56 -22.54 2.02 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.731 -1.122 . . . . 1.3200000000000001 114.021 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -92.08 -15.63 27.52 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.374 0.509 . . . . 1.3 112.374 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -136.24 -40.47 0.66 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.097 -0.377 . . . . 3.6800000000000002 111.878 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.57 -154.45 16.95 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 121.282 -0.485 . . . . 0.19 112.801 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.544 ' HZ3' ' O ' ' A' ' 47' ' ' ARG . 30.1 m95 -57.75 123.42 15.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.396 0.617 . . . . 0.39000000000000001 111.265 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.0 p -74.48 152.85 39.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.138 -0.937 . . . . 0.35999999999999999 110.879 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -62.05 129.41 40.72 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.231 -0.655 . . . . 1.8400000000000001 109.231 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -50.63 125.01 12.01 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.445 -0.798 . . . . 1.0 112.985 -173.019 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.425 ' SG ' HD12 ' A' ' 81' ' ' LEU . 58.9 m -86.95 100.85 12.9 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.174 -1.375 . . . . 0.35999999999999999 108.865 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.44 HD13 ' CA ' ' A' ' 45' ' ' GLY . 29.2 mm -83.07 123.92 39.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.919 -0.582 . . . . 0.73999999999999999 110.703 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.84 -175.86 51.03 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 121.052 -0.594 . . . . 0.23000000000000001 112.002 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HG2' ' OG ' ' A' ' 73' ' ' SER . 11.1 pt-20 -87.02 149.46 47.69 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 110.167 -0.309 . . . . 1.3700000000000001 110.167 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.33 108.76 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.813 2.342 . . . . 0.51000000000000001 111.61 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.409 ' SD ' ' HG3' ' A' ' 69' ' ' LYS . 15.1 mmt -108.87 143.75 28.22 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.166 -0.47 . . . . 0.67000000000000004 110.964 -174.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -83.34 10.47 3.65 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.683 2.255 . . . . 0.32000000000000001 112.845 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.7 m -153.15 138.03 17.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.444 -0.576 . . . . 1.3 109.444 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 m -68.63 -25.76 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 112.253 0.464 . . . . 1.1399999999999999 112.253 -173.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -73.06 -41.39 64.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.672 0.272 . . . . 2.8199999999999998 111.075 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HG3' ' SD ' ' A' ' 64' ' ' MET . 7.2 ptmm? -82.08 -17.62 45.93 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.891 -0.323 . . . . 1.3600000000000001 110.334 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.93 -61.78 2.37 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.198 -0.455 . . . . 0.20999999999999999 111.175 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.653 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -56.39 -42.58 78.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.589 0.233 . . . . 2.4199999999999999 111.09 177.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -53.44 -46.37 69.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.868 -0.605 . . . . 2.0099999999999998 112.199 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.645 ' O ' HG12 ' A' ' 76' ' ' VAL . 41.9 t -62.93 -45.07 94.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.039 0.447 . . . . 1.1399999999999999 111.185 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.419 ' HB1' HG23 ' A' ' 46' ' ' VAL . . . -68.34 -40.82 81.45 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.294 0.568 . . . . 0.17999999999999999 110.23 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.444 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -56.88 -37.57 71.56 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.274 -0.875 . . . . 0.26000000000000001 112.069 177.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.645 HG12 ' O ' ' A' ' 73' ' ' SER . 1.8 p -70.95 -26.82 28.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 O-C-N 121.917 -0.489 . . . . 0.82999999999999996 110.669 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.3 mt -78.79 -31.61 46.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.791 0.805 . . . . 0.39000000000000001 109.401 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.441 HD22 HG11 ' A' ' 46' ' ' VAL . 28.0 tp -66.88 -36.77 83.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.865 -1.061 . . . . 0.81000000000000005 110.461 175.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.6 mm? -61.21 -25.4 67.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.736 -0.666 . . . . 1.6100000000000001 110.861 175.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -71.71 -37.94 70.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.093 0.473 . . . . 2.1299999999999999 109.968 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.425 HD12 ' SG ' ' A' ' 59' ' ' CYS . 1.3 tt -62.99 -47.24 83.99 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.049 -0.723 . . . . 1.1699999999999999 109.049 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mp -74.39 0.91 12.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.191 -0.913 . . . . 1.1499999999999999 111.661 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.2 t30 . . . . . 0 C--N 1.322 -0.613 0 CA-C-O 121.763 0.792 . . . . 1.46 109.38 175.011 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.8 mp . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 121.449 0.642 . . . . 0.80000000000000004 109.961 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.3 m -65.1 -42.91 93.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.029 -0.987 . . . . 1.3500000000000001 110.204 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.83 -51.98 67.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.877 -1.056 . . . . 1.1599999999999999 110.284 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -57.02 -37.08 71.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.398 -0.819 . . . . 3.8399999999999999 111.923 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -72.81 1.96 7.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.066 -0.515 . . . . 1.1000000000000001 111.975 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.2 t30 65.59 32.67 9.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.938 -1.028 . . . . 1.9199999999999999 109.699 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.469 ' CH2' HG22 ' A' ' 50' ' ' THR . 38.2 m0 -99.21 160.58 27.23 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.201 -0.909 . . . . 0.40000000000000002 109.367 175.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.42 170.65 18.78 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.126 1.884 . . . . 0.44 110.048 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 50.0 mmm -72.68 134.49 81.7 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 110.347 -0.242 . . . . 1.0 110.347 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.517 ' HB3' HG22 ' A' ' 48' ' ' VAL . 23.6 Cg_exo -63.82 161.39 32.83 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.962 2.441 . . . . 0.46000000000000002 113.117 -177.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.571 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 16.6 t -87.63 141.49 28.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.961 -1.018 . . . . 0.29999999999999999 109.841 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.439 ' HD2' ' CZ ' ' A' ' 44' ' ' PHE . 78.6 m-85 -139.56 110.67 6.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.815 -0.809 . . . . 0.29999999999999999 108.815 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.445 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 26.7 ttm180 -153.39 123.45 6.95 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.972 -0.381 . . . . 3.6899999999999999 109.972 -176.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.481 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 62.5 m -61.87 124.93 22.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.136 0.493 . . . . 1.53 111.381 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.472 ' H ' ' HA ' ' A' ' 44' ' ' PHE . 53.3 t -80.74 -29.97 11.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.615 -0.72 . . . . 1.1499999999999999 109.784 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.7 tptt . . . . . 0 N--CA 1.447 -0.605 0 CA-C-N 115.883 -0.599 . . . . 2.25 110.22 178.252 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 109.476 -0.564 . . . . 3.6400000000000001 109.476 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 5.0 m-85 -109.87 136.26 49.45 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.311 -0.859 . . . . 0.79000000000000004 110.041 -173.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.3 m -118.44 125.91 50.93 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.938 -1.134 . . . . 0.26000000000000001 107.938 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.681 ' CZ ' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -132.65 151.75 51.87 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 121.843 -0.535 . . . . 0.17000000000000001 109.802 -171.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.44 ' CA ' HD13 ' A' ' 60' ' ' ILE . . . -125.57 129.16 6.78 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.14 -0.784 . . . . 0.17000000000000001 111.14 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.681 ' HB ' ' CZ ' ' A' ' 44' ' ' PHE . 7.3 p -109.94 145.94 15.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 110.057 -0.349 . . . . 0.80000000000000004 110.057 -173.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.633 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 2.9 ptp180 -140.32 145.92 37.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.836 -0.802 . . . . 2.6200000000000001 108.836 -176.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.582 HG23 HD11 ' A' ' 78' ' ' LEU . 57.6 t -125.89 154.55 34.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.461 -0.336 . . . . 0.23999999999999999 110.29 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -93.85 83.92 4.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.61 0.719 . . . . 1.5900000000000001 110.086 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.469 HG22 ' CH2' ' A' ' 23' ' ' TRP . 30.2 p -70.96 116.43 11.25 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.523 -1.217 . . . . 0.33000000000000002 110.062 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 p -51.13 -25.72 5.6 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.583 -1.189 . . . . 1.3200000000000001 113.522 -172.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -92.95 -12.89 29.67 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.745 0.646 . . . . 1.3 112.745 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -136.74 -42.03 0.6 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.792 -0.567 . . . . 3.6800000000000002 111.703 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.15 -152.83 17.12 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.891 -0.484 . . . . 0.19 111.891 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.633 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 9.4 m95 -54.15 117.78 3.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.119 0.485 . . . . 0.39000000000000001 110.956 176.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 56.1 p -69.59 150.6 46.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.436 -0.802 . . . . 0.35999999999999999 110.315 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -61.18 116.96 4.98 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.3 -1.0 . . . . 1.8400000000000001 108.3 171.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 3.9 pt-20 -55.39 140.57 39.38 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 114.802 -1.09 . . . . 1.0 111.934 -168.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 63.8 m -97.83 101.79 13.38 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.804 -1.089 . . . . 0.35999999999999999 109.458 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.44 HD13 ' CA ' ' A' ' 45' ' ' GLY . 25.6 mm -73.54 120.33 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.575 -0.739 . . . . 0.73999999999999999 110.143 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.58 -165.25 39.3 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.934 -0.65 . . . . 0.23000000000000001 112.265 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 64' ' ' MET . 43.6 mt-10 -80.69 139.56 50.76 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.926 -0.398 . . . . 1.3700000000000001 109.926 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 32.1 Cg_exo -57.96 110.38 0.62 Allowed 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.14 1.893 . . . . 0.51000000000000001 110.415 171.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.671 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 16.9 mmt -113.06 141.33 25.43 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.086 -0.507 . . . . 0.67000000000000004 111.312 -169.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.06 9.55 2.72 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.763 2.309 . . . . 0.32000000000000001 113.132 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.3 m -154.55 137.18 15.16 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.454 -0.573 . . . . 1.3 109.454 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.4 m -65.64 -34.18 68.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.295 0.85 . . . . 1.1399999999999999 113.295 -170.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -67.32 -40.94 86.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.589 0.233 . . . . 2.8199999999999998 111.459 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.671 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 0.5 OUTLIER -81.2 -20.2 41.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.844 0.354 . . . . 1.3600000000000001 110.451 -179.339 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.38 -61.41 2.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.24 -0.436 . . . . 0.20999999999999999 111.2 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.581 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 13.2 ptmm? -56.19 -43.75 78.75 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.051 0.453 . . . . 2.4199999999999999 110.674 176.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.477 ' O ' HG23 ' A' ' 76' ' ' VAL . 36.8 t70 -51.98 -47.05 65.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.113 -0.949 . . . . 2.0099999999999998 112.022 177.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.5 t -60.65 -47.53 85.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.612 0.244 . . . . 1.1399999999999999 111.606 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.04 -38.78 89.24 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.175 0.512 . . . . 0.17999999999999999 110.488 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.404 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -54.64 -37.25 65.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.238 -0.892 . . . . 0.26000000000000001 111.294 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.492 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 91.7 t -59.16 -42.05 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 CA-C-O 120.837 0.351 . . . . 0.82999999999999996 110.849 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.2 mt -77.17 -30.42 54.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.597 0.713 . . . . 0.39000000000000001 109.661 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.582 HD11 HG23 ' A' ' 48' ' ' VAL . 40.1 tp -65.73 -44.43 86.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.808 -1.087 . . . . 0.81000000000000005 111.052 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 75' ' ' ALA . 8.6 mp -63.3 -21.57 66.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.654 -0.703 . . . . 1.6100000000000001 111.493 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 8.6 mm-40 -73.71 -38.37 64.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.348 0.594 . . . . 2.1299999999999999 109.862 173.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 tt -66.78 -46.18 76.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.013 -0.994 . . . . 1.1699999999999999 109.382 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mp -65.29 -16.7 63.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.349 -0.841 . . . . 1.1499999999999999 112.338 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 121.484 0.659 . . . . 1.46 109.799 177.15 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.476 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 121.158 0.504 . . . . 0.80000000000000004 109.968 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 22.5 m -66.92 -44.68 80.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.613 -0.721 . . . . 1.3500000000000001 109.747 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.1 tp -61.39 -46.83 88.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.713 -1.131 . . . . 1.1599999999999999 110.151 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -62.26 -36.15 81.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.654 -1.157 . . . . 3.8399999999999999 111.334 -177.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 11.0 mmmm -74.15 6.03 3.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 1.1000000000000001 111.611 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.4 t30 67.03 30.8 7.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.82 0.819 . . . . 1.9199999999999999 110.268 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -96.23 158.85 33.3 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.562 -0.744 . . . . 0.40000000000000002 109.277 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.88 -171.43 0.57 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.318 2.012 . . . . 0.44 111.515 173.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.443 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 26.9 mmt -75.95 138.88 69.19 Favored Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 110.063 -0.347 . . . . 1.0 110.063 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.521 ' HB3' HG22 ' A' ' 48' ' ' VAL . 6.3 Cg_exo -72.79 164.6 35.12 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.361 2.04 . . . . 0.46000000000000002 112.468 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.428 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 23.0 t -89.57 144.17 26.23 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.261 -0.881 . . . . 0.29999999999999999 109.941 178.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.512 ' HD2' ' CZ ' ' A' ' 44' ' ' PHE . 66.0 m-85 -139.6 111.08 7.11 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.625 -0.88 . . . . 0.29999999999999999 108.625 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.472 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 20.5 ttp-105 -144.79 119.95 10.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.88 -0.415 . . . . 3.6899999999999999 109.88 -173.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 21.3 p -66.98 124.55 23.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.098 0.475 . . . . 1.53 110.534 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 43' ' ' THR . 23.3 m -85.82 -41.5 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 116.106 -0.497 . . . . 1.1499999999999999 111.102 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.1 tttt . . . . . 0 C--N 1.323 -0.562 0 C-N-CA 121.172 -0.211 . . . . 2.25 111.32 179.601 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 . . . . . 0 N--CA 1.444 -0.73 0 N-CA-C 107.109 -1.441 . . . . 3.6400000000000001 107.109 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -109.89 130.8 55.48 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.393 -0.595 . . . . 0.79000000000000004 109.393 -172.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 31' ' ' VAL . 5.4 m -123.19 131.84 53.83 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.994 -1.113 . . . . 0.26000000000000001 107.994 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.728 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -142.35 155.75 45.18 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.588 -0.523 . . . . 0.17000000000000001 109.588 -174.627 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.535 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -128.74 139.66 11.16 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.9 -0.667 . . . . 0.17000000000000001 112.507 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.728 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -106.74 156.8 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.767 -0.457 . . . . 0.80000000000000004 109.767 -176.307 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.599 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 18.6 ptt180 -147.28 148.27 31.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.92 -0.77 . . . . 2.6200000000000001 108.92 172.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.537 HG23 HD11 ' A' ' 78' ' ' LEU . 86.0 t -127.31 154.79 38.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.296 -0.411 . . . . 0.23999999999999999 110.616 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -91.13 84.15 5.66 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.19 0.519 . . . . 1.5900000000000001 110.248 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.2 p -70.4 115.52 9.68 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.175 -0.92 . . . . 0.33000000000000002 109.611 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.2 p -51.04 -27.19 7.4 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.724 -1.125 . . . . 1.3200000000000001 113.404 -172.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -98.81 -8.43 25.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.601 0.593 . . . . 1.3 112.601 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -129.0 -47.66 1.23 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.871 -0.518 . . . . 3.6800000000000002 111.469 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.13 -151.69 17.23 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.648 -0.706 . . . . 0.19 111.795 -175.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.599 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.7 m95 -54.85 120.4 6.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.065 0.46 . . . . 0.39000000000000001 111.051 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.5 p -73.38 162.67 29.06 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.749 -0.66 . . . . 0.35999999999999999 111.288 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -60.0 129.41 41.66 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.314 -0.625 . . . . 1.8400000000000001 109.314 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -59.03 115.08 2.91 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.714 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.463 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 59.7 m -87.92 97.6 11.03 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.924 -1.035 . . . . 0.35999999999999999 110.037 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.535 HD13 ' HA3' ' A' ' 45' ' ' GLY . 32.3 mm -76.02 123.92 33.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.449 -0.796 . . . . 0.73999999999999999 110.417 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.06 -170.49 44.8 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.987 -0.625 . . . . 0.23000000000000001 112.021 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 64' ' ' MET . 44.5 mt-10 -89.14 150.82 45.83 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 110.045 -0.354 . . . . 1.3700000000000001 110.045 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.98 109.32 1.09 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.562 2.174 . . . . 0.51000000000000001 111.378 176.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.62 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 90.9 mmm -114.94 144.46 32.05 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.119 -0.491 . . . . 0.67000000000000004 110.207 -171.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.55 12.26 2.2 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.534 2.156 . . . . 0.32000000000000001 113.537 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.5 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 19.9 m -154.86 138.96 16.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.413 -0.588 . . . . 1.3 109.413 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -66.98 -28.17 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.769 0.655 . . . . 1.1399999999999999 112.769 -170.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.01 -42.08 73.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.833 0.349 . . . . 2.8199999999999998 110.92 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.5 ' HG2' ' HB2' ' A' ' 66' ' ' SER . 4.3 ptpp? -81.48 -18.1 46.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.421 -0.354 . . . . 1.3600000000000001 110.678 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.79 -59.24 5.75 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.45 -0.341 . . . . 0.20999999999999999 110.486 172.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.623 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 57.9 mttp -52.81 -47.06 67.91 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.325 -0.398 . . . . 2.4199999999999999 110.543 175.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -50.21 -50.0 50.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.416 -0.811 . . . . 2.0099999999999998 112.128 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.584 ' O ' HG12 ' A' ' 76' ' ' VAL . 45.2 t -61.37 -44.49 97.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.83 0.347 . . . . 1.1399999999999999 111.252 -177.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.502 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -68.64 -47.42 66.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.168 0.509 . . . . 0.17999999999999999 110.867 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.446 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -55.6 -36.55 67.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.403 -0.817 . . . . 0.26000000000000001 112.059 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 73' ' ' SER . 2.0 p -71.42 -27.66 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 121.205 0.526 . . . . 0.82999999999999996 110.617 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.9 mt -79.04 -31.83 44.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.727 0.775 . . . . 0.39000000000000001 109.436 175.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.537 HD11 HG23 ' A' ' 48' ' ' VAL . 28.6 tp -63.79 -35.29 80.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.107 -0.952 . . . . 0.81000000000000005 110.406 173.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.5 mm? -62.25 -22.65 66.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.565 -0.743 . . . . 1.6100000000000001 111.449 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -69.41 -38.0 77.71 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.318 0.58 . . . . 2.1299999999999999 109.715 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.438 HD12 ' SG ' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -68.31 -31.17 70.4 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.225 1.012 . . . . 1.1699999999999999 109.635 179.421 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.3 mp -84.58 -3.18 58.32 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.145 -0.934 . . . . 1.1499999999999999 112.28 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 . . . . . 0 C--N 1.32 -0.687 0 CA-C-O 121.586 0.708 . . . . 1.46 109.81 177.21 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.7 mp . . . . . 0 N--CA 1.461 0.113 0 CA-C-O 121.148 0.499 . . . . 0.80000000000000004 109.883 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.454 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 68.5 m -64.78 -42.64 94.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.477 -0.783 . . . . 1.3500000000000001 109.969 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.66 -45.1 91.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.872 -1.058 . . . . 1.1599999999999999 110.543 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -65.52 -35.34 80.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.33 -0.85 . . . . 3.8399999999999999 111.068 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 9.1 mmmm -76.07 4.02 9.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 1.1000000000000001 111.162 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.6 t30 66.02 38.84 4.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.248 -0.887 . . . . 1.9199999999999999 110.27 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.454 ' CE3' ' HA ' ' A' ' 18' ' ' CYS . 37.9 m0 -104.04 156.62 35.44 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.414 -0.812 . . . . 0.40000000000000002 109.431 175.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.13 -172.84 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.36 2.04 . . . . 0.44 111.05 171.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.453 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 29.4 mmt -75.19 142.9 76.08 Favored Pre-proline 0 N--CA 1.447 -0.617 0 O-C-N 122.078 -0.389 . . . . 1.0 110.511 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HB3' HG22 ' A' ' 48' ' ' VAL . 3.1 Cg_exo -76.24 165.32 29.67 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.718 2.279 . . . . 0.46000000000000002 112.864 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.3 t -83.58 141.99 31.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.247 -0.888 . . . . 0.29999999999999999 110.059 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.474 ' CD1' ' HZ ' ' A' ' 44' ' ' PHE . 66.5 m-85 -145.98 110.18 4.98 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.034 -0.728 . . . . 0.29999999999999999 109.034 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.525 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 23.7 ttm180 -158.63 128.39 5.79 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.394 -0.225 . . . . 3.6899999999999999 110.394 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.542 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 86.4 m -63.34 123.48 18.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.846 0.355 . . . . 1.53 110.688 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -84.49 -34.27 9.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.298 0.57 . . . . 1.1499999999999999 109.805 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.5 tttp . . . . . 0 C--N 1.32 -0.715 0 CA-C-N 115.581 -0.736 . . . . 2.25 109.294 177.013 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 . . . . . 0 N--CA 1.442 -0.848 0 N-CA-C 106.553 -1.647 . . . . 3.6400000000000001 106.553 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 6.9 m-85 -110.23 131.86 54.68 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.368 -0.533 . . . . 0.79000000000000004 109.777 -169.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.1 m -122.2 132.02 54.23 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.813 -1.18 . . . . 0.26000000000000001 107.813 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.716 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -142.24 153.16 43.75 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.553 -0.536 . . . . 0.17000000000000001 109.553 -173.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.504 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -127.55 140.7 12.03 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.099 -0.572 . . . . 0.17000000000000001 112.327 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.716 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 2.1 t -105.91 156.36 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 109.605 -0.517 . . . . 0.80000000000000004 109.605 -175.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 56' ' ' THR . 5.3 tpp85 -142.64 145.57 33.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.558 -0.904 . . . . 2.6200000000000001 108.558 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.719 HG23 HD11 ' A' ' 78' ' ' LEU . 61.8 t -131.36 153.11 38.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 110.058 -0.349 . . . . 0.23999999999999999 110.058 177.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -96.29 85.14 3.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.442 0.639 . . . . 1.5900000000000001 110.015 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 54' ' ' GLY . 26.2 p -69.29 106.99 3.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.69 -1.141 . . . . 0.33000000000000002 109.106 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 t -49.77 -26.8 4.19 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.834 0.679 . . . . 1.3200000000000001 112.834 -171.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -88.17 -18.27 29.11 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.428 0.529 . . . . 1.3 112.428 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -129.82 -46.29 1.15 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.015 0.436 . . . . 3.6800000000000002 111.294 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 125.6 -156.04 19.19 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.933 -0.576 . . . . 0.19 112.607 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -52.28 119.72 4.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.22 0.533 . . . . 0.39000000000000001 110.89 175.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.458 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 46.3 p -68.95 -179.26 1.43 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.987 -1.006 . . . . 0.35999999999999999 112.487 -173.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.38 132.22 43.65 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.577 -0.898 . . . . 1.8400000000000001 108.577 171.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -64.81 114.44 4.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.581 0.705 . . . . 1.0 110.766 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.482 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 61.5 m -88.19 97.82 11.22 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.56 -1.2 . . . . 0.35999999999999999 109.999 -177.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.504 HD13 ' HA3' ' A' ' 45' ' ' GLY . 26.9 mm -81.58 122.03 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.666 -0.697 . . . . 0.73999999999999999 110.07 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.76 -171.0 47.76 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.073 -0.584 . . . . 0.23000000000000001 112.428 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.597 ' O ' ' HG2' ' A' ' 64' ' ' MET . 33.0 mt-10 -81.91 146.38 55.68 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 110.023 -0.362 . . . . 1.3700000000000001 110.023 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 27.7 Cg_exo -62.8 109.62 0.94 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.487 2.125 . . . . 0.51000000000000001 110.907 171.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.597 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 89.6 mmm -115.4 149.1 42.27 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.208 -0.451 . . . . 0.67000000000000004 110.081 -172.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.2 12.33 2.34 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.594 2.196 . . . . 0.32000000000000001 113.535 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.445 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 30.0 t -154.99 142.2 19.41 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.658 -0.497 . . . . 1.3 109.658 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.6 m -68.2 -27.95 39.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.619 -0.718 . . . . 1.1399999999999999 111.946 -173.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -64.6 -50.53 66.84 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.245 0.545 . . . . 2.8199999999999998 110.851 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.445 ' HG2' ' HB3' ' A' ' 66' ' ' SER . 15.4 ptpt -79.66 -17.54 53.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.455 -0.793 . . . . 1.3600000000000001 110.708 -174.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.11 -54.28 47.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.20999999999999999 109.823 172.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.669 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 54.5 mtmt -56.05 -52.0 65.82 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.015 -0.539 . . . . 2.4199999999999999 111.018 176.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.602 ' O ' HG23 ' A' ' 76' ' ' VAL . 4.6 m-20 -53.74 -46.72 70.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.561 . . . . 2.0099999999999998 112.308 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 t -58.24 -46.01 86.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 1.1399999999999999 110.981 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.536 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -69.01 -43.42 74.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.986 -0.552 . . . . 0.17999999999999999 110.491 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.464 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -54.49 -36.93 64.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.465 -0.789 . . . . 0.26000000000000001 111.4 176.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 72' ' ' ASP . 91.0 t -63.06 -37.96 80.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 121.119 0.485 . . . . 0.82999999999999996 110.293 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.8 mt -77.85 -24.25 48.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.865 0.84 . . . . 0.39000000000000001 109.533 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.719 HD11 HG23 ' A' ' 48' ' ' VAL . 16.7 tp -69.15 -37.94 78.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.134 -0.939 . . . . 0.81000000000000005 110.468 171.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.3 mm? -65.14 -28.78 69.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.755 -0.657 . . . . 1.6100000000000001 112.146 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -77.27 -31.61 55.02 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.887 -0.725 . . . . 2.1299999999999999 110.085 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.05 -47.69 85.21 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.708 -0.849 . . . . 1.1699999999999999 108.708 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mp -71.77 -4.38 27.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.12 -0.945 . . . . 1.1499999999999999 112.036 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 121.601 0.715 . . . . 1.46 109.686 179.155 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.5 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.861 0.362 . . . . 0.80000000000000004 111.007 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.464 ' SG ' ' HE3' ' A' ' 23' ' ' TRP . 36.2 t -71.61 -39.06 70.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.754 0.787 . . . . 1.3500000000000001 109.157 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 tt -64.47 -46.26 83.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.552 -1.204 . . . . 1.1599999999999999 110.079 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -61.63 -31.5 71.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.025 -0.534 . . . . 3.8399999999999999 111.412 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt -73.12 -3.88 29.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.329 0.585 . . . . 1.1000000000000001 111.447 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.0 t30 64.51 30.77 12.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.511 -1.222 . . . . 1.9199999999999999 110.173 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.464 ' HE3' ' SG ' ' A' ' 18' ' ' CYS . 33.6 m0 -89.6 165.56 24.83 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.367 -0.833 . . . . 0.40000000000000002 109.088 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 36.9 Cg_endo -69.44 -176.6 1.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 121.973 1.782 . . . . 0.44 111.186 170.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.405 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 21.4 mmt -74.77 137.52 73.57 Favored Pre-proline 0 C--N 1.323 -0.566 0 O-C-N 122.257 -0.277 . . . . 1.0 110.366 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.479 ' HB3' HG22 ' A' ' 48' ' ' VAL . 9.5 Cg_exo -70.04 161.69 45.04 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.812 2.342 . . . . 0.46000000000000002 112.457 -177.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.5 t -88.12 138.03 31.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.411 -0.813 . . . . 0.29999999999999999 110.191 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.529 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 63.3 m-85 -143.78 111.28 5.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.651 -0.5 . . . . 0.29999999999999999 109.651 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.48 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 79.3 ttt180 -164.17 131.61 3.32 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.977 -0.379 . . . . 3.6899999999999999 109.977 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 8.8 p -64.53 130.6 44.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.054 0.454 . . . . 1.53 111.326 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.5 t -86.32 -28.45 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.666 -0.697 . . . . 1.1499999999999999 109.9 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.3 tttp . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 109.169 -0.678 . . . . 2.25 109.169 176.589 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 . . . . . 0 N--CA 1.444 -0.75 0 N-CA-C 107.948 -1.13 . . . . 3.6400000000000001 107.948 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 8.2 m-85 -109.05 133.84 52.46 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.823 -0.626 . . . . 0.79000000000000004 110.438 -169.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.1 m -119.8 116.33 25.66 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.851 -1.166 . . . . 0.26000000000000001 107.851 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.71 ' CE2' ' HA ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -126.93 153.1 46.25 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.898 -0.408 . . . . 0.17000000000000001 109.898 -170.06 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -126.87 140.38 11.89 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.574 -0.61 . . . . 0.17000000000000001 111.574 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.75 HG11 HD22 ' A' ' 78' ' ' LEU . 1.7 t -105.66 156.1 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.636 -0.505 . . . . 0.80000000000000004 109.636 -175.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.729 ' HD2' ' O ' ' A' ' 56' ' ' THR . 0.4 OUTLIER -142.24 145.87 34.55 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.478 -0.934 . . . . 2.6200000000000001 108.478 177.591 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.652 HG23 HD11 ' A' ' 78' ' ' LEU . 38.8 t -132.08 150.71 33.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.544 -0.298 . . . . 0.23999999999999999 110.293 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -94.61 83.66 4.14 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.825 0.821 . . . . 1.5900000000000001 109.528 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.418 HG22 ' CH2' ' A' ' 23' ' ' TRP . 23.0 p -75.0 101.23 4.4 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.192 -1.367 . . . . 0.33000000000000002 109.21 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t -43.76 -35.24 1.8 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.84 0.856 . . . . 1.3200000000000001 113.173 -170.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.86 -33.36 72.95 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.598 0.592 . . . . 1.3 112.598 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -131.12 -38.6 1.22 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.806 0.336 . . . . 3.6800000000000002 111.875 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.24 -151.96 16.88 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 116.253 -0.431 . . . . 0.19 112.272 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -52.91 126.24 19.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.172 0.51 . . . . 0.39000000000000001 110.858 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.729 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 37.4 p -74.2 -174.71 2.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.351 -0.84 . . . . 0.35999999999999999 112.372 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -76.62 169.92 17.39 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.82 -1.178 . . . . 1.8400000000000001 107.82 165.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -92.34 119.78 32.23 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.222 0.534 . . . . 1.0 111.372 -171.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.462 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 28.6 m -85.46 97.61 10.13 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.104 -0.953 . . . . 0.35999999999999999 109.293 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.411 HD13 ' HA3' ' A' ' 45' ' ' GLY . 26.4 mm -86.92 121.16 37.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.196 -0.456 . . . . 0.73999999999999999 110.613 -177.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.64 -174.47 49.94 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.835 -0.698 . . . . 0.23000000000000001 111.519 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.657 ' O ' ' HG2' ' A' ' 64' ' ' MET . 42.8 mm-40 -85.89 148.41 48.21 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.687 0.244 . . . . 1.3700000000000001 110.452 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 40.7 Cg_exo -57.26 109.14 0.42 Allowed 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.571 2.18 . . . . 0.51000000000000001 111.186 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.657 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.0 mmm -117.32 149.97 45.55 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.692 -0.484 . . . . 0.67000000000000004 109.692 -172.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -80.77 15.01 1.9 Allowed 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.539 2.16 . . . . 0.32000000000000001 114.817 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.1 t -163.8 145.87 9.35 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.96 -0.463 . . . . 1.3 110.402 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.4 t -59.18 -50.98 77.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.315 0.487 . . . . 1.1399999999999999 112.315 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -55.57 -43.81 76.27 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.202 0.445 . . . . 2.8199999999999998 112.202 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.88 -21.89 40.26 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.991 -0.284 . . . . 1.3600000000000001 110.607 -178.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.91 -56.15 19.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.756 -0.202 . . . . 0.20999999999999999 111.039 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.71 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 32.3 pttt -56.6 -42.04 78.04 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 120.917 0.389 . . . . 2.4199999999999999 110.129 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.505 ' O ' HG23 ' A' ' 76' ' ' VAL . 31.3 t70 -54.17 -47.7 71.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.544 -0.753 . . . . 2.0099999999999998 112.068 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.4 t -60.09 -45.84 91.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.34 . . . . 1.1399999999999999 111.457 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.451 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -69.87 -40.6 75.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.039 0.447 . . . . 0.17999999999999999 110.925 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.431 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -52.52 -33.97 47.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.505 -0.771 . . . . 0.26000000000000001 111.307 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 72' ' ' ASP . 96.9 t -61.24 -37.41 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.967 0.413 . . . . 0.82999999999999996 110.739 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.1 mt -77.29 -33.09 55.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.75 0.785 . . . . 0.39000000000000001 109.597 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.75 HD22 HG11 ' A' ' 46' ' ' VAL . 15.3 tp -65.5 -40.83 93.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.716 -1.129 . . . . 0.81000000000000005 110.58 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.431 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.2 mp -61.57 -26.14 67.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.435 -0.802 . . . . 1.6100000000000001 111.045 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.82 -35.55 62.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.239 0.543 . . . . 2.1299999999999999 110.076 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.41 -46.17 77.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.35 -0.841 . . . . 1.1699999999999999 109.329 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mp -70.45 -9.8 57.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.295 -0.866 . . . . 1.1499999999999999 111.971 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 121.679 0.752 . . . . 1.46 109.456 174.864 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.464 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.7 mp . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 121.041 0.448 . . . . 0.80000000000000004 110.52 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.433 ' SG ' HG13 ' A' ' 48' ' ' VAL . 47.3 t -69.54 -40.52 76.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.631 0.729 . . . . 1.3500000000000001 109.512 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.1 tp -63.73 -49.53 72.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.867 -1.061 . . . . 1.1599999999999999 110.661 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -61.0 -36.63 79.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.383 -0.826 . . . . 3.8399999999999999 111.745 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -73.29 8.75 1.55 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 1.1000000000000001 111.985 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.3 t30 60.21 34.67 21.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.261 -0.881 . . . . 1.9199999999999999 110.065 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.627 ' HD1' ' HG ' ' A' ' 51' ' ' SER . 41.6 m0 -97.12 163.34 20.17 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 114.93 -1.032 . . . . 0.40000000000000002 108.818 174.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 44.3 Cg_endo -70.0 -168.33 0.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.029 1.819 . . . . 0.44 111.497 173.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.7 mmt -80.18 136.26 53.7 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.97 -0.381 . . . . 1.0 109.97 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HB3' HG22 ' A' ' 48' ' ' VAL . 6.4 Cg_exo -71.42 162.8 41.18 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.597 2.198 . . . . 0.46000000000000002 112.24 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.7 t -87.36 140.14 29.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.568 -0.742 . . . . 0.29999999999999999 109.759 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.562 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 66.4 m-85 -140.8 109.82 6.13 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.265 -1.013 . . . . 0.29999999999999999 108.265 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.584 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 33.8 ptt180 -145.24 130.71 18.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.891 0.377 . . . . 3.6899999999999999 110.524 -173.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.9 t -65.76 119.84 11.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.201 -0.454 . . . . 1.53 110.529 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.3 t -86.73 -42.93 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.975 -0.557 . . . . 1.1499999999999999 110.737 -177.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.0 tttm . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 120.751 0.31 . . . . 2.25 110.664 179.267 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 107.799 -1.186 . . . . 3.6400000000000001 107.799 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -109.0 141.2 41.45 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.966 0.413 . . . . 0.79000000000000004 110.57 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.4 m -129.93 124.77 33.89 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.551 -0.75 . . . . 0.26000000000000001 109.172 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.691 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -132.96 156.89 46.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.652 -0.499 . . . . 0.17000000000000001 109.652 -173.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -130.12 142.06 13.29 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.912 -0.661 . . . . 0.17000000000000001 112.015 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.691 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.5 t -105.36 156.29 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 117.027 0.413 . . . . 0.80000000000000004 110.286 -174.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.519 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -137.01 142.04 42.51 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.928 -1.138 . . . . 2.6200000000000001 107.928 178.717 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.474 HG23 HD11 ' A' ' 78' ' ' LEU . 39.6 t -132.68 149.96 32.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 110.609 -0.145 . . . . 0.23999999999999999 110.609 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -99.86 88.43 3.78 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.632 0.73 . . . . 1.5900000000000001 110.889 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.5 p -68.52 113.33 5.96 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.38 -1.282 . . . . 0.33000000000000002 109.634 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.627 ' HG ' ' HD1' ' A' ' 23' ' ' TRP . 52.3 m -49.22 -25.99 2.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.311 -0.858 . . . . 1.3200000000000001 113.265 -176.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -93.45 -16.78 24.18 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.527 0.566 . . . . 1.3 112.527 -176.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -134.9 -46.72 0.73 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.035 0.445 . . . . 3.6800000000000002 111.315 -172.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.12 -156.59 19.08 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.8 -0.636 . . . . 0.19 112.698 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.519 ' CZ3' ' HB3' ' A' ' 47' ' ' ARG . 20.4 m95 -52.77 121.75 7.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.149 0.5 . . . . 0.39000000000000001 111.312 176.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 42.3 p -73.42 177.41 5.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.478 -0.783 . . . . 0.35999999999999999 111.912 -175.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -66.88 133.07 49.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.076 -0.713 . . . . 1.8400000000000001 109.076 172.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.477 ' HB2' ' NH1' ' A' ' 47' ' ' ARG . 26.0 tt0 -65.39 110.75 2.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.24 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.494 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 62.0 m -84.89 97.65 9.88 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.567 -1.197 . . . . 0.35999999999999999 109.913 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.478 HD13 ' HA3' ' A' ' 45' ' ' GLY . 32.1 mm -76.96 124.13 34.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.428 -0.805 . . . . 0.73999999999999999 110.599 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.75 -170.28 46.87 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.922 -0.581 . . . . 0.23000000000000001 112.657 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.621 ' O ' ' HG2' ' A' ' 64' ' ' MET . 36.6 mt-10 -83.93 151.34 60.55 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-O 120.603 0.239 . . . . 1.3700000000000001 110.995 -175.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.71 99.22 0.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.754 2.303 . . . . 0.51000000000000001 110.961 170.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.621 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 92.4 mmm -113.59 138.64 22.68 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.514 -0.312 . . . . 0.67000000000000004 110.561 -170.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.79 7.35 2.82 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.669 2.246 . . . . 0.32000000000000001 113.422 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.4 t -144.85 136.79 25.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.113 -0.699 . . . . 1.3 109.113 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.23 -28.11 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.897 -0.592 . . . . 1.1399999999999999 111.726 -175.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -67.99 -43.21 79.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.11 -0.495 . . . . 2.8199999999999998 110.481 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 43.5 mtpt -74.21 -26.29 60.17 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.077 -0.511 . . . . 1.3600000000000001 109.745 -176.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.73 -58.98 6.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.875 -0.602 . . . . 0.20999999999999999 110.581 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.669 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 66.3 mttm -54.1 -51.72 63.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.391 -0.368 . . . . 2.4199999999999999 111.07 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.56 ' O ' HG23 ' A' ' 76' ' ' VAL . 18.3 m-20 -53.45 -49.04 68.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.828 -0.624 . . . . 2.0099999999999998 112.672 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.5 p -64.13 -38.68 91.93 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.922 -0.311 . . . . 1.1399999999999999 111.253 -175.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.422 ' HB1' HG23 ' A' ' 46' ' ' VAL . . . -67.83 -46.18 72.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.31 0.576 . . . . 0.17999999999999999 110.301 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.493 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -53.31 -36.4 61.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.9 -1.046 . . . . 0.26000000000000001 111.628 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 72' ' ' ASP . 96.1 t -63.83 -36.95 78.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.946 0.403 . . . . 0.82999999999999996 110.763 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.7 mt -77.92 -28.9 49.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.738 0.78 . . . . 0.39000000000000001 109.833 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.583 HD22 HG11 ' A' ' 46' ' ' VAL . 19.3 tp -66.54 -45.1 80.53 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.954 -1.021 . . . . 0.81000000000000005 110.589 173.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.493 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.0 mp -62.96 -30.75 71.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.441 -0.799 . . . . 1.6100000000000001 112.358 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -78.87 -30.84 45.29 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.013 -0.675 . . . . 2.1299999999999999 110.389 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.7 tt -65.19 -45.0 86.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.673 -0.862 . . . . 1.1699999999999999 108.673 174.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mp -65.53 -20.65 66.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.928 -1.033 . . . . 1.1499999999999999 111.878 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.46 0 CA-C-O 121.778 0.799 . . . . 1.46 109.172 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.4 mp . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.869 0.366 . . . . 0.80000000000000004 110.593 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.0 t -71.86 -42.23 67.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.925 -0.579 . . . . 1.3500000000000001 109.955 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.9 tp -61.92 -48.73 79.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.282 -0.872 . . . . 1.1599999999999999 110.443 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -56.61 -37.36 70.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.954 -1.021 . . . . 3.8399999999999999 111.854 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -73.45 0.37 12.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.291 -0.413 . . . . 1.1000000000000001 111.426 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.5 t30 70.99 20.26 5.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.206 -0.906 . . . . 1.9199999999999999 110.172 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -86.81 158.57 53.42 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.433 -0.803 . . . . 0.40000000000000002 109.723 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.94 -168.82 0.25 Allowed 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 122.425 2.084 . . . . 0.44 111.449 174.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 7.2 mmt -83.6 134.93 44.0 Favored Pre-proline 0 C--N 1.322 -0.624 0 O-C-N 122.032 -0.417 . . . . 1.0 109.91 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.479 ' HB3' HG22 ' A' ' 48' ' ' VAL . 15.8 Cg_exo -67.14 166.99 21.26 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.807 2.338 . . . . 0.46000000000000002 113.133 -177.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.523 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 33.0 t -84.74 144.01 28.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.998 -1.001 . . . . 0.29999999999999999 109.898 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.494 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 72.4 m-85 -142.96 110.78 5.91 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.826 -0.805 . . . . 0.29999999999999999 108.826 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.499 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 45.6 ttm105 -156.64 124.14 5.4 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.522 -0.547 . . . . 3.6899999999999999 109.522 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -69.23 128.0 35.08 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.062 -0.517 . . . . 1.53 110.184 -176.559 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.85 -33.92 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.287 0.565 . . . . 1.1499999999999999 109.625 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.6 tttm . . . . . 0 C--N 1.32 -0.715 0 CA-C-N 115.418 -0.81 . . . . 2.25 109.605 171.361 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 . . . . . 0 CA--C 1.514 -0.405 0 N-CA-C 107.77 -1.196 . . . . 3.6400000000000001 107.77 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 7.5 m-85 -111.14 130.82 55.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.112 0.482 . . . . 0.79000000000000004 110.028 -173.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.4 m -118.47 127.59 53.8 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.874 -1.158 . . . . 0.26000000000000001 107.874 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.7 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -138.5 150.58 46.55 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.317 -0.623 . . . . 0.17000000000000001 109.317 -174.14 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.31 141.08 12.26 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.915 -0.66 . . . . 0.17000000000000001 112.313 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.7 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -107.37 156.05 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.628 -0.508 . . . . 0.80000000000000004 109.628 -176.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.632 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 16.7 ptp180 -145.67 147.82 32.39 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.806 -0.813 . . . . 2.6200000000000001 108.806 173.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.637 HG23 HD11 ' A' ' 78' ' ' LEU . 94.2 t -124.79 152.26 30.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 123.086 0.241 . . . . 0.23999999999999999 110.64 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -95.14 85.25 4.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.708 0.766 . . . . 1.5900000000000001 110.146 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.1 p -67.26 112.9 4.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.346 -1.297 . . . . 0.33000000000000002 109.365 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -52.48 -26.46 12.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.659 -0.7 . . . . 1.3200000000000001 112.215 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -94.85 -16.42 22.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.506 0.558 . . . . 1.3 112.506 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -132.63 -46.55 0.88 Allowed 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.934 -0.479 . . . . 3.6800000000000002 111.493 -175.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.13 -158.07 20.9 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.13 -0.557 . . . . 0.19 113.142 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.632 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.1 m95 -52.48 118.53 3.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.863 0.364 . . . . 0.39000000000000001 110.719 175.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.4 p -71.75 161.35 31.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.786 -0.643 . . . . 0.35999999999999999 111.005 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -61.66 125.77 24.98 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.131 -0.692 . . . . 1.8400000000000001 109.131 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.417 ' HG2' HD12 ' A' ' 60' ' ' ILE . 33.5 tt0 -59.49 124.81 21.28 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.246 -0.888 . . . . 1.0 111.245 -173.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 52.7 m -96.75 99.09 10.7 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.73 -1.123 . . . . 0.35999999999999999 110.361 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.417 HD12 ' HG2' ' A' ' 58' ' ' GLU . 1.7 mp -76.57 126.93 37.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.918 -0.583 . . . . 0.73999999999999999 110.37 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.57 -166.82 41.88 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.436 -0.802 . . . . 0.23000000000000001 112.634 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 46.9 mt-10 -91.24 135.94 27.7 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 110.096 -0.335 . . . . 1.3700000000000001 110.096 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 50.4 Cg_exo -54.8 115.23 2.27 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.101 2.534 . . . . 0.51000000000000001 112.174 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 14.7 mmt -112.93 152.22 44.71 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.766 -0.652 . . . . 0.67000000000000004 111.236 -172.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -85.25 9.88 3.95 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.666 2.244 . . . . 0.32000000000000001 112.911 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -155.63 138.63 15.44 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.477 -0.564 . . . . 1.3 109.477 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.06 -27.88 42.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.588 -0.733 . . . . 1.1399999999999999 112.748 -170.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -72.17 -42.3 66.07 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.822 -0.351 . . . . 2.8199999999999998 111.045 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -80.74 -18.01 49.16 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.914 -0.315 . . . . 1.3600000000000001 110.316 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.39 -59.22 5.47 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.337 -0.392 . . . . 0.20999999999999999 110.391 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.628 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 8.9 mtmp? -51.85 -47.1 64.58 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 116.303 -0.408 . . . . 2.4199999999999999 111.16 175.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.545 ' O ' HG23 ' A' ' 76' ' ' VAL . 15.0 m-20 -50.86 -51.56 50.13 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.404 0.44 . . . . 2.0099999999999998 112.074 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.9 t -60.66 -43.75 97.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.638 0.256 . . . . 1.1399999999999999 111.249 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.64 -43.0 77.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.074 0.464 . . . . 0.17999999999999999 110.53 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.471 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -54.24 -38.19 65.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.338 -0.846 . . . . 0.26000000000000001 111.454 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 72' ' ' ASP . 99.0 t -65.37 -36.53 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-O 120.815 0.34 . . . . 0.82999999999999996 110.757 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.7 mt -73.95 -34.43 64.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.784 0.802 . . . . 0.39000000000000001 109.208 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.637 HD11 HG23 ' A' ' 48' ' ' VAL . 28.5 tp -65.51 -43.05 91.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.401 -1.272 . . . . 0.81000000000000005 110.887 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.2 mp -62.57 -24.94 67.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.704 -0.68 . . . . 1.6100000000000001 111.134 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 76' ' ' VAL . 39.5 mt-10 -74.01 -39.52 63.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.159 0.504 . . . . 2.1299999999999999 109.68 175.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.99 -51.7 65.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.331 -0.85 . . . . 1.1699999999999999 110.324 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.534 HD11 HG21 ' A' ' 48' ' ' VAL . 34.6 mt -65.76 -18.1 65.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.578 -1.192 . . . . 1.1499999999999999 111.594 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 . . . . . 0 C--N 1.321 -0.663 0 CA-C-O 122.04 0.924 . . . . 1.46 109.352 176.896 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.8 mp . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.909 0.385 . . . . 0.80000000000000004 110.807 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.62 ' SG ' ' HG3' ' A' ' 26' ' ' PRO . 42.8 t -60.21 -38.78 84.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.572 0.701 . . . . 1.3500000000000001 109.985 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.5 tp -63.78 -43.99 94.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.767 -1.106 . . . . 1.1599999999999999 110.355 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -66.9 -33.12 74.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.652 -1.158 . . . . 3.8399999999999999 111.529 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 28.9 mmmt -73.95 6.54 3.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 1.1000000000000001 111.469 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.0 t30 61.9 28.75 17.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.132 -0.94 . . . . 1.9199999999999999 110.522 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.488 ' CH2' HG22 ' A' ' 50' ' ' THR . 37.1 m0 -91.03 162.92 31.37 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.487 -0.779 . . . . 0.40000000000000002 109.051 174.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HG3' HD22 ' A' ' 49' ' ' ASN . 33.9 Cg_endo -67.45 -170.31 0.25 Allowed 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 121.984 1.79 . . . . 0.44 111.535 173.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.44 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 1.6 mmt -81.8 130.98 58.73 Favored Pre-proline 0 C--N 1.321 -0.643 0 O-C-N 122.036 -0.415 . . . . 1.0 110.281 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.62 ' HG3' ' SG ' ' A' ' 18' ' ' CYS . 11.0 Cg_exo -68.46 168.01 20.87 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.632 2.221 . . . . 0.46000000000000002 112.192 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.8 t -88.82 137.56 32.21 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.543 -0.753 . . . . 0.29999999999999999 110.052 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.49 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 84.9 m-85 -146.46 109.35 4.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.632 -0.507 . . . . 0.29999999999999999 109.632 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.436 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 78.9 ttt180 -160.07 130.17 5.41 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 110.066 -0.346 . . . . 3.6899999999999999 110.066 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.431 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 63.5 m -61.78 126.42 27.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.076 0.465 . . . . 1.53 110.809 -178.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.22 -39.58 12.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.804 -0.634 . . . . 1.1499999999999999 111.326 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 32.3 mmtt . . . . . 0 C--N 1.323 -0.574 0 CA-C-O 121.022 0.439 . . . . 2.25 111.884 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 121.515 0.674 . . . . 3.6400000000000001 109.624 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -109.54 139.88 44.0 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.96 -1.018 . . . . 0.79000000000000004 109.448 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 32' ' ' LYS . 32.9 m -123.66 123.77 41.29 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.462 -0.94 . . . . 0.26000000000000001 108.462 -175.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.662 ' CZ ' ' HB ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -125.82 152.27 45.67 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.609 -0.515 . . . . 0.17000000000000001 109.609 -173.728 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.22 126.94 5.92 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.455 -0.658 . . . . 0.17000000000000001 111.455 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.662 ' HB ' ' CZ ' ' A' ' 44' ' ' PHE . 7.4 p -109.27 149.26 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 110.002 -0.37 . . . . 0.80000000000000004 110.002 -176.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.559 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 11.2 ptt180 -145.14 150.48 36.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.017 -0.735 . . . . 2.6200000000000001 109.017 176.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 26' ' ' PRO . 67.4 t -125.99 155.45 35.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.022 -0.535 . . . . 0.23999999999999999 111.005 -176.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.403 HD22 ' HG3' ' A' ' 24' ' ' PRO . 54.9 t30 -95.6 83.78 3.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.758 0.789 . . . . 1.5900000000000001 110.061 178.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.488 HG22 ' CH2' ' A' ' 23' ' ' TRP . 24.9 p -69.56 112.24 5.93 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.163 -1.38 . . . . 0.33000000000000002 109.446 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.5 t -50.74 -23.61 2.82 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.961 0.726 . . . . 1.3200000000000001 112.961 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -77.89 -29.54 50.29 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.129 0.789 . . . . 1.3 113.129 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -138.11 -36.62 0.59 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.599 -0.441 . . . . 3.6800000000000002 111.977 -173.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.6 -147.86 17.29 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.904 -0.665 . . . . 0.19 112.663 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.559 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.3 m95 -49.8 119.93 3.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.315 0.579 . . . . 0.39000000000000001 111.891 177.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -73.91 167.12 22.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.248 -0.887 . . . . 0.35999999999999999 110.721 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -63.06 128.57 36.47 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.259 -0.645 . . . . 1.8400000000000001 109.259 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.39 114.44 3.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.566 0.698 . . . . 1.0 110.511 -176.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.1 m -90.93 102.63 15.4 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.707 -1.133 . . . . 0.35999999999999999 110.328 -175.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.08 122.25 26.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.649 -0.705 . . . . 0.73999999999999999 110.228 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -78.36 -173.14 41.61 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.687 -0.688 . . . . 0.23000000000000001 112.566 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 64' ' ' MET . 50.6 mt-10 -86.15 137.6 35.01 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 110.289 -0.263 . . . . 1.3700000000000001 110.289 -177.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.07 104.92 0.13 Allowed 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 123.071 2.514 . . . . 0.51000000000000001 111.566 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.651 ' SD ' ' HE2' ' A' ' 69' ' ' LYS . 16.5 mmt -113.15 147.36 37.15 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.578 -0.737 . . . . 0.67000000000000004 111.133 -172.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.71 13.21 2.17 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.717 2.278 . . . . 0.32000000000000001 113.241 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.8 t -155.61 138.91 15.71 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.451 -0.574 . . . . 1.3 109.451 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.06 -23.23 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.146 -0.479 . . . . 1.1399999999999999 112.244 -172.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -71.45 -45.33 62.88 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.748 0.309 . . . . 2.8199999999999998 110.786 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.651 ' HE2' ' SD ' ' A' ' 64' ' ' MET . 19.0 ptmt -81.79 -16.94 49.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.367 -0.379 . . . . 1.3600000000000001 110.377 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.78 -56.0 27.1 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.018 -0.537 . . . . 0.20999999999999999 109.868 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.603 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 56.6 mtpt -49.91 -51.59 39.59 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 115.995 -0.548 . . . . 2.4199999999999999 111.543 174.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.575 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.7 m-20 -51.96 -47.48 64.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.765 0.654 . . . . 2.0099999999999998 112.765 -177.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 83.9 p -62.78 -39.14 93.29 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.69 -0.404 . . . . 1.1399999999999999 111.251 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.6 -38.97 70.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.304 0.573 . . . . 0.17999999999999999 110.025 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.57 -30.75 69.98 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.389 -0.823 . . . . 0.26000000000000001 111.54 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 72' ' ' ASP . 96.1 t -70.35 -32.59 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.191 0.52 . . . . 0.82999999999999996 110.31 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.6 mt -73.86 -27.48 61.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.042 0.925 . . . . 0.39000000000000001 109.218 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.511 HD11 HG23 ' A' ' 48' ' ' VAL . 12.3 tp -65.72 -33.58 76.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.679 -1.146 . . . . 0.81000000000000005 109.931 173.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 76' ' ' VAL . 3.1 mm? -60.72 -38.67 85.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.909 -0.587 . . . . 1.6100000000000001 111.961 177.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -81.0 -33.42 33.69 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.489 -0.484 . . . . 2.1299999999999999 110.245 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.31 -53.32 59.08 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.294 -0.632 . . . . 1.1699999999999999 109.294 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.34 -3.24 5.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.981 -1.009 . . . . 1.1499999999999999 112.204 174.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.547 0 N-CA-C 108.641 -0.874 . . . . 1.46 108.641 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.472 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 C--O 1.231 0.12 0 CA-C-O 121.006 0.431 . . . . 0.80000000000000004 110.315 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.44 ' SG ' ' HE3' ' A' ' 23' ' ' TRP . 19.6 t -64.96 -42.02 94.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.59 -0.732 . . . . 1.3500000000000001 109.568 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.9 tp -60.85 -48.18 82.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.86 -1.064 . . . . 1.1599999999999999 110.53 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.44 -36.12 75.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.001 -0.999 . . . . 3.8399999999999999 110.981 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 30.2 mmmt -74.0 2.8 7.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.869 -0.605 . . . . 1.1000000000000001 111.574 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 71.77 20.68 4.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.065 0.936 . . . . 1.9199999999999999 109.71 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.44 ' HE3' ' SG ' ' A' ' 18' ' ' CYS . 35.3 m0 -91.93 155.35 43.32 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.403 -0.817 . . . . 0.40000000000000002 109.437 175.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 49' ' ' ASN . 45.9 Cg_exo -63.56 -173.73 0.19 Allowed 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.808 2.338 . . . . 0.44 111.795 168.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.492 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 21.7 mmt -81.99 131.46 56.77 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.308 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.569 ' HB3' HG22 ' A' ' 48' ' ' VAL . 22.3 Cg_exo -62.98 160.26 34.59 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.715 2.277 . . . . 0.46000000000000002 112.822 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.46 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 13.6 t -84.79 142.01 30.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.21 -0.905 . . . . 0.29999999999999999 109.791 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.485 ' CD2' ' CZ ' ' A' ' 44' ' ' PHE . 71.2 m-85 -139.54 110.96 7.05 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.81 -0.811 . . . . 0.29999999999999999 108.81 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.526 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 43.3 ttt180 -145.5 122.86 11.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.521 0.201 . . . . 3.6899999999999999 110.525 -174.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.5 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 76.5 m -63.57 120.81 12.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.766 0.317 . . . . 1.53 110.569 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.8 m -86.05 -38.54 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.314 -0.403 . . . . 1.1499999999999999 111.105 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.0 tttt . . . . . 0 C--N 1.322 -0.619 0 CA-C-O 120.865 0.364 . . . . 2.25 110.882 -179.78 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 108.997 -0.742 . . . . 3.6400000000000001 108.997 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 14.4 m-85 -110.05 143.88 39.44 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.307 -0.861 . . . . 0.79000000000000004 110.879 -171.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.7 m -129.05 137.51 51.33 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.302 -0.863 . . . . 0.26000000000000001 109.025 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.721 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -141.16 153.64 45.46 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.283 -0.636 . . . . 0.17000000000000001 109.283 -176.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -125.09 139.28 11.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 0.17000000000000001 111.914 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.721 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.1 t -106.8 154.02 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 117.096 0.448 . . . . 0.80000000000000004 109.895 -174.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.565 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 18.0 ptp180 -145.06 144.05 30.77 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.481 -0.933 . . . . 2.6200000000000001 108.481 172.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.668 HG23 HD11 ' A' ' 78' ' ' LEU . 97.3 t -122.64 152.81 27.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.392 -0.367 . . . . 0.23999999999999999 110.664 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.405 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 23.4 t-20 -92.37 83.46 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.542 0.687 . . . . 1.5900000000000001 109.953 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.2 p -74.52 109.77 8.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.792 -1.095 . . . . 0.33000000000000002 109.527 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.2 t -49.21 -27.85 4.02 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.93 0.715 . . . . 1.3200000000000001 112.93 -172.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -84.44 -21.21 30.8 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.299 0.481 . . . . 1.3 112.299 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.09 -44.85 1.03 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.167 0.508 . . . . 3.6800000000000002 111.073 -173.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.46 -152.04 16.87 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.762 -0.654 . . . . 0.19 111.834 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.565 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 5.5 m95 -53.78 119.98 5.67 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.171 0.51 . . . . 0.39000000000000001 110.638 173.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.9 p -69.2 170.44 10.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.58 -0.737 . . . . 0.35999999999999999 111.521 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -63.68 125.68 25.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.453 -0.943 . . . . 1.8400000000000001 108.453 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 38.2 tt0 -61.58 118.38 6.97 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.621 0.724 . . . . 1.0 110.666 -175.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.562 ' SG ' HD12 ' A' ' 81' ' ' LEU . 57.2 m -91.94 98.18 11.42 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.785 -1.098 . . . . 0.35999999999999999 110.499 -175.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.433 HD12 ' HG2' ' A' ' 58' ' ' GLU . 1.7 mp -74.63 124.34 32.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.945 -0.57 . . . . 0.73999999999999999 110.313 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.72 -167.65 43.72 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.1 -0.955 . . . . 0.23000000000000001 112.848 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 64' ' ' MET . 40.9 mt-10 -89.74 148.62 40.38 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-O 120.545 0.212 . . . . 1.3700000000000001 111.013 -174.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 62' ' ' GLU . 38.3 Cg_exo -60.57 106.7 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.814 2.342 . . . . 0.51000000000000001 111.396 172.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.558 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.4 mmm -115.08 143.49 30.31 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.077 -0.51 . . . . 0.67000000000000004 110.409 -173.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.32 3.89 5.38 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.737 2.291 . . . . 0.32000000000000001 113.312 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.9 t -143.65 140.06 29.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.498 -0.556 . . . . 1.3 109.498 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.6 m -64.62 -32.93 59.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.772 -0.649 . . . . 1.1399999999999999 111.482 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -64.07 -42.13 97.1 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 120.927 0.394 . . . . 2.8199999999999998 110.559 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.421 ' HE2' ' CE ' ' A' ' 64' ' ' MET . 43.4 mtpt -74.6 -25.16 59.08 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.99 -0.55 . . . . 1.3600000000000001 110.091 -177.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.52 -59.81 4.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.792 -0.64 . . . . 0.20999999999999999 110.696 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.707 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 52.8 pttt -61.92 -43.03 99.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.726 -0.215 . . . . 2.4199999999999999 110.91 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.526 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.9 m-20 -52.35 -50.8 61.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.879 0.696 . . . . 2.0099999999999998 112.879 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.3 p -66.54 -39.45 88.56 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.882 0.327 . . . . 1.1399999999999999 111.882 -175.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.481 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -68.18 -42.29 80.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.262 0.553 . . . . 0.17999999999999999 110.464 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.472 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -53.72 -36.05 61.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.222 -0.899 . . . . 0.26000000000000001 111.275 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 72' ' ' ASP . 94.9 t -62.36 -37.13 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.009 0.433 . . . . 0.82999999999999996 110.595 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.0 mt -75.11 -32.94 61.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.611 0.719 . . . . 0.39000000000000001 109.543 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.668 HD11 HG23 ' A' ' 48' ' ' VAL . 19.1 tp -64.59 -39.21 93.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.825 -1.08 . . . . 0.81000000000000005 110.905 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.7 mm? -59.52 -28.24 66.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.578 -0.737 . . . . 1.6100000000000001 111.039 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -72.76 -35.4 67.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.081 0.467 . . . . 2.1299999999999999 110.695 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.562 HD12 ' SG ' ' A' ' 59' ' ' CYS . 1.3 tt -62.96 -49.57 74.22 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.968 -0.753 . . . . 1.1699999999999999 108.968 175.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 mp -70.16 -2.77 14.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.198 -0.91 . . . . 1.1499999999999999 111.655 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 . . . . . 0 C--N 1.322 -0.6 0 CA-C-O 121.481 0.658 . . . . 1.46 109.478 178.296 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.3 mp . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 121.042 0.449 . . . . 0.80000000000000004 110.325 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.4 m -68.56 -44.64 74.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.906 0.86 . . . . 1.3500000000000001 110.003 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 tt -62.43 -45.69 91.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.228 -1.351 . . . . 1.1599999999999999 110.483 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.42 ' NH2' HG23 ' A' ' 17' ' ' ILE . 51.8 ttp85 -60.37 -38.2 83.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.578 -0.737 . . . . 3.8399999999999999 111.644 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 28.2 mmmt -72.93 0.39 11.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.549 -0.751 . . . . 1.1000000000000001 112.082 -176.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 62.87 51.05 3.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.092 0.948 . . . . 1.9199999999999999 110.011 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.416 ' CZ3' ' HG ' ' A' ' 82' ' ' LEU . 39.6 m0 -113.26 166.11 11.85 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.183 -0.917 . . . . 0.40000000000000002 109.223 175.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.62 162.04 33.35 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.957 1.771 . . . . 0.44 109.407 167.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 65.2 mmm -74.75 127.96 86.22 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 110.212 -0.292 . . . . 1.0 110.212 -173.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.518 ' HB3' HG22 ' A' ' 48' ' ' VAL . 1.2 Cg_endo -50.99 163.63 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 124.01 3.14 . . . . 0.46000000000000002 114.887 -173.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.476 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 25.3 t -81.02 144.25 31.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.338 -1.301 . . . . 0.29999999999999999 109.232 175.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.475 ' HD2' ' CZ ' ' A' ' 44' ' ' PHE . 72.6 m-85 -140.52 111.76 7.2 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.844 -0.798 . . . . 0.29999999999999999 108.844 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.46 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 36.4 ttm180 -151.92 124.07 8.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.042 -0.355 . . . . 3.6899999999999999 110.042 -176.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.461 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 83.8 m -66.84 124.92 24.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.953 0.406 . . . . 1.53 110.435 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -85.2 -35.81 10.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.835 -0.62 . . . . 1.1499999999999999 110.829 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.6 tptt . . . . . 0 C--N 1.318 -0.768 0 CA-C-N 115.985 -0.552 . . . . 2.25 110.277 178.081 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 108.535 -0.913 . . . . 3.6400000000000001 108.535 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 8.0 m-85 -112.84 132.09 55.43 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.63 -0.714 . . . . 0.79000000000000004 110.158 -174.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.0 m -119.85 130.01 54.68 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.064 -1.087 . . . . 0.26000000000000001 108.064 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.697 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -137.81 152.66 49.35 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.526 -0.546 . . . . 0.17000000000000001 109.526 -175.049 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.417 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -128.82 138.74 10.49 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.037 -0.602 . . . . 0.17000000000000001 111.901 177.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.697 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -105.93 157.71 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 109.503 -0.554 . . . . 0.80000000000000004 109.503 -176.691 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.58 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 24.2 ptt180 -146.72 141.81 27.16 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.983 -1.118 . . . . 2.6200000000000001 107.983 173.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.518 HG22 ' HB3' ' A' ' 26' ' ' PRO . 39.8 t -118.62 155.47 20.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.523 -0.308 . . . . 0.23999999999999999 110.374 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -96.05 84.04 3.75 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.635 0.731 . . . . 1.5900000000000001 109.635 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.539 ' OG1' ' HB2' ' A' ' 53' ' ' ARG . 37.7 p -68.29 113.33 5.8 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.298 -1.319 . . . . 0.33000000000000002 109.223 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.0 t -52.48 -27.29 15.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.776 -0.647 . . . . 1.3200000000000001 112.664 -171.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -100.54 -4.69 28.14 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.416 0.525 . . . . 1.3 112.416 -176.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.539 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 68.6 mtt180 -130.44 -52.25 1.09 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.232 0.539 . . . . 3.6800000000000002 110.897 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.73 -152.86 17.21 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.326 -0.852 . . . . 0.19 112.397 -175.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.58 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.4 m95 -55.79 120.28 7.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.067 0.461 . . . . 0.39000000000000001 111.23 176.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.9 p -71.73 161.54 30.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.742 -0.663 . . . . 0.35999999999999999 110.837 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.96 132.15 51.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.271 -0.641 . . . . 1.8400000000000001 109.271 174.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -56.57 116.94 3.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.58 -0.737 . . . . 1.0 110.937 -175.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.41 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 35.1 m -93.19 97.89 10.94 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.908 -1.042 . . . . 0.35999999999999999 110.114 -177.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.417 HD13 ' HA3' ' A' ' 45' ' ' GLY . 29.3 mm -75.62 123.77 32.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.572 -0.74 . . . . 0.73999999999999999 110.619 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.36 -167.01 42.77 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.867 -0.606 . . . . 0.23000000000000001 112.073 177.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -88.44 137.2 30.76 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 110.236 -0.283 . . . . 1.3700000000000001 110.236 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 50.2 Cg_exo -53.79 116.35 2.95 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.843 2.362 . . . . 0.51000000000000001 111.602 176.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.663 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 18.6 mmt -115.37 153.01 47.53 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.113 -0.494 . . . . 0.67000000000000004 111.082 -173.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -82.23 9.79 3.83 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.897 2.398 . . . . 0.32000000000000001 113.135 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.9 t -155.78 139.38 15.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.2 -0.667 . . . . 1.3 109.2 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.65 -22.86 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 1.1399999999999999 111.901 -173.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -75.24 -42.93 54.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.901 0.381 . . . . 2.8199999999999998 110.597 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.663 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 0.2 OUTLIER -82.31 -17.36 46.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.188 -0.46 . . . . 1.3600000000000001 110.384 178.711 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.76 -57.55 12.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.252 -0.431 . . . . 0.20999999999999999 110.425 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.644 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 61.2 mttm -52.66 -49.34 65.41 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.072 -0.513 . . . . 2.4199999999999999 110.433 174.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.518 ' O ' HG23 ' A' ' 76' ' ' VAL . 25.9 t70 -49.34 -49.87 42.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.933 -1.031 . . . . 2.0099999999999998 112.3 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.0 t -58.42 -48.53 80.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.788 0.328 . . . . 1.1399999999999999 111.453 -178.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.43 ' HB1' HG23 ' A' ' 46' ' ' VAL . . . -67.35 -37.51 83.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.28 0.562 . . . . 0.17999999999999999 110.777 -176.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.409 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -60.38 -30.74 69.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.475 -0.784 . . . . 0.26000000000000001 111.646 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 72' ' ' ASP . 73.9 t -63.72 -37.81 80.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 121.09 0.472 . . . . 0.82999999999999996 110.248 176.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.92 -28.73 58.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.841 -0.618 . . . . 0.39000000000000001 109.796 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 78' ' ' LEU . 4.0 mt -60.1 -44.32 94.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.341 -0.845 . . . . 0.81000000000000005 110.553 173.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.409 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.6 mp -61.47 -28.42 69.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.518 -0.764 . . . . 1.6100000000000001 111.777 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -71.95 -44.54 63.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.859 0.361 . . . . 2.1299999999999999 110.46 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.2 tt -61.39 -48.94 78.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.608 0.718 . . . . 1.1699999999999999 109.23 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.416 ' HG ' ' CZ3' ' A' ' 23' ' ' TRP . 1.6 mp -65.02 -20.12 66.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.792 -1.094 . . . . 1.1499999999999999 112.414 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.2 t30 . . . . . 0 C--N 1.323 -0.57 0 CA-C-O 121.691 0.757 . . . . 1.46 109.528 179.698 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.477 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 CA--C 1.522 -0.111 0 CA-C-O 121.016 0.436 . . . . 0.80000000000000004 110.119 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.415 ' SG ' ' HG3' ' A' ' 26' ' ' PRO . 84.0 m -65.54 -43.99 88.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.654 -0.703 . . . . 1.3500000000000001 110.007 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.5 tp -60.02 -52.1 66.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.249 -0.887 . . . . 1.1599999999999999 110.081 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -55.81 -41.6 74.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.908 -1.042 . . . . 3.8399999999999999 111.451 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -75.06 0.87 14.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.867 -0.606 . . . . 1.1000000000000001 112.096 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.8 t30 68.11 25.43 7.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.905 0.859 . . . . 1.9199999999999999 110.007 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -91.52 161.36 34.58 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.314 -0.857 . . . . 0.40000000000000002 109.79 176.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -74.08 178.82 6.41 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 122.149 1.899 . . . . 0.44 110.763 168.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.448 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 23.9 mmt -80.05 139.94 53.39 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.01 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.489 ' HB3' HG22 ' A' ' 48' ' ' VAL . 12.1 Cg_exo -67.17 159.01 54.13 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.507 2.138 . . . . 0.46000000000000002 112.578 -174.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.5 t -82.12 143.89 31.15 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.314 -0.857 . . . . 0.29999999999999999 109.392 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.555 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 64.7 m-85 -136.71 110.19 7.96 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.474 -0.935 . . . . 0.29999999999999999 108.474 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.535 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 67.6 mtp180 -143.0 122.33 13.06 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.658 -0.247 . . . . 3.6899999999999999 110.638 -173.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 35.5 t -71.4 120.49 17.06 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.979 -0.378 . . . . 1.53 109.979 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -86.55 -35.68 9.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.234 -0.439 . . . . 1.1499999999999999 111.384 -176.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.1 tptt . . . . . 0 C--N 1.32 -0.685 0 CA-C-O 121.287 0.565 . . . . 2.25 111.13 179.787 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 107.772 -1.195 . . . . 3.6400000000000001 107.772 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -110.35 136.57 49.32 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.119 0.485 . . . . 0.79000000000000004 110.365 -168.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 m -126.4 133.49 51.27 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.335 -0.848 . . . . 0.26000000000000001 109.056 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.735 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -140.37 152.89 46.13 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.305 -0.628 . . . . 0.17000000000000001 109.305 -174.55 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -126.24 139.89 11.7 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.801 -0.714 . . . . 0.17000000000000001 112.287 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.735 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -107.75 156.14 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.908 -0.405 . . . . 0.80000000000000004 109.908 -176.482 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.514 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 11.7 ptp180 -146.45 148.86 32.69 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.526 -0.916 . . . . 2.6200000000000001 108.526 172.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.628 HG23 HD11 ' A' ' 78' ' ' LEU . 98.0 t -123.75 152.4 29.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 O-C-N 123.157 0.286 . . . . 0.23999999999999999 110.616 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -94.62 88.82 5.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.765 0.793 . . . . 1.5900000000000001 110.243 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.568 ' OG1' ' HB3' ' A' ' 53' ' ' ARG . 37.7 p -71.65 113.3 8.54 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.422 -1.263 . . . . 0.33000000000000002 109.585 177.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.9 t -52.09 -25.23 8.28 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.925 0.713 . . . . 1.3200000000000001 112.925 -172.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -113.32 12.12 18.78 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.599 -0.44 . . . . 1.3 112.012 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.568 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 41.5 ttm180 -146.56 -50.27 0.21 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.946 0.403 . . . . 3.6800000000000002 110.886 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.77 -162.47 19.0 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 116.156 -0.474 . . . . 0.19 113.03 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.514 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 15.3 m95 -52.57 117.97 3.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.111 0.481 . . . . 0.39000000000000001 110.765 174.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.0 p -70.83 178.89 2.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.36 -0.836 . . . . 0.35999999999999999 112.063 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -63.73 134.83 56.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.517 -0.765 . . . . 1.8400000000000001 109.697 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.65 113.53 4.31 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.399 0.619 . . . . 1.0 110.166 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.495 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 63.7 m -88.75 97.4 11.12 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.966 -1.016 . . . . 0.35999999999999999 109.849 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.426 HD13 ' HA3' ' A' ' 45' ' ' GLY . 26.3 mm -81.66 122.92 37.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.451 -0.795 . . . . 0.73999999999999999 110.068 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.26 -171.97 48.15 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.953 -0.641 . . . . 0.23000000000000001 112.037 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.608 ' O ' ' HG2' ' A' ' 64' ' ' MET . 40.1 mt-10 -86.35 151.08 53.12 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.972 -0.381 . . . . 1.3700000000000001 109.972 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.68 112.6 1.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.379 2.053 . . . . 0.51000000000000001 110.83 172.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.608 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 97.1 mmm -115.51 142.44 28.82 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.384 -0.371 . . . . 0.67000000000000004 110.35 -173.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.99 14.32 1.54 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.66 2.24 . . . . 0.32000000000000001 113.713 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.465 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 30.0 t -157.57 143.2 17.29 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.646 -0.502 . . . . 1.3 109.646 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.1 m -71.44 -22.31 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.892 -0.595 . . . . 1.1399999999999999 111.675 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -73.56 -47.31 41.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.119 -0.492 . . . . 2.8199999999999998 110.419 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 66' ' ' SER . 15.5 ptpt -81.15 -16.86 51.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.863 -0.608 . . . . 1.3600000000000001 110.768 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.1 -56.21 24.95 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.316 -0.402 . . . . 0.20999999999999999 110.47 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.645 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 55.5 mttp -54.19 -47.18 72.35 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.186 -0.461 . . . . 2.4199999999999999 110.837 176.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.575 ' O ' HG23 ' A' ' 76' ' ' VAL . 19.6 m-20 -52.09 -49.45 63.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.017 -0.538 . . . . 2.0099999999999998 111.85 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.7 t -59.95 -46.64 88.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.595 0.236 . . . . 1.1399999999999999 111.538 -175.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.473 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -66.38 -42.04 88.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.189 0.519 . . . . 0.17999999999999999 110.554 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.422 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -53.33 -38.26 63.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.209 -0.905 . . . . 0.26000000000000001 111.516 177.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 72' ' ' ASP . 57.6 t -63.02 -36.68 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.897 0.38 . . . . 0.82999999999999996 110.743 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 85.3 mt -74.66 -32.88 62.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.765 0.793 . . . . 0.39000000000000001 109.44 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.628 HD11 HG23 ' A' ' 48' ' ' VAL . 42.9 tp -65.42 -39.38 92.07 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.557 -1.201 . . . . 0.81000000000000005 110.781 176.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.3 mp -58.94 -29.86 67.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.745 -0.662 . . . . 1.6100000000000001 111.045 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -69.84 -38.6 76.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.08 0.467 . . . . 2.1299999999999999 110.422 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.467 HD12 ' SG ' ' A' ' 59' ' ' CYS . 1.4 tt -63.85 -52.56 59.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.543 -0.753 . . . . 1.1699999999999999 109.607 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.2 mp -67.26 -10.32 49.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.402 -0.817 . . . . 1.1499999999999999 112.219 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.4 t30 . . . . . 0 C--N 1.32 -0.681 0 CA-C-O 121.498 0.666 . . . . 1.46 109.87 179.136 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.7 mp . . . . . 0 CA--C 1.52 -0.176 0 CA-C-O 121.403 0.621 . . . . 0.80000000000000004 109.813 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.0 m -55.32 -40.18 70.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.577 -1.192 . . . . 1.3500000000000001 110.786 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.1 tp -61.78 -53.52 54.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.039 -0.982 . . . . 1.1599999999999999 110.584 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -61.61 -28.9 69.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.303 -0.862 . . . . 3.8399999999999999 111.242 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 29.6 mmmt -73.75 2.51 8.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.958 -0.564 . . . . 1.1000000000000001 112.338 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.9 t30 63.9 37.59 9.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.278 -0.874 . . . . 1.9199999999999999 110.056 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.581 ' CH2' HG22 ' A' ' 50' ' ' THR . 34.9 m0 -103.63 160.18 26.93 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.421 -0.809 . . . . 0.40000000000000002 109.657 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.33 177.98 3.44 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.256 1.971 . . . . 0.44 111.265 171.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.433 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 24.4 mmt -71.83 127.29 90.95 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 120.824 0.345 . . . . 1.0 110.721 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 23.7 Cg_exo -62.19 159.43 34.97 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.749 2.299 . . . . 0.46000000000000002 111.928 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.531 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 10.5 t -88.61 140.3 29.59 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.696 -0.684 . . . . 0.29999999999999999 109.721 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.49 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 74.1 m-85 -137.15 110.77 8.05 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.247 -1.02 . . . . 0.29999999999999999 108.247 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.564 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 37.8 ttm180 -136.17 117.9 15.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.473 0.178 . . . . 3.6899999999999999 110.79 -172.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.473 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 73.0 m -62.01 116.93 5.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.889 0.376 . . . . 1.53 110.29 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.6 t -87.36 -41.92 14.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.929 -0.578 . . . . 1.1499999999999999 110.809 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 27.0 tptp . . . . . 0 C--N 1.325 -0.492 0 CA-C-O 121.068 0.461 . . . . 2.25 111.208 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' A' ' 63' ' ' PRO . 9.5 ptm180 . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.511 0.672 . . . . 3.6400000000000001 111.012 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -109.85 131.77 54.76 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.015 -0.993 . . . . 0.79000000000000004 109.197 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 32' ' ' LYS . 27.6 m -130.49 125.15 33.64 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.705 -0.68 . . . . 0.26000000000000001 109.169 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.763 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -139.13 153.86 48.04 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.655 -0.498 . . . . 0.17000000000000001 109.655 -175.038 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 60' ' ' ILE . . . -127.99 138.93 10.73 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.99 -0.624 . . . . 0.17000000000000001 112.2 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.763 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -107.01 158.46 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 110.166 -0.309 . . . . 0.80000000000000004 110.166 -174.672 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.564 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 19.7 ptt180 -148.3 146.99 28.81 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.835 -0.802 . . . . 2.6200000000000001 108.835 173.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.614 HG23 HD11 ' A' ' 78' ' ' LEU . 28.6 t -124.3 156.75 32.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.565 0.221 . . . . 0.23999999999999999 110.889 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.413 ' N ' HG12 ' A' ' 48' ' ' VAL . 5.9 t30 -94.61 83.89 4.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.397 0.618 . . . . 1.5900000000000001 110.031 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.581 HG22 ' CH2' ' A' ' 23' ' ' TRP . 34.4 p -78.1 105.73 9.51 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.932 -1.031 . . . . 0.33000000000000002 109.71 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.2 m -43.98 -33.06 1.3 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.069 -0.969 . . . . 1.3200000000000001 113.042 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.432 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 4.6 p-10 -63.02 -40.17 96.95 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.758 0.651 . . . . 1.3 112.758 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -129.01 -37.56 1.7 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.993 0.425 . . . . 3.6800000000000002 111.653 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.76 -148.24 16.74 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.93 -0.577 . . . . 0.19 112.364 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.564 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.9 m95 -51.24 119.19 3.81 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.17 0.509 . . . . 0.39000000000000001 111.342 175.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.3 p -69.48 167.55 16.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.559 -0.746 . . . . 0.35999999999999999 110.735 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.85 132.84 49.63 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.829 -0.804 . . . . 1.8400000000000001 108.829 174.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 40.9 tt0 -65.76 115.75 6.23 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.912 -1.04 . . . . 1.0 110.706 -174.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.8 m -96.14 105.3 17.33 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.63 -1.168 . . . . 0.35999999999999999 110.65 -174.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.522 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 1.8 mp -88.03 132.13 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.305 0.574 . . . . 0.73999999999999999 111.305 -177.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.54 -176.62 51.05 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 114.909 -1.041 . . . . 0.23000000000000001 111.809 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 64' ' ' MET . 13.0 pt-20 -92.07 158.06 40.04 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.816 0.308 . . . . 1.3700000000000001 110.673 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.429 ' HB3' ' HB2' ' A' ' 41' ' ' ARG . 72.0 Cg_exo -50.45 105.21 0.1 OUTLIER 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.398 2.732 . . . . 0.51000000000000001 112.683 174.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.0 mmm -108.74 145.27 31.29 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 110.152 -0.314 . . . . 0.67000000000000004 110.152 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.85 13.13 2.22 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.703 2.269 . . . . 0.32000000000000001 113.75 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.4 t -154.05 142.11 20.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.498 -0.927 . . . . 1.3 108.498 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.0 p -71.74 -22.01 21.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.149 -0.478 . . . . 1.1399999999999999 110.529 -174.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -73.13 -39.4 65.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.021 -0.536 . . . . 2.8199999999999998 109.616 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HE3' ' CE ' ' A' ' 64' ' ' MET . 27.5 mtpp -75.34 -23.39 57.22 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.975 -0.557 . . . . 1.3600000000000001 109.943 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.08 -53.41 58.55 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.579 -0.737 . . . . 0.20999999999999999 109.93 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.641 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 66.4 mttm -52.49 -54.58 30.57 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 115.611 -0.722 . . . . 2.4199999999999999 111.067 176.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.525 ' O ' HG23 ' A' ' 76' ' ' VAL . 33.4 m-20 -55.22 -44.78 75.74 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.945 -0.571 . . . . 2.0099999999999998 112.452 -177.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.495 ' OG ' ' HG2' ' A' ' 62' ' ' GLU . 44.3 t -59.25 -46.29 88.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 1.1399999999999999 111.113 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.443 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -68.44 -38.7 81.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.185 0.517 . . . . 0.17999999999999999 110.15 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.44 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -56.44 -37.35 70.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.261 -0.881 . . . . 0.26000000000000001 111.514 177.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 72' ' ' ASP . 94.7 t -63.24 -38.08 81.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.981 0.42 . . . . 0.82999999999999996 110.679 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.7 mt -77.82 -23.35 49.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.885 0.85 . . . . 0.39000000000000001 109.334 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.739 HD13 ' HB ' ' A' ' 46' ' ' VAL . 16.4 tp -70.34 -49.01 53.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.716 -1.129 . . . . 0.81000000000000005 110.403 173.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 75' ' ' ALA . 6.2 mp -53.67 -34.12 57.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.581 -0.736 . . . . 1.6100000000000001 112.248 -177.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -78.86 -34.02 45.33 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.373 -0.531 . . . . 2.1299999999999999 110.855 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.87 -51.68 60.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.883 0.373 . . . . 1.1699999999999999 110.086 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.459 HD21 HG21 ' A' ' 48' ' ' VAL . 1.9 mm? -71.43 -7.46 47.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 1.1499999999999999 111.37 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 C--N 1.319 -0.719 0 CA-C-O 121.442 0.639 . . . . 1.46 109.841 175.531 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.442 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 N--CA 1.46 0.031 0 CA-C-O 120.875 0.369 . . . . 0.80000000000000004 110.688 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.411 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 41.5 t -63.89 -45.33 89.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.367 0.603 . . . . 1.3500000000000001 110.273 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.19 -44.1 97.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.109 -0.95 . . . . 1.1599999999999999 110.838 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -65.13 -33.75 76.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.971 -1.013 . . . . 3.8399999999999999 111.12 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 4.6 mmmp? -74.18 2.69 8.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.123 -0.49 . . . . 1.1000000000000001 111.574 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 67.39 30.2 7.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.935 0.874 . . . . 1.9199999999999999 109.991 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.411 ' CE3' ' HA ' ' A' ' 18' ' ' CYS . 27.7 m0 -93.54 160.24 33.35 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.406 -0.815 . . . . 0.40000000000000002 109.073 174.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.6 -173.29 0.67 Allowed 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.183 1.922 . . . . 0.44 111.087 172.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.459 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.9 mmt -75.64 145.67 79.08 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.677 -0.49 . . . . 1.0 109.677 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.501 ' HB3' HG22 ' A' ' 48' ' ' VAL . 2.7 Cg_exo -74.89 165.96 30.29 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.495 2.13 . . . . 0.46000000000000002 112.421 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.407 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 26.3 t -84.73 144.4 28.54 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.161 -0.927 . . . . 0.29999999999999999 109.912 178.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.523 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 69.0 m-85 -143.95 109.93 5.34 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.361 -0.607 . . . . 0.29999999999999999 109.361 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.513 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 14.0 ptm180 -152.52 128.92 10.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.949 0.404 . . . . 3.6899999999999999 110.874 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 77.3 m -65.89 124.87 23.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.865 -0.607 . . . . 1.53 111.286 -176.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -84.82 -37.67 12.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.808 -0.633 . . . . 1.1499999999999999 110.286 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 121.173 0.511 . . . . 2.25 111.178 -179.318 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.064 -0.717 . . . . 3.6400000000000001 109.064 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 7.0 m-85 -109.56 149.1 30.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.532 -0.758 . . . . 0.79000000000000004 110.877 -172.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.5 m -129.76 129.6 44.32 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.142 -0.935 . . . . 0.26000000000000001 109.289 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.735 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -137.13 153.65 50.46 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.069 -0.715 . . . . 0.17000000000000001 109.069 -174.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -126.66 138.73 10.82 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.757 -0.735 . . . . 0.17000000000000001 112.317 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.735 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -107.15 158.6 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 109.309 -0.626 . . . . 0.80000000000000004 109.309 -177.124 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.571 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 11.8 ptp180 -148.49 148.96 30.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.05 -0.722 . . . . 2.6200000000000001 109.05 173.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.6 HG23 HD11 ' A' ' 78' ' ' LEU . 73.9 t -125.06 153.7 32.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 123.309 0.381 . . . . 0.23999999999999999 110.627 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -92.52 85.31 5.28 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.562 0.696 . . . . 1.5900000000000001 110.576 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 54' ' ' GLY . 38.2 p -73.32 112.37 9.32 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.933 -1.031 . . . . 0.33000000000000002 109.716 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 t -49.84 -28.4 6.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.68 -0.691 . . . . 1.3200000000000001 112.151 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -82.24 -22.78 35.69 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.154 0.798 . . . . 1.3 113.154 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -134.47 -43.66 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.905 -0.497 . . . . 3.6800000000000002 111.609 -173.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 122.77 -152.57 16.88 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 116.093 -0.503 . . . . 0.19 111.896 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.571 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.9 m95 -53.01 120.79 6.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.99 0.424 . . . . 0.39000000000000001 110.686 174.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.2 p -71.05 160.96 31.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.679 -0.691 . . . . 0.35999999999999999 111.0 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -60.64 128.34 36.1 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.221 -0.659 . . . . 1.8400000000000001 109.221 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -54.71 123.58 13.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.931 -1.032 . . . . 1.0 111.026 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.44 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 57.8 m -95.77 97.8 9.96 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.356 -0.838 . . . . 0.35999999999999999 110.124 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.12 126.23 38.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.556 -0.747 . . . . 0.73999999999999999 110.887 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.5 -177.89 51.87 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.238 -0.892 . . . . 0.23000000000000001 112.896 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -85.14 147.08 46.76 Favored Pre-proline 0 C--N 1.317 -0.826 0 N-CA-C 109.966 -0.383 . . . . 1.3700000000000001 109.966 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 52.1 Cg_exo -55.05 105.79 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.643 2.228 . . . . 0.51000000000000001 111.45 175.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.641 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 16.3 mmt -113.27 139.84 23.62 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.152 -0.477 . . . . 0.67000000000000004 111.192 -173.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.74 10.14 2.39 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.662 2.242 . . . . 0.32000000000000001 113.323 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.8 t -152.54 137.88 17.55 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.144 -0.687 . . . . 1.3 109.144 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -68.06 -23.21 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 1.1399999999999999 111.688 -173.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -74.1 -44.99 51.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.904 0.383 . . . . 2.8199999999999998 110.423 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.641 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 0.2 OUTLIER -81.04 -17.76 49.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 1.3600000000000001 109.973 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.87 -56.65 19.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.847 -0.615 . . . . 0.20999999999999999 110.092 173.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.646 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 58.1 mtpt -50.92 -48.16 60.76 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 116.261 -0.427 . . . . 2.4199999999999999 110.753 174.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.534 ' O ' HG23 ' A' ' 76' ' ' VAL . 36.8 m-20 -52.46 -51.72 57.89 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.389 0.514 . . . . 2.0099999999999998 112.389 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.2 p -60.9 -40.23 92.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.707 0.289 . . . . 1.1399999999999999 111.456 -175.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.432 ' HB1' HG23 ' A' ' 46' ' ' VAL . . . -69.38 -44.97 70.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.144 0.497 . . . . 0.17999999999999999 110.376 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.509 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -55.99 -35.99 67.4 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.306 -0.861 . . . . 0.26000000000000001 111.754 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 72' ' ' ASP . 91.8 t -64.92 -38.23 82.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.978 0.418 . . . . 0.82999999999999996 110.7 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.6 mt -76.42 -26.43 55.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.916 0.865 . . . . 0.39000000000000001 109.271 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.6 HD11 HG23 ' A' ' 48' ' ' VAL . 16.0 tp -70.98 -54.5 11.04 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.553 -1.203 . . . . 0.81000000000000005 111.256 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 75' ' ' ALA . 4.2 mp -55.32 -29.24 57.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.914 -0.584 . . . . 1.6100000000000001 112.546 -174.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.86 -33.8 60.02 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.276 -0.57 . . . . 2.1299999999999999 110.598 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.1 -50.54 63.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.108 -0.496 . . . . 1.1699999999999999 110.091 -177.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.509 ' CD2' ' HG ' ' A' ' 78' ' ' LEU . 1.4 mm? -67.04 -29.45 69.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 1.1499999999999999 111.124 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.6 t30 . . . . . 0 C--N 1.32 -0.704 0 N-CA-C 109.329 -0.619 . . . . 1.46 109.329 -179.943 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.442 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.4 mp . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 121.353 0.597 . . . . 0.80000000000000004 110.457 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 23' ' ' TRP . 22.4 t -75.18 -38.49 60.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.397 -0.82 . . . . 1.3500000000000001 109.708 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.7 tp -60.1 -53.08 62.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.139 -0.937 . . . . 1.1599999999999999 110.606 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -56.53 -37.94 71.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.064 -0.971 . . . . 3.8399999999999999 111.71 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.8 mmtm -73.96 5.63 4.06 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.993 -0.549 . . . . 1.1000000000000001 111.918 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 66.48 27.22 9.83 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.597 -0.728 . . . . 1.9199999999999999 110.937 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.558 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.0 m0 -101.0 154.11 37.34 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.557 -0.747 . . . . 0.40000000000000002 109.011 175.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.91 173.65 14.14 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.232 1.955 . . . . 0.44 110.631 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.424 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 31.6 mmt -62.26 127.4 89.62 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.791 0.329 . . . . 1.0 110.921 -177.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.531 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 70.1 Cg_exo -54.89 165.01 2.9 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.567 2.845 . . . . 0.46000000000000002 113.678 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.515 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 25.1 t -89.58 142.39 27.72 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.987 -1.006 . . . . 0.29999999999999999 109.388 177.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.531 ' CE1' ' HB2' ' A' ' 26' ' ' PRO . 95.9 m-85 -140.75 108.72 5.71 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.277 -1.008 . . . . 0.29999999999999999 108.277 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.552 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 48.7 mmt-85 -147.83 118.5 7.52 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.324 -0.621 . . . . 3.6899999999999999 109.324 -173.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.549 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 15.5 p -69.47 129.09 38.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.041 0.448 . . . . 1.53 110.953 -177.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.1 m -85.79 -32.81 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.82 -0.627 . . . . 1.1499999999999999 111.15 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.0 tttm . . . . . 0 C--N 1.319 -0.718 0 CA-C-N 116.081 -0.509 . . . . 2.25 110.226 177.199 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 . . . . . 0 N--CA 1.448 -0.553 0 CA-C-O 121.181 0.515 . . . . 3.6400000000000001 109.66 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.629 ' CZ ' HG22 ' A' ' 67' ' ' VAL . 71.2 m-85 -111.54 131.43 55.25 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.469 -0.787 . . . . 0.79000000000000004 110.191 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 m -120.24 121.68 39.23 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.466 -1.309 . . . . 0.26000000000000001 107.466 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.69 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -136.85 151.28 48.94 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.631 -0.507 . . . . 0.17000000000000001 109.631 -170.158 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.558 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -123.69 137.96 11.19 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.204 -0.522 . . . . 0.17000000000000001 111.932 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.69 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -106.75 155.57 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 109.731 -0.47 . . . . 0.80000000000000004 109.731 -174.636 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.62 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 8.3 ptp85 -147.95 142.31 26.3 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.626 -0.879 . . . . 2.6200000000000001 108.626 176.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.628 HG23 HD11 ' A' ' 78' ' ' LEU . 95.4 t -124.65 153.24 31.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.342 -0.39 . . . . 0.23999999999999999 110.381 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -92.01 82.8 5.1 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.723 0.773 . . . . 1.5900000000000001 110.203 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 35.3 p -67.94 116.82 9.02 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.438 -1.256 . . . . 0.33000000000000002 110.143 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.8 p -51.95 -26.53 10.67 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.462 -1.244 . . . . 1.3200000000000001 113.013 -176.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -89.11 -17.42 29.27 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.032 0.753 . . . . 1.3 113.032 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -139.16 -44.72 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.488 0.585 . . . . 3.6800000000000002 112.408 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.66 -150.61 17.14 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.919 -0.658 . . . . 0.19 112.337 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.62 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.9 m95 -53.66 118.17 3.71 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.034 0.445 . . . . 0.39000000000000001 110.771 176.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.3 p -65.63 165.06 13.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.56 -0.745 . . . . 0.35999999999999999 111.37 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -61.46 135.27 57.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.046 -0.724 . . . . 1.8400000000000001 109.046 172.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.94 113.27 2.0 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.889 -175.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 60.1 m -91.39 97.32 11.02 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.089 -0.959 . . . . 0.35999999999999999 109.831 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.558 HD13 ' HA3' ' A' ' 45' ' ' GLY . 13.2 mm -81.84 126.01 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 115.832 -0.622 . . . . 0.73999999999999999 110.251 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.82 -170.84 47.07 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.913 -0.66 . . . . 0.23000000000000001 111.96 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.6 ' O ' ' HG2' ' A' ' 64' ' ' MET . 38.7 mt-10 -88.54 145.07 34.62 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.214 -0.662 . . . . 1.3700000000000001 109.214 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -55.83 110.44 0.56 Allowed 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.587 2.191 . . . . 0.51000000000000001 111.758 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.6 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.8 mmm -112.2 140.59 23.75 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.633 -0.506 . . . . 0.67000000000000004 109.633 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.61 18.51 0.96 Allowed 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.637 2.225 . . . . 0.32000000000000001 113.667 -175.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.419 ' HB2' ' CD ' ' A' ' 69' ' ' LYS . 28.7 m -157.56 139.09 13.83 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.227 -0.657 . . . . 1.3 109.227 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.629 HG22 ' CZ ' ' A' ' 42' ' ' PHE . 1.1 t -67.35 -38.67 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.335 -0.848 . . . . 1.1399999999999999 112.259 -167.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -71.21 -39.71 71.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.463 -0.335 . . . . 2.8199999999999998 111.118 -175.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.419 ' CD ' ' HB2' ' A' ' 66' ' ' SER . 17.3 ptmt -80.92 -18.52 46.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.888 0.375 . . . . 1.3600000000000001 110.182 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.62 -55.9 25.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.20999999999999999 110.645 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.642 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 5.6 ptpp? -58.54 -43.18 89.19 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 116.592 -0.276 . . . . 2.4199999999999999 110.767 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.576 ' O ' HG23 ' A' ' 76' ' ' VAL . 5.7 m-20 -54.92 -47.08 74.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 2.0099999999999998 111.973 176.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.2 t -58.65 -46.36 87.32 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.851 0.358 . . . . 1.1399999999999999 111.321 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.436 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -68.85 -42.81 76.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.022 0.439 . . . . 0.17999999999999999 110.589 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.48 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -56.12 -34.19 65.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.447 -0.797 . . . . 0.26000000000000001 111.517 177.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 72' ' ' ASP . 94.2 t -63.51 -36.57 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.916 0.389 . . . . 0.82999999999999996 110.61 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.98 -34.04 64.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.712 0.767 . . . . 0.39000000000000001 109.271 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.663 HD22 HG11 ' A' ' 46' ' ' VAL . 26.3 tp -64.82 -42.56 94.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.602 -1.181 . . . . 0.81000000000000005 110.797 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.3 mp -60.33 -26.96 66.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.03 -0.532 . . . . 1.6100000000000001 111.215 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -71.37 -40.0 70.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.227 0.537 . . . . 2.1299999999999999 110.274 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.8 tp -65.55 -46.55 79.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.359 -0.837 . . . . 1.1699999999999999 110.077 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.554 HD11 HG21 ' A' ' 48' ' ' VAL . 42.2 mt -70.09 -12.89 61.93 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.514 -1.221 . . . . 1.1499999999999999 111.19 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 . . . . . 0 C--N 1.317 -0.828 0 CA-C-O 121.588 0.709 . . . . 1.46 109.554 176.694 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.5 mp . . . . . 0 C--O 1.232 0.164 0 CA-C-O 121.006 0.431 . . . . 0.80000000000000004 110.734 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 23' ' ' TRP . 41.2 t -72.29 -39.81 68.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.274 0.559 . . . . 1.3500000000000001 109.971 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.0 tp -61.08 -51.54 68.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.305 -0.861 . . . . 1.1599999999999999 110.153 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -54.98 -36.53 65.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.218 -0.901 . . . . 3.8399999999999999 111.489 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -72.52 1.84 7.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.906 -0.588 . . . . 1.1000000000000001 111.971 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 64.96 26.08 12.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.35 -0.841 . . . . 1.9199999999999999 111.361 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.445 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 34.0 m0 -96.62 154.29 38.52 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.695 -0.483 . . . . 0.40000000000000002 109.695 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.414 ' HG2' ' HB3' ' A' ' 49' ' ' ASN . 63.2 Cg_endo -71.87 169.71 20.58 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.519 2.146 . . . . 0.44 110.811 173.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.8 mmt -63.03 130.22 93.97 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.691 -0.231 . . . . 1.0 111.106 -175.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.415 ' HB3' HG22 ' A' ' 48' ' ' VAL . 15.2 Cg_exo -67.31 165.78 25.71 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.881 2.387 . . . . 0.46000000000000002 112.865 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.431 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 16.8 t -87.97 141.34 28.65 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.045 -0.98 . . . . 0.29999999999999999 109.995 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.507 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 75.6 m-85 -138.92 110.63 7.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.768 -0.827 . . . . 0.29999999999999999 108.768 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.501 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 78.0 mtp180 -148.29 123.93 10.47 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 110.165 -0.309 . . . . 3.6899999999999999 110.165 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.531 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 71.2 m -61.12 121.08 11.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.997 0.427 . . . . 1.53 110.648 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.2 t -82.34 -38.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.787 -0.642 . . . . 1.1499999999999999 110.046 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--N 1.324 -0.54 0 N-CA-C 109.297 -0.631 . . . . 2.25 109.297 176.795 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 107.102 -1.444 . . . . 3.6400000000000001 107.102 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -108.92 131.2 55.26 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.285 0.564 . . . . 0.79000000000000004 109.743 -172.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.6 m -120.01 118.0 29.5 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.886 -1.153 . . . . 0.26000000000000001 107.886 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.711 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -129.74 153.56 48.07 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.329 -0.619 . . . . 0.17000000000000001 109.329 -172.266 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.555 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -127.79 137.76 10.01 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.514 -0.634 . . . . 0.17000000000000001 111.514 178.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.711 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -105.99 155.0 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 N-CA-C 109.406 -0.59 . . . . 0.80000000000000004 109.406 -177.462 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.56 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 12.4 ptp180 -143.68 141.27 30.46 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 107.784 -1.191 . . . . 2.6200000000000001 107.784 173.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.415 HG22 ' HB3' ' A' ' 26' ' ' PRO . 39.1 t -117.19 152.4 19.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.304 -0.407 . . . . 0.23999999999999999 110.11 -178.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.414 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 58.3 t30 -94.95 83.62 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.049 0.928 . . . . 1.5900000000000001 109.853 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.8 p -70.48 116.05 10.37 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.775 -1.557 . . . . 0.33000000000000002 109.488 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.4 t -52.49 -28.2 19.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.924 -0.58 . . . . 1.3200000000000001 110.254 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -63.36 -56.27 17.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.402 -0.817 . . . . 1.3 112.755 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -122.99 -33.43 3.34 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.156 0.428 . . . . 3.6800000000000002 112.156 -171.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.56 -149.87 16.93 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 121.149 -0.548 . . . . 0.19 112.324 -177.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.56 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.9 m95 -54.04 117.81 3.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.929 0.395 . . . . 0.39000000000000001 111.045 175.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.1 p -67.63 170.02 8.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.57 -0.741 . . . . 0.35999999999999999 111.413 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -65.32 126.65 28.88 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.191 -1.04 . . . . 1.8400000000000001 108.191 172.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -58.71 114.62 2.6 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.557 0.694 . . . . 1.0 110.49 -175.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.474 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 59.8 m -87.02 97.01 10.48 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.944 -1.025 . . . . 0.35999999999999999 109.659 -177.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.555 HD13 ' HA3' ' A' ' 45' ' ' GLY . 21.6 mm -77.63 120.67 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.341 -0.845 . . . . 0.73999999999999999 109.593 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.51 -165.8 35.56 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.757 -0.735 . . . . 0.23000000000000001 112.217 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 64' ' ' MET . 38.6 mt-10 -92.66 142.22 25.47 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.259 -0.645 . . . . 1.3700000000000001 109.259 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.51 114.63 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.693 2.262 . . . . 0.51000000000000001 111.952 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.644 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 95.8 mmm -118.58 138.88 26.3 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.216 -0.447 . . . . 0.67000000000000004 109.941 -174.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.15 11.64 1.44 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.637 2.225 . . . . 0.32000000000000001 113.827 -175.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.497 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 50.5 m -152.67 137.59 17.16 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.317 -0.623 . . . . 1.3 109.317 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.71 -31.79 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 113.147 0.795 . . . . 1.1399999999999999 113.147 -169.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -69.83 -42.44 73.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.766 0.317 . . . . 2.8199999999999998 111.25 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.497 ' HG2' ' HB2' ' A' ' 66' ' ' SER . 17.3 ptpt -81.0 -18.9 45.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.369 -0.378 . . . . 1.3600000000000001 110.49 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.51 -57.94 10.79 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.342 -0.39 . . . . 0.20999999999999999 110.299 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.683 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 53.1 mtmt -56.51 -45.37 81.12 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.25 -0.432 . . . . 2.4199999999999999 110.729 175.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 76' ' ' VAL . 22.3 t70 -49.79 -50.13 45.98 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.887 -0.597 . . . . 2.0099999999999998 111.812 176.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.0 t -58.91 -47.56 84.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 1.1399999999999999 111.618 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.99 81.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.251 0.548 . . . . 0.17999999999999999 111.007 -177.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.603 ' O ' ' HG ' ' A' ' 79' ' ' LEU . . . -60.44 -29.94 69.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.553 -0.749 . . . . 0.26000000000000001 111.692 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 72' ' ' ASP . 55.6 t -65.71 -32.82 59.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 121.102 0.477 . . . . 0.82999999999999996 109.961 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.3 mt -74.26 -30.76 62.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.856 -0.611 . . . . 0.39000000000000001 109.506 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 78' ' ' LEU . 6.2 mt -61.87 -42.64 99.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.195 -0.911 . . . . 0.81000000000000005 110.24 175.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 17.8 mt -58.3 -35.59 72.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.199 -0.91 . . . . 1.6100000000000001 111.037 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -69.67 -43.81 71.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.895 0.379 . . . . 2.1299999999999999 110.268 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.0 tt -62.87 -47.57 82.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.716 -0.675 . . . . 1.1699999999999999 109.259 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.35 -32.91 72.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.081 -0.963 . . . . 1.1499999999999999 111.68 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 121.358 0.599 . . . . 1.46 110.597 178.793 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.487 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.817 0.341 . . . . 0.80000000000000004 110.607 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.409 ' SG ' ' HE3' ' A' ' 23' ' ' TRP . 54.1 t -72.24 -41.19 67.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.661 0.743 . . . . 1.3500000000000001 109.247 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.75 -42.85 99.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.628 -1.169 . . . . 1.1599999999999999 109.614 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -61.65 -33.9 74.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.556 -0.747 . . . . 3.8399999999999999 110.919 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 31.6 mmmt -74.28 2.07 10.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.029 -0.532 . . . . 1.1000000000000001 111.485 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.9 t30 68.24 27.04 6.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.998 0.904 . . . . 1.9199999999999999 109.712 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.409 ' HE3' ' SG ' ' A' ' 18' ' ' CYS . 41.8 m0 -92.67 160.88 33.48 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.017 -0.992 . . . . 0.40000000000000002 109.055 174.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.38 -169.53 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.106 1.871 . . . . 0.44 111.482 173.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.424 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 10.6 mmt -77.22 132.5 70.08 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HB3' HG22 ' A' ' 48' ' ' VAL . 16.9 Cg_exo -65.63 164.37 26.73 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.512 2.141 . . . . 0.46000000000000002 112.268 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.525 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 22.5 t -87.84 140.99 28.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.494 -0.776 . . . . 0.29999999999999999 109.859 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.51 ' HD1' ' CZ ' ' A' ' 44' ' ' PHE . 66.1 m-85 -141.19 111.04 6.54 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.889 -0.782 . . . . 0.29999999999999999 108.889 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.51 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 36.2 ttm180 -153.01 128.68 10.1 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.196 -0.298 . . . . 3.6899999999999999 110.196 -175.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.4 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 7.8 p -65.32 124.68 22.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.924 0.392 . . . . 1.53 110.459 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.404 ' H ' ' HA ' ' A' ' 44' ' ' PHE . 34.1 m -82.57 -34.61 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.141 0.496 . . . . 1.1499999999999999 110.302 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.7 tttt . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.681 -0.691 . . . . 2.25 110.201 174.095 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 . . . . . 0 CA--C 1.512 -0.512 0 N-CA-C 106.471 -1.677 . . . . 3.6400000000000001 106.471 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 9.0 m-85 -111.0 130.15 55.68 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 120.474 -0.49 . . . . 0.79000000000000004 110.284 -172.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.6 m -121.92 125.43 46.37 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.03 -1.1 . . . . 0.26000000000000001 108.03 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.728 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -134.36 151.61 51.32 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.582 -0.525 . . . . 0.17000000000000001 109.582 -175.108 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.91 139.41 11.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.96 -0.638 . . . . 0.17000000000000001 111.883 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.728 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -107.05 157.6 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 N-CA-C 110.03 -0.359 . . . . 0.80000000000000004 110.03 -174.689 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.615 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 15.2 ptp180 -148.5 147.39 29.04 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.674 -0.862 . . . . 2.6200000000000001 108.674 171.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.638 HG23 HD11 ' A' ' 78' ' ' LEU . 73.0 t -124.98 153.07 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.474 -0.33 . . . . 0.23999999999999999 110.807 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -93.89 84.54 4.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.729 0.776 . . . . 1.5900000000000001 110.213 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' A' ' 53' ' ' ARG . 40.3 p -72.52 108.11 5.41 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.374 -1.285 . . . . 0.33000000000000002 109.05 177.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.1 t -49.83 -28.28 6.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.011 -0.541 . . . . 1.3200000000000001 112.251 -175.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -88.44 -15.82 34.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.705 0.631 . . . . 1.3 112.705 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.44 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 25.3 ttm180 -132.22 -49.38 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.915 -0.491 . . . . 3.6800000000000002 111.307 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 125.59 -156.82 19.48 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.842 -0.617 . . . . 0.19 112.288 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.615 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.7 m95 -52.0 117.95 3.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.969 0.414 . . . . 0.39000000000000001 110.611 173.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 47.9 p -69.85 168.98 14.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.533 -0.758 . . . . 0.35999999999999999 111.306 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.48 125.51 25.93 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.164 -0.68 . . . . 1.8400000000000001 109.164 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 45.4 tt0 -60.75 118.11 6.22 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.297 -0.865 . . . . 1.0 111.036 -174.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 68.6 m -97.96 102.26 13.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.713 -1.13 . . . . 0.35999999999999999 110.731 -175.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.43 127.7 36.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.77 -0.65 . . . . 0.73999999999999999 110.533 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.15 -161.93 34.93 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.574 -0.739 . . . . 0.23000000000000001 113.019 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 64' ' ' MET . 32.5 mt-10 -92.03 131.94 33.85 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.744 -0.228 . . . . 1.3700000000000001 110.612 -175.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 54.1 Cg_exo -52.9 108.92 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.765 2.31 . . . . 0.51000000000000001 111.477 175.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.472 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 7.1 mmt -110.96 151.51 43.03 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.006 -0.543 . . . . 0.67000000000000004 111.772 -171.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.59 5.78 6.06 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.949 2.432 . . . . 0.32000000000000001 112.989 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.4 t -151.61 142.39 22.87 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.5 -0.556 . . . . 1.3 109.5 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.4 t -62.16 -33.3 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.457 -0.792 . . . . 1.1399999999999999 111.406 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -66.76 -37.07 83.89 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.242 -0.435 . . . . 2.8199999999999998 110.439 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.472 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 29.1 mtpp -74.27 -31.44 62.53 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.079 -0.509 . . . . 1.3600000000000001 110.315 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.74 -60.89 2.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.68 -0.691 . . . . 0.20999999999999999 110.955 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.538 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 32.6 mmtp -51.46 -49.51 61.62 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.289 -0.414 . . . . 2.4199999999999999 110.995 176.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.508 ' O ' HG23 ' A' ' 76' ' ' VAL . 17.4 t70 -51.84 -52.27 50.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.281 -0.872 . . . . 2.0099999999999998 112.566 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 91.6 p -62.4 -41.31 98.57 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.835 0.309 . . . . 1.1399999999999999 111.835 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.493 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -69.46 -41.44 76.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.222 0.534 . . . . 0.17999999999999999 110.543 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.409 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -54.23 -33.68 58.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.231 -0.895 . . . . 0.26000000000000001 111.395 176.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 72' ' ' ASP . 88.7 t -62.55 -37.96 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 120.971 0.415 . . . . 0.82999999999999996 110.833 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.08 -30.47 62.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.868 0.842 . . . . 0.39000000000000001 109.042 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.638 HD11 HG23 ' A' ' 48' ' ' VAL . 18.1 tp -67.3 -42.88 82.99 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.438 -1.255 . . . . 0.81000000000000005 110.329 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.9 mm? -61.26 -29.5 69.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.713 -0.676 . . . . 1.6100000000000001 110.971 177.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 76' ' ' VAL . 35.1 mt-10 -75.98 -38.5 57.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.932 0.396 . . . . 2.1299999999999999 110.112 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.9 tt -62.65 -48.95 77.11 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.277 -0.638 . . . . 1.1699999999999999 109.277 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.9 -14.73 60.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.324 -0.853 . . . . 1.1499999999999999 112.191 177.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.5 t30 . . . . . 0 C--N 1.322 -0.627 0 CA-C-O 121.633 0.73 . . . . 1.46 109.613 178.528 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.3 mp . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 121.537 0.684 . . . . 0.80000000000000004 110.11 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.501 ' SG ' ' HG3' ' A' ' 26' ' ' PRO . 57.6 m -66.41 -43.65 85.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.072 -0.967 . . . . 1.3500000000000001 110.412 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.7 tp -63.81 -53.03 57.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.964 -1.016 . . . . 1.1599999999999999 111.194 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -59.23 -35.51 73.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.893 -0.594 . . . . 3.8399999999999999 111.371 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 37.3 mmtt -74.18 -1.26 19.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.126 0.489 . . . . 1.1000000000000001 111.939 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 61.89 36.8 15.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.851 -1.068 . . . . 1.9199999999999999 110.632 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 29.8 m0 -94.7 161.73 27.82 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.489 -0.778 . . . . 0.40000000000000002 109.014 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.18 177.98 4.0 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.965 1.776 . . . . 0.44 110.459 170.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 22.0 mmt -77.61 123.08 86.66 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-O 120.931 0.396 . . . . 1.0 110.403 -176.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.527 ' HB3' HG22 ' A' ' 48' ' ' VAL . 9.6 Cg_endo -56.47 163.15 7.08 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.695 2.93 . . . . 0.46000000000000002 114.015 -176.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.538 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 25.6 t -88.46 143.35 27.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.811 -1.086 . . . . 0.29999999999999999 110.461 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.541 ' HD1' ' CZ ' ' A' ' 44' ' ' PHE . 65.5 m-85 -143.33 111.37 6.1 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.146 -0.687 . . . . 0.29999999999999999 109.146 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.47 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 79.2 ttt180 -155.71 129.87 8.78 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.599 -0.519 . . . . 3.6899999999999999 109.599 -176.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 13.8 p -69.78 132.0 45.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.216 0.531 . . . . 1.53 111.2 -176.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.71 -31.66 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.61 -0.723 . . . . 1.1499999999999999 109.983 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.408 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 87.7 tttt . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 115.984 -0.553 . . . . 2.25 110.897 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 107.545 -1.28 . . . . 3.6400000000000001 107.545 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 7.7 m-85 -109.64 134.64 51.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.015 0.436 . . . . 0.79000000000000004 110.355 -170.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 32' ' ' LYS . 19.7 m -123.61 120.6 33.29 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.66 -0.867 . . . . 0.26000000000000001 108.66 -178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.736 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -131.58 154.18 49.12 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.649 -0.5 . . . . 0.17000000000000001 109.649 -172.369 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -128.5 140.44 11.76 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.951 -0.642 . . . . 0.17000000000000001 112.168 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.736 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -106.93 154.81 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 109.661 -0.496 . . . . 0.80000000000000004 109.661 -176.653 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.575 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 12.4 ptp180 -145.79 142.7 29.13 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.907 -1.146 . . . . 2.6200000000000001 107.907 173.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.602 HG23 HD11 ' A' ' 78' ' ' LEU . 43.7 t -124.8 156.04 33.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.714 -0.221 . . . . 0.23999999999999999 110.606 -178.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.405 ' N ' HG12 ' A' ' 48' ' ' VAL . 26.6 t-20 -91.89 84.19 5.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.739 0.78 . . . . 1.5900000000000001 109.782 178.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.8 p -78.25 103.14 8.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.581 -1.19 . . . . 0.33000000000000002 109.167 177.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 t -44.25 -34.87 2.04 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.351 -0.84 . . . . 1.3200000000000001 113.095 -170.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -68.26 -26.95 65.93 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.858 0.688 . . . . 1.3 112.858 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -132.24 -42.2 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.013 0.435 . . . . 3.6800000000000002 111.487 -174.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.49 -150.02 16.94 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.965 -0.562 . . . . 0.19 112.03 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.575 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.9 m95 -51.5 120.06 4.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.024 0.44 . . . . 0.39000000000000001 111.327 175.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.6 p -68.34 156.92 36.79 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.726 -0.67 . . . . 0.35999999999999999 110.346 176.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -61.84 124.88 21.98 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.866 -0.79 . . . . 1.8400000000000001 108.866 173.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 40.5 tt0 -59.64 118.03 5.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.104 -0.953 . . . . 1.0 111.242 -170.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.419 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 50.6 m -93.3 102.64 14.91 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.704 -1.134 . . . . 0.35999999999999999 110.614 -174.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.02 128.56 38.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.819 -0.628 . . . . 0.73999999999999999 110.739 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.27 -167.58 43.51 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.478 -0.783 . . . . 0.23000000000000001 111.999 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.638 ' O ' ' HG2' ' A' ' 64' ' ' MET . 40.9 mt-10 -86.62 148.14 45.61 Favored Pre-proline 0 C--N 1.318 -0.795 0 O-C-N 122.731 -0.276 . . . . 1.3700000000000001 110.311 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 32.1 Cg_exo -59.62 107.87 0.42 Allowed 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.492 2.128 . . . . 0.51000000000000001 110.753 170.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.638 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 95.9 mmm -114.62 148.77 41.04 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.063 -0.517 . . . . 0.67000000000000004 110.139 -172.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.74 8.67 4.13 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.619 2.212 . . . . 0.32000000000000001 113.667 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.425 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 37.9 m -153.88 137.91 16.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.349 -0.612 . . . . 1.3 109.349 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.571 ' O ' ' HD3' ' A' ' 71' ' ' LYS . 28.3 m -64.84 -29.3 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 112.646 0.61 . . . . 1.1399999999999999 112.646 -170.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.68 -42.86 77.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.965 0.412 . . . . 2.8199999999999998 111.33 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.425 ' HG2' ' HB2' ' A' ' 66' ' ' SER . 14.5 ptpt -81.84 -18.21 44.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.362 -0.381 . . . . 1.3600000000000001 111.058 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.42 -51.22 68.39 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.517 -0.549 . . . . 0.20999999999999999 109.517 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.653 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -52.57 -51.56 59.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.135 -0.939 . . . . 2.4199999999999999 110.461 174.018 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -52.76 -46.95 67.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.254 -0.884 . . . . 2.0099999999999998 112.277 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.536 ' O ' HG12 ' A' ' 76' ' ' VAL . 95.7 p -65.58 -39.36 91.54 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.901 -0.319 . . . . 1.1399999999999999 111.5 -176.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.425 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -70.99 -48.15 54.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.026 0.441 . . . . 0.17999999999999999 110.552 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.472 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -54.31 -38.89 66.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.501 -0.772 . . . . 0.26000000000000001 111.808 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 73' ' ' SER . 3.0 p -72.25 -26.62 25.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 0.82999999999999996 110.958 -176.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.8 mt -78.2 -34.07 49.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.852 0.834 . . . . 0.39000000000000001 109.402 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.602 HD11 HG23 ' A' ' 48' ' ' VAL . 17.5 tp -64.68 -38.65 91.73 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.691 -1.14 . . . . 0.81000000000000005 110.693 175.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 75' ' ' ALA . 6.1 mp -61.09 -26.26 67.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.548 -0.751 . . . . 1.6100000000000001 111.357 177.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -70.61 -38.04 73.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.479 0.657 . . . . 2.1299999999999999 109.985 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.34 -46.96 75.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.134 -0.939 . . . . 1.1699999999999999 109.177 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mp -69.22 -13.58 62.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.191 -0.913 . . . . 1.1499999999999999 111.686 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.6 t30 . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 122.011 0.91 . . . . 1.46 109.208 175.953 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.731 0.301 . . . . 0.80000000000000004 111.045 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.594 ' SG ' ' HD3' ' A' ' 26' ' ' PRO . 53.3 t -62.22 -41.1 98.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.445 0.64 . . . . 1.3500000000000001 110.388 -176.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 38.5 tp -62.27 -51.97 65.6 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.001 -0.999 . . . . 1.1599999999999999 110.899 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.9 ttp-105 -61.59 -31.89 71.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.262 -0.881 . . . . 3.8399999999999999 111.525 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -72.58 -1.59 16.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.961 -0.563 . . . . 1.1000000000000001 111.437 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 59.67 27.79 17.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.853 -1.067 . . . . 1.9199999999999999 111.841 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.482 ' CH2' HG22 ' A' ' 50' ' ' THR . 27.3 m0 -85.4 162.86 47.09 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.234 -0.654 . . . . 0.40000000000000002 109.234 174.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.08 174.34 7.09 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 121.981 1.788 . . . . 0.44 110.437 170.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 5.7 mmt -79.2 132.94 61.55 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.981 0.42 . . . . 1.0 111.402 -170.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.594 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 12.1 Cg_endo -58.82 156.42 32.99 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.832 3.021 . . . . 0.46000000000000002 113.819 -177.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.1 t -90.35 144.21 26.03 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.841 -1.072 . . . . 0.29999999999999999 110.238 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.54 ' CD2' ' CZ ' ' A' ' 44' ' ' PHE . 60.7 m-85 -141.58 110.32 6.12 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.933 -0.766 . . . . 0.29999999999999999 108.933 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.532 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 57.5 mtp180 -146.05 125.67 13.33 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 110.39 -0.226 . . . . 3.6899999999999999 110.39 -176.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 74.6 m -65.24 126.77 29.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.749 0.309 . . . . 1.53 110.795 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 43' ' ' THR . 30.5 m -87.48 -38.67 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 1.1499999999999999 110.927 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.4 tttt . . . . . 0 C--N 1.325 -0.484 0 CA-C-N 116.411 -0.359 . . . . 2.25 110.764 177.975 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.018 -0.734 . . . . 3.6400000000000001 109.018 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -110.47 136.01 50.27 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.025 -0.534 . . . . 0.79000000000000004 110.807 -172.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 31' ' ' VAL . 16.7 m -124.6 127.84 47.98 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.234 -1.024 . . . . 0.26000000000000001 108.234 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.747 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -142.85 154.4 44.11 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.499 -0.556 . . . . 0.17000000000000001 109.499 -175.771 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.556 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -126.85 139.75 11.46 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.903 -0.665 . . . . 0.17000000000000001 112.519 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.747 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -107.18 159.02 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.659 -0.497 . . . . 0.80000000000000004 109.659 -175.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.616 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 14.6 ptp180 -148.43 147.87 29.66 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.61 -0.885 . . . . 2.6200000000000001 108.61 171.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.572 HG23 HD11 ' A' ' 78' ' ' LEU . 85.1 t -125.76 156.18 35.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.305 -0.407 . . . . 0.23999999999999999 110.178 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -92.12 82.2 5.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.087 0.47 . . . . 1.5900000000000001 109.949 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.482 HG22 ' CH2' ' A' ' 23' ' ' TRP . 41.5 p -74.5 107.2 6.49 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.548 -0.751 . . . . 0.33000000000000002 109.479 178.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.7 t -47.53 -30.54 3.58 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.825 0.676 . . . . 1.3200000000000001 112.825 -173.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -80.32 -14.58 58.25 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.417 0.895 . . . . 1.3 113.417 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -140.07 -42.09 0.43 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.525 0.602 . . . . 3.6800000000000002 111.105 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 122.75 -153.75 16.95 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 116.111 -0.495 . . . . 0.19 112.048 -178.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.616 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 9.4 m95 -51.81 120.48 5.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.812 0.339 . . . . 0.39000000000000001 110.732 173.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 47.4 p -68.92 157.73 36.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.709 -0.678 . . . . 0.35999999999999999 111.045 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -58.22 131.67 51.28 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.065 -0.717 . . . . 1.8400000000000001 109.065 174.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.66 113.02 2.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.744 0.783 . . . . 1.0 111.262 -171.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.457 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 38.7 m -85.87 98.67 10.9 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.177 -1.374 . . . . 0.35999999999999999 109.984 -176.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.556 HD13 ' HA3' ' A' ' 45' ' ' GLY . 19.1 mm -80.71 128.96 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 115.892 -0.594 . . . . 0.73999999999999999 110.364 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.11 175.21 49.87 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.921 -0.872 . . . . 0.23000000000000001 110.921 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' A' ' 64' ' ' MET . 12.5 pt-20 -85.5 150.5 54.18 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.572 -0.529 . . . . 1.3700000000000001 109.572 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.97 109.97 0.39 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.651 2.234 . . . . 0.51000000000000001 111.692 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.606 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 98.0 mmm -114.73 139.19 23.8 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.816 -0.629 . . . . 0.67000000000000004 109.493 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.69 13.69 0.73 Allowed 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.576 2.184 . . . . 0.32000000000000001 114.072 -174.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.52 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 28.6 m -157.46 143.1 17.36 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.715 -0.476 . . . . 1.3 109.715 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.77 -41.23 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.337 -0.847 . . . . 1.1399999999999999 112.693 -170.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.35 -42.39 96.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.919 0.39 . . . . 2.8199999999999998 111.146 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.52 ' HG2' ' HB2' ' A' ' 66' ' ' SER . 15.8 ptpt -81.26 -18.95 44.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.462 -0.335 . . . . 1.3600000000000001 110.67 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.45 -55.63 25.81 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.397 -0.365 . . . . 0.20999999999999999 110.301 171.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.613 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 53.5 mtpt -54.29 -52.17 62.31 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 116.063 -0.517 . . . . 2.4199999999999999 110.29 175.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.38 -42.13 73.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.128 -0.942 . . . . 2.0099999999999998 112.194 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.547 ' O ' HG12 ' A' ' 76' ' ' VAL . 17.1 t -62.75 -43.06 99.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.778 0.323 . . . . 1.1399999999999999 110.981 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.435 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -69.95 -44.4 69.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.134 0.493 . . . . 0.17999999999999999 110.401 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.479 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -57.52 -38.51 74.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.631 -0.713 . . . . 0.26000000000000001 112.208 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 73' ' ' SER . 3.1 p -68.79 -31.19 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 O-C-N 121.952 -0.467 . . . . 0.82999999999999996 110.669 -178.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.5 mt -76.19 -31.79 58.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.808 0.813 . . . . 0.39000000000000001 109.103 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.572 HD11 HG23 ' A' ' 48' ' ' VAL . 14.3 tp -66.16 -43.31 87.33 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.496 -1.229 . . . . 0.81000000000000005 110.728 175.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.479 HD13 ' O ' ' A' ' 75' ' ' ALA . 6.3 mp -59.15 -29.19 67.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 1.6100000000000001 111.424 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 6.2 mm-40 -71.78 -38.93 70.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.191 -0.459 . . . . 2.1299999999999999 110.698 177.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.3 tp -75.05 -41.97 58.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.908 0.861 . . . . 1.1699999999999999 110.335 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 82' ' ' LEU . 8.7 tp -65.4 -38.92 91.43 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.062 -1.426 . . . . 1.1499999999999999 111.341 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.1 t30 . . . . . 0 C--N 1.318 -0.793 0 CA-C-N 114.804 -1.089 . . . . 1.46 109.816 173.332 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.477 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.4 mp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.998 0.428 . . . . 0.80000000000000004 110.638 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.412 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 42.8 t -71.57 -41.73 68.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.987 -0.551 . . . . 1.3500000000000001 110.218 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.8 -54.63 42.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.357 -0.838 . . . . 1.1599999999999999 110.605 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -58.06 -33.89 69.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.211 -0.904 . . . . 3.8399999999999999 111.906 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.427 ' HB3' ' CE2' ' A' ' 23' ' ' TRP . 34.4 mmtt -72.71 4.02 4.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.071 0.462 . . . . 1.1000000000000001 111.968 -178.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 63.28 38.71 10.15 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.867 -1.06 . . . . 1.9199999999999999 110.28 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 29.0 m0 -104.81 165.09 13.88 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.423 -0.808 . . . . 0.40000000000000002 109.631 176.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 55.0 Cg_endo -72.39 -171.51 0.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.349 2.033 . . . . 0.44 110.913 170.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.487 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 12.0 mmt -82.33 135.94 46.68 Favored Pre-proline 0 C--N 1.323 -0.582 0 O-C-N 122.024 -0.422 . . . . 1.0 110.633 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.571 ' HB3' HG22 ' A' ' 48' ' ' VAL . 14.4 Cg_exo -68.88 168.45 20.33 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.916 2.411 . . . . 0.46000000000000002 113.045 -177.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.2 t -89.51 141.23 28.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.936 -1.029 . . . . 0.29999999999999999 110.32 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.464 ' CD2' ' HZ ' ' A' ' 44' ' ' PHE . 67.7 m-85 -144.17 110.52 5.51 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.29 -0.633 . . . . 0.29999999999999999 109.29 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.478 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 24.2 ttm180 -156.52 128.42 7.31 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.751 0.31 . . . . 3.6899999999999999 110.512 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 4.5 p -65.68 124.26 21.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.069 0.461 . . . . 1.53 110.957 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.7 m -87.57 -37.07 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.987 -0.552 . . . . 1.1499999999999999 111.439 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.9 tttt . . . . . 0 C--N 1.321 -0.634 0 CA-C-O 121.06 0.457 . . . . 2.25 110.52 -179.707 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 108.4 -0.963 . . . . 3.6400000000000001 108.4 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -110.31 135.66 50.7 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.904 -0.589 . . . . 0.79000000000000004 110.637 -170.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.8 m -122.54 130.69 53.3 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.868 -1.16 . . . . 0.26000000000000001 107.868 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.738 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -139.18 151.33 46.5 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.417 -0.586 . . . . 0.17000000000000001 109.417 -174.898 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.551 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -125.58 136.84 9.94 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.973 -0.632 . . . . 0.17000000000000001 112.017 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.738 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -107.1 156.72 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 109.308 -0.627 . . . . 0.80000000000000004 109.308 -176.899 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.562 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 16.2 ptt180 -148.99 147.7 28.88 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.774 -0.825 . . . . 2.6200000000000001 108.774 171.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.571 HG22 ' HB3' ' A' ' 26' ' ' PRO . 78.2 t -125.13 153.44 32.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.076 -0.511 . . . . 0.23999999999999999 110.339 -177.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -93.58 83.4 4.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.507 0.67 . . . . 1.5900000000000001 109.835 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 54' ' ' GLY . 29.6 p -69.89 105.58 2.86 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.628 -1.169 . . . . 0.33000000000000002 108.963 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.1 t -43.78 -44.33 6.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.804 0.668 . . . . 1.3200000000000001 112.804 -169.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -81.5 -6.44 58.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.254 0.835 . . . . 1.3 113.254 -175.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -133.1 -48.65 0.86 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.739 -0.601 . . . . 3.6800000000000002 111.547 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 123.71 -153.68 17.35 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.899 -0.591 . . . . 0.19 112.585 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.562 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 5.2 m95 -52.43 117.61 2.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.869 0.366 . . . . 0.39000000000000001 110.676 174.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.0 p -68.48 169.78 10.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.725 -0.671 . . . . 0.35999999999999999 111.214 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -62.41 129.45 40.72 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.708 -0.849 . . . . 1.8400000000000001 108.708 172.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -60.63 119.74 8.68 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.39 0.614 . . . . 1.0 110.609 -176.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.51 ' SG ' HD12 ' A' ' 81' ' ' LEU . 51.5 m -92.34 98.52 11.54 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.892 -1.049 . . . . 0.35999999999999999 110.231 -175.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.551 HD13 ' HA3' ' A' ' 45' ' ' GLY . 24.6 mm -80.42 124.02 37.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.778 -0.646 . . . . 0.73999999999999999 110.066 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.99 -174.84 50.0 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.882 -0.675 . . . . 0.23000000000000001 112.243 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 64' ' ' MET . 42.9 mt-10 -83.81 152.01 62.1 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 109.728 -0.471 . . . . 1.3700000000000001 109.728 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.43 109.14 1.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.363 2.042 . . . . 0.51000000000000001 111.222 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.562 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 89.3 mmm -115.37 141.57 27.41 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.697 -0.483 . . . . 0.67000000000000004 109.697 -173.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.05 17.97 1.1 Allowed 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.57 2.18 . . . . 0.32000000000000001 113.581 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.424 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 11.2 t -155.09 139.91 17.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.315 -0.624 . . . . 1.3 109.315 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.2 -23.88 27.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.838 -0.619 . . . . 1.1399999999999999 111.032 -173.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -73.96 -43.69 57.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.039 0.447 . . . . 2.8199999999999998 110.235 -176.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.424 ' HG2' ' HB3' ' A' ' 66' ' ' SER . 5.7 ptpp? -81.64 -18.37 44.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.939 -0.573 . . . . 1.3600000000000001 110.634 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.28 -57.49 12.56 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.496 -0.32 . . . . 0.20999999999999999 110.496 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.462 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 61.5 mttm -52.95 -50.08 64.78 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.946 0.403 . . . . 2.4199999999999999 110.257 174.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.534 ' O ' HG23 ' A' ' 76' ' ' VAL . 32.1 t70 -51.54 -51.56 54.3 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.362 -0.835 . . . . 2.0099999999999998 112.295 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.4 t -56.31 -46.64 79.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.787 0.327 . . . . 1.1399999999999999 111.178 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.441 ' HB1' HG23 ' A' ' 46' ' ' VAL . . . -69.5 -43.14 73.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.259 -0.428 . . . . 0.17999999999999999 110.951 -177.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.91 -41.06 70.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.819 -0.628 . . . . 0.26000000000000001 111.84 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 72' ' ' ASP . 97.0 t -63.64 -35.04 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.043 0.449 . . . . 0.82999999999999996 110.731 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.6 mt -74.89 -36.63 62.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.732 0.777 . . . . 0.39000000000000001 109.66 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.531 HD22 HG11 ' A' ' 46' ' ' VAL . 21.0 tp -64.72 -43.12 94.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.749 -1.114 . . . . 0.81000000000000005 111.103 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 mp -62.69 -21.13 65.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.85 -0.613 . . . . 1.6100000000000001 111.497 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -76.43 -38.44 55.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.752 0.31 . . . . 2.1299999999999999 110.234 174.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.51 HD12 ' SG ' ' A' ' 59' ' ' CYS . 0.8 OUTLIER -66.35 -42.98 87.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.766 0.793 . . . . 1.1699999999999999 109.063 178.579 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.418 ' HG ' ' CZ3' ' A' ' 23' ' ' TRP . 1.6 mp -69.24 -17.75 63.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.678 -1.146 . . . . 1.1499999999999999 111.943 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 . . . . . 0 C--N 1.319 -0.734 0 N-CA-C 108.833 -0.803 . . . . 1.46 108.833 174.811 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.3 t30 . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.483 0.182 . . . . 2.4900000000000002 110.773 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -61.39 -44.43 97.16 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.614 0.245 . . . . 2.46 111.379 -175.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -64.23 -41.32 92.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.088 -0.505 . . . . 0.80000000000000004 110.855 -176.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 23' ' ' TRP . 35.4 t -68.29 -40.92 81.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.412 0.625 . . . . 1.3500000000000001 109.775 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.2 tp -62.22 -50.03 73.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.095 -0.957 . . . . 1.1599999999999999 110.219 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -60.18 -36.81 78.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.966 -1.015 . . . . 3.8399999999999999 111.635 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.406 ' HB3' ' CE2' ' A' ' 23' ' ' TRP . 49.0 mmtt -73.3 -3.25 25.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.394 0.616 . . . . 1.1000000000000001 111.646 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 64.95 43.63 3.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.396 -1.274 . . . . 1.9199999999999999 110.648 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.486 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 19.1 m0 -105.14 162.79 18.67 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.742 -0.663 . . . . 0.40000000000000002 109.426 174.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 34.4 Cg_endo -67.92 -178.8 1.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.073 1.849 . . . . 0.44 110.75 171.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 16.7 mmt -80.66 127.89 73.88 Favored Pre-proline 0 C--N 1.322 -0.596 0 O-C-N 121.984 -0.447 . . . . 1.0 109.892 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HB3' HG22 ' A' ' 48' ' ' VAL . 22.0 Cg_exo -63.4 167.99 12.05 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.947 2.431 . . . . 0.46000000000000002 113.462 -174.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.5 t -86.6 140.37 29.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.952 -1.022 . . . . 0.29999999999999999 109.979 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.464 ' CD1' ' HZ ' ' A' ' 44' ' ' PHE . 69.4 m-85 -145.57 110.99 5.35 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.566 -0.531 . . . . 0.29999999999999999 109.566 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 72.7 ttt180 -158.68 130.37 6.56 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 110.359 -0.237 . . . . 3.6899999999999999 110.359 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.5 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 70.0 m -64.23 124.49 21.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.339 -0.392 . . . . 1.53 110.766 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -82.53 -32.59 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.248 0.547 . . . . 1.1499999999999999 110.362 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -136.37 124.21 22.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.568 -0.742 . . . . 2.25 109.475 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.557 ' HG2' ' CD1' ' A' ' 42' ' ' PHE . 3.1 tm-20 -148.0 127.34 13.07 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.672 -0.492 . . . . 2.6000000000000001 109.672 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.24 -177.84 52.12 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.834 -0.698 . . . . 1.6899999999999999 112.315 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.06 -148.99 19.51 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.688 -0.768 . . . . 2.1299999999999999 111.959 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.96 57.75 3.95 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 123.411 2.741 . . . . 3.0 112.663 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 70.01 -59.59 0.5 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.811 0.845 . . . . 2.6099999999999999 112.465 176.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -79.03 18.06 0.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.334 . . . . 2.1000000000000001 111.631 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -126.32 39.26 3.97 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.955 0.407 . . . . 1.28 110.812 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -88.29 18.23 4.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.495 0.664 . . . . 1.9299999999999999 110.198 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -85.6 138.68 32.0 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.726 -1.213 . . . . 3.6400000000000001 107.726 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.557 ' CD1' ' HG2' ' A' ' 33' ' ' GLU . 5.6 m-85 -110.57 131.65 54.87 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.103 0.477 . . . . 0.79000000000000004 110.387 -172.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.0 m -120.01 130.99 54.99 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.876 -1.157 . . . . 0.26000000000000001 107.876 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.727 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -137.94 151.79 48.33 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.642 -0.503 . . . . 0.17000000000000001 109.642 -173.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -125.47 136.47 9.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.232 -0.508 . . . . 0.17000000000000001 111.987 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.727 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.3 t -107.72 154.41 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 117.14 0.47 . . . . 0.80000000000000004 109.856 -175.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.56 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 10.9 ptt180 -149.51 145.23 26.75 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.681 -0.859 . . . . 2.6200000000000001 108.681 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.616 HG23 HD11 ' A' ' 78' ' ' LEU . 61.0 t -125.5 155.85 34.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.355 -0.384 . . . . 0.23999999999999999 110.394 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -95.12 83.87 3.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.601 0.715 . . . . 1.5900000000000001 110.37 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.456 HG22 ' CZ2' ' A' ' 23' ' ' TRP . 30.1 p -72.92 103.08 3.62 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.423 -1.262 . . . . 0.33000000000000002 108.944 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.9 t -46.06 -32.97 3.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.654 -0.703 . . . . 1.3200000000000001 112.858 -170.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -72.31 -22.57 61.16 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.753 0.649 . . . . 1.3 112.753 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -134.56 -45.69 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.022 -0.424 . . . . 3.6800000000000002 111.279 -175.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 126.64 -154.34 19.14 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.914 -0.584 . . . . 0.19 112.343 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.56 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 7.1 m95 -49.22 120.28 3.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.97 0.453 . . . . 0.39000000000000001 110.882 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 42.8 p -70.33 172.99 7.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.647 -0.706 . . . . 0.35999999999999999 111.418 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -61.05 131.84 51.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.883 -0.784 . . . . 1.8400000000000001 108.883 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 27.0 tt0 -64.64 114.96 4.76 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.342 0.591 . . . . 1.0 109.749 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 59.8 m -92.21 97.42 10.89 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.095 -0.957 . . . . 0.35999999999999999 110.258 -175.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.66 126.22 38.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.647 -0.706 . . . . 0.73999999999999999 110.361 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.22 -170.99 47.82 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.47 -0.787 . . . . 0.23000000000000001 111.727 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.607 ' O ' ' HG2' ' A' ' 64' ' ' MET . 41.4 mt-10 -88.36 152.07 49.45 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 110.281 -0.266 . . . . 1.3700000000000001 110.281 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.12 107.91 0.32 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.643 2.229 . . . . 0.51000000000000001 111.256 172.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.607 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 95.8 mmm -110.4 147.23 35.93 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.202 -0.454 . . . . 0.67000000000000004 110.482 -173.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.24 4.36 7.06 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.739 2.292 . . . . 0.32000000000000001 113.765 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.441 ' HB2' ' HG3' ' A' ' 69' ' ' LYS . 26.9 m -147.53 137.15 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.742 -0.466 . . . . 1.3 109.742 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.3 m -65.29 -28.77 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.178 -0.465 . . . . 1.1399999999999999 112.046 -171.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -71.19 -36.16 71.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.4 -0.364 . . . . 2.8199999999999998 110.454 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.441 ' HG3' ' HB2' ' A' ' 66' ' ' SER . 46.9 mtpt -74.47 -28.33 60.98 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.764 -0.458 . . . . 1.3600000000000001 109.764 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.49 -59.03 6.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.831 -0.622 . . . . 0.20999999999999999 110.623 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.632 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 56.8 mttm -53.6 -58.59 6.64 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.086 -0.506 . . . . 2.4199999999999999 111.471 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.589 ' O ' HG23 ' A' ' 76' ' ' VAL . 29.6 t70 -57.69 -42.37 83.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.656 -0.702 . . . . 2.0099999999999998 112.718 -173.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 m -70.31 -36.63 74.43 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 121.006 -0.278 . . . . 1.1399999999999999 111.418 -175.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.415 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -67.36 -42.89 82.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.613 0.721 . . . . 0.17999999999999999 109.541 174.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 79' ' ' LEU . . . -54.23 -34.67 61.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.48 -1.236 . . . . 0.26000000000000001 111.533 176.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 72' ' ' ASP . 98.3 t -64.56 -34.79 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.007 0.432 . . . . 0.82999999999999996 110.7 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.3 mt -74.6 -33.07 62.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.818 0.818 . . . . 0.39000000000000001 109.194 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.616 HD11 HG23 ' A' ' 48' ' ' VAL . 26.5 tp -64.1 -37.31 86.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.547 -1.206 . . . . 0.81000000000000005 110.272 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 20.8 mt -60.66 -28.27 68.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.233 -0.894 . . . . 1.6100000000000001 110.835 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 89.8 mt-10 -72.98 -36.69 67.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.042 0.448 . . . . 2.1299999999999999 110.027 178.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.2 tt -66.86 -46.22 75.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.645 0.735 . . . . 1.1699999999999999 109.052 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.456 ' HB3' HG21 ' A' ' 17' ' ' ILE . 3.8 mp -70.61 -11.35 60.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.915 -1.039 . . . . 1.1499999999999999 112.051 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -85.18 -4.46 59.16 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.592 0.71 . . . . 1.46 109.65 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 50.6 mttp -114.41 45.77 1.48 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.286 -0.87 . . . . 4.1699999999999999 109.621 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.0 p . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.902 -0.571 . . . . 3.79 111.183 -175.364 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.564 ' N ' HD21 ' A' ' 15' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 111.174 0.064 . . . . 2.4900000000000002 111.174 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -62.98 -45.28 93.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.773 0.32 . . . . 2.46 111.149 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.483 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.5 mp -62.19 -43.62 98.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.927 -0.579 . . . . 0.80000000000000004 110.72 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.416 ' SG ' HG13 ' A' ' 48' ' ' VAL . 34.4 t -69.3 -42.11 75.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.312 0.577 . . . . 1.3500000000000001 109.824 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.3 tp -61.8 -49.31 76.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.309 -0.859 . . . . 1.1599999999999999 110.398 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -63.97 -31.44 72.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.799 -1.091 . . . . 3.8399999999999999 111.395 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 27.7 mmmt -74.31 3.11 7.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.362 -0.381 . . . . 1.1000000000000001 111.459 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.4 t30 67.69 27.95 7.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.306 -0.861 . . . . 1.9199999999999999 110.25 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -94.65 160.2 31.93 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.389 -0.823 . . . . 0.40000000000000002 109.429 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.49 -169.53 0.43 Allowed 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.178 1.919 . . . . 0.44 111.554 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.429 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 9.3 mmt -78.28 134.63 62.59 Favored Pre-proline 0 C--N 1.324 -0.542 0 O-C-N 122.163 -0.336 . . . . 1.0 110.649 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 16.7 Cg_exo -66.62 156.69 64.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.648 2.232 . . . . 0.46000000000000002 112.042 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.45 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 12.9 t -89.32 142.6 27.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.899 -0.591 . . . . 0.29999999999999999 110.082 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.477 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 62.6 m-85 -142.21 111.98 6.78 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.308 -0.627 . . . . 0.29999999999999999 109.308 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.564 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 33.7 ttm180 -163.03 122.69 2.21 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.473 -0.566 . . . . 3.6899999999999999 109.473 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 73.8 m -61.77 131.33 49.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.196 0.522 . . . . 1.53 111.833 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.425 ' H ' ' HA ' ' A' ' 44' ' ' PHE . 27.2 m -82.98 -30.74 8.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.372 -0.831 . . . . 1.1499999999999999 110.357 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -135.12 124.88 25.35 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.539 -0.755 . . . . 2.25 110.125 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -151.16 141.06 21.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.542 -0.754 . . . . 2.6000000000000001 109.178 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.16 177.32 51.37 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.695 -0.764 . . . . 1.6899999999999999 113.311 173.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.16 -156.18 26.88 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.815 -0.914 . . . . 2.1299999999999999 110.815 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.43 -74.0 0.02 OUTLIER 'Trans proline' 0 CA--C 1.529 0.247 0 C-N-CA 122.498 2.132 . . . . 3.0 111.722 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -164.63 -41.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.994 -0.548 . . . . 2.6099999999999999 109.877 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -71.9 -4.02 25.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.758 -0.656 . . . . 2.1000000000000001 110.818 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.78 32.15 6.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.218 -0.446 . . . . 1.28 110.921 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.425 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 12.4 tptp -92.36 17.86 9.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.441 0.639 . . . . 1.9299999999999999 109.607 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -84.18 137.36 33.55 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.084 -1.45 . . . . 3.6400000000000001 107.084 169.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -109.47 134.27 52.08 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.253 0.549 . . . . 0.79000000000000004 110.45 -169.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.8 m -123.24 127.08 48.09 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.02 -1.104 . . . . 0.26000000000000001 108.02 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.676 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -138.47 154.4 48.83 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.789 -0.448 . . . . 0.17000000000000001 109.789 -171.045 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.44 ' CA ' HD13 ' A' ' 60' ' ' ILE . . . -127.41 137.39 9.83 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.209 -0.52 . . . . 0.17000000000000001 111.923 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.676 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.3 t -107.33 153.98 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 N-CA-C 108.853 -0.795 . . . . 0.80000000000000004 108.853 -176.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.544 ' O ' ' HZ3' ' A' ' 55' ' ' TRP . 11.3 ptt180 -143.63 146.77 33.52 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.521 -0.918 . . . . 2.6200000000000001 108.521 173.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.416 HG13 ' SG ' ' A' ' 18' ' ' CYS . 74.7 t -125.36 150.71 30.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.757 -0.656 . . . . 0.23999999999999999 109.688 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -91.63 84.51 5.49 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.458 0.647 . . . . 1.5900000000000001 109.686 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.3 p -71.71 109.87 5.89 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.627 -1.17 . . . . 0.33000000000000002 109.45 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 62.0 p -50.56 -22.54 2.02 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.731 -1.122 . . . . 1.3200000000000001 114.021 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -92.08 -15.63 27.52 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.374 0.509 . . . . 1.3 112.374 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -136.24 -40.47 0.66 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.097 -0.377 . . . . 3.6800000000000002 111.878 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.57 -154.45 16.95 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 121.282 -0.485 . . . . 0.19 112.801 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.544 ' HZ3' ' O ' ' A' ' 47' ' ' ARG . 30.1 m95 -57.75 123.42 15.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.396 0.617 . . . . 0.39000000000000001 111.265 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.0 p -74.48 152.85 39.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.138 -0.937 . . . . 0.35999999999999999 110.879 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -62.05 129.41 40.72 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.231 -0.655 . . . . 1.8400000000000001 109.231 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -50.63 125.01 12.01 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.445 -0.798 . . . . 1.0 112.985 -173.019 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.425 ' SG ' HD12 ' A' ' 81' ' ' LEU . 58.9 m -86.95 100.85 12.9 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.174 -1.375 . . . . 0.35999999999999999 108.865 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.44 HD13 ' CA ' ' A' ' 45' ' ' GLY . 29.2 mm -83.07 123.92 39.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.919 -0.582 . . . . 0.73999999999999999 110.703 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.84 -175.86 51.03 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 121.052 -0.594 . . . . 0.23000000000000001 112.002 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HG2' ' OG ' ' A' ' 73' ' ' SER . 11.1 pt-20 -87.02 149.46 47.69 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 110.167 -0.309 . . . . 1.3700000000000001 110.167 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.33 108.76 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.813 2.342 . . . . 0.51000000000000001 111.61 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.409 ' SD ' ' HG3' ' A' ' 69' ' ' LYS . 15.1 mmt -108.87 143.75 28.22 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.166 -0.47 . . . . 0.67000000000000004 110.964 -174.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -83.34 10.47 3.65 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.683 2.255 . . . . 0.32000000000000001 112.845 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.7 m -153.15 138.03 17.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.444 -0.576 . . . . 1.3 109.444 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 m -68.63 -25.76 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 112.253 0.464 . . . . 1.1399999999999999 112.253 -173.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -73.06 -41.39 64.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.672 0.272 . . . . 2.8199999999999998 111.075 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HG3' ' SD ' ' A' ' 64' ' ' MET . 7.2 ptmm? -82.08 -17.62 45.93 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.891 -0.323 . . . . 1.3600000000000001 110.334 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.93 -61.78 2.37 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.198 -0.455 . . . . 0.20999999999999999 111.175 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.653 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -56.39 -42.58 78.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.589 0.233 . . . . 2.4199999999999999 111.09 177.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -53.44 -46.37 69.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.868 -0.605 . . . . 2.0099999999999998 112.199 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.645 ' O ' HG12 ' A' ' 76' ' ' VAL . 41.9 t -62.93 -45.07 94.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.039 0.447 . . . . 1.1399999999999999 111.185 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.419 ' HB1' HG23 ' A' ' 46' ' ' VAL . . . -68.34 -40.82 81.45 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.294 0.568 . . . . 0.17999999999999999 110.23 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.444 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -56.88 -37.57 71.56 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.274 -0.875 . . . . 0.26000000000000001 112.069 177.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.645 HG12 ' O ' ' A' ' 73' ' ' SER . 1.8 p -70.95 -26.82 28.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 O-C-N 121.917 -0.489 . . . . 0.82999999999999996 110.669 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.3 mt -78.79 -31.61 46.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.791 0.805 . . . . 0.39000000000000001 109.401 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.441 HD22 HG11 ' A' ' 46' ' ' VAL . 28.0 tp -66.88 -36.77 83.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.865 -1.061 . . . . 0.81000000000000005 110.461 175.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.6 mm? -61.21 -25.4 67.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.736 -0.666 . . . . 1.6100000000000001 110.861 175.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 44.6 mt-10 -71.71 -37.94 70.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.093 0.473 . . . . 2.1299999999999999 109.968 175.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.425 HD12 ' SG ' ' A' ' 59' ' ' CYS . 1.3 tt -62.99 -47.24 83.99 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.049 -0.723 . . . . 1.1699999999999999 109.049 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mp -74.39 0.91 12.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.191 -0.913 . . . . 1.1499999999999999 111.661 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -97.55 -14.24 21.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.763 0.792 . . . . 1.46 109.38 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 8.2 mtmp? -120.2 43.73 2.62 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.945 -1.025 . . . . 4.1699999999999999 110.188 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.251 1.134 0 CA-C-N 115.43 -0.805 . . . . 3.79 110.907 -179.569 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 111.826 0.306 . . . . 2.4900000000000002 111.826 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -70.4 -37.31 74.47 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.317 -0.239 . . . . 2.46 111.395 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.8 mp -63.95 -41.68 93.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.449 0.642 . . . . 0.80000000000000004 109.961 174.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.3 m -65.1 -42.91 93.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.029 -0.987 . . . . 1.3500000000000001 110.204 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.83 -51.98 67.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.877 -1.056 . . . . 1.1599999999999999 110.284 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -57.02 -37.08 71.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.398 -0.819 . . . . 3.8399999999999999 111.923 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -72.81 1.96 7.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.066 -0.515 . . . . 1.1000000000000001 111.975 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.2 t30 65.59 32.67 9.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.938 -1.028 . . . . 1.9199999999999999 109.699 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.469 ' CH2' HG22 ' A' ' 50' ' ' THR . 38.2 m0 -99.21 160.58 27.23 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.201 -0.909 . . . . 0.40000000000000002 109.367 175.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.42 170.65 18.78 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.126 1.884 . . . . 0.44 110.048 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 50.0 mmm -72.68 134.49 81.7 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 110.347 -0.242 . . . . 1.0 110.347 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.517 ' HB3' HG22 ' A' ' 48' ' ' VAL . 23.6 Cg_exo -63.82 161.39 32.83 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.962 2.441 . . . . 0.46000000000000002 113.117 -177.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.571 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 16.6 t -87.63 141.49 28.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.961 -1.018 . . . . 0.29999999999999999 109.841 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.439 ' HD2' ' CZ ' ' A' ' 44' ' ' PHE . 78.6 m-85 -139.56 110.67 6.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.815 -0.809 . . . . 0.29999999999999999 108.815 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.445 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 26.7 ttm180 -153.39 123.45 6.95 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.972 -0.381 . . . . 3.6899999999999999 109.972 -176.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.481 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 62.5 m -61.87 124.93 22.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.136 0.493 . . . . 1.53 111.381 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.472 ' H ' ' HA ' ' A' ' 44' ' ' PHE . 53.3 t -80.74 -29.97 11.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.615 -0.72 . . . . 1.1499999999999999 109.784 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -134.93 129.7 34.69 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.883 -0.599 . . . . 2.25 110.22 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -98.92 154.08 18.32 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.846 -1.07 . . . . 2.6000000000000001 109.892 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 40' ' ' LYS . . . -74.86 137.04 21.7 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.884 -0.674 . . . . 1.6899999999999999 112.687 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.06 -142.94 1.99 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.638 -0.315 . . . . 2.1299999999999999 112.976 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.58 -67.35 0.11 Allowed 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.997 3.131 . . . . 3.0 112.914 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.68 -41.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.994 0.426 . . . . 2.6099999999999999 109.949 175.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -71.74 5.97 2.22 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.748 -0.66 . . . . 2.1000000000000001 111.199 176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.81 31.1 1.17 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.243 -0.435 . . . . 1.28 110.272 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.53 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 31.9 tptt -84.29 20.03 1.73 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.159 -0.473 . . . . 1.9299999999999999 111.901 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -83.58 135.93 34.44 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.688 -0.805 . . . . 3.6400000000000001 109.476 174.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 5.0 m-85 -109.87 136.26 49.45 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.311 -0.859 . . . . 0.79000000000000004 110.041 -173.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.3 m -118.44 125.91 50.93 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.938 -1.134 . . . . 0.26000000000000001 107.938 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.681 ' CZ ' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -132.65 151.75 51.87 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 121.843 -0.535 . . . . 0.17000000000000001 109.802 -171.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.44 ' CA ' HD13 ' A' ' 60' ' ' ILE . . . -125.57 129.16 6.78 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.14 -0.784 . . . . 0.17000000000000001 111.14 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.681 ' HB ' ' CZ ' ' A' ' 44' ' ' PHE . 7.3 p -109.94 145.94 15.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 110.057 -0.349 . . . . 0.80000000000000004 110.057 -173.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.633 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 2.9 ptp180 -140.32 145.92 37.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.836 -0.802 . . . . 2.6200000000000001 108.836 -176.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.582 HG23 HD11 ' A' ' 78' ' ' LEU . 57.6 t -125.89 154.55 34.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.461 -0.336 . . . . 0.23999999999999999 110.29 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -93.85 83.92 4.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.61 0.719 . . . . 1.5900000000000001 110.086 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.469 HG22 ' CH2' ' A' ' 23' ' ' TRP . 30.2 p -70.96 116.43 11.25 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.523 -1.217 . . . . 0.33000000000000002 110.062 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 p -51.13 -25.72 5.6 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.583 -1.189 . . . . 1.3200000000000001 113.522 -172.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -92.95 -12.89 29.67 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.745 0.646 . . . . 1.3 112.745 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -136.74 -42.03 0.6 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.792 -0.567 . . . . 3.6800000000000002 111.703 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.15 -152.83 17.12 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.891 -0.484 . . . . 0.19 111.891 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.633 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 9.4 m95 -54.15 117.78 3.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.119 0.485 . . . . 0.39000000000000001 110.956 176.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 56.1 p -69.59 150.6 46.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.436 -0.802 . . . . 0.35999999999999999 110.315 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -61.18 116.96 4.98 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.3 -1.0 . . . . 1.8400000000000001 108.3 171.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 3.9 pt-20 -55.39 140.57 39.38 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 114.802 -1.09 . . . . 1.0 111.934 -168.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 63.8 m -97.83 101.79 13.38 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.804 -1.089 . . . . 0.35999999999999999 109.458 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.44 HD13 ' CA ' ' A' ' 45' ' ' GLY . 25.6 mm -73.54 120.33 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.575 -0.739 . . . . 0.73999999999999999 110.143 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.58 -165.25 39.3 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.934 -0.65 . . . . 0.23000000000000001 112.265 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 64' ' ' MET . 43.6 mt-10 -80.69 139.56 50.76 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.926 -0.398 . . . . 1.3700000000000001 109.926 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 32.1 Cg_exo -57.96 110.38 0.62 Allowed 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.14 1.893 . . . . 0.51000000000000001 110.415 171.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.671 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 16.9 mmt -113.06 141.33 25.43 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.086 -0.507 . . . . 0.67000000000000004 111.312 -169.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.06 9.55 2.72 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.763 2.309 . . . . 0.32000000000000001 113.132 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.3 m -154.55 137.18 15.16 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.454 -0.573 . . . . 1.3 109.454 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.4 m -65.64 -34.18 68.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.295 0.85 . . . . 1.1399999999999999 113.295 -170.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -67.32 -40.94 86.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.589 0.233 . . . . 2.8199999999999998 111.459 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.671 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 0.5 OUTLIER -81.2 -20.2 41.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.844 0.354 . . . . 1.3600000000000001 110.451 -179.339 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.38 -61.41 2.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.24 -0.436 . . . . 0.20999999999999999 111.2 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.581 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 13.2 ptmm? -56.19 -43.75 78.75 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.051 0.453 . . . . 2.4199999999999999 110.674 176.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.477 ' O ' HG23 ' A' ' 76' ' ' VAL . 36.8 t70 -51.98 -47.05 65.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.113 -0.949 . . . . 2.0099999999999998 112.022 177.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.5 t -60.65 -47.53 85.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.612 0.244 . . . . 1.1399999999999999 111.606 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.04 -38.78 89.24 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.175 0.512 . . . . 0.17999999999999999 110.488 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.404 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -54.64 -37.25 65.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.238 -0.892 . . . . 0.26000000000000001 111.294 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.492 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 91.7 t -59.16 -42.05 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 CA-C-O 120.837 0.351 . . . . 0.82999999999999996 110.849 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.2 mt -77.17 -30.42 54.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.597 0.713 . . . . 0.39000000000000001 109.661 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.582 HD11 HG23 ' A' ' 48' ' ' VAL . 40.1 tp -65.73 -44.43 86.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.808 -1.087 . . . . 0.81000000000000005 111.052 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 75' ' ' ALA . 8.6 mp -63.3 -21.57 66.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.654 -0.703 . . . . 1.6100000000000001 111.493 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 8.6 mm-40 -73.71 -38.37 64.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.348 0.594 . . . . 2.1299999999999999 109.862 173.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 tt -66.78 -46.18 76.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.013 -0.994 . . . . 1.1699999999999999 109.382 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mp -65.29 -16.7 63.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.349 -0.841 . . . . 1.1499999999999999 112.338 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -83.99 -4.93 59.09 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.484 0.659 . . . . 1.46 109.799 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -121.76 39.76 3.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.523 -0.762 . . . . 4.1699999999999999 110.484 -176.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.603 -0.713 . . . . 3.79 110.298 -179.029 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 111.84 0.311 . . . . 2.4900000000000002 111.84 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -68.42 -46.35 70.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.992 0.425 . . . . 2.46 111.189 -174.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.476 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -66.7 -34.97 73.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.637 -0.71 . . . . 0.80000000000000004 109.968 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 22.5 m -66.92 -44.68 80.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.613 -0.721 . . . . 1.3500000000000001 109.747 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.1 tp -61.39 -46.83 88.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.713 -1.131 . . . . 1.1599999999999999 110.151 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -62.26 -36.15 81.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.654 -1.157 . . . . 3.8399999999999999 111.334 -177.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 11.0 mmmm -74.15 6.03 3.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 1.1000000000000001 111.611 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.4 t30 67.03 30.8 7.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.82 0.819 . . . . 1.9199999999999999 110.268 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -96.23 158.85 33.3 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.562 -0.744 . . . . 0.40000000000000002 109.277 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.88 -171.43 0.57 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.318 2.012 . . . . 0.44 111.515 173.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.443 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 26.9 mmt -75.95 138.88 69.19 Favored Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 110.063 -0.347 . . . . 1.0 110.063 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.521 ' HB3' HG22 ' A' ' 48' ' ' VAL . 6.3 Cg_exo -72.79 164.6 35.12 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.361 2.04 . . . . 0.46000000000000002 112.468 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.428 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 23.0 t -89.57 144.17 26.23 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.261 -0.881 . . . . 0.29999999999999999 109.941 178.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.512 ' HD2' ' CZ ' ' A' ' 44' ' ' PHE . 66.0 m-85 -139.6 111.08 7.11 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.625 -0.88 . . . . 0.29999999999999999 108.625 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.472 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 20.5 ttp-105 -144.79 119.95 10.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.88 -0.415 . . . . 3.6899999999999999 109.88 -173.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 21.3 p -66.98 124.55 23.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.098 0.475 . . . . 1.53 110.534 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 43' ' ' THR . 23.3 m -85.82 -41.5 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 116.106 -0.497 . . . . 1.1499999999999999 111.102 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -137.35 128.76 28.19 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.172 -0.211 . . . . 2.25 111.32 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -148.32 141.73 25.28 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.555 0.534 . . . . 2.6000000000000001 110.206 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.95 -57.67 5.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.621 -0.799 . . . . 1.6899999999999999 113.424 173.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.39 -144.36 48.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.677 -0.773 . . . . 2.1299999999999999 111.692 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.38 -52.53 6.22 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.884 2.389 . . . . 3.0 111.149 174.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 175.26 -41.85 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.061 -0.972 . . . . 2.6099999999999999 109.502 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -80.9 18.96 0.91 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.53 -0.759 . . . . 2.1000000000000001 111.644 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.15 61.37 0.91 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.065 0.459 . . . . 1.28 110.7 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -85.37 16.88 3.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 121.381 0.61 . . . . 1.9299999999999999 110.575 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -83.07 136.86 34.33 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.109 -1.441 . . . . 3.6400000000000001 107.109 169.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -109.89 130.8 55.48 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.393 -0.595 . . . . 0.79000000000000004 109.393 -172.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 31' ' ' VAL . 5.4 m -123.19 131.84 53.83 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.994 -1.113 . . . . 0.26000000000000001 107.994 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.728 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -142.35 155.75 45.18 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.588 -0.523 . . . . 0.17000000000000001 109.588 -174.627 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.535 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -128.74 139.66 11.16 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.9 -0.667 . . . . 0.17000000000000001 112.507 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.728 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -106.74 156.8 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.767 -0.457 . . . . 0.80000000000000004 109.767 -176.307 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.599 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 18.6 ptt180 -147.28 148.27 31.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.92 -0.77 . . . . 2.6200000000000001 108.92 172.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.537 HG23 HD11 ' A' ' 78' ' ' LEU . 86.0 t -127.31 154.79 38.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.296 -0.411 . . . . 0.23999999999999999 110.616 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -91.13 84.15 5.66 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.19 0.519 . . . . 1.5900000000000001 110.248 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.2 p -70.4 115.52 9.68 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.175 -0.92 . . . . 0.33000000000000002 109.611 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.2 p -51.04 -27.19 7.4 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.724 -1.125 . . . . 1.3200000000000001 113.404 -172.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -98.81 -8.43 25.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.601 0.593 . . . . 1.3 112.601 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -129.0 -47.66 1.23 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.871 -0.518 . . . . 3.6800000000000002 111.469 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.13 -151.69 17.23 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.648 -0.706 . . . . 0.19 111.795 -175.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.599 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.7 m95 -54.85 120.4 6.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.065 0.46 . . . . 0.39000000000000001 111.051 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.5 p -73.38 162.67 29.06 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.749 -0.66 . . . . 0.35999999999999999 111.288 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -60.0 129.41 41.66 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.314 -0.625 . . . . 1.8400000000000001 109.314 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -59.03 115.08 2.91 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.714 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.463 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 59.7 m -87.92 97.6 11.03 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.924 -1.035 . . . . 0.35999999999999999 110.037 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.535 HD13 ' HA3' ' A' ' 45' ' ' GLY . 32.3 mm -76.02 123.92 33.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.449 -0.796 . . . . 0.73999999999999999 110.417 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.06 -170.49 44.8 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.987 -0.625 . . . . 0.23000000000000001 112.021 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 64' ' ' MET . 44.5 mt-10 -89.14 150.82 45.83 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 110.045 -0.354 . . . . 1.3700000000000001 110.045 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.98 109.32 1.09 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.562 2.174 . . . . 0.51000000000000001 111.378 176.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.62 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 90.9 mmm -114.94 144.46 32.05 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.119 -0.491 . . . . 0.67000000000000004 110.207 -171.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.55 12.26 2.2 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.534 2.156 . . . . 0.32000000000000001 113.537 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.5 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 19.9 m -154.86 138.96 16.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.413 -0.588 . . . . 1.3 109.413 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -66.98 -28.17 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.769 0.655 . . . . 1.1399999999999999 112.769 -170.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.01 -42.08 73.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.833 0.349 . . . . 2.8199999999999998 110.92 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.5 ' HG2' ' HB2' ' A' ' 66' ' ' SER . 4.3 ptpp? -81.48 -18.1 46.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.421 -0.354 . . . . 1.3600000000000001 110.678 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.79 -59.24 5.75 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.45 -0.341 . . . . 0.20999999999999999 110.486 172.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.623 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 57.9 mttp -52.81 -47.06 67.91 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.325 -0.398 . . . . 2.4199999999999999 110.543 175.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -50.21 -50.0 50.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.416 -0.811 . . . . 2.0099999999999998 112.128 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.584 ' O ' HG12 ' A' ' 76' ' ' VAL . 45.2 t -61.37 -44.49 97.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.83 0.347 . . . . 1.1399999999999999 111.252 -177.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.502 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -68.64 -47.42 66.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.168 0.509 . . . . 0.17999999999999999 110.867 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.446 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -55.6 -36.55 67.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.403 -0.817 . . . . 0.26000000000000001 112.059 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 73' ' ' SER . 2.0 p -71.42 -27.66 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 121.205 0.526 . . . . 0.82999999999999996 110.617 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.9 mt -79.04 -31.83 44.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.727 0.775 . . . . 0.39000000000000001 109.436 175.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.537 HD11 HG23 ' A' ' 48' ' ' VAL . 28.6 tp -63.79 -35.29 80.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.107 -0.952 . . . . 0.81000000000000005 110.406 173.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.5 mm? -62.25 -22.65 66.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.565 -0.743 . . . . 1.6100000000000001 111.449 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -69.41 -38.0 77.71 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.318 0.58 . . . . 2.1299999999999999 109.715 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 85' ' ' THR . 0.9 OUTLIER -68.31 -31.17 70.4 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.225 1.012 . . . . 1.1699999999999999 109.635 179.421 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.3 mp -84.58 -3.18 58.32 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.145 -0.934 . . . . 1.1499999999999999 112.28 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -111.68 -17.15 13.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.586 0.708 . . . . 1.46 109.81 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -147.9 148.69 31.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.919 -1.037 . . . . 4.1699999999999999 108.913 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.482 -0.77 . . . . 3.79 110.772 -166.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.1 p30 . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.515 0.198 . . . . 2.4900000000000002 111.205 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -75.08 -41.93 57.78 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.576 0.213 . . . . 2.46 111.576 -173.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.7 mp -64.41 -39.78 86.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.148 0.499 . . . . 0.80000000000000004 109.883 174.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.454 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 68.5 m -64.78 -42.64 94.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.477 -0.783 . . . . 1.3500000000000001 109.969 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.66 -45.1 91.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.872 -1.058 . . . . 1.1599999999999999 110.543 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -65.52 -35.34 80.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.33 -0.85 . . . . 3.8399999999999999 111.068 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 9.1 mmmm -76.07 4.02 9.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 1.1000000000000001 111.162 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.6 t30 66.02 38.84 4.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.248 -0.887 . . . . 1.9199999999999999 110.27 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.454 ' CE3' ' HA ' ' A' ' 18' ' ' CYS . 37.9 m0 -104.04 156.62 35.44 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.414 -0.812 . . . . 0.40000000000000002 109.431 175.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.13 -172.84 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.36 2.04 . . . . 0.44 111.05 171.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.453 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 29.4 mmt -75.19 142.9 76.08 Favored Pre-proline 0 N--CA 1.447 -0.617 0 O-C-N 122.078 -0.389 . . . . 1.0 110.511 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HB3' HG22 ' A' ' 48' ' ' VAL . 3.1 Cg_exo -76.24 165.32 29.67 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.718 2.279 . . . . 0.46000000000000002 112.864 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.3 t -83.58 141.99 31.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.247 -0.888 . . . . 0.29999999999999999 110.059 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.474 ' CD1' ' HZ ' ' A' ' 44' ' ' PHE . 66.5 m-85 -145.98 110.18 4.98 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.034 -0.728 . . . . 0.29999999999999999 109.034 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.525 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 23.7 ttm180 -158.63 128.39 5.79 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.394 -0.225 . . . . 3.6899999999999999 110.394 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.542 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 86.4 m -63.34 123.48 18.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.846 0.355 . . . . 1.53 110.688 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -84.49 -34.27 9.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.298 0.57 . . . . 1.1499999999999999 109.805 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -136.01 116.48 13.74 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.581 -0.736 . . . . 2.25 109.294 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -152.03 134.02 14.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.327 -0.397 . . . . 2.6000000000000001 110.889 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 56.96 63.91 4.89 Favored Glycine 0 C--N 1.332 0.307 0 O-C-N 123.404 0.44 . . . . 1.6899999999999999 113.637 172.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 39' ' ' ALA . . . -94.74 -155.61 31.66 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.533 -0.841 . . . . 2.1299999999999999 112.054 176.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -70.49 74.55 1.6 Allowed 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.418 2.745 . . . . 3.0 113.097 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 69.26 -65.12 0.31 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.487 0.715 . . . . 2.6099999999999999 112.48 175.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -71.49 9.72 0.77 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.592 0.357 . . . . 2.1000000000000001 111.502 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.401 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . . . -129.27 40.9 3.55 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.952 0.406 . . . . 1.28 110.855 -177.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -94.66 9.74 37.63 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 122.212 1.006 . . . . 1.9299999999999999 108.818 169.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -85.18 132.24 34.32 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.553 -1.647 . . . . 3.6400000000000001 106.553 161.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 6.9 m-85 -110.23 131.86 54.68 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.368 -0.533 . . . . 0.79000000000000004 109.777 -169.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.1 m -122.2 132.02 54.23 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.813 -1.18 . . . . 0.26000000000000001 107.813 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.716 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -142.24 153.16 43.75 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.553 -0.536 . . . . 0.17000000000000001 109.553 -173.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.504 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -127.55 140.7 12.03 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.099 -0.572 . . . . 0.17000000000000001 112.327 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.716 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 2.1 t -105.91 156.36 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 109.605 -0.517 . . . . 0.80000000000000004 109.605 -175.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 56' ' ' THR . 5.3 tpp85 -142.64 145.57 33.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.558 -0.904 . . . . 2.6200000000000001 108.558 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.719 HG23 HD11 ' A' ' 78' ' ' LEU . 61.8 t -131.36 153.11 38.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 110.058 -0.349 . . . . 0.23999999999999999 110.058 177.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -96.29 85.14 3.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.442 0.639 . . . . 1.5900000000000001 110.015 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 54' ' ' GLY . 26.2 p -69.29 106.99 3.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.69 -1.141 . . . . 0.33000000000000002 109.106 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 t -49.77 -26.8 4.19 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.834 0.679 . . . . 1.3200000000000001 112.834 -171.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -88.17 -18.27 29.11 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.428 0.529 . . . . 1.3 112.428 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -129.82 -46.29 1.15 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.015 0.436 . . . . 3.6800000000000002 111.294 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 125.6 -156.04 19.19 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.933 -0.576 . . . . 0.19 112.607 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -52.28 119.72 4.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.22 0.533 . . . . 0.39000000000000001 110.89 175.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.458 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 46.3 p -68.95 -179.26 1.43 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.987 -1.006 . . . . 0.35999999999999999 112.487 -173.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.38 132.22 43.65 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.577 -0.898 . . . . 1.8400000000000001 108.577 171.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -64.81 114.44 4.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.581 0.705 . . . . 1.0 110.766 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.482 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 61.5 m -88.19 97.82 11.22 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.56 -1.2 . . . . 0.35999999999999999 109.999 -177.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.504 HD13 ' HA3' ' A' ' 45' ' ' GLY . 26.9 mm -81.58 122.03 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.666 -0.697 . . . . 0.73999999999999999 110.07 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.76 -171.0 47.76 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.073 -0.584 . . . . 0.23000000000000001 112.428 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.597 ' O ' ' HG2' ' A' ' 64' ' ' MET . 33.0 mt-10 -81.91 146.38 55.68 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 110.023 -0.362 . . . . 1.3700000000000001 110.023 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 27.7 Cg_exo -62.8 109.62 0.94 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.487 2.125 . . . . 0.51000000000000001 110.907 171.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.597 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 89.6 mmm -115.4 149.1 42.27 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.208 -0.451 . . . . 0.67000000000000004 110.081 -172.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.2 12.33 2.34 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.594 2.196 . . . . 0.32000000000000001 113.535 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.445 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 30.0 t -154.99 142.2 19.41 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.658 -0.497 . . . . 1.3 109.658 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.6 m -68.2 -27.95 39.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.619 -0.718 . . . . 1.1399999999999999 111.946 -173.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -64.6 -50.53 66.84 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.245 0.545 . . . . 2.8199999999999998 110.851 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.445 ' HG2' ' HB3' ' A' ' 66' ' ' SER . 15.4 ptpt -79.66 -17.54 53.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.455 -0.793 . . . . 1.3600000000000001 110.708 -174.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.11 -54.28 47.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.20999999999999999 109.823 172.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.669 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 54.5 mtmt -56.05 -52.0 65.82 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.015 -0.539 . . . . 2.4199999999999999 111.018 176.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.602 ' O ' HG23 ' A' ' 76' ' ' VAL . 4.6 m-20 -53.74 -46.72 70.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.561 . . . . 2.0099999999999998 112.308 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 t -58.24 -46.01 86.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 1.1399999999999999 110.981 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.536 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -69.01 -43.42 74.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.986 -0.552 . . . . 0.17999999999999999 110.491 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.464 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -54.49 -36.93 64.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.465 -0.789 . . . . 0.26000000000000001 111.4 176.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 72' ' ' ASP . 91.0 t -63.06 -37.96 80.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 121.119 0.485 . . . . 0.82999999999999996 110.293 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.8 mt -77.85 -24.25 48.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.865 0.84 . . . . 0.39000000000000001 109.533 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.719 HD11 HG23 ' A' ' 48' ' ' VAL . 16.7 tp -69.15 -37.94 78.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.134 -0.939 . . . . 0.81000000000000005 110.468 171.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.3 mm? -65.14 -28.78 69.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.755 -0.657 . . . . 1.6100000000000001 112.146 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.617 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 8.8 pt-20 -77.27 -31.61 55.02 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.887 -0.725 . . . . 2.1299999999999999 110.085 176.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.05 -47.69 85.21 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.708 -0.849 . . . . 1.1699999999999999 108.708 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mp -71.77 -4.38 27.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.12 -0.945 . . . . 1.1499999999999999 112.036 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -93.91 -14.48 25.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.601 0.715 . . . . 1.46 109.686 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 41.1 mtpt -112.64 40.44 2.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.062 -0.972 . . . . 4.1699999999999999 110.343 -176.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.509 -0.757 . . . . 3.79 110.542 -177.594 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.8 t30 . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.596 0.236 . . . . 2.4900000000000002 110.976 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.0 -42.07 99.75 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.801 0.334 . . . . 2.46 111.357 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.5 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -65.86 -39.21 84.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.083 -0.508 . . . . 0.80000000000000004 111.007 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.464 ' SG ' ' HE3' ' A' ' 23' ' ' TRP . 36.2 t -71.61 -39.06 70.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.754 0.787 . . . . 1.3500000000000001 109.157 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 tt -64.47 -46.26 83.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.552 -1.204 . . . . 1.1599999999999999 110.079 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -61.63 -31.5 71.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.025 -0.534 . . . . 3.8399999999999999 111.412 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt -73.12 -3.88 29.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.329 0.585 . . . . 1.1000000000000001 111.447 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.0 t30 64.51 30.77 12.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.511 -1.222 . . . . 1.9199999999999999 110.173 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.464 ' HE3' ' SG ' ' A' ' 18' ' ' CYS . 33.6 m0 -89.6 165.56 24.83 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.367 -0.833 . . . . 0.40000000000000002 109.088 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 36.9 Cg_endo -69.44 -176.6 1.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 121.973 1.782 . . . . 0.44 111.186 170.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.405 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 21.4 mmt -74.77 137.52 73.57 Favored Pre-proline 0 C--N 1.323 -0.566 0 O-C-N 122.257 -0.277 . . . . 1.0 110.366 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.479 ' HB3' HG22 ' A' ' 48' ' ' VAL . 9.5 Cg_exo -70.04 161.69 45.04 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.812 2.342 . . . . 0.46000000000000002 112.457 -177.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.5 t -88.12 138.03 31.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.411 -0.813 . . . . 0.29999999999999999 110.191 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.529 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 63.3 m-85 -143.78 111.28 5.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.651 -0.5 . . . . 0.29999999999999999 109.651 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.48 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 79.3 ttt180 -164.17 131.61 3.32 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.977 -0.379 . . . . 3.6899999999999999 109.977 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 8.8 p -64.53 130.6 44.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.054 0.454 . . . . 1.53 111.326 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.5 t -86.32 -28.45 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.666 -0.697 . . . . 1.1499999999999999 109.9 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -136.25 120.74 18.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.169 -0.678 . . . . 2.25 109.169 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.486 ' HG2' ' CD1' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -150.84 126.11 10.01 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.007 -0.542 . . . . 2.6000000000000001 109.775 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.65 165.65 39.59 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.601 -0.809 . . . . 1.6899999999999999 112.547 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.84 -155.57 26.85 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 111.567 -0.613 . . . . 2.1299999999999999 111.567 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.09 -71.44 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 123.378 2.719 . . . . 3.0 112.673 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.64 -47.85 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.216 0.532 . . . . 2.6099999999999999 109.86 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -80.84 18.48 0.99 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.517 -0.765 . . . . 2.1000000000000001 111.186 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -122.05 32.17 5.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.138 0.494 . . . . 1.28 110.85 -177.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 27.8 tptt -93.39 17.1 11.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 122.015 0.912 . . . . 1.9299999999999999 109.369 174.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -85.53 137.86 32.59 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.479 -1.237 . . . . 3.6400000000000001 107.948 167.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 8.2 m-85 -109.05 133.84 52.46 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.823 -0.626 . . . . 0.79000000000000004 110.438 -169.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.1 m -119.8 116.33 25.66 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.851 -1.166 . . . . 0.26000000000000001 107.851 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.71 ' CE2' ' HA ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -126.93 153.1 46.25 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.898 -0.408 . . . . 0.17000000000000001 109.898 -170.06 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -126.87 140.38 11.89 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.574 -0.61 . . . . 0.17000000000000001 111.574 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.75 HG11 HD22 ' A' ' 78' ' ' LEU . 1.7 t -105.66 156.1 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.636 -0.505 . . . . 0.80000000000000004 109.636 -175.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.729 ' HD2' ' O ' ' A' ' 56' ' ' THR . 0.4 OUTLIER -142.24 145.87 34.55 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.478 -0.934 . . . . 2.6200000000000001 108.478 177.591 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.652 HG23 HD11 ' A' ' 78' ' ' LEU . 38.8 t -132.08 150.71 33.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.544 -0.298 . . . . 0.23999999999999999 110.293 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -94.61 83.66 4.14 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.825 0.821 . . . . 1.5900000000000001 109.528 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.418 HG22 ' CH2' ' A' ' 23' ' ' TRP . 23.0 p -75.0 101.23 4.4 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.192 -1.367 . . . . 0.33000000000000002 109.21 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t -43.76 -35.24 1.8 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.84 0.856 . . . . 1.3200000000000001 113.173 -170.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.86 -33.36 72.95 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.598 0.592 . . . . 1.3 112.598 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -131.12 -38.6 1.22 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.806 0.336 . . . . 3.6800000000000002 111.875 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.24 -151.96 16.88 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 116.253 -0.431 . . . . 0.19 112.272 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -52.91 126.24 19.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.172 0.51 . . . . 0.39000000000000001 110.858 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.729 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 37.4 p -74.2 -174.71 2.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.351 -0.84 . . . . 0.35999999999999999 112.372 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -76.62 169.92 17.39 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.82 -1.178 . . . . 1.8400000000000001 107.82 165.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -92.34 119.78 32.23 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.222 0.534 . . . . 1.0 111.372 -171.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.462 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 28.6 m -85.46 97.61 10.13 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.104 -0.953 . . . . 0.35999999999999999 109.293 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.411 HD13 ' HA3' ' A' ' 45' ' ' GLY . 26.4 mm -86.92 121.16 37.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.196 -0.456 . . . . 0.73999999999999999 110.613 -177.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.64 -174.47 49.94 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.835 -0.698 . . . . 0.23000000000000001 111.519 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.657 ' O ' ' HG2' ' A' ' 64' ' ' MET . 42.8 mm-40 -85.89 148.41 48.21 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.687 0.244 . . . . 1.3700000000000001 110.452 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 40.7 Cg_exo -57.26 109.14 0.42 Allowed 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.571 2.18 . . . . 0.51000000000000001 111.186 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.657 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.0 mmm -117.32 149.97 45.55 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.692 -0.484 . . . . 0.67000000000000004 109.692 -172.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -80.77 15.01 1.9 Allowed 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.539 2.16 . . . . 0.32000000000000001 114.817 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.1 t -163.8 145.87 9.35 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.96 -0.463 . . . . 1.3 110.402 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.4 t -59.18 -50.98 77.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.315 0.487 . . . . 1.1399999999999999 112.315 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -55.57 -43.81 76.27 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.202 0.445 . . . . 2.8199999999999998 112.202 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.88 -21.89 40.26 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.991 -0.284 . . . . 1.3600000000000001 110.607 -178.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.91 -56.15 19.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.756 -0.202 . . . . 0.20999999999999999 111.039 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.71 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 32.3 pttt -56.6 -42.04 78.04 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 120.917 0.389 . . . . 2.4199999999999999 110.129 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.505 ' O ' HG23 ' A' ' 76' ' ' VAL . 31.3 t70 -54.17 -47.7 71.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.544 -0.753 . . . . 2.0099999999999998 112.068 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.4 t -60.09 -45.84 91.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.34 . . . . 1.1399999999999999 111.457 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.451 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -69.87 -40.6 75.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.039 0.447 . . . . 0.17999999999999999 110.925 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.431 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -52.52 -33.97 47.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.505 -0.771 . . . . 0.26000000000000001 111.307 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 72' ' ' ASP . 96.9 t -61.24 -37.41 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.967 0.413 . . . . 0.82999999999999996 110.739 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.1 mt -77.29 -33.09 55.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.75 0.785 . . . . 0.39000000000000001 109.597 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.75 HD22 HG11 ' A' ' 46' ' ' VAL . 15.3 tp -65.5 -40.83 93.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.716 -1.129 . . . . 0.81000000000000005 110.58 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.431 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.2 mp -61.57 -26.14 67.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.435 -0.802 . . . . 1.6100000000000001 111.045 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.82 -35.55 62.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.239 0.543 . . . . 2.1299999999999999 110.076 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.41 -46.17 77.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.35 -0.841 . . . . 1.1699999999999999 109.329 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mp -70.45 -9.8 57.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.295 -0.866 . . . . 1.1499999999999999 111.971 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -86.41 -7.54 58.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.679 0.752 . . . . 1.46 109.456 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -113.5 44.73 1.53 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.217 -0.901 . . . . 4.1699999999999999 109.896 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.8 p . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.487 -0.768 . . . . 3.79 110.339 -179.402 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.5 p30 . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 111.425 0.158 . . . . 2.4900000000000002 111.425 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.4 -44.69 78.21 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.816 0.302 . . . . 2.46 111.816 -172.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.464 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.7 mp -66.02 -35.83 76.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.041 0.448 . . . . 0.80000000000000004 110.52 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.433 ' SG ' HG13 ' A' ' 48' ' ' VAL . 47.3 t -69.54 -40.52 76.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.631 0.729 . . . . 1.3500000000000001 109.512 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.1 tp -63.73 -49.53 72.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.867 -1.061 . . . . 1.1599999999999999 110.661 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -61.0 -36.63 79.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.383 -0.826 . . . . 3.8399999999999999 111.745 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -73.29 8.75 1.55 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 1.1000000000000001 111.985 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.3 t30 60.21 34.67 21.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.261 -0.881 . . . . 1.9199999999999999 110.065 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.627 ' HD1' ' HG ' ' A' ' 51' ' ' SER . 41.6 m0 -97.12 163.34 20.17 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 114.93 -1.032 . . . . 0.40000000000000002 108.818 174.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 44.3 Cg_endo -70.0 -168.33 0.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.029 1.819 . . . . 0.44 111.497 173.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.7 mmt -80.18 136.26 53.7 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.97 -0.381 . . . . 1.0 109.97 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HB3' HG22 ' A' ' 48' ' ' VAL . 6.4 Cg_exo -71.42 162.8 41.18 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.597 2.198 . . . . 0.46000000000000002 112.24 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.7 t -87.36 140.14 29.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.568 -0.742 . . . . 0.29999999999999999 109.759 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.562 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 66.4 m-85 -140.8 109.82 6.13 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.265 -1.013 . . . . 0.29999999999999999 108.265 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.584 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 33.8 ptt180 -145.24 130.71 18.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.891 0.377 . . . . 3.6899999999999999 110.524 -173.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.53 ' SG ' ' HB2' ' A' ' 33' ' ' GLU . 43.9 t -65.76 119.84 11.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.201 -0.454 . . . . 1.53 110.529 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.3 t -86.73 -42.93 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.975 -0.557 . . . . 1.1499999999999999 110.737 -177.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -137.83 126.82 24.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.751 0.31 . . . . 2.25 110.664 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.571 ' HG3' ' CD1' ' A' ' 42' ' ' PHE . 40.2 tt0 -150.13 141.01 22.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.849 -0.614 . . . . 2.6000000000000001 109.699 175.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.68 -161.84 46.58 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.555 -0.831 . . . . 1.6899999999999999 112.687 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.59 -149.17 20.75 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.07 -0.812 . . . . 2.1299999999999999 111.07 -174.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -52.17 -65.75 0.13 Allowed 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 123.018 2.478 . . . . 3.0 111.884 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -173.41 -41.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.291 0.567 . . . . 2.6099999999999999 109.784 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -81.35 19.11 1.01 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.579 -0.737 . . . . 2.1000000000000001 111.528 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -119.42 43.13 2.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.972 0.415 . . . . 1.28 111.655 -173.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -87.98 17.16 5.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.616 0.722 . . . . 1.9299999999999999 109.69 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -85.75 132.99 34.02 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.799 -1.186 . . . . 3.6400000000000001 107.799 169.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.571 ' CD1' ' HG3' ' A' ' 33' ' ' GLU . 6.8 m-85 -109.0 141.2 41.45 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.966 0.413 . . . . 0.79000000000000004 110.57 -169.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.4 m -129.93 124.77 33.89 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.551 -0.75 . . . . 0.26000000000000001 109.172 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.691 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -132.96 156.89 46.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.652 -0.499 . . . . 0.17000000000000001 109.652 -173.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -130.12 142.06 13.29 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.912 -0.661 . . . . 0.17000000000000001 112.015 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.691 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.5 t -105.36 156.29 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 117.027 0.413 . . . . 0.80000000000000004 110.286 -174.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.519 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -137.01 142.04 42.51 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.928 -1.138 . . . . 2.6200000000000001 107.928 178.717 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.474 HG23 HD11 ' A' ' 78' ' ' LEU . 39.6 t -132.68 149.96 32.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 110.609 -0.145 . . . . 0.23999999999999999 110.609 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -99.86 88.43 3.78 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.632 0.73 . . . . 1.5900000000000001 110.889 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.5 p -68.52 113.33 5.96 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.38 -1.282 . . . . 0.33000000000000002 109.634 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.627 ' HG ' ' HD1' ' A' ' 23' ' ' TRP . 52.3 m -49.22 -25.99 2.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.311 -0.858 . . . . 1.3200000000000001 113.265 -176.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -93.45 -16.78 24.18 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.527 0.566 . . . . 1.3 112.527 -176.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -134.9 -46.72 0.73 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.035 0.445 . . . . 3.6800000000000002 111.315 -172.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.12 -156.59 19.08 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.8 -0.636 . . . . 0.19 112.698 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.519 ' CZ3' ' HB3' ' A' ' 47' ' ' ARG . 20.4 m95 -52.77 121.75 7.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.149 0.5 . . . . 0.39000000000000001 111.312 176.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 42.3 p -73.42 177.41 5.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.478 -0.783 . . . . 0.35999999999999999 111.912 -175.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -66.88 133.07 49.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.076 -0.713 . . . . 1.8400000000000001 109.076 172.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.477 ' HB2' ' NH1' ' A' ' 47' ' ' ARG . 26.0 tt0 -65.39 110.75 2.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.24 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.494 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 62.0 m -84.89 97.65 9.88 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.567 -1.197 . . . . 0.35999999999999999 109.913 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.478 HD13 ' HA3' ' A' ' 45' ' ' GLY . 32.1 mm -76.96 124.13 34.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.428 -0.805 . . . . 0.73999999999999999 110.599 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.75 -170.28 46.87 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.922 -0.581 . . . . 0.23000000000000001 112.657 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.621 ' O ' ' HG2' ' A' ' 64' ' ' MET . 36.6 mt-10 -83.93 151.34 60.55 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-O 120.603 0.239 . . . . 1.3700000000000001 110.995 -175.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.71 99.22 0.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.754 2.303 . . . . 0.51000000000000001 110.961 170.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.621 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 92.4 mmm -113.59 138.64 22.68 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.514 -0.312 . . . . 0.67000000000000004 110.561 -170.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.79 7.35 2.82 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.669 2.246 . . . . 0.32000000000000001 113.422 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.4 t -144.85 136.79 25.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.113 -0.699 . . . . 1.3 109.113 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.23 -28.11 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.897 -0.592 . . . . 1.1399999999999999 111.726 -175.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -67.99 -43.21 79.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.11 -0.495 . . . . 2.8199999999999998 110.481 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 43.5 mtpt -74.21 -26.29 60.17 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.077 -0.511 . . . . 1.3600000000000001 109.745 -176.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.73 -58.98 6.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.875 -0.602 . . . . 0.20999999999999999 110.581 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.669 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 66.3 mttm -54.1 -51.72 63.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.391 -0.368 . . . . 2.4199999999999999 111.07 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.56 ' O ' HG23 ' A' ' 76' ' ' VAL . 18.3 m-20 -53.45 -49.04 68.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.828 -0.624 . . . . 2.0099999999999998 112.672 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.5 p -64.13 -38.68 91.93 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.922 -0.311 . . . . 1.1399999999999999 111.253 -175.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.422 ' HB1' HG23 ' A' ' 46' ' ' VAL . . . -67.83 -46.18 72.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.31 0.576 . . . . 0.17999999999999999 110.301 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.493 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -53.31 -36.4 61.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.9 -1.046 . . . . 0.26000000000000001 111.628 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 72' ' ' ASP . 96.1 t -63.83 -36.95 78.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.946 0.403 . . . . 0.82999999999999996 110.763 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.7 mt -77.92 -28.9 49.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.738 0.78 . . . . 0.39000000000000001 109.833 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.583 HD22 HG11 ' A' ' 46' ' ' VAL . 19.3 tp -66.54 -45.1 80.53 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.954 -1.021 . . . . 0.81000000000000005 110.589 173.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.493 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.0 mp -62.96 -30.75 71.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.441 -0.799 . . . . 1.6100000000000001 112.358 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -78.87 -30.84 45.29 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.013 -0.675 . . . . 2.1299999999999999 110.389 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.7 tt -65.19 -45.0 86.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.673 -0.862 . . . . 1.1699999999999999 108.673 174.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mp -65.53 -20.65 66.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.928 -1.033 . . . . 1.1499999999999999 111.878 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.38 -4.83 59.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.778 0.799 . . . . 1.46 109.172 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -115.9 38.52 3.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.255 -0.884 . . . . 4.1699999999999999 109.574 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.8 p . . . . . 0 C--O 1.249 1.041 0 CA-C-N 115.111 -0.95 . . . . 3.79 110.96 -177.821 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.565 ' N ' HD21 ' A' ' 15' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 120.297 0.094 . . . . 2.4900000000000002 111.152 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -65.67 -42.59 91.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.396 0.141 . . . . 2.46 111.146 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.4 mp -59.62 -41.56 85.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.869 0.366 . . . . 0.80000000000000004 110.593 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.0 t -71.86 -42.23 67.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.925 -0.579 . . . . 1.3500000000000001 109.955 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.9 tp -61.92 -48.73 79.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.282 -0.872 . . . . 1.1599999999999999 110.443 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -56.61 -37.36 70.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.954 -1.021 . . . . 3.8399999999999999 111.854 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -73.45 0.37 12.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.291 -0.413 . . . . 1.1000000000000001 111.426 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.5 t30 70.99 20.26 5.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.206 -0.906 . . . . 1.9199999999999999 110.172 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -86.81 158.57 53.42 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.433 -0.803 . . . . 0.40000000000000002 109.723 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.94 -168.82 0.25 Allowed 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 122.425 2.084 . . . . 0.44 111.449 174.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 7.2 mmt -83.6 134.93 44.0 Favored Pre-proline 0 C--N 1.322 -0.624 0 O-C-N 122.032 -0.417 . . . . 1.0 109.91 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.479 ' HB3' HG22 ' A' ' 48' ' ' VAL . 15.8 Cg_exo -67.14 166.99 21.26 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.807 2.338 . . . . 0.46000000000000002 113.133 -177.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.523 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 33.0 t -84.74 144.01 28.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.998 -1.001 . . . . 0.29999999999999999 109.898 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.494 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 72.4 m-85 -142.96 110.78 5.91 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.826 -0.805 . . . . 0.29999999999999999 108.826 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.499 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 45.6 ttm105 -156.64 124.14 5.4 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.522 -0.547 . . . . 3.6899999999999999 109.522 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -69.23 128.0 35.08 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.062 -0.517 . . . . 1.53 110.184 -176.559 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.85 -33.92 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.287 0.565 . . . . 1.1499999999999999 109.625 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -134.94 128.58 32.79 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.418 -0.81 . . . . 2.25 109.605 171.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -145.58 138.77 26.23 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.847 -0.427 . . . . 2.6000000000000001 109.847 175.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.47 -150.8 44.0 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.233 -0.984 . . . . 1.6899999999999999 111.902 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.31 -162.06 12.89 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 110.455 -1.058 . . . . 2.1299999999999999 110.455 -173.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 39' ' ' ALA . 32.0 Cg_exo -60.53 160.49 23.91 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.338 2.025 . . . . 3.0 112.132 177.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.32 -45.6 54.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.153 0.427 . . . . 2.6099999999999999 112.153 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -71.71 -13.99 61.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 2.1000000000000001 111.742 -177.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.427 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . . . -117.01 38.4 3.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.804 0.335 . . . . 1.28 111.3 -174.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -84.14 20.39 1.59 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.11 0.481 . . . . 1.9299999999999999 110.551 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -82.67 139.59 33.61 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.77 -1.196 . . . . 3.6400000000000001 107.77 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 7.5 m-85 -111.14 130.82 55.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.112 0.482 . . . . 0.79000000000000004 110.028 -173.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.4 m -118.47 127.59 53.8 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.874 -1.158 . . . . 0.26000000000000001 107.874 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.7 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -138.5 150.58 46.55 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.317 -0.623 . . . . 0.17000000000000001 109.317 -174.14 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.31 141.08 12.26 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.915 -0.66 . . . . 0.17000000000000001 112.313 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.7 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -107.37 156.05 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.628 -0.508 . . . . 0.80000000000000004 109.628 -176.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.632 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 16.7 ptp180 -145.67 147.82 32.39 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.806 -0.813 . . . . 2.6200000000000001 108.806 173.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.637 HG23 HD11 ' A' ' 78' ' ' LEU . 94.2 t -124.79 152.26 30.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 123.086 0.241 . . . . 0.23999999999999999 110.64 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -95.14 85.25 4.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.708 0.766 . . . . 1.5900000000000001 110.146 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.1 p -67.26 112.9 4.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.346 -1.297 . . . . 0.33000000000000002 109.365 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -52.48 -26.46 12.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.659 -0.7 . . . . 1.3200000000000001 112.215 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -94.85 -16.42 22.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.506 0.558 . . . . 1.3 112.506 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -132.63 -46.55 0.88 Allowed 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.934 -0.479 . . . . 3.6800000000000002 111.493 -175.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.13 -158.07 20.9 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.13 -0.557 . . . . 0.19 113.142 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.632 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.1 m95 -52.48 118.53 3.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.863 0.364 . . . . 0.39000000000000001 110.719 175.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.4 p -71.75 161.35 31.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.786 -0.643 . . . . 0.35999999999999999 111.005 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -61.66 125.77 24.98 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.131 -0.692 . . . . 1.8400000000000001 109.131 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.417 ' HG2' HD12 ' A' ' 60' ' ' ILE . 33.5 tt0 -59.49 124.81 21.28 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.246 -0.888 . . . . 1.0 111.245 -173.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 52.7 m -96.75 99.09 10.7 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.73 -1.123 . . . . 0.35999999999999999 110.361 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.417 HD12 ' HG2' ' A' ' 58' ' ' GLU . 1.7 mp -76.57 126.93 37.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.918 -0.583 . . . . 0.73999999999999999 110.37 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.57 -166.82 41.88 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.436 -0.802 . . . . 0.23000000000000001 112.634 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 46.9 mt-10 -91.24 135.94 27.7 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 110.096 -0.335 . . . . 1.3700000000000001 110.096 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 50.4 Cg_exo -54.8 115.23 2.27 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.101 2.534 . . . . 0.51000000000000001 112.174 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 14.7 mmt -112.93 152.22 44.71 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.766 -0.652 . . . . 0.67000000000000004 111.236 -172.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -85.25 9.88 3.95 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.666 2.244 . . . . 0.32000000000000001 112.911 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -155.63 138.63 15.44 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.477 -0.564 . . . . 1.3 109.477 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.06 -27.88 42.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.588 -0.733 . . . . 1.1399999999999999 112.748 -170.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -72.17 -42.3 66.07 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.822 -0.351 . . . . 2.8199999999999998 111.045 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -80.74 -18.01 49.16 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.914 -0.315 . . . . 1.3600000000000001 110.316 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.39 -59.22 5.47 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.337 -0.392 . . . . 0.20999999999999999 110.391 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.628 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 8.9 mtmp? -51.85 -47.1 64.58 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 116.303 -0.408 . . . . 2.4199999999999999 111.16 175.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.545 ' O ' HG23 ' A' ' 76' ' ' VAL . 15.0 m-20 -50.86 -51.56 50.13 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.404 0.44 . . . . 2.0099999999999998 112.074 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.9 t -60.66 -43.75 97.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.638 0.256 . . . . 1.1399999999999999 111.249 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.64 -43.0 77.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.074 0.464 . . . . 0.17999999999999999 110.53 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.471 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -54.24 -38.19 65.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.338 -0.846 . . . . 0.26000000000000001 111.454 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 72' ' ' ASP . 99.0 t -65.37 -36.53 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-O 120.815 0.34 . . . . 0.82999999999999996 110.757 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.7 mt -73.95 -34.43 64.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.784 0.802 . . . . 0.39000000000000001 109.208 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.637 HD11 HG23 ' A' ' 48' ' ' VAL . 28.5 tp -65.51 -43.05 91.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.401 -1.272 . . . . 0.81000000000000005 110.887 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.2 mp -62.57 -24.94 67.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.704 -0.68 . . . . 1.6100000000000001 111.134 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 76' ' ' VAL . 39.5 mt-10 -74.01 -39.52 63.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.159 0.504 . . . . 2.1299999999999999 109.68 175.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.99 -51.7 65.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.331 -0.85 . . . . 1.1699999999999999 110.324 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.534 HD11 HG21 ' A' ' 48' ' ' VAL . 34.6 mt -65.76 -18.1 65.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.578 -1.192 . . . . 1.1499999999999999 111.594 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -88.98 -1.62 58.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.04 0.924 . . . . 1.46 109.352 176.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 28.4 mtpp -107.46 -146.55 0.4 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.564 -1.198 . . . . 4.1699999999999999 108.763 175.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.25 1.131 0 O-C-N 124.373 1.046 . . . . 3.79 112.591 176.374 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.562 ' N ' HD21 ' A' ' 15' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.292 0 N-CA-C 111.878 0.325 . . . . 2.4900000000000002 111.878 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -66.68 -41.65 87.77 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.884 0.374 . . . . 2.46 111.478 -171.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.8 mp -69.29 -42.61 81.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.193 -0.458 . . . . 0.80000000000000004 110.807 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.62 ' SG ' ' HG3' ' A' ' 26' ' ' PRO . 42.8 t -60.21 -38.78 84.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.572 0.701 . . . . 1.3500000000000001 109.985 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.5 tp -63.78 -43.99 94.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.767 -1.106 . . . . 1.1599999999999999 110.355 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -66.9 -33.12 74.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.652 -1.158 . . . . 3.8399999999999999 111.529 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 28.9 mmmt -73.95 6.54 3.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 1.1000000000000001 111.469 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.0 t30 61.9 28.75 17.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.132 -0.94 . . . . 1.9199999999999999 110.522 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.488 ' CH2' HG22 ' A' ' 50' ' ' THR . 37.1 m0 -91.03 162.92 31.37 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.487 -0.779 . . . . 0.40000000000000002 109.051 174.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HG3' HD22 ' A' ' 49' ' ' ASN . 33.9 Cg_endo -67.45 -170.31 0.25 Allowed 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 121.984 1.79 . . . . 0.44 111.535 173.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.44 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 1.6 mmt -81.8 130.98 58.73 Favored Pre-proline 0 C--N 1.321 -0.643 0 O-C-N 122.036 -0.415 . . . . 1.0 110.281 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.62 ' HG3' ' SG ' ' A' ' 18' ' ' CYS . 11.0 Cg_exo -68.46 168.01 20.87 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.632 2.221 . . . . 0.46000000000000002 112.192 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.8 t -88.82 137.56 32.21 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.543 -0.753 . . . . 0.29999999999999999 110.052 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.49 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 84.9 m-85 -146.46 109.35 4.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.632 -0.507 . . . . 0.29999999999999999 109.632 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.436 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 78.9 ttt180 -160.07 130.17 5.41 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 110.066 -0.346 . . . . 3.6899999999999999 110.066 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.431 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 63.5 m -61.78 126.42 27.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.076 0.465 . . . . 1.53 110.809 -178.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.22 -39.58 12.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.804 -0.634 . . . . 1.1499999999999999 111.326 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 32.3 mmtt -136.8 171.34 14.65 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.022 0.439 . . . . 2.25 111.884 -173.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -149.67 158.41 44.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.134 -0.939 . . . . 2.6000000000000001 109.264 -175.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.45 -78.98 0.2 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.494 -0.86 . . . . 1.6899999999999999 113.801 -173.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.92 -126.47 1.94 Allowed Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.424 -0.67 . . . . 2.1299999999999999 111.424 -171.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -67.18 -172.2 0.33 Allowed 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 123.887 3.058 . . . . 3.0 112.362 173.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.97 -37.9 72.24 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.459 0.54 . . . . 2.6099999999999999 112.459 -174.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -73.08 -13.16 61.15 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.221 0.452 . . . . 2.1000000000000001 112.221 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -126.69 99.16 5.66 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.048 -0.353 . . . . 1.28 110.048 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -128.3 20.92 6.22 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.276 -0.638 . . . . 1.9299999999999999 109.276 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.598 ' HD3' ' H ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -83.74 131.96 34.88 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.002 -0.679 . . . . 3.6400000000000001 109.624 -177.157 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -109.54 139.88 44.0 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.96 -1.018 . . . . 0.79000000000000004 109.448 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 32' ' ' LYS . 32.9 m -123.66 123.77 41.29 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.462 -0.94 . . . . 0.26000000000000001 108.462 -175.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.662 ' CZ ' ' HB ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -125.82 152.27 45.67 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.609 -0.515 . . . . 0.17000000000000001 109.609 -173.728 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.22 126.94 5.92 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.455 -0.658 . . . . 0.17000000000000001 111.455 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.662 ' HB ' ' CZ ' ' A' ' 44' ' ' PHE . 7.4 p -109.27 149.26 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 110.002 -0.37 . . . . 0.80000000000000004 110.002 -176.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.559 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 11.2 ptt180 -145.14 150.48 36.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.017 -0.735 . . . . 2.6200000000000001 109.017 176.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 26' ' ' PRO . 67.4 t -125.99 155.45 35.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.022 -0.535 . . . . 0.23999999999999999 111.005 -176.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.403 HD22 ' HG3' ' A' ' 24' ' ' PRO . 54.9 t30 -95.6 83.78 3.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.758 0.789 . . . . 1.5900000000000001 110.061 178.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.488 HG22 ' CH2' ' A' ' 23' ' ' TRP . 24.9 p -69.56 112.24 5.93 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.163 -1.38 . . . . 0.33000000000000002 109.446 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.5 t -50.74 -23.61 2.82 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.961 0.726 . . . . 1.3200000000000001 112.961 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -77.89 -29.54 50.29 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.129 0.789 . . . . 1.3 113.129 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -138.11 -36.62 0.59 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.599 -0.441 . . . . 3.6800000000000002 111.977 -173.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.6 -147.86 17.29 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.904 -0.665 . . . . 0.19 112.663 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.559 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.3 m95 -49.8 119.93 3.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.315 0.579 . . . . 0.39000000000000001 111.891 177.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -73.91 167.12 22.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.248 -0.887 . . . . 0.35999999999999999 110.721 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -63.06 128.57 36.47 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.259 -0.645 . . . . 1.8400000000000001 109.259 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.39 114.44 3.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.566 0.698 . . . . 1.0 110.511 -176.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.1 m -90.93 102.63 15.4 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.707 -1.133 . . . . 0.35999999999999999 110.328 -175.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.08 122.25 26.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.649 -0.705 . . . . 0.73999999999999999 110.228 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -78.36 -173.14 41.61 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.687 -0.688 . . . . 0.23000000000000001 112.566 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 64' ' ' MET . 50.6 mt-10 -86.15 137.6 35.01 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 110.289 -0.263 . . . . 1.3700000000000001 110.289 -177.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.07 104.92 0.13 Allowed 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 123.071 2.514 . . . . 0.51000000000000001 111.566 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.651 ' SD ' ' HE2' ' A' ' 69' ' ' LYS . 16.5 mmt -113.15 147.36 37.15 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.578 -0.737 . . . . 0.67000000000000004 111.133 -172.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.71 13.21 2.17 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.717 2.278 . . . . 0.32000000000000001 113.241 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.8 t -155.61 138.91 15.71 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.451 -0.574 . . . . 1.3 109.451 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.06 -23.23 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.146 -0.479 . . . . 1.1399999999999999 112.244 -172.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -71.45 -45.33 62.88 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.748 0.309 . . . . 2.8199999999999998 110.786 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.651 ' HE2' ' SD ' ' A' ' 64' ' ' MET . 19.0 ptmt -81.79 -16.94 49.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.367 -0.379 . . . . 1.3600000000000001 110.377 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.78 -56.0 27.1 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.018 -0.537 . . . . 0.20999999999999999 109.868 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.603 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 56.6 mtpt -49.91 -51.59 39.59 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 115.995 -0.548 . . . . 2.4199999999999999 111.543 174.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.575 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.7 m-20 -51.96 -47.48 64.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.765 0.654 . . . . 2.0099999999999998 112.765 -177.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 83.9 p -62.78 -39.14 93.29 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.69 -0.404 . . . . 1.1399999999999999 111.251 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.6 -38.97 70.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.304 0.573 . . . . 0.17999999999999999 110.025 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.57 -30.75 69.98 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.389 -0.823 . . . . 0.26000000000000001 111.54 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 72' ' ' ASP . 96.1 t -70.35 -32.59 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.191 0.52 . . . . 0.82999999999999996 110.31 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.6 mt -73.86 -27.48 61.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.042 0.925 . . . . 0.39000000000000001 109.218 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.511 HD11 HG23 ' A' ' 48' ' ' VAL . 12.3 tp -65.72 -33.58 76.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.679 -1.146 . . . . 0.81000000000000005 109.931 173.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 76' ' ' VAL . 3.1 mm? -60.72 -38.67 85.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.909 -0.587 . . . . 1.6100000000000001 111.961 177.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -81.0 -33.42 33.69 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.489 -0.484 . . . . 2.1299999999999999 110.245 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.31 -53.32 59.08 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.294 -0.632 . . . . 1.1699999999999999 109.294 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.34 -3.24 5.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.981 -1.009 . . . . 1.1499999999999999 112.204 174.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.58 -6.56 25.15 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.641 -0.874 . . . . 1.46 108.641 176.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -114.16 30.82 7.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.12 -0.946 . . . . 4.1699999999999999 109.79 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.3 p . . . . . 0 C--O 1.25 1.101 0 CA-C-N 114.898 -1.046 . . . . 3.79 110.375 -177.506 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 111.783 0.29 . . . . 2.4900000000000002 111.783 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -64.98 -40.65 95.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.64 0.257 . . . . 2.46 111.303 -173.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.472 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -64.58 -41.88 93.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.006 0.431 . . . . 0.80000000000000004 110.315 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.44 ' SG ' ' HE3' ' A' ' 23' ' ' TRP . 19.6 t -64.96 -42.02 94.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.59 -0.732 . . . . 1.3500000000000001 109.568 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.9 tp -60.85 -48.18 82.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.86 -1.064 . . . . 1.1599999999999999 110.53 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.44 -36.12 75.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.001 -0.999 . . . . 3.8399999999999999 110.981 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 30.2 mmmt -74.0 2.8 7.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.869 -0.605 . . . . 1.1000000000000001 111.574 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 71.77 20.68 4.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.065 0.936 . . . . 1.9199999999999999 109.71 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.44 ' HE3' ' SG ' ' A' ' 18' ' ' CYS . 35.3 m0 -91.93 155.35 43.32 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.403 -0.817 . . . . 0.40000000000000002 109.437 175.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 49' ' ' ASN . 45.9 Cg_exo -63.56 -173.73 0.19 Allowed 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.808 2.338 . . . . 0.44 111.795 168.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.492 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 21.7 mmt -81.99 131.46 56.77 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.308 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.569 ' HB3' HG22 ' A' ' 48' ' ' VAL . 22.3 Cg_exo -62.98 160.26 34.59 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.715 2.277 . . . . 0.46000000000000002 112.822 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.46 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 13.6 t -84.79 142.01 30.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.21 -0.905 . . . . 0.29999999999999999 109.791 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.485 ' CD2' ' CZ ' ' A' ' 44' ' ' PHE . 71.2 m-85 -139.54 110.96 7.05 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.81 -0.811 . . . . 0.29999999999999999 108.81 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.526 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 43.3 ttt180 -145.5 122.86 11.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.521 0.201 . . . . 3.6899999999999999 110.525 -174.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.5 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 76.5 m -63.57 120.81 12.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.766 0.317 . . . . 1.53 110.569 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.8 m -86.05 -38.54 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.314 -0.403 . . . . 1.1499999999999999 111.105 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -136.36 127.75 28.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.865 0.364 . . . . 2.25 110.882 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -112.0 144.49 41.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.756 -0.656 . . . . 2.6000000000000001 109.397 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 40' ' ' LYS . . . -73.12 154.5 49.59 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.704 -0.76 . . . . 1.6899999999999999 113.487 -173.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.69 -132.46 0.37 Allowed Glycine 0 N--CA 1.452 -0.281 0 O-C-N 123.919 0.423 . . . . 2.1299999999999999 113.938 -176.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -42.18 -71.91 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 124.858 3.706 . . . . 3.0 114.015 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.08 -37.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 2.6099999999999999 110.537 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 39.1 p-80 -73.5 7.65 2.24 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.116 -0.493 . . . . 2.1000000000000001 111.195 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.89 32.88 0.92 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.106 -0.497 . . . . 1.28 110.216 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 20.4 tptt -79.03 23.28 0.36 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.186 0.517 . . . . 1.9299999999999999 111.517 -175.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -81.18 133.22 35.42 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.997 -0.742 . . . . 3.6400000000000001 108.997 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.456 ' CZ ' ' HG3' ' A' ' 40' ' ' LYS . 14.4 m-85 -110.05 143.88 39.44 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.307 -0.861 . . . . 0.79000000000000004 110.879 -171.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.7 m -129.05 137.51 51.33 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.302 -0.863 . . . . 0.26000000000000001 109.025 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.721 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -141.16 153.64 45.46 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.283 -0.636 . . . . 0.17000000000000001 109.283 -176.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -125.09 139.28 11.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 0.17000000000000001 111.914 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.721 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.1 t -106.8 154.02 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 117.096 0.448 . . . . 0.80000000000000004 109.895 -174.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.565 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 18.0 ptp180 -145.06 144.05 30.77 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.481 -0.933 . . . . 2.6200000000000001 108.481 172.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.668 HG23 HD11 ' A' ' 78' ' ' LEU . 97.3 t -122.64 152.81 27.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.392 -0.367 . . . . 0.23999999999999999 110.664 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.405 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 23.4 t-20 -92.37 83.46 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.542 0.687 . . . . 1.5900000000000001 109.953 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.2 p -74.52 109.77 8.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.792 -1.095 . . . . 0.33000000000000002 109.527 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.2 t -49.21 -27.85 4.02 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.93 0.715 . . . . 1.3200000000000001 112.93 -172.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -84.44 -21.21 30.8 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.299 0.481 . . . . 1.3 112.299 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.09 -44.85 1.03 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.167 0.508 . . . . 3.6800000000000002 111.073 -173.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.46 -152.04 16.87 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.762 -0.654 . . . . 0.19 111.834 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.565 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 5.5 m95 -53.78 119.98 5.67 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.171 0.51 . . . . 0.39000000000000001 110.638 173.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.9 p -69.2 170.44 10.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.58 -0.737 . . . . 0.35999999999999999 111.521 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -63.68 125.68 25.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.453 -0.943 . . . . 1.8400000000000001 108.453 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 38.2 tt0 -61.58 118.38 6.97 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.621 0.724 . . . . 1.0 110.666 -175.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.562 ' SG ' HD12 ' A' ' 81' ' ' LEU . 57.2 m -91.94 98.18 11.42 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.785 -1.098 . . . . 0.35999999999999999 110.499 -175.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.433 HD12 ' HG2' ' A' ' 58' ' ' GLU . 1.7 mp -74.63 124.34 32.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.945 -0.57 . . . . 0.73999999999999999 110.313 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.72 -167.65 43.72 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.1 -0.955 . . . . 0.23000000000000001 112.848 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 64' ' ' MET . 40.9 mt-10 -89.74 148.62 40.38 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-O 120.545 0.212 . . . . 1.3700000000000001 111.013 -174.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 62' ' ' GLU . 38.3 Cg_exo -60.57 106.7 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.814 2.342 . . . . 0.51000000000000001 111.396 172.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.558 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.4 mmm -115.08 143.49 30.31 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.077 -0.51 . . . . 0.67000000000000004 110.409 -173.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.32 3.89 5.38 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.737 2.291 . . . . 0.32000000000000001 113.312 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.9 t -143.65 140.06 29.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.498 -0.556 . . . . 1.3 109.498 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.6 m -64.62 -32.93 59.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.772 -0.649 . . . . 1.1399999999999999 111.482 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -64.07 -42.13 97.1 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 120.927 0.394 . . . . 2.8199999999999998 110.559 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.421 ' HE2' ' CE ' ' A' ' 64' ' ' MET . 43.4 mtpt -74.6 -25.16 59.08 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.99 -0.55 . . . . 1.3600000000000001 110.091 -177.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.52 -59.81 4.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.792 -0.64 . . . . 0.20999999999999999 110.696 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.707 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 52.8 pttt -61.92 -43.03 99.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.726 -0.215 . . . . 2.4199999999999999 110.91 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.526 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.9 m-20 -52.35 -50.8 61.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.879 0.696 . . . . 2.0099999999999998 112.879 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.3 p -66.54 -39.45 88.56 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.882 0.327 . . . . 1.1399999999999999 111.882 -175.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.481 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -68.18 -42.29 80.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.262 0.553 . . . . 0.17999999999999999 110.464 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.472 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -53.72 -36.05 61.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.222 -0.899 . . . . 0.26000000000000001 111.275 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 72' ' ' ASP . 94.9 t -62.36 -37.13 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.009 0.433 . . . . 0.82999999999999996 110.595 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.0 mt -75.11 -32.94 61.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.611 0.719 . . . . 0.39000000000000001 109.543 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.668 HD11 HG23 ' A' ' 48' ' ' VAL . 19.1 tp -64.59 -39.21 93.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.825 -1.08 . . . . 0.81000000000000005 110.905 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.7 mm? -59.52 -28.24 66.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.578 -0.737 . . . . 1.6100000000000001 111.039 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -72.76 -35.4 67.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.081 0.467 . . . . 2.1299999999999999 110.695 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.562 HD12 ' SG ' ' A' ' 59' ' ' CYS . 1.3 tt -62.96 -49.57 74.22 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.968 -0.753 . . . . 1.1699999999999999 108.968 175.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 mp -70.16 -2.77 14.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.198 -0.91 . . . . 1.1499999999999999 111.655 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -97.96 -13.07 21.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.481 0.658 . . . . 1.46 109.478 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -113.74 43.67 1.76 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.313 -0.858 . . . . 4.1699999999999999 110.427 -178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.532 -0.746 . . . . 3.79 110.197 -179.491 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.628 ' N ' HD21 ' A' ' 15' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 111.035 0.013 . . . . 2.4900000000000002 111.035 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -68.91 -46.87 67.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.971 0.415 . . . . 2.46 110.804 -176.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.3 mp -62.97 -39.59 85.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.544 -0.753 . . . . 0.80000000000000004 110.325 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.4 m -68.56 -44.64 74.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.906 0.86 . . . . 1.3500000000000001 110.003 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 15' ' ' ASN . 3.5 tt -62.43 -45.69 91.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.228 -1.351 . . . . 1.1599999999999999 110.483 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.42 ' NH2' HG23 ' A' ' 17' ' ' ILE . 51.8 ttp85 -60.37 -38.2 83.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.578 -0.737 . . . . 3.8399999999999999 111.644 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 28.2 mmmt -72.93 0.39 11.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.549 -0.751 . . . . 1.1000000000000001 112.082 -176.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 62.87 51.05 3.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.092 0.948 . . . . 1.9199999999999999 110.011 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.416 ' CZ3' ' HG ' ' A' ' 82' ' ' LEU . 39.6 m0 -113.26 166.11 11.85 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.183 -0.917 . . . . 0.40000000000000002 109.223 175.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.62 162.04 33.35 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.957 1.771 . . . . 0.44 109.407 167.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 65.2 mmm -74.75 127.96 86.22 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 110.212 -0.292 . . . . 1.0 110.212 -173.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.518 ' HB3' HG22 ' A' ' 48' ' ' VAL . 1.2 Cg_endo -50.99 163.63 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 124.01 3.14 . . . . 0.46000000000000002 114.887 -173.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.476 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 25.3 t -81.02 144.25 31.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.338 -1.301 . . . . 0.29999999999999999 109.232 175.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.475 ' HD2' ' CZ ' ' A' ' 44' ' ' PHE . 72.6 m-85 -140.52 111.76 7.2 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.844 -0.798 . . . . 0.29999999999999999 108.844 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.46 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 36.4 ttm180 -151.92 124.07 8.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.042 -0.355 . . . . 3.6899999999999999 110.042 -176.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.461 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 83.8 m -66.84 124.92 24.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.953 0.406 . . . . 1.53 110.435 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -85.2 -35.81 10.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.835 -0.62 . . . . 1.1499999999999999 110.829 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -140.9 127.04 19.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.985 -0.552 . . . . 2.25 110.277 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.444 ' HB2' ' CD1' ' A' ' 42' ' ' PHE . 7.6 pt-20 -151.01 154.92 37.97 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.974 -0.38 . . . . 2.6000000000000001 109.974 176.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.46 -171.42 29.31 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.595 -0.812 . . . . 1.6899999999999999 112.949 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.16 -145.27 12.57 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.915 -0.874 . . . . 2.1299999999999999 110.915 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -73.56 52.99 2.58 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 123.192 2.595 . . . . 3.0 112.415 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 68.51 -57.76 0.49 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.957 0.903 . . . . 2.6099999999999999 112.48 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -77.86 18.0 0.52 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.827 0.346 . . . . 2.1000000000000001 111.478 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.59 44.22 2.76 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.338 0.589 . . . . 1.28 110.114 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.6 tptp -81.55 19.71 0.99 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.79 -0.641 . . . . 1.9299999999999999 110.517 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -83.46 135.52 34.64 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.535 -0.913 . . . . 3.6400000000000001 108.535 174.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 8.0 m-85 -112.84 132.09 55.43 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.63 -0.714 . . . . 0.79000000000000004 110.158 -174.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.0 m -119.85 130.01 54.68 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.064 -1.087 . . . . 0.26000000000000001 108.064 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.697 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -137.81 152.66 49.35 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.526 -0.546 . . . . 0.17000000000000001 109.526 -175.049 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.417 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -128.82 138.74 10.49 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.037 -0.602 . . . . 0.17000000000000001 111.901 177.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.697 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -105.93 157.71 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 109.503 -0.554 . . . . 0.80000000000000004 109.503 -176.691 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.58 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 24.2 ptt180 -146.72 141.81 27.16 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.983 -1.118 . . . . 2.6200000000000001 107.983 173.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.518 HG22 ' HB3' ' A' ' 26' ' ' PRO . 39.8 t -118.62 155.47 20.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.523 -0.308 . . . . 0.23999999999999999 110.374 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -96.05 84.04 3.75 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.635 0.731 . . . . 1.5900000000000001 109.635 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.539 ' OG1' ' HB2' ' A' ' 53' ' ' ARG . 37.7 p -68.29 113.33 5.8 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.298 -1.319 . . . . 0.33000000000000002 109.223 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.0 t -52.48 -27.29 15.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.776 -0.647 . . . . 1.3200000000000001 112.664 -171.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -100.54 -4.69 28.14 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.416 0.525 . . . . 1.3 112.416 -176.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.539 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 68.6 mtt180 -130.44 -52.25 1.09 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.232 0.539 . . . . 3.6800000000000002 110.897 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.73 -152.86 17.21 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.326 -0.852 . . . . 0.19 112.397 -175.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.58 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.4 m95 -55.79 120.28 7.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.067 0.461 . . . . 0.39000000000000001 111.23 176.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.9 p -71.73 161.54 30.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.742 -0.663 . . . . 0.35999999999999999 110.837 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.96 132.15 51.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.271 -0.641 . . . . 1.8400000000000001 109.271 174.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -56.57 116.94 3.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.58 -0.737 . . . . 1.0 110.937 -175.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.41 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 35.1 m -93.19 97.89 10.94 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.908 -1.042 . . . . 0.35999999999999999 110.114 -177.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.417 HD13 ' HA3' ' A' ' 45' ' ' GLY . 29.3 mm -75.62 123.77 32.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.572 -0.74 . . . . 0.73999999999999999 110.619 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.36 -167.01 42.77 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.867 -0.606 . . . . 0.23000000000000001 112.073 177.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -88.44 137.2 30.76 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 110.236 -0.283 . . . . 1.3700000000000001 110.236 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 50.2 Cg_exo -53.79 116.35 2.95 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.843 2.362 . . . . 0.51000000000000001 111.602 176.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.663 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 18.6 mmt -115.37 153.01 47.53 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.113 -0.494 . . . . 0.67000000000000004 111.082 -173.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -82.23 9.79 3.83 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.897 2.398 . . . . 0.32000000000000001 113.135 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.9 t -155.78 139.38 15.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.2 -0.667 . . . . 1.3 109.2 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.65 -22.86 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 1.1399999999999999 111.901 -173.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -75.24 -42.93 54.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.901 0.381 . . . . 2.8199999999999998 110.597 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.663 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 0.2 OUTLIER -82.31 -17.36 46.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.188 -0.46 . . . . 1.3600000000000001 110.384 178.711 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.76 -57.55 12.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.252 -0.431 . . . . 0.20999999999999999 110.425 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.644 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 61.2 mttm -52.66 -49.34 65.41 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.072 -0.513 . . . . 2.4199999999999999 110.433 174.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.518 ' O ' HG23 ' A' ' 76' ' ' VAL . 25.9 t70 -49.34 -49.87 42.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.933 -1.031 . . . . 2.0099999999999998 112.3 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.0 t -58.42 -48.53 80.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.788 0.328 . . . . 1.1399999999999999 111.453 -178.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.43 ' HB1' HG23 ' A' ' 46' ' ' VAL . . . -67.35 -37.51 83.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.28 0.562 . . . . 0.17999999999999999 110.777 -176.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.409 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -60.38 -30.74 69.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.475 -0.784 . . . . 0.26000000000000001 111.646 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 72' ' ' ASP . 73.9 t -63.72 -37.81 80.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 121.09 0.472 . . . . 0.82999999999999996 110.248 176.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.92 -28.73 58.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.841 -0.618 . . . . 0.39000000000000001 109.796 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 78' ' ' LEU . 4.0 mt -60.1 -44.32 94.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.341 -0.845 . . . . 0.81000000000000005 110.553 173.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.409 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.6 mp -61.47 -28.42 69.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.518 -0.764 . . . . 1.6100000000000001 111.777 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -71.95 -44.54 63.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.859 0.361 . . . . 2.1299999999999999 110.46 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.2 tt -61.39 -48.94 78.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.608 0.718 . . . . 1.1699999999999999 109.23 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.416 ' HG ' ' CZ3' ' A' ' 23' ' ' TRP . 1.6 mp -65.02 -20.12 66.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.792 -1.094 . . . . 1.1499999999999999 112.414 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -92.31 -3.74 54.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.691 0.757 . . . . 1.46 109.528 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -114.09 36.14 3.83 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.305 -0.861 . . . . 4.1699999999999999 109.859 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.25 1.1 0 CA-C-N 115.186 -0.916 . . . . 3.79 110.819 -177.691 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.472 ' N ' HD21 ' A' ' 15' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 111.51 0.189 . . . . 2.4900000000000002 111.51 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -66.45 -46.51 76.18 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.902 0.382 . . . . 2.46 110.372 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.477 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -62.75 -39.35 84.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.762 -0.654 . . . . 0.80000000000000004 110.119 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.415 ' SG ' ' HG3' ' A' ' 26' ' ' PRO . 84.0 m -65.54 -43.99 88.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.654 -0.703 . . . . 1.3500000000000001 110.007 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.5 tp -60.02 -52.1 66.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.249 -0.887 . . . . 1.1599999999999999 110.081 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -55.81 -41.6 74.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.908 -1.042 . . . . 3.8399999999999999 111.451 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -75.06 0.87 14.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.867 -0.606 . . . . 1.1000000000000001 112.096 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.8 t30 68.11 25.43 7.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.905 0.859 . . . . 1.9199999999999999 110.007 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -91.52 161.36 34.58 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.314 -0.857 . . . . 0.40000000000000002 109.79 176.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -74.08 178.82 6.41 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 122.149 1.899 . . . . 0.44 110.763 168.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.448 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 23.9 mmt -80.05 139.94 53.39 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.01 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.489 ' HB3' HG22 ' A' ' 48' ' ' VAL . 12.1 Cg_exo -67.17 159.01 54.13 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.507 2.138 . . . . 0.46000000000000002 112.578 -174.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.5 t -82.12 143.89 31.15 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.314 -0.857 . . . . 0.29999999999999999 109.392 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.555 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 64.7 m-85 -136.71 110.19 7.96 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.474 -0.935 . . . . 0.29999999999999999 108.474 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.535 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 67.6 mtp180 -143.0 122.33 13.06 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.658 -0.247 . . . . 3.6899999999999999 110.638 -173.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 35.5 t -71.4 120.49 17.06 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.979 -0.378 . . . . 1.53 109.979 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -86.55 -35.68 9.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.234 -0.439 . . . . 1.1499999999999999 111.384 -176.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -136.27 123.62 21.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.287 0.565 . . . . 2.25 111.13 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.476 ' HG3' ' CD1' ' A' ' 42' ' ' PHE . 43.3 tt0 -152.86 129.37 10.7 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.886 -1.052 . . . . 2.6000000000000001 109.867 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.1 176.72 45.0 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.429 -0.891 . . . . 1.6899999999999999 113.099 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.0 -151.59 23.64 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.129 -0.788 . . . . 2.1299999999999999 111.129 -177.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.7 -73.46 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.18 2.587 . . . . 3.0 112.549 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.09 -43.97 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.095 0.474 . . . . 2.6099999999999999 109.982 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -78.04 12.02 2.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.8 -0.636 . . . . 2.1000000000000001 111.17 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.94 28.35 8.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.163 0.506 . . . . 1.28 110.856 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.46 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 22.8 tptt -90.22 15.81 9.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.056 0.931 . . . . 1.9299999999999999 108.973 175.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.04 135.04 34.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.456 -1.247 . . . . 3.6400000000000001 107.772 167.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD1' ' HG3' ' A' ' 33' ' ' GLU . 10.9 m-85 -110.35 136.57 49.32 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.119 0.485 . . . . 0.79000000000000004 110.365 -168.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 m -126.4 133.49 51.27 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.335 -0.848 . . . . 0.26000000000000001 109.056 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.735 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -140.37 152.89 46.13 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.305 -0.628 . . . . 0.17000000000000001 109.305 -174.55 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -126.24 139.89 11.7 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.801 -0.714 . . . . 0.17000000000000001 112.287 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.735 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -107.75 156.14 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.908 -0.405 . . . . 0.80000000000000004 109.908 -176.482 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.514 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 11.7 ptp180 -146.45 148.86 32.69 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.526 -0.916 . . . . 2.6200000000000001 108.526 172.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.628 HG23 HD11 ' A' ' 78' ' ' LEU . 98.0 t -123.75 152.4 29.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 O-C-N 123.157 0.286 . . . . 0.23999999999999999 110.616 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -94.62 88.82 5.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.765 0.793 . . . . 1.5900000000000001 110.243 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.568 ' OG1' ' HB3' ' A' ' 53' ' ' ARG . 37.7 p -71.65 113.3 8.54 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.422 -1.263 . . . . 0.33000000000000002 109.585 177.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.9 t -52.09 -25.23 8.28 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.925 0.713 . . . . 1.3200000000000001 112.925 -172.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -113.32 12.12 18.78 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.599 -0.44 . . . . 1.3 112.012 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.568 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 41.5 ttm180 -146.56 -50.27 0.21 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.946 0.403 . . . . 3.6800000000000002 110.886 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.77 -162.47 19.0 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 116.156 -0.474 . . . . 0.19 113.03 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.514 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 15.3 m95 -52.57 117.97 3.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.111 0.481 . . . . 0.39000000000000001 110.765 174.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.0 p -70.83 178.89 2.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.36 -0.836 . . . . 0.35999999999999999 112.063 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -63.73 134.83 56.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.517 -0.765 . . . . 1.8400000000000001 109.697 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.65 113.53 4.31 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.399 0.619 . . . . 1.0 110.166 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.495 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 63.7 m -88.75 97.4 11.12 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.966 -1.016 . . . . 0.35999999999999999 109.849 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.426 HD13 ' HA3' ' A' ' 45' ' ' GLY . 26.3 mm -81.66 122.92 37.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.451 -0.795 . . . . 0.73999999999999999 110.068 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.26 -171.97 48.15 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.953 -0.641 . . . . 0.23000000000000001 112.037 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.608 ' O ' ' HG2' ' A' ' 64' ' ' MET . 40.1 mt-10 -86.35 151.08 53.12 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.972 -0.381 . . . . 1.3700000000000001 109.972 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.68 112.6 1.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.379 2.053 . . . . 0.51000000000000001 110.83 172.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.608 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 97.1 mmm -115.51 142.44 28.82 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.384 -0.371 . . . . 0.67000000000000004 110.35 -173.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.99 14.32 1.54 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.66 2.24 . . . . 0.32000000000000001 113.713 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.465 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 30.0 t -157.57 143.2 17.29 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.646 -0.502 . . . . 1.3 109.646 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.1 m -71.44 -22.31 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.892 -0.595 . . . . 1.1399999999999999 111.675 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -73.56 -47.31 41.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.119 -0.492 . . . . 2.8199999999999998 110.419 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 66' ' ' SER . 15.5 ptpt -81.15 -16.86 51.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.863 -0.608 . . . . 1.3600000000000001 110.768 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.1 -56.21 24.95 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.316 -0.402 . . . . 0.20999999999999999 110.47 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.645 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 55.5 mttp -54.19 -47.18 72.35 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.186 -0.461 . . . . 2.4199999999999999 110.837 176.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.575 ' O ' HG23 ' A' ' 76' ' ' VAL . 19.6 m-20 -52.09 -49.45 63.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.017 -0.538 . . . . 2.0099999999999998 111.85 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.7 t -59.95 -46.64 88.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.595 0.236 . . . . 1.1399999999999999 111.538 -175.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.473 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -66.38 -42.04 88.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.189 0.519 . . . . 0.17999999999999999 110.554 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.422 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -53.33 -38.26 63.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.209 -0.905 . . . . 0.26000000000000001 111.516 177.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 72' ' ' ASP . 57.6 t -63.02 -36.68 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.897 0.38 . . . . 0.82999999999999996 110.743 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 85.3 mt -74.66 -32.88 62.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.765 0.793 . . . . 0.39000000000000001 109.44 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.628 HD11 HG23 ' A' ' 48' ' ' VAL . 42.9 tp -65.42 -39.38 92.07 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.557 -1.201 . . . . 0.81000000000000005 110.781 176.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.3 mp -58.94 -29.86 67.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.745 -0.662 . . . . 1.6100000000000001 111.045 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -69.84 -38.6 76.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.08 0.467 . . . . 2.1299999999999999 110.422 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.467 HD12 ' SG ' ' A' ' 59' ' ' CYS . 1.4 tt -63.85 -52.56 59.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.543 -0.753 . . . . 1.1699999999999999 109.607 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.2 mp -67.26 -10.32 49.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.402 -0.817 . . . . 1.1499999999999999 112.219 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -93.72 -9.61 37.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.498 0.666 . . . . 1.46 109.87 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -123.55 43.09 3.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.721 -0.672 . . . . 4.1699999999999999 110.506 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.417 -0.801 . . . . 3.79 109.984 179.171 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.633 ' N ' HD21 ' A' ' 15' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.168 0 N-CA-C 111.332 0.123 . . . . 2.4900000000000002 111.332 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -68.0 -39.1 83.28 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.778 0.323 . . . . 2.46 111.217 -174.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.7 mp -64.44 -48.96 82.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.403 0.621 . . . . 0.80000000000000004 109.813 176.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.0 m -55.32 -40.18 70.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.577 -1.192 . . . . 1.3500000000000001 110.786 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.1 tp -61.78 -53.52 54.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.039 -0.982 . . . . 1.1599999999999999 110.584 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -61.61 -28.9 69.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.303 -0.862 . . . . 3.8399999999999999 111.242 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 29.6 mmmt -73.75 2.51 8.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.958 -0.564 . . . . 1.1000000000000001 112.338 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.9 t30 63.9 37.59 9.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.278 -0.874 . . . . 1.9199999999999999 110.056 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.581 ' CH2' HG22 ' A' ' 50' ' ' THR . 34.9 m0 -103.63 160.18 26.93 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.421 -0.809 . . . . 0.40000000000000002 109.657 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.33 177.98 3.44 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.256 1.971 . . . . 0.44 111.265 171.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.433 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 24.4 mmt -71.83 127.29 90.95 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 120.824 0.345 . . . . 1.0 110.721 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 23.7 Cg_exo -62.19 159.43 34.97 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.749 2.299 . . . . 0.46000000000000002 111.928 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.531 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 10.5 t -88.61 140.3 29.59 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.696 -0.684 . . . . 0.29999999999999999 109.721 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.49 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 74.1 m-85 -137.15 110.77 8.05 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.247 -1.02 . . . . 0.29999999999999999 108.247 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.564 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 37.8 ttm180 -136.17 117.9 15.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.473 0.178 . . . . 3.6899999999999999 110.79 -172.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.473 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 73.0 m -62.01 116.93 5.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.889 0.376 . . . . 1.53 110.29 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.6 t -87.36 -41.92 14.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.929 -0.578 . . . . 1.1499999999999999 110.809 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 27.0 tptp -139.86 130.98 26.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.068 0.461 . . . . 2.25 111.208 -178.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -101.38 154.88 18.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.054 -0.975 . . . . 2.6000000000000001 108.926 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 40' ' ' LYS . . . -69.9 -69.26 1.42 Allowed Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.968 -1.11 . . . . 1.6899999999999999 113.515 -172.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.436 ' HA3' ' HD3' ' A' ' 36' ' ' PRO . . . 124.65 -123.89 5.23 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.166 -1.016 . . . . 2.1299999999999999 112.143 -170.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.436 ' HD3' ' HA3' ' A' ' 35' ' ' GLY . 24.4 Cg_exo -65.19 -162.44 0.05 OUTLIER 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 124.12 3.214 . . . . 3.0 113.525 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.52 -46.1 20.36 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.199 -0.313 . . . . 2.6099999999999999 111.816 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -70.05 -24.29 63.23 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.123 0.487 . . . . 2.1000000000000001 110.656 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -122.88 91.22 3.45 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.841 -0.8 . . . . 1.28 108.841 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.439 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 21.4 tptm -126.73 21.27 7.03 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.55 -0.908 . . . . 1.9299999999999999 108.55 -177.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' A' ' 63' ' ' PRO . 9.5 ptm180 -79.8 138.08 37.15 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.562 -0.745 . . . . 3.6400000000000001 111.012 -171.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -109.85 131.77 54.76 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.015 -0.993 . . . . 0.79000000000000004 109.197 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 32' ' ' LYS . 27.6 m -130.49 125.15 33.64 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.705 -0.68 . . . . 0.26000000000000001 109.169 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.763 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -139.13 153.86 48.04 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.655 -0.498 . . . . 0.17000000000000001 109.655 -175.038 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 60' ' ' ILE . . . -127.99 138.93 10.73 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.99 -0.624 . . . . 0.17000000000000001 112.2 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.763 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -107.01 158.46 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 110.166 -0.309 . . . . 0.80000000000000004 110.166 -174.672 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.564 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 19.7 ptt180 -148.3 146.99 28.81 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.835 -0.802 . . . . 2.6200000000000001 108.835 173.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.614 HG23 HD11 ' A' ' 78' ' ' LEU . 28.6 t -124.3 156.75 32.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.565 0.221 . . . . 0.23999999999999999 110.889 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.413 ' N ' HG12 ' A' ' 48' ' ' VAL . 5.9 t30 -94.61 83.89 4.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.397 0.618 . . . . 1.5900000000000001 110.031 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.581 HG22 ' CH2' ' A' ' 23' ' ' TRP . 34.4 p -78.1 105.73 9.51 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.932 -1.031 . . . . 0.33000000000000002 109.71 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.2 m -43.98 -33.06 1.3 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.069 -0.969 . . . . 1.3200000000000001 113.042 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.432 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 4.6 p-10 -63.02 -40.17 96.95 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.758 0.651 . . . . 1.3 112.758 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -129.01 -37.56 1.7 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.993 0.425 . . . . 3.6800000000000002 111.653 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.76 -148.24 16.74 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.93 -0.577 . . . . 0.19 112.364 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.564 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.9 m95 -51.24 119.19 3.81 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.17 0.509 . . . . 0.39000000000000001 111.342 175.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.3 p -69.48 167.55 16.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.559 -0.746 . . . . 0.35999999999999999 110.735 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.85 132.84 49.63 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.829 -0.804 . . . . 1.8400000000000001 108.829 174.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 40.9 tt0 -65.76 115.75 6.23 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.912 -1.04 . . . . 1.0 110.706 -174.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.8 m -96.14 105.3 17.33 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.63 -1.168 . . . . 0.35999999999999999 110.65 -174.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.522 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 1.8 mp -88.03 132.13 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.305 0.574 . . . . 0.73999999999999999 111.305 -177.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.54 -176.62 51.05 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 114.909 -1.041 . . . . 0.23000000000000001 111.809 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 64' ' ' MET . 13.0 pt-20 -92.07 158.06 40.04 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.816 0.308 . . . . 1.3700000000000001 110.673 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.429 ' HB3' ' HB2' ' A' ' 41' ' ' ARG . 72.0 Cg_exo -50.45 105.21 0.1 OUTLIER 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.398 2.732 . . . . 0.51000000000000001 112.683 174.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.0 mmm -108.74 145.27 31.29 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 110.152 -0.314 . . . . 0.67000000000000004 110.152 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.85 13.13 2.22 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.703 2.269 . . . . 0.32000000000000001 113.75 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.4 t -154.05 142.11 20.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.498 -0.927 . . . . 1.3 108.498 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.0 p -71.74 -22.01 21.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.149 -0.478 . . . . 1.1399999999999999 110.529 -174.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -73.13 -39.4 65.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.021 -0.536 . . . . 2.8199999999999998 109.616 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HE3' ' CE ' ' A' ' 64' ' ' MET . 27.5 mtpp -75.34 -23.39 57.22 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.975 -0.557 . . . . 1.3600000000000001 109.943 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.08 -53.41 58.55 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.579 -0.737 . . . . 0.20999999999999999 109.93 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.641 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 66.4 mttm -52.49 -54.58 30.57 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 115.611 -0.722 . . . . 2.4199999999999999 111.067 176.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.525 ' O ' HG23 ' A' ' 76' ' ' VAL . 33.4 m-20 -55.22 -44.78 75.74 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.945 -0.571 . . . . 2.0099999999999998 112.452 -177.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.495 ' OG ' ' HG2' ' A' ' 62' ' ' GLU . 44.3 t -59.25 -46.29 88.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 1.1399999999999999 111.113 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.443 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -68.44 -38.7 81.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.185 0.517 . . . . 0.17999999999999999 110.15 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.44 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -56.44 -37.35 70.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.261 -0.881 . . . . 0.26000000000000001 111.514 177.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 72' ' ' ASP . 94.7 t -63.24 -38.08 81.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.981 0.42 . . . . 0.82999999999999996 110.679 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.7 mt -77.82 -23.35 49.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.885 0.85 . . . . 0.39000000000000001 109.334 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.739 HD13 ' HB ' ' A' ' 46' ' ' VAL . 16.4 tp -70.34 -49.01 53.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.716 -1.129 . . . . 0.81000000000000005 110.403 173.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 75' ' ' ALA . 6.2 mp -53.67 -34.12 57.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.581 -0.736 . . . . 1.6100000000000001 112.248 -177.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -78.86 -34.02 45.33 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.373 -0.531 . . . . 2.1299999999999999 110.855 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.87 -51.68 60.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.883 0.373 . . . . 1.1699999999999999 110.086 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.459 HD21 HG21 ' A' ' 48' ' ' VAL . 1.9 mm? -71.43 -7.46 47.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 1.1499999999999999 111.37 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -94.09 -6.49 44.93 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.442 0.639 . . . . 1.46 109.841 175.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -115.71 39.08 3.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.708 -0.678 . . . . 4.1699999999999999 110.174 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.251 1.144 0 CA-C-N 115.363 -0.835 . . . . 3.79 110.038 -179.005 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.616 ' N ' HD21 ' A' ' 15' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 111.451 0.167 . . . . 2.4900000000000002 111.451 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.46 -46.78 85.9 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.783 0.29 . . . . 2.46 111.783 -176.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.442 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -60.83 -47.53 92.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.035 -0.53 . . . . 0.80000000000000004 110.688 -177.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.411 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 41.5 t -63.89 -45.33 89.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.367 0.603 . . . . 1.3500000000000001 110.273 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.19 -44.1 97.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.109 -0.95 . . . . 1.1599999999999999 110.838 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -65.13 -33.75 76.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.971 -1.013 . . . . 3.8399999999999999 111.12 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 4.6 mmmp? -74.18 2.69 8.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.123 -0.49 . . . . 1.1000000000000001 111.574 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 67.39 30.2 7.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.935 0.874 . . . . 1.9199999999999999 109.991 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.411 ' CE3' ' HA ' ' A' ' 18' ' ' CYS . 27.7 m0 -93.54 160.24 33.35 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.406 -0.815 . . . . 0.40000000000000002 109.073 174.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.6 -173.29 0.67 Allowed 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.183 1.922 . . . . 0.44 111.087 172.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.459 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.9 mmt -75.64 145.67 79.08 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.677 -0.49 . . . . 1.0 109.677 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.501 ' HB3' HG22 ' A' ' 48' ' ' VAL . 2.7 Cg_exo -74.89 165.96 30.29 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.495 2.13 . . . . 0.46000000000000002 112.421 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.407 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 26.3 t -84.73 144.4 28.54 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.161 -0.927 . . . . 0.29999999999999999 109.912 178.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.523 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 69.0 m-85 -143.95 109.93 5.34 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.361 -0.607 . . . . 0.29999999999999999 109.361 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.513 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 14.0 ptm180 -152.52 128.92 10.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.949 0.404 . . . . 3.6899999999999999 110.874 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 77.3 m -65.89 124.87 23.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.865 -0.607 . . . . 1.53 111.286 -176.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -84.82 -37.67 12.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.808 -0.633 . . . . 1.1499999999999999 110.286 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -135.78 131.47 35.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.173 0.511 . . . . 2.25 111.178 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -99.79 152.39 20.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.923 -1.035 . . . . 2.6000000000000001 108.819 174.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 40' ' ' LYS . . . -85.14 163.47 37.77 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.284 -0.96 . . . . 1.6899999999999999 112.69 -176.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.67 -142.56 1.37 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.678 -0.296 . . . . 2.1299999999999999 113.056 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.73 -74.13 0.03 OUTLIER 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.817 3.011 . . . . 3.0 113.117 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.21 -36.39 0.08 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.028 0.442 . . . . 2.6099999999999999 110.053 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -70.22 -9.65 56.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.742 -0.663 . . . . 2.1000000000000001 110.799 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.99 29.94 4.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.065 -0.516 . . . . 1.28 110.516 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.511 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 15.2 tptp -79.05 22.5 0.39 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.136 0.493 . . . . 1.9299999999999999 111.332 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -83.53 132.32 34.94 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.064 -0.717 . . . . 3.6400000000000001 109.064 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.433 ' CZ ' ' HG3' ' A' ' 40' ' ' LYS . 7.0 m-85 -109.56 149.1 30.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.532 -0.758 . . . . 0.79000000000000004 110.877 -172.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.5 m -129.76 129.6 44.32 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.142 -0.935 . . . . 0.26000000000000001 109.289 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.735 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -137.13 153.65 50.46 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.069 -0.715 . . . . 0.17000000000000001 109.069 -174.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -126.66 138.73 10.82 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.757 -0.735 . . . . 0.17000000000000001 112.317 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.735 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -107.15 158.6 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 109.309 -0.626 . . . . 0.80000000000000004 109.309 -177.124 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.571 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 11.8 ptp180 -148.49 148.96 30.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.05 -0.722 . . . . 2.6200000000000001 109.05 173.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.6 HG23 HD11 ' A' ' 78' ' ' LEU . 73.9 t -125.06 153.7 32.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 123.309 0.381 . . . . 0.23999999999999999 110.627 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -92.52 85.31 5.28 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.562 0.696 . . . . 1.5900000000000001 110.576 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 54' ' ' GLY . 38.2 p -73.32 112.37 9.32 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.933 -1.031 . . . . 0.33000000000000002 109.716 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 t -49.84 -28.4 6.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.68 -0.691 . . . . 1.3200000000000001 112.151 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -82.24 -22.78 35.69 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.154 0.798 . . . . 1.3 113.154 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -134.47 -43.66 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.905 -0.497 . . . . 3.6800000000000002 111.609 -173.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 122.77 -152.57 16.88 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 116.093 -0.503 . . . . 0.19 111.896 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.571 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.9 m95 -53.01 120.79 6.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.99 0.424 . . . . 0.39000000000000001 110.686 174.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.2 p -71.05 160.96 31.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.679 -0.691 . . . . 0.35999999999999999 111.0 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -60.64 128.34 36.1 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.221 -0.659 . . . . 1.8400000000000001 109.221 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -54.71 123.58 13.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.931 -1.032 . . . . 1.0 111.026 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.44 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 57.8 m -95.77 97.8 9.96 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.356 -0.838 . . . . 0.35999999999999999 110.124 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.12 126.23 38.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.556 -0.747 . . . . 0.73999999999999999 110.887 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.5 -177.89 51.87 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.238 -0.892 . . . . 0.23000000000000001 112.896 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -85.14 147.08 46.76 Favored Pre-proline 0 C--N 1.317 -0.826 0 N-CA-C 109.966 -0.383 . . . . 1.3700000000000001 109.966 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 52.1 Cg_exo -55.05 105.79 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.643 2.228 . . . . 0.51000000000000001 111.45 175.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.641 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 16.3 mmt -113.27 139.84 23.62 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.152 -0.477 . . . . 0.67000000000000004 111.192 -173.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.74 10.14 2.39 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.662 2.242 . . . . 0.32000000000000001 113.323 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.8 t -152.54 137.88 17.55 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.144 -0.687 . . . . 1.3 109.144 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -68.06 -23.21 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 1.1399999999999999 111.688 -173.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -74.1 -44.99 51.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.904 0.383 . . . . 2.8199999999999998 110.423 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.641 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 0.2 OUTLIER -81.04 -17.76 49.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 1.3600000000000001 109.973 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.87 -56.65 19.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.847 -0.615 . . . . 0.20999999999999999 110.092 173.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.646 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 58.1 mtpt -50.92 -48.16 60.76 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 116.261 -0.427 . . . . 2.4199999999999999 110.753 174.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.534 ' O ' HG23 ' A' ' 76' ' ' VAL . 36.8 m-20 -52.46 -51.72 57.89 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.389 0.514 . . . . 2.0099999999999998 112.389 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.2 p -60.9 -40.23 92.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.707 0.289 . . . . 1.1399999999999999 111.456 -175.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.432 ' HB1' HG23 ' A' ' 46' ' ' VAL . . . -69.38 -44.97 70.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.144 0.497 . . . . 0.17999999999999999 110.376 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.509 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -55.99 -35.99 67.4 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.306 -0.861 . . . . 0.26000000000000001 111.754 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 72' ' ' ASP . 91.8 t -64.92 -38.23 82.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.978 0.418 . . . . 0.82999999999999996 110.7 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.6 mt -76.42 -26.43 55.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.916 0.865 . . . . 0.39000000000000001 109.271 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.6 HD11 HG23 ' A' ' 48' ' ' VAL . 16.0 tp -70.98 -54.5 11.04 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.553 -1.203 . . . . 0.81000000000000005 111.256 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 75' ' ' ALA . 4.2 mp -55.32 -29.24 57.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.914 -0.584 . . . . 1.6100000000000001 112.546 -174.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.86 -33.8 60.02 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.276 -0.57 . . . . 2.1299999999999999 110.598 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.1 -50.54 63.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.108 -0.496 . . . . 1.1699999999999999 110.091 -177.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.509 ' CD2' ' HG ' ' A' ' 78' ' ' LEU . 1.4 mm? -67.04 -29.45 69.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 1.1499999999999999 111.124 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 84' ' ' LYS . 63.6 t30 -86.64 2.69 47.49 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.329 -0.619 . . . . 1.46 109.329 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 83' ' ' ASN . 23.5 mtmm 71.59 119.71 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.5 -1.227 . . . . 4.1699999999999999 111.448 177.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.213 -0.899 . . . . 3.79 110.233 -175.033 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.56 ' N ' HD21 ' A' ' 15' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 111.258 0.095 . . . . 2.4900000000000002 111.258 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.32 -39.07 93.17 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.62 0.23 . . . . 2.46 111.62 -172.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.442 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.4 mp -56.63 -41.98 75.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.353 0.597 . . . . 0.80000000000000004 110.457 177.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 23' ' ' TRP . 22.4 t -75.18 -38.49 60.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.397 -0.82 . . . . 1.3500000000000001 109.708 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.7 tp -60.1 -53.08 62.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.139 -0.937 . . . . 1.1599999999999999 110.606 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -56.53 -37.94 71.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.064 -0.971 . . . . 3.8399999999999999 111.71 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.8 mmtm -73.96 5.63 4.06 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.993 -0.549 . . . . 1.1000000000000001 111.918 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 66.48 27.22 9.83 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.597 -0.728 . . . . 1.9199999999999999 110.937 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.558 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.0 m0 -101.0 154.11 37.34 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.557 -0.747 . . . . 0.40000000000000002 109.011 175.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.91 173.65 14.14 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.232 1.955 . . . . 0.44 110.631 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.424 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 31.6 mmt -62.26 127.4 89.62 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.791 0.329 . . . . 1.0 110.921 -177.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.531 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 70.1 Cg_exo -54.89 165.01 2.9 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.567 2.845 . . . . 0.46000000000000002 113.678 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.515 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 25.1 t -89.58 142.39 27.72 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.987 -1.006 . . . . 0.29999999999999999 109.388 177.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.531 ' CE1' ' HB2' ' A' ' 26' ' ' PRO . 95.9 m-85 -140.75 108.72 5.71 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.277 -1.008 . . . . 0.29999999999999999 108.277 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.552 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 48.7 mmt-85 -147.83 118.5 7.52 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.324 -0.621 . . . . 3.6899999999999999 109.324 -173.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.549 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 15.5 p -69.47 129.09 38.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.041 0.448 . . . . 1.53 110.953 -177.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.1 m -85.79 -32.81 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.82 -0.627 . . . . 1.1499999999999999 111.15 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -136.66 124.44 22.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.081 -0.509 . . . . 2.25 110.226 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.78 159.17 44.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.109 -0.496 . . . . 2.6000000000000001 110.463 177.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.41 145.83 15.76 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.152 -1.023 . . . . 1.6899999999999999 112.999 174.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.38 163.31 12.7 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.043 -0.823 . . . . 2.1299999999999999 111.043 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -44.67 -75.59 0.03 OUTLIER 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 123.633 2.889 . . . . 3.0 112.529 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.26 -44.58 0.08 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.568 -0.53 . . . . 2.6099999999999999 109.568 173.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -70.79 -8.98 56.37 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.81 -0.632 . . . . 2.1000000000000001 110.33 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.439 ' C ' ' H ' ' A' ' 41' ' ' ARG . . . -120.85 15.67 11.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.266 0.555 . . . . 1.28 110.882 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.412 ' HZ3' ' HZ ' ' A' ' 42' ' ' PHE . 21.7 tptp -79.08 21.43 0.44 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.235 -0.893 . . . . 1.9299999999999999 109.972 177.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.439 ' H ' ' C ' ' A' ' 39' ' ' ALA . 11.2 ptp180 -82.1 144.26 30.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.63 -0.713 . . . . 3.6400000000000001 109.66 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.629 ' CZ ' HG22 ' A' ' 67' ' ' VAL . 71.2 m-85 -111.54 131.43 55.25 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.469 -0.787 . . . . 0.79000000000000004 110.191 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 m -120.24 121.68 39.23 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.466 -1.309 . . . . 0.26000000000000001 107.466 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.69 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -136.85 151.28 48.94 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.631 -0.507 . . . . 0.17000000000000001 109.631 -170.158 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.558 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -123.69 137.96 11.19 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.204 -0.522 . . . . 0.17000000000000001 111.932 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.69 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -106.75 155.57 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 109.731 -0.47 . . . . 0.80000000000000004 109.731 -174.636 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.62 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 8.3 ptp85 -147.95 142.31 26.3 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.626 -0.879 . . . . 2.6200000000000001 108.626 176.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.628 HG23 HD11 ' A' ' 78' ' ' LEU . 95.4 t -124.65 153.24 31.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.342 -0.39 . . . . 0.23999999999999999 110.381 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -92.01 82.8 5.1 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.723 0.773 . . . . 1.5900000000000001 110.203 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 35.3 p -67.94 116.82 9.02 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.438 -1.256 . . . . 0.33000000000000002 110.143 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.8 p -51.95 -26.53 10.67 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.462 -1.244 . . . . 1.3200000000000001 113.013 -176.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -89.11 -17.42 29.27 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.032 0.753 . . . . 1.3 113.032 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -139.16 -44.72 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.488 0.585 . . . . 3.6800000000000002 112.408 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.66 -150.61 17.14 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.919 -0.658 . . . . 0.19 112.337 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.62 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.9 m95 -53.66 118.17 3.71 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.034 0.445 . . . . 0.39000000000000001 110.771 176.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.3 p -65.63 165.06 13.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.56 -0.745 . . . . 0.35999999999999999 111.37 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -61.46 135.27 57.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.046 -0.724 . . . . 1.8400000000000001 109.046 172.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.94 113.27 2.0 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.889 -175.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 60.1 m -91.39 97.32 11.02 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.089 -0.959 . . . . 0.35999999999999999 109.831 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.558 HD13 ' HA3' ' A' ' 45' ' ' GLY . 13.2 mm -81.84 126.01 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 115.832 -0.622 . . . . 0.73999999999999999 110.251 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.82 -170.84 47.07 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.913 -0.66 . . . . 0.23000000000000001 111.96 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.6 ' O ' ' HG2' ' A' ' 64' ' ' MET . 38.7 mt-10 -88.54 145.07 34.62 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.214 -0.662 . . . . 1.3700000000000001 109.214 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -55.83 110.44 0.56 Allowed 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.587 2.191 . . . . 0.51000000000000001 111.758 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.6 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.8 mmm -112.2 140.59 23.75 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.633 -0.506 . . . . 0.67000000000000004 109.633 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.61 18.51 0.96 Allowed 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.637 2.225 . . . . 0.32000000000000001 113.667 -175.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.419 ' HB2' ' CD ' ' A' ' 69' ' ' LYS . 28.7 m -157.56 139.09 13.83 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.227 -0.657 . . . . 1.3 109.227 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.629 HG22 ' CZ ' ' A' ' 42' ' ' PHE . 1.1 t -67.35 -38.67 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.335 -0.848 . . . . 1.1399999999999999 112.259 -167.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -71.21 -39.71 71.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.463 -0.335 . . . . 2.8199999999999998 111.118 -175.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.419 ' CD ' ' HB2' ' A' ' 66' ' ' SER . 17.3 ptmt -80.92 -18.52 46.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.888 0.375 . . . . 1.3600000000000001 110.182 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.62 -55.9 25.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.20999999999999999 110.645 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.642 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 5.6 ptpp? -58.54 -43.18 89.19 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 116.592 -0.276 . . . . 2.4199999999999999 110.767 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.576 ' O ' HG23 ' A' ' 76' ' ' VAL . 5.7 m-20 -54.92 -47.08 74.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 2.0099999999999998 111.973 176.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.2 t -58.65 -46.36 87.32 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.851 0.358 . . . . 1.1399999999999999 111.321 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.436 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -68.85 -42.81 76.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.022 0.439 . . . . 0.17999999999999999 110.589 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.48 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -56.12 -34.19 65.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.447 -0.797 . . . . 0.26000000000000001 111.517 177.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 72' ' ' ASP . 94.2 t -63.51 -36.57 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.916 0.389 . . . . 0.82999999999999996 110.61 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.98 -34.04 64.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.712 0.767 . . . . 0.39000000000000001 109.271 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.663 HD22 HG11 ' A' ' 46' ' ' VAL . 26.3 tp -64.82 -42.56 94.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.602 -1.181 . . . . 0.81000000000000005 110.797 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.3 mp -60.33 -26.96 66.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.03 -0.532 . . . . 1.6100000000000001 111.215 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -71.37 -40.0 70.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.227 0.537 . . . . 2.1299999999999999 110.274 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.8 tp -65.55 -46.55 79.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.359 -0.837 . . . . 1.1699999999999999 110.077 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.554 HD11 HG21 ' A' ' 48' ' ' VAL . 42.2 mt -70.09 -12.89 61.93 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.514 -1.221 . . . . 1.1499999999999999 111.19 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -88.81 -7.7 55.71 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.588 0.709 . . . . 1.46 109.554 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -104.27 40.68 1.42 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.322 -0.854 . . . . 4.1699999999999999 110.197 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.248 1.019 0 CA-C-N 115.205 -0.907 . . . . 3.79 110.018 -179.819 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 121.027 0.442 . . . . 2.4900000000000002 110.402 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -61.32 -41.98 97.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.068 -0.514 . . . . 2.46 111.539 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.5 mp -61.51 -38.49 80.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.61 -0.723 . . . . 0.80000000000000004 110.734 -178.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 23' ' ' TRP . 41.2 t -72.29 -39.81 68.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.274 0.559 . . . . 1.3500000000000001 109.971 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.0 tp -61.08 -51.54 68.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.305 -0.861 . . . . 1.1599999999999999 110.153 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -54.98 -36.53 65.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.218 -0.901 . . . . 3.8399999999999999 111.489 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -72.52 1.84 7.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.906 -0.588 . . . . 1.1000000000000001 111.971 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 64.96 26.08 12.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.35 -0.841 . . . . 1.9199999999999999 111.361 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.445 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 34.0 m0 -96.62 154.29 38.52 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.695 -0.483 . . . . 0.40000000000000002 109.695 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.414 ' HG2' ' HB3' ' A' ' 49' ' ' ASN . 63.2 Cg_endo -71.87 169.71 20.58 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.519 2.146 . . . . 0.44 110.811 173.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.8 mmt -63.03 130.22 93.97 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.691 -0.231 . . . . 1.0 111.106 -175.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.415 ' HB3' HG22 ' A' ' 48' ' ' VAL . 15.2 Cg_exo -67.31 165.78 25.71 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.881 2.387 . . . . 0.46000000000000002 112.865 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.431 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 16.8 t -87.97 141.34 28.65 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.045 -0.98 . . . . 0.29999999999999999 109.995 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.507 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 75.6 m-85 -138.92 110.63 7.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.768 -0.827 . . . . 0.29999999999999999 108.768 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.501 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 78.0 mtp180 -148.29 123.93 10.47 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 110.165 -0.309 . . . . 3.6899999999999999 110.165 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.531 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 71.2 m -61.12 121.08 11.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.997 0.427 . . . . 1.53 110.648 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.2 t -82.34 -38.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.787 -0.642 . . . . 1.1499999999999999 110.046 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -136.14 123.31 21.69 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.297 -0.631 . . . . 2.25 109.297 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -150.19 137.47 19.61 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.1 -0.5 . . . . 2.6000000000000001 110.646 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.57 -67.14 3.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.966 -0.635 . . . . 1.6899999999999999 112.935 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.24 -157.4 36.43 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.986 -0.626 . . . . 2.1299999999999999 112.406 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.99 -58.77 0.91 Allowed 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.031 2.488 . . . . 3.0 112.161 175.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -175.41 -49.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.466 0.651 . . . . 2.6099999999999999 109.792 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -79.07 18.29 0.66 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.14 -0.936 . . . . 2.1000000000000001 111.508 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -122.97 49.41 1.65 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.153 0.501 . . . . 1.28 110.724 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -88.15 14.38 9.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.369 0.604 . . . . 1.9299999999999999 109.931 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -86.31 132.77 33.9 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.102 -1.444 . . . . 3.6400000000000001 107.102 166.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -108.92 131.2 55.26 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.285 0.564 . . . . 0.79000000000000004 109.743 -172.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.6 m -120.01 118.0 29.5 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.886 -1.153 . . . . 0.26000000000000001 107.886 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.711 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -129.74 153.56 48.07 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.329 -0.619 . . . . 0.17000000000000001 109.329 -172.266 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.555 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -127.79 137.76 10.01 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.514 -0.634 . . . . 0.17000000000000001 111.514 178.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.711 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -105.99 155.0 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 N-CA-C 109.406 -0.59 . . . . 0.80000000000000004 109.406 -177.462 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.56 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 12.4 ptp180 -143.68 141.27 30.46 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 107.784 -1.191 . . . . 2.6200000000000001 107.784 173.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.415 HG22 ' HB3' ' A' ' 26' ' ' PRO . 39.1 t -117.19 152.4 19.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.304 -0.407 . . . . 0.23999999999999999 110.11 -178.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.414 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 58.3 t30 -94.95 83.62 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.049 0.928 . . . . 1.5900000000000001 109.853 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.8 p -70.48 116.05 10.37 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.775 -1.557 . . . . 0.33000000000000002 109.488 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.4 t -52.49 -28.2 19.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.924 -0.58 . . . . 1.3200000000000001 110.254 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -63.36 -56.27 17.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.402 -0.817 . . . . 1.3 112.755 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -122.99 -33.43 3.34 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.156 0.428 . . . . 3.6800000000000002 112.156 -171.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.56 -149.87 16.93 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 121.149 -0.548 . . . . 0.19 112.324 -177.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.56 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.9 m95 -54.04 117.81 3.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.929 0.395 . . . . 0.39000000000000001 111.045 175.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.1 p -67.63 170.02 8.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.57 -0.741 . . . . 0.35999999999999999 111.413 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -65.32 126.65 28.88 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.191 -1.04 . . . . 1.8400000000000001 108.191 172.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -58.71 114.62 2.6 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.557 0.694 . . . . 1.0 110.49 -175.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.474 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 59.8 m -87.02 97.01 10.48 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.944 -1.025 . . . . 0.35999999999999999 109.659 -177.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.555 HD13 ' HA3' ' A' ' 45' ' ' GLY . 21.6 mm -77.63 120.67 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.341 -0.845 . . . . 0.73999999999999999 109.593 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.51 -165.8 35.56 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.757 -0.735 . . . . 0.23000000000000001 112.217 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 64' ' ' MET . 38.6 mt-10 -92.66 142.22 25.47 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.259 -0.645 . . . . 1.3700000000000001 109.259 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.51 114.63 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.693 2.262 . . . . 0.51000000000000001 111.952 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.644 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 95.8 mmm -118.58 138.88 26.3 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.216 -0.447 . . . . 0.67000000000000004 109.941 -174.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.15 11.64 1.44 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.637 2.225 . . . . 0.32000000000000001 113.827 -175.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.497 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 50.5 m -152.67 137.59 17.16 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.317 -0.623 . . . . 1.3 109.317 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.71 -31.79 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 113.147 0.795 . . . . 1.1399999999999999 113.147 -169.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -69.83 -42.44 73.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.766 0.317 . . . . 2.8199999999999998 111.25 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.497 ' HG2' ' HB2' ' A' ' 66' ' ' SER . 17.3 ptpt -81.0 -18.9 45.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.369 -0.378 . . . . 1.3600000000000001 110.49 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.51 -57.94 10.79 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.342 -0.39 . . . . 0.20999999999999999 110.299 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.683 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 53.1 mtmt -56.51 -45.37 81.12 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.25 -0.432 . . . . 2.4199999999999999 110.729 175.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 76' ' ' VAL . 22.3 t70 -49.79 -50.13 45.98 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.887 -0.597 . . . . 2.0099999999999998 111.812 176.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.0 t -58.91 -47.56 84.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 1.1399999999999999 111.618 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.99 81.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.251 0.548 . . . . 0.17999999999999999 111.007 -177.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.603 ' O ' ' HG ' ' A' ' 79' ' ' LEU . . . -60.44 -29.94 69.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.553 -0.749 . . . . 0.26000000000000001 111.692 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 72' ' ' ASP . 55.6 t -65.71 -32.82 59.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 121.102 0.477 . . . . 0.82999999999999996 109.961 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.3 mt -74.26 -30.76 62.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.856 -0.611 . . . . 0.39000000000000001 109.506 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 78' ' ' LEU . 6.2 mt -61.87 -42.64 99.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.195 -0.911 . . . . 0.81000000000000005 110.24 175.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 17.8 mt -58.3 -35.59 72.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.199 -0.91 . . . . 1.6100000000000001 111.037 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -69.67 -43.81 71.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.895 0.379 . . . . 2.1299999999999999 110.268 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.0 tt -62.87 -47.57 82.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.716 -0.675 . . . . 1.1699999999999999 109.259 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.35 -32.91 72.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.081 -0.963 . . . . 1.1499999999999999 111.68 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -78.17 -6.77 55.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.358 0.599 . . . . 1.46 110.597 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -114.79 40.2 2.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.277 0.56 . . . . 4.1699999999999999 110.163 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 C--O 1.25 1.084 0 CA-C-N 115.318 -0.855 . . . . 3.79 110.967 179.932 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 111.665 0.246 . . . . 2.4900000000000002 111.665 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -64.63 -38.0 89.49 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.74 0.305 . . . . 2.46 111.106 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.487 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -65.29 -38.35 82.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.177 -0.465 . . . . 0.80000000000000004 110.607 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.409 ' SG ' ' HE3' ' A' ' 23' ' ' TRP . 54.1 t -72.24 -41.19 67.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.661 0.743 . . . . 1.3500000000000001 109.247 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.75 -42.85 99.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.628 -1.169 . . . . 1.1599999999999999 109.614 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -61.65 -33.9 74.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.556 -0.747 . . . . 3.8399999999999999 110.919 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 31.6 mmmt -74.28 2.07 10.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.029 -0.532 . . . . 1.1000000000000001 111.485 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.9 t30 68.24 27.04 6.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.998 0.904 . . . . 1.9199999999999999 109.712 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.409 ' HE3' ' SG ' ' A' ' 18' ' ' CYS . 41.8 m0 -92.67 160.88 33.48 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.017 -0.992 . . . . 0.40000000000000002 109.055 174.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.38 -169.53 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.106 1.871 . . . . 0.44 111.482 173.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.424 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 10.6 mmt -77.22 132.5 70.08 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HB3' HG22 ' A' ' 48' ' ' VAL . 16.9 Cg_exo -65.63 164.37 26.73 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.512 2.141 . . . . 0.46000000000000002 112.268 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.525 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 22.5 t -87.84 140.99 28.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.494 -0.776 . . . . 0.29999999999999999 109.859 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.51 ' HD1' ' CZ ' ' A' ' 44' ' ' PHE . 66.1 m-85 -141.19 111.04 6.54 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.889 -0.782 . . . . 0.29999999999999999 108.889 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.51 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 36.2 ttm180 -153.01 128.68 10.1 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.196 -0.298 . . . . 3.6899999999999999 110.196 -175.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.4 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 7.8 p -65.32 124.68 22.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.924 0.392 . . . . 1.53 110.459 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.404 ' H ' ' HA ' ' A' ' 44' ' ' PHE . 34.1 m -82.57 -34.61 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.141 0.496 . . . . 1.1499999999999999 110.302 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -139.99 125.33 18.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.681 -0.691 . . . . 2.25 110.201 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.462 ' HG3' ' CD1' ' A' ' 42' ' ' PHE . 36.3 tt0 -152.03 139.78 19.86 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.441 -0.577 . . . . 2.6000000000000001 109.441 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.81 -137.3 21.32 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.34 -0.933 . . . . 1.6899999999999999 112.487 178.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.54 -140.06 15.91 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.215 -0.993 . . . . 2.1299999999999999 112.016 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -53.32 -68.73 0.06 OUTLIER 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 123.575 2.85 . . . . 3.0 112.304 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -177.48 -44.66 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.011 -0.54 . . . . 2.6099999999999999 110.511 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -71.86 -23.25 61.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.936 -0.575 . . . . 2.1000000000000001 111.855 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.67 57.96 4.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.073 0.463 . . . . 1.28 111.329 -172.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -92.09 18.61 7.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.379 0.609 . . . . 1.9299999999999999 110.045 177.725 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -83.4 140.48 32.36 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 106.471 -1.677 . . . . 3.6400000000000001 106.471 168.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.462 ' CD1' ' HG3' ' A' ' 33' ' ' GLU . 9.0 m-85 -111.0 130.15 55.68 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 120.474 -0.49 . . . . 0.79000000000000004 110.284 -172.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.6 m -121.92 125.43 46.37 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.03 -1.1 . . . . 0.26000000000000001 108.03 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.728 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -134.36 151.61 51.32 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.582 -0.525 . . . . 0.17000000000000001 109.582 -175.108 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.91 139.41 11.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.96 -0.638 . . . . 0.17000000000000001 111.883 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.728 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -107.05 157.6 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 N-CA-C 110.03 -0.359 . . . . 0.80000000000000004 110.03 -174.689 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.615 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 15.2 ptp180 -148.5 147.39 29.04 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.674 -0.862 . . . . 2.6200000000000001 108.674 171.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.638 HG23 HD11 ' A' ' 78' ' ' LEU . 73.0 t -124.98 153.07 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.474 -0.33 . . . . 0.23999999999999999 110.807 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -93.89 84.54 4.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.729 0.776 . . . . 1.5900000000000001 110.213 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' A' ' 53' ' ' ARG . 40.3 p -72.52 108.11 5.41 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.374 -1.285 . . . . 0.33000000000000002 109.05 177.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.1 t -49.83 -28.28 6.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.011 -0.541 . . . . 1.3200000000000001 112.251 -175.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -88.44 -15.82 34.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.705 0.631 . . . . 1.3 112.705 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.44 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 25.3 ttm180 -132.22 -49.38 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.915 -0.491 . . . . 3.6800000000000002 111.307 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 125.59 -156.82 19.48 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.842 -0.617 . . . . 0.19 112.288 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.615 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.7 m95 -52.0 117.95 3.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.969 0.414 . . . . 0.39000000000000001 110.611 173.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 47.9 p -69.85 168.98 14.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.533 -0.758 . . . . 0.35999999999999999 111.306 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.48 125.51 25.93 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.164 -0.68 . . . . 1.8400000000000001 109.164 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 45.4 tt0 -60.75 118.11 6.22 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.297 -0.865 . . . . 1.0 111.036 -174.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 68.6 m -97.96 102.26 13.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.713 -1.13 . . . . 0.35999999999999999 110.731 -175.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.43 127.7 36.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.77 -0.65 . . . . 0.73999999999999999 110.533 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.15 -161.93 34.93 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.574 -0.739 . . . . 0.23000000000000001 113.019 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 64' ' ' MET . 32.5 mt-10 -92.03 131.94 33.85 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.744 -0.228 . . . . 1.3700000000000001 110.612 -175.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 54.1 Cg_exo -52.9 108.92 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.765 2.31 . . . . 0.51000000000000001 111.477 175.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.472 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 7.1 mmt -110.96 151.51 43.03 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.006 -0.543 . . . . 0.67000000000000004 111.772 -171.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.59 5.78 6.06 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.949 2.432 . . . . 0.32000000000000001 112.989 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.4 t -151.61 142.39 22.87 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.5 -0.556 . . . . 1.3 109.5 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.4 t -62.16 -33.3 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.457 -0.792 . . . . 1.1399999999999999 111.406 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -66.76 -37.07 83.89 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.242 -0.435 . . . . 2.8199999999999998 110.439 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.472 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 29.1 mtpp -74.27 -31.44 62.53 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.079 -0.509 . . . . 1.3600000000000001 110.315 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.74 -60.89 2.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.68 -0.691 . . . . 0.20999999999999999 110.955 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.538 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 32.6 mmtp -51.46 -49.51 61.62 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.289 -0.414 . . . . 2.4199999999999999 110.995 176.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.508 ' O ' HG23 ' A' ' 76' ' ' VAL . 17.4 t70 -51.84 -52.27 50.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.281 -0.872 . . . . 2.0099999999999998 112.566 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 91.6 p -62.4 -41.31 98.57 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.835 0.309 . . . . 1.1399999999999999 111.835 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.493 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -69.46 -41.44 76.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.222 0.534 . . . . 0.17999999999999999 110.543 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.409 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -54.23 -33.68 58.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.231 -0.895 . . . . 0.26000000000000001 111.395 176.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 72' ' ' ASP . 88.7 t -62.55 -37.96 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 120.971 0.415 . . . . 0.82999999999999996 110.833 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.08 -30.47 62.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.868 0.842 . . . . 0.39000000000000001 109.042 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.638 HD11 HG23 ' A' ' 48' ' ' VAL . 18.1 tp -67.3 -42.88 82.99 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.438 -1.255 . . . . 0.81000000000000005 110.329 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.9 mm? -61.26 -29.5 69.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.713 -0.676 . . . . 1.6100000000000001 110.971 177.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 76' ' ' VAL . 35.1 mt-10 -75.98 -38.5 57.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.932 0.396 . . . . 2.1299999999999999 110.112 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.9 tt -62.65 -48.95 77.11 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.277 -0.638 . . . . 1.1699999999999999 109.277 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.9 -14.73 60.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.324 -0.853 . . . . 1.1499999999999999 112.191 177.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -96.51 -6.79 36.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.633 0.73 . . . . 1.46 109.613 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -113.69 34.35 4.64 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.291 -0.868 . . . . 4.1699999999999999 110.108 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.251 1.146 0 CA-C-N 115.442 -0.799 . . . . 3.79 109.892 -179.102 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 111.5 0.185 . . . . 2.4900000000000002 111.5 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -68.11 -47.68 67.5 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.855 0.36 . . . . 2.46 110.543 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.3 mp -58.46 -43.45 86.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.565 -0.743 . . . . 0.80000000000000004 110.11 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.501 ' SG ' ' HG3' ' A' ' 26' ' ' PRO . 57.6 m -66.41 -43.65 85.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.072 -0.967 . . . . 1.3500000000000001 110.412 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.7 tp -63.81 -53.03 57.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.964 -1.016 . . . . 1.1599999999999999 111.194 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -59.23 -35.51 73.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.893 -0.594 . . . . 3.8399999999999999 111.371 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 37.3 mmtt -74.18 -1.26 19.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.126 0.489 . . . . 1.1000000000000001 111.939 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 61.89 36.8 15.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.851 -1.068 . . . . 1.9199999999999999 110.632 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 29.8 m0 -94.7 161.73 27.82 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.489 -0.778 . . . . 0.40000000000000002 109.014 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.18 177.98 4.0 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.965 1.776 . . . . 0.44 110.459 170.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 22.0 mmt -77.61 123.08 86.66 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-O 120.931 0.396 . . . . 1.0 110.403 -176.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.527 ' HB3' HG22 ' A' ' 48' ' ' VAL . 9.6 Cg_endo -56.47 163.15 7.08 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.695 2.93 . . . . 0.46000000000000002 114.015 -176.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.538 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 25.6 t -88.46 143.35 27.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.811 -1.086 . . . . 0.29999999999999999 110.461 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.541 ' HD1' ' CZ ' ' A' ' 44' ' ' PHE . 65.5 m-85 -143.33 111.37 6.1 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.146 -0.687 . . . . 0.29999999999999999 109.146 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.47 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 79.2 ttt180 -155.71 129.87 8.78 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.599 -0.519 . . . . 3.6899999999999999 109.599 -176.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 13.8 p -69.78 132.0 45.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.216 0.531 . . . . 1.53 111.2 -176.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.71 -31.66 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.61 -0.723 . . . . 1.1499999999999999 109.983 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.408 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 87.7 tttt -143.44 127.06 17.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.984 -0.553 . . . . 2.25 110.897 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -150.27 139.31 21.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.543 -0.753 . . . . 2.6000000000000001 110.044 176.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.12 167.1 37.34 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.743 -0.741 . . . . 1.6899999999999999 114.072 172.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 163.02 -151.24 20.87 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.122 -0.791 . . . . 2.1299999999999999 111.122 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.67 -68.9 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 123.144 2.563 . . . . 3.0 112.144 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -168.0 -38.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.284 0.564 . . . . 2.6099999999999999 109.499 176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -78.91 18.95 0.56 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.49 -0.777 . . . . 2.1000000000000001 110.866 174.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.93 29.63 5.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.062 0.458 . . . . 1.28 111.633 -174.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -90.78 17.79 7.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.701 0.762 . . . . 1.9299999999999999 109.409 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -85.54 134.84 34.01 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.545 -1.28 . . . . 3.6400000000000001 107.545 168.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 7.7 m-85 -109.64 134.64 51.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.015 0.436 . . . . 0.79000000000000004 110.355 -170.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 32' ' ' LYS . 19.7 m -123.61 120.6 33.29 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.66 -0.867 . . . . 0.26000000000000001 108.66 -178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.736 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -131.58 154.18 49.12 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.649 -0.5 . . . . 0.17000000000000001 109.649 -172.369 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -128.5 140.44 11.76 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.951 -0.642 . . . . 0.17000000000000001 112.168 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.736 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -106.93 154.81 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 109.661 -0.496 . . . . 0.80000000000000004 109.661 -176.653 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.575 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 12.4 ptp180 -145.79 142.7 29.13 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.907 -1.146 . . . . 2.6200000000000001 107.907 173.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.602 HG23 HD11 ' A' ' 78' ' ' LEU . 43.7 t -124.8 156.04 33.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.714 -0.221 . . . . 0.23999999999999999 110.606 -178.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.405 ' N ' HG12 ' A' ' 48' ' ' VAL . 26.6 t-20 -91.89 84.19 5.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.739 0.78 . . . . 1.5900000000000001 109.782 178.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.8 p -78.25 103.14 8.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.581 -1.19 . . . . 0.33000000000000002 109.167 177.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 t -44.25 -34.87 2.04 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.351 -0.84 . . . . 1.3200000000000001 113.095 -170.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -68.26 -26.95 65.93 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.858 0.688 . . . . 1.3 112.858 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -132.24 -42.2 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.013 0.435 . . . . 3.6800000000000002 111.487 -174.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.49 -150.02 16.94 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.965 -0.562 . . . . 0.19 112.03 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.575 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.9 m95 -51.5 120.06 4.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.024 0.44 . . . . 0.39000000000000001 111.327 175.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.6 p -68.34 156.92 36.79 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.726 -0.67 . . . . 0.35999999999999999 110.346 176.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -61.84 124.88 21.98 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.866 -0.79 . . . . 1.8400000000000001 108.866 173.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 40.5 tt0 -59.64 118.03 5.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.104 -0.953 . . . . 1.0 111.242 -170.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.419 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 50.6 m -93.3 102.64 14.91 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.704 -1.134 . . . . 0.35999999999999999 110.614 -174.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.02 128.56 38.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.819 -0.628 . . . . 0.73999999999999999 110.739 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.27 -167.58 43.51 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.478 -0.783 . . . . 0.23000000000000001 111.999 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.638 ' O ' ' HG2' ' A' ' 64' ' ' MET . 40.9 mt-10 -86.62 148.14 45.61 Favored Pre-proline 0 C--N 1.318 -0.795 0 O-C-N 122.731 -0.276 . . . . 1.3700000000000001 110.311 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 32.1 Cg_exo -59.62 107.87 0.42 Allowed 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.492 2.128 . . . . 0.51000000000000001 110.753 170.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.638 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 95.9 mmm -114.62 148.77 41.04 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.063 -0.517 . . . . 0.67000000000000004 110.139 -172.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.74 8.67 4.13 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.619 2.212 . . . . 0.32000000000000001 113.667 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.425 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 37.9 m -153.88 137.91 16.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.349 -0.612 . . . . 1.3 109.349 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.571 ' O ' ' HD3' ' A' ' 71' ' ' LYS . 28.3 m -64.84 -29.3 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 112.646 0.61 . . . . 1.1399999999999999 112.646 -170.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.68 -42.86 77.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.965 0.412 . . . . 2.8199999999999998 111.33 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.425 ' HG2' ' HB2' ' A' ' 66' ' ' SER . 14.5 ptpt -81.84 -18.21 44.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.362 -0.381 . . . . 1.3600000000000001 111.058 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.42 -51.22 68.39 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.517 -0.549 . . . . 0.20999999999999999 109.517 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.653 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -52.57 -51.56 59.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.135 -0.939 . . . . 2.4199999999999999 110.461 174.018 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -52.76 -46.95 67.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.254 -0.884 . . . . 2.0099999999999998 112.277 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.536 ' O ' HG12 ' A' ' 76' ' ' VAL . 95.7 p -65.58 -39.36 91.54 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.901 -0.319 . . . . 1.1399999999999999 111.5 -176.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.425 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -70.99 -48.15 54.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.026 0.441 . . . . 0.17999999999999999 110.552 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.472 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -54.31 -38.89 66.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.501 -0.772 . . . . 0.26000000000000001 111.808 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 73' ' ' SER . 3.0 p -72.25 -26.62 25.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 0.82999999999999996 110.958 -176.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.8 mt -78.2 -34.07 49.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.852 0.834 . . . . 0.39000000000000001 109.402 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.602 HD11 HG23 ' A' ' 48' ' ' VAL . 17.5 tp -64.68 -38.65 91.73 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.691 -1.14 . . . . 0.81000000000000005 110.693 175.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 75' ' ' ALA . 6.1 mp -61.09 -26.26 67.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.548 -0.751 . . . . 1.6100000000000001 111.357 177.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -70.61 -38.04 73.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.479 0.657 . . . . 2.1299999999999999 109.985 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.34 -46.96 75.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.134 -0.939 . . . . 1.1699999999999999 109.177 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mp -69.22 -13.58 62.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.191 -0.913 . . . . 1.1499999999999999 111.686 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -84.17 -4.45 58.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.011 0.91 . . . . 1.46 109.208 175.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -118.65 45.86 1.96 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.886 -1.052 . . . . 4.1699999999999999 109.668 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.569 -0.729 . . . . 3.79 110.847 -178.237 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.0 t30 . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 120.609 0.242 . . . . 2.4900000000000002 110.735 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -61.8 -45.45 93.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.98 0.419 . . . . 2.46 111.221 -171.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -64.71 -49.1 81.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.7 -0.682 . . . . 0.80000000000000004 111.045 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.594 ' SG ' ' HD3' ' A' ' 26' ' ' PRO . 53.3 t -62.22 -41.1 98.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.445 0.64 . . . . 1.3500000000000001 110.388 -176.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 38.5 tp -62.27 -51.97 65.6 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.001 -0.999 . . . . 1.1599999999999999 110.899 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.9 ttp-105 -61.59 -31.89 71.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.262 -0.881 . . . . 3.8399999999999999 111.525 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -72.58 -1.59 16.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.961 -0.563 . . . . 1.1000000000000001 111.437 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 59.67 27.79 17.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.853 -1.067 . . . . 1.9199999999999999 111.841 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.482 ' CH2' HG22 ' A' ' 50' ' ' THR . 27.3 m0 -85.4 162.86 47.09 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.234 -0.654 . . . . 0.40000000000000002 109.234 174.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.08 174.34 7.09 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 121.981 1.788 . . . . 0.44 110.437 170.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 5.7 mmt -79.2 132.94 61.55 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.981 0.42 . . . . 1.0 111.402 -170.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.594 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 12.1 Cg_endo -58.82 156.42 32.99 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.832 3.021 . . . . 0.46000000000000002 113.819 -177.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.1 t -90.35 144.21 26.03 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.841 -1.072 . . . . 0.29999999999999999 110.238 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.54 ' CD2' ' CZ ' ' A' ' 44' ' ' PHE . 60.7 m-85 -141.58 110.32 6.12 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.933 -0.766 . . . . 0.29999999999999999 108.933 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.532 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 57.5 mtp180 -146.05 125.67 13.33 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 110.39 -0.226 . . . . 3.6899999999999999 110.39 -176.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 74.6 m -65.24 126.77 29.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.749 0.309 . . . . 1.53 110.795 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 43' ' ' THR . 30.5 m -87.48 -38.67 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 1.1499999999999999 110.927 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -140.84 130.28 23.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.411 -0.359 . . . . 2.25 110.764 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.01 151.3 35.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.134 -0.485 . . . . 2.6000000000000001 110.708 175.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.27 -167.92 39.03 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.959 -0.638 . . . . 1.6899999999999999 113.313 175.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.72 -150.59 21.6 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.076 -0.81 . . . . 2.1299999999999999 111.076 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -52.03 -57.21 2.27 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 123.104 2.536 . . . . 3.0 111.882 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -177.59 -50.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.528 -0.76 . . . . 2.6099999999999999 109.373 177.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -77.57 19.46 0.37 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.183 -0.917 . . . . 2.1000000000000001 111.701 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.92 45.7 2.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.972 0.415 . . . . 1.28 111.025 -176.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -83.21 18.93 1.58 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.032 0.444 . . . . 1.9299999999999999 110.659 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -85.58 141.12 30.06 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.018 -0.734 . . . . 3.6400000000000001 109.018 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -110.47 136.01 50.27 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.025 -0.534 . . . . 0.79000000000000004 110.807 -172.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 31' ' ' VAL . 16.7 m -124.6 127.84 47.98 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.234 -1.024 . . . . 0.26000000000000001 108.234 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.747 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -142.85 154.4 44.11 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.499 -0.556 . . . . 0.17000000000000001 109.499 -175.771 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.556 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -126.85 139.75 11.46 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.903 -0.665 . . . . 0.17000000000000001 112.519 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.747 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -107.18 159.02 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.659 -0.497 . . . . 0.80000000000000004 109.659 -175.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.616 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 14.6 ptp180 -148.43 147.87 29.66 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.61 -0.885 . . . . 2.6200000000000001 108.61 171.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.572 HG23 HD11 ' A' ' 78' ' ' LEU . 85.1 t -125.76 156.18 35.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.305 -0.407 . . . . 0.23999999999999999 110.178 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -92.12 82.2 5.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.087 0.47 . . . . 1.5900000000000001 109.949 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.482 HG22 ' CH2' ' A' ' 23' ' ' TRP . 41.5 p -74.5 107.2 6.49 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.548 -0.751 . . . . 0.33000000000000002 109.479 178.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.7 t -47.53 -30.54 3.58 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.825 0.676 . . . . 1.3200000000000001 112.825 -173.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -80.32 -14.58 58.25 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.417 0.895 . . . . 1.3 113.417 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -140.07 -42.09 0.43 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.525 0.602 . . . . 3.6800000000000002 111.105 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 122.75 -153.75 16.95 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 116.111 -0.495 . . . . 0.19 112.048 -178.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.616 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 9.4 m95 -51.81 120.48 5.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.812 0.339 . . . . 0.39000000000000001 110.732 173.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 47.4 p -68.92 157.73 36.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.709 -0.678 . . . . 0.35999999999999999 111.045 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -58.22 131.67 51.28 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.065 -0.717 . . . . 1.8400000000000001 109.065 174.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.66 113.02 2.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.744 0.783 . . . . 1.0 111.262 -171.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.457 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 38.7 m -85.87 98.67 10.9 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.177 -1.374 . . . . 0.35999999999999999 109.984 -176.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.556 HD13 ' HA3' ' A' ' 45' ' ' GLY . 19.1 mm -80.71 128.96 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 115.892 -0.594 . . . . 0.73999999999999999 110.364 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.11 175.21 49.87 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.921 -0.872 . . . . 0.23000000000000001 110.921 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' A' ' 64' ' ' MET . 12.5 pt-20 -85.5 150.5 54.18 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.572 -0.529 . . . . 1.3700000000000001 109.572 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.97 109.97 0.39 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.651 2.234 . . . . 0.51000000000000001 111.692 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.606 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 98.0 mmm -114.73 139.19 23.8 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.816 -0.629 . . . . 0.67000000000000004 109.493 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.69 13.69 0.73 Allowed 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.576 2.184 . . . . 0.32000000000000001 114.072 -174.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.52 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 28.6 m -157.46 143.1 17.36 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.715 -0.476 . . . . 1.3 109.715 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.77 -41.23 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.337 -0.847 . . . . 1.1399999999999999 112.693 -170.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.35 -42.39 96.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.919 0.39 . . . . 2.8199999999999998 111.146 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.52 ' HG2' ' HB2' ' A' ' 66' ' ' SER . 15.8 ptpt -81.26 -18.95 44.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.462 -0.335 . . . . 1.3600000000000001 110.67 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.45 -55.63 25.81 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.397 -0.365 . . . . 0.20999999999999999 110.301 171.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.613 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 53.5 mtpt -54.29 -52.17 62.31 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 116.063 -0.517 . . . . 2.4199999999999999 110.29 175.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.38 -42.13 73.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.128 -0.942 . . . . 2.0099999999999998 112.194 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.547 ' O ' HG12 ' A' ' 76' ' ' VAL . 17.1 t -62.75 -43.06 99.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.778 0.323 . . . . 1.1399999999999999 110.981 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.435 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -69.95 -44.4 69.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.134 0.493 . . . . 0.17999999999999999 110.401 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.479 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -57.52 -38.51 74.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.631 -0.713 . . . . 0.26000000000000001 112.208 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 73' ' ' SER . 3.1 p -68.79 -31.19 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 O-C-N 121.952 -0.467 . . . . 0.82999999999999996 110.669 -178.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.5 mt -76.19 -31.79 58.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.808 0.813 . . . . 0.39000000000000001 109.103 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.572 HD11 HG23 ' A' ' 48' ' ' VAL . 14.3 tp -66.16 -43.31 87.33 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.496 -1.229 . . . . 0.81000000000000005 110.728 175.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.479 HD13 ' O ' ' A' ' 75' ' ' ALA . 6.3 mp -59.15 -29.19 67.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 1.6100000000000001 111.424 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 6.2 mm-40 -71.78 -38.93 70.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.191 -0.459 . . . . 2.1299999999999999 110.698 177.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.3 tp -75.05 -41.97 58.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.908 0.861 . . . . 1.1699999999999999 110.335 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.453 ' C ' ' H ' ' A' ' 84' ' ' LYS . 8.7 tp -65.4 -38.92 91.43 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.062 -1.426 . . . . 1.1499999999999999 111.341 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -68.04 -3.58 10.65 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.804 -1.089 . . . . 1.46 109.816 173.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.453 ' H ' ' C ' ' A' ' 82' ' ' LEU . 82.4 mttt 62.1 157.69 0.05 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.175 -1.375 . . . . 4.1699999999999999 111.585 -173.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.8 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.918 -0.563 . . . . 3.79 110.853 -162.216 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.9 p30 . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 111.683 0.253 . . . . 2.4900000000000002 111.683 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -66.35 -45.86 78.77 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.837 0.351 . . . . 2.46 111.221 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.477 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.4 mp -61.38 -41.5 90.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.662 -0.699 . . . . 0.80000000000000004 110.638 -178.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.412 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 42.8 t -71.57 -41.73 68.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.987 -0.551 . . . . 1.3500000000000001 110.218 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.8 -54.63 42.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.357 -0.838 . . . . 1.1599999999999999 110.605 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -58.06 -33.89 69.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.211 -0.904 . . . . 3.8399999999999999 111.906 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.427 ' HB3' ' CE2' ' A' ' 23' ' ' TRP . 34.4 mmtt -72.71 4.02 4.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.071 0.462 . . . . 1.1000000000000001 111.968 -178.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 63.28 38.71 10.15 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.867 -1.06 . . . . 1.9199999999999999 110.28 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 29.0 m0 -104.81 165.09 13.88 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.423 -0.808 . . . . 0.40000000000000002 109.631 176.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 55.0 Cg_endo -72.39 -171.51 0.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.349 2.033 . . . . 0.44 110.913 170.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.487 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 12.0 mmt -82.33 135.94 46.68 Favored Pre-proline 0 C--N 1.323 -0.582 0 O-C-N 122.024 -0.422 . . . . 1.0 110.633 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.571 ' HB3' HG22 ' A' ' 48' ' ' VAL . 14.4 Cg_exo -68.88 168.45 20.33 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.916 2.411 . . . . 0.46000000000000002 113.045 -177.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.2 t -89.51 141.23 28.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.936 -1.029 . . . . 0.29999999999999999 110.32 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.464 ' CD2' ' HZ ' ' A' ' 44' ' ' PHE . 67.7 m-85 -144.17 110.52 5.51 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.29 -0.633 . . . . 0.29999999999999999 109.29 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.478 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 24.2 ttm180 -156.52 128.42 7.31 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.751 0.31 . . . . 3.6899999999999999 110.512 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 4.5 p -65.68 124.26 21.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.069 0.461 . . . . 1.53 110.957 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.7 m -87.57 -37.07 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.987 -0.552 . . . . 1.1499999999999999 111.439 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -135.89 122.7 21.16 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.06 0.457 . . . . 2.25 110.52 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.406 ' HG3' ' CD1' ' A' ' 42' ' ' PHE . 26.4 tt0 -151.45 143.22 23.73 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.323 -0.853 . . . . 2.6000000000000001 110.289 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.93 -170.85 38.4 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.143 -1.027 . . . . 1.6899999999999999 114.018 171.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.78 -155.32 26.1 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.442 -1.063 . . . . 2.1299999999999999 110.442 -173.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -53.85 -65.43 0.13 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.944 2.429 . . . . 3.0 111.999 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -170.46 -42.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.692 -0.686 . . . . 2.6099999999999999 109.623 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -78.81 18.22 0.63 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.439 -0.8 . . . . 2.1000000000000001 111.226 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.19 36.32 4.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.434 0.635 . . . . 1.28 110.646 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -87.88 19.0 3.74 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.747 -0.66 . . . . 1.9299999999999999 110.618 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -82.84 134.05 35.11 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.4 -0.963 . . . . 3.6400000000000001 108.4 172.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.406 ' CD1' ' HG3' ' A' ' 33' ' ' GLU . 23.4 m-85 -110.31 135.66 50.7 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.904 -0.589 . . . . 0.79000000000000004 110.637 -170.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.8 m -122.54 130.69 53.3 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.868 -1.16 . . . . 0.26000000000000001 107.868 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.738 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -139.18 151.33 46.5 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.417 -0.586 . . . . 0.17000000000000001 109.417 -174.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.551 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -125.58 136.84 9.94 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.973 -0.632 . . . . 0.17000000000000001 112.017 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.738 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -107.1 156.72 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 109.308 -0.627 . . . . 0.80000000000000004 109.308 -176.899 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.562 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 16.2 ptt180 -148.99 147.7 28.88 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.774 -0.825 . . . . 2.6200000000000001 108.774 171.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.571 HG22 ' HB3' ' A' ' 26' ' ' PRO . 78.2 t -125.13 153.44 32.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.076 -0.511 . . . . 0.23999999999999999 110.339 -177.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -93.58 83.4 4.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.507 0.67 . . . . 1.5900000000000001 109.835 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 54' ' ' GLY . 29.6 p -69.89 105.58 2.86 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.628 -1.169 . . . . 0.33000000000000002 108.963 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.1 t -43.78 -44.33 6.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.804 0.668 . . . . 1.3200000000000001 112.804 -169.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -81.5 -6.44 58.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.254 0.835 . . . . 1.3 113.254 -175.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -133.1 -48.65 0.86 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.739 -0.601 . . . . 3.6800000000000002 111.547 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 123.71 -153.68 17.35 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.899 -0.591 . . . . 0.19 112.585 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.562 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 5.2 m95 -52.43 117.61 2.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.869 0.366 . . . . 0.39000000000000001 110.676 174.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.0 p -68.48 169.78 10.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.725 -0.671 . . . . 0.35999999999999999 111.214 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -62.41 129.45 40.72 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.708 -0.849 . . . . 1.8400000000000001 108.708 172.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -60.63 119.74 8.68 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.39 0.614 . . . . 1.0 110.609 -176.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.51 ' SG ' HD12 ' A' ' 81' ' ' LEU . 51.5 m -92.34 98.52 11.54 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.892 -1.049 . . . . 0.35999999999999999 110.231 -175.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.551 HD13 ' HA3' ' A' ' 45' ' ' GLY . 24.6 mm -80.42 124.02 37.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.778 -0.646 . . . . 0.73999999999999999 110.066 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.99 -174.84 50.0 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.882 -0.675 . . . . 0.23000000000000001 112.243 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 64' ' ' MET . 42.9 mt-10 -83.81 152.01 62.1 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 109.728 -0.471 . . . . 1.3700000000000001 109.728 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.43 109.14 1.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.363 2.042 . . . . 0.51000000000000001 111.222 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.562 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 89.3 mmm -115.37 141.57 27.41 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.697 -0.483 . . . . 0.67000000000000004 109.697 -173.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.05 17.97 1.1 Allowed 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.57 2.18 . . . . 0.32000000000000001 113.581 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.424 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 11.2 t -155.09 139.91 17.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.315 -0.624 . . . . 1.3 109.315 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.2 -23.88 27.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.838 -0.619 . . . . 1.1399999999999999 111.032 -173.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -73.96 -43.69 57.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.039 0.447 . . . . 2.8199999999999998 110.235 -176.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.424 ' HG2' ' HB3' ' A' ' 66' ' ' SER . 5.7 ptpp? -81.64 -18.37 44.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.939 -0.573 . . . . 1.3600000000000001 110.634 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.28 -57.49 12.56 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.496 -0.32 . . . . 0.20999999999999999 110.496 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.462 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 61.5 mttm -52.95 -50.08 64.78 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.946 0.403 . . . . 2.4199999999999999 110.257 174.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.534 ' O ' HG23 ' A' ' 76' ' ' VAL . 32.1 t70 -51.54 -51.56 54.3 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.362 -0.835 . . . . 2.0099999999999998 112.295 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.4 t -56.31 -46.64 79.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.787 0.327 . . . . 1.1399999999999999 111.178 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.441 ' HB1' HG23 ' A' ' 46' ' ' VAL . . . -69.5 -43.14 73.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.259 -0.428 . . . . 0.17999999999999999 110.951 -177.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.91 -41.06 70.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.819 -0.628 . . . . 0.26000000000000001 111.84 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 72' ' ' ASP . 97.0 t -63.64 -35.04 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.043 0.449 . . . . 0.82999999999999996 110.731 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.6 mt -74.89 -36.63 62.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.732 0.777 . . . . 0.39000000000000001 109.66 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.531 HD22 HG11 ' A' ' 46' ' ' VAL . 21.0 tp -64.72 -43.12 94.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.749 -1.114 . . . . 0.81000000000000005 111.103 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 mp -62.69 -21.13 65.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.85 -0.613 . . . . 1.6100000000000001 111.497 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -76.43 -38.44 55.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.752 0.31 . . . . 2.1299999999999999 110.234 174.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.51 HD12 ' SG ' ' A' ' 59' ' ' CYS . 0.8 OUTLIER -66.35 -42.98 87.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.766 0.793 . . . . 1.1699999999999999 109.063 178.579 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.418 ' HG ' ' CZ3' ' A' ' 23' ' ' TRP . 1.6 mp -69.24 -17.75 63.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.678 -1.146 . . . . 1.1499999999999999 111.943 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.59 ' O ' ' HB2' ' A' ' 84' ' ' LYS . 22.9 t-20 -88.51 0.83 55.89 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.833 -0.803 . . . . 1.46 108.833 174.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 83' ' ' ASN . 53.5 mtpt 80.32 146.76 0.09 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.384 -1.28 . . . . 4.1699999999999999 110.161 -178.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.782 -0.627 . . . . 3.79 110.432 -168.764 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.838 0.352 . . . . 0.80000000000000004 110.855 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 23' ' ' TRP . 35.4 t -68.29 -40.92 81.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.412 0.625 . . . . 1.3500000000000001 109.775 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.2 tp -62.22 -50.03 73.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.095 -0.957 . . . . 1.1599999999999999 110.219 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -60.18 -36.81 78.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.966 -1.015 . . . . 3.8399999999999999 111.635 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.406 ' HB3' ' CE2' ' A' ' 23' ' ' TRP . 49.0 mmtt -73.3 -3.25 25.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.394 0.616 . . . . 1.1000000000000001 111.646 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 64.95 43.63 3.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.396 -1.274 . . . . 1.9199999999999999 110.648 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.486 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 19.1 m0 -105.14 162.79 18.67 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.742 -0.663 . . . . 0.40000000000000002 109.426 174.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 34.4 Cg_endo -67.92 -178.8 1.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.073 1.849 . . . . 0.44 110.75 171.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 16.7 mmt -80.66 127.89 73.88 Favored Pre-proline 0 C--N 1.322 -0.596 0 O-C-N 121.984 -0.447 . . . . 1.0 109.892 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HB3' HG22 ' A' ' 48' ' ' VAL . 22.0 Cg_exo -63.4 167.99 12.05 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.947 2.431 . . . . 0.46000000000000002 113.462 -174.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.5 t -86.6 140.37 29.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.952 -1.022 . . . . 0.29999999999999999 109.979 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.464 ' CD1' ' HZ ' ' A' ' 44' ' ' PHE . 69.4 m-85 -145.57 110.99 5.35 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.566 -0.531 . . . . 0.29999999999999999 109.566 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.488 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 72.7 ttt180 -158.68 130.37 6.56 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 110.359 -0.237 . . . . 3.6899999999999999 110.359 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.5 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 70.0 m -64.23 124.49 21.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.339 -0.392 . . . . 1.53 110.766 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -82.53 -32.59 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.248 0.547 . . . . 1.1499999999999999 110.362 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.8 tttp . . . . . 0 C--N 1.319 -0.754 0 CA-C-N 115.568 -0.742 . . . . 2.25 109.475 174.379 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 107.726 -1.213 . . . . 3.6400000000000001 107.726 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -110.57 131.65 54.87 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.103 0.477 . . . . 0.79000000000000004 110.387 -172.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.0 m -120.01 130.99 54.99 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.876 -1.157 . . . . 0.26000000000000001 107.876 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.727 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -137.94 151.79 48.33 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.642 -0.503 . . . . 0.17000000000000001 109.642 -173.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -125.47 136.47 9.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.232 -0.508 . . . . 0.17000000000000001 111.987 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.727 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.3 t -107.72 154.41 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 117.14 0.47 . . . . 0.80000000000000004 109.856 -175.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.56 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 10.9 ptt180 -149.51 145.23 26.75 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.681 -0.859 . . . . 2.6200000000000001 108.681 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.616 HG23 HD11 ' A' ' 78' ' ' LEU . 61.0 t -125.5 155.85 34.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.355 -0.384 . . . . 0.23999999999999999 110.394 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -95.12 83.87 3.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.601 0.715 . . . . 1.5900000000000001 110.37 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.456 HG22 ' CZ2' ' A' ' 23' ' ' TRP . 30.1 p -72.92 103.08 3.62 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.423 -1.262 . . . . 0.33000000000000002 108.944 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.9 t -46.06 -32.97 3.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.654 -0.703 . . . . 1.3200000000000001 112.858 -170.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -72.31 -22.57 61.16 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.753 0.649 . . . . 1.3 112.753 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -134.56 -45.69 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.022 -0.424 . . . . 3.6800000000000002 111.279 -175.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 126.64 -154.34 19.14 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.914 -0.584 . . . . 0.19 112.343 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.56 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 7.1 m95 -49.22 120.28 3.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.97 0.453 . . . . 0.39000000000000001 110.882 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 42.8 p -70.33 172.99 7.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.647 -0.706 . . . . 0.35999999999999999 111.418 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -61.05 131.84 51.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.883 -0.784 . . . . 1.8400000000000001 108.883 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 27.0 tt0 -64.64 114.96 4.76 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.342 0.591 . . . . 1.0 109.749 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 59.8 m -92.21 97.42 10.89 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.095 -0.957 . . . . 0.35999999999999999 110.258 -175.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.66 126.22 38.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.647 -0.706 . . . . 0.73999999999999999 110.361 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.22 -170.99 47.82 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.47 -0.787 . . . . 0.23000000000000001 111.727 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.607 ' O ' ' HG2' ' A' ' 64' ' ' MET . 41.4 mt-10 -88.36 152.07 49.45 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 110.281 -0.266 . . . . 1.3700000000000001 110.281 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.12 107.91 0.32 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.643 2.229 . . . . 0.51000000000000001 111.256 172.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.607 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 95.8 mmm -110.4 147.23 35.93 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.202 -0.454 . . . . 0.67000000000000004 110.482 -173.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.24 4.36 7.06 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.739 2.292 . . . . 0.32000000000000001 113.765 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.441 ' HB2' ' HG3' ' A' ' 69' ' ' LYS . 26.9 m -147.53 137.15 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.742 -0.466 . . . . 1.3 109.742 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.3 m -65.29 -28.77 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.178 -0.465 . . . . 1.1399999999999999 112.046 -171.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -71.19 -36.16 71.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.4 -0.364 . . . . 2.8199999999999998 110.454 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.441 ' HG3' ' HB2' ' A' ' 66' ' ' SER . 46.9 mtpt -74.47 -28.33 60.98 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.764 -0.458 . . . . 1.3600000000000001 109.764 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.49 -59.03 6.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.831 -0.622 . . . . 0.20999999999999999 110.623 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.632 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 56.8 mttm -53.6 -58.59 6.64 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.086 -0.506 . . . . 2.4199999999999999 111.471 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.589 ' O ' HG23 ' A' ' 76' ' ' VAL . 29.6 t70 -57.69 -42.37 83.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.656 -0.702 . . . . 2.0099999999999998 112.718 -173.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 m -70.31 -36.63 74.43 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 121.006 -0.278 . . . . 1.1399999999999999 111.418 -175.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.415 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -67.36 -42.89 82.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.613 0.721 . . . . 0.17999999999999999 109.541 174.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 79' ' ' LEU . . . -54.23 -34.67 61.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.48 -1.236 . . . . 0.26000000000000001 111.533 176.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 72' ' ' ASP . 98.3 t -64.56 -34.79 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.007 0.432 . . . . 0.82999999999999996 110.7 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.3 mt -74.6 -33.07 62.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.818 0.818 . . . . 0.39000000000000001 109.194 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.616 HD11 HG23 ' A' ' 48' ' ' VAL . 26.5 tp -64.1 -37.31 86.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.547 -1.206 . . . . 0.81000000000000005 110.272 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 20.8 mt -60.66 -28.27 68.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.233 -0.894 . . . . 1.6100000000000001 110.835 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -72.98 -36.69 67.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.042 0.448 . . . . 2.1299999999999999 110.027 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.2 tt -66.86 -46.22 75.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.645 0.735 . . . . 1.1699999999999999 109.052 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.456 ' HB3' HG21 ' A' ' 17' ' ' ILE . 3.8 mp -70.61 -11.35 60.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.915 -1.039 . . . . 1.1499999999999999 112.051 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.7 t30 . . . . . 0 C--N 1.321 -0.639 0 CA-C-O 121.592 0.71 . . . . 1.46 109.65 176.568 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.483 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.5 mp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.787 0.327 . . . . 0.80000000000000004 110.72 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.416 ' SG ' HG13 ' A' ' 48' ' ' VAL . 34.4 t -69.3 -42.11 75.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.312 0.577 . . . . 1.3500000000000001 109.824 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.3 tp -61.8 -49.31 76.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.309 -0.859 . . . . 1.1599999999999999 110.398 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -63.97 -31.44 72.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.799 -1.091 . . . . 3.8399999999999999 111.395 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.431 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 27.7 mmmt -74.31 3.11 7.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.362 -0.381 . . . . 1.1000000000000001 111.459 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 67.69 27.95 7.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.306 -0.861 . . . . 1.9199999999999999 110.25 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -94.65 160.2 31.93 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.389 -0.823 . . . . 0.40000000000000002 109.429 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.49 -169.53 0.43 Allowed 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.178 1.919 . . . . 0.44 111.554 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.429 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 9.3 mmt -78.28 134.63 62.59 Favored Pre-proline 0 C--N 1.324 -0.542 0 O-C-N 122.163 -0.336 . . . . 1.0 110.649 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 16.7 Cg_exo -66.62 156.69 64.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.648 2.232 . . . . 0.46000000000000002 112.042 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.45 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 12.9 t -89.32 142.6 27.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.899 -0.591 . . . . 0.29999999999999999 110.082 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.477 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 62.6 m-85 -142.21 111.98 6.78 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.308 -0.627 . . . . 0.29999999999999999 109.308 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.564 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 33.7 ttm180 -163.03 122.69 2.21 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.473 -0.566 . . . . 3.6899999999999999 109.473 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 73.8 m -61.77 131.33 49.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.196 0.522 . . . . 1.53 111.833 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.425 ' H ' ' HA ' ' A' ' 44' ' ' PHE . 27.2 m -82.98 -30.74 8.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.372 -0.831 . . . . 1.1499999999999999 110.357 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.7 tttp . . . . . 0 C--N 1.317 -0.839 0 CA-C-N 115.539 -0.755 . . . . 2.25 110.125 174.289 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 . . . . . 0 N--CA 1.445 -0.677 0 N-CA-C 107.084 -1.45 . . . . 3.6400000000000001 107.084 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -109.47 134.27 52.08 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.253 0.549 . . . . 0.79000000000000004 110.45 -169.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.8 m -123.24 127.08 48.09 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.02 -1.104 . . . . 0.26000000000000001 108.02 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.676 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -138.47 154.4 48.83 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.789 -0.448 . . . . 0.17000000000000001 109.789 -171.045 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.44 ' CA ' HD13 ' A' ' 60' ' ' ILE . . . -127.41 137.39 9.83 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.209 -0.52 . . . . 0.17000000000000001 111.923 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.676 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.3 t -107.33 153.98 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 N-CA-C 108.853 -0.795 . . . . 0.80000000000000004 108.853 -176.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.544 ' O ' ' HZ3' ' A' ' 55' ' ' TRP . 11.3 ptt180 -143.63 146.77 33.52 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.521 -0.918 . . . . 2.6200000000000001 108.521 173.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.416 HG13 ' SG ' ' A' ' 18' ' ' CYS . 74.7 t -125.36 150.71 30.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.757 -0.656 . . . . 0.23999999999999999 109.688 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -91.63 84.51 5.49 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.458 0.647 . . . . 1.5900000000000001 109.686 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.3 p -71.71 109.87 5.89 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.627 -1.17 . . . . 0.33000000000000002 109.45 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 62.0 p -50.56 -22.54 2.02 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.731 -1.122 . . . . 1.3200000000000001 114.021 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -92.08 -15.63 27.52 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.374 0.509 . . . . 1.3 112.374 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -136.24 -40.47 0.66 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.097 -0.377 . . . . 3.6800000000000002 111.878 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.57 -154.45 16.95 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 121.282 -0.485 . . . . 0.19 112.801 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.544 ' HZ3' ' O ' ' A' ' 47' ' ' ARG . 30.1 m95 -57.75 123.42 15.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.396 0.617 . . . . 0.39000000000000001 111.265 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.0 p -74.48 152.85 39.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.138 -0.937 . . . . 0.35999999999999999 110.879 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -62.05 129.41 40.72 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.231 -0.655 . . . . 1.8400000000000001 109.231 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -50.63 125.01 12.01 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.445 -0.798 . . . . 1.0 112.985 -173.019 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.425 ' SG ' HD12 ' A' ' 81' ' ' LEU . 58.9 m -86.95 100.85 12.9 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.174 -1.375 . . . . 0.35999999999999999 108.865 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.44 HD13 ' CA ' ' A' ' 45' ' ' GLY . 29.2 mm -83.07 123.92 39.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.919 -0.582 . . . . 0.73999999999999999 110.703 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.84 -175.86 51.03 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 121.052 -0.594 . . . . 0.23000000000000001 112.002 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HG2' ' OG ' ' A' ' 73' ' ' SER . 11.1 pt-20 -87.02 149.46 47.69 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 110.167 -0.309 . . . . 1.3700000000000001 110.167 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.33 108.76 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.813 2.342 . . . . 0.51000000000000001 111.61 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.409 ' SD ' ' HG3' ' A' ' 69' ' ' LYS . 15.1 mmt -108.87 143.75 28.22 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.166 -0.47 . . . . 0.67000000000000004 110.964 -174.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -83.34 10.47 3.65 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.683 2.255 . . . . 0.32000000000000001 112.845 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.7 m -153.15 138.03 17.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.444 -0.576 . . . . 1.3 109.444 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 m -68.63 -25.76 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 112.253 0.464 . . . . 1.1399999999999999 112.253 -173.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -73.06 -41.39 64.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.672 0.272 . . . . 2.8199999999999998 111.075 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HG3' ' SD ' ' A' ' 64' ' ' MET . 7.2 ptmm? -82.08 -17.62 45.93 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.891 -0.323 . . . . 1.3600000000000001 110.334 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.93 -61.78 2.37 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.198 -0.455 . . . . 0.20999999999999999 111.175 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.653 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -56.39 -42.58 78.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.589 0.233 . . . . 2.4199999999999999 111.09 177.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -53.44 -46.37 69.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.868 -0.605 . . . . 2.0099999999999998 112.199 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.645 ' O ' HG12 ' A' ' 76' ' ' VAL . 41.9 t -62.93 -45.07 94.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.039 0.447 . . . . 1.1399999999999999 111.185 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.419 ' HB1' HG23 ' A' ' 46' ' ' VAL . . . -68.34 -40.82 81.45 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.294 0.568 . . . . 0.17999999999999999 110.23 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.444 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -56.88 -37.57 71.56 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.274 -0.875 . . . . 0.26000000000000001 112.069 177.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.645 HG12 ' O ' ' A' ' 73' ' ' SER . 1.8 p -70.95 -26.82 28.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 O-C-N 121.917 -0.489 . . . . 0.82999999999999996 110.669 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.3 mt -78.79 -31.61 46.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.791 0.805 . . . . 0.39000000000000001 109.401 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.441 HD22 HG11 ' A' ' 46' ' ' VAL . 28.0 tp -66.88 -36.77 83.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.865 -1.061 . . . . 0.81000000000000005 110.461 175.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.6 mm? -61.21 -25.4 67.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.736 -0.666 . . . . 1.6100000000000001 110.861 175.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -71.71 -37.94 70.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.093 0.473 . . . . 2.1299999999999999 109.968 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.425 HD12 ' SG ' ' A' ' 59' ' ' CYS . 1.3 tt -62.99 -47.24 83.99 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.049 -0.723 . . . . 1.1699999999999999 109.049 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mp -74.39 0.91 12.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.191 -0.913 . . . . 1.1499999999999999 111.661 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.2 t30 . . . . . 0 C--N 1.322 -0.613 0 CA-C-O 121.763 0.792 . . . . 1.46 109.38 175.011 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.8 mp . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 121.449 0.642 . . . . 0.80000000000000004 109.961 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.3 m -65.1 -42.91 93.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.029 -0.987 . . . . 1.3500000000000001 110.204 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.83 -51.98 67.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.877 -1.056 . . . . 1.1599999999999999 110.284 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -57.02 -37.08 71.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.398 -0.819 . . . . 3.8399999999999999 111.923 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -72.81 1.96 7.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.066 -0.515 . . . . 1.1000000000000001 111.975 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.2 t30 65.59 32.67 9.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.938 -1.028 . . . . 1.9199999999999999 109.699 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.469 ' CH2' HG22 ' A' ' 50' ' ' THR . 38.2 m0 -99.21 160.58 27.23 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.201 -0.909 . . . . 0.40000000000000002 109.367 175.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.42 170.65 18.78 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.126 1.884 . . . . 0.44 110.048 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 50.0 mmm -72.68 134.49 81.7 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 110.347 -0.242 . . . . 1.0 110.347 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.517 ' HB3' HG22 ' A' ' 48' ' ' VAL . 23.6 Cg_exo -63.82 161.39 32.83 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.962 2.441 . . . . 0.46000000000000002 113.117 -177.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.571 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 16.6 t -87.63 141.49 28.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.961 -1.018 . . . . 0.29999999999999999 109.841 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.439 ' HD2' ' CZ ' ' A' ' 44' ' ' PHE . 78.6 m-85 -139.56 110.67 6.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.815 -0.809 . . . . 0.29999999999999999 108.815 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.445 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 26.7 ttm180 -153.39 123.45 6.95 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.972 -0.381 . . . . 3.6899999999999999 109.972 -176.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.481 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 62.5 m -61.87 124.93 22.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.136 0.493 . . . . 1.53 111.381 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.472 ' H ' ' HA ' ' A' ' 44' ' ' PHE . 53.3 t -80.74 -29.97 11.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.615 -0.72 . . . . 1.1499999999999999 109.784 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.7 tptt . . . . . 0 N--CA 1.447 -0.605 0 CA-C-N 115.883 -0.599 . . . . 2.25 110.22 178.252 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 109.476 -0.564 . . . . 3.6400000000000001 109.476 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 5.0 m-85 -109.87 136.26 49.45 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.311 -0.859 . . . . 0.79000000000000004 110.041 -173.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.3 m -118.44 125.91 50.93 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.938 -1.134 . . . . 0.26000000000000001 107.938 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.681 ' CZ ' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -132.65 151.75 51.87 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 121.843 -0.535 . . . . 0.17000000000000001 109.802 -171.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.44 ' CA ' HD13 ' A' ' 60' ' ' ILE . . . -125.57 129.16 6.78 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.14 -0.784 . . . . 0.17000000000000001 111.14 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.681 ' HB ' ' CZ ' ' A' ' 44' ' ' PHE . 7.3 p -109.94 145.94 15.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 110.057 -0.349 . . . . 0.80000000000000004 110.057 -173.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.633 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 2.9 ptp180 -140.32 145.92 37.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.836 -0.802 . . . . 2.6200000000000001 108.836 -176.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.582 HG23 HD11 ' A' ' 78' ' ' LEU . 57.6 t -125.89 154.55 34.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.461 -0.336 . . . . 0.23999999999999999 110.29 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -93.85 83.92 4.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.61 0.719 . . . . 1.5900000000000001 110.086 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.469 HG22 ' CH2' ' A' ' 23' ' ' TRP . 30.2 p -70.96 116.43 11.25 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.523 -1.217 . . . . 0.33000000000000002 110.062 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 p -51.13 -25.72 5.6 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.583 -1.189 . . . . 1.3200000000000001 113.522 -172.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -92.95 -12.89 29.67 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.745 0.646 . . . . 1.3 112.745 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -136.74 -42.03 0.6 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.792 -0.567 . . . . 3.6800000000000002 111.703 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.15 -152.83 17.12 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.891 -0.484 . . . . 0.19 111.891 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.633 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 9.4 m95 -54.15 117.78 3.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.119 0.485 . . . . 0.39000000000000001 110.956 176.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 56.1 p -69.59 150.6 46.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.436 -0.802 . . . . 0.35999999999999999 110.315 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -61.18 116.96 4.98 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.3 -1.0 . . . . 1.8400000000000001 108.3 171.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 3.9 pt-20 -55.39 140.57 39.38 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 114.802 -1.09 . . . . 1.0 111.934 -168.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 63.8 m -97.83 101.79 13.38 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.804 -1.089 . . . . 0.35999999999999999 109.458 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.44 HD13 ' CA ' ' A' ' 45' ' ' GLY . 25.6 mm -73.54 120.33 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.575 -0.739 . . . . 0.73999999999999999 110.143 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.58 -165.25 39.3 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.934 -0.65 . . . . 0.23000000000000001 112.265 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 64' ' ' MET . 43.6 mt-10 -80.69 139.56 50.76 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.926 -0.398 . . . . 1.3700000000000001 109.926 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 32.1 Cg_exo -57.96 110.38 0.62 Allowed 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.14 1.893 . . . . 0.51000000000000001 110.415 171.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.671 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 16.9 mmt -113.06 141.33 25.43 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.086 -0.507 . . . . 0.67000000000000004 111.312 -169.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.06 9.55 2.72 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.763 2.309 . . . . 0.32000000000000001 113.132 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.3 m -154.55 137.18 15.16 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.454 -0.573 . . . . 1.3 109.454 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.4 m -65.64 -34.18 68.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.295 0.85 . . . . 1.1399999999999999 113.295 -170.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -67.32 -40.94 86.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.589 0.233 . . . . 2.8199999999999998 111.459 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.671 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 0.5 OUTLIER -81.2 -20.2 41.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.844 0.354 . . . . 1.3600000000000001 110.451 -179.339 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.38 -61.41 2.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.24 -0.436 . . . . 0.20999999999999999 111.2 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.581 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 13.2 ptmm? -56.19 -43.75 78.75 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.051 0.453 . . . . 2.4199999999999999 110.674 176.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.477 ' O ' HG23 ' A' ' 76' ' ' VAL . 36.8 t70 -51.98 -47.05 65.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.113 -0.949 . . . . 2.0099999999999998 112.022 177.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.5 t -60.65 -47.53 85.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.612 0.244 . . . . 1.1399999999999999 111.606 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.04 -38.78 89.24 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.175 0.512 . . . . 0.17999999999999999 110.488 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.404 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -54.64 -37.25 65.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.238 -0.892 . . . . 0.26000000000000001 111.294 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.492 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 91.7 t -59.16 -42.05 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 CA-C-O 120.837 0.351 . . . . 0.82999999999999996 110.849 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.2 mt -77.17 -30.42 54.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.597 0.713 . . . . 0.39000000000000001 109.661 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.582 HD11 HG23 ' A' ' 48' ' ' VAL . 40.1 tp -65.73 -44.43 86.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.808 -1.087 . . . . 0.81000000000000005 111.052 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 75' ' ' ALA . 8.6 mp -63.3 -21.57 66.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.654 -0.703 . . . . 1.6100000000000001 111.493 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 8.6 mm-40 -73.71 -38.37 64.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.348 0.594 . . . . 2.1299999999999999 109.862 173.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 tt -66.78 -46.18 76.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.013 -0.994 . . . . 1.1699999999999999 109.382 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mp -65.29 -16.7 63.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.349 -0.841 . . . . 1.1499999999999999 112.338 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 121.484 0.659 . . . . 1.46 109.799 177.15 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.476 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 121.158 0.504 . . . . 0.80000000000000004 109.968 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 22.5 m -66.92 -44.68 80.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.613 -0.721 . . . . 1.3500000000000001 109.747 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.1 tp -61.39 -46.83 88.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.713 -1.131 . . . . 1.1599999999999999 110.151 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -62.26 -36.15 81.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.654 -1.157 . . . . 3.8399999999999999 111.334 -177.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 11.0 mmmm -74.15 6.03 3.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 1.1000000000000001 111.611 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.4 t30 67.03 30.8 7.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.82 0.819 . . . . 1.9199999999999999 110.268 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -96.23 158.85 33.3 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.562 -0.744 . . . . 0.40000000000000002 109.277 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.88 -171.43 0.57 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.318 2.012 . . . . 0.44 111.515 173.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.443 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 26.9 mmt -75.95 138.88 69.19 Favored Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 110.063 -0.347 . . . . 1.0 110.063 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.521 ' HB3' HG22 ' A' ' 48' ' ' VAL . 6.3 Cg_exo -72.79 164.6 35.12 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.361 2.04 . . . . 0.46000000000000002 112.468 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.428 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 23.0 t -89.57 144.17 26.23 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.261 -0.881 . . . . 0.29999999999999999 109.941 178.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.512 ' HD2' ' CZ ' ' A' ' 44' ' ' PHE . 66.0 m-85 -139.6 111.08 7.11 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.625 -0.88 . . . . 0.29999999999999999 108.625 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.472 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 20.5 ttp-105 -144.79 119.95 10.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.88 -0.415 . . . . 3.6899999999999999 109.88 -173.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 21.3 p -66.98 124.55 23.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.098 0.475 . . . . 1.53 110.534 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 43' ' ' THR . 23.3 m -85.82 -41.5 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 116.106 -0.497 . . . . 1.1499999999999999 111.102 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.1 tttt . . . . . 0 C--N 1.323 -0.562 0 C-N-CA 121.172 -0.211 . . . . 2.25 111.32 179.601 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 . . . . . 0 N--CA 1.444 -0.73 0 N-CA-C 107.109 -1.441 . . . . 3.6400000000000001 107.109 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -109.89 130.8 55.48 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.393 -0.595 . . . . 0.79000000000000004 109.393 -172.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 31' ' ' VAL . 5.4 m -123.19 131.84 53.83 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.994 -1.113 . . . . 0.26000000000000001 107.994 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.728 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -142.35 155.75 45.18 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.588 -0.523 . . . . 0.17000000000000001 109.588 -174.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.535 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -128.74 139.66 11.16 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.9 -0.667 . . . . 0.17000000000000001 112.507 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.728 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -106.74 156.8 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.767 -0.457 . . . . 0.80000000000000004 109.767 -176.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.599 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 18.6 ptt180 -147.28 148.27 31.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.92 -0.77 . . . . 2.6200000000000001 108.92 172.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.537 HG23 HD11 ' A' ' 78' ' ' LEU . 86.0 t -127.31 154.79 38.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.296 -0.411 . . . . 0.23999999999999999 110.616 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -91.13 84.15 5.66 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.19 0.519 . . . . 1.5900000000000001 110.248 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.2 p -70.4 115.52 9.68 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.175 -0.92 . . . . 0.33000000000000002 109.611 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.2 p -51.04 -27.19 7.4 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.724 -1.125 . . . . 1.3200000000000001 113.404 -172.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -98.81 -8.43 25.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.601 0.593 . . . . 1.3 112.601 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -129.0 -47.66 1.23 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.871 -0.518 . . . . 3.6800000000000002 111.469 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.13 -151.69 17.23 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.648 -0.706 . . . . 0.19 111.795 -175.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.599 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.7 m95 -54.85 120.4 6.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.065 0.46 . . . . 0.39000000000000001 111.051 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.5 p -73.38 162.67 29.06 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.749 -0.66 . . . . 0.35999999999999999 111.288 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -60.0 129.41 41.66 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.314 -0.625 . . . . 1.8400000000000001 109.314 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -59.03 115.08 2.91 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.714 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.463 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 59.7 m -87.92 97.6 11.03 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.924 -1.035 . . . . 0.35999999999999999 110.037 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.535 HD13 ' HA3' ' A' ' 45' ' ' GLY . 32.3 mm -76.02 123.92 33.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.449 -0.796 . . . . 0.73999999999999999 110.417 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.06 -170.49 44.8 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.987 -0.625 . . . . 0.23000000000000001 112.021 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 64' ' ' MET . 44.5 mt-10 -89.14 150.82 45.83 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 110.045 -0.354 . . . . 1.3700000000000001 110.045 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.98 109.32 1.09 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.562 2.174 . . . . 0.51000000000000001 111.378 176.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.62 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 90.9 mmm -114.94 144.46 32.05 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.119 -0.491 . . . . 0.67000000000000004 110.207 -171.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.55 12.26 2.2 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.534 2.156 . . . . 0.32000000000000001 113.537 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.5 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 19.9 m -154.86 138.96 16.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.413 -0.588 . . . . 1.3 109.413 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -66.98 -28.17 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.769 0.655 . . . . 1.1399999999999999 112.769 -170.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.01 -42.08 73.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.833 0.349 . . . . 2.8199999999999998 110.92 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.5 ' HG2' ' HB2' ' A' ' 66' ' ' SER . 4.3 ptpp? -81.48 -18.1 46.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.421 -0.354 . . . . 1.3600000000000001 110.678 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.79 -59.24 5.75 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.45 -0.341 . . . . 0.20999999999999999 110.486 172.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.623 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 57.9 mttp -52.81 -47.06 67.91 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.325 -0.398 . . . . 2.4199999999999999 110.543 175.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -50.21 -50.0 50.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.416 -0.811 . . . . 2.0099999999999998 112.128 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.584 ' O ' HG12 ' A' ' 76' ' ' VAL . 45.2 t -61.37 -44.49 97.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.83 0.347 . . . . 1.1399999999999999 111.252 -177.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.502 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -68.64 -47.42 66.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.168 0.509 . . . . 0.17999999999999999 110.867 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.446 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -55.6 -36.55 67.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.403 -0.817 . . . . 0.26000000000000001 112.059 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 73' ' ' SER . 2.0 p -71.42 -27.66 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 121.205 0.526 . . . . 0.82999999999999996 110.617 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.9 mt -79.04 -31.83 44.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.727 0.775 . . . . 0.39000000000000001 109.436 175.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.537 HD11 HG23 ' A' ' 48' ' ' VAL . 28.6 tp -63.79 -35.29 80.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.107 -0.952 . . . . 0.81000000000000005 110.406 173.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.5 mm? -62.25 -22.65 66.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.565 -0.743 . . . . 1.6100000000000001 111.449 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -69.41 -38.0 77.71 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.318 0.58 . . . . 2.1299999999999999 109.715 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.438 HD12 ' SG ' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -68.31 -31.17 70.4 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.225 1.012 . . . . 1.1699999999999999 109.635 179.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.3 mp -84.58 -3.18 58.32 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.145 -0.934 . . . . 1.1499999999999999 112.28 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 . . . . . 0 C--N 1.32 -0.687 0 CA-C-O 121.586 0.708 . . . . 1.46 109.81 177.21 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.7 mp . . . . . 0 N--CA 1.461 0.113 0 CA-C-O 121.148 0.499 . . . . 0.80000000000000004 109.883 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.454 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 68.5 m -64.78 -42.64 94.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.477 -0.783 . . . . 1.3500000000000001 109.969 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.66 -45.1 91.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.872 -1.058 . . . . 1.1599999999999999 110.543 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -65.52 -35.34 80.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.33 -0.85 . . . . 3.8399999999999999 111.068 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 9.1 mmmm -76.07 4.02 9.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 1.1000000000000001 111.162 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.6 t30 66.02 38.84 4.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.248 -0.887 . . . . 1.9199999999999999 110.27 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.454 ' CE3' ' HA ' ' A' ' 18' ' ' CYS . 37.9 m0 -104.04 156.62 35.44 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.414 -0.812 . . . . 0.40000000000000002 109.431 175.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.13 -172.84 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.36 2.04 . . . . 0.44 111.05 171.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.453 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 29.4 mmt -75.19 142.9 76.08 Favored Pre-proline 0 N--CA 1.447 -0.617 0 O-C-N 122.078 -0.389 . . . . 1.0 110.511 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HB3' HG22 ' A' ' 48' ' ' VAL . 3.1 Cg_exo -76.24 165.32 29.67 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.718 2.279 . . . . 0.46000000000000002 112.864 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.3 t -83.58 141.99 31.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.247 -0.888 . . . . 0.29999999999999999 110.059 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.474 ' CD1' ' HZ ' ' A' ' 44' ' ' PHE . 66.5 m-85 -145.98 110.18 4.98 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.034 -0.728 . . . . 0.29999999999999999 109.034 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.525 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 23.7 ttm180 -158.63 128.39 5.79 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.394 -0.225 . . . . 3.6899999999999999 110.394 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.542 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 86.4 m -63.34 123.48 18.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.846 0.355 . . . . 1.53 110.688 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -84.49 -34.27 9.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.298 0.57 . . . . 1.1499999999999999 109.805 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.5 tttp . . . . . 0 C--N 1.32 -0.715 0 CA-C-N 115.581 -0.736 . . . . 2.25 109.294 177.013 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 . . . . . 0 N--CA 1.442 -0.848 0 N-CA-C 106.553 -1.647 . . . . 3.6400000000000001 106.553 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 6.9 m-85 -110.23 131.86 54.68 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.368 -0.533 . . . . 0.79000000000000004 109.777 -169.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.1 m -122.2 132.02 54.23 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.813 -1.18 . . . . 0.26000000000000001 107.813 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.716 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -142.24 153.16 43.75 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.553 -0.536 . . . . 0.17000000000000001 109.553 -173.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.504 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -127.55 140.7 12.03 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.099 -0.572 . . . . 0.17000000000000001 112.327 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.716 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 2.1 t -105.91 156.36 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 109.605 -0.517 . . . . 0.80000000000000004 109.605 -175.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 56' ' ' THR . 5.3 tpp85 -142.64 145.57 33.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.558 -0.904 . . . . 2.6200000000000001 108.558 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.719 HG23 HD11 ' A' ' 78' ' ' LEU . 61.8 t -131.36 153.11 38.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 110.058 -0.349 . . . . 0.23999999999999999 110.058 177.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -96.29 85.14 3.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.442 0.639 . . . . 1.5900000000000001 110.015 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 54' ' ' GLY . 26.2 p -69.29 106.99 3.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.69 -1.141 . . . . 0.33000000000000002 109.106 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 t -49.77 -26.8 4.19 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.834 0.679 . . . . 1.3200000000000001 112.834 -171.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -88.17 -18.27 29.11 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.428 0.529 . . . . 1.3 112.428 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -129.82 -46.29 1.15 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.015 0.436 . . . . 3.6800000000000002 111.294 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 125.6 -156.04 19.19 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.933 -0.576 . . . . 0.19 112.607 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -52.28 119.72 4.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.22 0.533 . . . . 0.39000000000000001 110.89 175.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.458 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 46.3 p -68.95 -179.26 1.43 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.987 -1.006 . . . . 0.35999999999999999 112.487 -173.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.38 132.22 43.65 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.577 -0.898 . . . . 1.8400000000000001 108.577 171.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -64.81 114.44 4.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.581 0.705 . . . . 1.0 110.766 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.482 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 61.5 m -88.19 97.82 11.22 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.56 -1.2 . . . . 0.35999999999999999 109.999 -177.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.504 HD13 ' HA3' ' A' ' 45' ' ' GLY . 26.9 mm -81.58 122.03 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.666 -0.697 . . . . 0.73999999999999999 110.07 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.76 -171.0 47.76 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.073 -0.584 . . . . 0.23000000000000001 112.428 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.597 ' O ' ' HG2' ' A' ' 64' ' ' MET . 33.0 mt-10 -81.91 146.38 55.68 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 110.023 -0.362 . . . . 1.3700000000000001 110.023 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 27.7 Cg_exo -62.8 109.62 0.94 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.487 2.125 . . . . 0.51000000000000001 110.907 171.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.597 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 89.6 mmm -115.4 149.1 42.27 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.208 -0.451 . . . . 0.67000000000000004 110.081 -172.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.2 12.33 2.34 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.594 2.196 . . . . 0.32000000000000001 113.535 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.445 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 30.0 t -154.99 142.2 19.41 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.658 -0.497 . . . . 1.3 109.658 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.6 m -68.2 -27.95 39.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.619 -0.718 . . . . 1.1399999999999999 111.946 -173.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -64.6 -50.53 66.84 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.245 0.545 . . . . 2.8199999999999998 110.851 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.445 ' HG2' ' HB3' ' A' ' 66' ' ' SER . 15.4 ptpt -79.66 -17.54 53.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.455 -0.793 . . . . 1.3600000000000001 110.708 -174.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.11 -54.28 47.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.20999999999999999 109.823 172.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.669 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 54.5 mtmt -56.05 -52.0 65.82 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.015 -0.539 . . . . 2.4199999999999999 111.018 176.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.602 ' O ' HG23 ' A' ' 76' ' ' VAL . 4.6 m-20 -53.74 -46.72 70.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.561 . . . . 2.0099999999999998 112.308 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 t -58.24 -46.01 86.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 1.1399999999999999 110.981 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.536 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -69.01 -43.42 74.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.986 -0.552 . . . . 0.17999999999999999 110.491 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.464 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -54.49 -36.93 64.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.465 -0.789 . . . . 0.26000000000000001 111.4 176.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 72' ' ' ASP . 91.0 t -63.06 -37.96 80.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 121.119 0.485 . . . . 0.82999999999999996 110.293 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.8 mt -77.85 -24.25 48.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.865 0.84 . . . . 0.39000000000000001 109.533 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.719 HD11 HG23 ' A' ' 48' ' ' VAL . 16.7 tp -69.15 -37.94 78.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.134 -0.939 . . . . 0.81000000000000005 110.468 171.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.3 mm? -65.14 -28.78 69.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.755 -0.657 . . . . 1.6100000000000001 112.146 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -77.27 -31.61 55.02 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.887 -0.725 . . . . 2.1299999999999999 110.085 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.05 -47.69 85.21 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.708 -0.849 . . . . 1.1699999999999999 108.708 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mp -71.77 -4.38 27.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.12 -0.945 . . . . 1.1499999999999999 112.036 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 121.601 0.715 . . . . 1.46 109.686 179.155 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.5 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.861 0.362 . . . . 0.80000000000000004 111.007 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.464 ' SG ' ' HE3' ' A' ' 23' ' ' TRP . 36.2 t -71.61 -39.06 70.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.754 0.787 . . . . 1.3500000000000001 109.157 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 tt -64.47 -46.26 83.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.552 -1.204 . . . . 1.1599999999999999 110.079 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -61.63 -31.5 71.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.025 -0.534 . . . . 3.8399999999999999 111.412 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt -73.12 -3.88 29.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.329 0.585 . . . . 1.1000000000000001 111.447 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.0 t30 64.51 30.77 12.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.511 -1.222 . . . . 1.9199999999999999 110.173 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.464 ' HE3' ' SG ' ' A' ' 18' ' ' CYS . 33.6 m0 -89.6 165.56 24.83 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.367 -0.833 . . . . 0.40000000000000002 109.088 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 36.9 Cg_endo -69.44 -176.6 1.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 121.973 1.782 . . . . 0.44 111.186 170.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.405 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 21.4 mmt -74.77 137.52 73.57 Favored Pre-proline 0 C--N 1.323 -0.566 0 O-C-N 122.257 -0.277 . . . . 1.0 110.366 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.479 ' HB3' HG22 ' A' ' 48' ' ' VAL . 9.5 Cg_exo -70.04 161.69 45.04 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.812 2.342 . . . . 0.46000000000000002 112.457 -177.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.5 t -88.12 138.03 31.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.411 -0.813 . . . . 0.29999999999999999 110.191 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.529 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 63.3 m-85 -143.78 111.28 5.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.651 -0.5 . . . . 0.29999999999999999 109.651 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.48 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 79.3 ttt180 -164.17 131.61 3.32 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.977 -0.379 . . . . 3.6899999999999999 109.977 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 8.8 p -64.53 130.6 44.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.054 0.454 . . . . 1.53 111.326 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.5 t -86.32 -28.45 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.666 -0.697 . . . . 1.1499999999999999 109.9 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.3 tttp . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 109.169 -0.678 . . . . 2.25 109.169 176.589 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 . . . . . 0 N--CA 1.444 -0.75 0 N-CA-C 107.948 -1.13 . . . . 3.6400000000000001 107.948 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 8.2 m-85 -109.05 133.84 52.46 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.823 -0.626 . . . . 0.79000000000000004 110.438 -169.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.1 m -119.8 116.33 25.66 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.851 -1.166 . . . . 0.26000000000000001 107.851 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.71 ' CE2' ' HA ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -126.93 153.1 46.25 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.898 -0.408 . . . . 0.17000000000000001 109.898 -170.06 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -126.87 140.38 11.89 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.574 -0.61 . . . . 0.17000000000000001 111.574 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.75 HG11 HD22 ' A' ' 78' ' ' LEU . 1.7 t -105.66 156.1 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.636 -0.505 . . . . 0.80000000000000004 109.636 -175.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.729 ' HD2' ' O ' ' A' ' 56' ' ' THR . 0.4 OUTLIER -142.24 145.87 34.55 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.478 -0.934 . . . . 2.6200000000000001 108.478 177.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.652 HG23 HD11 ' A' ' 78' ' ' LEU . 38.8 t -132.08 150.71 33.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.544 -0.298 . . . . 0.23999999999999999 110.293 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -94.61 83.66 4.14 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.825 0.821 . . . . 1.5900000000000001 109.528 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.418 HG22 ' CH2' ' A' ' 23' ' ' TRP . 23.0 p -75.0 101.23 4.4 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.192 -1.367 . . . . 0.33000000000000002 109.21 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t -43.76 -35.24 1.8 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.84 0.856 . . . . 1.3200000000000001 113.173 -170.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.86 -33.36 72.95 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.598 0.592 . . . . 1.3 112.598 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -131.12 -38.6 1.22 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.806 0.336 . . . . 3.6800000000000002 111.875 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.24 -151.96 16.88 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 116.253 -0.431 . . . . 0.19 112.272 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -52.91 126.24 19.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.172 0.51 . . . . 0.39000000000000001 110.858 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.729 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 37.4 p -74.2 -174.71 2.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.351 -0.84 . . . . 0.35999999999999999 112.372 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -76.62 169.92 17.39 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.82 -1.178 . . . . 1.8400000000000001 107.82 165.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -92.34 119.78 32.23 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.222 0.534 . . . . 1.0 111.372 -171.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.462 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 28.6 m -85.46 97.61 10.13 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.104 -0.953 . . . . 0.35999999999999999 109.293 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.411 HD13 ' HA3' ' A' ' 45' ' ' GLY . 26.4 mm -86.92 121.16 37.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.196 -0.456 . . . . 0.73999999999999999 110.613 -177.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.64 -174.47 49.94 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.835 -0.698 . . . . 0.23000000000000001 111.519 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.657 ' O ' ' HG2' ' A' ' 64' ' ' MET . 42.8 mm-40 -85.89 148.41 48.21 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.687 0.244 . . . . 1.3700000000000001 110.452 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 40.7 Cg_exo -57.26 109.14 0.42 Allowed 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.571 2.18 . . . . 0.51000000000000001 111.186 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.657 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.0 mmm -117.32 149.97 45.55 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.692 -0.484 . . . . 0.67000000000000004 109.692 -172.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -80.77 15.01 1.9 Allowed 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.539 2.16 . . . . 0.32000000000000001 114.817 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.1 t -163.8 145.87 9.35 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.96 -0.463 . . . . 1.3 110.402 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.4 t -59.18 -50.98 77.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.315 0.487 . . . . 1.1399999999999999 112.315 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -55.57 -43.81 76.27 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.202 0.445 . . . . 2.8199999999999998 112.202 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.88 -21.89 40.26 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.991 -0.284 . . . . 1.3600000000000001 110.607 -178.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.91 -56.15 19.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.756 -0.202 . . . . 0.20999999999999999 111.039 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.71 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 32.3 pttt -56.6 -42.04 78.04 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 120.917 0.389 . . . . 2.4199999999999999 110.129 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.505 ' O ' HG23 ' A' ' 76' ' ' VAL . 31.3 t70 -54.17 -47.7 71.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.544 -0.753 . . . . 2.0099999999999998 112.068 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.4 t -60.09 -45.84 91.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.34 . . . . 1.1399999999999999 111.457 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.451 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -69.87 -40.6 75.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.039 0.447 . . . . 0.17999999999999999 110.925 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.431 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -52.52 -33.97 47.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.505 -0.771 . . . . 0.26000000000000001 111.307 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 72' ' ' ASP . 96.9 t -61.24 -37.41 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.967 0.413 . . . . 0.82999999999999996 110.739 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.1 mt -77.29 -33.09 55.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.75 0.785 . . . . 0.39000000000000001 109.597 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.75 HD22 HG11 ' A' ' 46' ' ' VAL . 15.3 tp -65.5 -40.83 93.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.716 -1.129 . . . . 0.81000000000000005 110.58 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.431 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.2 mp -61.57 -26.14 67.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.435 -0.802 . . . . 1.6100000000000001 111.045 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.82 -35.55 62.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.239 0.543 . . . . 2.1299999999999999 110.076 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.41 -46.17 77.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.35 -0.841 . . . . 1.1699999999999999 109.329 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mp -70.45 -9.8 57.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.295 -0.866 . . . . 1.1499999999999999 111.971 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 121.679 0.752 . . . . 1.46 109.456 174.864 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.464 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.7 mp . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 121.041 0.448 . . . . 0.80000000000000004 110.52 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.433 ' SG ' HG13 ' A' ' 48' ' ' VAL . 47.3 t -69.54 -40.52 76.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.631 0.729 . . . . 1.3500000000000001 109.512 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.1 tp -63.73 -49.53 72.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.867 -1.061 . . . . 1.1599999999999999 110.661 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -61.0 -36.63 79.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.383 -0.826 . . . . 3.8399999999999999 111.745 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -73.29 8.75 1.55 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 1.1000000000000001 111.985 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.3 t30 60.21 34.67 21.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.261 -0.881 . . . . 1.9199999999999999 110.065 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.627 ' HD1' ' HG ' ' A' ' 51' ' ' SER . 41.6 m0 -97.12 163.34 20.17 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 114.93 -1.032 . . . . 0.40000000000000002 108.818 174.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 44.3 Cg_endo -70.0 -168.33 0.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.029 1.819 . . . . 0.44 111.497 173.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.7 mmt -80.18 136.26 53.7 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.97 -0.381 . . . . 1.0 109.97 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HB3' HG22 ' A' ' 48' ' ' VAL . 6.4 Cg_exo -71.42 162.8 41.18 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.597 2.198 . . . . 0.46000000000000002 112.24 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.7 t -87.36 140.14 29.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.568 -0.742 . . . . 0.29999999999999999 109.759 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.562 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 66.4 m-85 -140.8 109.82 6.13 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.265 -1.013 . . . . 0.29999999999999999 108.265 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.584 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 33.8 ptt180 -145.24 130.71 18.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.891 0.377 . . . . 3.6899999999999999 110.524 -173.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.9 t -65.76 119.84 11.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.201 -0.454 . . . . 1.53 110.529 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.3 t -86.73 -42.93 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.975 -0.557 . . . . 1.1499999999999999 110.737 -177.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.0 tttm . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 120.751 0.31 . . . . 2.25 110.664 179.267 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 107.799 -1.186 . . . . 3.6400000000000001 107.799 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -109.0 141.2 41.45 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.966 0.413 . . . . 0.79000000000000004 110.57 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.4 m -129.93 124.77 33.89 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.551 -0.75 . . . . 0.26000000000000001 109.172 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.691 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -132.96 156.89 46.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.652 -0.499 . . . . 0.17000000000000001 109.652 -173.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -130.12 142.06 13.29 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.912 -0.661 . . . . 0.17000000000000001 112.015 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.691 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.5 t -105.36 156.29 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 117.027 0.413 . . . . 0.80000000000000004 110.286 -174.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.519 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -137.01 142.04 42.51 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.928 -1.138 . . . . 2.6200000000000001 107.928 178.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.474 HG23 HD11 ' A' ' 78' ' ' LEU . 39.6 t -132.68 149.96 32.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 110.609 -0.145 . . . . 0.23999999999999999 110.609 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -99.86 88.43 3.78 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.632 0.73 . . . . 1.5900000000000001 110.889 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.5 p -68.52 113.33 5.96 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.38 -1.282 . . . . 0.33000000000000002 109.634 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.627 ' HG ' ' HD1' ' A' ' 23' ' ' TRP . 52.3 m -49.22 -25.99 2.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.311 -0.858 . . . . 1.3200000000000001 113.265 -176.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -93.45 -16.78 24.18 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.527 0.566 . . . . 1.3 112.527 -176.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -134.9 -46.72 0.73 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.035 0.445 . . . . 3.6800000000000002 111.315 -172.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.12 -156.59 19.08 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.8 -0.636 . . . . 0.19 112.698 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.519 ' CZ3' ' HB3' ' A' ' 47' ' ' ARG . 20.4 m95 -52.77 121.75 7.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.149 0.5 . . . . 0.39000000000000001 111.312 176.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 42.3 p -73.42 177.41 5.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.478 -0.783 . . . . 0.35999999999999999 111.912 -175.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -66.88 133.07 49.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.076 -0.713 . . . . 1.8400000000000001 109.076 172.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.477 ' HB2' ' NH1' ' A' ' 47' ' ' ARG . 26.0 tt0 -65.39 110.75 2.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.24 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.494 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 62.0 m -84.89 97.65 9.88 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.567 -1.197 . . . . 0.35999999999999999 109.913 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.478 HD13 ' HA3' ' A' ' 45' ' ' GLY . 32.1 mm -76.96 124.13 34.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.428 -0.805 . . . . 0.73999999999999999 110.599 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.75 -170.28 46.87 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.922 -0.581 . . . . 0.23000000000000001 112.657 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.621 ' O ' ' HG2' ' A' ' 64' ' ' MET . 36.6 mt-10 -83.93 151.34 60.55 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-O 120.603 0.239 . . . . 1.3700000000000001 110.995 -175.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.71 99.22 0.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.754 2.303 . . . . 0.51000000000000001 110.961 170.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.621 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 92.4 mmm -113.59 138.64 22.68 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.514 -0.312 . . . . 0.67000000000000004 110.561 -170.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.79 7.35 2.82 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.669 2.246 . . . . 0.32000000000000001 113.422 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.4 t -144.85 136.79 25.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.113 -0.699 . . . . 1.3 109.113 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.23 -28.11 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.897 -0.592 . . . . 1.1399999999999999 111.726 -175.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -67.99 -43.21 79.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.11 -0.495 . . . . 2.8199999999999998 110.481 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 43.5 mtpt -74.21 -26.29 60.17 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.077 -0.511 . . . . 1.3600000000000001 109.745 -176.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.73 -58.98 6.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.875 -0.602 . . . . 0.20999999999999999 110.581 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.669 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 66.3 mttm -54.1 -51.72 63.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.391 -0.368 . . . . 2.4199999999999999 111.07 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.56 ' O ' HG23 ' A' ' 76' ' ' VAL . 18.3 m-20 -53.45 -49.04 68.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.828 -0.624 . . . . 2.0099999999999998 112.672 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.5 p -64.13 -38.68 91.93 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.922 -0.311 . . . . 1.1399999999999999 111.253 -175.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.422 ' HB1' HG23 ' A' ' 46' ' ' VAL . . . -67.83 -46.18 72.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.31 0.576 . . . . 0.17999999999999999 110.301 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.493 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -53.31 -36.4 61.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.9 -1.046 . . . . 0.26000000000000001 111.628 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 72' ' ' ASP . 96.1 t -63.83 -36.95 78.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.946 0.403 . . . . 0.82999999999999996 110.763 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.7 mt -77.92 -28.9 49.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.738 0.78 . . . . 0.39000000000000001 109.833 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.583 HD22 HG11 ' A' ' 46' ' ' VAL . 19.3 tp -66.54 -45.1 80.53 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.954 -1.021 . . . . 0.81000000000000005 110.589 173.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.493 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.0 mp -62.96 -30.75 71.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.441 -0.799 . . . . 1.6100000000000001 112.358 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -78.87 -30.84 45.29 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.013 -0.675 . . . . 2.1299999999999999 110.389 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.7 tt -65.19 -45.0 86.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.673 -0.862 . . . . 1.1699999999999999 108.673 174.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mp -65.53 -20.65 66.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.928 -1.033 . . . . 1.1499999999999999 111.878 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 . . . . . 0 C--N 1.325 -0.46 0 CA-C-O 121.778 0.799 . . . . 1.46 109.172 179.004 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.4 mp . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.869 0.366 . . . . 0.80000000000000004 110.593 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.0 t -71.86 -42.23 67.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.925 -0.579 . . . . 1.3500000000000001 109.955 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.9 tp -61.92 -48.73 79.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.282 -0.872 . . . . 1.1599999999999999 110.443 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -56.61 -37.36 70.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.954 -1.021 . . . . 3.8399999999999999 111.854 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -73.45 0.37 12.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.291 -0.413 . . . . 1.1000000000000001 111.426 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.5 t30 70.99 20.26 5.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.206 -0.906 . . . . 1.9199999999999999 110.172 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -86.81 158.57 53.42 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.433 -0.803 . . . . 0.40000000000000002 109.723 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.94 -168.82 0.25 Allowed 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 122.425 2.084 . . . . 0.44 111.449 174.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 7.2 mmt -83.6 134.93 44.0 Favored Pre-proline 0 C--N 1.322 -0.624 0 O-C-N 122.032 -0.417 . . . . 1.0 109.91 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.479 ' HB3' HG22 ' A' ' 48' ' ' VAL . 15.8 Cg_exo -67.14 166.99 21.26 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.807 2.338 . . . . 0.46000000000000002 113.133 -177.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.523 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 33.0 t -84.74 144.01 28.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.998 -1.001 . . . . 0.29999999999999999 109.898 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.494 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 72.4 m-85 -142.96 110.78 5.91 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.826 -0.805 . . . . 0.29999999999999999 108.826 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.499 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 45.6 ttm105 -156.64 124.14 5.4 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.522 -0.547 . . . . 3.6899999999999999 109.522 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -69.23 128.0 35.08 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.062 -0.517 . . . . 1.53 110.184 -176.559 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.85 -33.92 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.287 0.565 . . . . 1.1499999999999999 109.625 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.6 tttm . . . . . 0 C--N 1.32 -0.715 0 CA-C-N 115.418 -0.81 . . . . 2.25 109.605 171.361 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 . . . . . 0 CA--C 1.514 -0.405 0 N-CA-C 107.77 -1.196 . . . . 3.6400000000000001 107.77 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 7.5 m-85 -111.14 130.82 55.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.112 0.482 . . . . 0.79000000000000004 110.028 -173.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.4 m -118.47 127.59 53.8 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.874 -1.158 . . . . 0.26000000000000001 107.874 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.7 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -138.5 150.58 46.55 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.317 -0.623 . . . . 0.17000000000000001 109.317 -174.14 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.31 141.08 12.26 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.915 -0.66 . . . . 0.17000000000000001 112.313 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.7 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -107.37 156.05 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.628 -0.508 . . . . 0.80000000000000004 109.628 -176.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.632 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 16.7 ptp180 -145.67 147.82 32.39 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.806 -0.813 . . . . 2.6200000000000001 108.806 173.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.637 HG23 HD11 ' A' ' 78' ' ' LEU . 94.2 t -124.79 152.26 30.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 123.086 0.241 . . . . 0.23999999999999999 110.64 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -95.14 85.25 4.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.708 0.766 . . . . 1.5900000000000001 110.146 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.1 p -67.26 112.9 4.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.346 -1.297 . . . . 0.33000000000000002 109.365 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -52.48 -26.46 12.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.659 -0.7 . . . . 1.3200000000000001 112.215 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -94.85 -16.42 22.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.506 0.558 . . . . 1.3 112.506 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -132.63 -46.55 0.88 Allowed 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.934 -0.479 . . . . 3.6800000000000002 111.493 -175.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.13 -158.07 20.9 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.13 -0.557 . . . . 0.19 113.142 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.632 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.1 m95 -52.48 118.53 3.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.863 0.364 . . . . 0.39000000000000001 110.719 175.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.4 p -71.75 161.35 31.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.786 -0.643 . . . . 0.35999999999999999 111.005 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -61.66 125.77 24.98 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.131 -0.692 . . . . 1.8400000000000001 109.131 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.417 ' HG2' HD12 ' A' ' 60' ' ' ILE . 33.5 tt0 -59.49 124.81 21.28 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.246 -0.888 . . . . 1.0 111.245 -173.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 52.7 m -96.75 99.09 10.7 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.73 -1.123 . . . . 0.35999999999999999 110.361 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.417 HD12 ' HG2' ' A' ' 58' ' ' GLU . 1.7 mp -76.57 126.93 37.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.918 -0.583 . . . . 0.73999999999999999 110.37 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.57 -166.82 41.88 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.436 -0.802 . . . . 0.23000000000000001 112.634 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 46.9 mt-10 -91.24 135.94 27.7 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 110.096 -0.335 . . . . 1.3700000000000001 110.096 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 50.4 Cg_exo -54.8 115.23 2.27 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.101 2.534 . . . . 0.51000000000000001 112.174 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 14.7 mmt -112.93 152.22 44.71 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.766 -0.652 . . . . 0.67000000000000004 111.236 -172.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -85.25 9.88 3.95 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.666 2.244 . . . . 0.32000000000000001 112.911 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -155.63 138.63 15.44 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.477 -0.564 . . . . 1.3 109.477 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.06 -27.88 42.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.588 -0.733 . . . . 1.1399999999999999 112.748 -170.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -72.17 -42.3 66.07 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.822 -0.351 . . . . 2.8199999999999998 111.045 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -80.74 -18.01 49.16 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.914 -0.315 . . . . 1.3600000000000001 110.316 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.39 -59.22 5.47 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.337 -0.392 . . . . 0.20999999999999999 110.391 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.628 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 8.9 mtmp? -51.85 -47.1 64.58 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 116.303 -0.408 . . . . 2.4199999999999999 111.16 175.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.545 ' O ' HG23 ' A' ' 76' ' ' VAL . 15.0 m-20 -50.86 -51.56 50.13 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.404 0.44 . . . . 2.0099999999999998 112.074 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.9 t -60.66 -43.75 97.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.638 0.256 . . . . 1.1399999999999999 111.249 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.64 -43.0 77.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.074 0.464 . . . . 0.17999999999999999 110.53 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.471 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -54.24 -38.19 65.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.338 -0.846 . . . . 0.26000000000000001 111.454 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 72' ' ' ASP . 99.0 t -65.37 -36.53 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-O 120.815 0.34 . . . . 0.82999999999999996 110.757 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.7 mt -73.95 -34.43 64.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.784 0.802 . . . . 0.39000000000000001 109.208 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.637 HD11 HG23 ' A' ' 48' ' ' VAL . 28.5 tp -65.51 -43.05 91.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.401 -1.272 . . . . 0.81000000000000005 110.887 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.2 mp -62.57 -24.94 67.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.704 -0.68 . . . . 1.6100000000000001 111.134 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 76' ' ' VAL . 39.5 mt-10 -74.01 -39.52 63.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.159 0.504 . . . . 2.1299999999999999 109.68 175.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.99 -51.7 65.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.331 -0.85 . . . . 1.1699999999999999 110.324 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.534 HD11 HG21 ' A' ' 48' ' ' VAL . 34.6 mt -65.76 -18.1 65.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.578 -1.192 . . . . 1.1499999999999999 111.594 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 . . . . . 0 C--N 1.321 -0.663 0 CA-C-O 122.04 0.924 . . . . 1.46 109.352 176.896 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.8 mp . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.909 0.385 . . . . 0.80000000000000004 110.807 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.62 ' SG ' ' HG3' ' A' ' 26' ' ' PRO . 42.8 t -60.21 -38.78 84.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.572 0.701 . . . . 1.3500000000000001 109.985 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.5 tp -63.78 -43.99 94.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.767 -1.106 . . . . 1.1599999999999999 110.355 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -66.9 -33.12 74.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.652 -1.158 . . . . 3.8399999999999999 111.529 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 28.9 mmmt -73.95 6.54 3.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 1.1000000000000001 111.469 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.0 t30 61.9 28.75 17.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.132 -0.94 . . . . 1.9199999999999999 110.522 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.488 ' CH2' HG22 ' A' ' 50' ' ' THR . 37.1 m0 -91.03 162.92 31.37 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.487 -0.779 . . . . 0.40000000000000002 109.051 174.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HG3' HD22 ' A' ' 49' ' ' ASN . 33.9 Cg_endo -67.45 -170.31 0.25 Allowed 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 121.984 1.79 . . . . 0.44 111.535 173.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.44 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 1.6 mmt -81.8 130.98 58.73 Favored Pre-proline 0 C--N 1.321 -0.643 0 O-C-N 122.036 -0.415 . . . . 1.0 110.281 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.62 ' HG3' ' SG ' ' A' ' 18' ' ' CYS . 11.0 Cg_exo -68.46 168.01 20.87 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.632 2.221 . . . . 0.46000000000000002 112.192 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.8 t -88.82 137.56 32.21 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.543 -0.753 . . . . 0.29999999999999999 110.052 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.49 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 84.9 m-85 -146.46 109.35 4.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.632 -0.507 . . . . 0.29999999999999999 109.632 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.436 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 78.9 ttt180 -160.07 130.17 5.41 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 110.066 -0.346 . . . . 3.6899999999999999 110.066 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.431 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 63.5 m -61.78 126.42 27.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.076 0.465 . . . . 1.53 110.809 -178.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.22 -39.58 12.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.804 -0.634 . . . . 1.1499999999999999 111.326 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 32.3 mmtt . . . . . 0 C--N 1.323 -0.574 0 CA-C-O 121.022 0.439 . . . . 2.25 111.884 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 121.515 0.674 . . . . 3.6400000000000001 109.624 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -109.54 139.88 44.0 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.96 -1.018 . . . . 0.79000000000000004 109.448 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 32' ' ' LYS . 32.9 m -123.66 123.77 41.29 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.462 -0.94 . . . . 0.26000000000000001 108.462 -175.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.662 ' CZ ' ' HB ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -125.82 152.27 45.67 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.609 -0.515 . . . . 0.17000000000000001 109.609 -173.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.22 126.94 5.92 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.455 -0.658 . . . . 0.17000000000000001 111.455 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.662 ' HB ' ' CZ ' ' A' ' 44' ' ' PHE . 7.4 p -109.27 149.26 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 110.002 -0.37 . . . . 0.80000000000000004 110.002 -176.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.559 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 11.2 ptt180 -145.14 150.48 36.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.017 -0.735 . . . . 2.6200000000000001 109.017 176.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 26' ' ' PRO . 67.4 t -125.99 155.45 35.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.022 -0.535 . . . . 0.23999999999999999 111.005 -176.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.403 HD22 ' HG3' ' A' ' 24' ' ' PRO . 54.9 t30 -95.6 83.78 3.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.758 0.789 . . . . 1.5900000000000001 110.061 178.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.488 HG22 ' CH2' ' A' ' 23' ' ' TRP . 24.9 p -69.56 112.24 5.93 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.163 -1.38 . . . . 0.33000000000000002 109.446 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.5 t -50.74 -23.61 2.82 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.961 0.726 . . . . 1.3200000000000001 112.961 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -77.89 -29.54 50.29 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.129 0.789 . . . . 1.3 113.129 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -138.11 -36.62 0.59 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.599 -0.441 . . . . 3.6800000000000002 111.977 -173.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.6 -147.86 17.29 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.904 -0.665 . . . . 0.19 112.663 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.559 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.3 m95 -49.8 119.93 3.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.315 0.579 . . . . 0.39000000000000001 111.891 177.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -73.91 167.12 22.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.248 -0.887 . . . . 0.35999999999999999 110.721 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -63.06 128.57 36.47 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.259 -0.645 . . . . 1.8400000000000001 109.259 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.39 114.44 3.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.566 0.698 . . . . 1.0 110.511 -176.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.1 m -90.93 102.63 15.4 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.707 -1.133 . . . . 0.35999999999999999 110.328 -175.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.08 122.25 26.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.649 -0.705 . . . . 0.73999999999999999 110.228 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -78.36 -173.14 41.61 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.687 -0.688 . . . . 0.23000000000000001 112.566 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 64' ' ' MET . 50.6 mt-10 -86.15 137.6 35.01 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 110.289 -0.263 . . . . 1.3700000000000001 110.289 -177.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.07 104.92 0.13 Allowed 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 123.071 2.514 . . . . 0.51000000000000001 111.566 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.651 ' SD ' ' HE2' ' A' ' 69' ' ' LYS . 16.5 mmt -113.15 147.36 37.15 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.578 -0.737 . . . . 0.67000000000000004 111.133 -172.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.71 13.21 2.17 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.717 2.278 . . . . 0.32000000000000001 113.241 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.8 t -155.61 138.91 15.71 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.451 -0.574 . . . . 1.3 109.451 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.06 -23.23 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.146 -0.479 . . . . 1.1399999999999999 112.244 -172.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -71.45 -45.33 62.88 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.748 0.309 . . . . 2.8199999999999998 110.786 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.651 ' HE2' ' SD ' ' A' ' 64' ' ' MET . 19.0 ptmt -81.79 -16.94 49.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.367 -0.379 . . . . 1.3600000000000001 110.377 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.78 -56.0 27.1 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.018 -0.537 . . . . 0.20999999999999999 109.868 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.603 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 56.6 mtpt -49.91 -51.59 39.59 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 115.995 -0.548 . . . . 2.4199999999999999 111.543 174.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.575 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.7 m-20 -51.96 -47.48 64.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.765 0.654 . . . . 2.0099999999999998 112.765 -177.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 83.9 p -62.78 -39.14 93.29 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.69 -0.404 . . . . 1.1399999999999999 111.251 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.6 -38.97 70.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.304 0.573 . . . . 0.17999999999999999 110.025 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.57 -30.75 69.98 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.389 -0.823 . . . . 0.26000000000000001 111.54 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 72' ' ' ASP . 96.1 t -70.35 -32.59 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.191 0.52 . . . . 0.82999999999999996 110.31 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.6 mt -73.86 -27.48 61.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.042 0.925 . . . . 0.39000000000000001 109.218 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.511 HD11 HG23 ' A' ' 48' ' ' VAL . 12.3 tp -65.72 -33.58 76.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.679 -1.146 . . . . 0.81000000000000005 109.931 173.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 76' ' ' VAL . 3.1 mm? -60.72 -38.67 85.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.909 -0.587 . . . . 1.6100000000000001 111.961 177.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -81.0 -33.42 33.69 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.489 -0.484 . . . . 2.1299999999999999 110.245 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.31 -53.32 59.08 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.294 -0.632 . . . . 1.1699999999999999 109.294 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.34 -3.24 5.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.981 -1.009 . . . . 1.1499999999999999 112.204 174.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 . . . . . 0 C--N 1.323 -0.547 0 N-CA-C 108.641 -0.874 . . . . 1.46 108.641 176.15 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.472 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 C--O 1.231 0.12 0 CA-C-O 121.006 0.431 . . . . 0.80000000000000004 110.315 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.44 ' SG ' ' HE3' ' A' ' 23' ' ' TRP . 19.6 t -64.96 -42.02 94.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.59 -0.732 . . . . 1.3500000000000001 109.568 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.9 tp -60.85 -48.18 82.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.86 -1.064 . . . . 1.1599999999999999 110.53 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.44 -36.12 75.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.001 -0.999 . . . . 3.8399999999999999 110.981 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 30.2 mmmt -74.0 2.8 7.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.869 -0.605 . . . . 1.1000000000000001 111.574 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 71.77 20.68 4.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.065 0.936 . . . . 1.9199999999999999 109.71 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.44 ' HE3' ' SG ' ' A' ' 18' ' ' CYS . 35.3 m0 -91.93 155.35 43.32 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.403 -0.817 . . . . 0.40000000000000002 109.437 175.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 49' ' ' ASN . 45.9 Cg_exo -63.56 -173.73 0.19 Allowed 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.808 2.338 . . . . 0.44 111.795 168.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.492 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 21.7 mmt -81.99 131.46 56.77 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.308 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.569 ' HB3' HG22 ' A' ' 48' ' ' VAL . 22.3 Cg_exo -62.98 160.26 34.59 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.715 2.277 . . . . 0.46000000000000002 112.822 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.46 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 13.6 t -84.79 142.01 30.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.21 -0.905 . . . . 0.29999999999999999 109.791 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.485 ' CD2' ' CZ ' ' A' ' 44' ' ' PHE . 71.2 m-85 -139.54 110.96 7.05 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.81 -0.811 . . . . 0.29999999999999999 108.81 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.526 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 43.3 ttt180 -145.5 122.86 11.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.521 0.201 . . . . 3.6899999999999999 110.525 -174.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.5 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 76.5 m -63.57 120.81 12.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.766 0.317 . . . . 1.53 110.569 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.8 m -86.05 -38.54 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.314 -0.403 . . . . 1.1499999999999999 111.105 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.0 tttt . . . . . 0 C--N 1.322 -0.619 0 CA-C-O 120.865 0.364 . . . . 2.25 110.882 -179.78 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 . . . . . 0 N--CA 1.449 -0.502 0 N-CA-C 108.997 -0.742 . . . . 3.6400000000000001 108.997 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 14.4 m-85 -110.05 143.88 39.44 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.307 -0.861 . . . . 0.79000000000000004 110.879 -171.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.7 m -129.05 137.51 51.33 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.302 -0.863 . . . . 0.26000000000000001 109.025 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.721 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -141.16 153.64 45.46 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.283 -0.636 . . . . 0.17000000000000001 109.283 -176.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -125.09 139.28 11.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 0.17000000000000001 111.914 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.721 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.1 t -106.8 154.02 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 117.096 0.448 . . . . 0.80000000000000004 109.895 -174.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.565 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 18.0 ptp180 -145.06 144.05 30.77 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.481 -0.933 . . . . 2.6200000000000001 108.481 172.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.668 HG23 HD11 ' A' ' 78' ' ' LEU . 97.3 t -122.64 152.81 27.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.392 -0.367 . . . . 0.23999999999999999 110.664 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.405 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 23.4 t-20 -92.37 83.46 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.542 0.687 . . . . 1.5900000000000001 109.953 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.2 p -74.52 109.77 8.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.792 -1.095 . . . . 0.33000000000000002 109.527 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.2 t -49.21 -27.85 4.02 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.93 0.715 . . . . 1.3200000000000001 112.93 -172.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -84.44 -21.21 30.8 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.299 0.481 . . . . 1.3 112.299 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.09 -44.85 1.03 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.167 0.508 . . . . 3.6800000000000002 111.073 -173.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.46 -152.04 16.87 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.762 -0.654 . . . . 0.19 111.834 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.565 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 5.5 m95 -53.78 119.98 5.67 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.171 0.51 . . . . 0.39000000000000001 110.638 173.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.9 p -69.2 170.44 10.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.58 -0.737 . . . . 0.35999999999999999 111.521 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -63.68 125.68 25.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.453 -0.943 . . . . 1.8400000000000001 108.453 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 38.2 tt0 -61.58 118.38 6.97 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.621 0.724 . . . . 1.0 110.666 -175.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.562 ' SG ' HD12 ' A' ' 81' ' ' LEU . 57.2 m -91.94 98.18 11.42 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.785 -1.098 . . . . 0.35999999999999999 110.499 -175.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.433 HD12 ' HG2' ' A' ' 58' ' ' GLU . 1.7 mp -74.63 124.34 32.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.945 -0.57 . . . . 0.73999999999999999 110.313 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.72 -167.65 43.72 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.1 -0.955 . . . . 0.23000000000000001 112.848 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 64' ' ' MET . 40.9 mt-10 -89.74 148.62 40.38 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-O 120.545 0.212 . . . . 1.3700000000000001 111.013 -174.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 62' ' ' GLU . 38.3 Cg_exo -60.57 106.7 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.814 2.342 . . . . 0.51000000000000001 111.396 172.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.558 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.4 mmm -115.08 143.49 30.31 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.077 -0.51 . . . . 0.67000000000000004 110.409 -173.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.32 3.89 5.38 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.737 2.291 . . . . 0.32000000000000001 113.312 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.9 t -143.65 140.06 29.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.498 -0.556 . . . . 1.3 109.498 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.6 m -64.62 -32.93 59.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.772 -0.649 . . . . 1.1399999999999999 111.482 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -64.07 -42.13 97.1 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 120.927 0.394 . . . . 2.8199999999999998 110.559 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.421 ' HE2' ' CE ' ' A' ' 64' ' ' MET . 43.4 mtpt -74.6 -25.16 59.08 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.99 -0.55 . . . . 1.3600000000000001 110.091 -177.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.52 -59.81 4.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.792 -0.64 . . . . 0.20999999999999999 110.696 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.707 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 52.8 pttt -61.92 -43.03 99.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.726 -0.215 . . . . 2.4199999999999999 110.91 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.526 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.9 m-20 -52.35 -50.8 61.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.879 0.696 . . . . 2.0099999999999998 112.879 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.3 p -66.54 -39.45 88.56 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.882 0.327 . . . . 1.1399999999999999 111.882 -175.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.481 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -68.18 -42.29 80.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.262 0.553 . . . . 0.17999999999999999 110.464 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.472 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -53.72 -36.05 61.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.222 -0.899 . . . . 0.26000000000000001 111.275 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 72' ' ' ASP . 94.9 t -62.36 -37.13 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.009 0.433 . . . . 0.82999999999999996 110.595 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.0 mt -75.11 -32.94 61.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.611 0.719 . . . . 0.39000000000000001 109.543 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.668 HD11 HG23 ' A' ' 48' ' ' VAL . 19.1 tp -64.59 -39.21 93.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.825 -1.08 . . . . 0.81000000000000005 110.905 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.7 mm? -59.52 -28.24 66.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.578 -0.737 . . . . 1.6100000000000001 111.039 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -72.76 -35.4 67.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.081 0.467 . . . . 2.1299999999999999 110.695 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.562 HD12 ' SG ' ' A' ' 59' ' ' CYS . 1.3 tt -62.96 -49.57 74.22 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.968 -0.753 . . . . 1.1699999999999999 108.968 175.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 mp -70.16 -2.77 14.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.198 -0.91 . . . . 1.1499999999999999 111.655 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 . . . . . 0 C--N 1.322 -0.6 0 CA-C-O 121.481 0.658 . . . . 1.46 109.478 178.296 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.3 mp . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 121.042 0.449 . . . . 0.80000000000000004 110.325 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.4 m -68.56 -44.64 74.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.906 0.86 . . . . 1.3500000000000001 110.003 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 tt -62.43 -45.69 91.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.228 -1.351 . . . . 1.1599999999999999 110.483 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.42 ' NH2' HG23 ' A' ' 17' ' ' ILE . 51.8 ttp85 -60.37 -38.2 83.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.578 -0.737 . . . . 3.8399999999999999 111.644 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 28.2 mmmt -72.93 0.39 11.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.549 -0.751 . . . . 1.1000000000000001 112.082 -176.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 62.87 51.05 3.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.092 0.948 . . . . 1.9199999999999999 110.011 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.416 ' CZ3' ' HG ' ' A' ' 82' ' ' LEU . 39.6 m0 -113.26 166.11 11.85 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.183 -0.917 . . . . 0.40000000000000002 109.223 175.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.62 162.04 33.35 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.957 1.771 . . . . 0.44 109.407 167.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 65.2 mmm -74.75 127.96 86.22 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 110.212 -0.292 . . . . 1.0 110.212 -173.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.518 ' HB3' HG22 ' A' ' 48' ' ' VAL . 1.2 Cg_endo -50.99 163.63 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 124.01 3.14 . . . . 0.46000000000000002 114.887 -173.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.476 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 25.3 t -81.02 144.25 31.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.338 -1.301 . . . . 0.29999999999999999 109.232 175.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.475 ' HD2' ' CZ ' ' A' ' 44' ' ' PHE . 72.6 m-85 -140.52 111.76 7.2 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.844 -0.798 . . . . 0.29999999999999999 108.844 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.46 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 36.4 ttm180 -151.92 124.07 8.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.042 -0.355 . . . . 3.6899999999999999 110.042 -176.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.461 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 83.8 m -66.84 124.92 24.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.953 0.406 . . . . 1.53 110.435 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -85.2 -35.81 10.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.835 -0.62 . . . . 1.1499999999999999 110.829 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.6 tptt . . . . . 0 C--N 1.318 -0.768 0 CA-C-N 115.985 -0.552 . . . . 2.25 110.277 178.081 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 108.535 -0.913 . . . . 3.6400000000000001 108.535 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 8.0 m-85 -112.84 132.09 55.43 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.63 -0.714 . . . . 0.79000000000000004 110.158 -174.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.0 m -119.85 130.01 54.68 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.064 -1.087 . . . . 0.26000000000000001 108.064 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.697 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -137.81 152.66 49.35 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.526 -0.546 . . . . 0.17000000000000001 109.526 -175.049 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.417 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -128.82 138.74 10.49 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.037 -0.602 . . . . 0.17000000000000001 111.901 177.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.697 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -105.93 157.71 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 109.503 -0.554 . . . . 0.80000000000000004 109.503 -176.691 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.58 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 24.2 ptt180 -146.72 141.81 27.16 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.983 -1.118 . . . . 2.6200000000000001 107.983 173.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.518 HG22 ' HB3' ' A' ' 26' ' ' PRO . 39.8 t -118.62 155.47 20.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.523 -0.308 . . . . 0.23999999999999999 110.374 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -96.05 84.04 3.75 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.635 0.731 . . . . 1.5900000000000001 109.635 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.539 ' OG1' ' HB2' ' A' ' 53' ' ' ARG . 37.7 p -68.29 113.33 5.8 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.298 -1.319 . . . . 0.33000000000000002 109.223 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.0 t -52.48 -27.29 15.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.776 -0.647 . . . . 1.3200000000000001 112.664 -171.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -100.54 -4.69 28.14 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.416 0.525 . . . . 1.3 112.416 -176.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.539 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 68.6 mtt180 -130.44 -52.25 1.09 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.232 0.539 . . . . 3.6800000000000002 110.897 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.73 -152.86 17.21 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.326 -0.852 . . . . 0.19 112.397 -175.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.58 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.4 m95 -55.79 120.28 7.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.067 0.461 . . . . 0.39000000000000001 111.23 176.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.9 p -71.73 161.54 30.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.742 -0.663 . . . . 0.35999999999999999 110.837 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.96 132.15 51.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.271 -0.641 . . . . 1.8400000000000001 109.271 174.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -56.57 116.94 3.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.58 -0.737 . . . . 1.0 110.937 -175.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.41 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 35.1 m -93.19 97.89 10.94 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.908 -1.042 . . . . 0.35999999999999999 110.114 -177.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.417 HD13 ' HA3' ' A' ' 45' ' ' GLY . 29.3 mm -75.62 123.77 32.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.572 -0.74 . . . . 0.73999999999999999 110.619 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.36 -167.01 42.77 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.867 -0.606 . . . . 0.23000000000000001 112.073 177.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -88.44 137.2 30.76 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 110.236 -0.283 . . . . 1.3700000000000001 110.236 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 50.2 Cg_exo -53.79 116.35 2.95 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.843 2.362 . . . . 0.51000000000000001 111.602 176.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.663 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 18.6 mmt -115.37 153.01 47.53 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.113 -0.494 . . . . 0.67000000000000004 111.082 -173.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -82.23 9.79 3.83 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.897 2.398 . . . . 0.32000000000000001 113.135 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.9 t -155.78 139.38 15.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.2 -0.667 . . . . 1.3 109.2 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.65 -22.86 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 1.1399999999999999 111.901 -173.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -75.24 -42.93 54.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.901 0.381 . . . . 2.8199999999999998 110.597 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.663 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 0.2 OUTLIER -82.31 -17.36 46.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.188 -0.46 . . . . 1.3600000000000001 110.384 178.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.76 -57.55 12.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.252 -0.431 . . . . 0.20999999999999999 110.425 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.644 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 61.2 mttm -52.66 -49.34 65.41 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.072 -0.513 . . . . 2.4199999999999999 110.433 174.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.518 ' O ' HG23 ' A' ' 76' ' ' VAL . 25.9 t70 -49.34 -49.87 42.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.933 -1.031 . . . . 2.0099999999999998 112.3 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.0 t -58.42 -48.53 80.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.788 0.328 . . . . 1.1399999999999999 111.453 -178.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.43 ' HB1' HG23 ' A' ' 46' ' ' VAL . . . -67.35 -37.51 83.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.28 0.562 . . . . 0.17999999999999999 110.777 -176.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.409 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -60.38 -30.74 69.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.475 -0.784 . . . . 0.26000000000000001 111.646 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 72' ' ' ASP . 73.9 t -63.72 -37.81 80.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 121.09 0.472 . . . . 0.82999999999999996 110.248 176.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.92 -28.73 58.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.841 -0.618 . . . . 0.39000000000000001 109.796 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 78' ' ' LEU . 4.0 mt -60.1 -44.32 94.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.341 -0.845 . . . . 0.81000000000000005 110.553 173.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.409 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.6 mp -61.47 -28.42 69.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.518 -0.764 . . . . 1.6100000000000001 111.777 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -71.95 -44.54 63.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.859 0.361 . . . . 2.1299999999999999 110.46 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.2 tt -61.39 -48.94 78.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.608 0.718 . . . . 1.1699999999999999 109.23 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.416 ' HG ' ' CZ3' ' A' ' 23' ' ' TRP . 1.6 mp -65.02 -20.12 66.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.792 -1.094 . . . . 1.1499999999999999 112.414 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.2 t30 . . . . . 0 C--N 1.323 -0.57 0 CA-C-O 121.691 0.757 . . . . 1.46 109.528 179.698 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.477 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 CA--C 1.522 -0.111 0 CA-C-O 121.016 0.436 . . . . 0.80000000000000004 110.119 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.415 ' SG ' ' HG3' ' A' ' 26' ' ' PRO . 84.0 m -65.54 -43.99 88.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.654 -0.703 . . . . 1.3500000000000001 110.007 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.5 tp -60.02 -52.1 66.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.249 -0.887 . . . . 1.1599999999999999 110.081 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -55.81 -41.6 74.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.908 -1.042 . . . . 3.8399999999999999 111.451 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -75.06 0.87 14.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.867 -0.606 . . . . 1.1000000000000001 112.096 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.8 t30 68.11 25.43 7.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.905 0.859 . . . . 1.9199999999999999 110.007 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -91.52 161.36 34.58 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.314 -0.857 . . . . 0.40000000000000002 109.79 176.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -74.08 178.82 6.41 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 122.149 1.899 . . . . 0.44 110.763 168.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.448 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 23.9 mmt -80.05 139.94 53.39 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.01 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.489 ' HB3' HG22 ' A' ' 48' ' ' VAL . 12.1 Cg_exo -67.17 159.01 54.13 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.507 2.138 . . . . 0.46000000000000002 112.578 -174.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.5 t -82.12 143.89 31.15 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.314 -0.857 . . . . 0.29999999999999999 109.392 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.555 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 64.7 m-85 -136.71 110.19 7.96 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.474 -0.935 . . . . 0.29999999999999999 108.474 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.535 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 67.6 mtp180 -143.0 122.33 13.06 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.658 -0.247 . . . . 3.6899999999999999 110.638 -173.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 35.5 t -71.4 120.49 17.06 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.979 -0.378 . . . . 1.53 109.979 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -86.55 -35.68 9.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.234 -0.439 . . . . 1.1499999999999999 111.384 -176.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.1 tptt . . . . . 0 C--N 1.32 -0.685 0 CA-C-O 121.287 0.565 . . . . 2.25 111.13 179.787 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 107.772 -1.195 . . . . 3.6400000000000001 107.772 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -110.35 136.57 49.32 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.119 0.485 . . . . 0.79000000000000004 110.365 -168.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 m -126.4 133.49 51.27 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.335 -0.848 . . . . 0.26000000000000001 109.056 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.735 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -140.37 152.89 46.13 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.305 -0.628 . . . . 0.17000000000000001 109.305 -174.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -126.24 139.89 11.7 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.801 -0.714 . . . . 0.17000000000000001 112.287 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.735 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -107.75 156.14 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.908 -0.405 . . . . 0.80000000000000004 109.908 -176.482 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.514 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 11.7 ptp180 -146.45 148.86 32.69 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.526 -0.916 . . . . 2.6200000000000001 108.526 172.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.628 HG23 HD11 ' A' ' 78' ' ' LEU . 98.0 t -123.75 152.4 29.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 O-C-N 123.157 0.286 . . . . 0.23999999999999999 110.616 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -94.62 88.82 5.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.765 0.793 . . . . 1.5900000000000001 110.243 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.568 ' OG1' ' HB3' ' A' ' 53' ' ' ARG . 37.7 p -71.65 113.3 8.54 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.422 -1.263 . . . . 0.33000000000000002 109.585 177.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.9 t -52.09 -25.23 8.28 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.925 0.713 . . . . 1.3200000000000001 112.925 -172.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -113.32 12.12 18.78 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.599 -0.44 . . . . 1.3 112.012 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.568 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 41.5 ttm180 -146.56 -50.27 0.21 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.946 0.403 . . . . 3.6800000000000002 110.886 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.77 -162.47 19.0 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 116.156 -0.474 . . . . 0.19 113.03 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.514 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 15.3 m95 -52.57 117.97 3.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.111 0.481 . . . . 0.39000000000000001 110.765 174.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.0 p -70.83 178.89 2.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.36 -0.836 . . . . 0.35999999999999999 112.063 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -63.73 134.83 56.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.517 -0.765 . . . . 1.8400000000000001 109.697 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.65 113.53 4.31 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.399 0.619 . . . . 1.0 110.166 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.495 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 63.7 m -88.75 97.4 11.12 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.966 -1.016 . . . . 0.35999999999999999 109.849 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.426 HD13 ' HA3' ' A' ' 45' ' ' GLY . 26.3 mm -81.66 122.92 37.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.451 -0.795 . . . . 0.73999999999999999 110.068 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.26 -171.97 48.15 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.953 -0.641 . . . . 0.23000000000000001 112.037 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.608 ' O ' ' HG2' ' A' ' 64' ' ' MET . 40.1 mt-10 -86.35 151.08 53.12 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.972 -0.381 . . . . 1.3700000000000001 109.972 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.68 112.6 1.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.379 2.053 . . . . 0.51000000000000001 110.83 172.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.608 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 97.1 mmm -115.51 142.44 28.82 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.384 -0.371 . . . . 0.67000000000000004 110.35 -173.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.99 14.32 1.54 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.66 2.24 . . . . 0.32000000000000001 113.713 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.465 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 30.0 t -157.57 143.2 17.29 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.646 -0.502 . . . . 1.3 109.646 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.1 m -71.44 -22.31 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.892 -0.595 . . . . 1.1399999999999999 111.675 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -73.56 -47.31 41.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.119 -0.492 . . . . 2.8199999999999998 110.419 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 66' ' ' SER . 15.5 ptpt -81.15 -16.86 51.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.863 -0.608 . . . . 1.3600000000000001 110.768 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.1 -56.21 24.95 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.316 -0.402 . . . . 0.20999999999999999 110.47 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.645 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 55.5 mttp -54.19 -47.18 72.35 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.186 -0.461 . . . . 2.4199999999999999 110.837 176.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.575 ' O ' HG23 ' A' ' 76' ' ' VAL . 19.6 m-20 -52.09 -49.45 63.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.017 -0.538 . . . . 2.0099999999999998 111.85 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.7 t -59.95 -46.64 88.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.595 0.236 . . . . 1.1399999999999999 111.538 -175.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.473 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -66.38 -42.04 88.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.189 0.519 . . . . 0.17999999999999999 110.554 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.422 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -53.33 -38.26 63.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.209 -0.905 . . . . 0.26000000000000001 111.516 177.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 72' ' ' ASP . 57.6 t -63.02 -36.68 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.897 0.38 . . . . 0.82999999999999996 110.743 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 85.3 mt -74.66 -32.88 62.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.765 0.793 . . . . 0.39000000000000001 109.44 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.628 HD11 HG23 ' A' ' 48' ' ' VAL . 42.9 tp -65.42 -39.38 92.07 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.557 -1.201 . . . . 0.81000000000000005 110.781 176.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.3 mp -58.94 -29.86 67.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.745 -0.662 . . . . 1.6100000000000001 111.045 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -69.84 -38.6 76.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.08 0.467 . . . . 2.1299999999999999 110.422 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.467 HD12 ' SG ' ' A' ' 59' ' ' CYS . 1.4 tt -63.85 -52.56 59.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.543 -0.753 . . . . 1.1699999999999999 109.607 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.2 mp -67.26 -10.32 49.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.402 -0.817 . . . . 1.1499999999999999 112.219 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.4 t30 . . . . . 0 C--N 1.32 -0.681 0 CA-C-O 121.498 0.666 . . . . 1.46 109.87 179.136 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.7 mp . . . . . 0 CA--C 1.52 -0.176 0 CA-C-O 121.403 0.621 . . . . 0.80000000000000004 109.813 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.0 m -55.32 -40.18 70.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.577 -1.192 . . . . 1.3500000000000001 110.786 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.1 tp -61.78 -53.52 54.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.039 -0.982 . . . . 1.1599999999999999 110.584 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -61.61 -28.9 69.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.303 -0.862 . . . . 3.8399999999999999 111.242 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 29.6 mmmt -73.75 2.51 8.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.958 -0.564 . . . . 1.1000000000000001 112.338 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.9 t30 63.9 37.59 9.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.278 -0.874 . . . . 1.9199999999999999 110.056 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.581 ' CH2' HG22 ' A' ' 50' ' ' THR . 34.9 m0 -103.63 160.18 26.93 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.421 -0.809 . . . . 0.40000000000000002 109.657 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.33 177.98 3.44 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.256 1.971 . . . . 0.44 111.265 171.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.433 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 24.4 mmt -71.83 127.29 90.95 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 120.824 0.345 . . . . 1.0 110.721 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 23.7 Cg_exo -62.19 159.43 34.97 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.749 2.299 . . . . 0.46000000000000002 111.928 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.531 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 10.5 t -88.61 140.3 29.59 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.696 -0.684 . . . . 0.29999999999999999 109.721 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.49 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 74.1 m-85 -137.15 110.77 8.05 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.247 -1.02 . . . . 0.29999999999999999 108.247 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.564 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 37.8 ttm180 -136.17 117.9 15.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.473 0.178 . . . . 3.6899999999999999 110.79 -172.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.473 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 73.0 m -62.01 116.93 5.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.889 0.376 . . . . 1.53 110.29 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.6 t -87.36 -41.92 14.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.929 -0.578 . . . . 1.1499999999999999 110.809 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 27.0 tptp . . . . . 0 C--N 1.325 -0.492 0 CA-C-O 121.068 0.461 . . . . 2.25 111.208 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' A' ' 63' ' ' PRO . 9.5 ptm180 . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.511 0.672 . . . . 3.6400000000000001 111.012 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -109.85 131.77 54.76 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.015 -0.993 . . . . 0.79000000000000004 109.197 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 32' ' ' LYS . 27.6 m -130.49 125.15 33.64 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.705 -0.68 . . . . 0.26000000000000001 109.169 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.763 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -139.13 153.86 48.04 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.655 -0.498 . . . . 0.17000000000000001 109.655 -175.038 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 60' ' ' ILE . . . -127.99 138.93 10.73 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.99 -0.624 . . . . 0.17000000000000001 112.2 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.763 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -107.01 158.46 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 110.166 -0.309 . . . . 0.80000000000000004 110.166 -174.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.564 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 19.7 ptt180 -148.3 146.99 28.81 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.835 -0.802 . . . . 2.6200000000000001 108.835 173.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.614 HG23 HD11 ' A' ' 78' ' ' LEU . 28.6 t -124.3 156.75 32.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.565 0.221 . . . . 0.23999999999999999 110.889 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.413 ' N ' HG12 ' A' ' 48' ' ' VAL . 5.9 t30 -94.61 83.89 4.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.397 0.618 . . . . 1.5900000000000001 110.031 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.581 HG22 ' CH2' ' A' ' 23' ' ' TRP . 34.4 p -78.1 105.73 9.51 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.932 -1.031 . . . . 0.33000000000000002 109.71 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.2 m -43.98 -33.06 1.3 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.069 -0.969 . . . . 1.3200000000000001 113.042 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.432 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 4.6 p-10 -63.02 -40.17 96.95 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.758 0.651 . . . . 1.3 112.758 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -129.01 -37.56 1.7 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.993 0.425 . . . . 3.6800000000000002 111.653 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.76 -148.24 16.74 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.93 -0.577 . . . . 0.19 112.364 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.564 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.9 m95 -51.24 119.19 3.81 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.17 0.509 . . . . 0.39000000000000001 111.342 175.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.3 p -69.48 167.55 16.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.559 -0.746 . . . . 0.35999999999999999 110.735 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.85 132.84 49.63 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.829 -0.804 . . . . 1.8400000000000001 108.829 174.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 40.9 tt0 -65.76 115.75 6.23 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.912 -1.04 . . . . 1.0 110.706 -174.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.8 m -96.14 105.3 17.33 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.63 -1.168 . . . . 0.35999999999999999 110.65 -174.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.522 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 1.8 mp -88.03 132.13 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.305 0.574 . . . . 0.73999999999999999 111.305 -177.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.54 -176.62 51.05 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 114.909 -1.041 . . . . 0.23000000000000001 111.809 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 64' ' ' MET . 13.0 pt-20 -92.07 158.06 40.04 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.816 0.308 . . . . 1.3700000000000001 110.673 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.429 ' HB3' ' HB2' ' A' ' 41' ' ' ARG . 72.0 Cg_exo -50.45 105.21 0.1 OUTLIER 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.398 2.732 . . . . 0.51000000000000001 112.683 174.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.0 mmm -108.74 145.27 31.29 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 110.152 -0.314 . . . . 0.67000000000000004 110.152 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.85 13.13 2.22 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.703 2.269 . . . . 0.32000000000000001 113.75 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.4 t -154.05 142.11 20.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.498 -0.927 . . . . 1.3 108.498 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.0 p -71.74 -22.01 21.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.149 -0.478 . . . . 1.1399999999999999 110.529 -174.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -73.13 -39.4 65.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.021 -0.536 . . . . 2.8199999999999998 109.616 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HE3' ' CE ' ' A' ' 64' ' ' MET . 27.5 mtpp -75.34 -23.39 57.22 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.975 -0.557 . . . . 1.3600000000000001 109.943 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.08 -53.41 58.55 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.579 -0.737 . . . . 0.20999999999999999 109.93 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.641 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 66.4 mttm -52.49 -54.58 30.57 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 115.611 -0.722 . . . . 2.4199999999999999 111.067 176.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.525 ' O ' HG23 ' A' ' 76' ' ' VAL . 33.4 m-20 -55.22 -44.78 75.74 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.945 -0.571 . . . . 2.0099999999999998 112.452 -177.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.495 ' OG ' ' HG2' ' A' ' 62' ' ' GLU . 44.3 t -59.25 -46.29 88.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 1.1399999999999999 111.113 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.443 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -68.44 -38.7 81.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.185 0.517 . . . . 0.17999999999999999 110.15 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.44 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -56.44 -37.35 70.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.261 -0.881 . . . . 0.26000000000000001 111.514 177.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 72' ' ' ASP . 94.7 t -63.24 -38.08 81.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.981 0.42 . . . . 0.82999999999999996 110.679 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.7 mt -77.82 -23.35 49.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.885 0.85 . . . . 0.39000000000000001 109.334 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.739 HD13 ' HB ' ' A' ' 46' ' ' VAL . 16.4 tp -70.34 -49.01 53.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.716 -1.129 . . . . 0.81000000000000005 110.403 173.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 75' ' ' ALA . 6.2 mp -53.67 -34.12 57.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.581 -0.736 . . . . 1.6100000000000001 112.248 -177.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -78.86 -34.02 45.33 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.373 -0.531 . . . . 2.1299999999999999 110.855 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.87 -51.68 60.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.883 0.373 . . . . 1.1699999999999999 110.086 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.459 HD21 HG21 ' A' ' 48' ' ' VAL . 1.9 mm? -71.43 -7.46 47.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 1.1499999999999999 111.37 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 C--N 1.319 -0.719 0 CA-C-O 121.442 0.639 . . . . 1.46 109.841 175.531 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.442 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 N--CA 1.46 0.031 0 CA-C-O 120.875 0.369 . . . . 0.80000000000000004 110.688 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.411 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 41.5 t -63.89 -45.33 89.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.367 0.603 . . . . 1.3500000000000001 110.273 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.19 -44.1 97.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.109 -0.95 . . . . 1.1599999999999999 110.838 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -65.13 -33.75 76.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.971 -1.013 . . . . 3.8399999999999999 111.12 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 4.6 mmmp? -74.18 2.69 8.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.123 -0.49 . . . . 1.1000000000000001 111.574 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 67.39 30.2 7.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.935 0.874 . . . . 1.9199999999999999 109.991 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.411 ' CE3' ' HA ' ' A' ' 18' ' ' CYS . 27.7 m0 -93.54 160.24 33.35 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.406 -0.815 . . . . 0.40000000000000002 109.073 174.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.6 -173.29 0.67 Allowed 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.183 1.922 . . . . 0.44 111.087 172.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.459 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.9 mmt -75.64 145.67 79.08 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.677 -0.49 . . . . 1.0 109.677 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.501 ' HB3' HG22 ' A' ' 48' ' ' VAL . 2.7 Cg_exo -74.89 165.96 30.29 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.495 2.13 . . . . 0.46000000000000002 112.421 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.407 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 26.3 t -84.73 144.4 28.54 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.161 -0.927 . . . . 0.29999999999999999 109.912 178.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.523 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 69.0 m-85 -143.95 109.93 5.34 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.361 -0.607 . . . . 0.29999999999999999 109.361 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.513 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 14.0 ptm180 -152.52 128.92 10.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.949 0.404 . . . . 3.6899999999999999 110.874 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 77.3 m -65.89 124.87 23.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.865 -0.607 . . . . 1.53 111.286 -176.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -84.82 -37.67 12.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.808 -0.633 . . . . 1.1499999999999999 110.286 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 121.173 0.511 . . . . 2.25 111.178 -179.318 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.064 -0.717 . . . . 3.6400000000000001 109.064 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 7.0 m-85 -109.56 149.1 30.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.532 -0.758 . . . . 0.79000000000000004 110.877 -172.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.5 m -129.76 129.6 44.32 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.142 -0.935 . . . . 0.26000000000000001 109.289 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.735 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -137.13 153.65 50.46 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.069 -0.715 . . . . 0.17000000000000001 109.069 -174.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -126.66 138.73 10.82 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.757 -0.735 . . . . 0.17000000000000001 112.317 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.735 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -107.15 158.6 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 109.309 -0.626 . . . . 0.80000000000000004 109.309 -177.124 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.571 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 11.8 ptp180 -148.49 148.96 30.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.05 -0.722 . . . . 2.6200000000000001 109.05 173.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.6 HG23 HD11 ' A' ' 78' ' ' LEU . 73.9 t -125.06 153.7 32.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 123.309 0.381 . . . . 0.23999999999999999 110.627 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -92.52 85.31 5.28 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.562 0.696 . . . . 1.5900000000000001 110.576 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 54' ' ' GLY . 38.2 p -73.32 112.37 9.32 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.933 -1.031 . . . . 0.33000000000000002 109.716 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 t -49.84 -28.4 6.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.68 -0.691 . . . . 1.3200000000000001 112.151 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -82.24 -22.78 35.69 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.154 0.798 . . . . 1.3 113.154 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -134.47 -43.66 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.905 -0.497 . . . . 3.6800000000000002 111.609 -173.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 122.77 -152.57 16.88 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 116.093 -0.503 . . . . 0.19 111.896 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.571 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.9 m95 -53.01 120.79 6.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.99 0.424 . . . . 0.39000000000000001 110.686 174.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.2 p -71.05 160.96 31.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.679 -0.691 . . . . 0.35999999999999999 111.0 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -60.64 128.34 36.1 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.221 -0.659 . . . . 1.8400000000000001 109.221 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -54.71 123.58 13.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.931 -1.032 . . . . 1.0 111.026 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.44 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 57.8 m -95.77 97.8 9.96 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.356 -0.838 . . . . 0.35999999999999999 110.124 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.12 126.23 38.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.556 -0.747 . . . . 0.73999999999999999 110.887 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.5 -177.89 51.87 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.238 -0.892 . . . . 0.23000000000000001 112.896 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -85.14 147.08 46.76 Favored Pre-proline 0 C--N 1.317 -0.826 0 N-CA-C 109.966 -0.383 . . . . 1.3700000000000001 109.966 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 52.1 Cg_exo -55.05 105.79 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.643 2.228 . . . . 0.51000000000000001 111.45 175.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.641 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 16.3 mmt -113.27 139.84 23.62 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.152 -0.477 . . . . 0.67000000000000004 111.192 -173.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.74 10.14 2.39 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.662 2.242 . . . . 0.32000000000000001 113.323 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.8 t -152.54 137.88 17.55 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.144 -0.687 . . . . 1.3 109.144 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -68.06 -23.21 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 1.1399999999999999 111.688 -173.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -74.1 -44.99 51.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.904 0.383 . . . . 2.8199999999999998 110.423 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.641 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 0.2 OUTLIER -81.04 -17.76 49.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 1.3600000000000001 109.973 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.87 -56.65 19.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.847 -0.615 . . . . 0.20999999999999999 110.092 173.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.646 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 58.1 mtpt -50.92 -48.16 60.76 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 116.261 -0.427 . . . . 2.4199999999999999 110.753 174.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.534 ' O ' HG23 ' A' ' 76' ' ' VAL . 36.8 m-20 -52.46 -51.72 57.89 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.389 0.514 . . . . 2.0099999999999998 112.389 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.2 p -60.9 -40.23 92.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.707 0.289 . . . . 1.1399999999999999 111.456 -175.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.432 ' HB1' HG23 ' A' ' 46' ' ' VAL . . . -69.38 -44.97 70.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.144 0.497 . . . . 0.17999999999999999 110.376 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.509 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -55.99 -35.99 67.4 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.306 -0.861 . . . . 0.26000000000000001 111.754 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 72' ' ' ASP . 91.8 t -64.92 -38.23 82.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.978 0.418 . . . . 0.82999999999999996 110.7 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.6 mt -76.42 -26.43 55.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.916 0.865 . . . . 0.39000000000000001 109.271 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.6 HD11 HG23 ' A' ' 48' ' ' VAL . 16.0 tp -70.98 -54.5 11.04 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.553 -1.203 . . . . 0.81000000000000005 111.256 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 75' ' ' ALA . 4.2 mp -55.32 -29.24 57.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.914 -0.584 . . . . 1.6100000000000001 112.546 -174.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.86 -33.8 60.02 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.276 -0.57 . . . . 2.1299999999999999 110.598 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.1 -50.54 63.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.108 -0.496 . . . . 1.1699999999999999 110.091 -177.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.509 ' CD2' ' HG ' ' A' ' 78' ' ' LEU . 1.4 mm? -67.04 -29.45 69.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 1.1499999999999999 111.124 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.418 HD22 ' HA ' ' A' ' 83' ' ' ASN . 2.2 t-20 . . . . . 0 C--N 1.32 -0.704 0 N-CA-C 109.329 -0.619 . . . . 1.46 109.329 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.442 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.4 mp . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 121.353 0.597 . . . . 0.80000000000000004 110.457 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 23' ' ' TRP . 22.4 t -75.18 -38.49 60.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.397 -0.82 . . . . 1.3500000000000001 109.708 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.7 tp -60.1 -53.08 62.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.139 -0.937 . . . . 1.1599999999999999 110.606 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -56.53 -37.94 71.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.064 -0.971 . . . . 3.8399999999999999 111.71 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.8 mmtm -73.96 5.63 4.06 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.993 -0.549 . . . . 1.1000000000000001 111.918 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 66.48 27.22 9.83 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.597 -0.728 . . . . 1.9199999999999999 110.937 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.558 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.0 m0 -101.0 154.11 37.34 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.557 -0.747 . . . . 0.40000000000000002 109.011 175.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.91 173.65 14.14 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.232 1.955 . . . . 0.44 110.631 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.424 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 31.6 mmt -62.26 127.4 89.62 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.791 0.329 . . . . 1.0 110.921 -177.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.531 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 70.1 Cg_exo -54.89 165.01 2.9 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.567 2.845 . . . . 0.46000000000000002 113.678 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.515 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 25.1 t -89.58 142.39 27.72 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.987 -1.006 . . . . 0.29999999999999999 109.388 177.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.531 ' CE1' ' HB2' ' A' ' 26' ' ' PRO . 95.9 m-85 -140.75 108.72 5.71 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.277 -1.008 . . . . 0.29999999999999999 108.277 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.552 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 48.7 mmt-85 -147.83 118.5 7.52 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.324 -0.621 . . . . 3.6899999999999999 109.324 -173.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.549 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 15.5 p -69.47 129.09 38.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.041 0.448 . . . . 1.53 110.953 -177.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.1 m -85.79 -32.81 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.82 -0.627 . . . . 1.1499999999999999 111.15 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.0 tttm . . . . . 0 C--N 1.319 -0.718 0 CA-C-N 116.081 -0.509 . . . . 2.25 110.226 177.199 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 . . . . . 0 N--CA 1.448 -0.553 0 CA-C-O 121.181 0.515 . . . . 3.6400000000000001 109.66 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.629 ' CZ ' HG22 ' A' ' 67' ' ' VAL . 71.2 m-85 -111.54 131.43 55.25 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.469 -0.787 . . . . 0.79000000000000004 110.191 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 m -120.24 121.68 39.23 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.466 -1.309 . . . . 0.26000000000000001 107.466 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.69 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -136.85 151.28 48.94 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.631 -0.507 . . . . 0.17000000000000001 109.631 -170.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.558 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -123.69 137.96 11.19 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.204 -0.522 . . . . 0.17000000000000001 111.932 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.69 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -106.75 155.57 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 109.731 -0.47 . . . . 0.80000000000000004 109.731 -174.636 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.62 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 8.3 ptp85 -147.95 142.31 26.3 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.626 -0.879 . . . . 2.6200000000000001 108.626 176.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.628 HG23 HD11 ' A' ' 78' ' ' LEU . 95.4 t -124.65 153.24 31.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.342 -0.39 . . . . 0.23999999999999999 110.381 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -92.01 82.8 5.1 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.723 0.773 . . . . 1.5900000000000001 110.203 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 35.3 p -67.94 116.82 9.02 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.438 -1.256 . . . . 0.33000000000000002 110.143 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.8 p -51.95 -26.53 10.67 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.462 -1.244 . . . . 1.3200000000000001 113.013 -176.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -89.11 -17.42 29.27 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.032 0.753 . . . . 1.3 113.032 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -139.16 -44.72 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.488 0.585 . . . . 3.6800000000000002 112.408 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.66 -150.61 17.14 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.919 -0.658 . . . . 0.19 112.337 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.62 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.9 m95 -53.66 118.17 3.71 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.034 0.445 . . . . 0.39000000000000001 110.771 176.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.3 p -65.63 165.06 13.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.56 -0.745 . . . . 0.35999999999999999 111.37 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -61.46 135.27 57.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.046 -0.724 . . . . 1.8400000000000001 109.046 172.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.94 113.27 2.0 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.889 -175.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 60.1 m -91.39 97.32 11.02 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.089 -0.959 . . . . 0.35999999999999999 109.831 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.558 HD13 ' HA3' ' A' ' 45' ' ' GLY . 13.2 mm -81.84 126.01 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 115.832 -0.622 . . . . 0.73999999999999999 110.251 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.82 -170.84 47.07 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.913 -0.66 . . . . 0.23000000000000001 111.96 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.6 ' O ' ' HG2' ' A' ' 64' ' ' MET . 38.7 mt-10 -88.54 145.07 34.62 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.214 -0.662 . . . . 1.3700000000000001 109.214 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -55.83 110.44 0.56 Allowed 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.587 2.191 . . . . 0.51000000000000001 111.758 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.6 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.8 mmm -112.2 140.59 23.75 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.633 -0.506 . . . . 0.67000000000000004 109.633 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.61 18.51 0.96 Allowed 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.637 2.225 . . . . 0.32000000000000001 113.667 -175.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.419 ' HB2' ' CD ' ' A' ' 69' ' ' LYS . 28.7 m -157.56 139.09 13.83 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.227 -0.657 . . . . 1.3 109.227 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.629 HG22 ' CZ ' ' A' ' 42' ' ' PHE . 1.1 t -67.35 -38.67 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.335 -0.848 . . . . 1.1399999999999999 112.259 -167.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -71.21 -39.71 71.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.463 -0.335 . . . . 2.8199999999999998 111.118 -175.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.419 ' CD ' ' HB2' ' A' ' 66' ' ' SER . 17.3 ptmt -80.92 -18.52 46.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.888 0.375 . . . . 1.3600000000000001 110.182 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.62 -55.9 25.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.20999999999999999 110.645 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.642 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 5.6 ptpp? -58.54 -43.18 89.19 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 116.592 -0.276 . . . . 2.4199999999999999 110.767 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.576 ' O ' HG23 ' A' ' 76' ' ' VAL . 5.7 m-20 -54.92 -47.08 74.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 2.0099999999999998 111.973 176.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.2 t -58.65 -46.36 87.32 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.851 0.358 . . . . 1.1399999999999999 111.321 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.436 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -68.85 -42.81 76.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.022 0.439 . . . . 0.17999999999999999 110.589 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.48 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -56.12 -34.19 65.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.447 -0.797 . . . . 0.26000000000000001 111.517 177.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 72' ' ' ASP . 94.2 t -63.51 -36.57 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.916 0.389 . . . . 0.82999999999999996 110.61 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.98 -34.04 64.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.712 0.767 . . . . 0.39000000000000001 109.271 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.663 HD22 HG11 ' A' ' 46' ' ' VAL . 26.3 tp -64.82 -42.56 94.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.602 -1.181 . . . . 0.81000000000000005 110.797 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.3 mp -60.33 -26.96 66.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.03 -0.532 . . . . 1.6100000000000001 111.215 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -71.37 -40.0 70.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.227 0.537 . . . . 2.1299999999999999 110.274 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.8 tp -65.55 -46.55 79.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.359 -0.837 . . . . 1.1699999999999999 110.077 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.554 HD11 HG21 ' A' ' 48' ' ' VAL . 42.2 mt -70.09 -12.89 61.93 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.514 -1.221 . . . . 1.1499999999999999 111.19 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 . . . . . 0 C--N 1.317 -0.828 0 CA-C-O 121.588 0.709 . . . . 1.46 109.554 176.694 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.5 mp . . . . . 0 C--O 1.232 0.164 0 CA-C-O 121.006 0.431 . . . . 0.80000000000000004 110.734 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 23' ' ' TRP . 41.2 t -72.29 -39.81 68.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.274 0.559 . . . . 1.3500000000000001 109.971 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.0 tp -61.08 -51.54 68.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.305 -0.861 . . . . 1.1599999999999999 110.153 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -54.98 -36.53 65.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.218 -0.901 . . . . 3.8399999999999999 111.489 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -72.52 1.84 7.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.906 -0.588 . . . . 1.1000000000000001 111.971 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 64.96 26.08 12.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.35 -0.841 . . . . 1.9199999999999999 111.361 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.445 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 34.0 m0 -96.62 154.29 38.52 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.695 -0.483 . . . . 0.40000000000000002 109.695 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.414 ' HG2' ' HB3' ' A' ' 49' ' ' ASN . 63.2 Cg_endo -71.87 169.71 20.58 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.519 2.146 . . . . 0.44 110.811 173.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.8 mmt -63.03 130.22 93.97 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.691 -0.231 . . . . 1.0 111.106 -175.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.415 ' HB3' HG22 ' A' ' 48' ' ' VAL . 15.2 Cg_exo -67.31 165.78 25.71 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.881 2.387 . . . . 0.46000000000000002 112.865 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.431 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 16.8 t -87.97 141.34 28.65 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.045 -0.98 . . . . 0.29999999999999999 109.995 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.507 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 75.6 m-85 -138.92 110.63 7.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.768 -0.827 . . . . 0.29999999999999999 108.768 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.501 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 78.0 mtp180 -148.29 123.93 10.47 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 110.165 -0.309 . . . . 3.6899999999999999 110.165 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.531 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 71.2 m -61.12 121.08 11.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.997 0.427 . . . . 1.53 110.648 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.2 t -82.34 -38.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.787 -0.642 . . . . 1.1499999999999999 110.046 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--N 1.324 -0.54 0 N-CA-C 109.297 -0.631 . . . . 2.25 109.297 176.795 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 107.102 -1.444 . . . . 3.6400000000000001 107.102 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -108.92 131.2 55.26 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.285 0.564 . . . . 0.79000000000000004 109.743 -172.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.6 m -120.01 118.0 29.5 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.886 -1.153 . . . . 0.26000000000000001 107.886 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.711 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -129.74 153.56 48.07 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.329 -0.619 . . . . 0.17000000000000001 109.329 -172.266 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.555 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -127.79 137.76 10.01 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.514 -0.634 . . . . 0.17000000000000001 111.514 178.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.711 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -105.99 155.0 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 N-CA-C 109.406 -0.59 . . . . 0.80000000000000004 109.406 -177.462 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.56 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 12.4 ptp180 -143.68 141.27 30.46 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 107.784 -1.191 . . . . 2.6200000000000001 107.784 173.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.415 HG22 ' HB3' ' A' ' 26' ' ' PRO . 39.1 t -117.19 152.4 19.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.304 -0.407 . . . . 0.23999999999999999 110.11 -178.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.414 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 58.3 t30 -94.95 83.62 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.049 0.928 . . . . 1.5900000000000001 109.853 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.8 p -70.48 116.05 10.37 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.775 -1.557 . . . . 0.33000000000000002 109.488 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.4 t -52.49 -28.2 19.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.924 -0.58 . . . . 1.3200000000000001 110.254 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -63.36 -56.27 17.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.402 -0.817 . . . . 1.3 112.755 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -122.99 -33.43 3.34 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.156 0.428 . . . . 3.6800000000000002 112.156 -171.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.56 -149.87 16.93 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 121.149 -0.548 . . . . 0.19 112.324 -177.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.56 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.9 m95 -54.04 117.81 3.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.929 0.395 . . . . 0.39000000000000001 111.045 175.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.1 p -67.63 170.02 8.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.57 -0.741 . . . . 0.35999999999999999 111.413 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -65.32 126.65 28.88 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.191 -1.04 . . . . 1.8400000000000001 108.191 172.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -58.71 114.62 2.6 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.557 0.694 . . . . 1.0 110.49 -175.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.474 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 59.8 m -87.02 97.01 10.48 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.944 -1.025 . . . . 0.35999999999999999 109.659 -177.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.555 HD13 ' HA3' ' A' ' 45' ' ' GLY . 21.6 mm -77.63 120.67 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.341 -0.845 . . . . 0.73999999999999999 109.593 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.51 -165.8 35.56 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.757 -0.735 . . . . 0.23000000000000001 112.217 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 64' ' ' MET . 38.6 mt-10 -92.66 142.22 25.47 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.259 -0.645 . . . . 1.3700000000000001 109.259 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.51 114.63 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.693 2.262 . . . . 0.51000000000000001 111.952 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.644 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 95.8 mmm -118.58 138.88 26.3 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.216 -0.447 . . . . 0.67000000000000004 109.941 -174.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.15 11.64 1.44 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.637 2.225 . . . . 0.32000000000000001 113.827 -175.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.497 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 50.5 m -152.67 137.59 17.16 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.317 -0.623 . . . . 1.3 109.317 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.71 -31.79 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 113.147 0.795 . . . . 1.1399999999999999 113.147 -169.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -69.83 -42.44 73.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.766 0.317 . . . . 2.8199999999999998 111.25 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.497 ' HG2' ' HB2' ' A' ' 66' ' ' SER . 17.3 ptpt -81.0 -18.9 45.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.369 -0.378 . . . . 1.3600000000000001 110.49 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.51 -57.94 10.79 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.342 -0.39 . . . . 0.20999999999999999 110.299 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.683 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 53.1 mtmt -56.51 -45.37 81.12 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.25 -0.432 . . . . 2.4199999999999999 110.729 175.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 76' ' ' VAL . 22.3 t70 -49.79 -50.13 45.98 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.887 -0.597 . . . . 2.0099999999999998 111.812 176.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.0 t -58.91 -47.56 84.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 1.1399999999999999 111.618 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.99 81.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.251 0.548 . . . . 0.17999999999999999 111.007 -177.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.603 ' O ' ' HG ' ' A' ' 79' ' ' LEU . . . -60.44 -29.94 69.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.553 -0.749 . . . . 0.26000000000000001 111.692 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 72' ' ' ASP . 55.6 t -65.71 -32.82 59.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 121.102 0.477 . . . . 0.82999999999999996 109.961 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.3 mt -74.26 -30.76 62.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.856 -0.611 . . . . 0.39000000000000001 109.506 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 78' ' ' LEU . 6.2 mt -61.87 -42.64 99.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.195 -0.911 . . . . 0.81000000000000005 110.24 175.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 17.8 mt -58.3 -35.59 72.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.199 -0.91 . . . . 1.6100000000000001 111.037 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -69.67 -43.81 71.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.895 0.379 . . . . 2.1299999999999999 110.268 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.0 tt -62.87 -47.57 82.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.716 -0.675 . . . . 1.1699999999999999 109.259 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.35 -32.91 72.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.081 -0.963 . . . . 1.1499999999999999 111.68 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 121.358 0.599 . . . . 1.46 110.597 178.793 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.487 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.817 0.341 . . . . 0.80000000000000004 110.607 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.409 ' SG ' ' HE3' ' A' ' 23' ' ' TRP . 54.1 t -72.24 -41.19 67.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.661 0.743 . . . . 1.3500000000000001 109.247 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.75 -42.85 99.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.628 -1.169 . . . . 1.1599999999999999 109.614 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -61.65 -33.9 74.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.556 -0.747 . . . . 3.8399999999999999 110.919 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 31.6 mmmt -74.28 2.07 10.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.029 -0.532 . . . . 1.1000000000000001 111.485 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.9 t30 68.24 27.04 6.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.998 0.904 . . . . 1.9199999999999999 109.712 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.409 ' HE3' ' SG ' ' A' ' 18' ' ' CYS . 41.8 m0 -92.67 160.88 33.48 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.017 -0.992 . . . . 0.40000000000000002 109.055 174.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.38 -169.53 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.106 1.871 . . . . 0.44 111.482 173.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.424 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 10.6 mmt -77.22 132.5 70.08 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HB3' HG22 ' A' ' 48' ' ' VAL . 16.9 Cg_exo -65.63 164.37 26.73 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.512 2.141 . . . . 0.46000000000000002 112.268 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.525 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 22.5 t -87.84 140.99 28.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.494 -0.776 . . . . 0.29999999999999999 109.859 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.51 ' HD1' ' CZ ' ' A' ' 44' ' ' PHE . 66.1 m-85 -141.19 111.04 6.54 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.889 -0.782 . . . . 0.29999999999999999 108.889 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.51 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 36.2 ttm180 -153.01 128.68 10.1 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.196 -0.298 . . . . 3.6899999999999999 110.196 -175.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.4 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 7.8 p -65.32 124.68 22.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.924 0.392 . . . . 1.53 110.459 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.404 ' H ' ' HA ' ' A' ' 44' ' ' PHE . 34.1 m -82.57 -34.61 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.141 0.496 . . . . 1.1499999999999999 110.302 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.7 tttt . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.681 -0.691 . . . . 2.25 110.201 174.095 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 . . . . . 0 CA--C 1.512 -0.512 0 N-CA-C 106.471 -1.677 . . . . 3.6400000000000001 106.471 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 9.0 m-85 -111.0 130.15 55.68 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 120.474 -0.49 . . . . 0.79000000000000004 110.284 -172.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.6 m -121.92 125.43 46.37 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.03 -1.1 . . . . 0.26000000000000001 108.03 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.728 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -134.36 151.61 51.32 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.582 -0.525 . . . . 0.17000000000000001 109.582 -175.108 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.91 139.41 11.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.96 -0.638 . . . . 0.17000000000000001 111.883 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.728 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -107.05 157.6 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 N-CA-C 110.03 -0.359 . . . . 0.80000000000000004 110.03 -174.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.615 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 15.2 ptp180 -148.5 147.39 29.04 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.674 -0.862 . . . . 2.6200000000000001 108.674 171.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.638 HG23 HD11 ' A' ' 78' ' ' LEU . 73.0 t -124.98 153.07 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.474 -0.33 . . . . 0.23999999999999999 110.807 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -93.89 84.54 4.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.729 0.776 . . . . 1.5900000000000001 110.213 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' A' ' 53' ' ' ARG . 40.3 p -72.52 108.11 5.41 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.374 -1.285 . . . . 0.33000000000000002 109.05 177.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.1 t -49.83 -28.28 6.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.011 -0.541 . . . . 1.3200000000000001 112.251 -175.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -88.44 -15.82 34.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.705 0.631 . . . . 1.3 112.705 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.44 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 25.3 ttm180 -132.22 -49.38 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.915 -0.491 . . . . 3.6800000000000002 111.307 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 125.59 -156.82 19.48 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.842 -0.617 . . . . 0.19 112.288 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.615 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.7 m95 -52.0 117.95 3.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.969 0.414 . . . . 0.39000000000000001 110.611 173.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 47.9 p -69.85 168.98 14.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.533 -0.758 . . . . 0.35999999999999999 111.306 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.48 125.51 25.93 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.164 -0.68 . . . . 1.8400000000000001 109.164 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 45.4 tt0 -60.75 118.11 6.22 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.297 -0.865 . . . . 1.0 111.036 -174.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 68.6 m -97.96 102.26 13.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.713 -1.13 . . . . 0.35999999999999999 110.731 -175.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.43 127.7 36.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.77 -0.65 . . . . 0.73999999999999999 110.533 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.15 -161.93 34.93 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.574 -0.739 . . . . 0.23000000000000001 113.019 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 64' ' ' MET . 32.5 mt-10 -92.03 131.94 33.85 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.744 -0.228 . . . . 1.3700000000000001 110.612 -175.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 54.1 Cg_exo -52.9 108.92 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.765 2.31 . . . . 0.51000000000000001 111.477 175.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.472 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 7.1 mmt -110.96 151.51 43.03 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.006 -0.543 . . . . 0.67000000000000004 111.772 -171.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.59 5.78 6.06 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.949 2.432 . . . . 0.32000000000000001 112.989 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.4 t -151.61 142.39 22.87 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.5 -0.556 . . . . 1.3 109.5 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.4 t -62.16 -33.3 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.457 -0.792 . . . . 1.1399999999999999 111.406 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -66.76 -37.07 83.89 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.242 -0.435 . . . . 2.8199999999999998 110.439 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.472 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 29.1 mtpp -74.27 -31.44 62.53 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.079 -0.509 . . . . 1.3600000000000001 110.315 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.74 -60.89 2.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.68 -0.691 . . . . 0.20999999999999999 110.955 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.538 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 32.6 mmtp -51.46 -49.51 61.62 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.289 -0.414 . . . . 2.4199999999999999 110.995 176.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.508 ' O ' HG23 ' A' ' 76' ' ' VAL . 17.4 t70 -51.84 -52.27 50.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.281 -0.872 . . . . 2.0099999999999998 112.566 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 91.6 p -62.4 -41.31 98.57 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.835 0.309 . . . . 1.1399999999999999 111.835 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.493 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -69.46 -41.44 76.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.222 0.534 . . . . 0.17999999999999999 110.543 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.409 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -54.23 -33.68 58.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.231 -0.895 . . . . 0.26000000000000001 111.395 176.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 72' ' ' ASP . 88.7 t -62.55 -37.96 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 120.971 0.415 . . . . 0.82999999999999996 110.833 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.08 -30.47 62.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.868 0.842 . . . . 0.39000000000000001 109.042 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.638 HD11 HG23 ' A' ' 48' ' ' VAL . 18.1 tp -67.3 -42.88 82.99 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.438 -1.255 . . . . 0.81000000000000005 110.329 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.9 mm? -61.26 -29.5 69.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.713 -0.676 . . . . 1.6100000000000001 110.971 177.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 76' ' ' VAL . 35.1 mt-10 -75.98 -38.5 57.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.932 0.396 . . . . 2.1299999999999999 110.112 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.9 tt -62.65 -48.95 77.11 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.277 -0.638 . . . . 1.1699999999999999 109.277 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.9 -14.73 60.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.324 -0.853 . . . . 1.1499999999999999 112.191 177.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.5 t30 . . . . . 0 C--N 1.322 -0.627 0 CA-C-O 121.633 0.73 . . . . 1.46 109.613 178.528 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.3 mp . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 121.537 0.684 . . . . 0.80000000000000004 110.11 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.501 ' SG ' ' HG3' ' A' ' 26' ' ' PRO . 57.6 m -66.41 -43.65 85.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.072 -0.967 . . . . 1.3500000000000001 110.412 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.7 tp -63.81 -53.03 57.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.964 -1.016 . . . . 1.1599999999999999 111.194 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -59.23 -35.51 73.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.893 -0.594 . . . . 3.8399999999999999 111.371 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 37.3 mmtt -74.18 -1.26 19.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.126 0.489 . . . . 1.1000000000000001 111.939 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 61.89 36.8 15.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.851 -1.068 . . . . 1.9199999999999999 110.632 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 29.8 m0 -94.7 161.73 27.82 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.489 -0.778 . . . . 0.40000000000000002 109.014 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.18 177.98 4.0 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.965 1.776 . . . . 0.44 110.459 170.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 22.0 mmt -77.61 123.08 86.66 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-O 120.931 0.396 . . . . 1.0 110.403 -176.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.527 ' HB3' HG22 ' A' ' 48' ' ' VAL . 9.6 Cg_endo -56.47 163.15 7.08 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.695 2.93 . . . . 0.46000000000000002 114.015 -176.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.538 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 25.6 t -88.46 143.35 27.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.811 -1.086 . . . . 0.29999999999999999 110.461 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.541 ' HD1' ' CZ ' ' A' ' 44' ' ' PHE . 65.5 m-85 -143.33 111.37 6.1 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.146 -0.687 . . . . 0.29999999999999999 109.146 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.47 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 79.2 ttt180 -155.71 129.87 8.78 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.599 -0.519 . . . . 3.6899999999999999 109.599 -176.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 13.8 p -69.78 132.0 45.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.216 0.531 . . . . 1.53 111.2 -176.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.71 -31.66 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.61 -0.723 . . . . 1.1499999999999999 109.983 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.408 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 87.7 tttt . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 115.984 -0.553 . . . . 2.25 110.897 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 107.545 -1.28 . . . . 3.6400000000000001 107.545 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 7.7 m-85 -109.64 134.64 51.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.015 0.436 . . . . 0.79000000000000004 110.355 -170.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 32' ' ' LYS . 19.7 m -123.61 120.6 33.29 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.66 -0.867 . . . . 0.26000000000000001 108.66 -178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.736 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -131.58 154.18 49.12 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.649 -0.5 . . . . 0.17000000000000001 109.649 -172.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -128.5 140.44 11.76 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.951 -0.642 . . . . 0.17000000000000001 112.168 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.736 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -106.93 154.81 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 109.661 -0.496 . . . . 0.80000000000000004 109.661 -176.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.575 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 12.4 ptp180 -145.79 142.7 29.13 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.907 -1.146 . . . . 2.6200000000000001 107.907 173.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.602 HG23 HD11 ' A' ' 78' ' ' LEU . 43.7 t -124.8 156.04 33.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.714 -0.221 . . . . 0.23999999999999999 110.606 -178.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.405 ' N ' HG12 ' A' ' 48' ' ' VAL . 26.6 t-20 -91.89 84.19 5.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.739 0.78 . . . . 1.5900000000000001 109.782 178.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.8 p -78.25 103.14 8.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.581 -1.19 . . . . 0.33000000000000002 109.167 177.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 t -44.25 -34.87 2.04 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.351 -0.84 . . . . 1.3200000000000001 113.095 -170.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -68.26 -26.95 65.93 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.858 0.688 . . . . 1.3 112.858 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -132.24 -42.2 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.013 0.435 . . . . 3.6800000000000002 111.487 -174.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.49 -150.02 16.94 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.965 -0.562 . . . . 0.19 112.03 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.575 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.9 m95 -51.5 120.06 4.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.024 0.44 . . . . 0.39000000000000001 111.327 175.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.6 p -68.34 156.92 36.79 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.726 -0.67 . . . . 0.35999999999999999 110.346 176.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -61.84 124.88 21.98 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.866 -0.79 . . . . 1.8400000000000001 108.866 173.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 40.5 tt0 -59.64 118.03 5.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.104 -0.953 . . . . 1.0 111.242 -170.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.419 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 50.6 m -93.3 102.64 14.91 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.704 -1.134 . . . . 0.35999999999999999 110.614 -174.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.02 128.56 38.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.819 -0.628 . . . . 0.73999999999999999 110.739 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.27 -167.58 43.51 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.478 -0.783 . . . . 0.23000000000000001 111.999 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.638 ' O ' ' HG2' ' A' ' 64' ' ' MET . 40.9 mt-10 -86.62 148.14 45.61 Favored Pre-proline 0 C--N 1.318 -0.795 0 O-C-N 122.731 -0.276 . . . . 1.3700000000000001 110.311 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 32.1 Cg_exo -59.62 107.87 0.42 Allowed 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.492 2.128 . . . . 0.51000000000000001 110.753 170.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.638 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 95.9 mmm -114.62 148.77 41.04 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.063 -0.517 . . . . 0.67000000000000004 110.139 -172.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.74 8.67 4.13 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.619 2.212 . . . . 0.32000000000000001 113.667 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.425 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 37.9 m -153.88 137.91 16.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.349 -0.612 . . . . 1.3 109.349 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.571 ' O ' ' HD3' ' A' ' 71' ' ' LYS . 28.3 m -64.84 -29.3 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 112.646 0.61 . . . . 1.1399999999999999 112.646 -170.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.68 -42.86 77.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.965 0.412 . . . . 2.8199999999999998 111.33 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.425 ' HG2' ' HB2' ' A' ' 66' ' ' SER . 14.5 ptpt -81.84 -18.21 44.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.362 -0.381 . . . . 1.3600000000000001 111.058 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.42 -51.22 68.39 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.517 -0.549 . . . . 0.20999999999999999 109.517 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.653 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -52.57 -51.56 59.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.135 -0.939 . . . . 2.4199999999999999 110.461 174.018 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -52.76 -46.95 67.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.254 -0.884 . . . . 2.0099999999999998 112.277 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.536 ' O ' HG12 ' A' ' 76' ' ' VAL . 95.7 p -65.58 -39.36 91.54 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.901 -0.319 . . . . 1.1399999999999999 111.5 -176.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.425 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -70.99 -48.15 54.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.026 0.441 . . . . 0.17999999999999999 110.552 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.472 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -54.31 -38.89 66.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.501 -0.772 . . . . 0.26000000000000001 111.808 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 73' ' ' SER . 3.0 p -72.25 -26.62 25.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 0.82999999999999996 110.958 -176.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.8 mt -78.2 -34.07 49.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.852 0.834 . . . . 0.39000000000000001 109.402 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.602 HD11 HG23 ' A' ' 48' ' ' VAL . 17.5 tp -64.68 -38.65 91.73 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.691 -1.14 . . . . 0.81000000000000005 110.693 175.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 75' ' ' ALA . 6.1 mp -61.09 -26.26 67.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.548 -0.751 . . . . 1.6100000000000001 111.357 177.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -70.61 -38.04 73.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.479 0.657 . . . . 2.1299999999999999 109.985 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.34 -46.96 75.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.134 -0.939 . . . . 1.1699999999999999 109.177 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mp -69.22 -13.58 62.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.191 -0.913 . . . . 1.1499999999999999 111.686 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.6 t30 . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 122.011 0.91 . . . . 1.46 109.208 175.953 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.731 0.301 . . . . 0.80000000000000004 111.045 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.594 ' SG ' ' HD3' ' A' ' 26' ' ' PRO . 53.3 t -62.22 -41.1 98.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.445 0.64 . . . . 1.3500000000000001 110.388 -176.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 38.5 tp -62.27 -51.97 65.6 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.001 -0.999 . . . . 1.1599999999999999 110.899 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.9 ttp-105 -61.59 -31.89 71.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.262 -0.881 . . . . 3.8399999999999999 111.525 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -72.58 -1.59 16.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.961 -0.563 . . . . 1.1000000000000001 111.437 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.4 m120 59.67 27.79 17.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.853 -1.067 . . . . 1.9199999999999999 111.841 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.482 ' CH2' HG22 ' A' ' 50' ' ' THR . 27.3 m0 -85.4 162.86 47.09 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.234 -0.654 . . . . 0.40000000000000002 109.234 174.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.08 174.34 7.09 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 121.981 1.788 . . . . 0.44 110.437 170.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 5.7 mmt -79.2 132.94 61.55 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.981 0.42 . . . . 1.0 111.402 -170.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.594 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 12.1 Cg_endo -58.82 156.42 32.99 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.832 3.021 . . . . 0.46000000000000002 113.819 -177.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.1 t -90.35 144.21 26.03 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.841 -1.072 . . . . 0.29999999999999999 110.238 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.54 ' CD2' ' CZ ' ' A' ' 44' ' ' PHE . 60.7 m-85 -141.58 110.32 6.12 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.933 -0.766 . . . . 0.29999999999999999 108.933 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.532 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 57.5 mtp180 -146.05 125.67 13.33 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 110.39 -0.226 . . . . 3.6899999999999999 110.39 -176.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 74.6 m -65.24 126.77 29.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.749 0.309 . . . . 1.53 110.795 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 43' ' ' THR . 30.5 m -87.48 -38.67 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 1.1499999999999999 110.927 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.4 tttt . . . . . 0 C--N 1.325 -0.484 0 CA-C-N 116.411 -0.359 . . . . 2.25 110.764 177.975 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.018 -0.734 . . . . 3.6400000000000001 109.018 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -110.47 136.01 50.27 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.025 -0.534 . . . . 0.79000000000000004 110.807 -172.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 31' ' ' VAL . 16.7 m -124.6 127.84 47.98 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.234 -1.024 . . . . 0.26000000000000001 108.234 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.747 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -142.85 154.4 44.11 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.499 -0.556 . . . . 0.17000000000000001 109.499 -175.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.556 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -126.85 139.75 11.46 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.903 -0.665 . . . . 0.17000000000000001 112.519 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.747 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -107.18 159.02 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.659 -0.497 . . . . 0.80000000000000004 109.659 -175.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.616 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 14.6 ptp180 -148.43 147.87 29.66 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.61 -0.885 . . . . 2.6200000000000001 108.61 171.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.572 HG23 HD11 ' A' ' 78' ' ' LEU . 85.1 t -125.76 156.18 35.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.305 -0.407 . . . . 0.23999999999999999 110.178 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -92.12 82.2 5.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.087 0.47 . . . . 1.5900000000000001 109.949 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.482 HG22 ' CH2' ' A' ' 23' ' ' TRP . 41.5 p -74.5 107.2 6.49 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.548 -0.751 . . . . 0.33000000000000002 109.479 178.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.7 t -47.53 -30.54 3.58 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.825 0.676 . . . . 1.3200000000000001 112.825 -173.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -80.32 -14.58 58.25 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.417 0.895 . . . . 1.3 113.417 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -140.07 -42.09 0.43 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.525 0.602 . . . . 3.6800000000000002 111.105 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 122.75 -153.75 16.95 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 116.111 -0.495 . . . . 0.19 112.048 -178.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.616 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 9.4 m95 -51.81 120.48 5.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.812 0.339 . . . . 0.39000000000000001 110.732 173.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 47.4 p -68.92 157.73 36.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.709 -0.678 . . . . 0.35999999999999999 111.045 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -58.22 131.67 51.28 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.065 -0.717 . . . . 1.8400000000000001 109.065 174.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.66 113.02 2.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.744 0.783 . . . . 1.0 111.262 -171.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.457 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 38.7 m -85.87 98.67 10.9 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.177 -1.374 . . . . 0.35999999999999999 109.984 -176.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.556 HD13 ' HA3' ' A' ' 45' ' ' GLY . 19.1 mm -80.71 128.96 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 115.892 -0.594 . . . . 0.73999999999999999 110.364 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.11 175.21 49.87 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.921 -0.872 . . . . 0.23000000000000001 110.921 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' A' ' 64' ' ' MET . 12.5 pt-20 -85.5 150.5 54.18 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.572 -0.529 . . . . 1.3700000000000001 109.572 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.97 109.97 0.39 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.651 2.234 . . . . 0.51000000000000001 111.692 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.606 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 98.0 mmm -114.73 139.19 23.8 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.816 -0.629 . . . . 0.67000000000000004 109.493 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.69 13.69 0.73 Allowed 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.576 2.184 . . . . 0.32000000000000001 114.072 -174.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.52 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 28.6 m -157.46 143.1 17.36 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.715 -0.476 . . . . 1.3 109.715 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.77 -41.23 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.337 -0.847 . . . . 1.1399999999999999 112.693 -170.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.35 -42.39 96.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.919 0.39 . . . . 2.8199999999999998 111.146 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.52 ' HG2' ' HB2' ' A' ' 66' ' ' SER . 15.8 ptpt -81.26 -18.95 44.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.462 -0.335 . . . . 1.3600000000000001 110.67 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.45 -55.63 25.81 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.397 -0.365 . . . . 0.20999999999999999 110.301 171.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.613 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 53.5 mtpt -54.29 -52.17 62.31 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 116.063 -0.517 . . . . 2.4199999999999999 110.29 175.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.38 -42.13 73.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.128 -0.942 . . . . 2.0099999999999998 112.194 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.547 ' O ' HG12 ' A' ' 76' ' ' VAL . 17.1 t -62.75 -43.06 99.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.778 0.323 . . . . 1.1399999999999999 110.981 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.435 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -69.95 -44.4 69.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.134 0.493 . . . . 0.17999999999999999 110.401 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.479 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -57.52 -38.51 74.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.631 -0.713 . . . . 0.26000000000000001 112.208 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 73' ' ' SER . 3.1 p -68.79 -31.19 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 O-C-N 121.952 -0.467 . . . . 0.82999999999999996 110.669 -178.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.5 mt -76.19 -31.79 58.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.808 0.813 . . . . 0.39000000000000001 109.103 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.572 HD11 HG23 ' A' ' 48' ' ' VAL . 14.3 tp -66.16 -43.31 87.33 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.496 -1.229 . . . . 0.81000000000000005 110.728 175.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.479 HD13 ' O ' ' A' ' 75' ' ' ALA . 6.3 mp -59.15 -29.19 67.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 1.6100000000000001 111.424 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 6.2 mm-40 -71.78 -38.93 70.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.191 -0.459 . . . . 2.1299999999999999 110.698 177.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.3 tp -75.05 -41.97 58.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.908 0.861 . . . . 1.1699999999999999 110.335 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 82' ' ' LEU . 8.7 tp -65.4 -38.92 91.43 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.062 -1.426 . . . . 1.1499999999999999 111.341 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.1 t30 . . . . . 0 C--N 1.318 -0.793 0 CA-C-N 114.804 -1.089 . . . . 1.46 109.816 173.332 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.477 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.4 mp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.998 0.428 . . . . 0.80000000000000004 110.638 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.412 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 42.8 t -71.57 -41.73 68.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.987 -0.551 . . . . 1.3500000000000001 110.218 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.8 -54.63 42.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.357 -0.838 . . . . 1.1599999999999999 110.605 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -58.06 -33.89 69.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.211 -0.904 . . . . 3.8399999999999999 111.906 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.427 ' HB3' ' CE2' ' A' ' 23' ' ' TRP . 34.4 mmtt -72.71 4.02 4.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.071 0.462 . . . . 1.1000000000000001 111.968 -178.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 63.28 38.71 10.15 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.867 -1.06 . . . . 1.9199999999999999 110.28 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 29.0 m0 -104.81 165.09 13.88 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.423 -0.808 . . . . 0.40000000000000002 109.631 176.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 55.0 Cg_endo -72.39 -171.51 0.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.349 2.033 . . . . 0.44 110.913 170.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.487 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 12.0 mmt -82.33 135.94 46.68 Favored Pre-proline 0 C--N 1.323 -0.582 0 O-C-N 122.024 -0.422 . . . . 1.0 110.633 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.571 ' HB3' HG22 ' A' ' 48' ' ' VAL . 14.4 Cg_exo -68.88 168.45 20.33 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.916 2.411 . . . . 0.46000000000000002 113.045 -177.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.2 t -89.51 141.23 28.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.936 -1.029 . . . . 0.29999999999999999 110.32 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.464 ' CD2' ' HZ ' ' A' ' 44' ' ' PHE . 67.7 m-85 -144.17 110.52 5.51 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.29 -0.633 . . . . 0.29999999999999999 109.29 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.478 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 24.2 ttm180 -156.52 128.42 7.31 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.751 0.31 . . . . 3.6899999999999999 110.512 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 4.5 p -65.68 124.26 21.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.069 0.461 . . . . 1.53 110.957 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.7 m -87.57 -37.07 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.987 -0.552 . . . . 1.1499999999999999 111.439 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.9 tttt . . . . . 0 C--N 1.321 -0.634 0 CA-C-O 121.06 0.457 . . . . 2.25 110.52 -179.707 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 108.4 -0.963 . . . . 3.6400000000000001 108.4 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -110.31 135.66 50.7 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.904 -0.589 . . . . 0.79000000000000004 110.637 -170.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.8 m -122.54 130.69 53.3 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.868 -1.16 . . . . 0.26000000000000001 107.868 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.738 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -139.18 151.33 46.5 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.417 -0.586 . . . . 0.17000000000000001 109.417 -174.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.551 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -125.58 136.84 9.94 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.973 -0.632 . . . . 0.17000000000000001 112.017 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.738 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -107.1 156.72 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 109.308 -0.627 . . . . 0.80000000000000004 109.308 -176.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.562 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 16.2 ptt180 -148.99 147.7 28.88 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.774 -0.825 . . . . 2.6200000000000001 108.774 171.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.571 HG22 ' HB3' ' A' ' 26' ' ' PRO . 78.2 t -125.13 153.44 32.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.076 -0.511 . . . . 0.23999999999999999 110.339 -177.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -93.58 83.4 4.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.507 0.67 . . . . 1.5900000000000001 109.835 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 54' ' ' GLY . 29.6 p -69.89 105.58 2.86 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.628 -1.169 . . . . 0.33000000000000002 108.963 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.1 t -43.78 -44.33 6.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.804 0.668 . . . . 1.3200000000000001 112.804 -169.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -81.5 -6.44 58.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.254 0.835 . . . . 1.3 113.254 -175.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -133.1 -48.65 0.86 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.739 -0.601 . . . . 3.6800000000000002 111.547 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 123.71 -153.68 17.35 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.899 -0.591 . . . . 0.19 112.585 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.562 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 5.2 m95 -52.43 117.61 2.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.869 0.366 . . . . 0.39000000000000001 110.676 174.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.0 p -68.48 169.78 10.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.725 -0.671 . . . . 0.35999999999999999 111.214 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -62.41 129.45 40.72 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.708 -0.849 . . . . 1.8400000000000001 108.708 172.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -60.63 119.74 8.68 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.39 0.614 . . . . 1.0 110.609 -176.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.51 ' SG ' HD12 ' A' ' 81' ' ' LEU . 51.5 m -92.34 98.52 11.54 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.892 -1.049 . . . . 0.35999999999999999 110.231 -175.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.551 HD13 ' HA3' ' A' ' 45' ' ' GLY . 24.6 mm -80.42 124.02 37.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.778 -0.646 . . . . 0.73999999999999999 110.066 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.99 -174.84 50.0 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.882 -0.675 . . . . 0.23000000000000001 112.243 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 64' ' ' MET . 42.9 mt-10 -83.81 152.01 62.1 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 109.728 -0.471 . . . . 1.3700000000000001 109.728 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.43 109.14 1.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.363 2.042 . . . . 0.51000000000000001 111.222 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.562 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 89.3 mmm -115.37 141.57 27.41 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.697 -0.483 . . . . 0.67000000000000004 109.697 -173.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.05 17.97 1.1 Allowed 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.57 2.18 . . . . 0.32000000000000001 113.581 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.424 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 11.2 t -155.09 139.91 17.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.315 -0.624 . . . . 1.3 109.315 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.2 -23.88 27.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.838 -0.619 . . . . 1.1399999999999999 111.032 -173.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -73.96 -43.69 57.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.039 0.447 . . . . 2.8199999999999998 110.235 -176.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.424 ' HG2' ' HB3' ' A' ' 66' ' ' SER . 5.7 ptpp? -81.64 -18.37 44.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.939 -0.573 . . . . 1.3600000000000001 110.634 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.28 -57.49 12.56 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.496 -0.32 . . . . 0.20999999999999999 110.496 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.462 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 61.5 mttm -52.95 -50.08 64.78 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.946 0.403 . . . . 2.4199999999999999 110.257 174.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.534 ' O ' HG23 ' A' ' 76' ' ' VAL . 32.1 t70 -51.54 -51.56 54.3 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.362 -0.835 . . . . 2.0099999999999998 112.295 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.4 t -56.31 -46.64 79.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.787 0.327 . . . . 1.1399999999999999 111.178 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.441 ' HB1' HG23 ' A' ' 46' ' ' VAL . . . -69.5 -43.14 73.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.259 -0.428 . . . . 0.17999999999999999 110.951 -177.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.91 -41.06 70.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.819 -0.628 . . . . 0.26000000000000001 111.84 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 72' ' ' ASP . 97.0 t -63.64 -35.04 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.043 0.449 . . . . 0.82999999999999996 110.731 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.6 mt -74.89 -36.63 62.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.732 0.777 . . . . 0.39000000000000001 109.66 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.531 HD22 HG11 ' A' ' 46' ' ' VAL . 21.0 tp -64.72 -43.12 94.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.749 -1.114 . . . . 0.81000000000000005 111.103 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 mp -62.69 -21.13 65.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.85 -0.613 . . . . 1.6100000000000001 111.497 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -76.43 -38.44 55.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.752 0.31 . . . . 2.1299999999999999 110.234 174.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.51 HD12 ' SG ' ' A' ' 59' ' ' CYS . 0.8 OUTLIER -66.35 -42.98 87.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.766 0.793 . . . . 1.1699999999999999 109.063 178.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.418 ' HG ' ' CZ3' ' A' ' 23' ' ' TRP . 1.6 mp -69.24 -17.75 63.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.678 -1.146 . . . . 1.1499999999999999 111.943 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 . . . . . 0 C--N 1.319 -0.734 0 N-CA-C 108.833 -0.803 . . . . 1.46 108.833 174.811 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.3 t30 . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.483 0.182 . . . . 2.4900000000000002 110.773 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -61.39 -44.43 97.16 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.614 0.245 . . . . 2.46 111.379 -175.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -64.23 -41.32 92.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.088 -0.505 . . . . 0.80000000000000004 110.855 -176.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 23' ' ' TRP . 35.4 t -68.29 -40.92 81.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.412 0.625 . . . . 1.3500000000000001 109.775 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.2 tp -62.22 -50.03 73.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.095 -0.957 . . . . 1.1599999999999999 110.219 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -60.18 -36.81 78.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.966 -1.015 . . . . 3.8399999999999999 111.635 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.406 ' HB3' ' CE2' ' A' ' 23' ' ' TRP . 49.0 mmtt -73.3 -3.25 25.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.394 0.616 . . . . 1.1000000000000001 111.646 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 64.95 43.63 3.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.396 -1.274 . . . . 1.9199999999999999 110.648 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.486 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 19.1 m0 -105.14 162.79 18.67 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.742 -0.663 . . . . 0.40000000000000002 109.426 174.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 34.4 Cg_endo -67.92 -178.8 1.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.073 1.849 . . . . 0.44 110.75 171.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 16.7 mmt -80.66 127.89 73.88 Favored Pre-proline 0 C--N 1.322 -0.596 0 O-C-N 121.984 -0.447 . . . . 1.0 109.892 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HB3' HG22 ' A' ' 48' ' ' VAL . 22.0 Cg_exo -63.4 167.99 12.05 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.947 2.431 . . . . 0.46000000000000002 113.462 -174.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.5 t -86.6 140.37 29.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.952 -1.022 . . . . 0.29999999999999999 109.979 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.464 ' CD1' ' HZ ' ' A' ' 44' ' ' PHE . 69.4 m-85 -145.57 110.99 5.35 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.566 -0.531 . . . . 0.29999999999999999 109.566 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 72.7 ttt180 -158.68 130.37 6.56 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 110.359 -0.237 . . . . 3.6899999999999999 110.359 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.5 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 70.0 m -64.23 124.49 21.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.339 -0.392 . . . . 1.53 110.766 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -82.53 -32.59 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.248 0.547 . . . . 1.1499999999999999 110.362 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -136.37 124.21 22.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.568 -0.742 . . . . 2.25 109.475 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.557 ' HG2' ' CD1' ' A' ' 42' ' ' PHE . 3.1 tm-20 -148.0 127.34 13.07 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.672 -0.492 . . . . 2.6000000000000001 109.672 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.24 -177.84 52.12 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.834 -0.698 . . . . 1.6899999999999999 112.315 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.06 -148.99 19.51 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.688 -0.768 . . . . 2.1299999999999999 111.959 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.96 57.75 3.95 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 123.411 2.741 . . . . 3.0 112.663 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 70.01 -59.59 0.5 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.811 0.845 . . . . 2.6099999999999999 112.465 176.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -79.03 18.06 0.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.334 . . . . 2.1000000000000001 111.631 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -126.32 39.26 3.97 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.955 0.407 . . . . 1.28 110.812 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -88.29 18.23 4.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.495 0.664 . . . . 1.9299999999999999 110.198 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -85.6 138.68 32.0 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.726 -1.213 . . . . 3.6400000000000001 107.726 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.557 ' CD1' ' HG2' ' A' ' 33' ' ' GLU . 5.6 m-85 -110.57 131.65 54.87 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.103 0.477 . . . . 0.79000000000000004 110.387 -172.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.0 m -120.01 130.99 54.99 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.876 -1.157 . . . . 0.26000000000000001 107.876 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.727 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -137.94 151.79 48.33 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.642 -0.503 . . . . 0.17000000000000001 109.642 -173.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -125.47 136.47 9.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.232 -0.508 . . . . 0.17000000000000001 111.987 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.727 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.3 t -107.72 154.41 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 117.14 0.47 . . . . 0.80000000000000004 109.856 -175.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.56 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 10.9 ptt180 -149.51 145.23 26.75 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.681 -0.859 . . . . 2.6200000000000001 108.681 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.616 HG23 HD11 ' A' ' 78' ' ' LEU . 61.0 t -125.5 155.85 34.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.355 -0.384 . . . . 0.23999999999999999 110.394 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -95.12 83.87 3.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.601 0.715 . . . . 1.5900000000000001 110.37 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.456 HG22 ' CZ2' ' A' ' 23' ' ' TRP . 30.1 p -72.92 103.08 3.62 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.423 -1.262 . . . . 0.33000000000000002 108.944 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.9 t -46.06 -32.97 3.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.654 -0.703 . . . . 1.3200000000000001 112.858 -170.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -72.31 -22.57 61.16 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.753 0.649 . . . . 1.3 112.753 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -134.56 -45.69 0.75 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.022 -0.424 . . . . 3.6800000000000002 111.279 -175.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 126.64 -154.34 19.14 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.914 -0.584 . . . . 0.19 112.343 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.56 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 7.1 m95 -49.22 120.28 3.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.97 0.453 . . . . 0.39000000000000001 110.882 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 42.8 p -70.33 172.99 7.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.647 -0.706 . . . . 0.35999999999999999 111.418 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -61.05 131.84 51.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.883 -0.784 . . . . 1.8400000000000001 108.883 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 27.0 tt0 -64.64 114.96 4.76 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.342 0.591 . . . . 1.0 109.749 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 59.8 m -92.21 97.42 10.89 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.095 -0.957 . . . . 0.35999999999999999 110.258 -175.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.66 126.22 38.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.647 -0.706 . . . . 0.73999999999999999 110.361 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.22 -170.99 47.82 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.47 -0.787 . . . . 0.23000000000000001 111.727 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.607 ' O ' ' HG2' ' A' ' 64' ' ' MET . 41.4 mt-10 -88.36 152.07 49.45 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 110.281 -0.266 . . . . 1.3700000000000001 110.281 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.12 107.91 0.32 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.643 2.229 . . . . 0.51000000000000001 111.256 172.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.607 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 95.8 mmm -110.4 147.23 35.93 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.202 -0.454 . . . . 0.67000000000000004 110.482 -173.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.24 4.36 7.06 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.739 2.292 . . . . 0.32000000000000001 113.765 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.441 ' HB2' ' HG3' ' A' ' 69' ' ' LYS . 26.9 m -147.53 137.15 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.742 -0.466 . . . . 1.3 109.742 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.3 m -65.29 -28.77 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.178 -0.465 . . . . 1.1399999999999999 112.046 -171.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -71.19 -36.16 71.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.4 -0.364 . . . . 2.8199999999999998 110.454 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.441 ' HG3' ' HB2' ' A' ' 66' ' ' SER . 46.9 mtpt -74.47 -28.33 60.98 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.764 -0.458 . . . . 1.3600000000000001 109.764 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.49 -59.03 6.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.831 -0.622 . . . . 0.20999999999999999 110.623 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.632 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 56.8 mttm -53.6 -58.59 6.64 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.086 -0.506 . . . . 2.4199999999999999 111.471 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.589 ' O ' HG23 ' A' ' 76' ' ' VAL . 29.6 t70 -57.69 -42.37 83.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.656 -0.702 . . . . 2.0099999999999998 112.718 -173.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 m -70.31 -36.63 74.43 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 121.006 -0.278 . . . . 1.1399999999999999 111.418 -175.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.415 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -67.36 -42.89 82.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.613 0.721 . . . . 0.17999999999999999 109.541 174.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 79' ' ' LEU . . . -54.23 -34.67 61.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.48 -1.236 . . . . 0.26000000000000001 111.533 176.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 72' ' ' ASP . 98.3 t -64.56 -34.79 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.007 0.432 . . . . 0.82999999999999996 110.7 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.3 mt -74.6 -33.07 62.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.818 0.818 . . . . 0.39000000000000001 109.194 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.616 HD11 HG23 ' A' ' 48' ' ' VAL . 26.5 tp -64.1 -37.31 86.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.547 -1.206 . . . . 0.81000000000000005 110.272 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 20.8 mt -60.66 -28.27 68.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.233 -0.894 . . . . 1.6100000000000001 110.835 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 89.8 mt-10 -72.98 -36.69 67.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.042 0.448 . . . . 2.1299999999999999 110.027 178.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.2 tt -66.86 -46.22 75.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.645 0.735 . . . . 1.1699999999999999 109.052 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.456 ' HB3' HG21 ' A' ' 17' ' ' ILE . 3.8 mp -70.61 -11.35 60.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.915 -1.039 . . . . 1.1499999999999999 112.051 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -85.18 -4.46 59.16 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.592 0.71 . . . . 1.46 109.65 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 50.6 mttp -114.41 45.77 1.48 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.286 -0.87 . . . . 4.1699999999999999 109.621 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.0 p . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.902 -0.571 . . . . 3.79 111.183 -175.364 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 111.174 0.064 . . . . 2.4900000000000002 111.174 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -62.98 -45.28 93.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.773 0.32 . . . . 2.46 111.149 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.483 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.5 mp -62.19 -43.62 98.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.927 -0.579 . . . . 0.80000000000000004 110.72 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.416 ' SG ' HG13 ' A' ' 48' ' ' VAL . 34.4 t -69.3 -42.11 75.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.312 0.577 . . . . 1.3500000000000001 109.824 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.3 tp -61.8 -49.31 76.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.309 -0.859 . . . . 1.1599999999999999 110.398 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -63.97 -31.44 72.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.799 -1.091 . . . . 3.8399999999999999 111.395 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 27.7 mmmt -74.31 3.11 7.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.362 -0.381 . . . . 1.1000000000000001 111.459 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 67.69 27.95 7.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.306 -0.861 . . . . 1.9199999999999999 110.25 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -94.65 160.2 31.93 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.389 -0.823 . . . . 0.40000000000000002 109.429 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.49 -169.53 0.43 Allowed 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.178 1.919 . . . . 0.44 111.554 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.429 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 9.3 mmt -78.28 134.63 62.59 Favored Pre-proline 0 C--N 1.324 -0.542 0 O-C-N 122.163 -0.336 . . . . 1.0 110.649 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 16.7 Cg_exo -66.62 156.69 64.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.648 2.232 . . . . 0.46000000000000002 112.042 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.45 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 12.9 t -89.32 142.6 27.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.899 -0.591 . . . . 0.29999999999999999 110.082 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.477 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 62.6 m-85 -142.21 111.98 6.78 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.308 -0.627 . . . . 0.29999999999999999 109.308 -177.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.564 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 33.7 ttm180 -163.03 122.69 2.21 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.473 -0.566 . . . . 3.6899999999999999 109.473 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 73.8 m -61.77 131.33 49.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.196 0.522 . . . . 1.53 111.833 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.425 ' H ' ' HA ' ' A' ' 44' ' ' PHE . 27.2 m -82.98 -30.74 8.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.372 -0.831 . . . . 1.1499999999999999 110.357 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -135.12 124.88 25.35 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.539 -0.755 . . . . 2.25 110.125 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -151.16 141.06 21.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.542 -0.754 . . . . 2.6000000000000001 109.178 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.16 177.32 51.37 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.695 -0.764 . . . . 1.6899999999999999 113.311 173.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.16 -156.18 26.88 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.815 -0.914 . . . . 2.1299999999999999 110.815 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.43 -74.0 0.02 OUTLIER 'Trans proline' 0 CA--C 1.529 0.247 0 C-N-CA 122.498 2.132 . . . . 3.0 111.722 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -164.63 -41.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.994 -0.548 . . . . 2.6099999999999999 109.877 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -71.9 -4.02 25.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.758 -0.656 . . . . 2.1000000000000001 110.818 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -113.78 32.15 6.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.218 -0.446 . . . . 1.28 110.921 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.425 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 12.4 tptp -92.36 17.86 9.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.441 0.639 . . . . 1.9299999999999999 109.607 177.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -84.18 137.36 33.55 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.084 -1.45 . . . . 3.6400000000000001 107.084 169.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -109.47 134.27 52.08 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.253 0.549 . . . . 0.79000000000000004 110.45 -169.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.8 m -123.24 127.08 48.09 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.02 -1.104 . . . . 0.26000000000000001 108.02 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.676 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -138.47 154.4 48.83 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.789 -0.448 . . . . 0.17000000000000001 109.789 -171.045 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.44 ' CA ' HD13 ' A' ' 60' ' ' ILE . . . -127.41 137.39 9.83 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.209 -0.52 . . . . 0.17000000000000001 111.923 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.676 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.3 t -107.33 153.98 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 N-CA-C 108.853 -0.795 . . . . 0.80000000000000004 108.853 -176.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.544 ' O ' ' HZ3' ' A' ' 55' ' ' TRP . 11.3 ptt180 -143.63 146.77 33.52 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.521 -0.918 . . . . 2.6200000000000001 108.521 173.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.416 HG13 ' SG ' ' A' ' 18' ' ' CYS . 74.7 t -125.36 150.71 30.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.757 -0.656 . . . . 0.23999999999999999 109.688 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -91.63 84.51 5.49 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.458 0.647 . . . . 1.5900000000000001 109.686 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.3 p -71.71 109.87 5.89 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.627 -1.17 . . . . 0.33000000000000002 109.45 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 62.0 p -50.56 -22.54 2.02 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.731 -1.122 . . . . 1.3200000000000001 114.021 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -92.08 -15.63 27.52 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.374 0.509 . . . . 1.3 112.374 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -136.24 -40.47 0.66 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.097 -0.377 . . . . 3.6800000000000002 111.878 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.57 -154.45 16.95 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 121.282 -0.485 . . . . 0.19 112.801 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.544 ' HZ3' ' O ' ' A' ' 47' ' ' ARG . 30.1 m95 -57.75 123.42 15.62 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.396 0.617 . . . . 0.39000000000000001 111.265 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.0 p -74.48 152.85 39.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.138 -0.937 . . . . 0.35999999999999999 110.879 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -62.05 129.41 40.72 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.231 -0.655 . . . . 1.8400000000000001 109.231 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -50.63 125.01 12.01 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.445 -0.798 . . . . 1.0 112.985 -173.019 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.425 ' SG ' HD12 ' A' ' 81' ' ' LEU . 58.9 m -86.95 100.85 12.9 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.174 -1.375 . . . . 0.35999999999999999 108.865 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.44 HD13 ' CA ' ' A' ' 45' ' ' GLY . 29.2 mm -83.07 123.92 39.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.919 -0.582 . . . . 0.73999999999999999 110.703 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.84 -175.86 51.03 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 121.052 -0.594 . . . . 0.23000000000000001 112.002 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HG2' ' OG ' ' A' ' 73' ' ' SER . 11.1 pt-20 -87.02 149.46 47.69 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 110.167 -0.309 . . . . 1.3700000000000001 110.167 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.33 108.76 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.813 2.342 . . . . 0.51000000000000001 111.61 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.409 ' SD ' ' HG3' ' A' ' 69' ' ' LYS . 15.1 mmt -108.87 143.75 28.22 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.166 -0.47 . . . . 0.67000000000000004 110.964 -174.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -83.34 10.47 3.65 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.683 2.255 . . . . 0.32000000000000001 112.845 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.7 m -153.15 138.03 17.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.444 -0.576 . . . . 1.3 109.444 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 m -68.63 -25.76 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 112.253 0.464 . . . . 1.1399999999999999 112.253 -173.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -73.06 -41.39 64.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.672 0.272 . . . . 2.8199999999999998 111.075 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HG3' ' SD ' ' A' ' 64' ' ' MET . 7.2 ptmm? -82.08 -17.62 45.93 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.891 -0.323 . . . . 1.3600000000000001 110.334 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.93 -61.78 2.37 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.198 -0.455 . . . . 0.20999999999999999 111.175 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.653 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 0.0 OUTLIER -56.39 -42.58 78.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.589 0.233 . . . . 2.4199999999999999 111.09 177.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -53.44 -46.37 69.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.868 -0.605 . . . . 2.0099999999999998 112.199 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.645 ' O ' HG12 ' A' ' 76' ' ' VAL . 41.9 t -62.93 -45.07 94.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.039 0.447 . . . . 1.1399999999999999 111.185 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.419 ' HB1' HG23 ' A' ' 46' ' ' VAL . . . -68.34 -40.82 81.45 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.294 0.568 . . . . 0.17999999999999999 110.23 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.444 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -56.88 -37.57 71.56 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.274 -0.875 . . . . 0.26000000000000001 112.069 177.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.645 HG12 ' O ' ' A' ' 73' ' ' SER . 1.8 p -70.95 -26.82 28.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 O-C-N 121.917 -0.489 . . . . 0.82999999999999996 110.669 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.3 mt -78.79 -31.61 46.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.791 0.805 . . . . 0.39000000000000001 109.401 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.441 HD22 HG11 ' A' ' 46' ' ' VAL . 28.0 tp -66.88 -36.77 83.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.865 -1.061 . . . . 0.81000000000000005 110.461 175.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.6 mm? -61.21 -25.4 67.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.736 -0.666 . . . . 1.6100000000000001 110.861 175.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 44.6 mt-10 -71.71 -37.94 70.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.093 0.473 . . . . 2.1299999999999999 109.968 175.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.425 HD12 ' SG ' ' A' ' 59' ' ' CYS . 1.3 tt -62.99 -47.24 83.99 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.049 -0.723 . . . . 1.1699999999999999 109.049 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mp -74.39 0.91 12.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.191 -0.913 . . . . 1.1499999999999999 111.661 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -97.55 -14.24 21.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.763 0.792 . . . . 1.46 109.38 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 8.2 mtmp? -120.2 43.73 2.62 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.945 -1.025 . . . . 4.1699999999999999 110.188 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.251 1.134 0 CA-C-N 115.43 -0.805 . . . . 3.79 110.907 -179.569 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 111.826 0.306 . . . . 2.4900000000000002 111.826 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -70.4 -37.31 74.47 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 122.317 -0.239 . . . . 2.46 111.395 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.8 mp -63.95 -41.68 93.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.449 0.642 . . . . 0.80000000000000004 109.961 174.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.3 m -65.1 -42.91 93.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.029 -0.987 . . . . 1.3500000000000001 110.204 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.83 -51.98 67.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.877 -1.056 . . . . 1.1599999999999999 110.284 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -57.02 -37.08 71.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.398 -0.819 . . . . 3.8399999999999999 111.923 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -72.81 1.96 7.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.066 -0.515 . . . . 1.1000000000000001 111.975 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.2 t30 65.59 32.67 9.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.938 -1.028 . . . . 1.9199999999999999 109.699 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.469 ' CH2' HG22 ' A' ' 50' ' ' THR . 38.2 m0 -99.21 160.58 27.23 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.201 -0.909 . . . . 0.40000000000000002 109.367 175.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.42 170.65 18.78 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.126 1.884 . . . . 0.44 110.048 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 50.0 mmm -72.68 134.49 81.7 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 110.347 -0.242 . . . . 1.0 110.347 -175.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.517 ' HB3' HG22 ' A' ' 48' ' ' VAL . 23.6 Cg_exo -63.82 161.39 32.83 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.962 2.441 . . . . 0.46000000000000002 113.117 -177.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.571 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 16.6 t -87.63 141.49 28.57 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.961 -1.018 . . . . 0.29999999999999999 109.841 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.439 ' HD2' ' CZ ' ' A' ' 44' ' ' PHE . 78.6 m-85 -139.56 110.67 6.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.815 -0.809 . . . . 0.29999999999999999 108.815 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.445 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 26.7 ttm180 -153.39 123.45 6.95 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.972 -0.381 . . . . 3.6899999999999999 109.972 -176.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.481 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 62.5 m -61.87 124.93 22.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.136 0.493 . . . . 1.53 111.381 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.472 ' H ' ' HA ' ' A' ' 44' ' ' PHE . 53.3 t -80.74 -29.97 11.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.615 -0.72 . . . . 1.1499999999999999 109.784 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -134.93 129.7 34.69 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.883 -0.599 . . . . 2.25 110.22 178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -98.92 154.08 18.32 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.846 -1.07 . . . . 2.6000000000000001 109.892 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 40' ' ' LYS . . . -74.86 137.04 21.7 Favored Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.884 -0.674 . . . . 1.6899999999999999 112.687 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.06 -142.94 1.99 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.638 -0.315 . . . . 2.1299999999999999 112.976 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.58 -67.35 0.11 Allowed 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.997 3.131 . . . . 3.0 112.914 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.68 -41.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.994 0.426 . . . . 2.6099999999999999 109.949 175.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -71.74 5.97 2.22 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.748 -0.66 . . . . 2.1000000000000001 111.199 176.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.81 31.1 1.17 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.243 -0.435 . . . . 1.28 110.272 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.53 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 31.9 tptt -84.29 20.03 1.73 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.159 -0.473 . . . . 1.9299999999999999 111.901 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -83.58 135.93 34.44 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.688 -0.805 . . . . 3.6400000000000001 109.476 174.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 5.0 m-85 -109.87 136.26 49.45 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.311 -0.859 . . . . 0.79000000000000004 110.041 -173.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.3 m -118.44 125.91 50.93 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.938 -1.134 . . . . 0.26000000000000001 107.938 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.681 ' CZ ' ' HB ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -132.65 151.75 51.87 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 121.843 -0.535 . . . . 0.17000000000000001 109.802 -171.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.44 ' CA ' HD13 ' A' ' 60' ' ' ILE . . . -125.57 129.16 6.78 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.14 -0.784 . . . . 0.17000000000000001 111.14 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.681 ' HB ' ' CZ ' ' A' ' 44' ' ' PHE . 7.3 p -109.94 145.94 15.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 110.057 -0.349 . . . . 0.80000000000000004 110.057 -173.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.633 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 2.9 ptp180 -140.32 145.92 37.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.836 -0.802 . . . . 2.6200000000000001 108.836 -176.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.582 HG23 HD11 ' A' ' 78' ' ' LEU . 57.6 t -125.89 154.55 34.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.461 -0.336 . . . . 0.23999999999999999 110.29 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -93.85 83.92 4.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.61 0.719 . . . . 1.5900000000000001 110.086 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.469 HG22 ' CH2' ' A' ' 23' ' ' TRP . 30.2 p -70.96 116.43 11.25 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.523 -1.217 . . . . 0.33000000000000002 110.062 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 p -51.13 -25.72 5.6 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.583 -1.189 . . . . 1.3200000000000001 113.522 -172.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -92.95 -12.89 29.67 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.745 0.646 . . . . 1.3 112.745 -177.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -136.74 -42.03 0.6 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.792 -0.567 . . . . 3.6800000000000002 111.703 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.15 -152.83 17.12 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.891 -0.484 . . . . 0.19 111.891 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.633 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 9.4 m95 -54.15 117.78 3.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.119 0.485 . . . . 0.39000000000000001 110.956 176.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 56.1 p -69.59 150.6 46.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.436 -0.802 . . . . 0.35999999999999999 110.315 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -61.18 116.96 4.98 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 108.3 -1.0 . . . . 1.8400000000000001 108.3 171.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 3.9 pt-20 -55.39 140.57 39.38 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 114.802 -1.09 . . . . 1.0 111.934 -168.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 63.8 m -97.83 101.79 13.38 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.804 -1.089 . . . . 0.35999999999999999 109.458 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.44 HD13 ' CA ' ' A' ' 45' ' ' GLY . 25.6 mm -73.54 120.33 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.575 -0.739 . . . . 0.73999999999999999 110.143 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.58 -165.25 39.3 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.934 -0.65 . . . . 0.23000000000000001 112.265 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 64' ' ' MET . 43.6 mt-10 -80.69 139.56 50.76 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.926 -0.398 . . . . 1.3700000000000001 109.926 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 32.1 Cg_exo -57.96 110.38 0.62 Allowed 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.14 1.893 . . . . 0.51000000000000001 110.415 171.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.671 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 16.9 mmt -113.06 141.33 25.43 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.086 -0.507 . . . . 0.67000000000000004 111.312 -169.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.06 9.55 2.72 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.763 2.309 . . . . 0.32000000000000001 113.132 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.3 m -154.55 137.18 15.16 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.454 -0.573 . . . . 1.3 109.454 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.4 m -65.64 -34.18 68.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.295 0.85 . . . . 1.1399999999999999 113.295 -170.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -67.32 -40.94 86.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.589 0.233 . . . . 2.8199999999999998 111.459 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.671 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 0.5 OUTLIER -81.2 -20.2 41.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.844 0.354 . . . . 1.3600000000000001 110.451 -179.339 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.38 -61.41 2.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.24 -0.436 . . . . 0.20999999999999999 111.2 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.581 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 13.2 ptmm? -56.19 -43.75 78.75 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.051 0.453 . . . . 2.4199999999999999 110.674 176.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.477 ' O ' HG23 ' A' ' 76' ' ' VAL . 36.8 t70 -51.98 -47.05 65.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.113 -0.949 . . . . 2.0099999999999998 112.022 177.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.5 t -60.65 -47.53 85.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.612 0.244 . . . . 1.1399999999999999 111.606 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.04 -38.78 89.24 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.175 0.512 . . . . 0.17999999999999999 110.488 -177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.404 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -54.64 -37.25 65.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.238 -0.892 . . . . 0.26000000000000001 111.294 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.492 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 91.7 t -59.16 -42.05 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 CA-C-O 120.837 0.351 . . . . 0.82999999999999996 110.849 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.2 mt -77.17 -30.42 54.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.597 0.713 . . . . 0.39000000000000001 109.661 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.582 HD11 HG23 ' A' ' 48' ' ' VAL . 40.1 tp -65.73 -44.43 86.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.808 -1.087 . . . . 0.81000000000000005 111.052 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 75' ' ' ALA . 8.6 mp -63.3 -21.57 66.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.654 -0.703 . . . . 1.6100000000000001 111.493 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 8.6 mm-40 -73.71 -38.37 64.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.348 0.594 . . . . 2.1299999999999999 109.862 173.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 tt -66.78 -46.18 76.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.013 -0.994 . . . . 1.1699999999999999 109.382 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mp -65.29 -16.7 63.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.349 -0.841 . . . . 1.1499999999999999 112.338 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -83.99 -4.93 59.09 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.484 0.659 . . . . 1.46 109.799 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -121.76 39.76 3.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.523 -0.762 . . . . 4.1699999999999999 110.484 -176.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.603 -0.713 . . . . 3.79 110.298 -179.029 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 111.84 0.311 . . . . 2.4900000000000002 111.84 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -68.42 -46.35 70.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.992 0.425 . . . . 2.46 111.189 -174.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.476 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -66.7 -34.97 73.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.637 -0.71 . . . . 0.80000000000000004 109.968 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 22.5 m -66.92 -44.68 80.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.613 -0.721 . . . . 1.3500000000000001 109.747 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.1 tp -61.39 -46.83 88.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.713 -1.131 . . . . 1.1599999999999999 110.151 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -62.26 -36.15 81.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.654 -1.157 . . . . 3.8399999999999999 111.334 -177.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 11.0 mmmm -74.15 6.03 3.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 1.1000000000000001 111.611 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.4 t30 67.03 30.8 7.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.82 0.819 . . . . 1.9199999999999999 110.268 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -96.23 158.85 33.3 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.562 -0.744 . . . . 0.40000000000000002 109.277 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.88 -171.43 0.57 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.318 2.012 . . . . 0.44 111.515 173.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.443 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 26.9 mmt -75.95 138.88 69.19 Favored Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 110.063 -0.347 . . . . 1.0 110.063 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.521 ' HB3' HG22 ' A' ' 48' ' ' VAL . 6.3 Cg_exo -72.79 164.6 35.12 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.361 2.04 . . . . 0.46000000000000002 112.468 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.428 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 23.0 t -89.57 144.17 26.23 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.261 -0.881 . . . . 0.29999999999999999 109.941 178.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.512 ' HD2' ' CZ ' ' A' ' 44' ' ' PHE . 66.0 m-85 -139.6 111.08 7.11 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.625 -0.88 . . . . 0.29999999999999999 108.625 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.472 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 20.5 ttp-105 -144.79 119.95 10.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.88 -0.415 . . . . 3.6899999999999999 109.88 -173.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 21.3 p -66.98 124.55 23.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.098 0.475 . . . . 1.53 110.534 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 43' ' ' THR . 23.3 m -85.82 -41.5 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 116.106 -0.497 . . . . 1.1499999999999999 111.102 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -137.35 128.76 28.19 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.172 -0.211 . . . . 2.25 111.32 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -148.32 141.73 25.28 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.555 0.534 . . . . 2.6000000000000001 110.206 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.95 -57.67 5.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.621 -0.799 . . . . 1.6899999999999999 113.424 173.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.39 -144.36 48.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.677 -0.773 . . . . 2.1299999999999999 111.692 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.38 -52.53 6.22 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.884 2.389 . . . . 3.0 111.149 174.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 175.26 -41.85 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.061 -0.972 . . . . 2.6099999999999999 109.502 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -80.9 18.96 0.91 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.53 -0.759 . . . . 2.1000000000000001 111.644 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.15 61.37 0.91 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.065 0.459 . . . . 1.28 110.7 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -85.37 16.88 3.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 121.381 0.61 . . . . 1.9299999999999999 110.575 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -83.07 136.86 34.33 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.109 -1.441 . . . . 3.6400000000000001 107.109 169.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -109.89 130.8 55.48 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.393 -0.595 . . . . 0.79000000000000004 109.393 -172.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 31' ' ' VAL . 5.4 m -123.19 131.84 53.83 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 107.994 -1.113 . . . . 0.26000000000000001 107.994 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.728 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -142.35 155.75 45.18 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.588 -0.523 . . . . 0.17000000000000001 109.588 -174.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.535 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -128.74 139.66 11.16 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.9 -0.667 . . . . 0.17000000000000001 112.507 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.728 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -106.74 156.8 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 109.767 -0.457 . . . . 0.80000000000000004 109.767 -176.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.599 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 18.6 ptt180 -147.28 148.27 31.25 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.92 -0.77 . . . . 2.6200000000000001 108.92 172.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.537 HG23 HD11 ' A' ' 78' ' ' LEU . 86.0 t -127.31 154.79 38.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.296 -0.411 . . . . 0.23999999999999999 110.616 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -91.13 84.15 5.66 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.19 0.519 . . . . 1.5900000000000001 110.248 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.2 p -70.4 115.52 9.68 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.175 -0.92 . . . . 0.33000000000000002 109.611 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.2 p -51.04 -27.19 7.4 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.724 -1.125 . . . . 1.3200000000000001 113.404 -172.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -98.81 -8.43 25.86 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.601 0.593 . . . . 1.3 112.601 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -129.0 -47.66 1.23 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.871 -0.518 . . . . 3.6800000000000002 111.469 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.13 -151.69 17.23 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.648 -0.706 . . . . 0.19 111.795 -175.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.599 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.7 m95 -54.85 120.4 6.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.065 0.46 . . . . 0.39000000000000001 111.051 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.5 p -73.38 162.67 29.06 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.749 -0.66 . . . . 0.35999999999999999 111.288 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -60.0 129.41 41.66 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.314 -0.625 . . . . 1.8400000000000001 109.314 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -59.03 115.08 2.91 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.714 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.463 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 59.7 m -87.92 97.6 11.03 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.924 -1.035 . . . . 0.35999999999999999 110.037 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.535 HD13 ' HA3' ' A' ' 45' ' ' GLY . 32.3 mm -76.02 123.92 33.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.449 -0.796 . . . . 0.73999999999999999 110.417 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.06 -170.49 44.8 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.987 -0.625 . . . . 0.23000000000000001 112.021 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 64' ' ' MET . 44.5 mt-10 -89.14 150.82 45.83 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 110.045 -0.354 . . . . 1.3700000000000001 110.045 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.98 109.32 1.09 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.562 2.174 . . . . 0.51000000000000001 111.378 176.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.62 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 90.9 mmm -114.94 144.46 32.05 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.119 -0.491 . . . . 0.67000000000000004 110.207 -171.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.55 12.26 2.2 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.534 2.156 . . . . 0.32000000000000001 113.537 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.5 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 19.9 m -154.86 138.96 16.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.413 -0.588 . . . . 1.3 109.413 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -66.98 -28.17 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 112.769 0.655 . . . . 1.1399999999999999 112.769 -170.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -70.01 -42.08 73.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.833 0.349 . . . . 2.8199999999999998 110.92 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.5 ' HG2' ' HB2' ' A' ' 66' ' ' SER . 4.3 ptpp? -81.48 -18.1 46.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.421 -0.354 . . . . 1.3600000000000001 110.678 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.79 -59.24 5.75 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.45 -0.341 . . . . 0.20999999999999999 110.486 172.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.623 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 57.9 mttp -52.81 -47.06 67.91 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 116.325 -0.398 . . . . 2.4199999999999999 110.543 175.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -50.21 -50.0 50.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.416 -0.811 . . . . 2.0099999999999998 112.128 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.584 ' O ' HG12 ' A' ' 76' ' ' VAL . 45.2 t -61.37 -44.49 97.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.83 0.347 . . . . 1.1399999999999999 111.252 -177.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.502 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -68.64 -47.42 66.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.168 0.509 . . . . 0.17999999999999999 110.867 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.446 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -55.6 -36.55 67.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.403 -0.817 . . . . 0.26000000000000001 112.059 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 73' ' ' SER . 2.0 p -71.42 -27.66 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 121.205 0.526 . . . . 0.82999999999999996 110.617 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.9 mt -79.04 -31.83 44.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.727 0.775 . . . . 0.39000000000000001 109.436 175.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.537 HD11 HG23 ' A' ' 48' ' ' VAL . 28.6 tp -63.79 -35.29 80.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.107 -0.952 . . . . 0.81000000000000005 110.406 173.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.5 mm? -62.25 -22.65 66.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.565 -0.743 . . . . 1.6100000000000001 111.449 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -69.41 -38.0 77.71 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.318 0.58 . . . . 2.1299999999999999 109.715 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 85' ' ' THR . 0.9 OUTLIER -68.31 -31.17 70.4 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.225 1.012 . . . . 1.1699999999999999 109.635 179.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.3 mp -84.58 -3.18 58.32 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.145 -0.934 . . . . 1.1499999999999999 112.28 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -111.68 -17.15 13.07 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.586 0.708 . . . . 1.46 109.81 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -147.9 148.69 31.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.919 -1.037 . . . . 4.1699999999999999 108.913 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.482 -0.77 . . . . 3.79 110.772 -166.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.1 p30 . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.515 0.198 . . . . 2.4900000000000002 111.205 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -75.08 -41.93 57.78 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.576 0.213 . . . . 2.46 111.576 -173.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.7 mp -64.41 -39.78 86.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.148 0.499 . . . . 0.80000000000000004 109.883 174.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.454 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 68.5 m -64.78 -42.64 94.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.477 -0.783 . . . . 1.3500000000000001 109.969 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.66 -45.1 91.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.872 -1.058 . . . . 1.1599999999999999 110.543 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -65.52 -35.34 80.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.33 -0.85 . . . . 3.8399999999999999 111.068 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 9.1 mmmm -76.07 4.02 9.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.276 -0.42 . . . . 1.1000000000000001 111.162 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.6 t30 66.02 38.84 4.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.248 -0.887 . . . . 1.9199999999999999 110.27 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.454 ' CE3' ' HA ' ' A' ' 18' ' ' CYS . 37.9 m0 -104.04 156.62 35.44 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.414 -0.812 . . . . 0.40000000000000002 109.431 175.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.13 -172.84 0.94 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.36 2.04 . . . . 0.44 111.05 171.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.453 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 29.4 mmt -75.19 142.9 76.08 Favored Pre-proline 0 N--CA 1.447 -0.617 0 O-C-N 122.078 -0.389 . . . . 1.0 110.511 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HB3' HG22 ' A' ' 48' ' ' VAL . 3.1 Cg_exo -76.24 165.32 29.67 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.718 2.279 . . . . 0.46000000000000002 112.864 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.3 t -83.58 141.99 31.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.247 -0.888 . . . . 0.29999999999999999 110.059 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.474 ' CD1' ' HZ ' ' A' ' 44' ' ' PHE . 66.5 m-85 -145.98 110.18 4.98 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.034 -0.728 . . . . 0.29999999999999999 109.034 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.525 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 23.7 ttm180 -158.63 128.39 5.79 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.394 -0.225 . . . . 3.6899999999999999 110.394 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.542 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 86.4 m -63.34 123.48 18.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.846 0.355 . . . . 1.53 110.688 178.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -84.49 -34.27 9.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.298 0.57 . . . . 1.1499999999999999 109.805 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -136.01 116.48 13.74 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.581 -0.736 . . . . 2.25 109.294 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -152.03 134.02 14.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.327 -0.397 . . . . 2.6000000000000001 110.889 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 56.96 63.91 4.89 Favored Glycine 0 C--N 1.332 0.307 0 O-C-N 123.404 0.44 . . . . 1.6899999999999999 113.637 172.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 39' ' ' ALA . . . -94.74 -155.61 31.66 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.533 -0.841 . . . . 2.1299999999999999 112.054 176.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -70.49 74.55 1.6 Allowed 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.418 2.745 . . . . 3.0 113.097 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 69.26 -65.12 0.31 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.487 0.715 . . . . 2.6099999999999999 112.48 175.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -71.49 9.72 0.77 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.592 0.357 . . . . 2.1000000000000001 111.502 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.401 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . . . -129.27 40.9 3.55 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.952 0.406 . . . . 1.28 110.855 -177.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -94.66 9.74 37.63 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 122.212 1.006 . . . . 1.9299999999999999 108.818 169.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -85.18 132.24 34.32 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.553 -1.647 . . . . 3.6400000000000001 106.553 161.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 6.9 m-85 -110.23 131.86 54.68 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 120.368 -0.533 . . . . 0.79000000000000004 109.777 -169.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.1 m -122.2 132.02 54.23 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.813 -1.18 . . . . 0.26000000000000001 107.813 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.716 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -142.24 153.16 43.75 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.553 -0.536 . . . . 0.17000000000000001 109.553 -173.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.504 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -127.55 140.7 12.03 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.099 -0.572 . . . . 0.17000000000000001 112.327 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.716 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 2.1 t -105.91 156.36 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 109.605 -0.517 . . . . 0.80000000000000004 109.605 -175.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 56' ' ' THR . 5.3 tpp85 -142.64 145.57 33.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.558 -0.904 . . . . 2.6200000000000001 108.558 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.719 HG23 HD11 ' A' ' 78' ' ' LEU . 61.8 t -131.36 153.11 38.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 110.058 -0.349 . . . . 0.23999999999999999 110.058 177.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -96.29 85.14 3.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.442 0.639 . . . . 1.5900000000000001 110.015 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 54' ' ' GLY . 26.2 p -69.29 106.99 3.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.69 -1.141 . . . . 0.33000000000000002 109.106 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 t -49.77 -26.8 4.19 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.834 0.679 . . . . 1.3200000000000001 112.834 -171.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -88.17 -18.27 29.11 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.428 0.529 . . . . 1.3 112.428 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -129.82 -46.29 1.15 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.015 0.436 . . . . 3.6800000000000002 111.294 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 125.6 -156.04 19.19 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.933 -0.576 . . . . 0.19 112.607 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -52.28 119.72 4.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.22 0.533 . . . . 0.39000000000000001 110.89 175.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.458 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 46.3 p -68.95 -179.26 1.43 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.987 -1.006 . . . . 0.35999999999999999 112.487 -173.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.38 132.22 43.65 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.577 -0.898 . . . . 1.8400000000000001 108.577 171.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -64.81 114.44 4.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.581 0.705 . . . . 1.0 110.766 -177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.482 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 61.5 m -88.19 97.82 11.22 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.56 -1.2 . . . . 0.35999999999999999 109.999 -177.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.504 HD13 ' HA3' ' A' ' 45' ' ' GLY . 26.9 mm -81.58 122.03 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.666 -0.697 . . . . 0.73999999999999999 110.07 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.76 -171.0 47.76 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.073 -0.584 . . . . 0.23000000000000001 112.428 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.597 ' O ' ' HG2' ' A' ' 64' ' ' MET . 33.0 mt-10 -81.91 146.38 55.68 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 110.023 -0.362 . . . . 1.3700000000000001 110.023 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 27.7 Cg_exo -62.8 109.62 0.94 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.487 2.125 . . . . 0.51000000000000001 110.907 171.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.597 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 89.6 mmm -115.4 149.1 42.27 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 116.208 -0.451 . . . . 0.67000000000000004 110.081 -172.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.2 12.33 2.34 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.594 2.196 . . . . 0.32000000000000001 113.535 -177.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.445 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 30.0 t -154.99 142.2 19.41 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.658 -0.497 . . . . 1.3 109.658 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.6 m -68.2 -27.95 39.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.619 -0.718 . . . . 1.1399999999999999 111.946 -173.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -64.6 -50.53 66.84 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.245 0.545 . . . . 2.8199999999999998 110.851 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.445 ' HG2' ' HB3' ' A' ' 66' ' ' SER . 15.4 ptpt -79.66 -17.54 53.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.455 -0.793 . . . . 1.3600000000000001 110.708 -174.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.11 -54.28 47.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.20999999999999999 109.823 172.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.669 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 54.5 mtmt -56.05 -52.0 65.82 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.015 -0.539 . . . . 2.4199999999999999 111.018 176.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.602 ' O ' HG23 ' A' ' 76' ' ' VAL . 4.6 m-20 -53.74 -46.72 70.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.561 . . . . 2.0099999999999998 112.308 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.3 t -58.24 -46.01 86.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.946 0.403 . . . . 1.1399999999999999 110.981 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.536 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -69.01 -43.42 74.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.986 -0.552 . . . . 0.17999999999999999 110.491 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.464 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -54.49 -36.93 64.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.465 -0.789 . . . . 0.26000000000000001 111.4 176.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 72' ' ' ASP . 91.0 t -63.06 -37.96 80.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 121.119 0.485 . . . . 0.82999999999999996 110.293 178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.8 mt -77.85 -24.25 48.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.865 0.84 . . . . 0.39000000000000001 109.533 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.719 HD11 HG23 ' A' ' 48' ' ' VAL . 16.7 tp -69.15 -37.94 78.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.134 -0.939 . . . . 0.81000000000000005 110.468 171.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.3 mm? -65.14 -28.78 69.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.755 -0.657 . . . . 1.6100000000000001 112.146 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.617 ' O ' ' HG3' ' A' ' 84' ' ' LYS . 8.8 pt-20 -77.27 -31.61 55.02 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.887 -0.725 . . . . 2.1299999999999999 110.085 176.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.05 -47.69 85.21 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.708 -0.849 . . . . 1.1699999999999999 108.708 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mp -71.77 -4.38 27.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.12 -0.945 . . . . 1.1499999999999999 112.036 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -93.91 -14.48 25.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.601 0.715 . . . . 1.46 109.686 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 41.1 mtpt -112.64 40.44 2.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.062 -0.972 . . . . 4.1699999999999999 110.343 -176.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.509 -0.757 . . . . 3.79 110.542 -177.594 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.8 t30 . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.596 0.236 . . . . 2.4900000000000002 110.976 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.0 -42.07 99.75 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.801 0.334 . . . . 2.46 111.357 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.5 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -65.86 -39.21 84.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.083 -0.508 . . . . 0.80000000000000004 111.007 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.464 ' SG ' ' HE3' ' A' ' 23' ' ' TRP . 36.2 t -71.61 -39.06 70.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.754 0.787 . . . . 1.3500000000000001 109.157 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 tt -64.47 -46.26 83.82 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.552 -1.204 . . . . 1.1599999999999999 110.079 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -61.63 -31.5 71.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.025 -0.534 . . . . 3.8399999999999999 111.412 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt -73.12 -3.88 29.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.329 0.585 . . . . 1.1000000000000001 111.447 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.0 t30 64.51 30.77 12.8 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.511 -1.222 . . . . 1.9199999999999999 110.173 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.464 ' HE3' ' SG ' ' A' ' 18' ' ' CYS . 33.6 m0 -89.6 165.56 24.83 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.367 -0.833 . . . . 0.40000000000000002 109.088 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 36.9 Cg_endo -69.44 -176.6 1.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 121.973 1.782 . . . . 0.44 111.186 170.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.405 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 21.4 mmt -74.77 137.52 73.57 Favored Pre-proline 0 C--N 1.323 -0.566 0 O-C-N 122.257 -0.277 . . . . 1.0 110.366 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.479 ' HB3' HG22 ' A' ' 48' ' ' VAL . 9.5 Cg_exo -70.04 161.69 45.04 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.812 2.342 . . . . 0.46000000000000002 112.457 -177.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.5 t -88.12 138.03 31.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.411 -0.813 . . . . 0.29999999999999999 110.191 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.529 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 63.3 m-85 -143.78 111.28 5.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.651 -0.5 . . . . 0.29999999999999999 109.651 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.48 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 79.3 ttt180 -164.17 131.61 3.32 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.977 -0.379 . . . . 3.6899999999999999 109.977 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 8.8 p -64.53 130.6 44.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.054 0.454 . . . . 1.53 111.326 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.5 t -86.32 -28.45 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.666 -0.697 . . . . 1.1499999999999999 109.9 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -136.25 120.74 18.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.169 -0.678 . . . . 2.25 109.169 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.486 ' HG2' ' CD1' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -150.84 126.11 10.01 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.007 -0.542 . . . . 2.6000000000000001 109.775 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.65 165.65 39.59 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.601 -0.809 . . . . 1.6899999999999999 112.547 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.84 -155.57 26.85 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 111.567 -0.613 . . . . 2.1299999999999999 111.567 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.09 -71.44 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 123.378 2.719 . . . . 3.0 112.673 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.64 -47.85 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.216 0.532 . . . . 2.6099999999999999 109.86 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -80.84 18.48 0.99 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.517 -0.765 . . . . 2.1000000000000001 111.186 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -122.05 32.17 5.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.138 0.494 . . . . 1.28 110.85 -177.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 27.8 tptt -93.39 17.1 11.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 122.015 0.912 . . . . 1.9299999999999999 109.369 174.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -85.53 137.86 32.59 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.479 -1.237 . . . . 3.6400000000000001 107.948 167.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 8.2 m-85 -109.05 133.84 52.46 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.823 -0.626 . . . . 0.79000000000000004 110.438 -169.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.1 m -119.8 116.33 25.66 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 107.851 -1.166 . . . . 0.26000000000000001 107.851 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.71 ' CE2' ' HA ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -126.93 153.1 46.25 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.898 -0.408 . . . . 0.17000000000000001 109.898 -170.06 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -126.87 140.38 11.89 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.574 -0.61 . . . . 0.17000000000000001 111.574 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.75 HG11 HD22 ' A' ' 78' ' ' LEU . 1.7 t -105.66 156.1 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.636 -0.505 . . . . 0.80000000000000004 109.636 -175.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.729 ' HD2' ' O ' ' A' ' 56' ' ' THR . 0.4 OUTLIER -142.24 145.87 34.55 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.478 -0.934 . . . . 2.6200000000000001 108.478 177.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.652 HG23 HD11 ' A' ' 78' ' ' LEU . 38.8 t -132.08 150.71 33.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.544 -0.298 . . . . 0.23999999999999999 110.293 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -94.61 83.66 4.14 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.825 0.821 . . . . 1.5900000000000001 109.528 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.418 HG22 ' CH2' ' A' ' 23' ' ' TRP . 23.0 p -75.0 101.23 4.4 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.192 -1.367 . . . . 0.33000000000000002 109.21 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.8 t -43.76 -35.24 1.8 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.84 0.856 . . . . 1.3200000000000001 113.173 -170.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.86 -33.36 72.95 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.598 0.592 . . . . 1.3 112.598 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -131.12 -38.6 1.22 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.806 0.336 . . . . 3.6800000000000002 111.875 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.24 -151.96 16.88 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 116.253 -0.431 . . . . 0.19 112.272 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -52.91 126.24 19.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.172 0.51 . . . . 0.39000000000000001 110.858 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.729 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 37.4 p -74.2 -174.71 2.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.351 -0.84 . . . . 0.35999999999999999 112.372 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -76.62 169.92 17.39 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.82 -1.178 . . . . 1.8400000000000001 107.82 165.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -92.34 119.78 32.23 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.222 0.534 . . . . 1.0 111.372 -171.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.462 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 28.6 m -85.46 97.61 10.13 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.104 -0.953 . . . . 0.35999999999999999 109.293 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.411 HD13 ' HA3' ' A' ' 45' ' ' GLY . 26.4 mm -86.92 121.16 37.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.196 -0.456 . . . . 0.73999999999999999 110.613 -177.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.64 -174.47 49.94 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.835 -0.698 . . . . 0.23000000000000001 111.519 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.657 ' O ' ' HG2' ' A' ' 64' ' ' MET . 42.8 mm-40 -85.89 148.41 48.21 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.687 0.244 . . . . 1.3700000000000001 110.452 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 40.7 Cg_exo -57.26 109.14 0.42 Allowed 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.571 2.18 . . . . 0.51000000000000001 111.186 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.657 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.0 mmm -117.32 149.97 45.55 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.692 -0.484 . . . . 0.67000000000000004 109.692 -172.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -80.77 15.01 1.9 Allowed 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.539 2.16 . . . . 0.32000000000000001 114.817 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.1 t -163.8 145.87 9.35 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.96 -0.463 . . . . 1.3 110.402 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 87.4 t -59.18 -50.98 77.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.315 0.487 . . . . 1.1399999999999999 112.315 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -55.57 -43.81 76.27 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.202 0.445 . . . . 2.8199999999999998 112.202 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.88 -21.89 40.26 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.991 -0.284 . . . . 1.3600000000000001 110.607 -178.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.91 -56.15 19.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.756 -0.202 . . . . 0.20999999999999999 111.039 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.71 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 32.3 pttt -56.6 -42.04 78.04 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 120.917 0.389 . . . . 2.4199999999999999 110.129 177.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.505 ' O ' HG23 ' A' ' 76' ' ' VAL . 31.3 t70 -54.17 -47.7 71.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.544 -0.753 . . . . 2.0099999999999998 112.068 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.4 t -60.09 -45.84 91.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.34 . . . . 1.1399999999999999 111.457 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.451 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -69.87 -40.6 75.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.039 0.447 . . . . 0.17999999999999999 110.925 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.431 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -52.52 -33.97 47.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.505 -0.771 . . . . 0.26000000000000001 111.307 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 72' ' ' ASP . 96.9 t -61.24 -37.41 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.967 0.413 . . . . 0.82999999999999996 110.739 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.1 mt -77.29 -33.09 55.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.75 0.785 . . . . 0.39000000000000001 109.597 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.75 HD22 HG11 ' A' ' 46' ' ' VAL . 15.3 tp -65.5 -40.83 93.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.716 -1.129 . . . . 0.81000000000000005 110.58 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.431 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.2 mp -61.57 -26.14 67.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.435 -0.802 . . . . 1.6100000000000001 111.045 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.82 -35.55 62.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.239 0.543 . . . . 2.1299999999999999 110.076 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.41 -46.17 77.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.35 -0.841 . . . . 1.1699999999999999 109.329 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mp -70.45 -9.8 57.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.295 -0.866 . . . . 1.1499999999999999 111.971 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -86.41 -7.54 58.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.679 0.752 . . . . 1.46 109.456 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -113.5 44.73 1.53 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.217 -0.901 . . . . 4.1699999999999999 109.896 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.8 p . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.487 -0.768 . . . . 3.79 110.339 -179.402 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.5 p30 . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 111.425 0.158 . . . . 2.4900000000000002 111.425 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.4 -44.69 78.21 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.816 0.302 . . . . 2.46 111.816 -172.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.464 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.7 mp -66.02 -35.83 76.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.041 0.448 . . . . 0.80000000000000004 110.52 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.433 ' SG ' HG13 ' A' ' 48' ' ' VAL . 47.3 t -69.54 -40.52 76.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.631 0.729 . . . . 1.3500000000000001 109.512 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.1 tp -63.73 -49.53 72.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.867 -1.061 . . . . 1.1599999999999999 110.661 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -61.0 -36.63 79.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.383 -0.826 . . . . 3.8399999999999999 111.745 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -73.29 8.75 1.55 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 1.1000000000000001 111.985 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.3 t30 60.21 34.67 21.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.261 -0.881 . . . . 1.9199999999999999 110.065 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.627 ' HD1' ' HG ' ' A' ' 51' ' ' SER . 41.6 m0 -97.12 163.34 20.17 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 114.93 -1.032 . . . . 0.40000000000000002 108.818 174.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 44.3 Cg_endo -70.0 -168.33 0.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.029 1.819 . . . . 0.44 111.497 173.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.7 mmt -80.18 136.26 53.7 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.97 -0.381 . . . . 1.0 109.97 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HB3' HG22 ' A' ' 48' ' ' VAL . 6.4 Cg_exo -71.42 162.8 41.18 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.597 2.198 . . . . 0.46000000000000002 112.24 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.7 t -87.36 140.14 29.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.568 -0.742 . . . . 0.29999999999999999 109.759 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.562 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 66.4 m-85 -140.8 109.82 6.13 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.265 -1.013 . . . . 0.29999999999999999 108.265 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.584 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 33.8 ptt180 -145.24 130.71 18.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.891 0.377 . . . . 3.6899999999999999 110.524 -173.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.53 ' SG ' ' HB2' ' A' ' 33' ' ' GLU . 43.9 t -65.76 119.84 11.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.201 -0.454 . . . . 1.53 110.529 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.3 t -86.73 -42.93 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.975 -0.557 . . . . 1.1499999999999999 110.737 -177.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -137.83 126.82 24.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.751 0.31 . . . . 2.25 110.664 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.571 ' HG3' ' CD1' ' A' ' 42' ' ' PHE . 40.2 tt0 -150.13 141.01 22.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.849 -0.614 . . . . 2.6000000000000001 109.699 175.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.68 -161.84 46.58 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.555 -0.831 . . . . 1.6899999999999999 112.687 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.59 -149.17 20.75 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.07 -0.812 . . . . 2.1299999999999999 111.07 -174.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -52.17 -65.75 0.13 Allowed 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 123.018 2.478 . . . . 3.0 111.884 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -173.41 -41.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.291 0.567 . . . . 2.6099999999999999 109.784 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -81.35 19.11 1.01 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.579 -0.737 . . . . 2.1000000000000001 111.528 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -119.42 43.13 2.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.972 0.415 . . . . 1.28 111.655 -173.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -87.98 17.16 5.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.616 0.722 . . . . 1.9299999999999999 109.69 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -85.75 132.99 34.02 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.799 -1.186 . . . . 3.6400000000000001 107.799 169.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.571 ' CD1' ' HG3' ' A' ' 33' ' ' GLU . 6.8 m-85 -109.0 141.2 41.45 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.966 0.413 . . . . 0.79000000000000004 110.57 -169.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.4 m -129.93 124.77 33.89 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.551 -0.75 . . . . 0.26000000000000001 109.172 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.691 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -132.96 156.89 46.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.652 -0.499 . . . . 0.17000000000000001 109.652 -173.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -130.12 142.06 13.29 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.912 -0.661 . . . . 0.17000000000000001 112.015 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.691 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.5 t -105.36 156.29 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 117.027 0.413 . . . . 0.80000000000000004 110.286 -174.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.519 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -137.01 142.04 42.51 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.928 -1.138 . . . . 2.6200000000000001 107.928 178.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.474 HG23 HD11 ' A' ' 78' ' ' LEU . 39.6 t -132.68 149.96 32.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 110.609 -0.145 . . . . 0.23999999999999999 110.609 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -99.86 88.43 3.78 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.632 0.73 . . . . 1.5900000000000001 110.889 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.5 p -68.52 113.33 5.96 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.38 -1.282 . . . . 0.33000000000000002 109.634 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.627 ' HG ' ' HD1' ' A' ' 23' ' ' TRP . 52.3 m -49.22 -25.99 2.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.311 -0.858 . . . . 1.3200000000000001 113.265 -176.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -93.45 -16.78 24.18 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.527 0.566 . . . . 1.3 112.527 -176.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -134.9 -46.72 0.73 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.035 0.445 . . . . 3.6800000000000002 111.315 -172.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.12 -156.59 19.08 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.8 -0.636 . . . . 0.19 112.698 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.519 ' CZ3' ' HB3' ' A' ' 47' ' ' ARG . 20.4 m95 -52.77 121.75 7.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.149 0.5 . . . . 0.39000000000000001 111.312 176.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 42.3 p -73.42 177.41 5.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.478 -0.783 . . . . 0.35999999999999999 111.912 -175.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -66.88 133.07 49.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.076 -0.713 . . . . 1.8400000000000001 109.076 172.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.477 ' HB2' ' NH1' ' A' ' 47' ' ' ARG . 26.0 tt0 -65.39 110.75 2.76 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.24 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.494 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 62.0 m -84.89 97.65 9.88 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.567 -1.197 . . . . 0.35999999999999999 109.913 -177.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.478 HD13 ' HA3' ' A' ' 45' ' ' GLY . 32.1 mm -76.96 124.13 34.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.428 -0.805 . . . . 0.73999999999999999 110.599 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.75 -170.28 46.87 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.922 -0.581 . . . . 0.23000000000000001 112.657 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.621 ' O ' ' HG2' ' A' ' 64' ' ' MET . 36.6 mt-10 -83.93 151.34 60.55 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-O 120.603 0.239 . . . . 1.3700000000000001 110.995 -175.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.71 99.22 0.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.754 2.303 . . . . 0.51000000000000001 110.961 170.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.621 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 92.4 mmm -113.59 138.64 22.68 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.514 -0.312 . . . . 0.67000000000000004 110.561 -170.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.79 7.35 2.82 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.669 2.246 . . . . 0.32000000000000001 113.422 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.4 t -144.85 136.79 25.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.113 -0.699 . . . . 1.3 109.113 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.23 -28.11 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.897 -0.592 . . . . 1.1399999999999999 111.726 -175.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -67.99 -43.21 79.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.11 -0.495 . . . . 2.8199999999999998 110.481 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 43.5 mtpt -74.21 -26.29 60.17 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.077 -0.511 . . . . 1.3600000000000001 109.745 -176.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.73 -58.98 6.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.875 -0.602 . . . . 0.20999999999999999 110.581 176.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.669 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 66.3 mttm -54.1 -51.72 63.27 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.391 -0.368 . . . . 2.4199999999999999 111.07 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.56 ' O ' HG23 ' A' ' 76' ' ' VAL . 18.3 m-20 -53.45 -49.04 68.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.828 -0.624 . . . . 2.0099999999999998 112.672 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.5 p -64.13 -38.68 91.93 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.922 -0.311 . . . . 1.1399999999999999 111.253 -175.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.422 ' HB1' HG23 ' A' ' 46' ' ' VAL . . . -67.83 -46.18 72.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.31 0.576 . . . . 0.17999999999999999 110.301 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.493 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -53.31 -36.4 61.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.9 -1.046 . . . . 0.26000000000000001 111.628 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 72' ' ' ASP . 96.1 t -63.83 -36.95 78.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.946 0.403 . . . . 0.82999999999999996 110.763 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.7 mt -77.92 -28.9 49.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.738 0.78 . . . . 0.39000000000000001 109.833 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.583 HD22 HG11 ' A' ' 46' ' ' VAL . 19.3 tp -66.54 -45.1 80.53 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.954 -1.021 . . . . 0.81000000000000005 110.589 173.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.493 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.0 mp -62.96 -30.75 71.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.441 -0.799 . . . . 1.6100000000000001 112.358 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -78.87 -30.84 45.29 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.013 -0.675 . . . . 2.1299999999999999 110.389 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.7 tt -65.19 -45.0 86.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.673 -0.862 . . . . 1.1699999999999999 108.673 174.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mp -65.53 -20.65 66.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.928 -1.033 . . . . 1.1499999999999999 111.878 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -87.38 -4.83 59.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.778 0.799 . . . . 1.46 109.172 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -115.9 38.52 3.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.255 -0.884 . . . . 4.1699999999999999 109.574 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.8 p . . . . . 0 C--O 1.249 1.041 0 CA-C-N 115.111 -0.95 . . . . 3.79 110.96 -177.821 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 120.297 0.094 . . . . 2.4900000000000002 111.152 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -65.67 -42.59 91.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.396 0.141 . . . . 2.46 111.146 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.4 mp -59.62 -41.56 85.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.869 0.366 . . . . 0.80000000000000004 110.593 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.0 t -71.86 -42.23 67.12 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.925 -0.579 . . . . 1.3500000000000001 109.955 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.9 tp -61.92 -48.73 79.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.282 -0.872 . . . . 1.1599999999999999 110.443 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -56.61 -37.36 70.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.954 -1.021 . . . . 3.8399999999999999 111.854 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -73.45 0.37 12.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.291 -0.413 . . . . 1.1000000000000001 111.426 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.5 t30 70.99 20.26 5.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.206 -0.906 . . . . 1.9199999999999999 110.172 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -86.81 158.57 53.42 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.433 -0.803 . . . . 0.40000000000000002 109.723 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.94 -168.82 0.25 Allowed 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 122.425 2.084 . . . . 0.44 111.449 174.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 7.2 mmt -83.6 134.93 44.0 Favored Pre-proline 0 C--N 1.322 -0.624 0 O-C-N 122.032 -0.417 . . . . 1.0 109.91 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.479 ' HB3' HG22 ' A' ' 48' ' ' VAL . 15.8 Cg_exo -67.14 166.99 21.26 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.807 2.338 . . . . 0.46000000000000002 113.133 -177.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.523 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 33.0 t -84.74 144.01 28.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.998 -1.001 . . . . 0.29999999999999999 109.898 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.494 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 72.4 m-85 -142.96 110.78 5.91 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.826 -0.805 . . . . 0.29999999999999999 108.826 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.499 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 45.6 ttm105 -156.64 124.14 5.4 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.522 -0.547 . . . . 3.6899999999999999 109.522 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -69.23 128.0 35.08 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.062 -0.517 . . . . 1.53 110.184 -176.559 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.85 -33.92 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.287 0.565 . . . . 1.1499999999999999 109.625 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -134.94 128.58 32.79 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.418 -0.81 . . . . 2.25 109.605 171.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -145.58 138.77 26.23 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.847 -0.427 . . . . 2.6000000000000001 109.847 175.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.47 -150.8 44.0 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.233 -0.984 . . . . 1.6899999999999999 111.902 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.31 -162.06 12.89 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 110.455 -1.058 . . . . 2.1299999999999999 110.455 -173.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 39' ' ' ALA . 32.0 Cg_exo -60.53 160.49 23.91 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.338 2.025 . . . . 3.0 112.132 177.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.32 -45.6 54.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.153 0.427 . . . . 2.6099999999999999 112.153 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -71.71 -13.99 61.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 2.1000000000000001 111.742 -177.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.427 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . . . -117.01 38.4 3.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.804 0.335 . . . . 1.28 111.3 -174.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -84.14 20.39 1.59 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.11 0.481 . . . . 1.9299999999999999 110.551 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -82.67 139.59 33.61 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.77 -1.196 . . . . 3.6400000000000001 107.77 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 7.5 m-85 -111.14 130.82 55.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.112 0.482 . . . . 0.79000000000000004 110.028 -173.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.4 m -118.47 127.59 53.8 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.874 -1.158 . . . . 0.26000000000000001 107.874 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.7 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -138.5 150.58 46.55 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.317 -0.623 . . . . 0.17000000000000001 109.317 -174.14 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.31 141.08 12.26 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.915 -0.66 . . . . 0.17000000000000001 112.313 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.7 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -107.37 156.05 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.628 -0.508 . . . . 0.80000000000000004 109.628 -176.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.632 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 16.7 ptp180 -145.67 147.82 32.39 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.806 -0.813 . . . . 2.6200000000000001 108.806 173.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.637 HG23 HD11 ' A' ' 78' ' ' LEU . 94.2 t -124.79 152.26 30.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 123.086 0.241 . . . . 0.23999999999999999 110.64 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -95.14 85.25 4.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.708 0.766 . . . . 1.5900000000000001 110.146 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.1 p -67.26 112.9 4.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.346 -1.297 . . . . 0.33000000000000002 109.365 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -52.48 -26.46 12.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.659 -0.7 . . . . 1.3200000000000001 112.215 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -94.85 -16.42 22.93 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.506 0.558 . . . . 1.3 112.506 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -132.63 -46.55 0.88 Allowed 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.934 -0.479 . . . . 3.6800000000000002 111.493 -175.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.13 -158.07 20.9 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.13 -0.557 . . . . 0.19 113.142 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.632 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.1 m95 -52.48 118.53 3.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.863 0.364 . . . . 0.39000000000000001 110.719 175.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.4 p -71.75 161.35 31.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.786 -0.643 . . . . 0.35999999999999999 111.005 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -61.66 125.77 24.98 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.131 -0.692 . . . . 1.8400000000000001 109.131 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.417 ' HG2' HD12 ' A' ' 60' ' ' ILE . 33.5 tt0 -59.49 124.81 21.28 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.246 -0.888 . . . . 1.0 111.245 -173.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 52.7 m -96.75 99.09 10.7 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.73 -1.123 . . . . 0.35999999999999999 110.361 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.417 HD12 ' HG2' ' A' ' 58' ' ' GLU . 1.7 mp -76.57 126.93 37.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.918 -0.583 . . . . 0.73999999999999999 110.37 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.57 -166.82 41.88 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.436 -0.802 . . . . 0.23000000000000001 112.634 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 46.9 mt-10 -91.24 135.94 27.7 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 110.096 -0.335 . . . . 1.3700000000000001 110.096 -178.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 50.4 Cg_exo -54.8 115.23 2.27 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.101 2.534 . . . . 0.51000000000000001 112.174 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 14.7 mmt -112.93 152.22 44.71 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.766 -0.652 . . . . 0.67000000000000004 111.236 -172.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -85.25 9.88 3.95 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.666 2.244 . . . . 0.32000000000000001 112.911 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -155.63 138.63 15.44 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.477 -0.564 . . . . 1.3 109.477 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.06 -27.88 42.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.588 -0.733 . . . . 1.1399999999999999 112.748 -170.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -72.17 -42.3 66.07 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.822 -0.351 . . . . 2.8199999999999998 111.045 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -80.74 -18.01 49.16 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.914 -0.315 . . . . 1.3600000000000001 110.316 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.39 -59.22 5.47 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.337 -0.392 . . . . 0.20999999999999999 110.391 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.628 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 8.9 mtmp? -51.85 -47.1 64.58 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 116.303 -0.408 . . . . 2.4199999999999999 111.16 175.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.545 ' O ' HG23 ' A' ' 76' ' ' VAL . 15.0 m-20 -50.86 -51.56 50.13 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.404 0.44 . . . . 2.0099999999999998 112.074 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.9 t -60.66 -43.75 97.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.638 0.256 . . . . 1.1399999999999999 111.249 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.64 -43.0 77.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.074 0.464 . . . . 0.17999999999999999 110.53 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.471 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -54.24 -38.19 65.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.338 -0.846 . . . . 0.26000000000000001 111.454 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 72' ' ' ASP . 99.0 t -65.37 -36.53 77.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-O 120.815 0.34 . . . . 0.82999999999999996 110.757 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.7 mt -73.95 -34.43 64.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.784 0.802 . . . . 0.39000000000000001 109.208 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.637 HD11 HG23 ' A' ' 48' ' ' VAL . 28.5 tp -65.51 -43.05 91.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.401 -1.272 . . . . 0.81000000000000005 110.887 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.2 mp -62.57 -24.94 67.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.704 -0.68 . . . . 1.6100000000000001 111.134 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 76' ' ' VAL . 39.5 mt-10 -74.01 -39.52 63.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.159 0.504 . . . . 2.1299999999999999 109.68 175.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.99 -51.7 65.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.331 -0.85 . . . . 1.1699999999999999 110.324 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.534 HD11 HG21 ' A' ' 48' ' ' VAL . 34.6 mt -65.76 -18.1 65.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.578 -1.192 . . . . 1.1499999999999999 111.594 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -88.98 -1.62 58.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.04 0.924 . . . . 1.46 109.352 176.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 28.4 mtpp -107.46 -146.55 0.4 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.564 -1.198 . . . . 4.1699999999999999 108.763 175.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.25 1.131 0 O-C-N 124.373 1.046 . . . . 3.79 112.591 176.374 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 . . . . . 0 N--CA 1.485 1.292 0 N-CA-C 111.878 0.325 . . . . 2.4900000000000002 111.878 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -66.68 -41.65 87.77 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.884 0.374 . . . . 2.46 111.478 -171.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.8 mp -69.29 -42.61 81.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.193 -0.458 . . . . 0.80000000000000004 110.807 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.62 ' SG ' ' HG3' ' A' ' 26' ' ' PRO . 42.8 t -60.21 -38.78 84.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.572 0.701 . . . . 1.3500000000000001 109.985 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.5 tp -63.78 -43.99 94.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.767 -1.106 . . . . 1.1599999999999999 110.355 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -66.9 -33.12 74.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.652 -1.158 . . . . 3.8399999999999999 111.529 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 28.9 mmmt -73.95 6.54 3.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 1.1000000000000001 111.469 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.0 t30 61.9 28.75 17.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.132 -0.94 . . . . 1.9199999999999999 110.522 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.488 ' CH2' HG22 ' A' ' 50' ' ' THR . 37.1 m0 -91.03 162.92 31.37 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.487 -0.779 . . . . 0.40000000000000002 109.051 174.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HG3' HD22 ' A' ' 49' ' ' ASN . 33.9 Cg_endo -67.45 -170.31 0.25 Allowed 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 121.984 1.79 . . . . 0.44 111.535 173.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.44 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 1.6 mmt -81.8 130.98 58.73 Favored Pre-proline 0 C--N 1.321 -0.643 0 O-C-N 122.036 -0.415 . . . . 1.0 110.281 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.62 ' HG3' ' SG ' ' A' ' 18' ' ' CYS . 11.0 Cg_exo -68.46 168.01 20.87 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.632 2.221 . . . . 0.46000000000000002 112.192 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.8 t -88.82 137.56 32.21 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.543 -0.753 . . . . 0.29999999999999999 110.052 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.49 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 84.9 m-85 -146.46 109.35 4.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.632 -0.507 . . . . 0.29999999999999999 109.632 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.436 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 78.9 ttt180 -160.07 130.17 5.41 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 110.066 -0.346 . . . . 3.6899999999999999 110.066 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.431 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 63.5 m -61.78 126.42 27.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.076 0.465 . . . . 1.53 110.809 -178.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.22 -39.58 12.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.804 -0.634 . . . . 1.1499999999999999 111.326 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 32.3 mmtt -136.8 171.34 14.65 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.022 0.439 . . . . 2.25 111.884 -173.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -149.67 158.41 44.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.134 -0.939 . . . . 2.6000000000000001 109.264 -175.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.45 -78.98 0.2 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.494 -0.86 . . . . 1.6899999999999999 113.801 -173.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.92 -126.47 1.94 Allowed Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.424 -0.67 . . . . 2.1299999999999999 111.424 -171.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -67.18 -172.2 0.33 Allowed 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 123.887 3.058 . . . . 3.0 112.362 173.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.97 -37.9 72.24 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.459 0.54 . . . . 2.6099999999999999 112.459 -174.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -73.08 -13.16 61.15 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.221 0.452 . . . . 2.1000000000000001 112.221 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -126.69 99.16 5.66 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.048 -0.353 . . . . 1.28 110.048 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -128.3 20.92 6.22 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.276 -0.638 . . . . 1.9299999999999999 109.276 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.598 ' HD3' ' H ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -83.74 131.96 34.88 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.002 -0.679 . . . . 3.6400000000000001 109.624 -177.157 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -109.54 139.88 44.0 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.96 -1.018 . . . . 0.79000000000000004 109.448 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 32' ' ' LYS . 32.9 m -123.66 123.77 41.29 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.462 -0.94 . . . . 0.26000000000000001 108.462 -175.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.662 ' CZ ' ' HB ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -125.82 152.27 45.67 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.609 -0.515 . . . . 0.17000000000000001 109.609 -173.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.22 126.94 5.92 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.455 -0.658 . . . . 0.17000000000000001 111.455 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.662 ' HB ' ' CZ ' ' A' ' 44' ' ' PHE . 7.4 p -109.27 149.26 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 110.002 -0.37 . . . . 0.80000000000000004 110.002 -176.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.559 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 11.2 ptt180 -145.14 150.48 36.85 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.017 -0.735 . . . . 2.6200000000000001 109.017 176.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 26' ' ' PRO . 67.4 t -125.99 155.45 35.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.022 -0.535 . . . . 0.23999999999999999 111.005 -176.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.403 HD22 ' HG3' ' A' ' 24' ' ' PRO . 54.9 t30 -95.6 83.78 3.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.758 0.789 . . . . 1.5900000000000001 110.061 178.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.488 HG22 ' CH2' ' A' ' 23' ' ' TRP . 24.9 p -69.56 112.24 5.93 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.163 -1.38 . . . . 0.33000000000000002 109.446 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.5 t -50.74 -23.61 2.82 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.961 0.726 . . . . 1.3200000000000001 112.961 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -77.89 -29.54 50.29 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.129 0.789 . . . . 1.3 113.129 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -138.11 -36.62 0.59 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.599 -0.441 . . . . 3.6800000000000002 111.977 -173.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.6 -147.86 17.29 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.904 -0.665 . . . . 0.19 112.663 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.559 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.3 m95 -49.8 119.93 3.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.315 0.579 . . . . 0.39000000000000001 111.891 177.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -73.91 167.12 22.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.248 -0.887 . . . . 0.35999999999999999 110.721 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -63.06 128.57 36.47 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.259 -0.645 . . . . 1.8400000000000001 109.259 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.39 114.44 3.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.566 0.698 . . . . 1.0 110.511 -176.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.1 m -90.93 102.63 15.4 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.707 -1.133 . . . . 0.35999999999999999 110.328 -175.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.08 122.25 26.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.649 -0.705 . . . . 0.73999999999999999 110.228 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -78.36 -173.14 41.61 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.687 -0.688 . . . . 0.23000000000000001 112.566 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 64' ' ' MET . 50.6 mt-10 -86.15 137.6 35.01 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 110.289 -0.263 . . . . 1.3700000000000001 110.289 -177.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.07 104.92 0.13 Allowed 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 123.071 2.514 . . . . 0.51000000000000001 111.566 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.651 ' SD ' ' HE2' ' A' ' 69' ' ' LYS . 16.5 mmt -113.15 147.36 37.15 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.578 -0.737 . . . . 0.67000000000000004 111.133 -172.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.71 13.21 2.17 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.717 2.278 . . . . 0.32000000000000001 113.241 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.8 t -155.61 138.91 15.71 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.451 -0.574 . . . . 1.3 109.451 178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.06 -23.23 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.146 -0.479 . . . . 1.1399999999999999 112.244 -172.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -71.45 -45.33 62.88 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.748 0.309 . . . . 2.8199999999999998 110.786 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.651 ' HE2' ' SD ' ' A' ' 64' ' ' MET . 19.0 ptmt -81.79 -16.94 49.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.367 -0.379 . . . . 1.3600000000000001 110.377 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.78 -56.0 27.1 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.018 -0.537 . . . . 0.20999999999999999 109.868 173.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.603 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 56.6 mtpt -49.91 -51.59 39.59 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 115.995 -0.548 . . . . 2.4199999999999999 111.543 174.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.575 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.7 m-20 -51.96 -47.48 64.78 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.765 0.654 . . . . 2.0099999999999998 112.765 -177.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 83.9 p -62.78 -39.14 93.29 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.69 -0.404 . . . . 1.1399999999999999 111.251 -176.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.6 -38.97 70.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.304 0.573 . . . . 0.17999999999999999 110.025 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.57 -30.75 69.98 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.389 -0.823 . . . . 0.26000000000000001 111.54 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 72' ' ' ASP . 96.1 t -70.35 -32.59 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.191 0.52 . . . . 0.82999999999999996 110.31 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.6 mt -73.86 -27.48 61.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.042 0.925 . . . . 0.39000000000000001 109.218 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.511 HD11 HG23 ' A' ' 48' ' ' VAL . 12.3 tp -65.72 -33.58 76.21 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.679 -1.146 . . . . 0.81000000000000005 109.931 173.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 76' ' ' VAL . 3.1 mm? -60.72 -38.67 85.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.909 -0.587 . . . . 1.6100000000000001 111.961 177.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -81.0 -33.42 33.69 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.489 -0.484 . . . . 2.1299999999999999 110.245 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.31 -53.32 59.08 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.294 -0.632 . . . . 1.1699999999999999 109.294 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.34 -3.24 5.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.981 -1.009 . . . . 1.1499999999999999 112.204 174.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -100.58 -6.56 25.15 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.641 -0.874 . . . . 1.46 108.641 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -114.16 30.82 7.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.12 -0.946 . . . . 4.1699999999999999 109.79 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.3 p . . . . . 0 C--O 1.25 1.101 0 CA-C-N 114.898 -1.046 . . . . 3.79 110.375 -177.506 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 111.783 0.29 . . . . 2.4900000000000002 111.783 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -64.98 -40.65 95.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.64 0.257 . . . . 2.46 111.303 -173.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.472 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -64.58 -41.88 93.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.006 0.431 . . . . 0.80000000000000004 110.315 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.44 ' SG ' ' HE3' ' A' ' 23' ' ' TRP . 19.6 t -64.96 -42.02 94.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.59 -0.732 . . . . 1.3500000000000001 109.568 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.9 tp -60.85 -48.18 82.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.86 -1.064 . . . . 1.1599999999999999 110.53 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -59.44 -36.12 75.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.001 -0.999 . . . . 3.8399999999999999 110.981 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 30.2 mmmt -74.0 2.8 7.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.869 -0.605 . . . . 1.1000000000000001 111.574 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 71.77 20.68 4.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.065 0.936 . . . . 1.9199999999999999 109.71 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.44 ' HE3' ' SG ' ' A' ' 18' ' ' CYS . 35.3 m0 -91.93 155.35 43.32 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.403 -0.817 . . . . 0.40000000000000002 109.437 175.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 49' ' ' ASN . 45.9 Cg_exo -63.56 -173.73 0.19 Allowed 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.808 2.338 . . . . 0.44 111.795 168.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.492 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 21.7 mmt -81.99 131.46 56.77 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.308 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.569 ' HB3' HG22 ' A' ' 48' ' ' VAL . 22.3 Cg_exo -62.98 160.26 34.59 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.715 2.277 . . . . 0.46000000000000002 112.822 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.46 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 13.6 t -84.79 142.01 30.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.21 -0.905 . . . . 0.29999999999999999 109.791 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.485 ' CD2' ' CZ ' ' A' ' 44' ' ' PHE . 71.2 m-85 -139.54 110.96 7.05 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.81 -0.811 . . . . 0.29999999999999999 108.81 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.526 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 43.3 ttt180 -145.5 122.86 11.62 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.521 0.201 . . . . 3.6899999999999999 110.525 -174.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.5 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 76.5 m -63.57 120.81 12.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.766 0.317 . . . . 1.53 110.569 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.8 m -86.05 -38.54 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.314 -0.403 . . . . 1.1499999999999999 111.105 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -136.36 127.75 28.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.865 0.364 . . . . 2.25 110.882 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -112.0 144.49 41.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.756 -0.656 . . . . 2.6000000000000001 109.397 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 40' ' ' LYS . . . -73.12 154.5 49.59 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.704 -0.76 . . . . 1.6899999999999999 113.487 -173.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.69 -132.46 0.37 Allowed Glycine 0 N--CA 1.452 -0.281 0 O-C-N 123.919 0.423 . . . . 2.1299999999999999 113.938 -176.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -42.18 -71.91 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 124.858 3.706 . . . . 3.0 114.015 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.08 -37.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 2.6099999999999999 110.537 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 39.1 p-80 -73.5 7.65 2.24 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.116 -0.493 . . . . 2.1000000000000001 111.195 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.89 32.88 0.92 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.106 -0.497 . . . . 1.28 110.216 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 20.4 tptt -79.03 23.28 0.36 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.186 0.517 . . . . 1.9299999999999999 111.517 -175.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -81.18 133.22 35.42 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.997 -0.742 . . . . 3.6400000000000001 108.997 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.456 ' CZ ' ' HG3' ' A' ' 40' ' ' LYS . 14.4 m-85 -110.05 143.88 39.44 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.307 -0.861 . . . . 0.79000000000000004 110.879 -171.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.7 m -129.05 137.51 51.33 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.302 -0.863 . . . . 0.26000000000000001 109.025 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.721 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -141.16 153.64 45.46 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.283 -0.636 . . . . 0.17000000000000001 109.283 -176.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -125.09 139.28 11.54 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 0.17000000000000001 111.914 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.721 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.1 t -106.8 154.02 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-N 117.096 0.448 . . . . 0.80000000000000004 109.895 -174.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.565 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 18.0 ptp180 -145.06 144.05 30.77 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.481 -0.933 . . . . 2.6200000000000001 108.481 172.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.668 HG23 HD11 ' A' ' 78' ' ' LEU . 97.3 t -122.64 152.81 27.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.392 -0.367 . . . . 0.23999999999999999 110.664 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.405 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 23.4 t-20 -92.37 83.46 5.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.542 0.687 . . . . 1.5900000000000001 109.953 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.2 p -74.52 109.77 8.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.792 -1.095 . . . . 0.33000000000000002 109.527 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.2 t -49.21 -27.85 4.02 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.93 0.715 . . . . 1.3200000000000001 112.93 -172.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -84.44 -21.21 30.8 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.299 0.481 . . . . 1.3 112.299 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.09 -44.85 1.03 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.167 0.508 . . . . 3.6800000000000002 111.073 -173.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.46 -152.04 16.87 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.762 -0.654 . . . . 0.19 111.834 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.565 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 5.5 m95 -53.78 119.98 5.67 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.171 0.51 . . . . 0.39000000000000001 110.638 173.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.9 p -69.2 170.44 10.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.58 -0.737 . . . . 0.35999999999999999 111.521 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -63.68 125.68 25.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.453 -0.943 . . . . 1.8400000000000001 108.453 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 38.2 tt0 -61.58 118.38 6.97 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.621 0.724 . . . . 1.0 110.666 -175.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.562 ' SG ' HD12 ' A' ' 81' ' ' LEU . 57.2 m -91.94 98.18 11.42 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.785 -1.098 . . . . 0.35999999999999999 110.499 -175.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.433 HD12 ' HG2' ' A' ' 58' ' ' GLU . 1.7 mp -74.63 124.34 32.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.945 -0.57 . . . . 0.73999999999999999 110.313 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.72 -167.65 43.72 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.1 -0.955 . . . . 0.23000000000000001 112.848 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 64' ' ' MET . 40.9 mt-10 -89.74 148.62 40.38 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-O 120.545 0.212 . . . . 1.3700000000000001 111.013 -174.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 62' ' ' GLU . 38.3 Cg_exo -60.57 106.7 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.814 2.342 . . . . 0.51000000000000001 111.396 172.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.558 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.4 mmm -115.08 143.49 30.31 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.077 -0.51 . . . . 0.67000000000000004 110.409 -173.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.32 3.89 5.38 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.737 2.291 . . . . 0.32000000000000001 113.312 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.9 t -143.65 140.06 29.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.498 -0.556 . . . . 1.3 109.498 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.6 m -64.62 -32.93 59.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.772 -0.649 . . . . 1.1399999999999999 111.482 -176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -64.07 -42.13 97.1 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 120.927 0.394 . . . . 2.8199999999999998 110.559 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.421 ' HE2' ' CE ' ' A' ' 64' ' ' MET . 43.4 mtpt -74.6 -25.16 59.08 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.99 -0.55 . . . . 1.3600000000000001 110.091 -177.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.52 -59.81 4.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.792 -0.64 . . . . 0.20999999999999999 110.696 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.707 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 52.8 pttt -61.92 -43.03 99.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.726 -0.215 . . . . 2.4199999999999999 110.91 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.526 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.9 m-20 -52.35 -50.8 61.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.879 0.696 . . . . 2.0099999999999998 112.879 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.3 p -66.54 -39.45 88.56 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.882 0.327 . . . . 1.1399999999999999 111.882 -175.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.481 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -68.18 -42.29 80.17 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.262 0.553 . . . . 0.17999999999999999 110.464 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.472 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -53.72 -36.05 61.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.222 -0.899 . . . . 0.26000000000000001 111.275 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 72' ' ' ASP . 94.9 t -62.36 -37.13 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.009 0.433 . . . . 0.82999999999999996 110.595 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.0 mt -75.11 -32.94 61.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.611 0.719 . . . . 0.39000000000000001 109.543 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.668 HD11 HG23 ' A' ' 48' ' ' VAL . 19.1 tp -64.59 -39.21 93.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.825 -1.08 . . . . 0.81000000000000005 110.905 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.7 mm? -59.52 -28.24 66.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.578 -0.737 . . . . 1.6100000000000001 111.039 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -72.76 -35.4 67.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.081 0.467 . . . . 2.1299999999999999 110.695 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.562 HD12 ' SG ' ' A' ' 59' ' ' CYS . 1.3 tt -62.96 -49.57 74.22 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.968 -0.753 . . . . 1.1699999999999999 108.968 175.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.9 mp -70.16 -2.77 14.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.198 -0.91 . . . . 1.1499999999999999 111.655 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -97.96 -13.07 21.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.481 0.658 . . . . 1.46 109.478 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -113.74 43.67 1.76 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.313 -0.858 . . . . 4.1699999999999999 110.427 -178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.532 -0.746 . . . . 3.79 110.197 -179.491 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.506 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 26.7 p-10 . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 111.035 0.013 . . . . 2.4900000000000002 111.035 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -68.91 -46.87 67.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.971 0.415 . . . . 2.46 110.804 -176.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.3 mp -62.97 -39.59 85.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.544 -0.753 . . . . 0.80000000000000004 110.325 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.4 m -68.56 -44.64 74.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.906 0.86 . . . . 1.3500000000000001 110.003 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 15' ' ' ASN . 3.5 tt -62.43 -45.69 91.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.228 -1.351 . . . . 1.1599999999999999 110.483 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.42 ' NH2' HG23 ' A' ' 17' ' ' ILE . 51.8 ttp85 -60.37 -38.2 83.14 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.578 -0.737 . . . . 3.8399999999999999 111.644 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 28.2 mmmt -72.93 0.39 11.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.549 -0.751 . . . . 1.1000000000000001 112.082 -176.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 62.87 51.05 3.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.092 0.948 . . . . 1.9199999999999999 110.011 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.416 ' CZ3' ' HG ' ' A' ' 82' ' ' LEU . 39.6 m0 -113.26 166.11 11.85 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.183 -0.917 . . . . 0.40000000000000002 109.223 175.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.62 162.04 33.35 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.957 1.771 . . . . 0.44 109.407 167.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 65.2 mmm -74.75 127.96 86.22 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 110.212 -0.292 . . . . 1.0 110.212 -173.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.518 ' HB3' HG22 ' A' ' 48' ' ' VAL . 1.2 Cg_endo -50.99 163.63 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 124.01 3.14 . . . . 0.46000000000000002 114.887 -173.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.476 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 25.3 t -81.02 144.25 31.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.338 -1.301 . . . . 0.29999999999999999 109.232 175.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.475 ' HD2' ' CZ ' ' A' ' 44' ' ' PHE . 72.6 m-85 -140.52 111.76 7.2 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.844 -0.798 . . . . 0.29999999999999999 108.844 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.46 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 36.4 ttm180 -151.92 124.07 8.16 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.042 -0.355 . . . . 3.6899999999999999 110.042 -176.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.461 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 83.8 m -66.84 124.92 24.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.953 0.406 . . . . 1.53 110.435 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -85.2 -35.81 10.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.835 -0.62 . . . . 1.1499999999999999 110.829 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -140.9 127.04 19.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.985 -0.552 . . . . 2.25 110.277 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.444 ' HB2' ' CD1' ' A' ' 42' ' ' PHE . 7.6 pt-20 -151.01 154.92 37.97 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.974 -0.38 . . . . 2.6000000000000001 109.974 176.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.46 -171.42 29.31 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.595 -0.812 . . . . 1.6899999999999999 112.949 177.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.16 -145.27 12.57 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.915 -0.874 . . . . 2.1299999999999999 110.915 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -73.56 52.99 2.58 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 123.192 2.595 . . . . 3.0 112.415 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 68.51 -57.76 0.49 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.957 0.903 . . . . 2.6099999999999999 112.48 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -77.86 18.0 0.52 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.827 0.346 . . . . 2.1000000000000001 111.478 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.59 44.22 2.76 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.338 0.589 . . . . 1.28 110.114 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.6 tptp -81.55 19.71 0.99 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.79 -0.641 . . . . 1.9299999999999999 110.517 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -83.46 135.52 34.64 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.535 -0.913 . . . . 3.6400000000000001 108.535 174.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 8.0 m-85 -112.84 132.09 55.43 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.63 -0.714 . . . . 0.79000000000000004 110.158 -174.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.0 m -119.85 130.01 54.68 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.064 -1.087 . . . . 0.26000000000000001 108.064 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.697 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -137.81 152.66 49.35 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.526 -0.546 . . . . 0.17000000000000001 109.526 -175.049 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.417 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -128.82 138.74 10.49 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.037 -0.602 . . . . 0.17000000000000001 111.901 177.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.697 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -105.93 157.71 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 109.503 -0.554 . . . . 0.80000000000000004 109.503 -176.691 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.58 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 24.2 ptt180 -146.72 141.81 27.16 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.983 -1.118 . . . . 2.6200000000000001 107.983 173.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.518 HG22 ' HB3' ' A' ' 26' ' ' PRO . 39.8 t -118.62 155.47 20.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.523 -0.308 . . . . 0.23999999999999999 110.374 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -96.05 84.04 3.75 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 121.635 0.731 . . . . 1.5900000000000001 109.635 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.539 ' OG1' ' HB2' ' A' ' 53' ' ' ARG . 37.7 p -68.29 113.33 5.8 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.298 -1.319 . . . . 0.33000000000000002 109.223 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.0 t -52.48 -27.29 15.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.776 -0.647 . . . . 1.3200000000000001 112.664 -171.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -100.54 -4.69 28.14 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.416 0.525 . . . . 1.3 112.416 -176.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.539 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 68.6 mtt180 -130.44 -52.25 1.09 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.232 0.539 . . . . 3.6800000000000002 110.897 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.73 -152.86 17.21 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.326 -0.852 . . . . 0.19 112.397 -175.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.58 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.4 m95 -55.79 120.28 7.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.067 0.461 . . . . 0.39000000000000001 111.23 176.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.9 p -71.73 161.54 30.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.742 -0.663 . . . . 0.35999999999999999 110.837 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.96 132.15 51.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.271 -0.641 . . . . 1.8400000000000001 109.271 174.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -56.57 116.94 3.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.58 -0.737 . . . . 1.0 110.937 -175.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.41 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 35.1 m -93.19 97.89 10.94 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.908 -1.042 . . . . 0.35999999999999999 110.114 -177.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.417 HD13 ' HA3' ' A' ' 45' ' ' GLY . 29.3 mm -75.62 123.77 32.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.572 -0.74 . . . . 0.73999999999999999 110.619 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.36 -167.01 42.77 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.867 -0.606 . . . . 0.23000000000000001 112.073 177.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -88.44 137.2 30.76 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 110.236 -0.283 . . . . 1.3700000000000001 110.236 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 50.2 Cg_exo -53.79 116.35 2.95 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.843 2.362 . . . . 0.51000000000000001 111.602 176.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.663 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 18.6 mmt -115.37 153.01 47.53 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.113 -0.494 . . . . 0.67000000000000004 111.082 -173.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -82.23 9.79 3.83 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.897 2.398 . . . . 0.32000000000000001 113.135 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.9 t -155.78 139.38 15.99 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.2 -0.667 . . . . 1.3 109.2 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.65 -22.86 28.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 1.1399999999999999 111.901 -173.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -75.24 -42.93 54.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.901 0.381 . . . . 2.8199999999999998 110.597 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.663 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 0.2 OUTLIER -82.31 -17.36 46.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.188 -0.46 . . . . 1.3600000000000001 110.384 178.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.76 -57.55 12.5 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.252 -0.431 . . . . 0.20999999999999999 110.425 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.644 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 61.2 mttm -52.66 -49.34 65.41 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.072 -0.513 . . . . 2.4199999999999999 110.433 174.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.518 ' O ' HG23 ' A' ' 76' ' ' VAL . 25.9 t70 -49.34 -49.87 42.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.933 -1.031 . . . . 2.0099999999999998 112.3 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.0 t -58.42 -48.53 80.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.788 0.328 . . . . 1.1399999999999999 111.453 -178.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.43 ' HB1' HG23 ' A' ' 46' ' ' VAL . . . -67.35 -37.51 83.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.28 0.562 . . . . 0.17999999999999999 110.777 -176.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.409 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -60.38 -30.74 69.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.475 -0.784 . . . . 0.26000000000000001 111.646 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 72' ' ' ASP . 73.9 t -63.72 -37.81 80.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 121.09 0.472 . . . . 0.82999999999999996 110.248 176.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.5 mt -75.92 -28.73 58.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.841 -0.618 . . . . 0.39000000000000001 109.796 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 78' ' ' LEU . 4.0 mt -60.1 -44.32 94.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.341 -0.845 . . . . 0.81000000000000005 110.553 173.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.409 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.6 mp -61.47 -28.42 69.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.518 -0.764 . . . . 1.6100000000000001 111.777 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -71.95 -44.54 63.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.859 0.361 . . . . 2.1299999999999999 110.46 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.2 tt -61.39 -48.94 78.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.608 0.718 . . . . 1.1699999999999999 109.23 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.416 ' HG ' ' CZ3' ' A' ' 23' ' ' TRP . 1.6 mp -65.02 -20.12 66.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.792 -1.094 . . . . 1.1499999999999999 112.414 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -92.31 -3.74 54.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.691 0.757 . . . . 1.46 109.528 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -114.09 36.14 3.83 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.305 -0.861 . . . . 4.1699999999999999 109.859 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.25 1.1 0 CA-C-N 115.186 -0.916 . . . . 3.79 110.819 -177.691 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 111.51 0.189 . . . . 2.4900000000000002 111.51 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -66.45 -46.51 76.18 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.902 0.382 . . . . 2.46 110.372 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.477 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -62.75 -39.35 84.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.762 -0.654 . . . . 0.80000000000000004 110.119 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.415 ' SG ' ' HG3' ' A' ' 26' ' ' PRO . 84.0 m -65.54 -43.99 88.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.654 -0.703 . . . . 1.3500000000000001 110.007 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.5 tp -60.02 -52.1 66.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.249 -0.887 . . . . 1.1599999999999999 110.081 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -55.81 -41.6 74.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.908 -1.042 . . . . 3.8399999999999999 111.451 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -75.06 0.87 14.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.867 -0.606 . . . . 1.1000000000000001 112.096 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.8 t30 68.11 25.43 7.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.905 0.859 . . . . 1.9199999999999999 110.007 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -91.52 161.36 34.58 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.314 -0.857 . . . . 0.40000000000000002 109.79 176.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -74.08 178.82 6.41 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 122.149 1.899 . . . . 0.44 110.763 168.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.448 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 23.9 mmt -80.05 139.94 53.39 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.01 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.489 ' HB3' HG22 ' A' ' 48' ' ' VAL . 12.1 Cg_exo -67.17 159.01 54.13 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.507 2.138 . . . . 0.46000000000000002 112.578 -174.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.5 t -82.12 143.89 31.15 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.314 -0.857 . . . . 0.29999999999999999 109.392 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.555 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 64.7 m-85 -136.71 110.19 7.96 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.474 -0.935 . . . . 0.29999999999999999 108.474 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.535 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 67.6 mtp180 -143.0 122.33 13.06 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.658 -0.247 . . . . 3.6899999999999999 110.638 -173.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 35.5 t -71.4 120.49 17.06 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.979 -0.378 . . . . 1.53 109.979 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -86.55 -35.68 9.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.234 -0.439 . . . . 1.1499999999999999 111.384 -176.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -136.27 123.62 21.96 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.287 0.565 . . . . 2.25 111.13 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.476 ' HG3' ' CD1' ' A' ' 42' ' ' PHE . 43.3 tt0 -152.86 129.37 10.7 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.886 -1.052 . . . . 2.6000000000000001 109.867 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.1 176.72 45.0 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.429 -0.891 . . . . 1.6899999999999999 113.099 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.0 -151.59 23.64 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.129 -0.788 . . . . 2.1299999999999999 111.129 -177.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.7 -73.46 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.18 2.587 . . . . 3.0 112.549 178.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.09 -43.97 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.095 0.474 . . . . 2.6099999999999999 109.982 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -78.04 12.02 2.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.8 -0.636 . . . . 2.1000000000000001 111.17 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.94 28.35 8.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.163 0.506 . . . . 1.28 110.856 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.46 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 22.8 tptt -90.22 15.81 9.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.056 0.931 . . . . 1.9299999999999999 108.973 175.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.04 135.04 34.18 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.456 -1.247 . . . . 3.6400000000000001 107.772 167.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD1' ' HG3' ' A' ' 33' ' ' GLU . 10.9 m-85 -110.35 136.57 49.32 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.119 0.485 . . . . 0.79000000000000004 110.365 -168.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.5 m -126.4 133.49 51.27 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.335 -0.848 . . . . 0.26000000000000001 109.056 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.735 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -140.37 152.89 46.13 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.305 -0.628 . . . . 0.17000000000000001 109.305 -174.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -126.24 139.89 11.7 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.801 -0.714 . . . . 0.17000000000000001 112.287 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.735 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -107.75 156.14 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.908 -0.405 . . . . 0.80000000000000004 109.908 -176.482 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.514 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 11.7 ptp180 -146.45 148.86 32.69 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.526 -0.916 . . . . 2.6200000000000001 108.526 172.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.628 HG23 HD11 ' A' ' 78' ' ' LEU . 98.0 t -123.75 152.4 29.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 O-C-N 123.157 0.286 . . . . 0.23999999999999999 110.616 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -94.62 88.82 5.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.765 0.793 . . . . 1.5900000000000001 110.243 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.568 ' OG1' ' HB3' ' A' ' 53' ' ' ARG . 37.7 p -71.65 113.3 8.54 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.422 -1.263 . . . . 0.33000000000000002 109.585 177.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.9 t -52.09 -25.23 8.28 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.925 0.713 . . . . 1.3200000000000001 112.925 -172.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -113.32 12.12 18.78 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.599 -0.44 . . . . 1.3 112.012 -176.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.568 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 41.5 ttm180 -146.56 -50.27 0.21 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.946 0.403 . . . . 3.6800000000000002 110.886 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.77 -162.47 19.0 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 116.156 -0.474 . . . . 0.19 113.03 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.514 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 15.3 m95 -52.57 117.97 3.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.111 0.481 . . . . 0.39000000000000001 110.765 174.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.0 p -70.83 178.89 2.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.36 -0.836 . . . . 0.35999999999999999 112.063 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -63.73 134.83 56.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.517 -0.765 . . . . 1.8400000000000001 109.697 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -65.65 113.53 4.31 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.399 0.619 . . . . 1.0 110.166 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.495 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 63.7 m -88.75 97.4 11.12 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.966 -1.016 . . . . 0.35999999999999999 109.849 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.426 HD13 ' HA3' ' A' ' 45' ' ' GLY . 26.3 mm -81.66 122.92 37.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.451 -0.795 . . . . 0.73999999999999999 110.068 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.26 -171.97 48.15 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.953 -0.641 . . . . 0.23000000000000001 112.037 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.608 ' O ' ' HG2' ' A' ' 64' ' ' MET . 40.1 mt-10 -86.35 151.08 53.12 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.972 -0.381 . . . . 1.3700000000000001 109.972 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.68 112.6 1.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.379 2.053 . . . . 0.51000000000000001 110.83 172.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.608 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 97.1 mmm -115.51 142.44 28.82 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.384 -0.371 . . . . 0.67000000000000004 110.35 -173.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.99 14.32 1.54 Allowed 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 122.66 2.24 . . . . 0.32000000000000001 113.713 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.465 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 30.0 t -157.57 143.2 17.29 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.646 -0.502 . . . . 1.3 109.646 176.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.1 m -71.44 -22.31 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.892 -0.595 . . . . 1.1399999999999999 111.675 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -73.56 -47.31 41.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.119 -0.492 . . . . 2.8199999999999998 110.419 -177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 66' ' ' SER . 15.5 ptpt -81.15 -16.86 51.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.863 -0.608 . . . . 1.3600000000000001 110.768 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.1 -56.21 24.95 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.316 -0.402 . . . . 0.20999999999999999 110.47 174.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.645 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 55.5 mttp -54.19 -47.18 72.35 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.186 -0.461 . . . . 2.4199999999999999 110.837 176.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.575 ' O ' HG23 ' A' ' 76' ' ' VAL . 19.6 m-20 -52.09 -49.45 63.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.017 -0.538 . . . . 2.0099999999999998 111.85 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.7 t -59.95 -46.64 88.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.595 0.236 . . . . 1.1399999999999999 111.538 -175.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.473 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -66.38 -42.04 88.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.189 0.519 . . . . 0.17999999999999999 110.554 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.422 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -53.33 -38.26 63.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.209 -0.905 . . . . 0.26000000000000001 111.516 177.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 72' ' ' ASP . 57.6 t -63.02 -36.68 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.897 0.38 . . . . 0.82999999999999996 110.743 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 85.3 mt -74.66 -32.88 62.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.765 0.793 . . . . 0.39000000000000001 109.44 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.628 HD11 HG23 ' A' ' 48' ' ' VAL . 42.9 tp -65.42 -39.38 92.07 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.557 -1.201 . . . . 0.81000000000000005 110.781 176.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.3 mp -58.94 -29.86 67.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.745 -0.662 . . . . 1.6100000000000001 111.045 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -69.84 -38.6 76.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.08 0.467 . . . . 2.1299999999999999 110.422 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.467 HD12 ' SG ' ' A' ' 59' ' ' CYS . 1.4 tt -63.85 -52.56 59.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.543 -0.753 . . . . 1.1699999999999999 109.607 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.2 mp -67.26 -10.32 49.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.402 -0.817 . . . . 1.1499999999999999 112.219 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -93.72 -9.61 37.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.498 0.666 . . . . 1.46 109.87 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -123.55 43.09 3.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.721 -0.672 . . . . 4.1699999999999999 110.506 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.417 -0.801 . . . . 3.79 109.984 179.171 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 . . . . . 0 N--CA 1.482 1.168 0 N-CA-C 111.332 0.123 . . . . 2.4900000000000002 111.332 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -68.0 -39.1 83.28 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.778 0.323 . . . . 2.46 111.217 -174.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.7 mp -64.44 -48.96 82.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.403 0.621 . . . . 0.80000000000000004 109.813 176.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.0 m -55.32 -40.18 70.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.577 -1.192 . . . . 1.3500000000000001 110.786 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.1 tp -61.78 -53.52 54.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.039 -0.982 . . . . 1.1599999999999999 110.584 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -61.61 -28.9 69.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.303 -0.862 . . . . 3.8399999999999999 111.242 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 29.6 mmmt -73.75 2.51 8.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.958 -0.564 . . . . 1.1000000000000001 112.338 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.9 t30 63.9 37.59 9.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.278 -0.874 . . . . 1.9199999999999999 110.056 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.581 ' CH2' HG22 ' A' ' 50' ' ' THR . 34.9 m0 -103.63 160.18 26.93 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.421 -0.809 . . . . 0.40000000000000002 109.657 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.33 177.98 3.44 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.256 1.971 . . . . 0.44 111.265 171.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.433 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 24.4 mmt -71.83 127.29 90.95 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 120.824 0.345 . . . . 1.0 110.721 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 25' ' ' MET . 23.7 Cg_exo -62.19 159.43 34.97 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.749 2.299 . . . . 0.46000000000000002 111.928 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.531 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 10.5 t -88.61 140.3 29.59 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.696 -0.684 . . . . 0.29999999999999999 109.721 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.49 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 74.1 m-85 -137.15 110.77 8.05 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.247 -1.02 . . . . 0.29999999999999999 108.247 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.564 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 37.8 ttm180 -136.17 117.9 15.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.473 0.178 . . . . 3.6899999999999999 110.79 -172.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.473 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 73.0 m -62.01 116.93 5.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.889 0.376 . . . . 1.53 110.29 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.6 t -87.36 -41.92 14.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.929 -0.578 . . . . 1.1499999999999999 110.809 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.423 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 27.0 tptp -139.86 130.98 26.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.068 0.461 . . . . 2.25 111.208 -178.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -101.38 154.88 18.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.054 -0.975 . . . . 2.6000000000000001 108.926 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 40' ' ' LYS . . . -69.9 -69.26 1.42 Allowed Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.968 -1.11 . . . . 1.6899999999999999 113.515 -172.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.436 ' HA3' ' HD3' ' A' ' 36' ' ' PRO . . . 124.65 -123.89 5.23 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.166 -1.016 . . . . 2.1299999999999999 112.143 -170.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.436 ' HD3' ' HA3' ' A' ' 35' ' ' GLY . 24.4 Cg_exo -65.19 -162.44 0.05 OUTLIER 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 124.12 3.214 . . . . 3.0 113.525 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.52 -46.1 20.36 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.199 -0.313 . . . . 2.6099999999999999 111.816 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -70.05 -24.29 63.23 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.123 0.487 . . . . 2.1000000000000001 110.656 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -122.88 91.22 3.45 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.841 -0.8 . . . . 1.28 108.841 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.439 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 21.4 tptm -126.73 21.27 7.03 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.55 -0.908 . . . . 1.9299999999999999 108.55 -177.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' A' ' 63' ' ' PRO . 9.5 ptm180 -79.8 138.08 37.15 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.562 -0.745 . . . . 3.6400000000000001 111.012 -171.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -109.85 131.77 54.76 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.015 -0.993 . . . . 0.79000000000000004 109.197 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 32' ' ' LYS . 27.6 m -130.49 125.15 33.64 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.705 -0.68 . . . . 0.26000000000000001 109.169 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.763 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -139.13 153.86 48.04 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.655 -0.498 . . . . 0.17000000000000001 109.655 -175.038 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 60' ' ' ILE . . . -127.99 138.93 10.73 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.99 -0.624 . . . . 0.17000000000000001 112.2 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.763 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -107.01 158.46 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 110.166 -0.309 . . . . 0.80000000000000004 110.166 -174.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.564 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 19.7 ptt180 -148.3 146.99 28.81 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.835 -0.802 . . . . 2.6200000000000001 108.835 173.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.614 HG23 HD11 ' A' ' 78' ' ' LEU . 28.6 t -124.3 156.75 32.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.565 0.221 . . . . 0.23999999999999999 110.889 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.413 ' N ' HG12 ' A' ' 48' ' ' VAL . 5.9 t30 -94.61 83.89 4.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.397 0.618 . . . . 1.5900000000000001 110.031 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.581 HG22 ' CH2' ' A' ' 23' ' ' TRP . 34.4 p -78.1 105.73 9.51 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.932 -1.031 . . . . 0.33000000000000002 109.71 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.2 m -43.98 -33.06 1.3 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.069 -0.969 . . . . 1.3200000000000001 113.042 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.432 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 4.6 p-10 -63.02 -40.17 96.95 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.758 0.651 . . . . 1.3 112.758 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -129.01 -37.56 1.7 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.993 0.425 . . . . 3.6800000000000002 111.653 -174.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.76 -148.24 16.74 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.93 -0.577 . . . . 0.19 112.364 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.564 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.9 m95 -51.24 119.19 3.81 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.17 0.509 . . . . 0.39000000000000001 111.342 175.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.3 p -69.48 167.55 16.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.559 -0.746 . . . . 0.35999999999999999 110.735 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.85 132.84 49.63 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.829 -0.804 . . . . 1.8400000000000001 108.829 174.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 40.9 tt0 -65.76 115.75 6.23 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.912 -1.04 . . . . 1.0 110.706 -174.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.8 m -96.14 105.3 17.33 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.63 -1.168 . . . . 0.35999999999999999 110.65 -174.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.522 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 1.8 mp -88.03 132.13 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.305 0.574 . . . . 0.73999999999999999 111.305 -177.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.54 -176.62 51.05 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 114.909 -1.041 . . . . 0.23000000000000001 111.809 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 64' ' ' MET . 13.0 pt-20 -92.07 158.06 40.04 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.816 0.308 . . . . 1.3700000000000001 110.673 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.429 ' HB3' ' HB2' ' A' ' 41' ' ' ARG . 72.0 Cg_exo -50.45 105.21 0.1 OUTLIER 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.398 2.732 . . . . 0.51000000000000001 112.683 174.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.0 mmm -108.74 145.27 31.29 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 110.152 -0.314 . . . . 0.67000000000000004 110.152 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.85 13.13 2.22 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.703 2.269 . . . . 0.32000000000000001 113.75 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.4 t -154.05 142.11 20.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.498 -0.927 . . . . 1.3 108.498 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.0 p -71.74 -22.01 21.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.149 -0.478 . . . . 1.1399999999999999 110.529 -174.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -73.13 -39.4 65.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.021 -0.536 . . . . 2.8199999999999998 109.616 175.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HE3' ' CE ' ' A' ' 64' ' ' MET . 27.5 mtpp -75.34 -23.39 57.22 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.975 -0.557 . . . . 1.3600000000000001 109.943 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.08 -53.41 58.55 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.579 -0.737 . . . . 0.20999999999999999 109.93 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.641 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 66.4 mttm -52.49 -54.58 30.57 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 115.611 -0.722 . . . . 2.4199999999999999 111.067 176.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.525 ' O ' HG23 ' A' ' 76' ' ' VAL . 33.4 m-20 -55.22 -44.78 75.74 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.945 -0.571 . . . . 2.0099999999999998 112.452 -177.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.495 ' OG ' ' HG2' ' A' ' 62' ' ' GLU . 44.3 t -59.25 -46.29 88.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 1.1399999999999999 111.113 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.443 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -68.44 -38.7 81.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.185 0.517 . . . . 0.17999999999999999 110.15 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.44 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -56.44 -37.35 70.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.261 -0.881 . . . . 0.26000000000000001 111.514 177.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 72' ' ' ASP . 94.7 t -63.24 -38.08 81.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.981 0.42 . . . . 0.82999999999999996 110.679 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.7 mt -77.82 -23.35 49.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.885 0.85 . . . . 0.39000000000000001 109.334 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.739 HD13 ' HB ' ' A' ' 46' ' ' VAL . 16.4 tp -70.34 -49.01 53.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.716 -1.129 . . . . 0.81000000000000005 110.403 173.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 75' ' ' ALA . 6.2 mp -53.67 -34.12 57.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.581 -0.736 . . . . 1.6100000000000001 112.248 -177.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -78.86 -34.02 45.33 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.373 -0.531 . . . . 2.1299999999999999 110.855 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.87 -51.68 60.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.883 0.373 . . . . 1.1699999999999999 110.086 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.459 HD21 HG21 ' A' ' 48' ' ' VAL . 1.9 mm? -71.43 -7.46 47.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 1.1499999999999999 111.37 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -94.09 -6.49 44.93 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.442 0.639 . . . . 1.46 109.841 175.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -115.71 39.08 3.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.708 -0.678 . . . . 4.1699999999999999 110.174 -178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.251 1.144 0 CA-C-N 115.363 -0.835 . . . . 3.79 110.038 -179.005 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 111.451 0.167 . . . . 2.4900000000000002 111.451 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.46 -46.78 85.9 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.783 0.29 . . . . 2.46 111.783 -176.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.442 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -60.83 -47.53 92.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.035 -0.53 . . . . 0.80000000000000004 110.688 -177.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.411 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 41.5 t -63.89 -45.33 89.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.367 0.603 . . . . 1.3500000000000001 110.273 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.19 -44.1 97.83 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.109 -0.95 . . . . 1.1599999999999999 110.838 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -65.13 -33.75 76.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.971 -1.013 . . . . 3.8399999999999999 111.12 -177.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 4.6 mmmp? -74.18 2.69 8.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.123 -0.49 . . . . 1.1000000000000001 111.574 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 67.39 30.2 7.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.935 0.874 . . . . 1.9199999999999999 109.991 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.411 ' CE3' ' HA ' ' A' ' 18' ' ' CYS . 27.7 m0 -93.54 160.24 33.35 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.406 -0.815 . . . . 0.40000000000000002 109.073 174.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.6 -173.29 0.67 Allowed 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.183 1.922 . . . . 0.44 111.087 172.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.459 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.9 mmt -75.64 145.67 79.08 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.677 -0.49 . . . . 1.0 109.677 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.501 ' HB3' HG22 ' A' ' 48' ' ' VAL . 2.7 Cg_exo -74.89 165.96 30.29 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.495 2.13 . . . . 0.46000000000000002 112.421 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.407 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 26.3 t -84.73 144.4 28.54 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.161 -0.927 . . . . 0.29999999999999999 109.912 178.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.523 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 69.0 m-85 -143.95 109.93 5.34 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.361 -0.607 . . . . 0.29999999999999999 109.361 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.513 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 14.0 ptm180 -152.52 128.92 10.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.949 0.404 . . . . 3.6899999999999999 110.874 -176.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 77.3 m -65.89 124.87 23.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.865 -0.607 . . . . 1.53 111.286 -176.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -84.82 -37.67 12.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.808 -0.633 . . . . 1.1499999999999999 110.286 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -135.78 131.47 35.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.173 0.511 . . . . 2.25 111.178 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -99.79 152.39 20.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.923 -1.035 . . . . 2.6000000000000001 108.819 174.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 40' ' ' LYS . . . -85.14 163.47 37.77 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.284 -0.96 . . . . 1.6899999999999999 112.69 -176.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.67 -142.56 1.37 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.678 -0.296 . . . . 2.1299999999999999 113.056 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.73 -74.13 0.03 OUTLIER 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.817 3.011 . . . . 3.0 113.117 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.21 -36.39 0.08 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.028 0.442 . . . . 2.6099999999999999 110.053 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -70.22 -9.65 56.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.742 -0.663 . . . . 2.1000000000000001 110.799 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.99 29.94 4.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.065 -0.516 . . . . 1.28 110.516 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.511 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 15.2 tptp -79.05 22.5 0.39 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.136 0.493 . . . . 1.9299999999999999 111.332 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -83.53 132.32 34.94 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.064 -0.717 . . . . 3.6400000000000001 109.064 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.433 ' CZ ' ' HG3' ' A' ' 40' ' ' LYS . 7.0 m-85 -109.56 149.1 30.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.532 -0.758 . . . . 0.79000000000000004 110.877 -172.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.5 m -129.76 129.6 44.32 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.142 -0.935 . . . . 0.26000000000000001 109.289 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.735 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -137.13 153.65 50.46 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.069 -0.715 . . . . 0.17000000000000001 109.069 -174.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -126.66 138.73 10.82 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.757 -0.735 . . . . 0.17000000000000001 112.317 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.735 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -107.15 158.6 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 109.309 -0.626 . . . . 0.80000000000000004 109.309 -177.124 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.571 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 11.8 ptp180 -148.49 148.96 30.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.05 -0.722 . . . . 2.6200000000000001 109.05 173.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.6 HG23 HD11 ' A' ' 78' ' ' LEU . 73.9 t -125.06 153.7 32.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 123.309 0.381 . . . . 0.23999999999999999 110.627 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -92.52 85.31 5.28 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.562 0.696 . . . . 1.5900000000000001 110.576 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 54' ' ' GLY . 38.2 p -73.32 112.37 9.32 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.933 -1.031 . . . . 0.33000000000000002 109.716 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 t -49.84 -28.4 6.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.68 -0.691 . . . . 1.3200000000000001 112.151 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -82.24 -22.78 35.69 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.154 0.798 . . . . 1.3 113.154 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -134.47 -43.66 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.905 -0.497 . . . . 3.6800000000000002 111.609 -173.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 122.77 -152.57 16.88 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 116.093 -0.503 . . . . 0.19 111.896 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.571 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.9 m95 -53.01 120.79 6.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.99 0.424 . . . . 0.39000000000000001 110.686 174.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.2 p -71.05 160.96 31.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.679 -0.691 . . . . 0.35999999999999999 111.0 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -60.64 128.34 36.1 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.221 -0.659 . . . . 1.8400000000000001 109.221 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -54.71 123.58 13.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.931 -1.032 . . . . 1.0 111.026 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.44 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 57.8 m -95.77 97.8 9.96 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.356 -0.838 . . . . 0.35999999999999999 110.124 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.12 126.23 38.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.556 -0.747 . . . . 0.73999999999999999 110.887 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.5 -177.89 51.87 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.238 -0.892 . . . . 0.23000000000000001 112.896 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -85.14 147.08 46.76 Favored Pre-proline 0 C--N 1.317 -0.826 0 N-CA-C 109.966 -0.383 . . . . 1.3700000000000001 109.966 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 52.1 Cg_exo -55.05 105.79 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.643 2.228 . . . . 0.51000000000000001 111.45 175.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.641 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 16.3 mmt -113.27 139.84 23.62 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.152 -0.477 . . . . 0.67000000000000004 111.192 -173.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.74 10.14 2.39 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.662 2.242 . . . . 0.32000000000000001 113.323 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.8 t -152.54 137.88 17.55 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.144 -0.687 . . . . 1.3 109.144 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -68.06 -23.21 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 1.1399999999999999 111.688 -173.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -74.1 -44.99 51.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.904 0.383 . . . . 2.8199999999999998 110.423 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.641 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 0.2 OUTLIER -81.04 -17.76 49.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 1.3600000000000001 109.973 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.87 -56.65 19.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.847 -0.615 . . . . 0.20999999999999999 110.092 173.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.646 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 58.1 mtpt -50.92 -48.16 60.76 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 116.261 -0.427 . . . . 2.4199999999999999 110.753 174.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.534 ' O ' HG23 ' A' ' 76' ' ' VAL . 36.8 m-20 -52.46 -51.72 57.89 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.389 0.514 . . . . 2.0099999999999998 112.389 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.2 p -60.9 -40.23 92.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.707 0.289 . . . . 1.1399999999999999 111.456 -175.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.432 ' HB1' HG23 ' A' ' 46' ' ' VAL . . . -69.38 -44.97 70.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.144 0.497 . . . . 0.17999999999999999 110.376 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.509 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -55.99 -35.99 67.4 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.306 -0.861 . . . . 0.26000000000000001 111.754 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 72' ' ' ASP . 91.8 t -64.92 -38.23 82.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.978 0.418 . . . . 0.82999999999999996 110.7 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 90.6 mt -76.42 -26.43 55.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.916 0.865 . . . . 0.39000000000000001 109.271 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.6 HD11 HG23 ' A' ' 48' ' ' VAL . 16.0 tp -70.98 -54.5 11.04 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.553 -1.203 . . . . 0.81000000000000005 111.256 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 75' ' ' ALA . 4.2 mp -55.32 -29.24 57.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.914 -0.584 . . . . 1.6100000000000001 112.546 -174.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.86 -33.8 60.02 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.276 -0.57 . . . . 2.1299999999999999 110.598 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.1 -50.54 63.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.108 -0.496 . . . . 1.1699999999999999 110.091 -177.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.509 ' CD2' ' HG ' ' A' ' 78' ' ' LEU . 1.4 mm? -67.04 -29.45 69.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 1.1499999999999999 111.124 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 84' ' ' LYS . 2.2 t-20 -86.64 2.69 47.49 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.329 -0.619 . . . . 1.46 109.329 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 83' ' ' ASN . 23.5 mtmm 71.59 119.71 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.5 -1.227 . . . . 4.1699999999999999 111.448 177.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.9 t . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.213 -0.899 . . . . 3.79 110.233 -175.033 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 111.258 0.095 . . . . 2.4900000000000002 111.258 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.32 -39.07 93.17 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.62 0.23 . . . . 2.46 111.62 -172.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.442 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.4 mp -56.63 -41.98 75.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.353 0.597 . . . . 0.80000000000000004 110.457 177.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 23' ' ' TRP . 22.4 t -75.18 -38.49 60.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.397 -0.82 . . . . 1.3500000000000001 109.708 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.7 tp -60.1 -53.08 62.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.139 -0.937 . . . . 1.1599999999999999 110.606 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -56.53 -37.94 71.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.064 -0.971 . . . . 3.8399999999999999 111.71 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.8 mmtm -73.96 5.63 4.06 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.993 -0.549 . . . . 1.1000000000000001 111.918 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 66.48 27.22 9.83 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.597 -0.728 . . . . 1.9199999999999999 110.937 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.558 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 30.0 m0 -101.0 154.11 37.34 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.557 -0.747 . . . . 0.40000000000000002 109.011 175.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.91 173.65 14.14 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.232 1.955 . . . . 0.44 110.631 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.424 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 31.6 mmt -62.26 127.4 89.62 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.791 0.329 . . . . 1.0 110.921 -177.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.531 ' HB2' ' CE1' ' A' ' 28' ' ' TYR . 70.1 Cg_exo -54.89 165.01 2.9 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.567 2.845 . . . . 0.46000000000000002 113.678 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.515 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 25.1 t -89.58 142.39 27.72 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.987 -1.006 . . . . 0.29999999999999999 109.388 177.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.531 ' CE1' ' HB2' ' A' ' 26' ' ' PRO . 95.9 m-85 -140.75 108.72 5.71 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.277 -1.008 . . . . 0.29999999999999999 108.277 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.552 ' H ' ' HE1' ' A' ' 44' ' ' PHE . 48.7 mmt-85 -147.83 118.5 7.52 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.324 -0.621 . . . . 3.6899999999999999 109.324 -173.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.549 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 15.5 p -69.47 129.09 38.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.041 0.448 . . . . 1.53 110.953 -177.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.1 m -85.79 -32.81 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.82 -0.627 . . . . 1.1499999999999999 111.15 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -136.66 124.44 22.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.081 -0.509 . . . . 2.25 110.226 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.78 159.17 44.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.109 -0.496 . . . . 2.6000000000000001 110.463 177.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.41 145.83 15.76 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.152 -1.023 . . . . 1.6899999999999999 112.999 174.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.38 163.31 12.7 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.043 -0.823 . . . . 2.1299999999999999 111.043 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -44.67 -75.59 0.03 OUTLIER 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 123.633 2.889 . . . . 3.0 112.529 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.26 -44.58 0.08 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.568 -0.53 . . . . 2.6099999999999999 109.568 173.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -70.79 -8.98 56.37 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.81 -0.632 . . . . 2.1000000000000001 110.33 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.439 ' C ' ' H ' ' A' ' 41' ' ' ARG . . . -120.85 15.67 11.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.266 0.555 . . . . 1.28 110.882 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.412 ' HZ3' ' HZ ' ' A' ' 42' ' ' PHE . 21.7 tptp -79.08 21.43 0.44 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.235 -0.893 . . . . 1.9299999999999999 109.972 177.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.439 ' H ' ' C ' ' A' ' 39' ' ' ALA . 11.2 ptp180 -82.1 144.26 30.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.63 -0.713 . . . . 3.6400000000000001 109.66 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.629 ' CZ ' HG22 ' A' ' 67' ' ' VAL . 71.2 m-85 -111.54 131.43 55.25 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.469 -0.787 . . . . 0.79000000000000004 110.191 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 m -120.24 121.68 39.23 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.466 -1.309 . . . . 0.26000000000000001 107.466 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.69 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -136.85 151.28 48.94 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.631 -0.507 . . . . 0.17000000000000001 109.631 -170.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.558 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -123.69 137.96 11.19 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.204 -0.522 . . . . 0.17000000000000001 111.932 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.69 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -106.75 155.57 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 109.731 -0.47 . . . . 0.80000000000000004 109.731 -174.636 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.62 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 8.3 ptp85 -147.95 142.31 26.3 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.626 -0.879 . . . . 2.6200000000000001 108.626 176.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.628 HG23 HD11 ' A' ' 78' ' ' LEU . 95.4 t -124.65 153.24 31.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.342 -0.39 . . . . 0.23999999999999999 110.381 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -92.01 82.8 5.1 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.723 0.773 . . . . 1.5900000000000001 110.203 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 35.3 p -67.94 116.82 9.02 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.438 -1.256 . . . . 0.33000000000000002 110.143 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.8 p -51.95 -26.53 10.67 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.462 -1.244 . . . . 1.3200000000000001 113.013 -176.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -89.11 -17.42 29.27 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.032 0.753 . . . . 1.3 113.032 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -139.16 -44.72 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 118.488 0.585 . . . . 3.6800000000000002 112.408 -175.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.66 -150.61 17.14 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.919 -0.658 . . . . 0.19 112.337 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.62 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 4.9 m95 -53.66 118.17 3.71 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.034 0.445 . . . . 0.39000000000000001 110.771 176.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.3 p -65.63 165.06 13.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.56 -0.745 . . . . 0.35999999999999999 111.37 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -61.46 135.27 57.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.046 -0.724 . . . . 1.8400000000000001 109.046 172.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -58.94 113.27 2.0 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.889 -175.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 60.1 m -91.39 97.32 11.02 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.089 -0.959 . . . . 0.35999999999999999 109.831 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.558 HD13 ' HA3' ' A' ' 45' ' ' GLY . 13.2 mm -81.84 126.01 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 115.832 -0.622 . . . . 0.73999999999999999 110.251 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.82 -170.84 47.07 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.913 -0.66 . . . . 0.23000000000000001 111.96 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.6 ' O ' ' HG2' ' A' ' 64' ' ' MET . 38.7 mt-10 -88.54 145.07 34.62 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.214 -0.662 . . . . 1.3700000000000001 109.214 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -55.83 110.44 0.56 Allowed 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.587 2.191 . . . . 0.51000000000000001 111.758 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.6 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 99.8 mmm -112.2 140.59 23.75 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.633 -0.506 . . . . 0.67000000000000004 109.633 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.61 18.51 0.96 Allowed 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.637 2.225 . . . . 0.32000000000000001 113.667 -175.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.419 ' HB2' ' CD ' ' A' ' 69' ' ' LYS . 28.7 m -157.56 139.09 13.83 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.227 -0.657 . . . . 1.3 109.227 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.629 HG22 ' CZ ' ' A' ' 42' ' ' PHE . 1.1 t -67.35 -38.67 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.335 -0.848 . . . . 1.1399999999999999 112.259 -167.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -71.21 -39.71 71.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.463 -0.335 . . . . 2.8199999999999998 111.118 -175.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.419 ' CD ' ' HB2' ' A' ' 66' ' ' SER . 17.3 ptmt -80.92 -18.52 46.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.888 0.375 . . . . 1.3600000000000001 110.182 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.62 -55.9 25.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.20999999999999999 110.645 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.642 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 5.6 ptpp? -58.54 -43.18 89.19 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-N 116.592 -0.276 . . . . 2.4199999999999999 110.767 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.576 ' O ' HG23 ' A' ' 76' ' ' VAL . 5.7 m-20 -54.92 -47.08 74.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 2.0099999999999998 111.973 176.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.2 t -58.65 -46.36 87.32 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.851 0.358 . . . . 1.1399999999999999 111.321 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.436 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -68.85 -42.81 76.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.022 0.439 . . . . 0.17999999999999999 110.589 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.48 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -56.12 -34.19 65.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.447 -0.797 . . . . 0.26000000000000001 111.517 177.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 72' ' ' ASP . 94.2 t -63.51 -36.57 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.916 0.389 . . . . 0.82999999999999996 110.61 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.7 mt -73.98 -34.04 64.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.712 0.767 . . . . 0.39000000000000001 109.271 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.663 HD22 HG11 ' A' ' 46' ' ' VAL . 26.3 tp -64.82 -42.56 94.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.602 -1.181 . . . . 0.81000000000000005 110.797 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 75' ' ' ALA . 7.3 mp -60.33 -26.96 66.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.03 -0.532 . . . . 1.6100000000000001 111.215 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -71.37 -40.0 70.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.227 0.537 . . . . 2.1299999999999999 110.274 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.8 tp -65.55 -46.55 79.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.359 -0.837 . . . . 1.1699999999999999 110.077 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.554 HD11 HG21 ' A' ' 48' ' ' VAL . 42.2 mt -70.09 -12.89 61.93 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.514 -1.221 . . . . 1.1499999999999999 111.19 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -88.81 -7.7 55.71 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.588 0.709 . . . . 1.46 109.554 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -104.27 40.68 1.42 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.322 -0.854 . . . . 4.1699999999999999 110.197 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.248 1.019 0 CA-C-N 115.205 -0.907 . . . . 3.79 110.018 -179.819 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 121.027 0.442 . . . . 2.4900000000000002 110.402 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -61.32 -41.98 97.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.068 -0.514 . . . . 2.46 111.539 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.5 mp -61.51 -38.49 80.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.61 -0.723 . . . . 0.80000000000000004 110.734 -178.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 23' ' ' TRP . 41.2 t -72.29 -39.81 68.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.274 0.559 . . . . 1.3500000000000001 109.971 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.0 tp -61.08 -51.54 68.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.305 -0.861 . . . . 1.1599999999999999 110.153 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -54.98 -36.53 65.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.218 -0.901 . . . . 3.8399999999999999 111.489 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -72.52 1.84 7.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.906 -0.588 . . . . 1.1000000000000001 111.971 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 64.96 26.08 12.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.35 -0.841 . . . . 1.9199999999999999 111.361 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.445 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 34.0 m0 -96.62 154.29 38.52 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.695 -0.483 . . . . 0.40000000000000002 109.695 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.414 ' HG2' ' HB3' ' A' ' 49' ' ' ASN . 63.2 Cg_endo -71.87 169.71 20.58 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.519 2.146 . . . . 0.44 110.811 173.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.8 mmt -63.03 130.22 93.97 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.691 -0.231 . . . . 1.0 111.106 -175.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.415 ' HB3' HG22 ' A' ' 48' ' ' VAL . 15.2 Cg_exo -67.31 165.78 25.71 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.881 2.387 . . . . 0.46000000000000002 112.865 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.431 ' HB2' ' CH2' ' A' ' 55' ' ' TRP . 16.8 t -87.97 141.34 28.65 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.045 -0.98 . . . . 0.29999999999999999 109.995 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.507 ' HA ' ' HE1' ' A' ' 44' ' ' PHE . 75.6 m-85 -138.92 110.63 7.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.768 -0.827 . . . . 0.29999999999999999 108.768 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.501 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 78.0 mtp180 -148.29 123.93 10.47 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 110.165 -0.309 . . . . 3.6899999999999999 110.165 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.531 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 71.2 m -61.12 121.08 11.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.997 0.427 . . . . 1.53 110.648 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.2 t -82.34 -38.24 15.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.787 -0.642 . . . . 1.1499999999999999 110.046 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -136.14 123.31 21.69 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.297 -0.631 . . . . 2.25 109.297 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -150.19 137.47 19.61 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.1 -0.5 . . . . 2.6000000000000001 110.646 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.57 -67.14 3.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.966 -0.635 . . . . 1.6899999999999999 112.935 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.24 -157.4 36.43 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.986 -0.626 . . . . 2.1299999999999999 112.406 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.99 -58.77 0.91 Allowed 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.031 2.488 . . . . 3.0 112.161 175.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -175.41 -49.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.466 0.651 . . . . 2.6099999999999999 109.792 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -79.07 18.29 0.66 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.14 -0.936 . . . . 2.1000000000000001 111.508 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -122.97 49.41 1.65 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.153 0.501 . . . . 1.28 110.724 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -88.15 14.38 9.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.369 0.604 . . . . 1.9299999999999999 109.931 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -86.31 132.77 33.9 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.102 -1.444 . . . . 3.6400000000000001 107.102 166.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -108.92 131.2 55.26 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.285 0.564 . . . . 0.79000000000000004 109.743 -172.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 21.6 m -120.01 118.0 29.5 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.886 -1.153 . . . . 0.26000000000000001 107.886 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.711 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -129.74 153.56 48.07 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.329 -0.619 . . . . 0.17000000000000001 109.329 -172.266 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.555 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -127.79 137.76 10.01 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.514 -0.634 . . . . 0.17000000000000001 111.514 178.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.711 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -105.99 155.0 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 N-CA-C 109.406 -0.59 . . . . 0.80000000000000004 109.406 -177.462 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.56 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 12.4 ptp180 -143.68 141.27 30.46 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 107.784 -1.191 . . . . 2.6200000000000001 107.784 173.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.415 HG22 ' HB3' ' A' ' 26' ' ' PRO . 39.1 t -117.19 152.4 19.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.304 -0.407 . . . . 0.23999999999999999 110.11 -178.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.414 ' HB3' ' HG2' ' A' ' 24' ' ' PRO . 58.3 t30 -94.95 83.62 4.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.049 0.928 . . . . 1.5900000000000001 109.853 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.8 p -70.48 116.05 10.37 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.775 -1.557 . . . . 0.33000000000000002 109.488 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.4 t -52.49 -28.2 19.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.924 -0.58 . . . . 1.3200000000000001 110.254 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -63.36 -56.27 17.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.402 -0.817 . . . . 1.3 112.755 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -122.99 -33.43 3.34 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.156 0.428 . . . . 3.6800000000000002 112.156 -171.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.56 -149.87 16.93 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 121.149 -0.548 . . . . 0.19 112.324 -177.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.56 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.9 m95 -54.04 117.81 3.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.929 0.395 . . . . 0.39000000000000001 111.045 175.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.1 p -67.63 170.02 8.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.57 -0.741 . . . . 0.35999999999999999 111.413 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -65.32 126.65 28.88 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.191 -1.04 . . . . 1.8400000000000001 108.191 172.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -58.71 114.62 2.6 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.557 0.694 . . . . 1.0 110.49 -175.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.474 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 59.8 m -87.02 97.01 10.48 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.944 -1.025 . . . . 0.35999999999999999 109.659 -177.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.555 HD13 ' HA3' ' A' ' 45' ' ' GLY . 21.6 mm -77.63 120.67 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.341 -0.845 . . . . 0.73999999999999999 109.593 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.51 -165.8 35.56 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.757 -0.735 . . . . 0.23000000000000001 112.217 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 64' ' ' MET . 38.6 mt-10 -92.66 142.22 25.47 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.259 -0.645 . . . . 1.3700000000000001 109.259 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.51 114.63 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.693 2.262 . . . . 0.51000000000000001 111.952 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.644 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 95.8 mmm -118.58 138.88 26.3 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.216 -0.447 . . . . 0.67000000000000004 109.941 -174.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.15 11.64 1.44 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.637 2.225 . . . . 0.32000000000000001 113.827 -175.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.497 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 50.5 m -152.67 137.59 17.16 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.317 -0.623 . . . . 1.3 109.317 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.71 -31.79 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 113.147 0.795 . . . . 1.1399999999999999 113.147 -169.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -69.83 -42.44 73.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.766 0.317 . . . . 2.8199999999999998 111.25 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.497 ' HG2' ' HB2' ' A' ' 66' ' ' SER . 17.3 ptpt -81.0 -18.9 45.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.369 -0.378 . . . . 1.3600000000000001 110.49 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.51 -57.94 10.79 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.342 -0.39 . . . . 0.20999999999999999 110.299 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.683 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 53.1 mtmt -56.51 -45.37 81.12 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.25 -0.432 . . . . 2.4199999999999999 110.729 175.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 76' ' ' VAL . 22.3 t70 -49.79 -50.13 45.98 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.887 -0.597 . . . . 2.0099999999999998 111.812 176.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.0 t -58.91 -47.56 84.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 1.1399999999999999 111.618 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.85 -36.99 81.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.251 0.548 . . . . 0.17999999999999999 111.007 -177.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.603 ' O ' ' HG ' ' A' ' 79' ' ' LEU . . . -60.44 -29.94 69.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.553 -0.749 . . . . 0.26000000000000001 111.692 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 72' ' ' ASP . 55.6 t -65.71 -32.82 59.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 121.102 0.477 . . . . 0.82999999999999996 109.961 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.3 mt -74.26 -30.76 62.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.856 -0.611 . . . . 0.39000000000000001 109.506 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 78' ' ' LEU . 6.2 mt -61.87 -42.64 99.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.195 -0.911 . . . . 0.81000000000000005 110.24 175.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 75' ' ' ALA . 17.8 mt -58.3 -35.59 72.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.199 -0.91 . . . . 1.6100000000000001 111.037 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -69.67 -43.81 71.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.895 0.379 . . . . 2.1299999999999999 110.268 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.0 tt -62.87 -47.57 82.74 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.716 -0.675 . . . . 1.1699999999999999 109.259 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.35 -32.91 72.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.081 -0.963 . . . . 1.1499999999999999 111.68 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -78.17 -6.77 55.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.358 0.599 . . . . 1.46 110.597 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -114.79 40.2 2.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.277 0.56 . . . . 4.1699999999999999 110.163 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 C--O 1.25 1.084 0 CA-C-N 115.318 -0.855 . . . . 3.79 110.967 179.932 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 111.665 0.246 . . . . 2.4900000000000002 111.665 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -64.63 -38.0 89.49 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.74 0.305 . . . . 2.46 111.106 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.487 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -65.29 -38.35 82.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.177 -0.465 . . . . 0.80000000000000004 110.607 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.409 ' SG ' ' HE3' ' A' ' 23' ' ' TRP . 54.1 t -72.24 -41.19 67.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.661 0.743 . . . . 1.3500000000000001 109.247 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.75 -42.85 99.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.628 -1.169 . . . . 1.1599999999999999 109.614 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -61.65 -33.9 74.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.556 -0.747 . . . . 3.8399999999999999 110.919 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 21' ' ' LYS . 31.6 mmmt -74.28 2.07 10.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.029 -0.532 . . . . 1.1000000000000001 111.485 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.9 t30 68.24 27.04 6.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.998 0.904 . . . . 1.9199999999999999 109.712 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.409 ' HE3' ' SG ' ' A' ' 18' ' ' CYS . 41.8 m0 -92.67 160.88 33.48 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.017 -0.992 . . . . 0.40000000000000002 109.055 174.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.38 -169.53 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.106 1.871 . . . . 0.44 111.482 173.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.424 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 10.6 mmt -77.22 132.5 70.08 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HB3' HG22 ' A' ' 48' ' ' VAL . 16.9 Cg_exo -65.63 164.37 26.73 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.512 2.141 . . . . 0.46000000000000002 112.268 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.525 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 22.5 t -87.84 140.99 28.95 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.494 -0.776 . . . . 0.29999999999999999 109.859 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.51 ' HD1' ' CZ ' ' A' ' 44' ' ' PHE . 66.1 m-85 -141.19 111.04 6.54 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.889 -0.782 . . . . 0.29999999999999999 108.889 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.51 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 36.2 ttm180 -153.01 128.68 10.1 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.196 -0.298 . . . . 3.6899999999999999 110.196 -175.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.4 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 7.8 p -65.32 124.68 22.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.924 0.392 . . . . 1.53 110.459 178.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.404 ' H ' ' HA ' ' A' ' 44' ' ' PHE . 34.1 m -82.57 -34.61 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.141 0.496 . . . . 1.1499999999999999 110.302 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -139.99 125.33 18.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.681 -0.691 . . . . 2.25 110.201 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.462 ' HG3' ' CD1' ' A' ' 42' ' ' PHE . 36.3 tt0 -152.03 139.78 19.86 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.441 -0.577 . . . . 2.6000000000000001 109.441 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.81 -137.3 21.32 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.34 -0.933 . . . . 1.6899999999999999 112.487 178.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.54 -140.06 15.91 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.215 -0.993 . . . . 2.1299999999999999 112.016 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -53.32 -68.73 0.06 OUTLIER 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 123.575 2.85 . . . . 3.0 112.304 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -177.48 -44.66 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.011 -0.54 . . . . 2.6099999999999999 110.511 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -71.86 -23.25 61.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.936 -0.575 . . . . 2.1000000000000001 111.855 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.67 57.96 4.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.073 0.463 . . . . 1.28 111.329 -172.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -92.09 18.61 7.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.379 0.609 . . . . 1.9299999999999999 110.045 177.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -83.4 140.48 32.36 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 106.471 -1.677 . . . . 3.6400000000000001 106.471 168.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.462 ' CD1' ' HG3' ' A' ' 33' ' ' GLU . 9.0 m-85 -111.0 130.15 55.68 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 120.474 -0.49 . . . . 0.79000000000000004 110.284 -172.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.6 m -121.92 125.43 46.37 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.03 -1.1 . . . . 0.26000000000000001 108.03 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.728 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -134.36 151.61 51.32 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.582 -0.525 . . . . 0.17000000000000001 109.582 -175.108 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.91 139.41 11.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.96 -0.638 . . . . 0.17000000000000001 111.883 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.728 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -107.05 157.6 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 N-CA-C 110.03 -0.359 . . . . 0.80000000000000004 110.03 -174.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.615 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 15.2 ptp180 -148.5 147.39 29.04 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.674 -0.862 . . . . 2.6200000000000001 108.674 171.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.638 HG23 HD11 ' A' ' 78' ' ' LEU . 73.0 t -124.98 153.07 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.474 -0.33 . . . . 0.23999999999999999 110.807 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -93.89 84.54 4.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.729 0.776 . . . . 1.5900000000000001 110.213 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' A' ' 53' ' ' ARG . 40.3 p -72.52 108.11 5.41 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.374 -1.285 . . . . 0.33000000000000002 109.05 177.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.1 t -49.83 -28.28 6.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.011 -0.541 . . . . 1.3200000000000001 112.251 -175.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -88.44 -15.82 34.44 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.705 0.631 . . . . 1.3 112.705 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.44 ' HB3' ' OG1' ' A' ' 50' ' ' THR . 25.3 ttm180 -132.22 -49.38 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.915 -0.491 . . . . 3.6800000000000002 111.307 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 125.59 -156.82 19.48 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.842 -0.617 . . . . 0.19 112.288 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.615 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.7 m95 -52.0 117.95 3.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.969 0.414 . . . . 0.39000000000000001 110.611 173.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 47.9 p -69.85 168.98 14.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.533 -0.758 . . . . 0.35999999999999999 111.306 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.48 125.51 25.93 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.164 -0.68 . . . . 1.8400000000000001 109.164 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 45.4 tt0 -60.75 118.11 6.22 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.297 -0.865 . . . . 1.0 111.036 -174.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 68.6 m -97.96 102.26 13.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.713 -1.13 . . . . 0.35999999999999999 110.731 -175.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.43 127.7 36.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.77 -0.65 . . . . 0.73999999999999999 110.533 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.15 -161.93 34.93 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.574 -0.739 . . . . 0.23000000000000001 113.019 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 64' ' ' MET . 32.5 mt-10 -92.03 131.94 33.85 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.744 -0.228 . . . . 1.3700000000000001 110.612 -175.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 54.1 Cg_exo -52.9 108.92 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.765 2.31 . . . . 0.51000000000000001 111.477 175.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.472 ' SD ' ' HE3' ' A' ' 69' ' ' LYS . 7.1 mmt -110.96 151.51 43.03 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.006 -0.543 . . . . 0.67000000000000004 111.772 -171.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.59 5.78 6.06 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.949 2.432 . . . . 0.32000000000000001 112.989 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.4 t -151.61 142.39 22.87 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.5 -0.556 . . . . 1.3 109.5 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.4 t -62.16 -33.3 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.457 -0.792 . . . . 1.1399999999999999 111.406 -174.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -66.76 -37.07 83.89 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.242 -0.435 . . . . 2.8199999999999998 110.439 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.472 ' HE3' ' SD ' ' A' ' 64' ' ' MET . 29.1 mtpp -74.27 -31.44 62.53 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.079 -0.509 . . . . 1.3600000000000001 110.315 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.74 -60.89 2.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.68 -0.691 . . . . 0.20999999999999999 110.955 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.538 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 32.6 mmtp -51.46 -49.51 61.62 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.289 -0.414 . . . . 2.4199999999999999 110.995 176.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.508 ' O ' HG23 ' A' ' 76' ' ' VAL . 17.4 t70 -51.84 -52.27 50.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.281 -0.872 . . . . 2.0099999999999998 112.566 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 91.6 p -62.4 -41.31 98.57 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.835 0.309 . . . . 1.1399999999999999 111.835 -174.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.493 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -69.46 -41.44 76.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.222 0.534 . . . . 0.17999999999999999 110.543 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.409 ' O ' HD23 ' A' ' 79' ' ' LEU . . . -54.23 -33.68 58.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.231 -0.895 . . . . 0.26000000000000001 111.395 176.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 72' ' ' ASP . 88.7 t -62.55 -37.96 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 120.971 0.415 . . . . 0.82999999999999996 110.833 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.08 -30.47 62.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.868 0.842 . . . . 0.39000000000000001 109.042 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.638 HD11 HG23 ' A' ' 48' ' ' VAL . 18.1 tp -67.3 -42.88 82.99 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.438 -1.255 . . . . 0.81000000000000005 110.329 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 75' ' ' ALA . 3.9 mm? -61.26 -29.5 69.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.713 -0.676 . . . . 1.6100000000000001 110.971 177.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 76' ' ' VAL . 35.1 mt-10 -75.98 -38.5 57.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.932 0.396 . . . . 2.1299999999999999 110.112 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.9 tt -62.65 -48.95 77.11 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.277 -0.638 . . . . 1.1699999999999999 109.277 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.9 -14.73 60.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.324 -0.853 . . . . 1.1499999999999999 112.191 177.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -96.51 -6.79 36.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.633 0.73 . . . . 1.46 109.613 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -113.69 34.35 4.64 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.291 -0.868 . . . . 4.1699999999999999 110.108 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.251 1.146 0 CA-C-N 115.442 -0.799 . . . . 3.79 109.892 -179.102 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 111.5 0.185 . . . . 2.4900000000000002 111.5 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -68.11 -47.68 67.5 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.855 0.36 . . . . 2.46 110.543 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.3 mp -58.46 -43.45 86.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.565 -0.743 . . . . 0.80000000000000004 110.11 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.501 ' SG ' ' HG3' ' A' ' 26' ' ' PRO . 57.6 m -66.41 -43.65 85.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.072 -0.967 . . . . 1.3500000000000001 110.412 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.7 tp -63.81 -53.03 57.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.964 -1.016 . . . . 1.1599999999999999 111.194 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -59.23 -35.51 73.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.893 -0.594 . . . . 3.8399999999999999 111.371 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 37.3 mmtt -74.18 -1.26 19.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.126 0.489 . . . . 1.1000000000000001 111.939 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 61.89 36.8 15.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.851 -1.068 . . . . 1.9199999999999999 110.632 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 29.8 m0 -94.7 161.73 27.82 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.489 -0.778 . . . . 0.40000000000000002 109.014 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.18 177.98 4.0 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.965 1.776 . . . . 0.44 110.459 170.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 22.0 mmt -77.61 123.08 86.66 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-O 120.931 0.396 . . . . 1.0 110.403 -176.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.527 ' HB3' HG22 ' A' ' 48' ' ' VAL . 9.6 Cg_endo -56.47 163.15 7.08 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.695 2.93 . . . . 0.46000000000000002 114.015 -176.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.538 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 25.6 t -88.46 143.35 27.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.811 -1.086 . . . . 0.29999999999999999 110.461 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.541 ' HD1' ' CZ ' ' A' ' 44' ' ' PHE . 65.5 m-85 -143.33 111.37 6.1 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.146 -0.687 . . . . 0.29999999999999999 109.146 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.47 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 79.2 ttt180 -155.71 129.87 8.78 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.599 -0.519 . . . . 3.6899999999999999 109.599 -176.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 13.8 p -69.78 132.0 45.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.216 0.531 . . . . 1.53 111.2 -176.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.71 -31.66 6.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.61 -0.723 . . . . 1.1499999999999999 109.983 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.408 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 87.7 tttt -143.44 127.06 17.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.984 -0.553 . . . . 2.25 110.897 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -150.27 139.31 21.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.543 -0.753 . . . . 2.6000000000000001 110.044 176.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.12 167.1 37.34 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.743 -0.741 . . . . 1.6899999999999999 114.072 172.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 163.02 -151.24 20.87 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.122 -0.791 . . . . 2.1299999999999999 111.122 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.67 -68.9 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 123.144 2.563 . . . . 3.0 112.144 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -168.0 -38.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.284 0.564 . . . . 2.6099999999999999 109.499 176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -78.91 18.95 0.56 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.49 -0.777 . . . . 2.1000000000000001 110.866 174.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.93 29.63 5.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.062 0.458 . . . . 1.28 111.633 -174.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -90.78 17.79 7.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.701 0.762 . . . . 1.9299999999999999 109.409 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -85.54 134.84 34.01 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.545 -1.28 . . . . 3.6400000000000001 107.545 168.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 7.7 m-85 -109.64 134.64 51.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.015 0.436 . . . . 0.79000000000000004 110.355 -170.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 32' ' ' LYS . 19.7 m -123.61 120.6 33.29 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.66 -0.867 . . . . 0.26000000000000001 108.66 -178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.736 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -131.58 154.18 49.12 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.649 -0.5 . . . . 0.17000000000000001 109.649 -172.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 59' ' ' CYS . . . -128.5 140.44 11.76 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.951 -0.642 . . . . 0.17000000000000001 112.168 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.736 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 1.0 OUTLIER -106.93 154.81 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 109.661 -0.496 . . . . 0.80000000000000004 109.661 -176.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.575 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 12.4 ptp180 -145.79 142.7 29.13 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.907 -1.146 . . . . 2.6200000000000001 107.907 173.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.602 HG23 HD11 ' A' ' 78' ' ' LEU . 43.7 t -124.8 156.04 33.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.714 -0.221 . . . . 0.23999999999999999 110.606 -178.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.405 ' N ' HG12 ' A' ' 48' ' ' VAL . 26.6 t-20 -91.89 84.19 5.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.739 0.78 . . . . 1.5900000000000001 109.782 178.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.8 p -78.25 103.14 8.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.581 -1.19 . . . . 0.33000000000000002 109.167 177.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 t -44.25 -34.87 2.04 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.351 -0.84 . . . . 1.3200000000000001 113.095 -170.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -68.26 -26.95 65.93 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.858 0.688 . . . . 1.3 112.858 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -132.24 -42.2 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.013 0.435 . . . . 3.6800000000000002 111.487 -174.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.49 -150.02 16.94 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.965 -0.562 . . . . 0.19 112.03 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.575 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 3.9 m95 -51.5 120.06 4.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.024 0.44 . . . . 0.39000000000000001 111.327 175.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.6 p -68.34 156.92 36.79 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.726 -0.67 . . . . 0.35999999999999999 110.346 176.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -61.84 124.88 21.98 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.866 -0.79 . . . . 1.8400000000000001 108.866 173.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 40.5 tt0 -59.64 118.03 5.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.104 -0.953 . . . . 1.0 111.242 -170.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.419 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 50.6 m -93.3 102.64 14.91 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.704 -1.134 . . . . 0.35999999999999999 110.614 -174.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.02 128.56 38.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.819 -0.628 . . . . 0.73999999999999999 110.739 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.27 -167.58 43.51 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.478 -0.783 . . . . 0.23000000000000001 111.999 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.638 ' O ' ' HG2' ' A' ' 64' ' ' MET . 40.9 mt-10 -86.62 148.14 45.61 Favored Pre-proline 0 C--N 1.318 -0.795 0 O-C-N 122.731 -0.276 . . . . 1.3700000000000001 110.311 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 42' ' ' PHE . 32.1 Cg_exo -59.62 107.87 0.42 Allowed 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.492 2.128 . . . . 0.51000000000000001 110.753 170.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.638 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 95.9 mmm -114.62 148.77 41.04 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.063 -0.517 . . . . 0.67000000000000004 110.139 -172.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.74 8.67 4.13 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.619 2.212 . . . . 0.32000000000000001 113.667 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.425 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 37.9 m -153.88 137.91 16.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.349 -0.612 . . . . 1.3 109.349 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.571 ' O ' ' HD3' ' A' ' 71' ' ' LYS . 28.3 m -64.84 -29.3 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 112.646 0.61 . . . . 1.1399999999999999 112.646 -170.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.68 -42.86 77.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.965 0.412 . . . . 2.8199999999999998 111.33 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.425 ' HG2' ' HB2' ' A' ' 66' ' ' SER . 14.5 ptpt -81.84 -18.21 44.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.362 -0.381 . . . . 1.3600000000000001 111.058 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.42 -51.22 68.39 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 109.517 -0.549 . . . . 0.20999999999999999 109.517 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.653 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 0.4 OUTLIER -52.57 -51.56 59.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.135 -0.939 . . . . 2.4199999999999999 110.461 174.018 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -52.76 -46.95 67.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.254 -0.884 . . . . 2.0099999999999998 112.277 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.536 ' O ' HG12 ' A' ' 76' ' ' VAL . 95.7 p -65.58 -39.36 91.54 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.901 -0.319 . . . . 1.1399999999999999 111.5 -176.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.425 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -70.99 -48.15 54.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.026 0.441 . . . . 0.17999999999999999 110.552 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.472 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -54.31 -38.89 66.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.501 -0.772 . . . . 0.26000000000000001 111.808 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 73' ' ' SER . 3.0 p -72.25 -26.62 25.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 0.82999999999999996 110.958 -176.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.8 mt -78.2 -34.07 49.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.852 0.834 . . . . 0.39000000000000001 109.402 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.602 HD11 HG23 ' A' ' 48' ' ' VAL . 17.5 tp -64.68 -38.65 91.73 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.691 -1.14 . . . . 0.81000000000000005 110.693 175.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 75' ' ' ALA . 6.1 mp -61.09 -26.26 67.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.548 -0.751 . . . . 1.6100000000000001 111.357 177.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -70.61 -38.04 73.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.479 0.657 . . . . 2.1299999999999999 109.985 175.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.34 -46.96 75.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.134 -0.939 . . . . 1.1699999999999999 109.177 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mp -69.22 -13.58 62.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.191 -0.913 . . . . 1.1499999999999999 111.686 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -84.17 -4.45 58.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.011 0.91 . . . . 1.46 109.208 175.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -118.65 45.86 1.96 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.886 -1.052 . . . . 4.1699999999999999 109.668 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.569 -0.729 . . . . 3.79 110.847 -178.237 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.0 t30 . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 120.609 0.242 . . . . 2.4900000000000002 110.735 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -61.8 -45.45 93.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.98 0.419 . . . . 2.46 111.221 -171.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -64.71 -49.1 81.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.7 -0.682 . . . . 0.80000000000000004 111.045 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.594 ' SG ' ' HD3' ' A' ' 26' ' ' PRO . 53.3 t -62.22 -41.1 98.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.445 0.64 . . . . 1.3500000000000001 110.388 -176.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 38.5 tp -62.27 -51.97 65.6 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.001 -0.999 . . . . 1.1599999999999999 110.899 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.9 ttp-105 -61.59 -31.89 71.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.262 -0.881 . . . . 3.8399999999999999 111.525 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -72.58 -1.59 16.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.961 -0.563 . . . . 1.1000000000000001 111.437 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.4 m120 59.67 27.79 17.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.853 -1.067 . . . . 1.9199999999999999 111.841 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.482 ' CH2' HG22 ' A' ' 50' ' ' THR . 27.3 m0 -85.4 162.86 47.09 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.234 -0.654 . . . . 0.40000000000000002 109.234 174.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.08 174.34 7.09 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 121.981 1.788 . . . . 0.44 110.437 170.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 5.7 mmt -79.2 132.94 61.55 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.981 0.42 . . . . 1.0 111.402 -170.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.594 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 12.1 Cg_endo -58.82 156.42 32.99 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.832 3.021 . . . . 0.46000000000000002 113.819 -177.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.1 t -90.35 144.21 26.03 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.841 -1.072 . . . . 0.29999999999999999 110.238 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.54 ' CD2' ' CZ ' ' A' ' 44' ' ' PHE . 60.7 m-85 -141.58 110.32 6.12 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.933 -0.766 . . . . 0.29999999999999999 108.933 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.532 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 57.5 mtp180 -146.05 125.67 13.33 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 110.39 -0.226 . . . . 3.6899999999999999 110.39 -176.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 74.6 m -65.24 126.77 29.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.749 0.309 . . . . 1.53 110.795 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 43' ' ' THR . 30.5 m -87.48 -38.67 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 1.1499999999999999 110.927 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -140.84 130.28 23.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.411 -0.359 . . . . 2.25 110.764 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.01 151.3 35.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.134 -0.485 . . . . 2.6000000000000001 110.708 175.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.27 -167.92 39.03 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.959 -0.638 . . . . 1.6899999999999999 113.313 175.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.72 -150.59 21.6 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.076 -0.81 . . . . 2.1299999999999999 111.076 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -52.03 -57.21 2.27 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 123.104 2.536 . . . . 3.0 111.882 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -177.59 -50.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.528 -0.76 . . . . 2.6099999999999999 109.373 177.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -77.57 19.46 0.37 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.183 -0.917 . . . . 2.1000000000000001 111.701 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.92 45.7 2.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.972 0.415 . . . . 1.28 111.025 -176.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -83.21 18.93 1.58 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.032 0.444 . . . . 1.9299999999999999 110.659 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.1 mtm180 -85.58 141.12 30.06 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.018 -0.734 . . . . 3.6400000000000001 109.018 176.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -110.47 136.01 50.27 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.025 -0.534 . . . . 0.79000000000000004 110.807 -172.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 31' ' ' VAL . 16.7 m -124.6 127.84 47.98 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.234 -1.024 . . . . 0.26000000000000001 108.234 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.747 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -142.85 154.4 44.11 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.499 -0.556 . . . . 0.17000000000000001 109.499 -175.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.556 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -126.85 139.75 11.46 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.903 -0.665 . . . . 0.17000000000000001 112.519 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.747 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -107.18 159.02 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.659 -0.497 . . . . 0.80000000000000004 109.659 -175.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.616 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 14.6 ptp180 -148.43 147.87 29.66 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.61 -0.885 . . . . 2.6200000000000001 108.61 171.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.572 HG23 HD11 ' A' ' 78' ' ' LEU . 85.1 t -125.76 156.18 35.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.305 -0.407 . . . . 0.23999999999999999 110.178 179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -92.12 82.2 5.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.087 0.47 . . . . 1.5900000000000001 109.949 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.482 HG22 ' CH2' ' A' ' 23' ' ' TRP . 41.5 p -74.5 107.2 6.49 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.548 -0.751 . . . . 0.33000000000000002 109.479 178.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.7 t -47.53 -30.54 3.58 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.825 0.676 . . . . 1.3200000000000001 112.825 -173.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -80.32 -14.58 58.25 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.417 0.895 . . . . 1.3 113.417 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -140.07 -42.09 0.43 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.525 0.602 . . . . 3.6800000000000002 111.105 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 122.75 -153.75 16.95 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 116.111 -0.495 . . . . 0.19 112.048 -178.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.616 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 9.4 m95 -51.81 120.48 5.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.812 0.339 . . . . 0.39000000000000001 110.732 173.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 47.4 p -68.92 157.73 36.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.709 -0.678 . . . . 0.35999999999999999 111.045 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -58.22 131.67 51.28 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.065 -0.717 . . . . 1.8400000000000001 109.065 174.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.66 113.02 2.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.744 0.783 . . . . 1.0 111.262 -171.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.457 ' O ' ' HA2' ' A' ' 45' ' ' GLY . 38.7 m -85.87 98.67 10.9 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.177 -1.374 . . . . 0.35999999999999999 109.984 -176.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.556 HD13 ' HA3' ' A' ' 45' ' ' GLY . 19.1 mm -80.71 128.96 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-N 115.892 -0.594 . . . . 0.73999999999999999 110.364 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.11 175.21 49.87 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.921 -0.872 . . . . 0.23000000000000001 110.921 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' A' ' 64' ' ' MET . 12.5 pt-20 -85.5 150.5 54.18 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 109.572 -0.529 . . . . 1.3700000000000001 109.572 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -51.97 109.97 0.39 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.651 2.234 . . . . 0.51000000000000001 111.692 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.606 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 98.0 mmm -114.73 139.19 23.8 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.816 -0.629 . . . . 0.67000000000000004 109.493 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.69 13.69 0.73 Allowed 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.576 2.184 . . . . 0.32000000000000001 114.072 -174.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.52 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 28.6 m -157.46 143.1 17.36 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.715 -0.476 . . . . 1.3 109.715 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.77 -41.23 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.337 -0.847 . . . . 1.1399999999999999 112.693 -170.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.35 -42.39 96.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.919 0.39 . . . . 2.8199999999999998 111.146 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.52 ' HG2' ' HB2' ' A' ' 66' ' ' SER . 15.8 ptpt -81.26 -18.95 44.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.462 -0.335 . . . . 1.3600000000000001 110.67 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.45 -55.63 25.81 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.397 -0.365 . . . . 0.20999999999999999 110.301 171.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.613 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 53.5 mtpt -54.29 -52.17 62.31 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 116.063 -0.517 . . . . 2.4199999999999999 110.29 175.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -55.38 -42.13 73.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.128 -0.942 . . . . 2.0099999999999998 112.194 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.547 ' O ' HG12 ' A' ' 76' ' ' VAL . 17.1 t -62.75 -43.06 99.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.778 0.323 . . . . 1.1399999999999999 110.981 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.435 ' HB3' ' CE2' ' A' ' 44' ' ' PHE . . . -69.95 -44.4 69.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.134 0.493 . . . . 0.17999999999999999 110.401 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.479 ' O ' HD13 ' A' ' 79' ' ' LEU . . . -57.52 -38.51 74.8 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.631 -0.713 . . . . 0.26000000000000001 112.208 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 73' ' ' SER . 3.1 p -68.79 -31.19 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 O-C-N 121.952 -0.467 . . . . 0.82999999999999996 110.669 -178.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.5 mt -76.19 -31.79 58.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.808 0.813 . . . . 0.39000000000000001 109.103 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.572 HD11 HG23 ' A' ' 48' ' ' VAL . 14.3 tp -66.16 -43.31 87.33 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.496 -1.229 . . . . 0.81000000000000005 110.728 175.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.479 HD13 ' O ' ' A' ' 75' ' ' ALA . 6.3 mp -59.15 -29.19 67.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.214 -0.448 . . . . 1.6100000000000001 111.424 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 6.2 mm-40 -71.78 -38.93 70.23 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.191 -0.459 . . . . 2.1299999999999999 110.698 177.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.3 tp -75.05 -41.97 58.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.908 0.861 . . . . 1.1699999999999999 110.335 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.453 ' C ' ' H ' ' A' ' 84' ' ' LYS . 8.7 tp -65.4 -38.92 91.43 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.062 -1.426 . . . . 1.1499999999999999 111.341 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -68.04 -3.58 10.65 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.804 -1.089 . . . . 1.46 109.816 173.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.453 ' H ' ' C ' ' A' ' 82' ' ' LEU . 82.4 mttt 62.1 157.69 0.05 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.175 -1.375 . . . . 4.1699999999999999 111.585 -173.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.8 p . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.918 -0.563 . . . . 3.79 110.853 -162.216 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.9 p30 . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 111.683 0.253 . . . . 2.4900000000000002 111.683 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -66.35 -45.86 78.77 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.837 0.351 . . . . 2.46 111.221 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.477 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.4 mp -61.38 -41.5 90.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.662 -0.699 . . . . 0.80000000000000004 110.638 -178.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.412 ' HA ' ' CE3' ' A' ' 23' ' ' TRP . 42.8 t -71.57 -41.73 68.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.987 -0.551 . . . . 1.3500000000000001 110.218 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.8 -54.63 42.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.357 -0.838 . . . . 1.1599999999999999 110.605 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -58.06 -33.89 69.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.211 -0.904 . . . . 3.8399999999999999 111.906 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.427 ' HB3' ' CE2' ' A' ' 23' ' ' TRP . 34.4 mmtt -72.71 4.02 4.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.071 0.462 . . . . 1.1000000000000001 111.968 -178.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 63.28 38.71 10.15 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.867 -1.06 . . . . 1.9199999999999999 110.28 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 29.0 m0 -104.81 165.09 13.88 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.423 -0.808 . . . . 0.40000000000000002 109.631 176.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 23' ' ' TRP . 55.0 Cg_endo -72.39 -171.51 0.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.349 2.033 . . . . 0.44 110.913 170.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.487 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 12.0 mmt -82.33 135.94 46.68 Favored Pre-proline 0 C--N 1.323 -0.582 0 O-C-N 122.024 -0.422 . . . . 1.0 110.633 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.571 ' HB3' HG22 ' A' ' 48' ' ' VAL . 14.4 Cg_exo -68.88 168.45 20.33 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.916 2.411 . . . . 0.46000000000000002 113.045 -177.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.2 t -89.51 141.23 28.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.936 -1.029 . . . . 0.29999999999999999 110.32 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.464 ' CD2' ' HZ ' ' A' ' 44' ' ' PHE . 67.7 m-85 -144.17 110.52 5.51 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.29 -0.633 . . . . 0.29999999999999999 109.29 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.478 ' O ' ' HD1' ' A' ' 44' ' ' PHE . 24.2 ttm180 -156.52 128.42 7.31 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.751 0.31 . . . . 3.6899999999999999 110.512 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 44' ' ' PHE . 4.5 p -65.68 124.26 21.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.069 0.461 . . . . 1.53 110.957 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.7 m -87.57 -37.07 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.987 -0.552 . . . . 1.1499999999999999 111.439 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -135.89 122.7 21.16 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.06 0.457 . . . . 2.25 110.52 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.406 ' HG3' ' CD1' ' A' ' 42' ' ' PHE . 26.4 tt0 -151.45 143.22 23.73 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.323 -0.853 . . . . 2.6000000000000001 110.289 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.93 -170.85 38.4 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.143 -1.027 . . . . 1.6899999999999999 114.018 171.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.78 -155.32 26.1 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.442 -1.063 . . . . 2.1299999999999999 110.442 -173.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -53.85 -65.43 0.13 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.944 2.429 . . . . 3.0 111.999 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -170.46 -42.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.692 -0.686 . . . . 2.6099999999999999 109.623 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -78.81 18.22 0.63 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.439 -0.8 . . . . 2.1000000000000001 111.226 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.19 36.32 4.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.434 0.635 . . . . 1.28 110.646 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -87.88 19.0 3.74 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.747 -0.66 . . . . 1.9299999999999999 110.618 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -82.84 134.05 35.11 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.4 -0.963 . . . . 3.6400000000000001 108.4 172.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.406 ' CD1' ' HG3' ' A' ' 33' ' ' GLU . 23.4 m-85 -110.31 135.66 50.7 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.904 -0.589 . . . . 0.79000000000000004 110.637 -170.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.8 m -122.54 130.69 53.3 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.868 -1.16 . . . . 0.26000000000000001 107.868 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.738 ' CZ ' HG22 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -139.18 151.33 46.5 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.417 -0.586 . . . . 0.17000000000000001 109.417 -174.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.551 ' HA3' HD13 ' A' ' 60' ' ' ILE . . . -125.58 136.84 9.94 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.973 -0.632 . . . . 0.17000000000000001 112.017 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.738 HG22 ' CZ ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -107.1 156.72 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 109.308 -0.627 . . . . 0.80000000000000004 109.308 -176.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.562 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 16.2 ptt180 -148.99 147.7 28.88 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.774 -0.825 . . . . 2.6200000000000001 108.774 171.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.571 HG22 ' HB3' ' A' ' 26' ' ' PRO . 78.2 t -125.13 153.44 32.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 116.076 -0.511 . . . . 0.23999999999999999 110.339 -177.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -93.58 83.4 4.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.507 0.67 . . . . 1.5900000000000001 109.835 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 54' ' ' GLY . 29.6 p -69.89 105.58 2.86 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.628 -1.169 . . . . 0.33000000000000002 108.963 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.1 t -43.78 -44.33 6.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.804 0.668 . . . . 1.3200000000000001 112.804 -169.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -81.5 -6.44 58.96 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.254 0.835 . . . . 1.3 113.254 -175.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.4 mtp180 -133.1 -48.65 0.86 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 121.739 -0.601 . . . . 3.6800000000000002 111.547 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' THR . . . 123.71 -153.68 17.35 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.899 -0.591 . . . . 0.19 112.585 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.562 ' CZ3' ' HG3' ' A' ' 47' ' ' ARG . 5.2 m95 -52.43 117.61 2.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.869 0.366 . . . . 0.39000000000000001 110.676 174.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.0 p -68.48 169.78 10.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.725 -0.671 . . . . 0.35999999999999999 111.214 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -62.41 129.45 40.72 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.708 -0.849 . . . . 1.8400000000000001 108.708 172.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -60.63 119.74 8.68 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.39 0.614 . . . . 1.0 110.609 -176.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.51 ' SG ' HD12 ' A' ' 81' ' ' LEU . 51.5 m -92.34 98.52 11.54 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.892 -1.049 . . . . 0.35999999999999999 110.231 -175.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.551 HD13 ' HA3' ' A' ' 45' ' ' GLY . 24.6 mm -80.42 124.02 37.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.778 -0.646 . . . . 0.73999999999999999 110.066 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.99 -174.84 50.0 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.882 -0.675 . . . . 0.23000000000000001 112.243 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 64' ' ' MET . 42.9 mt-10 -83.81 152.01 62.1 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 109.728 -0.471 . . . . 1.3700000000000001 109.728 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.43 109.14 1.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.363 2.042 . . . . 0.51000000000000001 111.222 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.562 ' HG2' ' O ' ' A' ' 62' ' ' GLU . 89.3 mmm -115.37 141.57 27.41 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.697 -0.483 . . . . 0.67000000000000004 109.697 -173.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.05 17.97 1.1 Allowed 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.57 2.18 . . . . 0.32000000000000001 113.581 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.424 ' HB3' ' HG2' ' A' ' 69' ' ' LYS . 11.2 t -155.09 139.91 17.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.315 -0.624 . . . . 1.3 109.315 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.2 -23.88 27.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.838 -0.619 . . . . 1.1399999999999999 111.032 -173.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -73.96 -43.69 57.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.039 0.447 . . . . 2.8199999999999998 110.235 -176.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.424 ' HG2' ' HB3' ' A' ' 66' ' ' SER . 5.7 ptpp? -81.64 -18.37 44.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.939 -0.573 . . . . 1.3600000000000001 110.634 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.28 -57.49 12.56 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.496 -0.32 . . . . 0.20999999999999999 110.496 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.462 ' HA ' ' CE2' ' A' ' 44' ' ' PHE . 61.5 mttm -52.95 -50.08 64.78 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-O 120.946 0.403 . . . . 2.4199999999999999 110.257 174.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.534 ' O ' HG23 ' A' ' 76' ' ' VAL . 32.1 t70 -51.54 -51.56 54.3 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.362 -0.835 . . . . 2.0099999999999998 112.295 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.4 t -56.31 -46.64 79.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.787 0.327 . . . . 1.1399999999999999 111.178 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.441 ' HB1' HG23 ' A' ' 46' ' ' VAL . . . -69.5 -43.14 73.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.259 -0.428 . . . . 0.17999999999999999 110.951 -177.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.91 -41.06 70.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.819 -0.628 . . . . 0.26000000000000001 111.84 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 72' ' ' ASP . 97.0 t -63.64 -35.04 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 121.043 0.449 . . . . 0.82999999999999996 110.731 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.6 mt -74.89 -36.63 62.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.732 0.777 . . . . 0.39000000000000001 109.66 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.531 HD22 HG11 ' A' ' 46' ' ' VAL . 21.0 tp -64.72 -43.12 94.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.749 -1.114 . . . . 0.81000000000000005 111.103 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 mp -62.69 -21.13 65.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.85 -0.613 . . . . 1.6100000000000001 111.497 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -76.43 -38.44 55.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.752 0.31 . . . . 2.1299999999999999 110.234 174.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.51 HD12 ' SG ' ' A' ' 59' ' ' CYS . 0.8 OUTLIER -66.35 -42.98 87.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.766 0.793 . . . . 1.1699999999999999 109.063 178.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.418 ' HG ' ' CZ3' ' A' ' 23' ' ' TRP . 1.6 mp -69.24 -17.75 63.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.678 -1.146 . . . . 1.1499999999999999 111.943 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.59 ' O ' ' HB2' ' A' ' 84' ' ' LYS . 22.9 t-20 -88.51 0.83 55.89 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.833 -0.803 . . . . 1.46 108.833 174.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 83' ' ' ASN . 53.5 mtpt 80.32 146.76 0.09 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.384 -1.28 . . . . 4.1699999999999999 110.161 -178.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.782 -0.627 . . . . 3.79 110.432 -168.764 . . . . . . . . 0 0 . 1 stop_ save_